Query psy10160
Match_columns 558
No_of_seqs 426 out of 3368
Neff 9.8
Searched_HMMs 46136
Date Fri Aug 16 19:23:23 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy10160.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/10160hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PRK12425 fumarate hydratase; P 100.0 7.7E-60 1.7E-64 478.8 18.8 315 241-557 129-460 (464)
2 PRK00485 fumC fumarate hydrata 100.0 1.4E-59 3E-64 480.0 19.5 316 240-557 130-462 (464)
3 COG0114 FumC Fumarase [Energy 100.0 1.3E-57 2.7E-62 425.6 23.7 297 261-558 157-462 (462)
4 PLN00134 fumarate hydratase; P 100.0 5.9E-58 1.3E-62 465.1 22.5 314 243-558 125-455 (458)
5 TIGR00979 fumC_II fumarate hyd 100.0 2.9E-58 6.3E-63 467.4 17.8 309 246-556 133-458 (458)
6 COG1027 AspA Aspartate ammonia 100.0 5.1E-56 1.1E-60 413.2 23.9 290 267-557 165-463 (471)
7 PRK13353 aspartate ammonia-lya 100.0 1.4E-56 3.1E-61 457.5 15.8 313 243-557 134-462 (473)
8 PRK12273 aspA aspartate ammoni 100.0 5.1E-56 1.1E-60 453.4 16.0 310 246-557 139-464 (472)
9 cd01362 Fumarase_classII Class 100.0 2.3E-55 5E-60 446.5 19.6 312 241-554 127-455 (455)
10 PRK14515 aspartate ammonia-lya 100.0 6.4E-55 1.4E-59 442.4 22.1 312 244-557 141-468 (479)
11 TIGR00839 aspA aspartate ammon 100.0 3.8E-55 8.3E-60 444.3 17.7 310 246-557 135-460 (468)
12 COG0015 PurB Adenylosuccinate 100.0 2E-55 4.3E-60 431.8 13.7 310 239-557 87-427 (438)
13 cd01357 Aspartase Aspartase. T 100.0 1.6E-54 3.4E-59 440.5 16.0 305 244-550 130-450 (450)
14 cd01596 Aspartase_like asparta 100.0 6.7E-53 1.4E-57 427.3 22.4 305 244-550 130-450 (450)
15 PRK09053 3-carboxy-cis,cis-muc 100.0 1E-53 2.2E-58 437.4 15.4 308 240-557 98-435 (452)
16 PRK08470 adenylosuccinate lyas 100.0 7.4E-53 1.6E-57 428.0 16.1 308 241-557 85-432 (442)
17 PRK07492 adenylosuccinate lyas 100.0 7.2E-53 1.6E-57 425.9 14.1 308 241-557 88-423 (435)
18 PRK07380 adenylosuccinate lyas 100.0 1.6E-52 3.4E-57 422.9 14.8 309 240-557 84-421 (431)
19 cd03302 Adenylsuccinate_lyase_ 100.0 6.7E-52 1.5E-56 420.8 16.3 309 240-557 86-436 (436)
20 cd01597 pCLME prokaryotic 3-ca 100.0 1.8E-51 3.9E-56 420.7 16.0 307 241-557 90-426 (437)
21 COG0165 ArgH Argininosuccinate 100.0 2.2E-51 4.8E-56 401.0 15.7 267 281-555 148-432 (459)
22 KOG1317|consensus 100.0 2.8E-50 6.2E-55 364.3 18.6 297 261-558 182-487 (487)
23 TIGR00928 purB adenylosuccinat 100.0 5.2E-51 1.1E-55 416.6 14.6 308 241-557 88-427 (435)
24 PRK08540 adenylosuccinate lyas 100.0 8.3E-51 1.8E-55 416.2 16.1 309 240-557 93-432 (449)
25 PRK06705 argininosuccinate lya 100.0 7.3E-51 1.6E-55 417.9 13.7 308 240-557 106-448 (502)
26 PRK06390 adenylosuccinate lyas 100.0 2.9E-50 6.3E-55 411.2 15.9 308 241-557 93-430 (451)
27 PLN02646 argininosuccinate lya 100.0 1.9E-50 4.1E-55 412.0 13.2 308 241-556 114-446 (474)
28 cd01359 Argininosuccinate_lyas 100.0 4.3E-50 9.3E-55 410.8 12.7 306 241-556 78-411 (435)
29 TIGR00838 argH argininosuccina 100.0 8.7E-50 1.9E-54 409.3 12.0 308 241-556 98-430 (455)
30 cd01595 Adenylsuccinate_lyase_ 100.0 2.1E-48 4.6E-53 391.0 13.0 274 240-522 79-375 (381)
31 PRK09285 adenylosuccinate lyas 100.0 2.3E-48 4.9E-53 394.2 10.5 304 240-557 113-447 (456)
32 cd01360 Adenylsuccinate_lyase_ 100.0 5.3E-48 1.2E-52 387.4 12.6 274 240-522 81-374 (387)
33 PRK00855 argininosuccinate lya 100.0 5.2E-48 1.1E-52 396.1 12.5 306 241-556 102-434 (459)
34 PRK04833 argininosuccinate lya 100.0 6.3E-48 1.4E-52 393.3 12.4 304 241-555 100-431 (455)
35 PRK12308 bifunctional arginino 100.0 3.3E-47 7.2E-52 405.0 12.3 308 241-557 100-439 (614)
36 cd01598 PurB PurB_like adenylo 100.0 1.5E-46 3.3E-51 376.2 14.0 304 241-557 92-425 (425)
37 KOG1316|consensus 100.0 1.2E-46 2.5E-51 343.6 9.9 267 279-554 149-433 (464)
38 PRK02186 argininosuccinate lya 100.0 5.6E-46 1.2E-50 412.3 12.2 290 241-537 507-818 (887)
39 PLN02848 adenylosuccinate lyas 100.0 2.2E-45 4.7E-50 371.4 12.7 304 241-557 117-450 (458)
40 PRK06389 argininosuccinate lya 100.0 7E-42 1.5E-46 339.3 16.9 239 281-532 141-391 (434)
41 PRK05975 3-carboxy-cis,cis-muc 100.0 1.2E-42 2.6E-47 342.2 9.6 235 241-488 99-347 (351)
42 TIGR02426 protocat_pcaB 3-carb 100.0 2.5E-42 5.5E-47 339.6 10.3 235 241-486 90-338 (338)
43 cd01334 Lyase_I Lyase class I 100.0 6.3E-42 1.4E-46 337.8 9.8 242 241-489 71-325 (325)
44 KOG2700|consensus 100.0 5.1E-35 1.1E-39 277.8 16.0 304 243-557 102-449 (481)
45 PF00206 Lyase_1: Lyase; Inte 100.0 1.6E-36 3.4E-41 297.4 -0.6 193 240-437 101-312 (312)
46 PRK08937 adenylosuccinate lyas 100.0 3.9E-32 8.5E-37 253.1 17.1 178 375-556 22-216 (216)
47 KOG3513|consensus 99.9 2E-25 4.4E-30 236.7 24.2 284 8-305 288-595 (1051)
48 KOG3513|consensus 99.9 3.2E-25 6.9E-30 235.3 23.7 286 6-304 184-496 (1051)
49 KOG4221|consensus 99.9 1.5E-22 3.2E-27 213.9 20.5 280 8-302 90-396 (1381)
50 cd01594 Lyase_I_like Lyase cla 99.8 4.3E-21 9.3E-26 181.8 11.6 175 243-469 36-220 (231)
51 KOG4222|consensus 99.8 2E-20 4.3E-25 196.9 15.0 284 9-303 182-490 (1281)
52 KOG4194|consensus 99.8 1E-19 2.2E-24 179.9 16.2 205 14-218 574-796 (873)
53 PHA02785 IL-beta-binding prote 99.8 2.4E-18 5.1E-23 170.1 22.7 193 14-209 82-318 (326)
54 KOG4221|consensus 99.8 3.6E-19 7.9E-24 188.5 16.1 217 2-220 181-418 (1381)
55 KOG4222|consensus 99.8 1.3E-18 2.8E-23 183.3 14.7 278 5-305 78-394 (1281)
56 cd05762 Ig8_MLCK Eighth immuno 99.7 5.7E-17 1.2E-21 130.4 12.6 94 130-224 1-97 (98)
57 KOG4194|consensus 99.7 1.6E-16 3.5E-21 157.5 14.4 203 63-280 518-752 (873)
58 PHA02826 IL-1 receptor-like pr 99.7 5E-16 1.1E-20 144.0 16.7 65 141-206 141-211 (227)
59 cd05851 Ig3_Contactin-1 Third 99.7 2.3E-16 4.9E-21 124.4 11.7 88 129-218 1-88 (88)
60 cd05745 Ig3_Peroxidasin Third 99.7 3.9E-16 8.4E-21 119.0 9.5 74 143-217 1-74 (74)
61 cd05852 Ig5_Contactin-1 Fifth 99.7 4.6E-16 9.9E-21 117.5 9.6 73 144-217 1-73 (73)
62 cd05735 Ig8_DSCAM Eight immuno 99.7 8.9E-16 1.9E-20 120.9 11.0 81 144-224 1-88 (88)
63 cd05892 Ig_Myotilin_C C-termin 99.6 1.1E-15 2.3E-20 115.9 9.7 71 147-217 1-75 (75)
64 cd05894 Ig_C5_MyBP-C C5 immuno 99.6 2.5E-15 5.3E-20 117.7 11.4 80 138-217 4-86 (86)
65 cd05893 Ig_Palladin_C C-termin 99.6 1.4E-15 3.1E-20 115.4 9.4 71 147-217 1-75 (75)
66 cd04975 Ig4_SCFR_like Fourth i 99.6 4.4E-15 9.5E-20 119.5 11.8 82 137-218 11-100 (101)
67 cd05730 Ig3_NCAM-1_like Third 99.6 4.9E-15 1.1E-19 119.1 12.0 90 129-218 1-93 (95)
68 cd04968 Ig3_Contactin_like Thi 99.6 5.7E-15 1.2E-19 116.8 12.0 87 129-217 1-87 (88)
69 cd05865 Ig1_NCAM-1 First immun 99.6 5.8E-15 1.3E-19 117.8 11.4 85 133-217 4-95 (96)
70 cd05747 Ig5_Titin_like M5, fif 99.6 7.7E-15 1.7E-19 117.0 11.8 87 128-215 2-91 (92)
71 cd05723 Ig4_Neogenin Fourth im 99.6 5.8E-15 1.3E-19 111.3 10.2 71 146-217 1-71 (71)
72 cd05728 Ig4_Contactin-2-like F 99.6 6.7E-15 1.4E-19 115.3 10.6 83 133-217 3-85 (85)
73 cd04969 Ig5_Contactin_like Fif 99.6 6.8E-15 1.5E-19 111.8 9.9 73 144-217 1-73 (73)
74 cd05737 Ig_Myomesin_like_C C-t 99.6 1.3E-14 2.8E-19 115.7 11.8 82 135-217 7-92 (92)
75 cd05867 Ig4_L1-CAM_like Fourth 99.6 1.1E-14 2.5E-19 111.4 10.9 73 144-217 1-75 (76)
76 cd05859 Ig4_PDGFR-alpha Fourth 99.6 2.2E-14 4.8E-19 115.6 11.9 81 138-218 12-100 (101)
77 cd05863 Ig2_VEGFR-3 Second imm 99.6 1.1E-14 2.4E-19 107.2 9.1 65 147-217 1-65 (67)
78 cd05744 Ig_Myotilin_C_like Imm 99.6 1.4E-14 3E-19 110.4 9.8 71 147-217 1-75 (75)
79 cd05868 Ig4_NrCAM Fourth immun 99.6 2.1E-14 4.5E-19 109.7 10.6 74 144-217 1-75 (76)
80 cd05869 Ig5_NCAM-1 Fifth immun 99.6 2.9E-14 6.2E-19 114.9 11.8 89 129-217 2-97 (97)
81 cd05746 Ig4_Peroxidasin Fourth 99.6 1.3E-14 2.9E-19 108.7 8.7 68 147-215 1-68 (69)
82 cd04972 Ig_TrkABC_d4 Fourth do 99.6 3E-14 6.5E-19 113.1 11.1 83 135-217 6-90 (90)
83 cd05853 Ig6_Contactin-4 Sixth 99.6 2.4E-14 5.3E-19 110.5 9.8 77 145-221 1-85 (85)
84 cd05876 Ig3_L1-CAM Third immun 99.6 2.1E-14 4.5E-19 108.3 9.2 71 147-218 1-71 (71)
85 cd05870 Ig5_NCAM-2 Fifth immun 99.6 3.6E-14 7.8E-19 114.5 11.2 88 129-217 2-98 (98)
86 PF07679 I-set: Immunoglobulin 99.6 4.9E-14 1.1E-18 112.1 11.9 87 130-217 1-90 (90)
87 cd04978 Ig4_L1-NrCAM_like Four 99.6 3.4E-14 7.4E-19 109.0 10.5 74 144-217 1-75 (76)
88 cd07693 Ig1_Robo First immunog 99.6 5E-14 1.1E-18 114.5 11.6 89 129-217 1-99 (100)
89 cd05724 Ig2_Robo Second immuno 99.6 4.6E-14 1E-18 111.2 11.1 83 135-217 2-86 (86)
90 cd05726 Ig4_Robo Fhird immunog 99.5 3.5E-14 7.7E-19 112.7 10.1 78 144-221 1-85 (90)
91 PHA02785 IL-beta-binding prote 99.5 1.4E-13 3E-18 136.3 16.6 190 64-276 42-264 (326)
92 cd05849 Ig1_Contactin-1 First 99.5 7.2E-14 1.6E-18 111.0 11.8 85 130-215 2-91 (93)
93 cd05848 Ig1_Contactin-5 First 99.5 9.1E-14 2E-18 110.9 11.8 84 130-214 2-91 (94)
94 cd05773 Ig8_hNephrin_like Eigh 99.5 7.7E-14 1.7E-18 114.6 11.6 94 128-221 3-108 (109)
95 cd05854 Ig6_Contactin-2 Sixth 99.5 6.7E-14 1.5E-18 109.3 10.4 77 145-221 1-85 (85)
96 cd05891 Ig_M-protein_C C-termi 99.5 9.4E-14 2E-18 110.4 11.4 81 136-217 8-92 (92)
97 cd05850 Ig1_Contactin-2 First 99.5 1.5E-13 3.2E-18 109.7 12.5 85 130-215 2-92 (94)
98 cd05857 Ig2_FGFR Second immuno 99.5 9E-14 2E-18 109.2 10.9 79 139-217 4-85 (85)
99 cd05866 Ig1_NCAM-2 First immun 99.5 1E-13 2.2E-18 109.4 11.1 84 132-217 3-91 (92)
100 cd04970 Ig6_Contactin_like Six 99.5 7.4E-14 1.6E-18 109.5 10.1 77 145-221 1-85 (85)
101 cd05760 Ig2_PTK7 Second immuno 99.5 1E-13 2.2E-18 106.3 10.1 72 147-218 1-75 (77)
102 cd05764 Ig_2 Subgroup of the i 99.5 8.6E-14 1.9E-18 106.1 9.7 73 144-217 1-74 (74)
103 cd05732 Ig5_NCAM-1_like Fifth 99.5 1.3E-13 2.8E-18 111.1 11.2 88 129-217 2-96 (96)
104 cd05725 Ig3_Robo Third immunog 99.5 6.1E-14 1.3E-18 105.2 8.4 69 147-217 1-69 (69)
105 cd05748 Ig_Titin_like Immunogl 99.5 1.4E-13 3E-18 104.9 10.5 71 146-217 1-74 (74)
106 cd04976 Ig2_VEGFR Second immun 99.5 1E-13 2.2E-18 104.4 9.4 69 147-217 1-69 (71)
107 cd05864 Ig2_VEGFR-2 Second imm 99.5 7.8E-14 1.7E-18 104.0 8.7 68 147-217 1-68 (70)
108 cd05738 Ig2_RPTP_IIa_LAR_like 99.5 1.1E-13 2.4E-18 105.2 9.5 71 147-217 1-73 (74)
109 cd05722 Ig1_Neogenin First imm 99.5 2.5E-13 5.4E-18 109.0 10.9 86 132-217 2-95 (95)
110 cd05856 Ig2_FGFRL1-like Second 99.5 1.3E-13 2.8E-18 107.5 9.0 78 140-217 5-82 (82)
111 cd05740 Ig_CEACAM_D4 Fourth im 99.5 3E-13 6.5E-18 107.0 11.1 79 136-217 10-90 (91)
112 cd05731 Ig3_L1-CAM_like Third 99.5 1.6E-13 3.5E-18 103.7 9.1 70 147-217 1-70 (71)
113 cd04973 Ig1_FGFR First immunog 99.5 2.4E-13 5.2E-18 104.8 10.0 79 136-217 1-79 (79)
114 cd05739 Ig3_RPTP_IIa_LAR_like 99.5 3.3E-13 7.1E-18 100.7 10.1 68 144-215 1-68 (69)
115 cd05763 Ig_1 Subgroup of the i 99.5 2.7E-13 5.8E-18 103.6 9.2 71 147-217 1-74 (75)
116 cd05743 Ig_Perlecan_D2_like Im 99.5 2.9E-13 6.3E-18 104.1 9.4 72 144-216 1-75 (78)
117 cd05758 Ig5_KIRREL3-like Fifth 99.5 5.6E-13 1.2E-17 107.6 11.4 86 129-215 2-97 (98)
118 cd05855 Ig_TrkB_d5 Fifth domai 99.5 2.6E-13 5.7E-18 103.2 8.8 67 149-216 3-77 (79)
119 cd04974 Ig3_FGFR Third immunog 99.4 4.2E-13 9.1E-18 106.3 9.2 74 144-217 1-89 (90)
120 cd05749 Ig2_Tyro3_like Second 99.4 7E-13 1.5E-17 101.9 9.9 76 133-214 2-79 (81)
121 cd04971 Ig_TrKABC_d5 Fifth dom 99.4 7E-13 1.5E-17 102.2 9.5 68 149-216 3-79 (81)
122 cd07702 Ig2_VEGFR-1 Second imm 99.4 7.5E-13 1.6E-17 98.9 9.0 68 147-215 1-68 (72)
123 cd05858 Ig3_FGFR-2 Third immun 99.4 8.4E-13 1.8E-17 104.7 9.2 74 144-217 1-89 (90)
124 cd04977 Ig1_NCAM-1_like First 99.4 2.1E-12 4.6E-17 102.6 11.3 85 132-217 3-92 (92)
125 cd05734 Ig7_DSCAM Seventh immu 99.4 9E-13 1.9E-17 101.8 8.5 71 147-217 1-79 (79)
126 cd05765 Ig_3 Subgroup of the i 99.4 1.3E-12 2.9E-17 101.5 9.4 74 144-217 1-81 (81)
127 cd05756 Ig1_IL1R_like First im 99.4 1.2E-12 2.7E-17 104.0 8.9 80 137-217 7-94 (94)
128 cd05736 Ig2_Follistatin_like S 99.4 2.5E-12 5.5E-17 98.5 9.8 72 147-218 1-74 (76)
129 cd04967 Ig1_Contactin First Ig 99.4 6.6E-12 1.4E-16 99.8 11.0 81 130-211 2-87 (91)
130 cd05875 Ig6_hNeurofascin_like 99.4 5.5E-12 1.2E-16 96.5 9.8 64 147-210 1-70 (77)
131 cd05873 Ig_Sema4D_like Immunog 99.4 9.1E-12 2E-16 96.6 10.6 70 135-206 2-71 (87)
132 cd05874 Ig6_NrCAM Sixth immuno 99.3 7E-12 1.5E-16 95.8 9.4 69 147-215 1-76 (77)
133 cd05752 Ig1_FcgammaR_like Frst 99.3 4.4E-12 9.4E-17 96.9 8.1 75 131-216 2-77 (78)
134 cd05733 Ig6_L1-CAM_like Sixth 99.3 5.8E-12 1.3E-16 96.5 8.7 64 147-210 1-70 (77)
135 cd05898 Ig5_KIRREL3 Fifth immu 99.3 1.6E-11 3.5E-16 97.4 10.8 86 129-215 2-97 (98)
136 cd05754 Ig3_Perlecan_like Thir 99.3 1.4E-11 3.1E-16 96.5 9.7 77 135-215 7-84 (85)
137 cd05750 Ig_Pro_neuregulin Immu 99.3 7.2E-12 1.6E-16 95.7 7.8 68 147-214 1-74 (75)
138 cd05771 IgC_Tapasin_R Tapasin- 99.3 9E-11 2E-15 101.4 14.2 114 14-206 1-131 (139)
139 cd04979 Ig_Semaphorin_C Immuno 99.3 3.7E-11 8.1E-16 95.0 10.2 81 136-218 3-87 (89)
140 cd05757 Ig2_IL1R_like Second i 99.3 3.6E-11 7.7E-16 95.0 9.9 78 138-217 4-86 (92)
141 cd05742 Ig1_VEGFR_like First i 99.3 2.2E-11 4.7E-16 95.2 8.4 74 144-217 1-83 (84)
142 cd05729 Ig2_FGFR_like Second i 99.3 6.6E-11 1.4E-15 92.8 11.2 79 139-217 4-85 (85)
143 cd05882 Ig1_Necl-1 First (N-te 99.2 5.4E-11 1.2E-15 94.6 9.7 80 136-216 4-94 (95)
144 cd05727 Ig2_Contactin-2-like S 99.2 2.8E-11 6E-16 95.2 7.5 74 136-209 10-86 (96)
145 cd05861 Ig1_PDGFR-alphabeta Fr 99.2 7.9E-11 1.7E-15 91.7 9.4 75 144-218 1-83 (84)
146 cd05845 Ig2_L1-CAM_like Second 99.2 2.7E-11 5.9E-16 95.1 6.8 75 135-209 9-85 (95)
147 cd05895 Ig_Pro_neuregulin-1 Im 99.2 8.3E-11 1.8E-15 90.0 8.7 68 147-214 1-75 (76)
148 cd05753 Ig2_FcgammaR_like Seco 99.2 8.3E-11 1.8E-15 91.3 8.5 76 135-216 5-82 (83)
149 PHA02826 IL-1 receptor-like pr 99.2 5.8E-11 1.3E-15 110.3 8.3 151 137-305 30-206 (227)
150 cd07701 Ig1_Necl-3 First (N-te 99.2 2.3E-10 4.9E-15 91.3 9.7 80 136-217 4-95 (95)
151 PF10415 FumaraseC_C: Fumarase 99.1 2.7E-11 5.8E-16 84.0 2.9 55 503-557 1-55 (55)
152 smart00408 IGc2 Immunoglobulin 99.1 4.6E-10 9.9E-15 82.0 8.6 63 143-207 1-63 (63)
153 cd05897 Ig2_IL1R2_like Second 99.1 6.7E-10 1.5E-14 87.5 8.8 79 139-217 5-93 (95)
154 PF13895 Ig_2: Immunoglobulin 99.0 2.1E-09 4.7E-14 82.9 9.5 71 139-217 9-80 (80)
155 cd05871 Ig_Semaphorin_classIII 99.0 2.9E-09 6.2E-14 84.1 9.8 78 139-218 6-89 (91)
156 cd05862 Ig1_VEGFR First immuno 99.0 2.3E-09 4.9E-14 83.8 8.6 75 144-218 1-85 (86)
157 cd05717 Ig1_Necl-1-3_like Firs 99.0 3.4E-09 7.4E-14 84.9 9.8 81 136-217 4-95 (95)
158 smart00409 IG Immunoglobulin. 98.9 1.5E-08 3.3E-13 78.8 11.8 80 137-217 2-85 (86)
159 smart00410 IG_like Immunoglobu 98.9 1.5E-08 3.3E-13 78.8 11.8 80 137-217 2-85 (86)
160 cd05860 Ig4_SCFR Fourth immuno 98.9 1.1E-08 2.3E-13 80.6 10.3 81 138-218 12-100 (101)
161 cd07690 Ig1_CD4 First immunogl 98.9 7.2E-09 1.6E-13 81.8 8.4 71 140-210 3-92 (94)
162 PF00047 ig: Immunoglobulin do 98.9 4.7E-09 1E-13 77.2 5.7 59 144-202 1-64 (64)
163 cd05885 Ig2_Necl-4 Second immu 98.8 1.4E-08 2.9E-13 77.1 7.6 69 146-216 1-79 (80)
164 cd05774 Ig_CEACAM_D1 First imm 98.8 2.5E-08 5.5E-13 80.5 9.3 84 134-217 3-105 (105)
165 cd05759 Ig2_KIRREL3-like Secon 98.8 3.4E-08 7.3E-13 76.6 8.8 72 146-217 1-82 (82)
166 PF13927 Ig_3: Immunoglobulin 98.8 1.2E-08 2.6E-13 77.5 5.9 73 130-204 2-75 (75)
167 cd05872 Ig_Sema4B_like Immunog 98.8 5.1E-08 1.1E-12 75.1 9.1 77 137-217 4-82 (85)
168 cd05896 Ig1_IL1RAPL-1_like Fir 98.7 8.8E-08 1.9E-12 75.7 8.6 79 138-217 9-104 (104)
169 cd05881 Ig1_Necl-2 First (N-te 98.7 2.9E-07 6.3E-12 72.7 10.5 68 137-204 5-83 (95)
170 cd05751 Ig1_LILRB1_like First 98.6 8.9E-08 1.9E-12 75.8 7.2 73 130-205 3-75 (91)
171 cd05877 Ig_LP_like Immunoglobu 98.6 3.2E-07 7E-12 75.0 10.4 77 143-219 1-104 (106)
172 cd05741 Ig_CEACAM_D1_like Firs 98.6 1.6E-07 3.6E-12 74.6 8.0 74 144-217 1-92 (92)
173 cd05714 Ig_CSPGs_LP Immunoglob 98.6 5.9E-07 1.3E-11 73.5 10.4 77 143-219 1-104 (106)
174 cd05900 Ig_Aggrecan Immunoglob 98.5 6.6E-07 1.4E-11 73.2 9.7 77 143-219 1-110 (112)
175 cd04983 IgV_TCR_alpha_like Imm 98.5 3.9E-07 8.5E-12 75.0 8.1 73 135-207 4-94 (109)
176 cd05879 Ig_P0 Immunoglobulin ( 98.5 1.5E-06 3.3E-11 71.6 10.6 81 136-216 5-115 (116)
177 cd05713 Ig_MOG_like Immunoglob 98.5 1.2E-06 2.7E-11 70.7 9.7 74 144-217 1-99 (100)
178 cd05899 IgV_TCR_beta Immunoglo 98.4 1.2E-06 2.7E-11 72.1 8.0 72 134-206 3-95 (110)
179 cd05775 Ig_SLAM-CD84_like_N N- 98.4 1.4E-06 3.1E-11 69.7 7.8 76 142-217 2-96 (97)
180 cd05853 Ig6_Contactin-4 Sixth 98.4 7.1E-07 1.5E-11 69.0 5.5 40 12-51 45-85 (85)
181 cd05718 Ig1_PVR_like First imm 98.4 2.9E-06 6.3E-11 68.2 9.4 73 145-217 1-97 (98)
182 cd05878 Ig_Aggrecan_like Immun 98.4 4.8E-06 1E-10 68.3 10.7 77 143-219 1-108 (110)
183 PHA03376 BARF1; Provisional 98.4 3.5E-06 7.5E-11 72.8 9.8 122 138-274 20-163 (221)
184 cd04980 IgV_L_kappa Immunoglob 98.3 2.4E-06 5.2E-11 69.8 8.5 73 133-205 4-93 (106)
185 cd00099 IgV Immunoglobulin var 98.3 2.6E-06 5.6E-11 69.5 7.1 68 140-207 2-91 (105)
186 cd05902 Ig_Neurocan Immunoglob 98.3 5.8E-06 1.3E-10 67.4 8.9 77 143-219 1-108 (110)
187 cd05883 Ig2_Necl-2 Second immu 98.3 8.9E-06 1.9E-10 62.0 9.3 72 147-218 2-80 (82)
188 cd05755 Ig2_ICAM-1_like Second 98.3 4.5E-06 9.9E-11 66.3 8.0 77 130-209 2-88 (100)
189 cd05901 Ig_Versican Immunoglob 98.3 1.2E-05 2.6E-10 65.7 10.6 76 144-219 2-115 (117)
190 cd05715 Ig_P0-like Immunoglobu 98.2 8.1E-06 1.7E-10 67.9 9.6 73 136-208 5-105 (116)
191 cd05880 Ig_EVA1 Immunoglobulin 98.2 6.4E-06 1.4E-10 68.2 8.9 73 136-208 5-104 (115)
192 PF10397 ADSL_C: Adenylosuccin 98.2 1.2E-06 2.5E-11 67.3 3.6 58 498-557 6-72 (81)
193 cd05852 Ig5_Contactin-1 Fifth 98.2 2.9E-06 6.4E-11 63.8 5.7 41 6-46 30-72 (73)
194 cd05888 Ig1_Nectin-4_like Frst 98.2 1.3E-05 2.9E-10 64.5 9.5 72 146-217 2-99 (100)
195 cd05761 Ig2_Necl-1-4_like Seco 98.2 1.1E-05 2.3E-10 62.4 8.5 62 147-209 2-71 (82)
196 cd05771 IgC_Tapasin_R Tapasin- 98.2 3E-06 6.5E-11 73.0 5.7 77 184-275 2-80 (139)
197 cd04982 IgV_TCR_gamma Immunogl 98.2 5.2E-06 1.1E-10 69.1 6.8 70 135-204 4-98 (116)
198 cd05854 Ig6_Contactin-2 Sixth 98.2 3.5E-06 7.5E-11 65.6 5.4 40 12-51 45-85 (85)
199 cd07694 Ig2_CD4 Second immunog 98.2 1.9E-05 4.1E-10 60.0 9.0 76 138-217 8-85 (88)
200 PF07686 V-set: Immunoglobulin 98.2 1E-05 2.2E-10 66.8 8.5 84 134-217 6-114 (114)
201 cd05892 Ig_Myotilin_C C-termin 98.1 4E-06 8.6E-11 63.4 5.3 41 6-46 28-74 (75)
202 cd05886 Ig1_Nectin-1_like Firs 98.1 3E-05 6.5E-10 62.0 10.6 72 146-217 2-98 (99)
203 KOG3515|consensus 98.1 8.8E-06 1.9E-10 86.1 9.5 203 12-217 161-395 (741)
204 cd07705 Ig2_Necl-1 Second immu 98.1 2.3E-05 5.1E-10 60.5 9.3 63 147-209 2-72 (83)
205 cd05735 Ig8_DSCAM Eight immuno 98.1 6.8E-06 1.5E-10 64.5 6.4 39 14-52 47-86 (88)
206 cd04976 Ig2_VEGFR Second immun 98.1 5.8E-06 1.3E-10 61.9 5.7 42 7-48 28-70 (71)
207 cd04970 Ig6_Contactin_like Six 98.1 4.3E-06 9.4E-11 65.2 5.1 40 12-51 45-85 (85)
208 cd00098 IgC Immunoglobulin Con 98.1 1E-05 2.2E-10 64.6 7.3 67 142-208 11-87 (95)
209 cd05893 Ig_Palladin_C C-termin 98.1 4.9E-06 1.1E-10 63.0 5.0 41 6-46 28-74 (75)
210 cd04984 IgV_L_lambda Immunoglo 98.1 1.3E-05 2.8E-10 64.4 7.4 66 140-205 2-85 (98)
211 cd05864 Ig2_VEGFR-2 Second imm 98.1 8.8E-06 1.9E-10 60.6 5.8 37 12-48 32-69 (70)
212 cd05863 Ig2_VEGFR-3 Second imm 98.1 7.7E-06 1.7E-10 60.1 5.3 37 12-48 29-66 (67)
213 cd05876 Ig3_L1-CAM Third immun 98.1 8E-06 1.7E-10 61.2 5.5 38 10-47 32-70 (71)
214 cd05887 Ig1_Nectin-3_like Firs 98.1 4.6E-05 9.9E-10 60.3 10.1 73 145-217 1-95 (96)
215 cd05867 Ig4_L1-CAM_like Fourth 98.1 1.1E-05 2.4E-10 61.4 6.3 40 8-47 35-75 (76)
216 cd05740 Ig_CEACAM_D4 Fourth im 98.0 1.4E-05 3.1E-10 63.0 6.8 43 7-49 46-90 (91)
217 cd05866 Ig1_NCAM-2 First immun 98.0 1.2E-05 2.5E-10 63.5 6.2 43 7-49 45-91 (92)
218 cd05745 Ig3_Peroxidasin Third 98.0 1E-05 2.3E-10 61.1 5.3 36 11-46 37-73 (74)
219 cd05762 Ig8_MLCK Eighth immuno 98.0 1.7E-05 3.7E-10 63.6 6.8 40 13-52 55-95 (98)
220 KOG3515|consensus 98.0 3.5E-05 7.7E-10 81.7 10.7 209 60-279 18-251 (741)
221 cd05725 Ig3_Robo Third immunog 98.0 1.5E-05 3.3E-10 59.3 5.9 35 7-41 27-62 (69)
222 cd07702 Ig2_VEGFR-1 Second imm 98.0 1.3E-05 2.9E-10 59.8 5.5 42 7-48 29-71 (72)
223 cd05851 Ig3_Contactin-1 Third 98.0 1.5E-05 3.2E-10 62.6 5.8 40 8-47 47-87 (88)
224 cd05738 Ig2_RPTP_IIa_LAR_like 98.0 2E-05 4.4E-10 59.5 6.3 43 6-48 29-72 (74)
225 cd05711 Ig_FcalphaRI Immunoglo 98.0 2.2E-05 4.8E-10 62.4 6.7 65 138-203 9-75 (94)
226 cd05846 Ig1_MRC-OX-2_like Firs 98.0 6.5E-05 1.4E-09 60.2 9.5 74 144-217 1-96 (97)
227 cd05744 Ig_Myotilin_C_like Imm 97.9 2E-05 4.4E-10 59.7 5.6 31 15-45 42-73 (75)
228 cd05734 Ig7_DSCAM Seventh immu 97.9 2.5E-05 5.3E-10 59.9 6.1 42 6-47 35-77 (79)
229 cd05731 Ig3_L1-CAM_like Third 97.9 1.7E-05 3.7E-10 59.4 5.1 37 11-47 33-70 (71)
230 cd05884 Ig2_Necl-3 Second immu 97.9 5.5E-05 1.2E-09 58.4 7.9 62 147-208 2-71 (83)
231 cd07706 IgV_TCR_delta Immunogl 97.9 4.3E-05 9.3E-10 63.5 7.9 72 134-205 4-94 (116)
232 PHA02987 Ig domain OX-2-like p 97.9 0.00013 2.7E-09 63.8 10.6 84 138-221 24-125 (189)
233 cd04973 Ig1_FGFR First immunog 97.9 2.1E-05 4.6E-10 60.3 5.3 34 7-40 38-71 (79)
234 cd05760 Ig2_PTK7 Second immuno 97.9 2.7E-05 5.9E-10 59.3 5.9 39 12-50 36-75 (77)
235 cd05726 Ig4_Robo Fhird immunog 97.9 3.7E-05 7.9E-10 60.7 6.8 44 6-49 38-83 (90)
236 cd05763 Ig_1 Subgroup of the i 97.9 3.8E-05 8.3E-10 58.2 6.6 41 7-47 31-74 (75)
237 cd05716 Ig_pIgR Immunoglobulin 97.9 4.7E-05 1E-09 61.1 7.5 68 139-206 2-87 (98)
238 cd04969 Ig5_Contactin_like Fif 97.9 2.6E-05 5.7E-10 58.7 5.6 40 7-46 31-72 (73)
239 cd04974 Ig3_FGFR Third immunog 97.9 1.5E-05 3.2E-10 62.9 4.3 35 13-47 54-89 (90)
240 cd05746 Ig4_Peroxidasin Fourth 97.9 2.9E-05 6.3E-10 57.7 5.6 35 7-41 28-63 (69)
241 cd05756 Ig1_IL1R_like First im 97.9 2.4E-05 5.2E-10 62.1 5.4 40 7-46 53-93 (94)
242 cd05849 Ig1_Contactin-1 First 97.9 4.8E-05 1E-09 60.3 6.8 42 6-47 49-91 (93)
243 cd05865 Ig1_NCAM-1 First immun 97.8 3E-05 6.4E-10 61.8 5.5 36 14-49 60-95 (96)
244 cd04968 Ig3_Contactin_like Thi 97.8 4.7E-05 1E-09 59.8 6.5 39 9-47 48-87 (88)
245 cd05723 Ig4_Neogenin Fourth im 97.8 3.8E-05 8.2E-10 57.5 5.6 40 7-46 29-70 (71)
246 cd04975 Ig4_SCFR_like Fourth i 97.8 3.6E-05 7.7E-10 61.9 5.4 36 13-48 64-100 (101)
247 cd05868 Ig4_NrCAM Fourth immun 97.8 5.2E-05 1.1E-09 57.6 6.1 38 10-47 37-75 (76)
248 cd07700 IgV_CD8_beta Immunoglo 97.8 6.8E-05 1.5E-09 61.3 7.2 65 140-204 2-93 (107)
249 cd04978 Ig4_L1-NrCAM_like Four 97.8 4.6E-05 1E-09 57.9 5.7 39 9-47 36-75 (76)
250 cd00096 Ig Immunoglobulin doma 97.8 8.6E-05 1.9E-09 54.6 7.0 60 147-206 1-66 (74)
251 cd05894 Ig_C5_MyBP-C C5 immuno 97.8 6.4E-05 1.4E-09 58.6 6.1 39 7-45 41-84 (86)
252 cd05748 Ig_Titin_like Immunogl 97.8 4.3E-05 9.3E-10 57.7 5.0 29 13-41 39-67 (74)
253 cd05728 Ig4_Contactin-2-like F 97.8 4.3E-05 9.4E-10 59.5 5.1 39 7-45 44-83 (85)
254 cd04977 Ig1_NCAM-1_like First 97.8 3.8E-05 8.3E-10 60.8 4.7 35 14-48 57-91 (92)
255 cd05850 Ig1_Contactin-2 First 97.8 0.0001 2.3E-09 58.5 7.2 42 6-47 50-92 (94)
256 cd05765 Ig_3 Subgroup of the i 97.7 5.6E-05 1.2E-09 58.2 5.3 35 12-46 45-80 (81)
257 cd05724 Ig2_Robo Second immuno 97.7 8E-05 1.7E-09 58.1 6.2 41 7-47 43-84 (86)
258 cd05764 Ig_2 Subgroup of the i 97.7 4.9E-05 1.1E-09 57.4 4.8 30 11-40 37-66 (74)
259 cd05870 Ig5_NCAM-2 Fifth immun 97.7 5.4E-05 1.2E-09 60.8 5.3 39 7-45 53-96 (98)
260 PF08328 ASL_C: Adenylosuccina 97.7 0.00011 2.5E-09 58.2 6.5 100 450-555 2-115 (115)
261 cd05859 Ig4_PDGFR-alpha Fourth 97.7 4.9E-05 1.1E-09 61.2 4.6 36 13-48 64-100 (101)
262 cd04971 Ig_TrKABC_d5 Fifth dom 97.7 7.1E-05 1.5E-09 57.5 5.2 29 13-41 45-73 (81)
263 cd05848 Ig1_Contactin-5 First 97.7 0.0001 2.3E-09 58.5 6.3 41 7-47 51-92 (94)
264 cd05889 Ig1_DNAM-1_like First 97.7 0.00045 9.7E-09 54.8 9.7 71 145-215 1-93 (96)
265 cd05858 Ig3_FGFR-2 Third immun 97.7 4.4E-05 9.5E-10 60.2 4.0 34 14-47 55-89 (90)
266 cd05720 Ig_CD8_alpha Immunoglo 97.7 0.00012 2.7E-09 59.3 6.4 65 140-204 2-90 (104)
267 cd05730 Ig3_NCAM-1_like Third 97.7 0.00012 2.7E-09 58.3 6.3 37 12-48 56-93 (95)
268 cd05757 Ig2_IL1R_like Second i 97.6 0.00016 3.6E-09 57.0 6.8 29 12-40 50-78 (92)
269 cd05736 Ig2_Follistatin_like S 97.6 0.00019 4.1E-09 54.5 7.0 36 13-48 38-74 (76)
270 cd05855 Ig_TrkB_d5 Fifth domai 97.6 8.1E-05 1.8E-09 56.6 4.7 28 13-40 43-70 (79)
271 cd07698 IgC_MHC_I_alpha3 Class 97.6 0.00033 7.1E-09 55.5 8.3 75 129-206 2-83 (93)
272 cd05774 Ig_CEACAM_D1 First imm 97.6 0.00018 3.9E-09 58.1 6.9 45 4-48 59-104 (105)
273 PF14698 ASL_C2: Argininosucci 97.6 1.5E-05 3.2E-10 58.8 0.4 55 501-556 1-69 (70)
274 PF08205 C2-set_2: CD80-like C 97.6 0.00042 9E-09 54.4 8.7 66 144-209 14-87 (89)
275 cd05742 Ig1_VEGFR_like First i 97.6 9.3E-05 2E-09 57.5 4.9 35 13-47 48-83 (84)
276 cd05773 Ig8_hNephrin_like Eigh 97.6 0.00017 3.7E-09 59.0 6.4 39 13-51 68-108 (109)
277 cd05857 Ig2_FGFR Second immuno 97.6 0.00013 2.8E-09 56.7 5.4 35 12-46 49-84 (85)
278 cd05733 Ig6_L1-CAM_like Sixth 97.6 0.00019 4.2E-09 54.6 6.0 41 7-47 30-76 (77)
279 cd05882 Ig1_Necl-1 First (N-te 97.6 0.00014 3E-09 57.8 5.3 42 6-47 49-95 (95)
280 cd05874 Ig6_NrCAM Sixth immuno 97.6 0.00027 5.9E-09 53.7 6.7 36 12-47 37-76 (77)
281 cd05869 Ig5_NCAM-1 Fifth immun 97.5 0.00012 2.5E-09 58.7 4.8 33 14-46 63-96 (97)
282 cd05732 Ig5_NCAM-1_like Fifth 97.5 0.00018 3.9E-09 57.4 5.9 28 14-41 62-89 (96)
283 cd05737 Ig_Myomesin_like_C C-t 97.5 0.00011 2.5E-09 58.1 4.3 28 14-41 58-85 (92)
284 cd05861 Ig1_PDGFR-alphabeta Fr 97.5 0.00022 4.9E-09 55.3 5.7 37 13-49 45-82 (84)
285 cd05875 Ig6_hNeurofascin_like 97.5 0.00037 7.9E-09 53.0 6.8 42 6-47 29-76 (77)
286 cd04979 Ig_Semaphorin_C Immuno 97.5 0.00023 5E-09 55.9 5.8 43 7-49 44-86 (89)
287 cd05856 Ig2_FGFRL1-like Second 97.5 0.00015 3.3E-09 55.8 4.7 34 13-47 47-80 (82)
288 cd04981 IgV_H Immunoglobulin ( 97.5 0.00047 1E-08 57.2 7.9 70 135-204 3-97 (117)
289 cd05871 Ig_Semaphorin_classIII 97.5 0.00031 6.7E-09 55.3 6.3 42 6-47 45-88 (91)
290 cd05712 Ig_Siglec_N Immunoglob 97.5 0.00064 1.4E-08 56.7 8.4 70 136-205 6-102 (119)
291 cd05741 Ig_CEACAM_D1_like Firs 97.5 0.00036 7.8E-09 55.1 6.6 44 5-48 47-91 (92)
292 cd05897 Ig2_IL1R2_like Second 97.5 0.00038 8.2E-09 55.0 6.5 29 12-40 53-81 (95)
293 cd05775 Ig_SLAM-CD84_like_N N- 97.5 0.00032 7E-09 56.0 6.2 43 7-49 52-96 (97)
294 cd04967 Ig1_Contactin First Ig 97.5 0.00026 5.7E-09 55.9 5.6 38 6-43 50-88 (91)
295 cd05743 Ig_Perlecan_D2_like Im 97.5 0.00015 3.2E-09 55.4 4.0 28 14-41 42-69 (78)
296 smart00407 IGc1 Immunoglobulin 97.4 0.00076 1.6E-08 51.0 7.7 61 146-206 1-71 (75)
297 cd05750 Ig_Pro_neuregulin Immu 97.4 0.0002 4.4E-09 54.1 4.5 29 13-41 42-70 (75)
298 cd05717 Ig1_Necl-1-3_like Firs 97.4 0.00032 6.9E-09 55.9 5.8 42 6-47 49-95 (95)
299 cd07701 Ig1_Necl-3 First (N-te 97.4 0.00032 6.9E-09 55.8 5.7 42 6-47 49-95 (95)
300 PHA03376 BARF1; Provisional 97.4 0.00046 9.9E-09 60.0 6.9 80 12-91 85-167 (221)
301 cd05862 Ig1_VEGFR First immuno 97.4 0.00024 5.2E-09 55.3 4.8 36 13-48 49-85 (86)
302 cd05895 Ig_Pro_neuregulin-1 Im 97.4 0.00022 4.8E-09 54.1 4.4 28 13-40 43-70 (76)
303 cd05886 Ig1_Nectin-1_like Firs 97.4 0.00066 1.4E-08 54.3 7.2 42 6-48 50-97 (99)
304 cd05873 Ig_Sema4D_like Immunog 97.4 0.00037 7.9E-09 54.1 5.5 31 7-37 41-71 (87)
305 cd05891 Ig_M-protein_C C-termi 97.4 0.00023 5E-09 56.3 4.5 27 15-41 59-85 (92)
306 cd05896 Ig1_IL1RAPL-1_like Fir 97.4 0.00028 6.2E-09 56.0 4.7 34 7-40 63-96 (104)
307 cd05727 Ig2_Contactin-2-like S 97.4 0.00019 4E-09 56.7 3.6 35 6-40 51-86 (96)
308 cd04972 Ig_TrkABC_d4 Fourth do 97.3 0.00029 6.2E-09 55.5 4.4 34 13-46 55-89 (90)
309 cd05747 Ig5_Titin_like M5, fif 97.3 0.00034 7.3E-09 55.4 4.8 28 13-40 58-85 (92)
310 cd05753 Ig2_FcgammaR_like Seco 97.3 0.00024 5.2E-09 54.9 3.6 37 12-48 46-82 (83)
311 PF07679 I-set: Immunoglobulin 97.3 0.00028 6E-09 55.5 4.0 35 12-46 54-89 (90)
312 cd05772 IgC_SIRP Signal-regula 97.3 0.0031 6.8E-08 51.5 10.1 68 138-206 15-92 (111)
313 cd05722 Ig1_Neogenin First imm 97.3 0.00072 1.6E-08 53.8 6.1 38 11-48 51-94 (95)
314 cd05719 Ig2_PVR_like Second im 97.2 0.0015 3.3E-08 51.7 7.7 72 144-217 15-95 (95)
315 cd05739 Ig3_RPTP_IIa_LAR_like 97.2 0.00071 1.5E-08 50.1 5.5 32 8-41 32-63 (69)
316 cd05713 Ig_MOG_like Immunoglob 97.2 0.00078 1.7E-08 54.2 6.1 35 14-49 65-99 (100)
317 cd07692 Ig_CD3_epsilon Immunog 97.2 0.00078 1.7E-08 48.1 5.2 52 142-205 5-56 (65)
318 cd07699 IgC_L Immunoglobulin C 97.2 0.00082 1.8E-08 54.0 6.0 66 141-206 14-89 (100)
319 PHA02633 hypothetical protein; 97.2 0.00095 2.1E-08 46.7 5.3 38 12-49 16-54 (63)
320 cd05754 Ig3_Perlecan_like Thir 97.1 0.00065 1.4E-08 52.8 4.6 31 11-41 49-79 (85)
321 cd05770 IgC_beta2m Class I maj 97.1 0.0029 6.2E-08 49.8 8.2 63 142-205 13-82 (93)
322 smart00406 IGv Immunoglobulin 97.1 0.00097 2.1E-08 51.0 5.5 56 146-201 1-80 (81)
323 cd05887 Ig1_Nectin-3_like Firs 97.1 0.0017 3.6E-08 51.4 6.8 42 6-47 47-95 (96)
324 cd05888 Ig1_Nectin-4_like Frst 97.1 0.0016 3.5E-08 52.3 6.7 35 13-48 63-98 (100)
325 cd05767 IgC_MHC_II_alpha Class 97.1 0.0035 7.7E-08 49.5 8.3 61 142-205 13-83 (94)
326 cd05877 Ig_LP_like Immunoglobu 97.1 0.0015 3.3E-08 53.1 6.3 43 6-48 55-103 (106)
327 PHA02914 Immunoglobulin-like d 97.1 0.11 2.4E-06 50.6 19.5 82 136-217 271-380 (500)
328 cd05900 Ig_Aggrecan Immunoglob 97.0 0.0016 3.6E-08 53.3 6.1 36 12-47 72-108 (112)
329 cd05718 Ig1_PVR_like First imm 97.0 0.0026 5.7E-08 50.8 7.0 36 12-48 60-96 (98)
330 cd05878 Ig_Aggrecan_like Immun 97.0 0.002 4.4E-08 52.8 6.2 43 5-47 56-106 (110)
331 cd07691 Ig_CD3_gamma_delta Imm 97.0 0.0032 6.9E-08 45.3 6.3 50 143-204 5-54 (69)
332 cd07693 Ig1_Robo First immunog 97.0 0.0016 3.4E-08 52.2 5.5 29 21-49 71-99 (100)
333 cd05766 IgC_MHC_II_beta Class 97.0 0.0093 2E-07 47.2 9.8 66 142-207 12-84 (94)
334 cd05714 Ig_CSPGs_LP Immunoglob 97.0 0.0014 3.1E-08 53.3 5.3 37 12-48 66-103 (106)
335 cd05879 Ig_P0 Immunoglobulin ( 96.9 0.0019 4.1E-08 53.3 5.8 34 5-38 65-104 (116)
336 cd05881 Ig1_Necl-2 First (N-te 96.9 0.0023 5.1E-08 50.5 5.7 42 3-44 46-92 (95)
337 cd05768 IgC_CH4 CH4 domain (fo 96.9 0.0028 6E-08 51.1 6.3 65 141-205 13-90 (102)
338 cd07703 Ig2_Nectin-2_like Seco 96.9 0.0049 1.1E-07 48.7 7.3 64 145-210 16-86 (95)
339 cd05847 IgC_CH2_IgE CH2 domain 96.9 0.0044 9.5E-08 49.0 7.0 66 143-208 13-88 (94)
340 cd05758 Ig5_KIRREL3-like Fifth 96.8 0.0022 4.7E-08 51.4 5.2 28 14-41 64-92 (98)
341 cd05901 Ig_Versican Immunoglob 96.8 0.0039 8.5E-08 51.0 6.7 37 12-48 77-114 (117)
342 PHA02633 hypothetical protein; 96.8 0.0035 7.7E-08 43.9 5.4 38 181-218 16-53 (63)
343 cd05749 Ig2_Tyro3_like Second 96.8 0.0027 5.8E-08 48.7 4.9 35 11-47 46-80 (81)
344 cd05889 Ig1_DNAM-1_like First 96.7 0.0054 1.2E-07 48.6 6.7 40 7-47 48-93 (96)
345 cd05902 Ig_Neurocan Immunoglob 96.7 0.0032 6.9E-08 51.4 5.3 36 12-47 70-106 (110)
346 smart00408 IGc2 Immunoglobulin 96.7 0.0027 5.9E-08 45.3 4.2 28 11-38 36-63 (63)
347 cd07696 IgC_CH3 CH3 domain (th 96.6 0.0085 1.8E-07 47.6 7.1 69 138-206 8-86 (96)
348 cd05721 IgV_CTLA-4 Immunoglobu 96.6 0.012 2.6E-07 47.7 7.7 68 135-202 4-93 (115)
349 cd05729 Ig2_FGFR_like Second i 96.6 0.0033 7.1E-08 48.6 4.5 27 14-40 51-77 (85)
350 cd05752 Ig1_FcgammaR_like Frst 96.6 0.0016 3.4E-08 49.6 2.5 24 12-36 45-68 (78)
351 cd07690 Ig1_CD4 First immunogl 96.5 0.0018 4E-08 51.1 2.7 26 14-39 65-90 (94)
352 cd05846 Ig1_MRC-OX-2_like Firs 96.5 0.007 1.5E-07 48.3 6.1 29 12-40 59-88 (97)
353 cd05898 Ig5_KIRREL3 Fifth immu 96.5 0.007 1.5E-07 48.1 5.6 28 14-41 64-92 (98)
354 PF07654 C1-set: Immunoglobuli 96.3 0.018 3.9E-07 44.3 7.3 62 143-207 7-78 (83)
355 cd05880 Ig_EVA1 Immunoglobulin 96.3 0.0049 1.1E-07 51.0 4.2 27 13-39 78-104 (115)
356 cd05872 Ig_Sema4B_like Immunog 96.3 0.0096 2.1E-07 45.9 5.5 30 6-35 39-68 (85)
357 cd05715 Ig_P0-like Immunoglobu 96.3 0.0076 1.7E-07 49.9 5.2 27 13-39 79-105 (116)
358 cd07697 IgC_TCR_gamma T cell r 96.3 0.018 4E-07 45.5 7.1 32 141-172 13-46 (96)
359 cd05845 Ig2_L1-CAM_like Second 96.3 0.0032 6.8E-08 49.6 2.6 35 6-40 49-85 (95)
360 cd05769 IgC_TCR_beta T cell re 96.2 0.025 5.4E-07 46.5 7.8 75 136-210 10-96 (115)
361 cd07704 Ig2_Nectin-3-4_like Se 96.2 0.016 3.4E-07 45.8 6.3 67 139-207 11-85 (97)
362 PF07354 Sp38: Zona-pellucida- 96.1 0.0074 1.6E-07 55.6 4.6 50 157-206 11-60 (271)
363 PHA03273 envelope glycoprotein 96.0 0.42 9.1E-06 47.9 16.4 76 15-90 199-280 (486)
364 cd04985 IgC_CH1 CH1 domain (fi 96.0 0.055 1.2E-06 42.8 8.6 63 143-206 15-87 (95)
365 PF13895 Ig_2: Immunoglobulin 95.9 0.012 2.5E-07 44.7 4.3 34 15-48 46-79 (80)
366 PF00047 ig: Immunoglobulin do 95.9 0.0063 1.4E-07 44.1 2.6 18 16-33 47-64 (64)
367 KOG1480|consensus 95.9 0.0035 7.7E-08 65.7 1.7 87 132-219 132-222 (909)
368 smart00410 IG_like Immunoglobu 95.9 0.017 3.7E-07 43.9 5.3 34 14-48 51-84 (86)
369 smart00409 IG Immunoglobulin. 95.9 0.017 3.7E-07 43.9 5.3 34 14-48 51-84 (86)
370 PF08204 V-set_CD47: CD47 immu 95.9 0.02 4.4E-07 47.5 5.7 75 143-218 26-120 (130)
371 cd05860 Ig4_SCFR Fourth immuno 95.7 0.018 4E-07 45.6 4.7 34 14-47 65-99 (101)
372 cd04986 IgC_CH2 CH2 domain (se 95.7 0.03 6.5E-07 44.4 5.7 66 141-207 16-90 (99)
373 PF13927 Ig_3: Immunoglobulin 95.5 0.01 2.2E-07 44.3 2.6 24 12-35 52-75 (75)
374 cd05751 Ig1_LILRB1_like First 95.4 0.014 3E-07 46.0 2.9 24 13-36 52-75 (91)
375 PF07686 V-set: Immunoglobulin 95.3 0.021 4.6E-07 46.7 4.0 24 14-37 79-102 (114)
376 cd00099 IgV Immunoglobulin var 95.2 0.018 3.9E-07 46.5 3.2 25 14-38 67-91 (105)
377 PHA03270 envelope glycoprotein 95.2 1.5 3.2E-05 43.8 16.4 78 14-91 182-265 (466)
378 cd04983 IgV_TCR_alpha_like Imm 95.1 0.025 5.3E-07 46.1 3.6 33 5-37 55-93 (109)
379 PHA02987 Ig domain OX-2-like p 95.0 0.049 1.1E-06 47.9 5.4 43 6-48 72-122 (189)
380 KOG4597|consensus 94.9 0.029 6.3E-07 55.8 4.3 83 136-218 203-292 (560)
381 cd07689 Ig2_VCAM-1 Second immu 94.7 0.12 2.6E-06 40.7 6.4 61 141-204 12-84 (99)
382 PHA03269 envelope glycoprotein 94.2 4.5 9.7E-05 41.1 17.3 77 15-91 290-373 (566)
383 cd05716 Ig_pIgR Immunoglobulin 93.9 0.063 1.4E-06 42.8 3.5 24 14-37 64-87 (98)
384 cd05712 Ig_Siglec_N Immunoglob 93.9 0.1 2.3E-06 43.3 4.9 32 6-37 66-103 (119)
385 PF11465 Receptor_2B4: Natural 93.8 0.21 4.5E-06 39.6 6.0 39 11-49 68-106 (108)
386 PHA03042 CD47-like protein; Pr 93.6 0.31 6.7E-06 45.4 7.7 70 144-218 31-105 (286)
387 cd05899 IgV_TCR_beta Immunoglo 93.0 0.094 2E-06 42.8 3.2 24 14-37 72-95 (110)
388 cd05885 Ig2_Necl-4 Second immu 92.9 0.16 3.4E-06 38.6 3.9 28 13-40 42-69 (80)
389 cd04984 IgV_L_lambda Immunoglo 92.8 0.096 2.1E-06 41.7 2.9 23 14-36 63-85 (98)
390 smart00406 IGv Immunoglobulin 92.6 0.059 1.3E-06 40.9 1.4 20 14-33 62-81 (81)
391 cd04980 IgV_L_kappa Immunoglob 92.2 0.095 2.1E-06 42.5 2.2 23 14-36 71-93 (106)
392 PF11465 Receptor_2B4: Natural 92.0 0.46 1E-05 37.7 5.6 39 180-218 68-107 (108)
393 PHA03271 envelope glycoprotein 91.5 15 0.00034 36.6 16.4 80 14-93 207-293 (490)
394 cd07706 IgV_TCR_delta Immunogl 91.5 0.16 3.4E-06 42.0 2.7 31 5-35 57-93 (116)
395 cd07694 Ig2_CD4 Second immunog 91.3 0.63 1.4E-05 35.7 5.5 37 12-49 49-85 (88)
396 PF05790 C2-set: Immunoglobuli 91.1 1.8 3.9E-05 32.8 7.9 52 158-217 26-78 (80)
397 cd04982 IgV_TCR_gamma Immunogl 91.0 0.2 4.2E-06 41.3 2.9 30 6-35 63-98 (116)
398 cd05759 Ig2_KIRREL3-like Secon 91.0 0.32 7E-06 37.1 3.9 26 14-39 46-71 (82)
399 cd05720 Ig_CD8_alpha Immunoglo 90.2 0.18 4E-06 40.6 2.0 22 14-35 69-90 (104)
400 cd07700 IgV_CD8_beta Immunoglo 89.9 0.3 6.5E-06 39.6 3.0 21 15-35 73-93 (107)
401 PHA02982 hypothetical protein; 89.9 0.62 1.4E-05 41.5 5.0 75 11-88 97-173 (251)
402 PF06328 Lep_receptor_Ig: Ig-l 89.1 1.6 3.6E-05 33.9 6.4 65 135-201 9-80 (89)
403 cd00096 Ig Immunoglobulin doma 88.7 0.49 1.1E-05 33.7 3.2 27 11-37 40-66 (74)
404 PF02480 Herpes_gE: Alphaherpe 88.1 0.7 1.5E-05 47.6 4.8 43 8-50 83-125 (439)
405 PHA03283 envelope glycoprotein 87.4 5.2 0.00011 41.1 10.2 38 12-49 132-170 (542)
406 cd05711 Ig_FcalphaRI Immunoglo 86.1 0.83 1.8E-05 36.0 3.3 22 14-35 55-76 (94)
407 cd04981 IgV_H Immunoglobulin ( 83.9 0.74 1.6E-05 38.0 2.1 21 15-35 77-97 (117)
408 PHA02982 hypothetical protein; 83.3 2.6 5.5E-05 37.8 5.2 73 138-210 33-127 (251)
409 PHA02865 MHC-like TNF binding 82.9 4.7 0.0001 39.5 7.3 21 146-166 216-238 (338)
410 PF06832 BiPBP_C: Penicillin-B 82.7 20 0.00044 27.7 10.1 73 129-211 10-86 (89)
411 KOG0613|consensus 81.5 2.9 6.2E-05 47.7 6.0 80 138-217 343-427 (1205)
412 PHA03052 Hypothetical protein; 80.5 4.6 9.9E-05 29.1 4.6 35 137-171 5-42 (69)
413 PF07354 Sp38: Zona-pellucida- 78.8 2.1 4.5E-05 40.0 3.3 30 8-37 30-60 (271)
414 PHA03189 UL14 tegument protein 76.7 16 0.00034 34.9 8.4 74 135-209 58-159 (348)
415 PHA03282 envelope glycoprotein 75.7 5.2 0.00011 40.4 5.2 46 6-51 116-162 (540)
416 KOG1026|consensus 74.8 2.8 6.1E-05 45.6 3.4 75 138-220 201-275 (774)
417 PF05790 C2-set: Immunoglobuli 72.6 15 0.00032 27.9 6.0 24 12-35 41-64 (80)
418 KOG1480|consensus 71.5 2 4.4E-05 46.0 1.4 38 10-47 179-216 (909)
419 cd07691 Ig_CD3_gamma_delta Imm 70.8 5.7 0.00012 28.9 3.1 24 12-35 31-54 (69)
420 cd05890 Ig2_Nectin-1_like Seco 67.1 23 0.0005 27.7 5.9 68 146-217 22-98 (98)
421 PHA02914 Immunoglobulin-like d 66.7 42 0.00091 33.5 9.0 34 184-217 82-116 (500)
422 KOG1026|consensus 66.0 12 0.00026 41.0 5.8 151 65-221 209-366 (774)
423 PHA03240 envelope glycoprotein 64.3 11 0.00024 33.8 4.3 38 181-218 103-144 (258)
424 cd05761 Ig2_Necl-1-4_like Seco 64.2 7.8 0.00017 29.4 3.1 25 66-90 2-27 (82)
425 cd07698 IgC_MHC_I_alpha3 Class 63.5 28 0.00061 27.1 6.2 25 63-87 14-40 (93)
426 PHA03281 envelope glycoprotein 63.2 52 0.0011 34.2 9.3 29 12-40 296-324 (642)
427 cd05883 Ig2_Necl-2 Second immu 62.3 13 0.00029 28.3 3.9 35 14-48 44-80 (82)
428 PHA03270 envelope glycoprotein 61.6 99 0.0022 31.4 10.7 80 128-209 220-311 (466)
429 cd07692 Ig_CD3_epsilon Immunog 60.5 9 0.0002 27.6 2.5 22 14-36 35-56 (65)
430 KOG0613|consensus 60.3 25 0.00054 40.5 7.1 144 138-288 238-389 (1205)
431 PF03921 ICAM_N: Intercellular 59.1 84 0.0018 24.5 9.7 82 132-221 6-89 (91)
432 TIGR00864 PCC polycystin catio 56.5 5.7E+02 0.012 33.3 19.7 78 133-220 1515-1594(2740)
433 cd07705 Ig2_Necl-1 Second immu 56.4 14 0.0003 28.2 3.3 25 67-91 3-28 (83)
434 KOG2700|consensus 53.4 9.5 0.00021 38.4 2.3 33 408-440 325-357 (481)
435 cd05721 IgV_CTLA-4 Immunoglobu 53.0 12 0.00026 30.5 2.5 20 15-34 75-94 (115)
436 PF08204 V-set_CD47: CD47 immu 52.8 9.5 0.0002 31.9 1.8 35 13-49 85-119 (130)
437 cd00098 IgC Immunoglobulin Con 52.2 8.6 0.00019 29.9 1.5 24 15-38 63-86 (95)
438 PHA03271 envelope glycoprotein 48.6 1.8E+02 0.004 29.4 10.1 80 128-209 246-338 (490)
439 cd05884 Ig2_Necl-3 Second immu 47.6 23 0.00049 27.0 3.1 25 67-91 3-28 (83)
440 PHA03283 envelope glycoprotein 45.2 1E+02 0.0022 32.2 8.0 38 183-220 134-171 (542)
441 cd05755 Ig2_ICAM-1_like Second 43.4 85 0.0018 25.0 5.9 31 61-91 13-47 (100)
442 cd05770 IgC_beta2m Class I maj 43.3 63 0.0014 25.2 5.1 25 66-90 18-44 (93)
443 PF05924 SAMP: SAMP Motif; In 39.8 8.2 0.00018 20.4 -0.2 9 413-421 11-19 (20)
444 COG5475 Uncharacterized small 39.0 1.1E+02 0.0024 21.2 4.8 26 184-211 19-44 (60)
445 PHA03286 envelope glycoprotein 38.8 78 0.0017 32.3 6.0 30 12-41 125-154 (492)
446 PHA03269 envelope glycoprotein 38.5 3.3E+02 0.0072 28.3 10.3 33 140-172 338-373 (566)
447 PHA03112 IL-18 binding protein 38.0 1.2E+02 0.0027 25.6 6.2 26 142-167 36-63 (141)
448 cd05772 IgC_SIRP Signal-regula 38.0 38 0.00082 27.5 3.2 28 63-90 21-50 (111)
449 TIGR00864 PCC polycystin catio 37.7 1.1E+03 0.023 31.0 20.8 99 111-220 1848-1951(2740)
450 PF02440 Adeno_E3_CR1: Adenovi 35.7 92 0.002 22.4 4.4 21 141-165 2-22 (63)
451 KOG0200|consensus 34.6 1.7E+02 0.0036 32.1 8.5 26 10-35 9-34 (609)
452 KOG4597|consensus 33.2 36 0.00079 34.8 2.8 36 12-47 255-291 (560)
453 PF04255 DUF433: Protein of un 32.4 67 0.0015 22.3 3.3 28 522-549 26-53 (56)
454 PHA03273 envelope glycoprotein 29.4 1.5E+02 0.0034 30.4 6.4 34 184-217 199-232 (486)
455 PF03174 CHB_HEX_C: Chitobiase 29.2 1.2E+02 0.0025 22.4 4.4 65 136-212 7-71 (75)
456 PF02124 Marek_A: Marek's dise 29.0 4.6E+02 0.0099 24.1 10.7 18 142-159 146-163 (211)
457 cd05719 Ig2_PVR_like Second im 28.7 62 0.0013 25.4 3.0 20 66-85 18-38 (95)
458 PHA03282 envelope glycoprotein 26.6 86 0.0019 32.1 4.1 38 181-218 122-161 (540)
459 COG1102 Cmk Cytidylate kinase 26.2 64 0.0014 28.2 2.7 50 326-387 4-53 (179)
460 PF12643 MazG-like: MazG-like 26.2 2.1E+02 0.0046 22.6 5.5 54 474-527 18-73 (98)
461 PHA03290 envelope glycoprotein 24.1 1.8E+02 0.0039 28.5 5.5 40 14-53 129-169 (357)
462 PF10940 DUF2618: Protein of u 24.0 14 0.0003 22.8 -1.1 9 412-420 2-10 (40)
463 cd07703 Ig2_Nectin-2_like Seco 21.5 1.1E+02 0.0023 24.1 3.0 33 15-47 60-93 (95)
464 cd07704 Ig2_Nectin-3-4_like Se 21.3 1E+02 0.0022 24.4 2.8 20 68-87 23-42 (97)
465 PF11049 KSHV_K1: Glycoprotein 21.2 1.4E+02 0.003 21.6 3.1 55 148-218 2-56 (71)
466 PRK13696 hypothetical protein; 21.2 2.2E+02 0.0048 20.4 4.1 34 515-549 11-59 (62)
467 PF02480 Herpes_gE: Alphaherpe 21.0 52 0.0011 34.1 1.5 38 182-219 88-126 (439)
468 PHA03281 envelope glycoprotein 20.7 7.2E+02 0.016 26.4 9.3 39 182-220 297-336 (642)
469 COG2442 Uncharacterized conser 20.5 1.5E+02 0.0033 22.4 3.5 31 520-550 36-66 (79)
470 KOG3611|consensus 20.1 1.5E+02 0.0033 33.0 4.8 71 146-218 571-648 (737)
No 1
>PRK12425 fumarate hydratase; Provisional
Probab=100.00 E-value=7.7e-60 Score=478.85 Aligned_cols=315 Identities=47% Similarity=0.723 Sum_probs=283.3
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcc-cccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYG-PHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~-~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
..++|.|.+.+|+..++.. ...+..+ ..+...+.. ...+ .+++|.||||+|+|+|+|+||++++ |++.|
T Consensus 129 n~~vh~g~S~ND~~~Ta~~-L~~r~~l~~~l~~~L~~l~~~L~~~A~~~~~tim~GrTHlQ~A~PiT~G~~~~a-~~~~l 206 (464)
T PRK12425 129 NDHVNRSQSSNDCFPTAMH-IAAAQAVHEQLLPAIAELSGGLAEQSARHAKLVKTGRTHMMDATPITFGQELSA-FVAQL 206 (464)
T ss_pred hhcccCCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCeeecccccccCccchHHHHHHH-HHHHH
Confidence 4568888999998888765 3334443 233333222 2233 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhhhhhhh----cCCCCChhH----HHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIVSIFYFT----YLVKLSELL----ETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSL 383 (558)
Q Consensus 312 ~~~~~~l~~~~~~~~~~----g~~g~~~~~----~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l 383 (558)
.|+++||++++.+++.+ ||+||+... ++.+.+.||+.|||+.++.+|++|++++||+++|++++|++++++|
T Consensus 207 ~rd~~RL~~~~~r~~~~plGggAvGT~~~~~~~~~~~~~~~La~~LG~~~~~~~n~~da~~~rD~~~e~~~~l~~la~~L 286 (464)
T PRK12425 207 DYAERAIRAALPAVCELAQGGTAVGTGLNAPHGFAEAIAAELAALSGLPFVTAPNKFAALAGHEPLVSLSGALKTLAVAL 286 (464)
T ss_pred HHHHHHHHHHHHHHHHhcCCCchhcCcccCCccHHHHHHHHHHHHhCCCCcccccHHHHhcccHHHHHHHHHHHHHHHHH
Confidence 99999999888776654 367776554 4567888999999998789999999999999999999999999999
Q ss_pred HHHhhhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHH
Q psy10160 384 MKIANDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSN 463 (558)
Q Consensus 384 ~k~a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (558)
+|||+||++|+|||++||||+.+|+.++|||||||||||+.+|.++++|++++|++.+++..+.+++++.+.+.+.+...
T Consensus 287 ~kia~Dl~llsS~p~~g~~ei~lp~~~~GSSiMPqK~NP~~~E~i~~~a~~v~G~~~~v~~~~~~~~~q~n~~~~~~~~~ 366 (464)
T PRK12425 287 MKIANDLRLLGSGPRAGLAEVRLPANEPGSSIMPGKVNPTQCEALSMLACQVMGNDATIGFAASQGHLQLNVFKPVIIHN 366 (464)
T ss_pred HHHHHHHHHHccCccCCceEEECCCCCCCCCCCCCCcCCHHHHHHHHHHHHHHhHHHHHHHHHhcCCchhhhcchHHHHH
Confidence 99999999999999999999999988999999999999999999999999999999999999999999999888988899
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHH
Q psy10160 464 VLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEE 543 (558)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~ 543 (558)
+|+++..+.++++.++.+++++|+||++||+++++.+++++|+|++.+||++||+++++|.++|++++|++.+...++++
T Consensus 367 ~l~s~~~l~~~~~~~~~~~i~~l~vn~erm~~~l~~~~~~at~L~~~ig~~~A~~ia~~a~~~g~~l~e~~~~~~~l~~~ 446 (464)
T PRK12425 367 LLQSIRLLADGCRNFQQHCVAGLEPDAEQMAAHLERGLMLVTALNPHIGYDKAAEIAKKAYAEGTTLREAALALGYLTDE 446 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHcccHHHHHhhhccCHHHHHHHHHHHHHhCCCHHHHHHhcCCCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999889999
Q ss_pred HHhhhcCcccccCC
Q psy10160 544 EFNKWVVPEDMLGP 557 (558)
Q Consensus 544 ~~~~~~~p~~~~~~ 557 (558)
++++++||++|+++
T Consensus 447 el~~~ldP~~~~~~ 460 (464)
T PRK12425 447 QFDAWVRPENMLEA 460 (464)
T ss_pred HHHHHcCHHHhcCC
Confidence 99999999999986
No 2
>PRK00485 fumC fumarate hydratase; Reviewed
Probab=100.00 E-value=1.4e-59 Score=480.02 Aligned_cols=316 Identities=58% Similarity=0.815 Sum_probs=285.0
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcc-cccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYG-PHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVN 310 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~-~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~ 310 (558)
.+.++|+|.+.+|+..++.. ...+... ..+...+.. ...+ .+++|.||||+|+|+|+|||||+++ |++.
T Consensus 130 ~~~~vh~G~SrnD~v~Ta~~-L~lr~~l~~~l~~~l~~l~~~L~~~A~~~~dt~m~GrTH~Q~A~PiTfG~~~~~-~~~~ 207 (464)
T PRK00485 130 PNDHVNMSQSSNDTFPTAMH-IAAVLAIVERLLPALEHLRDTLAAKAEEFADIVKIGRTHLQDATPLTLGQEFSG-YAAQ 207 (464)
T ss_pred ccccCCCCCCchhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCeeeeeecCcCceeeeHHHHHHH-HHHH
Confidence 36778899999999998876 4555554 343333332 2223 7899999999999999999999998 9999
Q ss_pred ccchHHHHHhHhhhh---hhhc-CCCCChhH----HHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHH
Q psy10160 311 LDPNDRQALNIVSIF---YFTY-LVKLSELL----ETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVS 382 (558)
Q Consensus 311 l~~~~~~l~~~~~~~---~~~g-~~g~~~~~----~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~ 382 (558)
|.|+++||.+++.++ +++| ++||+... ++.+.+++|+.|||+.++.+|++|++++||+++|++++|++++++
T Consensus 208 l~R~~~RL~~~~~r~~~~pLGg~AvGT~~~~~~~~~~~v~~~~A~~LGl~~~~~~n~~da~~~rD~~~e~~~~la~la~~ 287 (464)
T PRK00485 208 LEHGIERIEAALPHLYELALGGTAVGTGLNAHPGFAERVAEELAELTGLPFVTAPNKFEALAAHDALVEASGALKTLAVS 287 (464)
T ss_pred HHHHHHHHHHHHHHHHHhccCCccccCCccCChhHHHHHHHHHHHHhCCCCccCcCHHHHHhccHHHHHHHHHHHHHHHH
Confidence 999999998776544 5565 67776544 346778999999999888999999999999999999999999999
Q ss_pred HHHHhhhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHH
Q psy10160 383 LMKIANDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVS 462 (558)
Q Consensus 383 l~k~a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (558)
|+|||+||++|+|+|++|||||.+|++++|||||||||||+.+|+++++|+++.|++..++...+.+++|++...|...|
T Consensus 288 L~ria~Dl~l~ss~~~~e~gev~lp~~~~GSSiMPqKrNP~~~E~ir~~a~~v~g~~~~~~~~~~~~~~e~~~~~~~~~~ 367 (464)
T PRK00485 288 LMKIANDIRWLASGPRCGLGEISLPENEPGSSIMPGKVNPTQCEALTMVCAQVMGNDAAVTFAGSQGNFELNVFKPVIAY 367 (464)
T ss_pred HHHHHHHHHHHcCCccCCCceEEcCCCCCCCCCCCCCCCcHHHHHHHHHHHHHhhhHHHHHHHhccCcccccccChHHHH
Confidence 99999999999999999999999999899999999999999999999999999999999988888999999999998899
Q ss_pred HHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCH
Q psy10160 463 NVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTE 542 (558)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~ 542 (558)
.++++++.+.++++.++..++++|+||++||++|++.++.++|+||+.+||++||++++++.++|.++++++.+...+++
T Consensus 368 ~~~~~~~~l~~~~~~~~~~~l~~l~v~~erm~~~l~~~~~~~t~La~~lg~~~A~~~~~~a~~~g~~l~~~~~~~~~l~~ 447 (464)
T PRK00485 368 NFLQSIRLLADAMRSFADHCVVGIEPNRERIKELLERSLMLVTALNPHIGYDKAAKIAKKAHKEGLTLKEAALELGYLTE 447 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhCCeeHHHhccccCHHHHHHHHHHHHHcCCCHHHHHHHcCCCCH
Confidence 99999999999999999889999999999999999999999999999999999999999999999999999999888999
Q ss_pred HHHhhhcCcccccCC
Q psy10160 543 EEFNKWVVPEDMLGP 557 (558)
Q Consensus 543 ~~~~~~~~p~~~~~~ 557 (558)
+++++++||++|+++
T Consensus 448 ~~l~~~ldP~~~~~~ 462 (464)
T PRK00485 448 EEFDRWVDPEKMTGP 462 (464)
T ss_pred HHHHHHcCHHHhcCC
Confidence 999999999999987
No 3
>COG0114 FumC Fumarase [Energy production and conversion]
Probab=100.00 E-value=1.3e-57 Score=425.55 Aligned_cols=297 Identities=59% Similarity=0.877 Sum_probs=281.1
Q ss_pred CCCCCcccccchhhhhhhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchHHHHHhHhhh---hhhhc-C----C
Q psy10160 261 GQLPSYGPHIKRAVEAEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQALNIVSI---FYFTY-L----V 331 (558)
Q Consensus 261 g~~~~~~~w~~~~l~~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~l~~~~~~---~~~~g-~----~ 331 (558)
..+.|.+..+++.+.....+ .+++..||||+|+|.|.|+|++|.+ |+..|+..+++++..... +-++| + +
T Consensus 157 ~~LiPaL~~L~~~L~~Ka~~~~~iVKiGRTHLqDAtPlTlGQE~sG-y~~ql~~~~~~i~~~l~~l~eLAiGGTAVGTGl 235 (462)
T COG0114 157 NRLIPALKHLIKTLAAKAEEFADVVKIGRTHLQDATPLTLGQEFSG-YAAQLEHALERIEASLPHLYELAIGGTAVGTGL 235 (462)
T ss_pred HHhHHHHHHHHHHHHHHHHHHhhhhhcCcccccccCcchhhhhhHH-HHHHHHHHHHHHHHHHHHHHHHccCCcccccCc
Confidence 46677777888888877777 9999999999999999999999999 999999999999876543 34455 3 5
Q ss_pred CCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhhhhhccCCCccccceecCCCCC
Q psy10160 332 KLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIANDIRFLASGPRCGLGELSLPENEP 411 (558)
Q Consensus 332 g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~~~~ 411 (558)
++.++|++++.+.+++..|+.+.+.+|.|.+.+++|.+++++++|..+|..|.|||+|||+|.||||+++||+.+|+.++
T Consensus 236 Na~p~f~ekva~~i~~~TG~~F~~a~NkF~al~~hd~lv~~~Gal~~lA~~L~KIAnDiR~l~SGPr~GLgEi~lPeneP 315 (462)
T COG0114 236 NAHPEFGEKVAEELAELTGLPFVTAPNKFEALAAHDALVEASGALRTLAVSLMKIANDIRWLGSGPRCGLGEIELPENEP 315 (462)
T ss_pred CCCccHHHHHHHHHHHHhCCCcccCCcHHHHHhcchHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCCCCccccccCCCCC
Confidence 56788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHHHHHHHHHHHHHHhhhcCcccCHH
Q psy10160 412 GSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSIRLIADSATAFTDKCVSGIVANEE 491 (558)
Q Consensus 412 gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~ 491 (558)
||||||+|+||+.+|.+.+.|.+|+|+.+++..+...++||+|++.+++.+++|.++.++.+++..|.+.|+.+|++|++
T Consensus 316 GSSIMPGKVNPtq~EA~tmv~~QV~Gnd~ai~~ags~GnFELNv~~Pvi~~N~LqS~~LLada~~~f~~~ci~gie~n~~ 395 (462)
T COG0114 316 GSSIMPGKVNPTQCEALTMVAAQVIGNDAAIAFAGSQGNFELNVFKPVIAYNFLQSVRLLADAMRSFADHCIVGIEPNEE 395 (462)
T ss_pred CccCCCCCCCchhHHHHHHHHHHHHcchHHHHHhhccCceeeccccHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhhhcCcccccCCC
Q psy10160 492 NIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNKWVVPEDMLGPK 558 (558)
Q Consensus 492 ~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~~~~p~~~~~~~ 558 (558)
+|+++++.++|++|+|++.+||++|.+++|.|+++|++++|++.+.++++++|+++++||+.++++.
T Consensus 396 ~i~~~l~~SlmLVTaLnp~IGYdkAa~IAK~A~keg~tlreaa~~~G~lte~efd~~v~Pe~mv~~~ 462 (462)
T COG0114 396 RIKELLERSLMLVTALNPHIGYDKAAKIAKKAHKEGTTLREAALELGLLSEEEFDKLVDPEKMVGPG 462 (462)
T ss_pred HHHHHHhhCchHHHhcccccchHHHHHHHHHHHHCCCcHHHHHHHcCCCCHHHHHHhcCHHHhcCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999864
No 4
>PLN00134 fumarate hydratase; Provisional
Probab=100.00 E-value=5.9e-58 Score=465.08 Aligned_cols=314 Identities=58% Similarity=0.814 Sum_probs=279.2
Q ss_pred eeecccceeEEEEeccCCCCCC-Ccccccchhhh-------hhhhh-hhhhhcccccchhhhhhhHHHhhcccccccccc
Q psy10160 243 YCQHHYYSQFCCESCTRAGQLP-SYGPHIKRAVE-------AEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDP 313 (558)
Q Consensus 243 ~~~~g~~~~~~c~~~~~~g~~~-~~~~w~~~~l~-------~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~ 313 (558)
.+|+|.+.+|+..++.. .... .....+...+. ....+ .+++|.||||+|+|+|+|+|||+++ |++.|.|
T Consensus 125 ~vh~G~S~nDiv~Ta~~-L~~~~~~~~~l~~~l~~l~~~L~~~A~~~~~t~m~grTH~Q~A~P~T~G~~~~~-~~~~l~r 202 (458)
T PLN00134 125 HVNRSQSSNDTFPTAMH-IAAATEIHSRLIPALKELHESLRAKSFEFKDIVKIGRTHLQDAVPLTLGQEFSG-YATQVKY 202 (458)
T ss_pred ccCCCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCccccccccCCCeeecHHHHHHH-HHHHHHH
Confidence 35589999999988866 3333 21222222222 22233 7899999999999999999999998 9999999
Q ss_pred hHHHHHhHh---hhhhhhc-CCCCChhH----HHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHH
Q psy10160 314 NDRQALNIV---SIFYFTY-LVKLSELL----ETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMK 385 (558)
Q Consensus 314 ~~~~l~~~~---~~~~~~g-~~g~~~~~----~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k 385 (558)
+++||.+++ ..++++| ++||+... +..+.+++|+.|||+.+..+|++|++++||+++|++++|+.++++|+|
T Consensus 203 ~~~RL~~~~~~~~~~~lGg~AvGT~~~~~~~~~~~v~~~la~~LGl~~~~~~n~~da~~~rD~~~e~~~~l~~la~~L~k 282 (458)
T PLN00134 203 GLNRVQCTLPRLYELAQGGTAVGTGLNTKKGFDEKIAAAVAEETGLPFVTAPNKFEALAAHDAFVELSGALNTVAVSLMK 282 (458)
T ss_pred HHHHHHHHHHHHHHhCCCCeeecCCccCChhHHHHHHHHHHHHhCCCCCCCccHHHHhcCCHHHHHHHHHHHHHHHHHHH
Confidence 999998766 4555666 67776543 356888999999999777899999999999999999999999999999
Q ss_pred HhhhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHH
Q psy10160 386 IANDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVL 465 (558)
Q Consensus 386 ~a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (558)
||+||++|+||||+||||+.+|+.++|||||||||||+.+|++++.|+++.|++.+++...++++++.+.+.+++.|.++
T Consensus 283 ia~Dl~llss~p~~e~gev~lp~~~~GSSiMP~KrNPv~~E~i~~~a~~v~g~~~~~~~~~~~~~~~~~~~~~~i~~~~l 362 (458)
T PLN00134 283 IANDIRLLGSGPRCGLGELNLPENEPGSSIMPGKVNPTQCEALTMVCAQVMGNHVAITVGGSAGHFELNVFKPLIAYNLL 362 (458)
T ss_pred HHHHHHHHhccccCCcceEECCCCCCCCCCCCCCcCCHHHHHHHHHHHHHHhHHHHHHHHHhcCCchhhccchHHHHHHH
Confidence 99999999999999999999999889999999999999999999999999999999987778889999888888899999
Q ss_pred HHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHH
Q psy10160 466 RSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEF 545 (558)
Q Consensus 466 ~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~ 545 (558)
+++..+.+++..++.+++++|+||++||+++++.+++++|+||+.+||++||+++++|.++|++++|++.+...|+++++
T Consensus 363 ~~~~~~~~~~~~~~~~~l~~l~vn~erm~~~l~~~~~l~~~La~~ig~~~A~~~~~~a~~~g~~l~e~~~~~~~l~~~el 442 (458)
T PLN00134 363 HSIRLLGDASASFRKNCVRGIEANRERISKLLHESLMLVTALNPKIGYDKAAAVAKKAHKEGTTLKEAALKLGVLTAEEF 442 (458)
T ss_pred HHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhccchHHHhhhccCHHHHHHHHHHHHHhCCCHHHHHHhcCCCCHHHH
Confidence 99999999999998899999999999999999999999999999999999999999999999999999999888999999
Q ss_pred hhhcCcccccCCC
Q psy10160 546 NKWVVPEDMLGPK 558 (558)
Q Consensus 546 ~~~~~p~~~~~~~ 558 (558)
++++||++|+|++
T Consensus 443 ~~~ldP~~~~~~~ 455 (458)
T PLN00134 443 DELVVPEKMTGPS 455 (458)
T ss_pred HHHcCHHHhcCCC
Confidence 9999999999863
No 5
>TIGR00979 fumC_II fumarate hydratase, class II. Putative fumarases from several species (Mycobacterium tuberculosis, Streptomyces coelicolor, Pseudomonas aeruginosa) branch deeply, although within the same branch of a phylogenetic tree rooted by aspartate ammonia-lyase sequences, and score between the trusted and noise cutoffs.
Probab=100.00 E-value=2.9e-58 Score=467.37 Aligned_cols=309 Identities=54% Similarity=0.790 Sum_probs=278.5
Q ss_pred cccceeEEEEeccCCCCCCCcc-cccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchHH
Q psy10160 246 HHYYSQFCCESCTRAGQLPSYG-PHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDR 316 (558)
Q Consensus 246 ~g~~~~~~c~~~~~~g~~~~~~-~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~ 316 (558)
+|.+.+|+..++.. ...+... ..+...+.. ...+ ++++|.||||+|+|+|+||||++++ |++.|.|+++
T Consensus 133 ~G~S~nDiv~Ta~~-L~lr~~l~~~l~~~l~~l~~~L~~~A~~~~dt~m~GrTH~Q~A~P~TfG~~~~~-~~~~l~r~~~ 210 (458)
T TIGR00979 133 KSQSSNDTFPTAMH-IAAVLAIKNQLIPALENLKKTLDAKSKEFAHIVKIGRTHLQDATPLTLGQEFSG-YVAQLEHGLE 210 (458)
T ss_pred CCCCcccHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHccCCeeecccccccceeeeHHHHHHH-HHHHHHHHHH
Confidence 69999999998876 4444444 233333222 2223 7899999999999999999999998 9999999999
Q ss_pred HHHhHhh---hhhhhc-CCCCChhHH----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhh
Q psy10160 317 QALNIVS---IFYFTY-LVKLSELLE----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAN 388 (558)
Q Consensus 317 ~l~~~~~---~~~~~g-~~g~~~~~~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~ 388 (558)
||.+++. .++++| ++||+...+ +.+.+++++.|||+.++.+|++|++++||+++|++++|++++++|+|||+
T Consensus 211 RL~~~~~~~~~~~lGg~AvGT~~~~~~~~~~~v~~~~a~~LGl~~~~~~n~~~~~~~rD~~~e~~~~La~la~~L~kia~ 290 (458)
T TIGR00979 211 RIAYSLPHLYELAIGGTAVGTGLNTHPGFDEKVAEEIAKETGLPFVTAPNKFEALAAHDAIVEAHGALKTLAASLMKIAN 290 (458)
T ss_pred HHHHHHHHHHHhcCCCChhcCCccCChhHHHHHHHHHHHHhCCCCeecCcHHHHHcccHHHHHHHHHHHHHHHHHHHHHH
Confidence 9987764 556666 688866544 46778999999999878999999999999999999999999999999999
Q ss_pred hhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHH
Q psy10160 389 DIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSI 468 (558)
Q Consensus 389 d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (558)
||++|+||||+|||||.+|++++|||||||||||+.+|+++++|+++.|++.+++..+..++++.+.+.+.+.|.+++++
T Consensus 291 Dl~llss~~~~e~gev~~p~~~~GSSiMP~K~NP~~~E~i~~~a~~v~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 370 (458)
T TIGR00979 291 DIRWLGSGPRCGLGELFIPENEPGSSIMPGKVNPTQCEALTMVCVQVMGNDATIGFAGSQGNFELNVFKPVIIYNFLQSV 370 (458)
T ss_pred HHHHHhccccCCceeEECCCCCCCCCCCCCCcCCHHHHHHHHHHHHHHhhHHHHHHHHHhccchhhhcchHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999888888999988888889999999
Q ss_pred HHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhhh
Q psy10160 469 RLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNKW 548 (558)
Q Consensus 469 ~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~~ 548 (558)
..+.+++..++..++++|+||+|||++|++.++.++|+||+.+||++||++++++.++|.+++|++.+...+++++++++
T Consensus 371 ~~~~~~~~~~~~~~l~~L~v~~erm~~nl~~~~~~~t~La~~lg~~~A~~~~~~a~~~~~~~~e~~~~~~~l~~~el~~~ 450 (458)
T TIGR00979 371 RLLSDAMESFRDHCVVGIEPNKERIQQLLNNSLMLVTALNPHIGYDNAAKIAKKAHKEGITLKEAALELGLLSEEEFDEW 450 (458)
T ss_pred HHHHHHHHHHHHHHHccCEECHHHHHHHHHcCccHHHHhhhccCHHHHHHHHHHHHHhCCCHHHHHHHcCCCCHHHHHHH
Confidence 99999999999889999999999999999999999999999999999999999999999999999999888999999999
Q ss_pred cCcccccC
Q psy10160 549 VVPEDMLG 556 (558)
Q Consensus 549 ~~p~~~~~ 556 (558)
+||++|+|
T Consensus 451 ldp~~~~~ 458 (458)
T TIGR00979 451 VVPEQMVG 458 (458)
T ss_pred cCHHHhcC
Confidence 99999986
No 6
>COG1027 AspA Aspartate ammonia-lyase [Amino acid transport and metabolism]
Probab=100.00 E-value=5.1e-56 Score=413.22 Aligned_cols=290 Identities=38% Similarity=0.576 Sum_probs=272.7
Q ss_pred ccccchhhhhhhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchHHHHHh---Hhhhhhhhc-----CCCCChhH
Q psy10160 267 GPHIKRAVEAEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQALN---IVSIFYFTY-----LVKLSELL 337 (558)
Q Consensus 267 ~~w~~~~l~~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~l~~---~~~~~~~~g-----~~g~~~~~ 337 (558)
+.-++..++....+ .++++.||||+|+|.|+|+|++|.+ |+..|.+|..||.. .+..+|++| ++++..+|
T Consensus 165 l~~L~~af~~Ka~EF~~ilKmGRTqLQDAvPmtlGqEF~A-fa~~l~ed~~ri~~~~~~l~evNlGgTAiGTGiNa~~~Y 243 (471)
T COG1027 165 LEDLIEAFERKAKEFADILKMGRTQLQDAVPMTLGQEFGA-FAVALKEDIKRIYRAAELLLEVNLGGTAIGTGINAPKGY 243 (471)
T ss_pred HHHHHHHHHHHHHHHhhhhhcChhhhcccccchhhhhHHH-HHHHHHHHHHHHHHHHHHHHhhcCCceeeccCcCCChhH
Confidence 33444444455555 8899999999999999999999998 99999999999974 456778887 36677788
Q ss_pred HHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhhhhhccCCCccccceecCCCCCCCCCCC
Q psy10160 338 ETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIANDIRFLASGPRCGLGELSLPENEPGSSIMP 417 (558)
Q Consensus 338 ~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP 417 (558)
.+.+.+++++.+|++..+.+|.+|+++..|.+++++++|..+|..|+|||+|||||+||||++++|+.+|+.|.||||||
T Consensus 244 ~~~vv~~l~evtg~~~~~A~~Lieatq~~~afv~vsg~lk~~Av~LsKI~NDlRLLsSGPr~Gl~EI~LP~~Q~GSSIMP 323 (471)
T COG1027 244 IELVVKKLAEVTGLPLVPAENLIEATQDTGAFVMVSGALKRLAVKLSKICNDLRLLSSGPRAGLNEINLPAVQAGSSIMP 323 (471)
T ss_pred HHHHHHHHHHHhCCCCccchhHHHHHhcccHHHHHHHHHHHHHHHHHHHhhhhhhhccCCccCcccccCCCCCCCCCCCC
Confidence 88899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHH
Q psy10160 418 GKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLL 497 (558)
Q Consensus 418 ~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~ 497 (558)
+|+||+++|.+.+.|.+|+|++.++.+++..+++|+|.++|.+.+.++.++.++..++..|.++|+++|++|+|+|++++
T Consensus 324 gKVNPVipEvvnQvcf~ViGnD~tit~AaeaGQLqLNvmePvI~~~l~~Si~iL~na~~~l~ekcI~gItaN~e~C~~~v 403 (471)
T COG1027 324 GKVNPVIPEVVNQVCFKVIGNDTTITMAAEAGQLQLNVMEPVIAYALFESISILTNACRNLREKCIDGITANEERCEEYV 403 (471)
T ss_pred CCcCchhHHHHHHHHHHHhcchHHHHHHHHhcchhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccCHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhhhcCcccccCC
Q psy10160 498 HESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 498 ~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~~~~p~~~~~~ 557 (558)
..|+.++|.|.+++||+.+.+++|+|.++|++++|++.+.+.|++++|+++|+|+++..+
T Consensus 404 ~nSigivTaLnp~iGy~~~~~iaK~a~~tgksv~evvLe~g~Lteeel~~Il~~~~m~~p 463 (471)
T COG1027 404 ENSIGIVTALNPYIGYENAAIIAKEALETGKSVREVVLERGLLTEEELDDILSPENMTKP 463 (471)
T ss_pred HhhhHHHHhhcccccchHHHHHHHHHHHcCCcHHHHHHHhCCCCHHHHHHHhChhhcCCc
Confidence 999999999999999999999999999999999999999999999999999999998765
No 7
>PRK13353 aspartate ammonia-lyase; Provisional
Probab=100.00 E-value=1.4e-56 Score=457.53 Aligned_cols=313 Identities=38% Similarity=0.550 Sum_probs=277.3
Q ss_pred eeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccccch
Q psy10160 243 YCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPN 314 (558)
Q Consensus 243 ~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~ 314 (558)
.+|+|.+.+|+..++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|.|+
T Consensus 134 ~vH~GrSrnD~v~Ta~~-L~~r~~l~~l~~~L~~l~~~L~~~A~~~~~~im~GrTH~Q~A~P~T~G~~~~~-~~~~l~r~ 211 (473)
T PRK13353 134 HVNMAQSTNDVFPTAIR-IAALNLLEGLLAAMGALQDVFEEKAAEFDHVIKMGRTQLQDAVPITLGQEFSA-YARALKRD 211 (473)
T ss_pred CccCCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCeeeccccCccceeecHHHHHHH-HHHHHHHH
Confidence 48999999999988866 4444444443333332 2233 7899999999999999999999998 99999999
Q ss_pred HHHHHhHhhhh---hhhc-CCCCChhHH----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHH
Q psy10160 315 DRQALNIVSIF---YFTY-LVKLSELLE----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKI 386 (558)
Q Consensus 315 ~~~l~~~~~~~---~~~g-~~g~~~~~~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~ 386 (558)
++||.+++.++ ++|| ++||+...+ ..+.+++++.|||+.++.+|++|++++||+++|++++|++++++|+||
T Consensus 212 ~~rL~~~~~~~~~~pLGg~AvGT~~~~~~~~~~~~~~~la~~LG~~~~~~~n~~~a~~~rD~~~e~~~~la~la~~l~ri 291 (473)
T PRK13353 212 RKRIQQAREHLYEVNLGGTAVGTGLNADPEYIERVVKHLAAITGLPLVGAEDLVDATQNTDAFVEVSGALKVCAVNLSKI 291 (473)
T ss_pred HHHHHHHHHHHhhhCCCCccccCCccCChhHHHHHHHHHHHHhCCCCccccchHhhhcccHHHHHHHHHHHHHHHHHHHH
Confidence 99998776544 5555 677765443 367788999999997778899999999999999999999999999999
Q ss_pred hhhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHH
Q psy10160 387 ANDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLR 466 (558)
Q Consensus 387 a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (558)
|+||++|+||||+|||||.+|++++|||||||||||+.+|+++++|+++.|++.+++....+.+++.+...|.+...++.
T Consensus 292 A~Dl~llss~pr~e~gev~lp~~~~GSSiMPqKrNP~~~E~ir~~a~~v~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (473)
T PRK13353 292 ANDLRLLSSGPRTGLGEINLPAVQPGSSIMPGKVNPVMPEVVNQIAFQVIGNDVTITLAAEAGQLELNVMEPVIAFNLLE 371 (473)
T ss_pred HHHHHHHcCCCcCCceEEECCCCCCCCCCCCCCcCChHHHHHHHHHHHHHhHHHHHHHHHHcCChhhhhhhhhHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999888888888888777777888888
Q ss_pred HHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHh
Q psy10160 467 SIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFN 546 (558)
Q Consensus 467 ~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~ 546 (558)
.+..+.+++..++..+|++|+||+|||+++++.+++++|+||+.|||+.+.++++.|.++|+++++++.+...+++++++
T Consensus 372 ~~~~~~~~~~~~~~~~l~gL~vn~erm~~~l~~~~~l~t~La~~Lgh~~v~~~~~~a~~~g~~l~e~~~~~~~~~~~el~ 451 (473)
T PRK13353 372 SISILTNACRAFTDNCVKGIEANEERCKEYVEKSVGIATALNPHIGYEAAARIAKEAIATGRSVRELALENGLLSEEELD 451 (473)
T ss_pred HHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHhhcCCCCHHHHH
Confidence 88888889999988899999999999999999999999999999999999999999999999999999988889999999
Q ss_pred hhcCcccccCC
Q psy10160 547 KWVVPEDMLGP 557 (558)
Q Consensus 547 ~~~~p~~~~~~ 557 (558)
+++||++|+++
T Consensus 452 ~~ldp~~~v~~ 462 (473)
T PRK13353 452 LILDPFRMTHP 462 (473)
T ss_pred HHcCHHHhcCC
Confidence 99999999975
No 8
>PRK12273 aspA aspartate ammonia-lyase; Provisional
Probab=100.00 E-value=5.1e-56 Score=453.36 Aligned_cols=310 Identities=37% Similarity=0.552 Sum_probs=270.2
Q ss_pred cccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchHHH
Q psy10160 246 HHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQ 317 (558)
Q Consensus 246 ~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~ 317 (558)
+|.+.+|+..++.. ...+.....+...+.. ...+ .+++|.||||+|+|+|+|||||+++ |++.|.|+++|
T Consensus 139 ~GrSrnD~v~Ta~~-L~lr~~l~~l~~~L~~l~~~L~~~A~~~~dt~m~GrTH~Q~AqP~TfG~~~a~-~~~~l~r~~~R 216 (472)
T PRK12273 139 MSQSTNDAYPTAIR-IALLLSLRKLLDALEQLQEAFEAKAKEFADILKMGRTQLQDAVPMTLGQEFGA-YAVALAEDRKR 216 (472)
T ss_pred CCCCchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHccCCEEeecccCccceeeeHHHHHHH-HHHHHHHHHHH
Confidence 88999999988876 4555554444443333 2223 7899999999999999999999998 99999999999
Q ss_pred HHhHhhhhhh---hc-CCCCChhHH----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 318 ALNIVSIFYF---TY-LVKLSELLE----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 318 l~~~~~~~~~---~g-~~g~~~~~~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|.+++.+++. || ++||+...+ +.+++++|+.|||+.++..|++|++++||+++|+++++++++++|+|||+|
T Consensus 217 L~~~~~~~~~~plGg~AvGT~~~i~~~~~~~v~~~~A~~LGf~~~~~~n~~da~~~rD~~~e~~~~la~la~~L~rlA~D 296 (472)
T PRK12273 217 LYRAAELLREVNLGATAIGTGLNAPPGYIELVVEKLAEITGLPLVPAEDLIEATQDTGAFVEVSGALKRLAVKLSKICND 296 (472)
T ss_pred HHHHHHHHhhcCCCccceeCCCCCChhHHHHHHHHHHHHcCCCcccCcCHHHHHhCcHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9987765554 45 677765433 467899999999997677899999999999999999999999999999999
Q ss_pred hhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSIR 469 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (558)
|++|+|+||+|||||.+|++++|||||||||||+.+|+++++++++.|++.+++....+.+++.+...|.+...+++.+.
T Consensus 297 i~llss~e~~e~gev~lp~~~~GSSiMPqKrNP~~~E~ir~~a~~v~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (472)
T PRK12273 297 LRLLSSGPRAGLNEINLPAVQAGSSIMPGKVNPVIPEVVNQVCFQVIGNDTTVTMAAEAGQLELNVMEPVIAYNLFESIS 376 (472)
T ss_pred HHHHhcCcccCceEEECCCCCCcCCCCCcccCcHHHHHHHHHHHHHhhhHHHHHHHHHcCCchhhhhhhhhHHHHHHHHH
Confidence 99999999999999999998999999999999999999999999999999999877777777766666666777777777
Q ss_pred HHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhhhc
Q psy10160 470 LIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNKWV 549 (558)
Q Consensus 470 ~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~~~ 549 (558)
.+..++..+..+++++|+||++||+++++.+++++|+||+.|||+.||++++.|.++|+++.+++.+...++++++++++
T Consensus 377 ~~~~~l~~~~~~~l~~l~v~~erm~~~l~~~~~~~t~LA~~L~~~~a~~lv~~a~~~g~~l~~~~~~~~~l~~~el~~~l 456 (472)
T PRK12273 377 ILTNACRTLREKCIDGITANEERCREYVENSIGIVTALNPYIGYENAAEIAKEALETGKSVRELVLERGLLTEEELDDIL 456 (472)
T ss_pred HHHHHHHHHHHHHHccCEECHHHHHHHHHhCCchHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHhhcCCCCHHHHHHHc
Confidence 77766655443699999999999999999999999999999999999999999999999999999988889999999999
Q ss_pred CcccccCC
Q psy10160 550 VPEDMLGP 557 (558)
Q Consensus 550 ~p~~~~~~ 557 (558)
||++|+++
T Consensus 457 dp~~~v~~ 464 (472)
T PRK12273 457 SPENMTHP 464 (472)
T ss_pred CHHHhCCC
Confidence 99999976
No 9
>cd01362 Fumarase_classII Class II fumarases. This subgroup contains Escherichia coli fumarase C, human mitochondrial fumarase, and related proteins. It is a member of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. Fumarase catalyzes the reversible hydration/dehydration of fumarate to L-malate during the Krebs cycle.
Probab=100.00 E-value=2.3e-55 Score=446.54 Aligned_cols=312 Identities=58% Similarity=0.809 Sum_probs=277.7
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcc-cccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYG-PHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~-~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
+.++|+|.+.+|+..++.. ...+..+ ..+...+.. ...+ ++++|.||||+|+|+|+|||||+++ |++.|
T Consensus 127 ~~~vH~G~SrnDiv~Ta~~-L~lr~~l~~~l~~~l~~l~~~L~~~A~~~~~t~m~grTh~Q~A~P~TfG~~~~~-~~~~l 204 (455)
T cd01362 127 NDHVNMSQSSNDTFPTAMH-IAAALALQERLLPALKHLIDALDAKADEFKDIVKIGRTHLQDATPLTLGQEFSG-YAAQL 204 (455)
T ss_pred cccccCCCCchhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHccCCeeeccccCCCCeeecHHHHHHH-HHHHH
Confidence 6789999999999999876 4444444 223222222 2223 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhhhh---hhhc-CCCCChhHH----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIVSIF---YFTY-LVKLSELLE----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSL 383 (558)
Q Consensus 312 ~~~~~~l~~~~~~~---~~~g-~~g~~~~~~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l 383 (558)
.|+++||.+++.++ +++| ++|+....+ +.+++++|+.|||+.+++.|++|++++||+++|+++++++++++|
T Consensus 205 ~r~~~rL~~~~~r~~~~~lGg~A~Gt~~~~~~~~~~~v~~~~a~~LGl~~~~~~n~~da~~~rD~~~e~~~~l~~la~~l 284 (455)
T cd01362 205 EHAIARIEAALPRLYELALGGTAVGTGLNAHPGFAEKVAAELAELTGLPFVTAPNKFEALAAHDALVEASGALKTLAVSL 284 (455)
T ss_pred HHHHHHHHHHHHHhhhcCcCCeeccCCccCChhHHHHHHHHHHHHhCCCCccCCCHHHHHhCCHHHHHHHHHHHHHHHHH
Confidence 99999999877544 5555 677765443 467789999999998788999999999999999999999999999
Q ss_pred HHHhhhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHH
Q psy10160 384 MKIANDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSN 463 (558)
Q Consensus 384 ~k~a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (558)
+|||+||++|+|+||+|||||.+|++++|||||||||||+.+|+++++++++.|.+..++..+..++++.+.+.+...|.
T Consensus 285 ~ria~Dl~~~~s~~~~e~gev~~~~~~~GSS~MPqKrNP~~~E~ir~~a~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (455)
T cd01362 285 MKIANDIRWLGSGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNDAAITIAGSSGNFELNVFKPVIIYN 364 (455)
T ss_pred HHHHHHHHHHccCccCCCceEECCCCCCCCCCCCCCCCcHHHHHHHHHHHHHhhhHHHHHHHHhcCchhhhhcchHHHHH
Confidence 99999999999999999999999998999999999999999999999999999999999988888888888777767799
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHH
Q psy10160 464 VLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEE 543 (558)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~ 543 (558)
++++++.+.++++.++..++++|+||++||++++..++.++++||+.+||++||++++.+.++|.++++++.+...++++
T Consensus 365 ~l~~~~~~~~~~~~~~~~~l~~L~v~~~rm~~~l~~~~~~~~~La~~ig~~~A~~l~~~a~~~~~~l~~~~~~~~~~~~~ 444 (455)
T cd01362 365 LLQSIRLLADACRSFADKCVAGIEPNRERIAELLERSLMLVTALNPHIGYDKAAKIAKKAHKEGLTLKEAALELGYLTEE 444 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhcchhHHHhccccCHHHHHHHHHHHHHcCCCHHHHHHhcCCCCHH
Confidence 99999999999999988899999999999999999999999999999999999999999999999999999988889999
Q ss_pred HHhhhcCcccc
Q psy10160 544 EFNKWVVPEDM 554 (558)
Q Consensus 544 ~~~~~~~p~~~ 554 (558)
++++++||.++
T Consensus 445 el~~~~dp~~~ 455 (455)
T cd01362 445 EFDRLVDPEKM 455 (455)
T ss_pred HHHHhcCcccC
Confidence 99999999864
No 10
>PRK14515 aspartate ammonia-lyase; Provisional
Probab=100.00 E-value=6.4e-55 Score=442.36 Aligned_cols=312 Identities=32% Similarity=0.497 Sum_probs=272.5
Q ss_pred eecccceeEEEEeccCCCCCCCcccccchhhh-------hhhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchH
Q psy10160 244 CQHHYYSQFCCESCTRAGQLPSYGPHIKRAVE-------AEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPND 315 (558)
Q Consensus 244 ~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~-------~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~ 315 (558)
++.+...+|+..++.. .........+...+. ....+ .+++|.||||+|+|+|+|+||++++ |++.|.|++
T Consensus 141 vn~grS~ND~v~Ta~~-L~~~~~l~~l~~~L~~L~~~L~~~A~~~~~~vm~GrTHlQ~A~PiT~G~~~~~-~a~~l~r~~ 218 (479)
T PRK14515 141 VNMAQSTNDAFPTAIH-IATLNALEGLLQTMGYMHDVFELKAEQFDHVIKMGRTHLQDAVPIRLGQEFKA-YSRVLERDM 218 (479)
T ss_pred CCCCCCchhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcccchhccccceeeeHHHHHHH-HHHHHHHHH
Confidence 3455556666666654 333333333332222 23333 7899999999999999999999998 999999999
Q ss_pred HHHHhHhhhhh---hh-cCCCCChhHH----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHh
Q psy10160 316 RQALNIVSIFY---FT-YLVKLSELLE----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIA 387 (558)
Q Consensus 316 ~~l~~~~~~~~---~~-g~~g~~~~~~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a 387 (558)
+||.+++.+++ +| |++||+...+ ..+..++++.+|+..+..+|++|++++||+++|++++|++++++|+|||
T Consensus 219 ~RL~~~~~~l~~~pLG~gAvGT~~~~~~~~~~~~l~~la~~~gl~~~~~~n~~da~~~rd~~~e~~~~l~~la~~L~kiA 298 (479)
T PRK14515 219 KRIQQSRQHLYEVNMGATAVGTGLNADPEYIEAVVKHLAAISELPLVGAEDLVDATQNTDAYTEVSAALKVCMMNMSKIA 298 (479)
T ss_pred HHHHHHHHHHhhccCCCccccCCCCCChhHHHHHHHHHHHHhCCCCCCCcchHHHhcccHHHHHHHHHHHHHHHHHHHHH
Confidence 99998765554 45 4677766554 3677889999999888788999999999999999999999999999999
Q ss_pred hhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHH
Q psy10160 388 NDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRS 467 (558)
Q Consensus 388 ~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (558)
+||++|+|||+.||+|+.+|++++|||||||||||+.+|.+++.|++++|++.+++....+++++++...+.+...++.+
T Consensus 299 ~Dl~llsS~p~~g~~Ei~lp~~~~GSSiMP~KrNP~~~E~i~~~a~~v~G~~~~~~~~~~~~~le~n~~~p~i~~~l~~s 378 (479)
T PRK14515 299 NDLRLMASGPRVGLAEIMLPARQPGSSIMPGKVNPVMPEVINQIAFQVIGNDHTICLASEAGQLELNVMEPVLVFNLLQS 378 (479)
T ss_pred HHHHHHcCCCcCCeeEEeCCCCCCCcCCCCcccCchHHHHHHHHHHHHHhHHHHHHHHHhcccHHHHHhcchhHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999998888888999999778778889999
Q ss_pred HHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhh
Q psy10160 468 IRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNK 547 (558)
Q Consensus 468 ~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~ 547 (558)
+..+..++..++++|+++|+||++||+++++.+++++|+||+.+||+.+++++++|.++|++++|++.+...++++|+++
T Consensus 379 i~~l~~al~~~~~~~l~gl~vn~erm~~~l~~s~~l~t~La~~iG~~~v~~~a~~A~~~g~~l~e~~~~~~~l~~~el~~ 458 (479)
T PRK14515 379 ISIMNNGFRAFTDNCLKGIEANEDRLKEYVEKSVGIITAVNPHIGYEAAARVAKEAIATGQSVRELCVKNGVLSQEDLEL 458 (479)
T ss_pred HHHHHHHHHHHHHHHHccCEECHHHHHHHHHhCccHHHHhcchhcHHHHHHHHHHHHHhCCCHHHHHHhcCCCCHHHHHH
Confidence 99999999889989999999999999999999999999999999999999999999999999999999988899999999
Q ss_pred hcCcccccCC
Q psy10160 548 WVVPEDMLGP 557 (558)
Q Consensus 548 ~~~p~~~~~~ 557 (558)
++||++++++
T Consensus 459 ~ldP~~~~~~ 468 (479)
T PRK14515 459 ILDPFEMTHP 468 (479)
T ss_pred hCCHHHcCCC
Confidence 9999999976
No 11
>TIGR00839 aspA aspartate ammonia-lyase. Fumarate hydratase scores as high as 570 bits against this model.
Probab=100.00 E-value=3.8e-55 Score=444.25 Aligned_cols=310 Identities=33% Similarity=0.481 Sum_probs=273.0
Q ss_pred cccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchHHH
Q psy10160 246 HHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQ 317 (558)
Q Consensus 246 ~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~ 317 (558)
.|.+.+|+..++.. ...+.....+...+.. ...+ ++++|.||||+|+|+|+|||||+++ |.+.|.|+++|
T Consensus 135 ~G~S~nD~v~Ta~~-L~lr~~l~~l~~~l~~l~~~L~~~A~~~~~t~m~grTH~Q~A~P~TfG~~~~~-~~~~l~r~~~R 212 (468)
T TIGR00839 135 KSQSTNDAYPTGFR-IAVYSSLIKLVDAINQLRDGFEQKAKEFADILKMGRTQLQDAVPMTLGQEFEA-FSILLEEEVKN 212 (468)
T ss_pred CCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHccCCeeeccccCccCccchHHHHHHH-HHHHHHHHHHH
Confidence 48999999998876 4555554444433332 2233 7899999999999999999999998 99999999999
Q ss_pred HHhHhhhhh---hhc-CCCCChhHH----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 318 ALNIVSIFY---FTY-LVKLSELLE----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 318 l~~~~~~~~---~~g-~~g~~~~~~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|.+.+.+++ ++| ++||+...+ +.+++++|+.|||+.+..+|++|++++||+++|++++|++++++|+|||+|
T Consensus 213 L~~~~~~~~~~~lGg~AvGT~~~~~~~~~~~v~~~~a~~LGl~~~~~~n~~da~~~rd~~~e~~~~l~~la~~L~ria~D 292 (468)
T TIGR00839 213 IKRTAELLLEVNLGATAIGTGLNTPPEYSPLVVKKLAEVTGLPCVPAENLIEATSDCGAYVMVHGALKRLAVKMSKICND 292 (468)
T ss_pred HHHHHHHhhhcCCCCcceeCCCcCChhHHHHHHHHHHHHhCCCCCCCccHHHHhcccHHHHHHHHHHHHHHHHHHHHHHH
Confidence 998776554 455 677765443 468999999999997767899999999999999999999999999999999
Q ss_pred hhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSIR 469 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (558)
|++|+|+|++||||+.+|.+++|||||||||||+.+|+++++++++.|++..++....+..++.+...|.....+++.+.
T Consensus 293 l~l~~s~~~~~~~ev~~~~~~~gSS~MPqKrNP~~~E~ir~~a~~~~g~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 372 (468)
T TIGR00839 293 LRLLSSGPRAGLNEINLPELQAGSSIMPAKVNPVVPEVVNQVCFKVIGNDTTVTLAAEAGQLQLNVMEPVIGQAMFESIH 372 (468)
T ss_pred HHHHhcCCcCCceEEeCCCCCCCCCCCCCCcCcHHHHHHHHHHHHHHhHHHHHHHHHhcCChHhhhhhHHHHHHHHHHHH
Confidence 99999999999999999988999999999999999999999999999999999776677777766666666677888889
Q ss_pred HHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhhhc
Q psy10160 470 LIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNKWV 549 (558)
Q Consensus 470 ~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~~~ 549 (558)
.+.+++..++..++++|+||+|||+++++.+..++++||+.+||+.||++++.+.++|+++.|++.+...++++++++++
T Consensus 373 ~~~~~~~~~~~~~l~~L~vn~erm~~~l~~~~~~~~~La~~~g~~~a~~~~~~a~~~g~~l~e~~~~~~~l~~~~l~~~l 452 (468)
T TIGR00839 373 ILTNACYNLTDKCVNGITANKEICEGYVFNSIGIVTYLNPFIGHHNGDIVGKICAETGKSVREVVLEKGLLTEEELDDIF 452 (468)
T ss_pred HHHHHHHHHHHHHHccCEECHHHHHHHHHHhHHHHHHHhhHhhHHHHHHHHHHHHHhCCCHHHHHHhcCCCCHHHHHHHc
Confidence 99999988888999999999999999999999999999999999999999999999999999999988889999999999
Q ss_pred CcccccCC
Q psy10160 550 VPEDMLGP 557 (558)
Q Consensus 550 ~p~~~~~~ 557 (558)
||++|+++
T Consensus 453 dP~~~v~~ 460 (468)
T TIGR00839 453 SVENLMHP 460 (468)
T ss_pred CHHHHcCC
Confidence 99999986
No 12
>COG0015 PurB Adenylosuccinate lyase [Nucleotide transport and metabolism]
Probab=100.00 E-value=2e-55 Score=431.76 Aligned_cols=310 Identities=23% Similarity=0.217 Sum_probs=274.7
Q ss_pred EeceeeecccceeEEEEeccCCCCCCCcccccchhhhhhh-------hh-hhhhhcccccchhhhhhhHHHhhccccccc
Q psy10160 239 VEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAEA-------AA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVN 310 (558)
Q Consensus 239 ~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~~-------~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~ 310 (558)
..++++|+|.|++|+.+++.+ .+.+.....+...+.... .. ++++|.||||+|+|.|+|+|++++. |..+
T Consensus 87 ~~~~~VH~GaTS~DI~Dta~~-L~lk~a~~ii~~~l~~l~~~L~~~A~~~k~t~m~GRTHgq~A~PtT~G~k~A~-w~~e 164 (438)
T COG0015 87 EASEYVHFGATSQDIIDTALA-LQLKEALDLILPDLKRLIEALAELALEHKDTPMLGRTHGQPAEPTTFGKKFAN-WLAE 164 (438)
T ss_pred ccccceecccchHHHHhHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCeecccccCCCCccchHHHHHHH-HHHH
Confidence 457899999999999999988 677777766665554422 33 8899999999999999999999998 9999
Q ss_pred ccchHHHHHhH---hhhhhhhcCCCCChhHHH---HHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHH
Q psy10160 311 LDPNDRQALNI---VSIFYFTYLVKLSELLET---KCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLM 384 (558)
Q Consensus 311 l~~~~~~l~~~---~~~~~~~g~~g~~~~~~~---~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~ 384 (558)
|.|+++||..+ +..++++|++||+++|++ .+++++++.|||.+.+.++ |+.+||+++|++++|++++++++
T Consensus 165 l~R~~~rL~~~~~~~~~g~i~Ga~Gt~Aa~~~~~~~ve~~v~e~LGL~~~p~st---q~~~RD~~ae~~~~La~i~~sl~ 241 (438)
T COG0015 165 LLRHLERLEEAEERIIVGKIGGAVGTLAALGDLGAEVEERVAEKLGLKPAPIST---QVSPRDRIAEFFSALALLAGSLE 241 (438)
T ss_pred HHHHHHHHHHHHhhhhhhccccchhhHhhcCchhHHHHHHHHHHcCCCCCCCCc---ccccchHHHHHHHHHHHHHHHHH
Confidence 99999999755 456888999999999997 8999999999999888876 79999999999999999999999
Q ss_pred HHhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHH
Q psy10160 385 KIANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVS 462 (558)
Q Consensus 385 k~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (558)
|||.||++|+ ++|++|+.+|+ +|+|||+|||||||+.+|++.++++.+.+++..++... ..|+||+...|..+|
T Consensus 242 k~a~dIr~l~---~~e~~Ev~E~f~~gq~GSSaMPHKrNPi~~E~~~glar~~r~~~~~~~e~~-~~whERdlt~ssver 317 (438)
T COG0015 242 KFARDIRLLQ---RTEVGEVEEPFAKGQVGSSAMPHKRNPIDSENVTGLARVARALVSTLLENL-VLWHERDLTDSSVER 317 (438)
T ss_pred HHHHHHHHHH---hccccccccccCCCCCCCCCCCcccCcHHHHHHHHHHHHHHHHHHHHHHHh-HHHHhccccchHHHH
Confidence 9999999999 69999999995 79999999999999999999999999999999887666 899999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhh------hhhccc-ccChHHHHHHHH----HHHHcCCCHH
Q psy10160 463 NVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLML------VTALNP-HIGYDKAAKIAK----TAHKEGTTLK 531 (558)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~------~~~la~-~l~~~~a~~~~~----~a~~~~~~~~ 531 (558)
..||+++.+.+.++..+..++++|.||+++|++|++..+.+ ..+|++ .+||++||++++ .+.++++++.
T Consensus 318 ~~Lp~~~~~~~~aL~~~~~vl~~L~v~~~~m~~nL~~~~gli~se~v~~~l~~~g~~Re~a~elvr~~a~~~~~~~~~~~ 397 (438)
T COG0015 318 VILPDAFIAADGALNRLLNVLEGLEVNPERMRRNLDLTLGLIASERVMLALRKKGMGREEAHELVREKAMKAWEQGKEFL 397 (438)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhCeeCHHHHHHHHhhccchhhhHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHhccchH
Confidence 99999999999999999999999999999999999643321 135565 799999999875 4567889997
Q ss_pred HHHHHc----CCCCHHHHhhhcCcccccCC
Q psy10160 532 VAALKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 532 ~~~~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
+.+.+. ..+++++++++|||.+|+|.
T Consensus 398 ~~~l~~~~v~~~~~~~~~~~~~dp~~y~G~ 427 (438)
T COG0015 398 ELLLADERVTKYLSEEELLELLDPANYLGR 427 (438)
T ss_pred HHhccchhhhccCcHHHHHHcCCHHHHhhH
Confidence 776654 67999999999999999985
No 13
>cd01357 Aspartase Aspartase. This subgroup contains Escherichia coli aspartase (L-aspartate ammonia-lyase), Bacillus aspartase and related proteins. It is a member of the Lyase class I family, which includes both aspartase (L-aspartate ammonia-lyase) and fumarase class II enzymes. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. Aspartase catalyzes the reversible deamination of aspartic acid.
Probab=100.00 E-value=1.6e-54 Score=440.53 Aligned_cols=305 Identities=38% Similarity=0.561 Sum_probs=264.6
Q ss_pred eecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchH
Q psy10160 244 CQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPND 315 (558)
Q Consensus 244 ~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~ 315 (558)
+|+|.+.+|+..++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|||||+++ |++.|.|++
T Consensus 130 vH~GrSrnD~v~Ta~~-L~lr~~l~~l~~~L~~l~~~L~~~A~~~~~t~m~GrTH~Q~A~P~TfG~~~~~-~~~~l~r~~ 207 (450)
T cd01357 130 VNMSQSTNDVYPTALR-LALILLLRKLLDALAALQEAFQAKAREFADVLKMGRTQLQDAVPMTLGQEFGA-YATALKRDR 207 (450)
T ss_pred ccCCCChHhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHccCCEeeccccCcccccchHHhHHHH-HHHHHHHHH
Confidence 7899999999988876 4555444444433332 2233 7899999999999999999999998 999999999
Q ss_pred HHHHhHhhhh---hhhc-CCCCChhH----HHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHh
Q psy10160 316 RQALNIVSIF---YFTY-LVKLSELL----ETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIA 387 (558)
Q Consensus 316 ~~l~~~~~~~---~~~g-~~g~~~~~----~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a 387 (558)
+||..++.++ +++| ++|++... ++.+++++|+.|||+.++..|++|++++||+++|++++|++++++|+|||
T Consensus 208 ~rL~~~~~~~~~~pLGg~AvGt~~~~~~~~~~~v~~~~a~~LGl~~~~~~n~~~a~~~rd~~~e~~~~l~~~a~~L~riA 287 (450)
T cd01357 208 ARIYKARERLREVNLGGTAIGTGINAPPGYIELVVEKLSEITGLPLKRAENLIDATQNTDAFVEVSGALKRLAVKLSKIA 287 (450)
T ss_pred HHHHHHHHHHHHhCCCCCceeCCCCCChhHHHHHHHHHHHHhCCCCccCcCHHHHHhccHHHHHHHHHHHHHHHHHHHHH
Confidence 9998776544 5555 67776543 35688999999999976778999999999999999999999999999999
Q ss_pred hhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHH
Q psy10160 388 NDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRS 467 (558)
Q Consensus 388 ~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (558)
+||++|+|+||+|||||.+|++++|||||||||||+.+|+++++|+++.|++.+++....+.+++.+...|.....++..
T Consensus 288 ~Di~l~ss~e~~~~gev~~p~~~~GSSiMPqKrNP~~~E~ir~~a~~v~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (450)
T cd01357 288 NDLRLLSSGPRAGLGEINLPAVQPGSSIMPGKVNPVIPEVVNQVAFQVIGNDLTITMAAEAGQLELNVFEPVIAYNLLES 367 (450)
T ss_pred HHHHHHhcCCcCCceeEECCCCCCcCCCCCCCcCcHHHHHHHHHHHHHhhHHHHHHHHHhcCcchhhcchHHHHHHHHHH
Confidence 99999999999999999999889999999999999999999999999999999886666777777776666667777777
Q ss_pred HHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhh
Q psy10160 468 IRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNK 547 (558)
Q Consensus 468 ~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~ 547 (558)
+..+..++..+...++++|+||++||+++++.+++++|+||+.|||+.||++++.|.++|++++|++.+.+.|+++||++
T Consensus 368 ~~~~~~~l~~~~~~~l~~l~v~~erm~~~l~~~~~~~t~La~~lg~~~a~~~~~~a~~~g~~l~e~~~~~~~l~~~el~~ 447 (450)
T cd01357 368 IDILTNAVRTLRERCIDGITANEERCREYVENSIGIVTALNPYIGYEAAAEIAKEALETGRSVRELVLEEGLLTEEELDE 447 (450)
T ss_pred HHHHHHHHHHHHHHHHccCEECHHHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHhcCCCCHHHHHH
Confidence 77777766555457999999999999999999999999999999999999999999999999999999988899999999
Q ss_pred hcC
Q psy10160 548 WVV 550 (558)
Q Consensus 548 ~~~ 550 (558)
++|
T Consensus 448 ~~~ 450 (450)
T cd01357 448 ILS 450 (450)
T ss_pred HhC
Confidence 986
No 14
>cd01596 Aspartase_like aspartase (L-aspartate ammonia-lyase) and fumarase class II enzymes. This group contains aspartase (L-aspartate ammonia-lyase), fumarase class II enzymes, and related proteins. It is a member of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. Aspartase catalyzes the reversible deamination of aspartic acid. Fumarase catalyzes the reversible hydration/dehydration of fumarate to L-malate during the Krebs cycle.
Probab=100.00 E-value=6.7e-53 Score=427.25 Aligned_cols=305 Identities=51% Similarity=0.697 Sum_probs=267.3
Q ss_pred eecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchH
Q psy10160 244 CQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPND 315 (558)
Q Consensus 244 ~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~ 315 (558)
+|+|.+.+++..++.. ...+.....+...+.. ...+ ++++|.||||+|+|+|+|||||+++ |++.|.|++
T Consensus 130 ~h~g~SrnD~v~t~~~-L~lr~~l~~l~~~l~~l~~~L~~lA~~~~~t~m~grTH~Q~A~P~T~G~~~~~-~~~~l~r~~ 207 (450)
T cd01596 130 NNSQSSNDDFPPAAHI-AAALALLERLLPALEQLQDALDAKAEEFADIVKIGRTHLQDAVPLTLGQEFSG-YAAQLARDI 207 (450)
T ss_pred CCCCCCchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCeeeccccccCCeeehHHHHHHH-HHHHHHHHH
Confidence 4577777777777654 3444444333333322 2223 7899999999999999999999998 999999999
Q ss_pred HHHHhHhhh---hhhhc-CCCCChhHH----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHh
Q psy10160 316 RQALNIVSI---FYFTY-LVKLSELLE----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIA 387 (558)
Q Consensus 316 ~~l~~~~~~---~~~~g-~~g~~~~~~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a 387 (558)
+||..++.+ ++++| ++|++...+ +.+++++|+.|||+.++.+|++||+++||+++++++++++++++|+|||
T Consensus 208 ~rL~~~~~~~~~~plGg~A~Gt~~~~~~~~~~~v~~~~a~~LGl~~~~~~n~~d~~~~rd~~~e~~~~la~~~~~l~ria 287 (450)
T cd01596 208 ARIEAALERLRELNLGGTAVGTGLNAPPGYAEKVAAELAELTGLPFVTAPNLFEATAAHDALVEVSGALKTLAVSLSKIA 287 (450)
T ss_pred HHHHHHHHHHHHhCCCCcceeCCCCCChhHHHHHHHHHHHHhCCCCccCcCHHHHHhcchHHHHHHHHHHHHHHHHHHHH
Confidence 999877654 45555 677765433 4678999999999977889999999999999999999999999999999
Q ss_pred hhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHH
Q psy10160 388 NDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRS 467 (558)
Q Consensus 388 ~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (558)
+||++|+|+||+|||||.+|++++|||||||||||+.+|+++++++++.|.+..++...+..++|++...|...+.++++
T Consensus 288 ~Dl~~~ss~~~~e~gev~~~~~~~GSS~MPqKrNP~~~E~ir~~a~~~~g~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~ 367 (450)
T cd01596 288 NDLRLLSSGPRAGLGEINLPANQPGSSIMPGKVNPVIPEAVNMVAAQVIGNDTAITMAGSAGQLELNVFKPVIAYNLLQS 367 (450)
T ss_pred HHHHHHcCCCcCCCeeEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHhccHHHHHHHhhcCcccccchhhHHHHHHHHH
Confidence 99999999889999999999989999999999999999999999999999999998888999999977776656779999
Q ss_pred HHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhh
Q psy10160 468 IRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNK 547 (558)
Q Consensus 468 ~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~ 547 (558)
++.+.++++.++..++++|+||++||++++..++.++|+||+.|||+.||+++++|.++|+++.+++.+.+.|+++++++
T Consensus 368 ~~~~~~~~~~~~~~~l~~l~v~~~rm~~~l~~~~~~~t~LA~~lg~~~a~~~v~~a~~~g~~l~~~~~~~~~~~~~~l~~ 447 (450)
T cd01596 368 IRLLANACRSFRDKCVEGIEANEERCKEYVENSLMLVTALNPHIGYEKAAEIAKEALKEGRTLREAALELGLLTEEELDE 447 (450)
T ss_pred HHHHHHHHHHHHHHHHccCEECHHHHHHHHHhCcchHHHHhHHHhHHHHHHHHHHHHHcCCCHHHHHHHhCCCCHHHHHH
Confidence 99999999999988999999999999999999999999999999999999999999999999999999888899999999
Q ss_pred hcC
Q psy10160 548 WVV 550 (558)
Q Consensus 548 ~~~ 550 (558)
++|
T Consensus 448 ~~d 450 (450)
T cd01596 448 ILD 450 (450)
T ss_pred HhC
Confidence 886
No 15
>PRK09053 3-carboxy-cis,cis-muconate cycloisomerase; Provisional
Probab=100.00 E-value=1e-53 Score=437.41 Aligned_cols=308 Identities=22% Similarity=0.208 Sum_probs=268.0
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
.+.++|+|.+++|+.+++.. ...+.....+...+.. ...+ ++++|.||||+|+|+|+||||++++ |++.|
T Consensus 98 ~~~~vH~G~SsnDi~~Ta~~-l~lr~~l~~l~~~l~~l~~~L~~~A~~~~~t~~~GrTH~Q~A~P~T~G~~~~~-~~~~l 175 (452)
T PRK09053 98 AARYVHWGATSQDIIDTGLV-LQLRDALDLLEPDLDRLCDALATLAARHRATPMVGRTWLQQALPVTLGLKFAG-WLDAL 175 (452)
T ss_pred hhccccCCCChhhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHccCCeeehhccCCcceechHHHHHHH-HHHHH
Confidence 36789999999999998876 4455444444333332 2233 8899999999999999999999998 99999
Q ss_pred cchHHHHHhHh---hhhhhhcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIV---SIFYFTYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMK 385 (558)
Q Consensus 312 ~~~~~~l~~~~---~~~~~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k 385 (558)
.|+++||.+++ ..++++|++|++++++ +.+++++|+.|||+.+...| +++||+++|++++|+.++++|+|
T Consensus 176 ~r~~~RL~~~~~~~~~~~lGgavGt~~~~~~~~~~v~~~~a~~LGl~~~~~~~----~~~rD~~~e~~~~la~la~~L~k 251 (452)
T PRK09053 176 LRHRQRLAALRPRALVLQFGGAAGTLASLGEQALPVAQALAAELQLALPALPW----HTQRDRIAEFASALGLLAGTLGK 251 (452)
T ss_pred HHHHHHHHHHHhhhhhccccchhhcccccccchHHHHHHHHHHcCCCCCCCCc----ccccHHHHHHHHHHHHHHHHHHH
Confidence 99999998776 5566788899977543 56789999999999766665 79999999999999999999999
Q ss_pred HhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHH
Q psy10160 386 IANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSN 463 (558)
Q Consensus 386 ~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (558)
||+||++|+ ++||||+.+|+ +++|||||||||||+.+|+++++|+++.|++..++ ....+++|++.+.|..+|.
T Consensus 252 ia~Di~ll~---~~e~gev~e~~~~~~~GSSiMP~KrNPv~~E~i~~~a~~v~g~~~~~~-~~~~~~~erd~~~~~~~~~ 327 (452)
T PRK09053 252 IARDVSLLM---QTEVGEVFEPAAAGKGGSSTMPHKRNPVGCAAVLTAATRAPGLVATLF-AAMPQEHERALGGWHAEWD 327 (452)
T ss_pred HHHHHHHHh---ccccchhhccccCCCCCcCCCCCCCCchHHHHHHHHHHHHHHHHHHHH-HhChhhhcccCCccHHHHH
Confidence 999999999 59999998886 47999999999999999999999999999999884 6667899999999999998
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhh------hhcccccChHHHHHH----HHHHHHcCCCHHHH
Q psy10160 464 VLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLV------TALNPHIGYDKAAKI----AKTAHKEGTTLKVA 533 (558)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~------~~la~~l~~~~a~~~----~~~a~~~~~~~~~~ 533 (558)
.++++..+...++..+..++++|+||++||+++++.+.+++ +.|++.+||++||++ ++.+.++|++++++
T Consensus 328 ~l~~~~~~~~~al~~~~~~l~~l~v~~erm~~~l~~s~~~~~ae~~~~~La~~lgr~~Ah~iV~~~~~~a~~~g~~~~~~ 407 (452)
T PRK09053 328 TLPELACLAAGALAQMAQIVEGLEVDAARMRANLDLTHGLILAEAVMLALADRIGRLDAHHLVEQASKRAVAEGRHLRDV 407 (452)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCEECHHHHHHHHHhcCCHHHHHHHHHHHHhccCHHHHHHHHHHHHHHHHHHCCCHHHH
Confidence 99999999999999999999999999999999998766444 899999999999998 56678899999999
Q ss_pred HHHc----CCCCHHHHhhhcCcccccCC
Q psy10160 534 ALKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 534 ~~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
+.+. ..|+++++++++||.+|+|.
T Consensus 408 ~~~~~~~~~~l~~~~l~~~l~P~~~~g~ 435 (452)
T PRK09053 408 LAEDPQVSAHLSPAALDRLLDPAHYLGQ 435 (452)
T ss_pred HHhChhhhccCCHHHHHHHcCHHHHhcc
Confidence 9875 66899999999999999985
No 16
>PRK08470 adenylosuccinate lyase; Provisional
Probab=100.00 E-value=7.4e-53 Score=427.95 Aligned_cols=308 Identities=18% Similarity=0.122 Sum_probs=266.0
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhhh-------hhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAE-------AAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~-------~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+++|+.+++.. ...+.....+...+... ... ++++|.||||+|+|+|+||||++++ |++.|.
T Consensus 85 ~~~vH~G~TsnDi~dTa~~-L~lr~~l~~l~~~l~~l~~~L~~lA~~~~~t~m~grTH~Q~A~P~TfG~~~a~-~~~~l~ 162 (442)
T PRK08470 85 SRFVHYGMTSSDCIDTAVA-LQMRDSLKLIIEDVKNLMEAIKKRALEHKDTLMVGRSHGIHGEPITFGLVLAI-WYDEIK 162 (442)
T ss_pred ccceecCCChhchHhHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCeeecccCCCcCeehhHHHHHHH-HHHHHH
Confidence 6889999999999999877 55555554444444332 223 7899999999999999999999998 999999
Q ss_pred chHHHHHhHh---hhhhhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 313 PNDRQALNIV---SIFYFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 313 ~~~~~l~~~~---~~~~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|+++||.+++ ..++++|++|++++++..+++++++.|||+.++++| ++++||+++|++++|++++++|+|||+|
T Consensus 163 r~~~RL~~~~~~~~~~~lgGAvGt~a~~~~~v~~~~a~~LGl~~~~~~~---~v~~RD~~~e~~~~La~~a~~L~ria~D 239 (442)
T PRK08470 163 RHLKALEHTMEVISVGKISGAMGNFAHAPLELEELVCEELGLKPAPVSN---QVIQRDRYARLASALALLASSCEKIAVA 239 (442)
T ss_pred HHHHHHHHHHHHhhhhcCcchhcccccCChHHHHHHHHHcCCCCCCCCC---CccCcHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999776 455667899999999877899999999999778888 5799999999999999999999999999
Q ss_pred hhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRS 467 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (558)
|++|++ +||+|+.++. +++|||||||||||+.+|+++++++.+.|.+..++ .....+++++...|..+|..+|+
T Consensus 240 i~~l~~---~E~~ev~e~~~~g~~GSS~MPhKrNPv~~E~i~~~a~~~~~~~~~~~-~~~~~~~eRD~~~~~~e~~~l~~ 315 (442)
T PRK08470 240 IRHLQR---TEVYEAEEYFSKGQKGSSAMPHKRNPVLSENITGLCRVIRSFATPAL-ENVALWHERDISHSSVERFILPD 315 (442)
T ss_pred HHHHhc---cccceecccCCCCCCCcCCCCCCcCcHHHHHHHHHHHHHHHHHHHHH-HhchHhhccCCchhHHHhhhHHH
Confidence 999995 9999999884 68999999999999999999999999999986665 44467799999888899999999
Q ss_pred HHHHHHHHHHHHHhhhcCcccCHHHHHHHHhh--hHhhhhhc----cc-ccChHHHHHHHH----HHHHc---CCC----
Q psy10160 468 IRLIADSATAFTDKCVSGIVANEENIHRLLHE--SLMLVTAL----NP-HIGYDKAAKIAK----TAHKE---GTT---- 529 (558)
Q Consensus 468 ~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~--~~~~~~~l----a~-~l~~~~a~~~~~----~a~~~---~~~---- 529 (558)
+..+...++..+..++++|+||++||++|++. ++++++++ ++ .+||++||++|+ ++.++ |++
T Consensus 316 ~~~~~~~~l~~~~~~l~~l~v~~~rm~~nl~~~~g~~~ae~l~~~L~~~G~~~~~Ah~~V~~~~~~a~~~~~~~~~~~~~ 395 (442)
T PRK08470 316 AFITTDFMLHRLNNVIENLVVYPENMMKNLNLTGGLVFSQRVLLELPKKGVSREDAYKIVQRNAMKVWEDLQQGKAAINE 395 (442)
T ss_pred HHHHHHHHHHHHHHHHccCEECHHHHHHHHHhccChHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHhhcCCCcccc
Confidence 99999999999999999999999999999965 56666554 44 478999999764 45566 888
Q ss_pred -----HHHHHHHc----CCCCHHHHhhhcCcccccCC
Q psy10160 530 -----LKVAALKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 530 -----~~~~~~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
|.|.+.+. ..+++++|+.+|||++|+|.
T Consensus 396 ~~~~~l~~~l~~~~~~~~~~~~~~l~~~~dp~~~~g~ 432 (442)
T PRK08470 396 KGESLFLQALLNDEDLRKSLSEEEIRACFDYSYYTKN 432 (442)
T ss_pred ccHHHHHHHHhcCHHhHhcCCHHHHHHHhCHHHHHhh
Confidence 99988764 56899999999999999984
No 17
>PRK07492 adenylosuccinate lyase; Provisional
Probab=100.00 E-value=7.2e-53 Score=425.87 Aligned_cols=308 Identities=16% Similarity=0.139 Sum_probs=266.1
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhhhh-------hh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAEA-------AA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~~-------~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+++|+.+++.. ...+.....+...+.... .. ++++|.||||+|+|+|+||||++++ |++.|.
T Consensus 88 ~~~vH~G~Ts~Di~dTa~~-L~lr~~~~~l~~~l~~l~~~L~~~A~~~~~t~m~grTH~Q~A~P~TfG~~~a~-~~~~l~ 165 (435)
T PRK07492 88 ARFVHQGMTSSDVLDTCLN-VQLVRAADLLLADLDRVLAALKKRAFEHKDTPTIGRSHGIHAEPTTFGLKLAR-FYAEFA 165 (435)
T ss_pred hhhhcCCCChhhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEEeeccCCccceehhHHHHHHH-HHHHHH
Confidence 7899999999999999877 555555555554444322 23 7899999999999999999999998 999999
Q ss_pred chHHHHHhHh---hhhhhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 313 PNDRQALNIV---SIFYFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 313 ~~~~~l~~~~---~~~~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|+++||+++. .+++++|++||++.+++.+++++++.|||+.++..| ++++||+++|++++|++++++|+|||+|
T Consensus 166 r~~~rL~~~~~~~~~~~lgGAvGT~~~~~~~~~~~~a~~LGl~~~~~~~---~v~~RD~~~e~~~~la~~~~~L~ria~D 242 (435)
T PRK07492 166 RNRERLVAAREEIATCAISGAVGTFANIDPRVEEHVAKKLGLKPEPVST---QVIPRDRHAMFFATLGVIASSIERLAIE 242 (435)
T ss_pred HHHHHHHHHHHhhhhccCcccccCCccCChHHHHHHHHHhCCCCCCccc---cccccHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999998775 566778899999988888889999999999765554 4699999999999999999999999999
Q ss_pred hhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRS 467 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (558)
|++|+ ++||+|+.++. +++|||||||||||+.+|+++++++.+.|.+..++ .....+++++...|..+|.++|+
T Consensus 243 i~~l~---~~e~~El~e~~~~g~~GSS~MPhKrNP~~~E~i~~~a~~~~~~~~~~~-~~~~~~~eRD~~~~~~e~~~lp~ 318 (435)
T PRK07492 243 IRHLQ---RTEVLEAEEFFSPGQKGSSAMPHKRNPVLTENLTGLARLVRSYVVPAM-ENVALWHERDISHSSVERMIGPD 318 (435)
T ss_pred HHHHh---ccccchhccccCCCCCCCCCCCCCCCcHHHHHHHHHHHHHHHHHHHHH-HhcchhhccCChHHHHhhhHHHH
Confidence 99999 59999999874 68999999999999999999999999999976664 44467789999889999999999
Q ss_pred HHHHHHHHHHHHHhhhcCcccCHHHHHHHHhh--hHhhhhhc----cc-ccChHHHHHHHH----HHHHcCCCHHHHHHH
Q psy10160 468 IRLIADSATAFTDKCVSGIVANEENIHRLLHE--SLMLVTAL----NP-HIGYDKAAKIAK----TAHKEGTTLKVAALK 536 (558)
Q Consensus 468 ~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~--~~~~~~~l----a~-~l~~~~a~~~~~----~a~~~~~~~~~~~~~ 536 (558)
+..+...++..+..++++|+||++||++|++. ++++++.+ ++ .+||++||++|+ ++.++|++|.|.+.+
T Consensus 319 ~~~~~~~~l~~~~~~l~~L~v~~~rm~~nl~~~~g~i~ae~~~~~L~~~g~~r~~Ah~~V~~~~~~a~~~~~~l~e~l~~ 398 (435)
T PRK07492 319 ATITLDFALNRLAGVIEKLVVYPENMLKNLNKFGGLVHSQRVLLALTQAGVSREDAYRLVQRNAMKVWEQGGDFLEELKA 398 (435)
T ss_pred HHHHHHHHHHHHHHHHccCEECHHHHHHHHhhcCChhHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHhCCCHHHHHhC
Confidence 99999999999999999999999999999984 55555444 45 489999998654 566789999999886
Q ss_pred c----CCCCHHHHhhhcCcccccCC
Q psy10160 537 L----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 537 ~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
+ ..|+++||++++||++|+|.
T Consensus 399 ~~~~~~~l~~~el~~~~dp~~ylg~ 423 (435)
T PRK07492 399 DPEVRAALSEEEIEELFDLGYHTKH 423 (435)
T ss_pred CHHhHhcCCHHHHHHHhCHHHHhcc
Confidence 4 57899999999999999985
No 18
>PRK07380 adenylosuccinate lyase; Provisional
Probab=100.00 E-value=1.6e-52 Score=422.88 Aligned_cols=309 Identities=18% Similarity=0.150 Sum_probs=266.2
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccccchhhhhh-------hhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAE-------AAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~-------~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
.+.++|+|.+++|+.+++.. ...+.....+...+... ..+ ++++|.||||+|+|+|+||||++++ |++.|
T Consensus 84 ~~~~vH~G~Ts~Di~dTa~~-L~lr~~l~~l~~~l~~l~~~L~~lA~~~~~t~m~grTH~Q~A~P~TfG~~~a~-~~~~l 161 (431)
T PRK07380 84 AGRYIHLGMTSSDVLDTGLA-LQLVASLDLLLEELEDLIQAIRYQAREHRNTVMIGRSHGIHAEPITFGFKLAG-WLAET 161 (431)
T ss_pred hhccccCCCChhhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCeeechhcCccceechHHHHHHH-HHHHH
Confidence 37899999999999999877 55555555544444432 223 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhh---hhhhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhh
Q psy10160 312 DPNDRQALNIVS---IFYFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAN 388 (558)
Q Consensus 312 ~~~~~~l~~~~~---~~~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~ 388 (558)
.|+++||.+++. .++++|++||++.+++.+++++++.|||+.+..+| ++.+||+++|++++|++++++|+|||+
T Consensus 162 ~r~~~RL~~~~~~~~~~~l~GAvGt~~~~~~~~~~~~a~~LGl~~~~~~~---~v~~rd~~~e~~~~la~~a~~L~kia~ 238 (431)
T PRK07380 162 LRNRERLVRLREDIAVGQISGAVGTYANTDPRVEAITCQKLGLKPDTAST---QVISRDRHAEYVQTLALVGASLERFAT 238 (431)
T ss_pred HHHHHHHHHHHHHHhccCcchhhcCcccCChhHHHHHHHHcCCCCCCCCC---CccCcHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999997764 45667889999988888888999999999766554 579999999999999999999999999
Q ss_pred hhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHH
Q psy10160 389 DIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLR 466 (558)
Q Consensus 389 d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (558)
||++|+ +.||+|+.++. +++|||||||||||+.+|+++++|+.+.|.+..++ .....++|++...|..+|..++
T Consensus 239 Di~~l~---~~~~~el~e~~~~g~~GSS~MPhKrNP~~~E~i~~~a~~~~g~~~~~~-~~~~~~~eRD~~~~~~e~~~l~ 314 (431)
T PRK07380 239 EIRNLQ---RTDVLEVEEYFAKGQKGSSAMPHKRNPIRSERLSGLARVLRSYAVAAL-ENVALWHERDISHSSVERVMLP 314 (431)
T ss_pred HHHHhc---ccCceeecccCCCCCCCCcCCCCCCCCHHHHHHHHHHHHHHHHHHHHH-HhchhhhccCchHHHHHHHHHH
Confidence 999999 59999998774 68999999999999999999999999999998764 4445778999988889999999
Q ss_pred HHHHHHHHHHHHHHhhhcCcccCHHHHHHHHh--hhHhhhhhc----cc-ccChHHHHHHH----HHHHH-cCCCHHHHH
Q psy10160 467 SIRLIADSATAFTDKCVSGIVANEENIHRLLH--ESLMLVTAL----NP-HIGYDKAAKIA----KTAHK-EGTTLKVAA 534 (558)
Q Consensus 467 ~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~--~~~~~~~~l----a~-~l~~~~a~~~~----~~a~~-~~~~~~~~~ 534 (558)
++..+...++..+..++++|+||++||++|++ .++++++++ ++ .+||++||++| ++|.+ +|.+|.|++
T Consensus 315 ~~~~~~~~~l~~~~~~l~~L~v~~~rm~~nl~~~~g~~~ae~~~~~Lv~~gl~r~~Ah~~V~~~~~~a~~~~~~~l~e~l 394 (431)
T PRK07380 315 DCSILLHFMLREMTDLVKNLLVYPENMRRNMNIYGGVVFSQRVLLALVEKGMSREEAYRLVQKNAHTAWNTEGGNFRANL 394 (431)
T ss_pred HHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhcCChHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHhCCCHHHHH
Confidence 99999999999999999999999999999996 566555554 45 48999999865 46677 899999999
Q ss_pred HHc----CCCCHHHHhhhcCcccccCC
Q psy10160 535 LKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 535 ~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
.++ ..|+++||++++||++|+|.
T Consensus 395 ~~~~~~~~~l~~~~l~~~~dp~~ylg~ 421 (431)
T PRK07380 395 EADPEVTQLLSAAELADCFDPQLHLKN 421 (431)
T ss_pred HcChHhhhcCCHHHHHHhhCHHHHhcc
Confidence 975 46899999999999999985
No 19
>cd03302 Adenylsuccinate_lyase_2 Adenylsuccinate lyase (ASL)_subgroup 2. This subgroup contains mainly eukaryotic proteins similar to ASL, a member of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. ASL catalyzes two steps in the de novo purine biosynthesis: the conversion of 5-aminoimidazole-(N-succinylocarboxamide) ribotide (SAICAR) into 5-aminoimidazole-4-carboxamide ribotide (AICAR) and, the conversion of adenylsuccinate (SAMP) into adenosine monophosphate (AMP). ASL deficiency has been linked to several pathologies including psychomotor retardation with autistic features, epilepsy and muscle wasting.
Probab=100.00 E-value=6.7e-52 Score=420.84 Aligned_cols=309 Identities=18% Similarity=0.116 Sum_probs=264.7
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccccchhhhhh-------hhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAE-------AAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~-------~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
.+.++|+|.|++++.+++.. ...+.....+...+... ..+ ++++|.||||+|+|+|+||||++++ |++.|
T Consensus 86 ~~~~vH~G~TS~Di~dta~~-L~lr~a~~~l~~~L~~l~~~L~~~A~~~~dt~m~GrTH~Q~A~P~TfG~~~a~-~~~~L 163 (436)
T cd03302 86 AAGIIHLGATSCFVTDNTDL-IQIRDALDLILPKLAAVIDRLAEFALEYKDLPTLGFTHYQPAQLTTVGKRACL-WIQDL 163 (436)
T ss_pred ccCeeeeCcCHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCeeeccccCCccccchHHHHHHH-HHHHH
Confidence 36899999999999998877 56666655554444432 223 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhhhhhh---hcCCCCChhHH----------HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIVSIFYF---TYLVKLSELLE----------TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNT 378 (558)
Q Consensus 312 ~~~~~~l~~~~~~~~~---~g~~g~~~~~~----------~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~ 378 (558)
.|+++||.+++.+++. +|++|++++++ +.+++++++.|||..+ . +..+++++||+++|++++|++
T Consensus 164 ~r~~~RL~~~~~~~~~~~~~GavGt~a~~~~~~~~dr~~~~~v~~~~a~~LGl~~~-~-~~~~~v~~rD~~~e~~~~la~ 241 (436)
T cd03302 164 LMDLRNLERLRDDLRFRGVKGTTGTQASFLDLFEGDHDKVEALDELVTKKAGFKKV-Y-PVTGQTYSRKVDIDVLNALSS 241 (436)
T ss_pred HHHHHHHHHHHHHHHhhcCcChhhhhHHHHhcCCchHHHHHHHHHHHHHHcCCCCC-C-CchhhhhccHHHHHHHHHHHH
Confidence 9999999988766654 67899988773 3456899999999954 2 333478999999999999999
Q ss_pred HHHHHHHHhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccc
Q psy10160 379 VAVSLMKIANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVF 456 (558)
Q Consensus 379 ~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (558)
++++|+|||+||++|+| +||+.+|. +++|||||||||||+.+|+++++|+.+.|++..++...+.+++|+|..
T Consensus 242 ~a~~L~riA~Dl~l~~s-----~~el~e~~~~g~~GSS~MPhKrNPv~~E~i~~~a~~~~g~~~~~~~~~~~~~~Erd~~ 316 (436)
T cd03302 242 LGATAHKIATDIRLLAN-----LKEVEEPFEKGQIGSSAMPYKRNPMRSERCCSLARHLMNLASNAAQTASTQWFERTLD 316 (436)
T ss_pred HHHHHHHHHHHHHHHhh-----CceecccccCCCCCcccCCCccCcHHHHHHHHHHHHHHhhHHHHHHHhhccccccCCc
Confidence 99999999999999995 89999994 589999999999999999999999999999999987888899999999
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhh--Hhhh----hhccc-ccChHHHHHHHH----HHHH
Q psy10160 457 KPLIVSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHES--LMLV----TALNP-HIGYDKAAKIAK----TAHK 525 (558)
Q Consensus 457 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~--~~~~----~~la~-~l~~~~a~~~~~----~a~~ 525 (558)
.|..+|..++++..+..+++.++..++++|+||++||++|++.+ ++++ ..|++ .+||++||++|+ ++.+
T Consensus 317 ~~~~~~~~l~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~l~~~~g~~~se~~~~~L~~~g~~~~~Ah~~v~~~~~~~~~ 396 (436)
T cd03302 317 DSANRRIAIPEAFLAADAILITLQNISEGLVVYPKVIERHIRQELPFMATENIIMAAVKAGGDRQDAHERIRVLSHQAAA 396 (436)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHcCCEECHHHHHHHHHhccChHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999875 4443 34555 489999998765 5556
Q ss_pred c------CCCHHHHHHHcCC--CCHHHHhhhcCcccccCC
Q psy10160 526 E------GTTLKVAALKLGY--LTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 526 ~------~~~~~~~~~~~~~--l~~~~~~~~~~p~~~~~~ 557 (558)
+ |.+|+|++.++.. -++++|++++||+.|+|.
T Consensus 397 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~dp~~~~g~ 436 (436)
T cd03302 397 VVKQEGGDNDLIERIKNDAYFKPIWDELDALLDPKTFIGR 436 (436)
T ss_pred HhhcccCCCCHHHHHhcCCCcCCCHHHHHHHhCHHhhhCc
Confidence 7 9999999997631 188899999999999984
No 20
>cd01597 pCLME prokaryotic 3-carboxy-cis,cis-muconate cycloisomerase (CMLE)_like. This subgroup contains pCLME and related proteins, and belongs to the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. CMLE catalyzes the cyclization of 3-carboxy-cis,cis-muconate (3CM) to 4-carboxy-muconolactone in the beta-ketoadipate pathway. This pathway is responsible for the catabolism of a variety of aromatic compounds into intermediates of the citric cycle in prokaryotic and eukaryotic micro-organisms.
Probab=100.00 E-value=1.8e-51 Score=420.72 Aligned_cols=307 Identities=24% Similarity=0.265 Sum_probs=260.9
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|.|.+.+|+..++.. ...+.....+...+.. ...+ .+++|.||||+|+|+|+|+|||+++ |+..|.
T Consensus 90 g~~lH~grSrnD~~~Ta~~-l~lr~~l~~l~~~l~~l~~~L~~~A~~~~~~~m~grTH~Q~A~P~T~G~~~~~-~~~~l~ 167 (437)
T cd01597 90 GEYVHWGATTQDIIDTALV-LQLRDALDLLERDLDALLDALARLAATHRDTPMVGRTHLQHALPITFGLKVAV-WLSELL 167 (437)
T ss_pred cCeeecCccHhHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCeeehhhcCccceechHHHHHHH-HHHHHH
Confidence 5788999999999888866 4444444333333322 2233 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhh---hhhhhcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHH
Q psy10160 313 PNDRQALNIVS---IFYFTYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKI 386 (558)
Q Consensus 313 ~~~~~l~~~~~---~~~~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~ 386 (558)
|+++||.+++. .+.+||++|++++++ +.+++++|+.|||+.+... ++++||+++|++++++.++++|+||
T Consensus 168 r~~~rL~~~~~~~~~~~lGga~Gtg~~~~~~~~~~~~~~a~~LGf~~~~~~----~~~~rd~~~e~~~~l~~~a~~l~rl 243 (437)
T cd01597 168 RHRERLDELRPRVLVVQFGGAAGTLASLGDQGLAVQEALAAELGLGVPAIP----WHTARDRIAELASFLALLTGTLGKI 243 (437)
T ss_pred HHHHHHHHHHHhhhhhccccccccccccCCcHHHHHHHHHHHcCCCCCCCc----cccCcHHHHHHHHHHHHHHHHHHHH
Confidence 99999998775 455677888888775 4689999999999976543 5899999999999999999999999
Q ss_pred hhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHH
Q psy10160 387 ANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNV 464 (558)
Q Consensus 387 a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (558)
|+||++|++ +||||+.+|+ .++|||||||||||+.+|+++++++++.|+.+.++. ...+++++|.+.|...|..
T Consensus 244 a~Dl~l~s~---~e~gel~~~~~~~~~GSSiMPqK~NP~~~E~i~~~a~~~~g~~~~~~~-~~~~~~erd~~~~~~~~~~ 319 (437)
T cd01597 244 ARDVYLLMQ---TEIGEVAEPFAKGRGGSSTMPHKRNPVGCELIVALARRVPGLAALLLD-AMVQEHERDAGAWHAEWIA 319 (437)
T ss_pred HHHHHHHhc---cccceeecccCCCCCCCCCCCCCcCcHHHHHHHHHHHHHHHHHHHHHH-hchhhcccCCchhHHHHHH
Confidence 999999995 8999999997 699999999999999999999999999999877654 4457899999888888999
Q ss_pred HHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhh------hhcccccChHHHHHH----HHHHHHcCCCHHHHH
Q psy10160 465 LRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLV------TALNPHIGYDKAAKI----AKTAHKEGTTLKVAA 534 (558)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~------~~la~~l~~~~a~~~----~~~a~~~~~~~~~~~ 534 (558)
++++..+...++.++..++++|+||++||++++..++++. ..|++.+||++||++ ++.+.++|.++.+++
T Consensus 320 l~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~~~~~~~~~~ae~l~~~l~~~i~~~~Ah~~v~~~~~~a~~~g~~~~~~~ 399 (437)
T cd01597 320 LPEIFLLASGALEQAEFLLSGLEVNEDRMRANLDLTGGLILSEAVMMALAPKLGRQEAHDLVYEACMRAVEEGRPLREVL 399 (437)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCEECHHHHHHHHHhccChHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCHHHHH
Confidence 9888888888888999999999999999999997655432 366677999999987 566778999999998
Q ss_pred HHc----CCCCHHHHhhhcCcccccCC
Q psy10160 535 LKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 535 ~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
.+. ..++++++++++||++|+|+
T Consensus 400 ~~~~~~~~~l~~~~l~~~ldp~~~v~~ 426 (437)
T cd01597 400 LEDPEVAAYLSDEELDALLDPANYLGS 426 (437)
T ss_pred HhChhhhccCCHHHHHHhcCHHHHhcc
Confidence 875 56889999999999999975
No 21
>COG0165 ArgH Argininosuccinate lyase [Amino acid transport and metabolism]
Probab=100.00 E-value=2.2e-51 Score=400.97 Aligned_cols=267 Identities=21% Similarity=0.270 Sum_probs=236.4
Q ss_pred hhhhhcccccchhhhhhhHHHhhcccccccccchHHHHHhHhhhhhhhc-CCCCChhHH-HHHHHHHHhHhCCCcccCCC
Q psy10160 281 ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQALNIVSIFYFTY-LVKLSELLE-TKCAAKIAELTGLPFKSAPN 358 (558)
Q Consensus 281 ~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~l~~~~~~~~~~g-~~g~~~~~~-~~~~~~~a~~lg~~~~~~~~ 358 (558)
.+++|+|+||+|.|||+|+|||+.+ |++.|.||++|+.+++.+++.+| +.|+++|.+ +++|+++|+.|||+ .+..|
T Consensus 148 ~~~imPGyTHlQ~AQPvtf~H~lla-y~~~l~RD~~Rl~d~~~rvn~sPLGagAlaGt~~~iDR~~tA~lLGF~-~~~~N 225 (459)
T COG0165 148 AETVMPGYTHLQRAQPVTFAHHLLA-YAEMLARDIERLRDALKRVNVSPLGAGALAGTPFPIDRERTAELLGFD-AVTRN 225 (459)
T ss_pred cCCccCCcccccccCcCcHHHHHHH-HHHHHHHHHHHHHHHHHHhccCCccccccCCCCCCCCHHHHHHHcCCc-hhhcC
Confidence 7899999999999999999999998 99999999999999999999995 344444444 58999999999999 78999
Q ss_pred hhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhhhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHc
Q psy10160 359 KFEALAAHDALVEVSGALNTVAVSLMKIANDIRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMG 437 (558)
Q Consensus 359 ~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~ 437 (558)
++|++++||+++|+++++++++.+|+|||+||.+|+| .|||+|.+|+. .+|||||||||||+.+|++|+.+++++|
T Consensus 226 sldavs~Rdf~le~l~~~s~~~~~LSRlaedlI~wss---~EfgfI~l~D~~sTGSSIMPQKKNPD~~ELiRgk~grv~G 302 (459)
T COG0165 226 SLDAVSDRDFILEFLSAAALIMVHLSRLAEDLILWSS---PEFGFIELPDEFSTGSSIMPQKKNPDVLELIRGKAGRVIG 302 (459)
T ss_pred chhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHcc---ccCceEeCCcccccccccCCCCCCCcHHHHHHHhhhhhHH
Confidence 9999999999999999999999999999999999998 89999999986 8999999999999999999999999999
Q ss_pred ccHHHHhhccccccccccchhhH--HHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccc-----
Q psy10160 438 NHVAVTIGGSNGHFELNVFKPLI--VSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPH----- 510 (558)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~----- 510 (558)
++.+++..+++ ++..|+++++ +..+|+++..+..++..+. .++++|+||+|+|++.+.+++++||+||++
T Consensus 303 ~l~~ll~~~k~--lPlaYnrDlQedke~lfds~~t~~~~l~~~~-~mv~~l~vn~e~~~~a~~~gfs~aTdlAd~lv~kG 379 (459)
T COG0165 303 ALTGLLTIMKG--LPLAYNRDLQEDKEPLFDSVDTLEDSLRVLA-GMVSGLTVNKERMREAAEAGFSTATDLADYLVRKG 379 (459)
T ss_pred HHHHHHHHHhc--CcccccHHHHhhhHHHHHHHHHHHHHHHHHH-HHHccCeeCHHHHHHHhhcccchHHHHHHHHHHcC
Confidence 99999988888 6666667765 6789999999988887655 599999999999999999999999999976
Q ss_pred cChHHHHHH----HHHHHHcCCCHHHHHHHc----CCCCHHHHhhhcCccccc
Q psy10160 511 IGYDKAAKI----AKTAHKEGTTLKVAALKL----GYLTEEEFNKWVVPEDML 555 (558)
Q Consensus 511 l~~~~a~~~----~~~a~~~~~~~~~~~~~~----~~l~~~~~~~~~~p~~~~ 555 (558)
++||+||++ |+.+.+.|+++.++..+. ..+-++++.++++|+..+
T Consensus 380 vPFReAh~ivG~~v~~~~~~~~~l~~l~~~~~~~~~~~~~~dv~~~l~~~~~v 432 (459)
T COG0165 380 VPFREAHEIVGEAVRRAEERGKDLADLSLEELQSISPLIDEDVYEVLTPEESV 432 (459)
T ss_pred CCHHHHHHHHHHHHHHHHHcCCCHHhccHHHHhhhccccchHHHHHhchHHHH
Confidence 599999985 567777888877765542 335667888888876544
No 22
>KOG1317|consensus
Probab=100.00 E-value=2.8e-50 Score=364.28 Aligned_cols=297 Identities=65% Similarity=0.953 Sum_probs=279.8
Q ss_pred CCCCCcccccchhhhhhhhh-hhhhhcccccchhhhhhhHHHhhcccccccccchHHHHHhHhhhhhh---hc-CCC---
Q psy10160 261 GQLPSYGPHIKRAVEAEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQALNIVSIFYF---TY-LVK--- 332 (558)
Q Consensus 261 g~~~~~~~w~~~~l~~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~l~~~~~~~~~---~g-~~g--- 332 (558)
..+.|.++.+++.++....+ ++++..||||.|+|.|.|+|++|.+ |++++...++|+.....++.. +| ++|
T Consensus 182 ~~L~P~l~~L~~aL~aKs~EfkdIiKIGRTHtqDAvPLTLGQEFsg-Y~qQ~~ngl~Rv~~~lpr~y~LA~GGTAVGTGL 260 (487)
T KOG1317|consen 182 SRLIPALTNLRDALEAKSKEFKDIIKIGRTHTQDAVPLTLGQEFSG-YVQQVTNGLQRVAATLPRLYQLAQGGTAVGTGL 260 (487)
T ss_pred HhhhHHHHHHHHHHHhhhHHHHHHHHhcccccccccccchhhhhhh-HHHHHHHHHHHHHhhhhHHHHHhcCCccccccc
Confidence 35677888899988888888 9999999999999999999999999 999999999999876655433 33 444
Q ss_pred -CChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhhhhhccCCCccccceecCCCCC
Q psy10160 333 -LSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIANDIRFLASGPRCGLGELSLPENEP 411 (558)
Q Consensus 333 -~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~~~~ 411 (558)
+-.||.+++.++++++.||++-..+|-|++.+.||.++|+.++|-.+|.+|.|||+|||++.||||.++||+.+|+..+
T Consensus 261 NTr~GFaeK~a~~va~ltgLpFvtApNkFEALAahDA~VE~~GalNt~A~SlmKianDIRfLGSGPRcGlgEL~LPENEP 340 (487)
T KOG1317|consen 261 NTRKGFAEKIAARVAELTGLPFVTAPNKFEALAAHDAMVEVSGALNTIAVSLMKIANDIRFLGSGPRCGLGELMLPENEP 340 (487)
T ss_pred cccccHHHHHHHHHHHHhCCCceecccHHHHHHhhhhHHHhcccHHHHHHHHHHHhhhhhhccCCCCCCccccccCCCCC
Confidence 4457778899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHHHHHHHHHHHHHHhhhcCcccCHH
Q psy10160 412 GSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSIRLIADSATAFTDKCVSGIVANEE 491 (558)
Q Consensus 412 gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~ 491 (558)
||||||+|+||..+|.+...|.+++|+..++.....+++||+|++.+++..++|.++.++.++...|...|+.+|+.|+|
T Consensus 341 GSSIMPGKVNPTQcEamTmvcaQVMGN~vAvtvgGsnGhFELNVFKP~i~~nvL~SirLl~D~~~sF~~nCV~GI~aN~e 420 (487)
T KOG1317|consen 341 GSSIMPGKVNPTQCEAMTMVCAQVMGNHVAVTVGGSNGHFELNVFKPLIASNVLHSIRLLADASVSFTKNCVVGIEANKE 420 (487)
T ss_pred CcccCCCCCCcHHHHHHHHHHHHHhcCceEEEecccCceeEEecchHHHHHHHHHHHHHhhhhhhhhhhhhhhcccCCHH
Confidence 99999999999999999999999999999888888899999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhHhhhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhhhcCcccccCCC
Q psy10160 492 NIHRLLHESLMLVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNKWVVPEDMLGPK 558 (558)
Q Consensus 492 ~~~~~~~~~~~~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~~~~p~~~~~~~ 558 (558)
|+.+.+.+++|++|+|.+.+||+.|..++|.|+++|.++++...+.+++++++++++..|+.++|++
T Consensus 421 rI~kll~eSLMLVTALNPhIGYD~aAkiAKtAhKng~TLk~eal~lG~lTeeqFdewV~Pe~Mlgpk 487 (487)
T KOG1317|consen 421 RIAKLLNESLMLVTALNPHIGYDNAAKIAKTAHKNGTTLKEEALKLGVLTEEQFDEWVVPEKMLGPK 487 (487)
T ss_pred HHHHHHHhhhhhhhccCCccCchhHHHHHHHHhhcCCcHHHHHHHhcCCCHHHHHhhhCHHhccCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999985
No 23
>TIGR00928 purB adenylosuccinate lyase. This family consists of adenylosuccinate lyase, the enzyme that catalyzes step 8 in the purine biosynthesis pathway for de novo synthesis of IMP and also the final reaction in the two-step sequence from IMP to AMP.
Probab=100.00 E-value=5.2e-51 Score=416.56 Aligned_cols=308 Identities=22% Similarity=0.186 Sum_probs=262.1
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|.|.+.+|+..++.. ...+.....+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|.
T Consensus 88 ~~~vh~g~SsnD~~~Ta~~-l~lr~~l~~l~~~l~~l~~~L~~~A~~~~~t~m~grTH~Q~A~P~T~G~~~~~-~~~~l~ 165 (435)
T TIGR00928 88 GEFIHFGATSNDIVDTALA-LLLRDALEIILPKLKQLIDRLKDLAVEYKDTVMLGRTHGQHAEPTTLGKKFAL-WADEMK 165 (435)
T ss_pred hhheeecccHHHHHHhHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHccchHhHHhcCCCCcchhHHHHHHH-HHHHHH
Confidence 6789999999999998876 4444444333333322 2233 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhhhh---hcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHH
Q psy10160 313 PNDRQALNIVSIFYF---TYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKI 386 (558)
Q Consensus 313 ~~~~~l~~~~~~~~~---~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~ 386 (558)
|+++||.+++.+++. +|++||+...+ +.+++++|+.|||+.+...| ++++||+++|++++|++++++|+||
T Consensus 166 r~~~rL~~~~~~~~~~~lgGa~Gt~~~~~~~~~~~~~~~a~~LGl~~~~~~~---~~~~rD~~~e~~~~l~~la~~L~ri 242 (435)
T TIGR00928 166 RQLERLLQAKERIKVGGISGAVGTHAAAYPLVEEVEERVTEFLGLKPVPIST---QIEPRDRHAELLDALALLATTLEKF 242 (435)
T ss_pred HHHHHHHHHHHHhHhhcccchhhhHhhccccHHHHHHHHHHhcCCCCCCCCc---cccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999988776665 45666666554 36789999999999776555 7899999999999999999999999
Q ss_pred hhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHH
Q psy10160 387 ANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNV 464 (558)
Q Consensus 387 a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (558)
|+||++|++ +||+|+.+|. +++|||||||||||+.+|+++++++.+.|+.+.++.. ..+++++|...|..+|.+
T Consensus 243 a~Dl~l~s~---~~~~el~~~~~~~~~GSS~MP~K~NP~~~E~i~~~a~~~~g~~~~~~~~-~~~~~erd~~~~~~~~~~ 318 (435)
T TIGR00928 243 AVDIRLLQR---TEHFEVEEPFGKGQVGSSAMPHKRNPIDFENVCGLARVIRSVLSPALEN-VPLWHERDLTDSSVERII 318 (435)
T ss_pred HHHHHHHHh---ccccceecccCCCCCCcCCCCcCcCcHHHHHHHHHHHHHHHHHHHHHHH-hhHHhccCChHHHHHHHH
Confidence 999999995 8999999996 4899999999999999999999999999999887644 367899999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHh--hhhhcc-----cccChHHHHHH----HHHHHH-cCCCHHH
Q psy10160 465 LRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLM--LVTALN-----PHIGYDKAAKI----AKTAHK-EGTTLKV 532 (558)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~--~~~~la-----~~l~~~~a~~~----~~~a~~-~~~~~~~ 532 (558)
++++..+..+++.++.+++++|+||++||+++++.++. ++++|+ +.+||++||++ ++.+.+ +|.++++
T Consensus 319 l~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~l~~~~~~~~a~~la~~L~~~g~g~~~Ah~~v~~~~~~a~~~~~~~l~~ 398 (435)
T TIGR00928 319 LPDSFILADIMLKTTLKVVKKLVVNPENILRNLELTLGLIASERVLIALVERGMGREEAYEIVRELAMGAAEVDEPDLLE 398 (435)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCEECHHHHHHHHHhccChHhHHHHHHHHHHhCCChhhHHHHHHHHHHHHHHcccccHHH
Confidence 99999999999999999999999999999999986665 444443 36899999995 566777 8999999
Q ss_pred HHHHc----CCCCHHHHhhhcCcccccCC
Q psy10160 533 AALKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 533 ~~~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
++.+. ..++++++++++||.+|+|.
T Consensus 399 ~~~~~~~~~~~l~~~~l~~~ldp~~~~~~ 427 (435)
T TIGR00928 399 FLLADERITKYLKEEELAELLDPETYIGN 427 (435)
T ss_pred HHhhCccchhhcCHHHHHHcCCHHHHhCh
Confidence 98875 56899999999999999984
No 24
>PRK08540 adenylosuccinate lyase; Reviewed
Probab=100.00 E-value=8.3e-51 Score=416.18 Aligned_cols=309 Identities=23% Similarity=0.243 Sum_probs=261.0
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
.+.++|.|.+.+|+..++.. ...+.....+...+.. ...+ .+++|.||||+|+|+|+|+|||+++ |++.|
T Consensus 93 ~~~~vH~g~S~nDi~~Ta~~-L~lr~~l~~l~~~L~~l~~~L~~~A~~~~~~~m~grTH~Q~A~P~T~G~~~~~-~~~~l 170 (449)
T PRK08540 93 AGEYVHFGATSNDIIDTATA-LQLKDSLEILEEKLKKLRGVLLKKAEEHKNTVCIGRTHGQHAVPTTYGMRFAI-WASEI 170 (449)
T ss_pred hhcceecCccHhhHHhHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchhhhcCCCcCeehhHHHHHHH-HHHHH
Confidence 37889999999999998876 4444444333333322 2233 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhh---hhhhhcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIVS---IFYFTYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMK 385 (558)
Q Consensus 312 ~~~~~~l~~~~~---~~~~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k 385 (558)
.|+++||.+++. ..+++|++|++++++ ..+.+++|+.|||+.+...| ++++||+++|++++|+.++++|+|
T Consensus 171 ~r~~~rL~~~~~~~~~~~lGgavGt~~a~~~~~~~i~~~~a~~LGl~~~~~~~---~~~~rd~~~e~~~~l~~~a~~l~k 247 (449)
T PRK08540 171 QRHLERLEQLKPRVCVGQMTGAVGTQAAFGEKGIEIQKRVMEILGLKPVLISN---QVIQRDRHAEFMMFLANIATTLDK 247 (449)
T ss_pred HHHHHHHHHHHHhhheccccccccchhhCCCccHHHHHHHHHHcCCCCCCCcC---CccccHHHHHHHHHHHHHHHHHHH
Confidence 999999987764 556677888876554 45668999999999766555 579999999999999999999999
Q ss_pred HhhhhhhhccCCCccccceecC--CCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHH
Q psy10160 386 IANDIRFLASGPRCGLGELSLP--ENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSN 463 (558)
Q Consensus 386 ~a~d~~~~~s~~~~e~~e~~~~--~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (558)
||+||++|++ +|||||.++ ++++|||||||||||+.+|+++++++++.|....++ .....+++++...|..+|.
T Consensus 248 ia~Dl~l~s~---~e~gei~e~~~~~~~GSSiMP~K~NP~~~E~i~~~a~~~~g~~~~~~-~~~~~~~~rd~~~~~~e~~ 323 (449)
T PRK08540 248 IGLEIRNLQR---TEIGEVEEEFGKKQVGSSTMPHKRNPITSEQICGLARVVRSNVEPAL-LNNPLWDERDLTNSSCERI 323 (449)
T ss_pred HHHHHHHHHh---hhhhhhhcccCCCCCCcCCCCCCcCcHHHHHHHHHHHHHHHHHHHHH-hcchhhhccCCchhHHHHH
Confidence 9999999994 999999865 569999999999999999999999999999987654 4445568888888888999
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHh--hhHhhhhhcc-----cccChHHHHHH----HHHHHHcCCCHHH
Q psy10160 464 VLRSIRLIADSATAFTDKCVSGIVANEENIHRLLH--ESLMLVTALN-----PHIGYDKAAKI----AKTAHKEGTTLKV 532 (558)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~--~~~~~~~~la-----~~l~~~~a~~~----~~~a~~~~~~~~~ 532 (558)
+++++..+..+++.++..++++|+||++||+++++ ..++++++|+ +.+||++||++ ++.+..+|+++.+
T Consensus 324 ~l~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~l~~~~~~~~ae~la~~L~~~glg~~~Ah~~v~~l~~~a~~~g~~l~e 403 (449)
T PRK08540 324 IFPESCVLTDHILKLMIKVLEGLRFNPENIRRNLELTKGLIMAEAVMIELAKRGMGRQEAHELVRQAAMKAHEEGRHLKE 403 (449)
T ss_pred HHHHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHHhcCHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHhCCCHHH
Confidence 99999999999999999999999999999999987 5666666664 35899999875 4567889999999
Q ss_pred HHHHc----CCCCHHHHhhhcCcccccCC
Q psy10160 533 AALKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 533 ~~~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
++.+. ..|+++++++++||.+|+|.
T Consensus 404 ~~~~~~~~~~~l~~~~l~~~ldp~~~~g~ 432 (449)
T PRK08540 404 VLLEDEEVMKYLTEEELEELLDPETYIGT 432 (449)
T ss_pred HHHhChhhhccCCHHHHHHHcCHHHhcCc
Confidence 98876 56899999999999999985
No 25
>PRK06705 argininosuccinate lyase; Provisional
Probab=100.00 E-value=7.3e-51 Score=417.93 Aligned_cols=308 Identities=15% Similarity=0.128 Sum_probs=256.7
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
.+.++|+|.+.+|+..++.. ...+..+.-+...+.. ...+ .+++|.||||+|+|+|+|+|||+++ |++.|
T Consensus 106 ~g~~lH~GrSrnD~v~Ta~~-L~lr~~l~~l~~~l~~l~~~l~~~A~~~~~t~m~g~TH~Q~AqP~T~G~~l~~-~~~~l 183 (502)
T PRK06705 106 FVSNMHIGRSRNDMGVTMYR-MSLRRYVLRLMEHHLLLQESILQLAADHKETIMPAYTHTQPAQPTTFGHYTLA-IYDTM 183 (502)
T ss_pred hhccccCCCCHhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEEecccCCccceehHHHHHHHH-HHHHH
Confidence 37889999999999998876 4455554333333332 2222 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhhhhh---hhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhh
Q psy10160 312 DPNDRQALNIVSIFY---FTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAN 388 (558)
Q Consensus 312 ~~~~~~l~~~~~~~~---~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~ 388 (558)
.|+++||.+++.+++ +||++|++++|+ .+++++|++|||+ .+..|++|++++||+++|+++++++++++|+|||+
T Consensus 184 ~r~~~rL~~~~~r~~~~plGgaag~gt~~~-~~r~~~a~~LGf~-~~~~ns~~a~~~rD~~~e~~~~la~~~~~L~Ria~ 261 (502)
T PRK06705 184 QRDLERMKKTYKLLNQSPMGAAALSTTSFP-IKRERVADLLGFT-NVIENSYDAVAGADYLLEVSSLLMVMMTNTSRWIH 261 (502)
T ss_pred HHHHHHHHHHHHHhCcCCchhhhhccCCch-HHHHHHHHHcCCC-CCcCCHHHHHhccHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999998776555 456788888886 8999999999999 46779999999999999999999999999999999
Q ss_pred hhhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHH
Q psy10160 389 DIRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRS 467 (558)
Q Consensus 389 d~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (558)
||++|+| +|||+|.+++. .+|||||||||||+.+|+++++++++.|++.+++..+++.+. .+..+ .+|.++|.
T Consensus 262 Dl~~~ss---~e~g~iel~e~~~~gSSiMPqKrNP~~~E~ir~~a~~~~g~~~~~l~~~~~~~~--~~~~d-~q~~~~~~ 335 (502)
T PRK06705 262 DFLLLAT---KEYDGITVARPYVQISSIMPQKRNPVSIEHARAITSSALGEAFTVFQMIHNTPF--GDIVD-TEDDLQPY 335 (502)
T ss_pred HHHHHcC---CCCCeeeecCCCCCccCCCCCCcCCHHHHHHHHHHHHHHHHHHHHHHHhcCCcc--hhhhh-hHhhhhhH
Confidence 9999996 89998777765 589999999999999999999999999999999877766433 33333 45666777
Q ss_pred HHHHHHHH---HHHHHhhhcCcccCHHHHHHHHhhhHhhhhhccc------ccChHHHHHHH----HHHHHcCCCHHHHH
Q psy10160 468 IRLIADSA---TAFTDKCVSGIVANEENIHRLLHESLMLVTALNP------HIGYDKAAKIA----KTAHKEGTTLKVAA 534 (558)
Q Consensus 468 ~~~~~~~~---~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~------~l~~~~a~~~~----~~a~~~~~~~~~~~ 534 (558)
+..+.+.+ +..+..++++|+||++||++++..+++++|+||+ .+||++||++| +.+.++|+++.++.
T Consensus 336 ~~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~~~~g~~~At~la~~Lv~~~Gl~fr~Ah~iV~~~v~~a~~~~~~l~~~~ 415 (502)
T PRK06705 336 LYKGIEKAIRVFCIMNAVIRTMKVEEDTLKRRSYKHAITITDFADVLTKNYGIPFRHAHHAASVIANMSLEQKKELHELC 415 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHCcCEECHHHHHHHHhcCchHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCCHHHhh
Confidence 77777777 7788889999999999999999999988888864 48999999865 45777899888876
Q ss_pred HHc----------CCCCHHHHhhhcCcccccCC
Q psy10160 535 LKL----------GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 535 ~~~----------~~l~~~~~~~~~~p~~~~~~ 557 (558)
.+. ..++++++++++||++|++.
T Consensus 416 ~~~~~~~~~~~~~~~~~~~~l~~~ldp~~~v~~ 448 (502)
T PRK06705 416 FKDVNIYLQEKFKIQLLEKEWEEIISPEAFIQK 448 (502)
T ss_pred HHHHHhhhhhhhhhcCCHHHHHHHCCHHHHHhh
Confidence 542 34788999999999999873
No 26
>PRK06390 adenylosuccinate lyase; Provisional
Probab=100.00 E-value=2.9e-50 Score=411.23 Aligned_cols=308 Identities=19% Similarity=0.227 Sum_probs=259.0
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+.+|+..++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|||||+++ |++.|.
T Consensus 93 ~~~iH~G~SsnDi~~Ta~~-L~lr~~l~~l~~~l~~l~~~L~~lA~~~~~t~m~grTH~Q~A~P~T~G~~~~~-~~~~l~ 170 (451)
T PRK06390 93 KNYVHFGVTSNDINDTATA-LQIHDFVSIIKDDIKNLMETLIKLIDEYKDSPMMGRTHGQHASPITFGLKFAV-YLDEMS 170 (451)
T ss_pred hhheecCccHhhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCchhhhhCCCcCeehhHHHHHHH-HHHHHH
Confidence 6889999999999999876 4555554444443332 2233 8899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhh---hhhcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHH
Q psy10160 313 PNDRQALNIVSIF---YFTYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKI 386 (558)
Q Consensus 313 ~~~~~l~~~~~~~---~~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~ 386 (558)
|+++||.+++.++ +++|++|+.+++| +.+++++|+.|||+.+... +++++||+++|++++|++++++|+||
T Consensus 171 r~~~RL~~~~~r~~~~~~~gavGt~a~~g~~~~~~~~~~a~~LGl~~~~~~---~~~~~rD~~~e~~~~l~~la~~l~ki 247 (451)
T PRK06390 171 RHLDRLTEMGDRAFAGKVLGPVGTGAALGKDALDIQNRVMEILGIYSEIGS---TQIVNRDRYIEYLSVINGISVTLEKI 247 (451)
T ss_pred HHHHHHHHHHHHhhhhccCChhcChhhCCCcHHHHHHHHHHHcCCCCCCCc---cccccchHHHHHHHHHHHHHHHHHHH
Confidence 9999999887544 5578999999887 5789999999999965443 37899999999999999999999999
Q ss_pred hhhhhhhccCCCccccceecC---CCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHH
Q psy10160 387 ANDIRFLASGPRCGLGELSLP---ENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSN 463 (558)
Q Consensus 387 a~d~~~~~s~~~~e~~e~~~~---~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (558)
|+||++|+| +||||+.++ ++++|||||||||||+.+|+++++++.+.+... ........+++++...|..+|.
T Consensus 248 a~Di~l~ss---~e~g~v~E~~~~~~~~GSSiMP~KrNPv~~E~i~~~a~~~~~l~~-~~~~~~~~~~erd~~~~~~e~~ 323 (451)
T PRK06390 248 ATEIRNLQR---PEIDEVSEYFDEESQVGSSSMPSKVNPINSENVVSLSRFIRSLII-PEYEAGVTWHERDLTNSALERF 323 (451)
T ss_pred HHHHHHHhc---cccchhhcccccCCCCCccCCCCCCCcHHHHHHHHHHHHHHHhHH-HHHHhhhHhhccCCcchHHHHh
Confidence 999999997 788888643 379999999999999999999999988777776 4345555668999888888999
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHh-----hhhhccc-ccChHHHHHH----HHHHHHcCCCHHHH
Q psy10160 464 VLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLM-----LVTALNP-HIGYDKAAKI----AKTAHKEGTTLKVA 533 (558)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~-----~~~~la~-~l~~~~a~~~----~~~a~~~~~~~~~~ 533 (558)
.+|.+..+.+.++..+..++++|+||++||+++++.++. +++.|++ .+||++||++ ++.+..+|++++++
T Consensus 324 ~~~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~l~~~~~~~se~la~~L~~~G~~~~~Ah~~v~~~~~~a~~~g~~l~~~ 403 (451)
T PRK06390 324 TIPYASILIDYVLYNMNDVLSHLIIKEDEIRRNLESDDSIMSESIVRALTLSGMPRQDAHEFVRRASMEARSNGKSLKSS 403 (451)
T ss_pred hHHHHHHHHHHHHHHHHHHHcCCEECHHHHHHHHhccchhhHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHhCCCHHHH
Confidence 899998888999999999999999999999999987333 4456776 4899999985 45577889999998
Q ss_pred HHHc---CCCCHHHHhhhcCcccccCC
Q psy10160 534 ALKL---GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 534 ~~~~---~~l~~~~~~~~~~p~~~~~~ 557 (558)
+.+. ..++++++++++||.+|+|.
T Consensus 404 ~~~~~~~~~l~~~~l~~~ldP~~~i~~ 430 (451)
T PRK06390 404 LIEAGILKYIDEKTLDRAMDPANFIGQ 430 (451)
T ss_pred HHhChhhhcCCHHHHHHhcCHHHHhhh
Confidence 8875 44899999999999999984
No 27
>PLN02646 argininosuccinate lyase
Probab=100.00 E-value=1.9e-50 Score=411.99 Aligned_cols=308 Identities=17% Similarity=0.103 Sum_probs=250.1
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|.|.+.+|++.++.. ...+..+..+...+.. ...+ .+++|.||||+|+|+|+|+|||+++ |++.|.
T Consensus 114 g~~lH~grSrND~v~Ta~~-L~lr~~l~~l~~~L~~L~~~L~~~A~~~~dtvmpGrTHlQ~AqPiT~G~~l~~-~~~~l~ 191 (474)
T PLN02646 114 AKKLHTARSRNDQVATDTR-LWCRDAIDVIRKRIKTLQVALVELAEKNVDLVVPGYTHLQRAQPVLLSHWLLS-HVEQLE 191 (474)
T ss_pred hCcccCCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEEecccCCccceeecHHHHHHH-HHHHHH
Confidence 4578999999999988866 4444444443333332 2223 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhhhhhc-CCCCChhHH-HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhh
Q psy10160 313 PNDRQALNIVSIFYFTY-LVKLSELLE-TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIANDI 390 (558)
Q Consensus 313 ~~~~~l~~~~~~~~~~g-~~g~~~~~~-~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~ 390 (558)
|+++||.+++.+++.++ +.|+.+|.+ +.+++++|+.|||. .+..|++|++++||+++|+++++++++.+|+|||+||
T Consensus 192 rd~~RL~~~~~r~~~~pLGgga~aGt~~~idr~~~A~~LGf~-~~~~n~~da~~~RD~~~e~~~~la~ia~~LsRia~Dl 270 (474)
T PLN02646 192 RDAGRLVDCRPRVNFCPLGSCALAGTGLPIDRFMTAKDLGFT-APMRNSIDAVSDRDFVLEFLFANSITAIHLSRLGEEW 270 (474)
T ss_pred HHHHHHHHHHHHhhhcCCcchhhcCCCCCCCHHHHHHHhCCC-CCCCChHHHHhccHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999988887764 224444444 46699999999997 6788999999999999999999999999999999999
Q ss_pred hhhccCCCccccceecCC-CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhH-HHHHHHHH
Q psy10160 391 RFLASGPRCGLGELSLPE-NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLI-VSNVLRSI 468 (558)
Q Consensus 391 ~~~~s~~~~e~~e~~~~~-~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 468 (558)
++|+| +||||+.+|+ .++|||||||||||+.+|++++++++++|++.+++...++.++ .+.++.+ .|..++++
T Consensus 271 ~l~ss---~e~g~v~~~d~~~~GSSiMPqKrNP~~~E~ir~~a~~v~G~~~~~~~~~~~~p~--~~~rD~q~~~~~l~~~ 345 (474)
T PLN02646 271 VLWAS---EEFGFVTPSDAVSTGSSIMPQKKNPDPMELVRGKSARVIGDLVTVLALCKGLPT--AYNRDLQEDKEPLFDS 345 (474)
T ss_pred HHHcC---CCCCeeeeCCCCCCCcCCCCCCCCCHHHHHHHHHHHHHHhhhHHHHHHhcCCch--HhhcchhhHHHHHHHH
Confidence 99997 8999999987 5899999999999999999999999999999999866655333 3333332 35555555
Q ss_pred HHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhccc-----ccChHHHHHHH----HHHHHcCCCHHHHHHHc--
Q psy10160 469 RLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNP-----HIGYDKAAKIA----KTAHKEGTTLKVAALKL-- 537 (558)
Q Consensus 469 ~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~-----~l~~~~a~~~~----~~a~~~~~~~~~~~~~~-- 537 (558)
..+...++..+..++++|+||++||+++++.+++++|+|++ .++|++||++| +.+.++|+++.++..+.
T Consensus 346 ~~~~~~~l~~~~~~l~~l~v~~~rm~~~l~~~~~~At~la~~Lv~~Gi~fr~Ah~iV~~~v~~a~~~g~~l~~l~~~~~~ 425 (474)
T PLN02646 346 VDTVSDMLEVATEFAQNITFNPERIKKSLPAGMLDATTLADYLVRKGVPFRETHHIVGAAVALAESKGCELSDLTLEDLK 425 (474)
T ss_pred HHHHHHHHHHHHHHHccCEECHHHHHHHHHcCccHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHH
Confidence 55555566677779999999999999999999999999875 47999999864 56778899999976642
Q ss_pred --CCCCHHHHhhhcCcccccC
Q psy10160 538 --GYLTEEEFNKWVVPEDMLG 556 (558)
Q Consensus 538 --~~l~~~~~~~~~~p~~~~~ 556 (558)
....++++.+++||++++.
T Consensus 426 ~~~~~~~~~~~~~l~~~~~v~ 446 (474)
T PLN02646 426 SINPVFEEDVYEVLGVENSVE 446 (474)
T ss_pred HhcccchHHHHHhCCHHHHHH
Confidence 3345778999999998773
No 28
>cd01359 Argininosuccinate_lyase Argininosuccinate lyase (argininosuccinase, ASAL). This group contains ASAL and related proteins. It is a member of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. ASAL is a cytosolic enzyme which catalyzes the reversible breakdown of argininosuccinate to arginine and fumarate during arginine biosynthesis. In ureotelic species ASAL also catalyzes a reaction involved in the production of urea. Included in this group are the major soluble avian eye lens proteins from duck, delta 1 and delta 2 crystallin. Of these two isoforms only delta 2 has retained ASAL activity. These crystallins may have evolved by, gene recruitment of ASAL followed by gene duplication.
Probab=100.00 E-value=4.3e-50 Score=410.84 Aligned_cols=306 Identities=18% Similarity=0.169 Sum_probs=257.8
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+.+|++.++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|||||+++ |++.|.
T Consensus 78 ~~~iH~G~SsnDi~~Ta~~-L~lr~~l~~l~~~l~~l~~~L~~~A~~~~~t~m~grTh~Q~A~P~T~G~~~~~-~~~~l~ 155 (435)
T cd01359 78 GGKLHTGRSRNDQVATDLR-LYLRDALLELLELLLDLQRALLDRAEEHADTIMPGYTHLQRAQPITFGHYLLA-YAEMLE 155 (435)
T ss_pred HhhhhccCCHHhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEecCCCCCccceeccHHHHHHH-HHHHHH
Confidence 5678999999999998876 4555555444444333 2233 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhh---hhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 313 PNDRQALNIVSIF---YFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 313 ~~~~~l~~~~~~~---~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|+++||.+.+.++ +++|++|++++++ .+++++|+.|||+ .+..|.++++++||++++++++|++++++|+|||+|
T Consensus 156 r~~~rL~~~~~~~~~~~lGgaag~gt~~~-~~~~~~a~~LG~~-~~~~~~~~a~~~rd~~~e~~~~l~~~a~~l~ria~D 233 (435)
T cd01359 156 RDLERLADAYKRVNVSPLGAGALAGTTFP-IDRERTAELLGFD-GPTENSLDAVSDRDFVLEFLSAAALLMVHLSRLAED 233 (435)
T ss_pred HHHHHHHHHHHHhCcCCcccccccCCCCC-CCHHHHHHHcCCC-CCccCHHHHHhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999877555 5677888888886 7899999999999 677788899999999999999999999999999999
Q ss_pred hhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccc--cccccccchhhHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSN--GHFELNVFKPLIVSNVLR 466 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 466 (558)
|++|+| +||||+.+|+. .+|||||||||||+.+|+++++++.+.|....++..+.+ .+++++.. ..|..++
T Consensus 234 l~l~~~---~e~gev~lpe~~~~GSS~MP~KrNP~~~E~i~~~a~~~~g~~~~~~~~~~~~~~~~~~d~~---~~~~~l~ 307 (435)
T cd01359 234 LILWST---QEFGFVELPDAYSTGSSIMPQKKNPDVLELIRGKAGRVIGALAGLLTTLKGLPLAYNKDLQ---EDKEPLF 307 (435)
T ss_pred HHHHcC---CCCCeeeCCCCCCCccccCCCCCCCcHHHHHHHHHHHHhhHHhHHHHHhcCCCCccchhHH---HhhHHHH
Confidence 999996 88999999986 499999999999999999999999999999998766543 22333332 2466677
Q ss_pred HHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhccc------ccChHHHHHH----HHHHHHcCCCHHHHHHH
Q psy10160 467 SIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNP------HIGYDKAAKI----AKTAHKEGTTLKVAALK 536 (558)
Q Consensus 467 ~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~------~l~~~~a~~~----~~~a~~~~~~~~~~~~~ 536 (558)
++..+...++..+..++++|+||+++|++++..++++++++++ .+||++||++ ++.+.++|+++.|++.+
T Consensus 308 ~~~~~~~~al~~~~~~l~~l~v~~~~m~~~l~~~~~~a~~l~~~l~~~~g~~~r~Ah~~v~~~~~~a~~~g~~~~~~~~~ 387 (435)
T cd01359 308 DAVDTLIASLRLLTGVISTLTVNPERMREAAEAGFSTATDLADYLVREKGVPFREAHHIVGRAVRLAEEKGKDLSDLTLA 387 (435)
T ss_pred HHHHHHHHHHHHHHHHHhhCEECHHHHHHHHhcCccHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHHcCCChhhcCHH
Confidence 7777777777777789999999999999999999998888873 5799999985 45677889999998776
Q ss_pred c----CCCCHHHHhhhcCcccccC
Q psy10160 537 L----GYLTEEEFNKWVVPEDMLG 556 (558)
Q Consensus 537 ~----~~l~~~~~~~~~~p~~~~~ 556 (558)
. ..++++++++++||++|++
T Consensus 388 ~~~~~~~l~~~~l~~~ldp~~~~~ 411 (435)
T cd01359 388 ELQAISPLFEEDVREALDPENSVE 411 (435)
T ss_pred HHHhhcccCHHHHHHhCCHHHHHH
Confidence 4 6789999999999999985
No 29
>TIGR00838 argH argininosuccinate lyase. This model describes argininosuccinate lyase, but may include examples of avian delta crystallins, in which argininosuccinate lyase activity may or may not be present and the biological role is to provide the optically clear cellular protein of the eye lens.
Probab=100.00 E-value=8.7e-50 Score=409.32 Aligned_cols=308 Identities=17% Similarity=0.155 Sum_probs=249.7
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+.+|+..++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|.
T Consensus 98 g~~iH~g~SrnD~~~Ta~~-L~lr~~l~~l~~~L~~l~~~L~~~A~~~~~~~m~grTH~Q~A~P~T~G~~~~~-~~~~L~ 175 (455)
T TIGR00838 98 GGKLHTGRSRNDQVATDLR-LYLRDHVLELAEALLDLQDALIELAEKHVETLMPGYTHLQRAQPITLAHHLLA-YAEMLL 175 (455)
T ss_pred cCCccCCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHccCCEeecccccccceeccHHHHHHH-HHHHHH
Confidence 4568999999999888865 3444444333333322 2233 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhhhhh---cCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 313 PNDRQALNIVSIFYFT---YLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 313 ~~~~~l~~~~~~~~~~---g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|+++||.+.+.+++.+ |+++++.++ +.+++++|+.|||+. +..|++||+++||+++|++++++.++++|+|||+|
T Consensus 176 r~~~rL~~~~~~~~~~plGg~a~aGt~~-~~~r~~~a~~LG~~~-~~~n~~~a~~~rd~~~e~~~~l~~~a~~L~ria~D 253 (455)
T TIGR00838 176 RDYERLQDALKRVNVSPLGSGALAGTGF-PIDREYLAELLGFDA-VTENSLDAVSDRDFILELLFVAALIMVHLSRFAED 253 (455)
T ss_pred HHHHHHHHHHHHhccCCcchhcccCCCC-CCCHHHHHHHcCCCC-CcCCHHHHHhCcHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999888766554 443333344 578899999999995 57889999999999999999999999999999999
Q ss_pred hhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSI 468 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (558)
|++|+| +||||+.+|+. ++|||||||||||+.+|+++++++++.|++.+++....+.+++.+.........+++.+
T Consensus 254 l~l~ss---~e~gei~lp~~~~~GSSiMP~K~NP~~~E~i~~~a~~~~g~~~~~~~~~~~~~~~~~rd~~~~~~~l~~~~ 330 (455)
T TIGR00838 254 LILWST---GEFGFVELPDEFSSGSSIMPQKKNPDVAELIRGKTGRVQGNLTGMLMTLKALPLAYNRDLQEDKEPLFDAL 330 (455)
T ss_pred HHHHhC---CCCCeeeCCCCCCCccCCCCCCcCChHHHHHHHHHHHHhhhHHHHHHHHhcCChHhhhhhHhhHHHHHHHH
Confidence 999997 78999999985 89999999999999999999999999999999987777766665554444334444444
Q ss_pred HHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccc-----cChHHHHHH----HHHHHHcCCCHHHHHHHcC-
Q psy10160 469 RLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPH-----IGYDKAAKI----AKTAHKEGTTLKVAALKLG- 538 (558)
Q Consensus 469 ~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~-----l~~~~a~~~----~~~a~~~~~~~~~~~~~~~- 538 (558)
..+ ..++..+..++++|+||++||++++..+++++|+|++. ++|++||++ ++.|.++|+++.|+..+..
T Consensus 331 ~~~-~~al~~~~~~i~~l~v~~~rm~~~~~~~~~~at~la~~Lv~~g~~~r~Ah~~v~~~~~~a~~~g~~l~~~~~~~~~ 409 (455)
T TIGR00838 331 KTV-ELSLEMATGMLDTITVNKERMEEAASAGFSNATELADYLVRKGVPFREAHHIVGELVATAIERGKGLEELTLEELQ 409 (455)
T ss_pred HHH-HHHHHHHHHHHccCEECHHHHHHHHHcCccHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHh
Confidence 555 44555566699999999999999999999999998864 688899875 4568889999999887652
Q ss_pred ---CCCHHHHhhhcCcccccC
Q psy10160 539 ---YLTEEEFNKWVVPEDMLG 556 (558)
Q Consensus 539 ---~l~~~~~~~~~~p~~~~~ 556 (558)
.+.++++++++||++|+.
T Consensus 410 ~~~~~~~~~l~~~ldp~~~v~ 430 (455)
T TIGR00838 410 KFSPEFDEDVYEALDPESSVE 430 (455)
T ss_pred hhcccCHHHHHHHCCHHHHHH
Confidence 255677999999999874
No 30
>cd01595 Adenylsuccinate_lyase_like Adenylsuccinate lyase (ASL)_like. This group contains ASL, prokaryotic-type 3-carboxy-cis,cis-muconate cycloisomerase (pCMLE), and related proteins. These proteins are members of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. ASL catalyzes two steps in the de novo purine biosynthesis: the conversion of 5-aminoimidazole-(N-succinylocarboxamide) ribotide (SAICAR) into 5-aminoimidazole-4-carboxamide ribotide (AICAR) and; the conversion of adenylsuccinate (SAMP) into adenosine monophosphate (AMP). pCMLE catalyzes the cyclization of 3-carboxy-cis,cis-muconate (3CM) to 4-carboxy-muconolactone, in the beta-ketoadipate pathway. ASL deficiency has been linked t
Probab=100.00 E-value=2.1e-48 Score=390.97 Aligned_cols=274 Identities=23% Similarity=0.238 Sum_probs=235.4
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
.+.++|+|.+.+|+..++.. ...+.....+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|
T Consensus 79 ~~~~vH~g~S~nDi~~Ta~~-l~lr~~l~~l~~~l~~l~~~L~~~A~~~~dt~m~grTH~Q~A~P~T~G~~~~~-~~~~L 156 (381)
T cd01595 79 AGEYVHFGATSQDINDTALA-LQLRDALDIILPDLDALIDALAKLALEHKDTPMLGRTHGQHALPTTFGKKFAV-WAAEL 156 (381)
T ss_pred hhhHeecCcCHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHcCChHHhhcCCCCCcchhHHHHHHH-HHHHH
Confidence 36789999999999998866 4444444333333222 2233 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhhhhh---hhcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIVSIFY---FTYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMK 385 (558)
Q Consensus 312 ~~~~~~l~~~~~~~~---~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k 385 (558)
.|+++||.+++.+++ ++|++|++++++ +.+++++|+.|||..+...| ++++||+++|+++++++++++|+|
T Consensus 157 ~r~~~rL~~~~~~~~~~~lGga~G~g~~~~~~~~~~~~~~a~~LGl~~~~~~~---~~~~rd~~~e~~~~l~~~~~~l~r 233 (381)
T cd01595 157 LRHLERLEEARERVLVGGISGAVGTHASLGPKGPEVEERVAEKLGLKVPPITT---QIEPRDRIAELLSALALIAGTLEK 233 (381)
T ss_pred HHHHHHHHHHHHhchhhhcccHhhhHhhcCCcHHHHHHHHHHHcCCCCCCCCC---CcccchHHHHHHHHHHHHHHHHHH
Confidence 999999998776554 566788888884 68999999999997544443 244999999999999999999999
Q ss_pred HhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHH
Q psy10160 386 IANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSN 463 (558)
Q Consensus 386 ~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (558)
||+||++|+| +|||||.+|+ +++|||||||||||+.+|+++++++++.|++.+++..+ .+++++|...|..+|.
T Consensus 234 ia~Dl~~~~s---~e~gev~~~~~~~~~GSS~MPqK~NP~~~E~i~~~a~~~~g~~~~~~~~~-~~~~erd~~~~~~~~~ 309 (381)
T cd01595 234 IATDIRLLQR---TEIGEVEEPFEKGQVGSSTMPHKRNPIDSENIEGLARLVRALAAPALENL-VQWHERDLSDSSVERN 309 (381)
T ss_pred HHHHHHHHHh---ccccceeccccCCCCCCccCCCcCCcHHHHHHHHHHHHHHHHHHHHHHhh-hHhhccCCcHHHHHHH
Confidence 9999999997 9999999996 48999999999999999999999999999999997666 7889999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhH--h----hhhhcccc-cChHHHHHHHHH
Q psy10160 464 VLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESL--M----LVTALNPH-IGYDKAAKIAKT 522 (558)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~--~----~~~~la~~-l~~~~a~~~~~~ 522 (558)
.++++..+..+++.++..++++|+||++||+++++.++ + +++.|++. +||++||+++++
T Consensus 310 ~l~~~~~~~~~~l~~~~~~l~~l~v~~~~m~~~l~~~~g~~~ae~~~~~L~~~g~g~~~Ah~~v~~ 375 (381)
T cd01595 310 ILPDAFLLLDAALSRLQGLLEGLVVNPERMRRNLDLTWGLILSEAVMMALAKKGLGRQEAYELVKE 375 (381)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCEECHHHHHHHHHhccCHHHHHHHHHHHHHhCCCHhHHHHHHHH
Confidence 99999999999999999999999999999999999855 3 34556675 999999999876
No 31
>PRK09285 adenylosuccinate lyase; Provisional
Probab=100.00 E-value=2.3e-48 Score=394.23 Aligned_cols=304 Identities=16% Similarity=0.102 Sum_probs=251.7
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccc-cchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPH-IKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVN 310 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w-~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~ 310 (558)
.+.++|+|.+++|+.+++.. ...+..... +...+.. ...+ ++++|.||||+|+|+|+||||++++ |++.
T Consensus 113 ~~~~vH~G~Ts~Di~dTa~~-L~lr~~l~~~l~~~L~~l~~~L~~lA~~~~~t~m~grTH~Q~A~P~TfG~~~a~-~~~~ 190 (456)
T PRK09285 113 VSEFIHFACTSEDINNLSHA-LMLKEAREEVLLPALRELIDALKELAHEYADVPMLSRTHGQPATPTTLGKEMAN-VAYR 190 (456)
T ss_pred HHhHccCCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCeeeceecCCCCeeehHHHHHHH-HHHH
Confidence 36889999999999998877 555555554 4443333 2233 7899999999999999999999998 9999
Q ss_pred ccchHHHHHhHhhhhhhhcCCCCC-hhH---H----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHH
Q psy10160 311 LDPNDRQALNIVSIFYFTYLVKLS-ELL---E----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVS 382 (558)
Q Consensus 311 l~~~~~~l~~~~~~~~~~g~~g~~-~~~---~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~ 382 (558)
|.|+++||.++...++++|++|++ +++ + +.+.+.+++.|||..++..| ++.+||+++|++++|+.++++
T Consensus 191 l~r~~~rL~~~~~~g~~~GAvGt~~a~~~~~~~~~~~~v~~~~~~~LGL~~~~~~~---~v~~rD~~~e~~~~la~~a~~ 267 (456)
T PRK09285 191 LERQLKQLEAVEILGKINGAVGNYNAHLAAYPEVDWHAFSREFVESLGLTWNPYTT---QIEPHDYIAELFDAVARFNTI 267 (456)
T ss_pred HHHHHHHHHHHHHhhhcccccccHHHHhhhcCCccHHHHHHHHHHHhCCCCCCCcc---chhccHHHHHHHHHHHHHHHH
Confidence 999999999998888999999998 443 2 35677777799998655444 369999999999999999999
Q ss_pred HHHHhhhhhhhccCCCccccceecC--CCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhH
Q psy10160 383 LMKIANDIRFLASGPRCGLGELSLP--ENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLI 460 (558)
Q Consensus 383 l~k~a~d~~~~~s~~~~e~~e~~~~--~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (558)
|+|||+||++|++ +||+.++ .+++|||||||||||+.+|+++++++.+.+.+..++..+...++|++...|..
T Consensus 268 L~kia~Di~ll~~-----~~e~~e~~~~~~~GSS~MPhKrNPv~~E~i~~~a~~~~~~~~~~~~~~~~~~~eRD~~~~~~ 342 (456)
T PRK09285 268 LIDLDRDVWGYIS-----LGYFKQKTKAGEIGSSTMPHKVNPIDFENSEGNLGLANALLEHLAAKLPISRWQRDLTDSTV 342 (456)
T ss_pred HHHHHHHHHHHhC-----chhhhccCCCCCCCCCCCCCCcCchHHHHHHHHHHHHHHHHHHHHhhccHHhhCCcCchhhh
Confidence 9999999999996 4555443 47999999999999999999999999999888777655435679999999988
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhh-----hhcccccChHHHHHHHH----HHHHcCCCHH
Q psy10160 461 VSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLV-----TALNPHIGYDKAAKIAK----TAHKEGTTLK 531 (558)
Q Consensus 461 ~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~-----~~la~~l~~~~a~~~~~----~a~~~~~~~~ 531 (558)
+|.+ +++..+...++..+..++++|+||++||++|++.++.+. +.|++ +|+++||++|+ .+.++|.+|+
T Consensus 343 e~~~-~~~~~~~~~~l~~~~~~l~~L~V~~~rm~~nl~~~~~~~sE~~~~~l~~-~gr~~A~~~v~~~~~~~~~~~~~~~ 420 (456)
T PRK09285 343 LRNL-GVAFGYSLIAYDSLLKGLGKLEVNEARLAEDLDANWEVLAEPIQTVMRR-YGIENPYEKLKELTRGKRITAEALR 420 (456)
T ss_pred hcch-HHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhcCcchHHHHHHHHHH-hChHhHHHHHHHHHHHHHhccCCHH
Confidence 9998 999999999999999999999999999999986555433 35566 89999998765 4557899999
Q ss_pred HH---HHHcCCCCHHHHhhhcCcccccCC
Q psy10160 532 VA---ALKLGYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 532 ~~---~~~~~~l~~~~~~~~~~p~~~~~~ 557 (558)
|+ +.+...+. ++| .+|||++|+|.
T Consensus 421 e~~~~l~~~~~~~-~~l-~~~~p~~ylg~ 447 (456)
T PRK09285 421 EFIDGLDLPEEAK-ARL-KALTPANYIGL 447 (456)
T ss_pred HHHHHhcCCHhHH-HHH-HcCCHHHHHhh
Confidence 99 66544333 678 99999999984
No 32
>cd01360 Adenylsuccinate_lyase_1 Adenylsuccinate lyase (ASL)_subgroup 1. This subgroup contains bacterial and archeal proteins similar to ASL, a member of the Lyase class I family. Members of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. ASL catalyzes two steps in the de novo purine biosynthesis: the conversion of 5-aminoimidazole-(N-succinylocarboxamide) ribotide (SAICAR) into 5-aminoimidazole-4-carboxamide ribotide (AICAR) and, the conversion of adenylsuccinate (SAMP) into adenosine monophosphate (AMP).
Probab=100.00 E-value=5.3e-48 Score=387.39 Aligned_cols=274 Identities=19% Similarity=0.187 Sum_probs=234.9
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
.+.++|.|.+.+|+..++.. ...+.....+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|
T Consensus 81 ~~~~lH~G~S~nDi~~ta~~-L~lr~~l~~l~~~l~~l~~~L~~~A~~~~~t~m~grTH~Q~A~P~TfG~~l~~-~~~~L 158 (387)
T cd01360 81 AGRYIHFGLTSSDVVDTALA-LQLREALDIILKDLKELLEVLKKKALEHKDTVMVGRTHGIHAEPTTFGLKFAL-WYAEF 158 (387)
T ss_pred hhhheeCCCChhhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCeeehhhcCCcceeehHHHHHHH-HHHHH
Confidence 47889999999999998876 4444444333333332 2223 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhh---hhhhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhh
Q psy10160 312 DPNDRQALNIVS---IFYFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAN 388 (558)
Q Consensus 312 ~~~~~~l~~~~~---~~~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~ 388 (558)
.|+++||.+++. .++++|++|+++++++.++++++++|||+.+...| ++++||+++|+++++++++++|+|||+
T Consensus 159 ~r~~~rL~~~~~~~~~~~lgga~Gt~~~~~~~~~~~~a~~LG~~~~~~~~---~~~~rD~~~e~~~~la~~~~~L~ria~ 235 (387)
T cd01360 159 KRHLERLKEARERILVGKISGAVGTYANLGPEVEERVAEKLGLKPEPIST---QVIQRDRHAEYLSTLALIASTLEKIAT 235 (387)
T ss_pred HHHHHHHHHHHHHhHhhccchHhhcCccCCHHHHHHHHHHcCCCCCCCCC---cccCcHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999998764 55667789999999867999999999999766555 679999999999999999999999999
Q ss_pred hhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHH
Q psy10160 389 DIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLR 466 (558)
Q Consensus 389 d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (558)
||++|++ +|||||.+|. +++|||||||||||+.+|+++++++.+.|++..++ .....+++++...|..+|..++
T Consensus 236 Dl~~~s~---~e~gel~e~~~~~~~GSS~MPqKrNP~~~E~i~~~a~~~~g~~~~~~-~~~~~~~~rd~~~~~~~~~~l~ 311 (387)
T cd01360 236 EIRHLQR---TEVLEVEEPFSKGQKGSSAMPHKRNPILSENICGLARVIRSNVIPAL-ENVALWHERDISHSSVERVILP 311 (387)
T ss_pred HHHHHhh---ccccceecCCCCCCCCcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH-hhhHHhcCCCcchhHHHHHHHH
Confidence 9999995 9999999984 57999999999999999999999999999987654 3444567888888888899999
Q ss_pred HHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhh--hHhhhhhcc----c-ccChHHHHHHHHH
Q psy10160 467 SIRLIADSATAFTDKCVSGIVANEENIHRLLHE--SLMLVTALN----P-HIGYDKAAKIAKT 522 (558)
Q Consensus 467 ~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~--~~~~~~~la----~-~l~~~~a~~~~~~ 522 (558)
++..+...++..+..++++|+||++||+++++. +++++++++ + .+||++||++|.+
T Consensus 312 ~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~l~~~~~~~~ae~la~~L~~~g~~~r~Ah~~V~~ 374 (387)
T cd01360 312 DATILLDYILRRMTRVLENLVVYPENMRRNLNLTKGLIFSQRVLLALVEKGMSREEAYEIVQR 374 (387)
T ss_pred HHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhccCHHHHHHHHHHHHHcCCCHHHHHHHHHH
Confidence 999999999999999999999999999999985 666676665 4 4899999999877
No 33
>PRK00855 argininosuccinate lyase; Provisional
Probab=100.00 E-value=5.2e-48 Score=396.13 Aligned_cols=306 Identities=18% Similarity=0.159 Sum_probs=246.8
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+.+|++.++.. ...+..+..+...+.. ...+ .+++|.||||+|+|+|+|+|||+++ |++.|.
T Consensus 102 g~~iH~g~SrnD~~~Ta~~-L~~r~~l~~l~~~L~~l~~~L~~~A~~~~~t~m~GrTH~Q~A~P~T~G~~l~~-~~~~L~ 179 (459)
T PRK00855 102 GGKLHTGRSRNDQVATDLR-LYLRDEIDEIAELLLELQKALLDLAEEHADTIMPGYTHLQRAQPVTFGHHLLA-YAEMLA 179 (459)
T ss_pred cCcccCCCCHhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEeecCcCCccceeecHHHHHHH-HHHHHH
Confidence 4568899999999888865 3344333333332222 2233 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhh---hhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 313 PNDRQALNIVSIF---YFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 313 ~~~~~l~~~~~~~---~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|+++||.+.+.++ ++||++|++++++ .+++++|+.|||+. +..|++||+++||++++++++|+.++++|+|||+|
T Consensus 180 r~~~rL~~~~~~~~~~plGgaag~gt~~~-~~r~~~a~~LG~~~-~~~n~~~a~~~rd~~~e~~~~l~~la~~L~ria~D 257 (459)
T PRK00855 180 RDLERLRDARKRVNRSPLGSAALAGTTFP-IDRERTAELLGFDG-VTENSLDAVSDRDFALEFLSAASLLMVHLSRLAEE 257 (459)
T ss_pred HHHHHHHHHHHHHhhcCcchhhhcCCCCC-cCHHHHHHHcCCCC-CCCCHHHHHHccHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999887655 4556777777775 78999999999995 78899999999999999999999999999999999
Q ss_pred hhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccc--cccccchhhHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGH--FELNVFKPLIVSNVLR 466 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 466 (558)
|++|+| .||||+.+|+. ++|||||||||||+.+|++++.++++.|++.+++...++.+ ++++... .+..++
T Consensus 258 l~l~ss---~e~gei~~p~~~~~gSSiMPqK~NP~~~E~i~~~a~~~~g~~~~~~~~~~~~~~~~~rD~~~---~~~~l~ 331 (459)
T PRK00855 258 LILWSS---QEFGFVELPDAFSTGSSIMPQKKNPDVAELIRGKTGRVYGNLTGLLTVMKGLPLAYNRDLQE---DKEPLF 331 (459)
T ss_pred HHHHhC---cCCCeEeCCCCCCCCcCCCCCCCCCHHHHHHHHHHHHHHhhHHHHHHHhcCchHHhhhhhhh---hHHHHH
Confidence 999997 79999999986 59999999999999999999999999999998876554432 4444322 233444
Q ss_pred HHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccc-----cChHHHHHH----HHHHHHcCCCHHHHHHHc
Q psy10160 467 SIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPH-----IGYDKAAKI----AKTAHKEGTTLKVAALKL 537 (558)
Q Consensus 467 ~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~-----l~~~~a~~~----~~~a~~~~~~~~~~~~~~ 537 (558)
++..+...++..+..++++|+||+++|++++..+++++|+|++. ++|++||++ ++++.++|+++.++..+.
T Consensus 332 ~~~~~~~~al~~~~~~l~~l~v~~~~m~~~l~~~~~~at~la~~Lv~~gi~~r~Ah~~v~~~~~~a~~~g~~~~~~~~~~ 411 (459)
T PRK00855 332 DAVDTLKLSLEAMAGMLETLTVNKERMREAAGKGFSTATDLADYLVRKGVPFREAHEIVGKAVREAEERGVDLADLSLEE 411 (459)
T ss_pred HHHHHHHHHHHHHHHHHccCEECHHHHHHHHHcchhHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHhCCCHHHHhHHH
Confidence 44444455555666699999999999999999999999999864 588888875 567888999999987653
Q ss_pred ----CCCCHHHHhhhcCcccccC
Q psy10160 538 ----GYLTEEEFNKWVVPEDMLG 556 (558)
Q Consensus 538 ----~~l~~~~~~~~~~p~~~~~ 556 (558)
..+.++++.+++||+.++.
T Consensus 412 ~~~~~~~~~~~~~~~~~~~~~v~ 434 (459)
T PRK00855 412 LQAFSPLITEDVYEVLTPEGSVA 434 (459)
T ss_pred HHHhcccchHHHHHHhChHHHHH
Confidence 3355777989999988764
No 34
>PRK04833 argininosuccinate lyase; Provisional
Probab=100.00 E-value=6.3e-48 Score=393.34 Aligned_cols=304 Identities=14% Similarity=0.123 Sum_probs=244.1
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+.+|++.++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|.
T Consensus 100 g~~lH~grSrnD~~~Ta~r-l~~r~~l~~l~~~l~~l~~~L~~~A~~~~~tvm~GrTH~Q~AqP~T~G~~~~~-~~~~l~ 177 (455)
T PRK04833 100 GKKLHTGRSRNDQVATDLK-LWCKDQVAELLTALRQLQSALVETAENNQDAVMPGYTHLQRAQPVTFAHWCLA-YVEMLA 177 (455)
T ss_pred cCcccCCCCchhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEEeccccCccceeccHHHHHHH-HHHHHH
Confidence 5578999999999998876 4444444333333332 2223 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhhhhh---cC--CCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHh
Q psy10160 313 PNDRQALNIVSIFYFT---YL--VKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIA 387 (558)
Q Consensus 313 ~~~~~l~~~~~~~~~~---g~--~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a 387 (558)
|+++||..++.+++.+ |+ +||... .+++++|++|||+. +..|++|++++||+++|++++|++++++|+|||
T Consensus 178 r~~~rL~~~~~~~~~~plGgaA~~GT~~~---~dr~~~a~~LGf~~-~~~n~~~a~~~rd~~~e~~~~l~~~a~~L~ria 253 (455)
T PRK04833 178 RDESRLQDALKRLDVSPLGSGALAGTAYE---IDREQLAGWLGFAS-ATRNSLDSVSDRDHVLELLSDASISMVHLSRFA 253 (455)
T ss_pred HHHHHHHHHHHHHhhcCCCccccccCCCC---CCHHHHHHHhCCCC-CCCCHHHHHhccHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999988777655 34 344433 45899999999995 678999999999999999999999999999999
Q ss_pred hhhhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHH-HHH
Q psy10160 388 NDIRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVS-NVL 465 (558)
Q Consensus 388 ~d~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 465 (558)
+||++|+| +|||.+++++. ++|||||||||||+.+|+++++++++.|++++++...++.++ .+.++.+.| ..+
T Consensus 254 ~Dl~l~ss---~e~g~~el~~~~~~gSSiMPqKrNP~~~E~ir~~a~~~~g~~~~~~~~~~~~~~--~~~rd~~~~~~~l 328 (455)
T PRK04833 254 EDLIFFNS---GEAGFVELSDRVTSGSSLMPQKKNPDALELIRGKCGRVQGALTGMLMTLKGLPL--AYNKDMQEDKEGL 328 (455)
T ss_pred HHHHHHhC---CCCCceeeCCCCCCCcccCCCCCCChHHHHHHHHHHHHHhhHHHHHHHHhCChH--HHhhhhhhhHHHH
Confidence 99999997 79998887764 799999999999999999999999999999998866665333 333333321 234
Q ss_pred HHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhccc-----ccChHHHHHHHH----HHHHcCCCHHHHHHH
Q psy10160 466 RSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNP-----HIGYDKAAKIAK----TAHKEGTTLKVAALK 536 (558)
Q Consensus 466 ~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~-----~l~~~~a~~~~~----~a~~~~~~~~~~~~~ 536 (558)
+++......++.++..++++|+||++||++++..++.+++++|+ .++|++||++|. .+.++|.++.++..+
T Consensus 329 ~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~~~~g~~~a~~~a~~L~~~g~~~r~Ah~~v~~~~~~a~~~~~~~~~~~~~ 408 (455)
T PRK04833 329 FDALDTWLDCLHMAALVLDGIQVKRPRCQEAAQQGYANATELADYLVAKGVPFREAHHIVGEAVVEAIRQGKPLEDLPLA 408 (455)
T ss_pred HHHHHHHHHHHHHHHHHHhhCeECHHHHHHHHHccHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHcCCChhhcCHH
Confidence 44555555577888899999999999999999999988888874 479999998654 677788888886543
Q ss_pred c----CCCCHHHHhhhcCccccc
Q psy10160 537 L----GYLTEEEFNKWVVPEDML 555 (558)
Q Consensus 537 ~----~~l~~~~~~~~~~p~~~~ 555 (558)
. ..+.++++.+++||+.++
T Consensus 409 ~~~~~~~~~~~~~~~~l~p~~~v 431 (455)
T PRK04833 409 ELQKFSSVIGDDVYPILSLQSCL 431 (455)
T ss_pred HHHHhcccchHHHHHhCCHHHHH
Confidence 2 334577799999999876
No 35
>PRK12308 bifunctional argininosuccinate lyase/N-acetylglutamate synthase; Provisional
Probab=100.00 E-value=3.3e-47 Score=405.02 Aligned_cols=308 Identities=15% Similarity=0.145 Sum_probs=249.4
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+.+|++.++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|.
T Consensus 100 ~~~iH~g~S~nD~~~Ta~~-L~~r~~~~~l~~~l~~l~~~l~~~a~~~~~t~m~grTH~Q~A~P~T~G~~~~~-~~~~l~ 177 (614)
T PRK12308 100 GKKLHTGRSRNDQVATDLK-LWCRQQGQQLLLALDQLQQQMVNVAERHQGTVLPGYTHLQRAQPVTFAHWCLA-YVEMFE 177 (614)
T ss_pred ccceecCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEeecCcCCcccEEecHHHHHHH-HHHHHH
Confidence 6889999999999988876 4445554444433332 2223 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhhhhhc-CCCCChhHH-HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhh
Q psy10160 313 PNDRQALNIVSIFYFTY-LVKLSELLE-TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIANDI 390 (558)
Q Consensus 313 ~~~~~l~~~~~~~~~~g-~~g~~~~~~-~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~ 390 (558)
|+++||.+++.+++.++ +.|+.+|.+ +.+++++|+.|||+ .+..|++||+++||+++|++++|++++++|+|||+||
T Consensus 178 r~~~rL~~~~~~~~~~plGgga~agt~~~~~r~~~a~~LG~~-~~~~n~~da~~~rd~~~e~~~~l~~~~~~l~ria~Dl 256 (614)
T PRK12308 178 RDYSRLEDALTRLDTCPLGSGALAGTAYPIDREALAHNLGFR-RATRNSLDSVSDRDHVMELMSVASISMLHLSRLAEDL 256 (614)
T ss_pred HHHHHHHHHHHHHhhCCchhccccCCCCCCCHHHHHHHhCCC-CCcCCHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999998887766653 225554544 57899999999998 5678999999999999999999999999999999999
Q ss_pred hhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccc--cccccchhhHHHHHHHH
Q psy10160 391 RFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGH--FELNVFKPLIVSNVLRS 467 (558)
Q Consensus 391 ~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 467 (558)
++|+| +|||++++++. ++|||||||||||+.+|+++++++++.|++++++....+.+ ++++...| |..+++
T Consensus 257 ~~~ss---~e~g~~el~~~~~~gSSiMPqK~NP~~~E~i~~~a~~~~g~~~~~~~~~~~~~~~~~rd~~~~---~~~l~~ 330 (614)
T PRK12308 257 IFYNS---GESGFIELADTVTSGSSLMPQKKNPDALELIRGKTGRVYGALAGMMMTVKALPLAYNKDMQED---KEGLFD 330 (614)
T ss_pred HHHhC---CCcCCEEeCccCCCccccCcCccCCcHHHHHHHHHHHHhhHHHHHHHHHcCCchhhccchhhh---HHHHHH
Confidence 99997 79997777764 69999999999999999999999999999999876555433 33443333 566777
Q ss_pred HHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhccc-----ccChHHHHHHHH----HHHHcCCCHHHHHHHc-
Q psy10160 468 IRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNP-----HIGYDKAAKIAK----TAHKEGTTLKVAALKL- 537 (558)
Q Consensus 468 ~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~-----~l~~~~a~~~~~----~a~~~~~~~~~~~~~~- 537 (558)
+..+...++.++..++++|+||++||++++..+++++++|++ .+||++||++|. .+.++|+++.+++.+.
T Consensus 331 ~~~~~~~~l~~~~~~l~~l~v~~~rm~~~~~~g~~~a~~la~~L~~~g~~~r~Ah~~v~~~v~~a~~~g~~l~~~~~~~~ 410 (614)
T PRK12308 331 ALDTWNDCMEMAALCFDGIKVNGERTLEAAKQGYANATELADYLVAKGIPFREAHHIVGVAVVGAIAKGCALEELSLEQL 410 (614)
T ss_pred HHHHHHHHHHHHHHHhCcCEECHHHHHHHHHcCHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHcCCChhhCCHHHH
Confidence 777777777899999999999999999999999888888874 479999998654 5778899998876543
Q ss_pred ----CCCCH-----HHHhhhcCcccccCC
Q psy10160 538 ----GYLTE-----EEFNKWVVPEDMLGP 557 (558)
Q Consensus 538 ----~~l~~-----~~~~~~~~p~~~~~~ 557 (558)
..+++ .+++.+++|+.++|.
T Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~ 439 (614)
T PRK12308 411 KEFSDVIEDDVYQILTIESCLEKRCALGG 439 (614)
T ss_pred HHhhhhhhHHHHHhCCHHHHHHhccCCCC
Confidence 34555 346677788888774
No 36
>cd01598 PurB PurB_like adenylosuccinases (adenylsuccinate lyase, ASL). This subgroup contains EcASL, the product of the purB gene in Escherichia coli, and related proteins. It is a member of the Lyase class I family of the Lyase_I superfamily. Members of the Lyase class I family function as homotetramers to catalyze similar beta-elimination reactions in which a Calpha-N or Calpha-O bond is cleaved with the subsequent release of fumarate as one of the products. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. ASL catalyzes two non-sequential steps in the de novo purine biosynthesis pathway: the conversion of 5-aminoimidazole-(N-succinylocarboxamide) ribotide (SAICAR) into 5-aminoimidazole-4-carboxamide ribotide (AICAR) and; the conversion of adenylsuccinate (SAMP) into adenosine monophosphate (AMP).
Probab=100.00 E-value=1.5e-46 Score=376.25 Aligned_cols=304 Identities=16% Similarity=0.104 Sum_probs=245.1
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcc-cccchhhh-------hhhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYG-PHIKRAVE-------AEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~-~w~~~~l~-------~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
+.++|+|.+++|+.+++.. ...+... ..+...+. ....+ ++++|.||||+|+|+|+||||++++ |++.|
T Consensus 92 ~~~vH~G~TsnDi~dTa~~-L~lr~~l~~~l~~~L~~l~~~L~~lA~~~~dt~m~GrTH~Q~A~P~TfG~~~a~-w~~~L 169 (425)
T cd01598 92 KEFIHFACTSEDINNLAYA-LMIKEARNEVILPLLKEIIDSLKKLAKEYADVPMLSRTHGQPATPTTLGKELAV-FVYRL 169 (425)
T ss_pred hhHhccCCChhhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCeeecccCCccCeehhHHHHHHH-HHHHH
Confidence 5689999999999999976 4455444 23322222 22233 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhhhhhhhcCCCCChhH--------HHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIVSIFYFTYLVKLSELL--------ETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSL 383 (558)
Q Consensus 312 ~~~~~~l~~~~~~~~~~g~~g~~~~~--------~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l 383 (558)
.|+++||+++...++++|++|+.+.+ +..+++++++.|||..++.+| ++++||+++|++++|++++++|
T Consensus 170 ~r~~~RL~~~~~~g~~gGavGt~~~~~~~~~~~~~~~~~~~~a~~LgL~~~~~~~---~v~~rD~~~e~~~~La~la~~L 246 (425)
T cd01598 170 ERQYKQLKQIEILGKFNGAVGNFNAHLVAYPDVDWRKFSEFFVTSLGLTWNPYTT---QIEPHDYIAELFDALARINTIL 246 (425)
T ss_pred HHHHHHHHHHHHhheeeCchhhhhhhhhccCcccHHHHHHHHHHHhCcCCCCccc---chhccHHHHHHHHHHHHHHHHH
Confidence 99999999998889999999988755 257889999999999777776 4799999999999999999999
Q ss_pred HHHhhhhhhhccCCCccccceecC--CCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHH
Q psy10160 384 MKIANDIRFLASGPRCGLGELSLP--ENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIV 461 (558)
Q Consensus 384 ~k~a~d~~~~~s~~~~e~~e~~~~--~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (558)
+|||+||++|+| + ||+.++ ++++|||||||||||+.+|+++++++.+.+....++..+...+++++...|..+
T Consensus 247 ~kia~Di~ll~s---~--ge~~e~~~~~~~GSS~MPhKrNPv~~E~i~~~a~~a~~~~~~~~~~~~~~~~eRD~~~~~~e 321 (425)
T cd01598 247 IDLCRDIWGYIS---L--GYFKQKVKKGEVGSSTMPHKVNPIDFENAEGNLGLSNALLNHLSAKLPISRLQRDLTDSTVL 321 (425)
T ss_pred HHHHHHHHHHhC---C--cceeecCCCCCCCcCCCCCCcCchHHHHHHHHHHHHHHHHHHHHhhhhhhhhcccccchhhh
Confidence 999999999997 4 455543 478999999999999999999999999988887776444357799999999889
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhh-----hcccccChHHHHHHHHHHHH-cCCCHHH---
Q psy10160 462 SNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVT-----ALNPHIGYDKAAKIAKTAHK-EGTTLKV--- 532 (558)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~-----~la~~l~~~~a~~~~~~a~~-~~~~~~~--- 532 (558)
|.+ +++..+...++..+..++++|+||++||++|++.++.+++ .|++ +|+++||++|.++.. ...+..+
T Consensus 322 ~~~-~~~~~~~~~al~~~~~ll~~L~v~~~rm~~nl~~~~~i~sE~~~~~l~~-~gr~~Ah~~V~~~~~~~~~~~~~~~~ 399 (425)
T cd01598 322 RNI-GVAFGHSLIAYKSLLRGLDKLELNEARLLEDLDANWEVLAEPIQTVMRR-YGIPNPYEKLKDLTRGKRIDKETLKE 399 (425)
T ss_pred ccH-HHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHhCcCHHHHHHHHHHHh-cChHhHHHHHHHHhCCCCCCHHHHHH
Confidence 988 8888888889999999999999999999999976665443 4455 899999999987654 3333333
Q ss_pred HHHHcCCCCHHHHhh--hcCcccccCC
Q psy10160 533 AALKLGYLTEEEFNK--WVVPEDMLGP 557 (558)
Q Consensus 533 ~~~~~~~l~~~~~~~--~~~p~~~~~~ 557 (558)
+..+.. .+++.-++ .|.|.+|+|.
T Consensus 400 ~~~~~~-~~~~~~~~~~~~~~~~~~~~ 425 (425)
T cd01598 400 FIDSLD-IPEEAKAELLALTPANYIGL 425 (425)
T ss_pred HHHhCC-CCHHHHHHHHhCCccccCCc
Confidence 333332 44443333 4589999984
No 37
>KOG1316|consensus
Probab=100.00 E-value=1.2e-46 Score=343.64 Aligned_cols=267 Identities=21% Similarity=0.195 Sum_probs=233.9
Q ss_pred hhhhhhhcccccchhhhhhhHHHhhcccccccccchHHHHHhHhhhhhhhc-CCCCChhHH-HHHHHHHHhHhCCCcccC
Q psy10160 279 AAADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQALNIVSIFYFTY-LVKLSELLE-TKCAAKIAELTGLPFKSA 356 (558)
Q Consensus 279 ~~~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~l~~~~~~~~~~g-~~g~~~~~~-~~~~~~~a~~lg~~~~~~ 356 (558)
.+.+++|+|+||+|.|||+.+.||+.+ |+..|.||+.||.+++.++|+.| ++|+.+|.+ .++|+.+++.|||. .++
T Consensus 149 ~~~dvlmpGYTHLQRAQpvrwsH~LlS-ha~~l~~D~~Rl~q~~~R~n~~PLGagALAGnpl~iDR~~la~~LgF~-~v~ 226 (464)
T KOG1316|consen 149 AELDVLMPGYTHLQRAQPVRWSHWLLS-HAEQLTRDLGRLVQIRKRLNQLPLGAGALAGNPLGIDREFLAEELGFE-GVI 226 (464)
T ss_pred hccCeeccChhhhhhccCchhHHHHHH-HHHHHHhHHHHHHHHHHHhccCCcccchhcCCCCCccHHHHHHhcCCc-ccc
Confidence 337899999999999999999999997 99999999999999999999997 577777765 48999999999999 789
Q ss_pred CChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhhhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHH
Q psy10160 357 PNKFEALAAHDALVEVSGALNTVAVSLMKIANDIRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQV 435 (558)
Q Consensus 357 ~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~ 435 (558)
-||+||++.||+++|+..+.++++.+|+|+|+|+.+|+| .|||++.+.+. .+|||+||||+||+.+|.+|+.+++|
T Consensus 227 ~NSm~AvsDRDFVvef~fw~sm~m~HlSRlaEdlIiy~t---~EF~Fv~lSDaySTGSSlMPQKKNpDslELlRgksgrV 303 (464)
T KOG1316|consen 227 MNSMDAVSDRDFVVEFLFWASMVMTHLSRLAEDLIIYST---KEFGFVTLSDAYSTGSSLMPQKKNPDSLELLRGKSGRV 303 (464)
T ss_pred hhhhhccccchhHHHHHHHHHHHHHHHHHHhhHhheeec---cccCceeeccccccCcccCCCCCCCCHHHHhcccccee
Confidence 999999999999999999999999999999999999998 99999999986 79999999999999999999999999
Q ss_pred HcccHHHHhhccccccccccchhh--HHHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhccccc--
Q psy10160 436 MGNHVAVTIGGSNGHFELNVFKPL--IVSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHI-- 511 (558)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l-- 511 (558)
.|.+.+++...++ ++..|+.++ ++..+|++...+.+.+...+ .++.+|+||+|+|++.|... |+||+||++|
T Consensus 304 ~gdl~g~lmt~KG--~PstYnkDlQeDKep~Fds~~tv~~~l~v~t-gv~stltvn~e~m~~aLt~d-mlATdlA~YLVr 379 (464)
T KOG1316|consen 304 FGDLTGLLMTLKG--LPSTYNKDLQEDKEPLFDSSKTVSDSLQVAT-GVISTLTVNQENMEKALTPD-MLATDLAYYLVR 379 (464)
T ss_pred hhhhHHHHHHhcC--CccccccchhhhhhHHHhhHHHHHHHHHHHH-HHhhheeECHHHHhhccCch-hhHhHHHHHHHH
Confidence 9999999999998 566666666 46789999999988886554 59999999999999999985 7899999775
Q ss_pred ---ChHHHHHH----HHHHHHcCCCHHHHHHH----cCCCCHHHHhhhcCcccc
Q psy10160 512 ---GYDKAAKI----AKTAHKEGTTLKVAALK----LGYLTEEEFNKWVVPEDM 554 (558)
Q Consensus 512 ---~~~~a~~~----~~~a~~~~~~~~~~~~~----~~~l~~~~~~~~~~p~~~ 554 (558)
+|+++|++ |..|.+.|.++.++..+ ...+-++|+-..+|-++-
T Consensus 380 KGvPFRqtHhisG~~V~~ae~rg~~l~~LsledlqklsplF~eDv~~v~~ye~s 433 (464)
T KOG1316|consen 380 KGVPFRQTHHISGKAVRMAEERGVTLDKLSLEDLQKLSPLFEEDVFCVFNYENS 433 (464)
T ss_pred cCCCchhhhhhhHHHHHHHHHcCCCcccCCHHHHhhcCcccccchHHhhchhhh
Confidence 99999985 56777888887665443 234555666666665543
No 38
>PRK02186 argininosuccinate lyase; Provisional
Probab=100.00 E-value=5.6e-46 Score=412.32 Aligned_cols=290 Identities=18% Similarity=0.161 Sum_probs=246.5
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhhh-------hhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAE-------AAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~-------~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|.|.+.+|+..++.. ...+..+..+...+... ..+ ++++|.||||+|+|+|+|+|||+++ |+++|.
T Consensus 507 ~~~lH~grSrnD~v~T~~~-l~lr~~~~~l~~~l~~l~~~L~~~A~~~~~~~m~g~TH~Q~A~P~T~G~~~~~-~~~~l~ 584 (887)
T PRK02186 507 GGVLQTARSRNDINATTTK-LHLREATSRAFDALWRLRRALVFKASANVDCALPIYSQYQPALPGSLGHYLLA-VDGALA 584 (887)
T ss_pred hcccCccccHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCEeecCccCCccccccHHHHHHH-HHHHHH
Confidence 5778999988888888766 45555544444433322 222 7899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhh---hhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhh
Q psy10160 313 PNDRQALNIVSIF---YFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAND 389 (558)
Q Consensus 313 ~~~~~l~~~~~~~---~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d 389 (558)
|+++||.+++.++ .++|++|++++++ .+++++|++|||+ .+..|++||+++||+++|++++|++++++|+|||+|
T Consensus 585 r~~~rl~~~~~r~~~~plG~aag~gt~~~-~~~~~~a~~LGf~-~~~~n~~da~~~rd~~~e~~~~l~~~~~~l~ria~D 662 (887)
T PRK02186 585 RETHALFALFEHIDVCPLGAGAGGGTTFP-IDPEFVARLLGFE-QPAPNSLDAVASRDGVLHFLSAMAAISTVLSRLAQD 662 (887)
T ss_pred HHHHHHHHHHHHhCcCCcccccccCCCCC-CCHHHHHHHcCCC-CCccCHHHHHcccHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999887666 4556788888875 5789999999999 677899999999999999999999999999999999
Q ss_pred hhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHH
Q psy10160 390 IRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSI 468 (558)
Q Consensus 390 ~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (558)
|++|+| +||||+.+|+. ++|||||||||||+.+|+++++++++.|++.+++...++.+++++...+...|..++++
T Consensus 663 l~~~~~---~e~g~i~~~~~~~~gSSiMPqKrNP~~~E~ir~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 739 (887)
T PRK02186 663 LQLWTT---REFALVSLPDALTGGSSMLPQKKNPFLLEFVKGRAGVVAGALASASAALGKTPFSNSFEAGSPMNGPIAQA 739 (887)
T ss_pred HHHHhC---CCCCcEECCCccccccCCCCCCCCCcHHHHHHHHHHHHhhHHHHHHHHHccCCcccccchhhhhHHHHHHH
Confidence 999996 89999999984 79999999999999999999999999999999988888889998877665567777777
Q ss_pred HHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhccc------ccChHHHHHHH----HHHHHcCCCHHHHHHHc
Q psy10160 469 RLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNP------HIGYDKAAKIA----KTAHKEGTTLKVAALKL 537 (558)
Q Consensus 469 ~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~------~l~~~~a~~~~----~~a~~~~~~~~~~~~~~ 537 (558)
..+...++.++..++++|+||++||++++..++.+||+||+ .+||++||++| +.+.++|.++.+.+.+.
T Consensus 740 ~~~~~~~l~~~~~~l~~l~v~~~rm~~~~~~~~~~at~la~~L~~~~g~~fr~Ah~~v~~~v~~~~~~~~~~~~~~~~~ 818 (887)
T PRK02186 740 CAAIEDAAAVLVLLIDGLEADQARMRAHLEDGGVSATAVAESLVVRRSISFRSAHTQVGQAIRQSLDQGRSSADALAAL 818 (887)
T ss_pred HHHHHHHHHHHHHHHhhCEECHHHHHHHHhcCcchHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHhcCCcccchHHHh
Confidence 77777777888899999999999999999998888888873 48999999865 45677887777766543
No 39
>PLN02848 adenylosuccinate lyase
Probab=100.00 E-value=2.2e-45 Score=371.42 Aligned_cols=304 Identities=16% Similarity=0.127 Sum_probs=248.3
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccc-cchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPH-IKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNL 311 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w-~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l 311 (558)
+.++|+|.+++|+.+++.. ...+..... +...+.. .... ++++|.||||+|+|+|+||||++++ |++.|
T Consensus 117 ~~~vH~G~TsqDi~dTa~~-L~lr~a~~~~l~~~L~~l~~aL~~lA~~~~dt~m~GRTH~Q~A~PiTfG~~~a~-w~~~L 194 (458)
T PLN02848 117 LEFFHFACTSEDINNLSHA-LMLKEGVNSVVLPTMDEIIKAISSLAHEFAYVPMLSRTHGQPASPTTLGKEMAN-FAYRL 194 (458)
T ss_pred hCcccCCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCeeeccccCccceeehHHHHHHH-HHHHH
Confidence 5789999999999999877 555555544 4433332 2233 7899999999999999999999998 99999
Q ss_pred cchHHHHHhHhhhhhhhcCCCCChhH----H----HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHH
Q psy10160 312 DPNDRQALNIVSIFYFTYLVKLSELL----E----TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSL 383 (558)
Q Consensus 312 ~~~~~~l~~~~~~~~~~g~~g~~~~~----~----~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l 383 (558)
.|+.+||.+....++++|++|+++++ + +.+.+.+++.|||...+.. +++++||+++|++++|++++++|
T Consensus 195 ~r~~~rL~~~~l~g~~~GAvGt~aa~~~~~~~~d~~~v~~~la~~LGL~~~~~~---~~v~~rD~~~e~~~~La~~a~~l 271 (458)
T PLN02848 195 SRQRKQLSEVKIKGKFAGAVGNYNAHMSAYPEVDWPAVAEEFVTSLGLTFNPYV---TQIEPHDYMAELFNAVSRFNNIL 271 (458)
T ss_pred HHHHHHHHHHHhccEeecccchhhhhhhccCCCCHHHHHHHHHHHhCCCCCCch---hhHhccHHHHHHHHHHHHHHHHH
Confidence 99999999988778999999998875 2 4678889999999853332 25799999999999999999999
Q ss_pred HHHhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHH
Q psy10160 384 MKIANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIV 461 (558)
Q Consensus 384 ~k~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (558)
+|||+|++.|+ |+||+.++. +++|||||||||||+.+|+++++++.+.|.+..++.....+++|++...|..+
T Consensus 272 ~kia~Di~~~~-----e~ge~~e~~~~~~~GSS~MP~KrNPv~~E~i~~~a~~~~~~~~~~~~~~~~~~~eRD~~~s~~e 346 (458)
T PLN02848 272 IDFDRDIWSYI-----SLGYFKQITKAGEVGSSTMPHKVNPIDFENSEGNLGLANAELSHLSMKLPISRMQRDLTDSTVL 346 (458)
T ss_pred HHHHHHHHhhh-----hcCCcccccCCCCCCcCCCCCCcCcHHHHHHHHHHHHHHHHHHHHHhcCcchhhccccchhhhh
Confidence 99999988776 577777653 68999999999999999999999999999999998665777899999999889
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhh-----hhcccccChHHHHHHHHHHHH-cCC---CHHH
Q psy10160 462 SNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLV-----TALNPHIGYDKAAKIAKTAHK-EGT---TLKV 532 (558)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~-----~~la~~l~~~~a~~~~~~a~~-~~~---~~~~ 532 (558)
|.+ +++..+...++..+..++++|+||++||++|++.++.+. +.|++ +|+++||++++++.. +.. .+++
T Consensus 347 ~~~-~~~~~~~~~al~~~~~~l~~L~v~~~rm~~nl~~~~~~~sE~~~~~l~~-~G~~~A~e~v~~~~~~~~~~~~~~~~ 424 (458)
T PLN02848 347 RNM-GVGLGHSLLAYKSTLRGIGKLQVNEARLAEDLDQTWEVLAEPIQTVMRR-YGVPEPYEKLKELTRGRAVTKESMRE 424 (458)
T ss_pred ccH-HHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHccchhHHHHHHHHHHH-hChHHHHHHHHHHHHHccCCHHHHHH
Confidence 998 888888888889999999999999999999987665433 34556 899999999987653 222 2333
Q ss_pred HHHHcCCCCHHHHhhh--cCcccccCC
Q psy10160 533 AALKLGYLTEEEFNKW--VVPEDMLGP 557 (558)
Q Consensus 533 ~~~~~~~l~~~~~~~~--~~p~~~~~~ 557 (558)
+..... ++++..+++ |.|.+|+|.
T Consensus 425 ~~~~~~-~~~~~~~~l~~~~~~~y~g~ 450 (458)
T PLN02848 425 FIEGLE-LPEEAKDQLLKLTPHTYIGA 450 (458)
T ss_pred HHHHcC-CCHHHHHHHHhCCchhhhch
Confidence 333333 676666655 489999985
No 40
>PRK06389 argininosuccinate lyase; Provisional
Probab=100.00 E-value=7e-42 Score=339.27 Aligned_cols=239 Identities=15% Similarity=0.102 Sum_probs=198.3
Q ss_pred hhhhhcccccchhhhhhhHHHhhcccccccccchHHHHHhHhhhhhhhcCCCCChhHH---HHHHHHHHhHhCCCcccCC
Q psy10160 281 ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPNDRQALNIVSIFYFTYLVKLSELLE---TKCAAKIAELTGLPFKSAP 357 (558)
Q Consensus 281 ~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~~~~l~~~~~~~~~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~ 357 (558)
.+++|+||||+|+|+|+|+|||+++ |++.|.|+++||.+++.+++.++ .|+.++.| +.+++++|++|||+. +..
T Consensus 141 ~dtimpGyTHlQ~AqP~TfG~~l~a-~a~~L~rd~~RL~~~~~r~~~~p-LGaga~~Gt~~~idr~~~A~lLGf~~-~~~ 217 (434)
T PRK06389 141 LKGRLPGYTHFRQAMPMTVNTYINY-IKSILYHHINNLDSFLMDLREMP-YGYGSGYGSPSSVKFNQMSELLGMEK-NIK 217 (434)
T ss_pred cCceeccccccCcCcchhHHHHHHH-HHHHHHHHHHHHHHHHHHHhhcc-hhhhhhhcCCchhhHHHHHHHhCCCC-CCC
Confidence 7899999999999999999999998 99999999999999998888873 32222222 368999999999994 667
Q ss_pred ChhHHhhcCcH-HHHHHHHHHHHHHHHHHHhhhhhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHH
Q psy10160 358 NKFEALAAHDA-LVEVSGALNTVAVSLMKIANDIRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQV 435 (558)
Q Consensus 358 ~~~~~~~~~d~-~~~~~~~l~~~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~ 435 (558)
|++++..++|+ ++|+++++++++.+|+|||+|+++|+| . |++++|+. ++|||||||||||+.+|.+++.++++
T Consensus 218 n~~~a~~~~~~~~~e~~~~la~la~~LsRiA~Dl~l~ss---~--g~ielpd~~~~GSSiMPqKrNP~~~E~ir~~a~~v 292 (434)
T PRK06389 218 NPVYSSSLYIKTIENISYLISSLAVDLSRICQDIIIYYE---N--GIITIPDEFTTGSSLMPNKRNPDYLELFQGIAAES 292 (434)
T ss_pred CCchhhhccchHHHHHHHHHHHHHHHHHHHHHHHHHHcC---C--CEEEecCCCCCCCCCCCCCcCcHHHHHHHHHHHHH
Confidence 88887667655 889999999999999999999999997 3 78888875 79999999999999999999999999
Q ss_pred HcccHHHHhhccccccccccchhhH--HHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccc---
Q psy10160 436 MGNHVAVTIGGSNGHFELNVFKPLI--VSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPH--- 510 (558)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~--- 510 (558)
.|.++++....++. +.+++.+.+ ...+++.+..+..++ .++..++++++||++| ++.++.. .+||+||+.
T Consensus 293 ~g~~~~~~~~~~n~--~~~y~~D~q~~~~~~~~~~~~~~~~l-~l~~~~i~~l~~~~~~-~~a~~~~-~~ATdlA~~lv~ 367 (434)
T PRK06389 293 ISVLSFIAQSELNK--TTGYHRDFQIVKDSTISFINNFERIL-LGLPDLLYNIKFEITN-EKNIKNS-VYATYNAWLAFK 367 (434)
T ss_pred HHHHHHHHHHHcCC--cchhhHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHhCeECHHH-HhhccCC-CcHHHHHHHHHH
Confidence 99999998777764 445555554 566777777776665 4566799999999999 5555444 458999854
Q ss_pred --cChHHHHHHHHHHHHcCCCHHH
Q psy10160 511 --IGYDKAAKIAKTAHKEGTTLKV 532 (558)
Q Consensus 511 --l~~~~a~~~~~~a~~~~~~~~~ 532 (558)
++||+||++|..+..+++-+.+
T Consensus 368 ~GipFR~AH~~Vg~~V~~~~~~~~ 391 (434)
T PRK06389 368 NGMDWKSAYAYIGNKIREGEVLDE 391 (434)
T ss_pred cCCCHHHHHHHHHHHHHhccchhh
Confidence 5999999999988887765433
No 41
>PRK05975 3-carboxy-cis,cis-muconate cycloisomerase; Provisional
Probab=100.00 E-value=1.2e-42 Score=342.24 Aligned_cols=235 Identities=17% Similarity=0.114 Sum_probs=207.1
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+++|+.+++.. ...+.....+...+.. ...+ ++++|.||||+|+|+|+||||++++ |++.|.
T Consensus 99 ~~~vH~G~TsnDi~dTa~~-L~lr~~l~~l~~~L~~l~~~L~~lA~~~~~t~m~grTH~Q~A~P~TfG~~~a~-~~~~l~ 176 (351)
T PRK05975 99 AAHVHFGATSQDVIDTSLM-LRLKAASEILAARLGALIARLDALEATFGQNALMGHTRMQAAIPITVADRLAS-WRAPLL 176 (351)
T ss_pred hCcccCCCChhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCeeecccCCCcCeehhHHHHHHH-HHHHHH
Confidence 6789999999999998877 5555555444444333 2223 7899999999999999999999998 999999
Q ss_pred chHHHHHhHh---hhhhhhcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHH
Q psy10160 313 PNDRQALNIV---SIFYFTYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKI 386 (558)
Q Consensus 313 ~~~~~l~~~~---~~~~~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~ 386 (558)
|+++||.+.+ ..++++|++|++++++ +.+++++|+.|||+.++ + |+++||+++|++++|++++++|+||
T Consensus 177 r~~~rL~~~~~~~~~~~lGGAvGt~~~~~~~~~~~~~~~a~~LGl~~~~-~----~~~~rD~~~e~~~~la~la~~l~ki 251 (351)
T PRK05975 177 RHRDRLEALRADVFPLQFGGAAGTLEKLGGKAAAVRARLAKRLGLEDAP-Q----WHSQRDFIADFAHLLSLVTGSLGKF 251 (351)
T ss_pred HHHHHHHHHHHHhhhcCCccHhccCccCCCcHHHHHHHHHHHhCcCCCc-c----hhhccHHHHHHHHHHHHHHHHHHHH
Confidence 9999998776 6678888999987664 68999999999998543 3 5899999999999999999999999
Q ss_pred hhhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHH
Q psy10160 387 ANDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLR 466 (558)
Q Consensus 387 a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (558)
|+||++|+| +| ||+.+|. ++|||||||||||+.+|+++++++.+.+++..+. ..+..++|++...|..+|..+|
T Consensus 252 A~Di~ll~s---~e-gev~~~~-~~GSS~MPhKrNPv~~E~i~~~ar~~~~~~~~~~-~~~~~~~er~~~~~~~e~~~lp 325 (351)
T PRK05975 252 GQDIALMAQ---AG-DEISLSG-GGGSSAMPHKQNPVAAETLVTLARFNATQVSGLH-QALVHEQERSGAAWTLEWMILP 325 (351)
T ss_pred HHHHHHHhC---CC-CcccCCC-CCccCCCCCCcCcHHHHHHHHHHHHHHHHHHHHH-hcccchhccCCchHHHHHHHHH
Confidence 999999996 89 9999997 6999999999999999999999999999988775 5567889999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhcCccc
Q psy10160 467 SIRLIADSATAFTDKCVSGIVA 488 (558)
Q Consensus 467 ~~~~~~~~~~~~~~~~l~~l~v 488 (558)
+++.+.++++..+..++++|++
T Consensus 326 ~~~~~~~~~l~~~~~ll~~l~~ 347 (351)
T PRK05975 326 QMVAATGAALRLALELAGNIRR 347 (351)
T ss_pred HHHHHHHHHHHHHHHHHhhhHh
Confidence 9999999999999999999975
No 42
>TIGR02426 protocat_pcaB 3-carboxy-cis,cis-muconate cycloisomerase. Members of this family are 3-carboxy-cis,cis-muconate cycloisomerase, the enzyme the catalyzes the second step in the protocatechuate degradation to beta-ketoadipate and then to succinyl-CoA and acetyl-CoA. 4-hydroxybenzoate, 3-hydroxybenzoate, and vanillate all can be converted in one step to protocatechuate. All members of the seed alignment for this model were chosen from within protocatechuate degradation operons of at least three genes of the pathway, from genomes with the complete pathway through beta-ketoadipate.
Probab=100.00 E-value=2.5e-42 Score=339.60 Aligned_cols=235 Identities=22% Similarity=0.161 Sum_probs=202.4
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|.|.+.+|+..++.. ...+..+..+...+.. ...+ ++++|.||||+|+|+|+|+|||+++ |++.|.
T Consensus 90 g~~vH~G~S~nD~~~Ta~~-L~lr~~l~~l~~~l~~l~~~L~~~A~~~~~~~m~grTH~Q~A~P~T~G~~l~~-~~~~l~ 167 (338)
T TIGR02426 90 ARYVHRGATSQDVIDTSLM-LQLRDALDLLLADLGRLADALADLAARHRDTPMTGRTLLQQAVPTTFGLKAAG-WLAAVL 167 (338)
T ss_pred cCcccCCCChhhhHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCceecccCCCcCeehhHHHHHHH-HHHHHH
Confidence 5788999999999988865 4444444333333222 2233 7899999999999999999999998 999999
Q ss_pred chHHHHHhHh---hhhhhhcCCCCChhHH---HHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHH
Q psy10160 313 PNDRQALNIV---SIFYFTYLVKLSELLE---TKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKI 386 (558)
Q Consensus 313 ~~~~~l~~~~---~~~~~~g~~g~~~~~~---~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~ 386 (558)
|+++||..++ ..++++|++|++++++ ..+++++++.|||+.+... ++++||+++|++++|++++++|+||
T Consensus 168 r~~~rL~~~~~~~~~~~lGgavGtg~~~~~~~~~v~~~~a~~LGl~~~~~~----~~~~rd~~~e~~~~l~~la~~l~ri 243 (338)
T TIGR02426 168 RARDRLAALRTRALPLQFGGAAGTLAALGTRGGAVAAALAARLGLPLPALP----WHTQRDRIAEFGSALALVAGALGKI 243 (338)
T ss_pred HHHHHHHHHHHHhHhcCCcchhccCCCccchHHHHHHHHHHHhCcCCCCCc----chhhhHHHHHHHHHHHHHHHHHHHH
Confidence 9999998776 4556677888887753 4679999999999965444 4899999999999999999999999
Q ss_pred hhhhhhhccCCCccccceecCCCCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHH
Q psy10160 387 ANDIRFLASGPRCGLGELSLPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLR 466 (558)
Q Consensus 387 a~d~~~~~s~~~~e~~e~~~~~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (558)
|+||++|++ +||||+.++ .++|||||||||||+.+|+++++++.+.|+...++ ..+..++|++...|..+|.++|
T Consensus 244 a~Dl~l~s~---~e~gei~~~-~~~GSSiMPqK~NP~~~E~i~~~a~~~~g~~~~~~-~~~~~~~Er~~~~~~~e~~~lp 318 (338)
T TIGR02426 244 AGDIALLSQ---TEVGEVFEA-GGGGSSAMPHKRNPVGAALLAAAARRVPGLAATLH-AALPQEHERSLGGWHAEWETLP 318 (338)
T ss_pred HHHHHHHhc---CCCChhhhC-CCCCcccCCCCCCcHHHHHHHHHHHHHHHHHHHHH-HhchHhhccCCCchHHHHHHHH
Confidence 999999995 999999984 46999999999999999999999999999998886 5577899999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhcCc
Q psy10160 467 SIRLIADSATAFTDKCVSGI 486 (558)
Q Consensus 467 ~~~~~~~~~~~~~~~~l~~l 486 (558)
+++.+.++++..+.+++++|
T Consensus 319 ~~~~~~~~~l~~~~~~l~~l 338 (338)
T TIGR02426 319 ELVRLTGGALRQAQVLAEGL 338 (338)
T ss_pred HHHHHHHHHHHHHHHHHhcC
Confidence 99999999999999999875
No 43
>cd01334 Lyase_I Lyase class I family; a group of proteins which catalyze similar beta-elimination reactions. The Lyase class I family contains class II fumarase, aspartase, adenylosuccinate lyase (ASL), argininosuccinate lyase (ASAL), prokaryotic-type 3-carboxy-cis,cis-muconate cycloisomerase (pCMLE), and related proteins. It belongs to the Lyase_I superfamily. Proteins of this family for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. These proteins are active as tetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits.
Probab=100.00 E-value=6.3e-42 Score=337.83 Aligned_cols=242 Identities=28% Similarity=0.336 Sum_probs=205.8
Q ss_pred ceeeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhccccccccc
Q psy10160 241 GRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLD 312 (558)
Q Consensus 241 ~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~ 312 (558)
+.++|+|.+.+|+.+++.. ...+..+.-+...+.. ...+ ++++|.||||+|+|+|+|||||+++ |++.|.
T Consensus 71 ~~~lH~G~S~nDi~~ta~~-l~lr~~~~~l~~~l~~l~~~L~~~A~~~~~t~m~grTH~Q~A~P~T~G~~~~~-~~~~l~ 148 (325)
T cd01334 71 GGYVHTGRSSNDIVDTALR-LALRDALDILLPALKALIDALAAKAEEHKDTVMPGRTHLQDAQPTTLGHELAA-WAAELE 148 (325)
T ss_pred CCCCccCCCCccHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHccCcEeecccccccCccccHHHHHHH-HHHHHH
Confidence 6789999999999888766 4444444333332222 2233 8899999999999999999999998 999999
Q ss_pred chHHHHHhHhhhhhh---h-cCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhh
Q psy10160 313 PNDRQALNIVSIFYF---T-YLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIAN 388 (558)
Q Consensus 313 ~~~~~l~~~~~~~~~---~-g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~ 388 (558)
|+++||.+.+.+++. + |++|+.+..++.+++++|+.|||. .+..|++|++++||+++|+++++++++++|+|||+
T Consensus 149 r~~~rL~~~~~~~~~~~lG~gA~g~~~~~~~~~~~~~a~~LG~~-~~~~~~~~a~~~rd~~~e~~~~l~~~~~~l~ria~ 227 (325)
T cd01334 149 RDLERLEEALKRLNVLPLGGGAVGTGANAPPIDRERVAELLGFF-GPAPNSTQAVSDRDFLVELLSALALLAVSLSKIAN 227 (325)
T ss_pred HHHHHHHHHHHHhhhcCCcHhHHhCcCCCCcchHHHHHHHhcCc-CcCcCHHHHHhCcHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999988876655 4 466666665678999999999995 47789999999999999999999999999999999
Q ss_pred hhhhhccCCCccccceecCCC-CCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHH
Q psy10160 389 DIRFLASGPRCGLGELSLPEN-EPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRS 467 (558)
Q Consensus 389 d~~~~~s~~~~e~~e~~~~~~-~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (558)
|+++|+| +||||+.+|+. ++|||||||||||+.+|+++++++++.|....++....+.+++ +...+..+|..+++
T Consensus 228 Dl~~~~~---~e~gev~~~~~~~~gSS~MP~KrNP~~~E~i~~~a~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 303 (325)
T cd01334 228 DLRLLSS---GEFGEVELPDAKQPGSSIMPQKVNPVILELVRGLAGRVIGNLAALLEALKGGPLE-DNVDSPVEREALPD 303 (325)
T ss_pred HHHHHcC---CCCCeEECCCCCCCCcccCCCCCCCHHHHHHHHHHHHHhhHHHHHHHHHhcCchh-hhcccHHHHHHHHH
Confidence 9999996 89999999986 8999999999999999999999999999999998777765555 55566667888888
Q ss_pred HHHHHHHHHHHHHhhhcCcccC
Q psy10160 468 IRLIADSATAFTDKCVSGIVAN 489 (558)
Q Consensus 468 ~~~~~~~~~~~~~~~l~~l~v~ 489 (558)
+..+...++..+..++++|+||
T Consensus 304 ~~~~~~~~l~~~~~~~~~l~v~ 325 (325)
T cd01334 304 SFDLLDAALRLLTGVLEGLEVN 325 (325)
T ss_pred HHHHHHHHHHHHHHHhCcCEeC
Confidence 8888888888888899999987
No 44
>KOG2700|consensus
Probab=100.00 E-value=5.1e-35 Score=277.82 Aligned_cols=304 Identities=18% Similarity=0.119 Sum_probs=253.6
Q ss_pred eeecccceeEEEEeccCCCCCCCcccccchhhhh-------hhhh-hhhhhcccccchhhhhhhHHHhhcccccccccch
Q psy10160 243 YCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEA-------EAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPN 314 (558)
Q Consensus 243 ~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~-------~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~ 314 (558)
.+|.|++..++.+.... -..+.....++..+.. .... +++++.|+||+|+|+++|+|+..+- |..+|.++
T Consensus 102 iihlgatsc~vtdnadl-i~~rd~~k~i~~~l~~vIdrls~~~~~~k~~~~~g~Th~q~A~l~tfgkr~~~-~~qel~~~ 179 (481)
T KOG2700|consen 102 IIHLGATSCFVTDNADL-IELRDASKLILPYLAGVIDRLSQFADKYKEKPTLGRTHLQPAQLTTFGKRMCL-WIQELLRD 179 (481)
T ss_pred eEEeeeeeeeecCCccc-eechhHHHHHHHHHHHHHHHHHHHHHHhccceecccccCccchhhHHHHHHHH-HHHHHHHH
Confidence 78888888888887766 4555555555544443 2233 7899999999999999999999996 99999999
Q ss_pred HHHHHhHhhhh---hhhcCCCCChhHHH----------HHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHH
Q psy10160 315 DRQALNIVSIF---YFTYLVKLSELLET----------KCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAV 381 (558)
Q Consensus 315 ~~~l~~~~~~~---~~~g~~g~~~~~~~----------~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~ 381 (558)
++++..+...+ +++|+.|+.++|-. +..+.+++.+||......| +++.+||..++++..|+++++
T Consensus 180 l~~f~~~~~~~~~~~~kga~gtqasf~~l~~~~~~kv~~ld~Lv~k~~gf~~~~~~T--GQt~sr~~~~~~~~~la~lga 257 (481)
T KOG2700|consen 180 LERFHRARTDVRFRGLKGATGTQASFLSLFLGDMDKVEKLDSLVTKELGFVPMYIVT--GQTYSRKTDAEEVAPLASLGA 257 (481)
T ss_pred HHHHHHhhhhhhccccccchhhHHHHHHhhcccHHHHHHHHHHHHHHhCCCcccccc--CCcCCchhHHHHHHHHHHHHH
Confidence 99998666544 45678999998863 3446888999999776666 679999999999999999999
Q ss_pred HHHHHhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhh
Q psy10160 382 SLMKIANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPL 459 (558)
Q Consensus 382 ~l~k~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (558)
+..|+|.|+++++. |+|+.+|+ +|.|||+||+||||+.+|++.++++.+....+.++....-.|+|+....+.
T Consensus 258 t~~k~~Tdirll~~-----~~ev~epFea~q~gsSaMp~krNpm~~E~itslar~l~~~v~~al~~~~~qw~Ertl~dSa 332 (481)
T KOG2700|consen 258 TAHKYATDIRLLAK-----FAEVEEPFEAHQIGSSAMPYKRNPMRCERITSLARHLRPYVTQALNTASVQWHERTLDDSA 332 (481)
T ss_pred HHHHHHHHHHHHHH-----HHHhhccccccccccccCCCCCCCchhHHHhHHHHHHHHHHHHHhhhHHHHHhhccccccc
Confidence 99999999999993 99999996 699999999999999999999999999999999887677788999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHh--------hhHhhhhhcccccC-hHHHHHHHH----HH---
Q psy10160 460 IVSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLH--------ESLMLVTALNPHIG-YDKAAKIAK----TA--- 523 (558)
Q Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~--------~~~~~~~~la~~l~-~~~a~~~~~----~a--- 523 (558)
..|.++|+.+..+++.+.....++.+|.|.+++|+++++ ++.+ ++|++.++ |++||+.++ ++
T Consensus 333 ~~rivlP~~Fl~ad~~L~~~~ni~~gl~v~p~~i~r~i~~e~~~~~~eni~--mAL~~~g~srq~ahe~I~~L~~~a~~~ 410 (481)
T KOG2700|consen 333 NRRIVLPDAFLTADGNLGTLLNILEGLVVYPKVIERNIRDELPFMVLENII--MALVKAGLSRQEAHEGIRKLSHQAAQV 410 (481)
T ss_pred ccceechHHHHHHHHHHHHHHHHHhhcccccHHHHHHHHhhhhHHHHHHHH--HHHHHhcccHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999778899999999999999985 4544 47887765 999998543 23
Q ss_pred -HHcCCCHHHHHHH--c--CCCCHHHHhhhcCcccccCC
Q psy10160 524 -HKEGTTLKVAALK--L--GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 524 -~~~~~~~~~~~~~--~--~~l~~~~~~~~~~p~~~~~~ 557 (558)
..+|..+....+. . .....+|++.+|||.+|+|.
T Consensus 411 v~~e~g~~~~ie~~k~~~~~~~v~ee~~~ll~p~~f~gr 449 (481)
T KOG2700|consen 411 VKQEGGDNDLIERAKEDPTFKPVKEELDSLLDPLNFTGR 449 (481)
T ss_pred HHHhcCCcHHHHHhcccccccchHHHHHhhccchhcccc
Confidence 4567766555443 2 45778999999999999986
No 45
>PF00206 Lyase_1: Lyase; InterPro: IPR022761 This entry represents the N-terminal region of lyase-1 family; PDB: 1DOF_C 1K62_B 1AOS_B 2VD6_D 2J91_B 1C3U_B 1C3C_A 3R6Y_C 3R6V_F 3R6Q_F ....
Probab=100.00 E-value=1.6e-36 Score=297.39 Aligned_cols=193 Identities=25% Similarity=0.280 Sum_probs=157.3
Q ss_pred eceeeecccceeEEEEeccCCCCCCCcc-cccchhhh-------hhhhh-hhhhhcccccchhhhhhhHHHhhccccccc
Q psy10160 240 EGRYCQHHYYSQFCCESCTRAGQLPSYG-PHIKRAVE-------AEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVN 310 (558)
Q Consensus 240 ~~~~~~~g~~~~~~c~~~~~~g~~~~~~-~w~~~~l~-------~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~ 310 (558)
.+.++|+|.+++|+.+++.. ...+... ..+...+. ....+ ++++|.||||+|+|+|+|||+++++ |++.
T Consensus 101 ~~~~vH~G~Ts~Di~~Ta~~-l~lr~~~~~~l~~~l~~l~~~L~~~a~~~~~t~~~grTh~Q~A~P~T~G~~~a~-~~~~ 178 (312)
T PF00206_consen 101 AGGWVHYGRTSNDIVDTALR-LQLRDALLELLLERLKALIDALAELAEEHKDTPMPGRTHGQPAQPTTFGHKLAA-WADE 178 (312)
T ss_dssp GGGGTTTT--HHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTSEEEEEETTEEEEEEEHHHHHHH-HHHH
T ss_pred ccccccCCCcHHHHHHHHHH-HHHHHhhHHHHHHHHHHHHHHHHHHHHhhcCceeccccccccccceeHHHHHHH-HHHH
Confidence 35788999999999888866 4444444 32332222 22233 8899999999999999999999998 9999
Q ss_pred ccchHHHHHhHh---hhhhhhcCCCCChhHH--HHHHHHHHhHhC-CCc--ccCCChhHHhhcCcHHHHHHHHHHHHHHH
Q psy10160 311 LDPNDRQALNIV---SIFYFTYLVKLSELLE--TKCAAKIAELTG-LPF--KSAPNKFEALAAHDALVEVSGALNTVAVS 382 (558)
Q Consensus 311 l~~~~~~l~~~~---~~~~~~g~~g~~~~~~--~~~~~~~a~~lg-~~~--~~~~~~~~~~~~~d~~~~~~~~l~~~~~~ 382 (558)
|.|+++||++.. ....++|++|++++++ +.+.+++++.|| |.. .+..+.++|+++||++++++++|++++++
T Consensus 179 l~r~~~rL~~~~~~~~~~~lgga~g~gt~~~~~~~~~~~~~~~L~~~~~l~~~~~~~~~~~~~rd~~~e~~~~l~~l~~~ 258 (312)
T PF00206_consen 179 LARDLERLEEARKRLNVSPLGGAVGAGTSLGIDREFQERVAEELGEFTGLGVPAPNWHDAVSSRDRLAELASALALLAGT 258 (312)
T ss_dssp HHHHHHHHHHHHHHHHEEETTTTTTTSSHTTSHHHHHHHHHHHHHHHHCSTEECSSHHHHHHCTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhHhHHHHHhccCCCccccccccCcchhhhHHhhhhhhhhcccchhhcccccccchHHHHHHHHHHHHHHH
Confidence 999999998776 5556677888888876 344457777777 431 36788999999999999999999999999
Q ss_pred HHHHhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHc
Q psy10160 383 LMKIANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMG 437 (558)
Q Consensus 383 l~k~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~ 437 (558)
|+|||+||++|+| +|+||+++|+ +++|||||||||||+.+|+++++|++++|
T Consensus 259 l~kia~Dl~~~~s---~e~g~~~~~~~~~~~GSS~MP~K~NP~~~E~i~~~a~~v~G 312 (312)
T PF00206_consen 259 LSKIAEDLRLLSS---TEIGEVEEPFPEGQVGSSIMPHKRNPVILENIRGLARQVIG 312 (312)
T ss_dssp HHHHHHHHHHHTS---TTTSSEEEEGGGSSSCSSSSTTCEETHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhC---CceeeeecccccccCCCccCCCCCCCHHHHHHHHhhhcCcC
Confidence 9999999999996 7899999885 57799999999999999999999999987
No 46
>PRK08937 adenylosuccinate lyase; Provisional
Probab=100.00 E-value=3.9e-32 Score=253.14 Aligned_cols=178 Identities=26% Similarity=0.261 Sum_probs=158.3
Q ss_pred HHHHHHHHHHHHhhhhhhhccCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccc
Q psy10160 375 ALNTVAVSLMKIANDIRFLASGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFE 452 (558)
Q Consensus 375 ~l~~~~~~l~k~a~d~~~~~s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (558)
+++.++++++|||+||++|+| +||||+.+|+ +++|||||||||||+.+|+++++++++.|++..++... .+++|
T Consensus 22 ~l~~i~~~l~ria~Dl~~~~s---~e~gei~~~~~~~~~gSSiMP~K~NP~~~E~i~~~a~~~~g~~~~~~~~~-~~~~e 97 (216)
T PRK08937 22 VLALIATSLEKFANEIRLLQR---SEIREVEEPFAKGQKGSSAMPHKRNPIGSERITGLARVLRSYLVTALENV-PLWHE 97 (216)
T ss_pred HHHHHHHHHHHHHHHHHHHhc---cccceeecccccCCCCCccCCCccCcHHHHHHHHHHHHHHHHHHHHHHHh-HHHhc
Confidence 999999999999999999997 9999999995 68999999999999999999999999999999887666 78899
Q ss_pred cccchhhHHHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhh--hHhhhhhcc-----cccChHHHHHHH----H
Q psy10160 453 LNVFKPLIVSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHE--SLMLVTALN-----PHIGYDKAAKIA----K 521 (558)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~--~~~~~~~la-----~~l~~~~a~~~~----~ 521 (558)
+|...|..+|..++++..+...++..+..++++|+||++||++++.. .+.+++.++ ..+||++||++| +
T Consensus 98 rd~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~l~v~~~rm~~~~~~~~~~~~a~~l~~~L~~~g~~~~~Ah~~v~~~~~ 177 (216)
T PRK08937 98 RDLSHSSAERIALPDAFLALDYILNRFVNILENLVVFPENIERNLDKTLGFIATERVLLELVEKGMGREEAHELIREKAM 177 (216)
T ss_pred cCCchhHHHhhHHHHHHHHHHHHHHHHHHHHccCEECHHHHHHHHHHhcChHHHHHHHHHHHHcCCCHHHHHHHHHHHHH
Confidence 99999998998888888888888899999999999999999999986 555555554 358999999854 4
Q ss_pred HHHHcCCCHHHHHHHc----CCCCHHHHhhhcCcccccC
Q psy10160 522 TAHKEGTTLKVAALKL----GYLTEEEFNKWVVPEDMLG 556 (558)
Q Consensus 522 ~a~~~~~~~~~~~~~~----~~l~~~~~~~~~~p~~~~~ 556 (558)
.+.++|+++.+.+.+. ..++++++++++||++|+|
T Consensus 178 ~~~~~g~~~~~~~~~~~~~~~~l~~~~l~~~ldp~~~vg 216 (216)
T PRK08937 178 EAWKNQKDLRELLEADERFTKQLTKEELDELFDPEAFVG 216 (216)
T ss_pred HHHHhCCCHHHHHHhChHhHhcCCHHHHHHHhCHHhhcC
Confidence 5677899999988875 3689999999999999987
No 47
>KOG3513|consensus
Probab=99.94 E-value=2e-25 Score=236.74 Aligned_cols=284 Identities=20% Similarity=0.221 Sum_probs=207.3
Q ss_pred ceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCCCCccCCCCc-c-ccCceeEEeccCCCCCCcEEEEe
Q psy10160 8 NYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALPSEKVADPNA-I-DYGTILSSAFPSESASPVVTQTT 84 (558)
Q Consensus 8 r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p~~~~~~~~~-v-~~~~~~~~~~~~~~p~p~v~W~~ 84 (558)
++...+.+|.|.+++.+|+|.|+|.|.|..|... +..+.|...|.+....... + .+..+.+.|...+.|.|.++|.+
T Consensus 288 ~~~~~~~vL~I~nv~~~D~G~Y~C~AeN~~G~~~~~~~v~v~a~P~w~~~~~d~~~~~gs~v~~eC~a~g~P~p~v~Wlk 367 (1051)
T KOG3513|consen 288 TYSNYGKVLKIPNVQYEDAGEYECIAENSRGSATHSGHVTVYAPPYWLQKPQDTEADTGSNVTLECKASGKPNPTVKWLK 367 (1051)
T ss_pred eeeccccEEEecccCcCCCeEEEEEEecccccceeeEEEEEecCchhhcccceeEecCCCCeEEEEEecCCCCCceEEee
Confidence 3445678999999999999999999999999764 7788888888776543333 2 33467799999999999999999
Q ss_pred CCcccCCCCcee-----ec------cccceeeceeEEeeccceeeEEeeeceeeeC-cEEEecCCce--EeeCCCcEEEE
Q psy10160 85 TTTTEATSPHVY-----AA------LTHCVPWSNVCLFGARSGYLKETQNGGYLVP-VKVNITLETQ--VFGVGSDISIP 150 (558)
Q Consensus 85 ~~~~~~~~~~~~-----~g------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~--~v~~G~~v~L~ 150 (558)
|+.++....+.. .| ......-.|-|.++|+.+.+.....+.+... |.+...+... .+..|..+.|.
T Consensus 368 Ng~pl~~~~r~~~~~i~~g~L~is~v~~~dsg~YQC~A~Nk~G~i~anA~L~V~a~~P~f~~~p~~~~~~a~~g~~v~i~ 447 (1051)
T KOG3513|consen 368 NGEPLEPAERDPRYKIDDGTLIISNVQESDSGVYQCIAENKYGTIYANAELKVLASAPVFPLNPVERKVMAVVGGTVTID 447 (1051)
T ss_pred CCeecCccCCCcceEEeCCEEEEEecccccCeEEEeeeecccceEeeeeEEEEEccCCCCCCCccceEEEEEeCCeEEEe
Confidence 998887665521 11 1111122456888899888888887777654 6666665555 45789999999
Q ss_pred eEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEeccCCCCCCCCCC
Q psy10160 151 CDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVEGIFIHPSCRDLP 230 (558)
Q Consensus 151 C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~p~~~~~~ 230 (558)
|...+.|.|.+.|.|.+..+ .+++|+.+..+|+|.|.+++.+|+|.|+|.|.|..|.......|.|+++. .+...|
T Consensus 448 C~~~asP~p~~~W~k~~~~~-~~~~r~~i~edGtL~I~n~t~~DaG~YtC~A~N~~G~a~~~~~L~Vkd~t---ri~~~P 523 (1051)
T KOG3513|consen 448 CKPFASPKPKVSWLKGGEKL-LQSGRIRILEDGTLEISNVTRSDAGKYTCVAENKLGKAESTGNLIVKDAT---RITLAP 523 (1051)
T ss_pred eccCCCCcceEEEEcCCccc-ccCceEEECCCCcEEecccCcccCcEEEEEEEcccCccceEEEEEEecCc---eEEecc
Confidence 99999999999999999844 44569999999999999999999999999999999999999999997654 222211
Q ss_pred ccccceeEEeceeeecccceeEEEEeccCCCCCCCcccccchhhhhhhhh-------hhhhhcccccchhhhhhhHHHhh
Q psy10160 231 LFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAEAAA-------ADKKRRSRRSLSVVNKWSLRQAF 303 (558)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~~~~-------~~~~~~grth~q~a~~~t~g~~~ 303 (558)
.+.. +..|....+.|..... -.+...+.|.+|+....... .+-...||...+.++-.+.|.|.
T Consensus 524 --~~~~-------v~~g~~v~l~Ce~shD-~~ld~~f~W~~nG~~id~~~~~~~~~~~~~~~~g~L~i~nv~l~~~G~Y~ 593 (1051)
T KOG3513|consen 524 --SNTD-------VKVGESVTLTCEASHD-PSLDITFTWKKNGRPIDFNPDGDHFEINDGSDSGRLTIANVSLEDSGKYT 593 (1051)
T ss_pred --chhh-------hccCceEEEEeecccC-CCcceEEEEEECCEEhhccCCCCceEEeCCcCccceEEEeeccccCceEE
Confidence 1111 1222234455554433 46677789999876443222 11122256777777778888887
Q ss_pred cc
Q psy10160 304 TT 305 (558)
Q Consensus 304 ~~ 305 (558)
+.
T Consensus 594 C~ 595 (1051)
T KOG3513|consen 594 CV 595 (1051)
T ss_pred EE
Confidence 64
No 48
>KOG3513|consensus
Probab=99.94 E-value=3.2e-25 Score=235.28 Aligned_cols=286 Identities=16% Similarity=0.244 Sum_probs=211.6
Q ss_pred CCceE-ecCCeEEEcCCCCCCCEEEEEEEEeCCcceE----EEEEEEE-------eCCCCccCCCCc---cccCceeEEe
Q psy10160 6 SENYE-LNKNMLTIKRVEPERLGAYTCQAYNGLGRAV----SWTVTLQ-------ALPSEKVADPNA---IDYGTILSSA 70 (558)
Q Consensus 6 ~~r~~-~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~----s~~l~V~-------~~p~~~~~~~~~---v~~~~~~~~~ 70 (558)
.+|+. ..+|.|.|.+|..+|.|.|.|.+.+...... -+.|.+. ..|.+....|+. .++..+.+.|
T Consensus 184 ~~r~~~~~~G~Lyfs~V~~~D~~~Y~C~a~~~~~~~~v~~~~~~L~~~~~~~~~~~~P~i~~~~p~~~~a~~G~~v~LEC 263 (1051)
T KOG3513|consen 184 NRRVFSQENGNLYFSNVETSDFGNYICSATFPSTQTIVQGPPFPLIVRSNNVMREYAPKILVPFPETETALKGQSVKLEC 263 (1051)
T ss_pred cceeEecccceEEEeecchhhcCceEEEEEchhhcccccCCceeEEEcccccccccCCccccCCCCcccccCCCeEEEEE
Confidence 34554 4789999999999999999999998544331 2344431 234444444433 3445667999
Q ss_pred ccCCCCCCcEEEEeCCcccCCCCceeeccccc---------eeeceeEEeeccceeeEEeeeceeeeCcEEEecCCceEe
Q psy10160 71 FPSESASPVVTQTTTTTTEATSPHVYAALTHC---------VPWSNVCLFGARSGYLKETQNGGYLVPVKVNITLETQVF 141 (558)
Q Consensus 71 ~~~~~p~p~v~W~~~~~~~~~~~~~~~g~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v 141 (558)
++-|+|.|.|.|.+.+.....+.......... ..-.|.|.+.|..+.......+.+..+|.+...+.+..+
T Consensus 264 fA~G~P~P~i~W~k~~g~~~~~r~~~~~~~~vL~I~nv~~~D~G~Y~C~AeN~~G~~~~~~~v~v~a~P~w~~~~~d~~~ 343 (1051)
T KOG3513|consen 264 FALGNPTPQIKWRKVDGKPPPRRATYSNYGKVLKIPNVQYEDAGEYECIAENSRGSATHSGHVTVYAPPYWLQKPQDTEA 343 (1051)
T ss_pred EecCCCCCcEEEEeCCCCCCCcceeeeccccEEEecccCcCCCeEEEEEEecccccceeeEEEEEecCchhhcccceeEe
Confidence 99999999999999988544433222111111 122456777788776666677778889999999999999
Q ss_pred eCCCcEEEEeEeeccCCCeEEEEECCEEeccCCc--eEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEec
Q psy10160 142 GVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGV--HYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVEG 219 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~--~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 219 (558)
..|+.++|.|.+.|.|.|.|.|++||.++....+ ++.+ .+++|+|.+++.+|+|+|+|.|+|.+|....++.|+|..
T Consensus 344 ~~gs~v~~eC~a~g~P~p~v~WlkNg~pl~~~~r~~~~~i-~~g~L~is~v~~~dsg~YQC~A~Nk~G~i~anA~L~V~a 422 (1051)
T KOG3513|consen 344 DTGSNVTLECKASGKPNPTVKWLKNGEPLEPAERDPRYKI-DDGTLIISNVQESDSGVYQCIAENKYGTIYANAELKVLA 422 (1051)
T ss_pred cCCCCeEEEEEecCCCCCceEEeeCCeecCccCCCcceEE-eCCEEEEEecccccCeEEEeeeecccceEeeeeEEEEEc
Confidence 9999999999999999999999999999985442 2443 578999999999999999999999999999999999975
Q ss_pred cCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCCCCcccccchhhhhhhhh-hhhhhcccccchhhhhhh
Q psy10160 220 IFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAEAAA-ADKKRRSRRSLSVVNKWS 298 (558)
Q Consensus 220 ~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~~~~-~~~~~~grth~q~a~~~t 298 (558)
. .|.+...+......... +..+...|...+.|+|.+.|.+.+....... ..+...|...+..++...
T Consensus 423 ~--~P~f~~~p~~~~~~a~~----------g~~v~i~C~~~asP~p~~~W~k~~~~~~~~~r~~i~edGtL~I~n~t~~D 490 (1051)
T KOG3513|consen 423 S--APVFPLNPVERKVMAVV----------GGTVTIDCKPFASPKPKVSWLKGGEKLLQSGRIRILEDGTLEISNVTRSD 490 (1051)
T ss_pred c--CCCCCCCccceEEEEEe----------CCeEEEeeccCCCCcceEEEEcCCcccccCceEEECCCCcEEecccCccc
Confidence 4 24444333222111111 4445567888899999999999987444444 566677888888888899
Q ss_pred HHHhhc
Q psy10160 299 LRQAFT 304 (558)
Q Consensus 299 ~g~~~~ 304 (558)
.|.|.+
T Consensus 491 aG~YtC 496 (1051)
T KOG3513|consen 491 AGKYTC 496 (1051)
T ss_pred CcEEEE
Confidence 998887
No 49
>KOG4221|consensus
Probab=99.90 E-value=1.5e-22 Score=213.86 Aligned_cols=280 Identities=19% Similarity=0.200 Sum_probs=191.8
Q ss_pred ceEecCCeEEEcCCCC-----CCCEEEEEEEEeC-CcceEEEEEEEE--eCCCCcc-CCCCccc-cCceeEEeccCCCCC
Q psy10160 8 NYELNKNMLTIKRVEP-----ERLGAYTCQAYNG-LGRAVSWTVTLQ--ALPSEKV-ADPNAID-YGTILSSAFPSESAS 77 (558)
Q Consensus 8 r~~~~~~~L~I~~v~~-----~D~G~Y~C~a~n~-~g~~~s~~l~V~--~~p~~~~-~~~~~v~-~~~~~~~~~~~~~p~ 77 (558)
+-.+.|++|.|.++.. -|+|.|+|.|.-. .|..-+.+..|. ..+.+.. .....+. .+.+.+.|.+.+.|.
T Consensus 90 ~~~LsNgSl~i~~v~~~kh~~~~eg~Yqc~atv~~~gsi~Sr~a~v~~a~~~~f~~~~~~~t~~~g~ta~f~c~vn~e~~ 169 (1381)
T KOG4221|consen 90 RQLLSNGSLYISSVLASKHNKVDEGVYQCLATVEDVGSILSRTAKVALAGLADFALQPESTTLLYGQTALFSCEVNAEPV 169 (1381)
T ss_pred HhhccCCceeEeeecccccccccCceEEEEEEccccceeecceEEEEecccCccccCccceeEecCCcEEEEEEEcCccC
Confidence 3447899999999988 7899999999865 555544444444 3343322 2233444 457778999999999
Q ss_pred CcEEEEeCCcccCCCCcee----------------eccccceeeceeEEeeccceeeEEeeeceeeeCcEEEecCCceEe
Q psy10160 78 PVVTQTTTTTTEATSPHVY----------------AALTHCVPWSNVCLFGARSGYLKETQNGGYLVPVKVNITLETQVF 141 (558)
Q Consensus 78 p~v~W~~~~~~~~~~~~~~----------------~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v 141 (558)
|.+.|.++...++...++- .|.|.|.+.+...........+.+...........|...+...++
T Consensus 170 p~i~w~kn~~pl~~~~r~i~lpsG~L~I~~~qp~d~g~yrc~vt~g~~~r~S~~a~ltv~s~~~~~~~~~fl~~p~~~~v 249 (1381)
T KOG4221|consen 170 PTIMWLKNDQPLPLDSRVIVLPSGALEISGLQPSDTGEYRCVVTGGASQRTSNEAELTVLSDPGALNKLVFLDEPSNAVV 249 (1381)
T ss_pred ceeEEecccccccCCCcEEEcCCCcEEecccccCCCceEEEEEecCCcCCccceeEEEecCCcccccceeeecCCCcccc
Confidence 9999999988776655543 566777666543332222222222211111222336677888999
Q ss_pred eCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEeccC
Q psy10160 142 GVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVEGIF 221 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~ 221 (558)
.+|+.+.|+|.+.|.|+|.|.|.|||..+..++.++.+...++|.|.+++.+|+|.|+|+|+|......+...|.|..+|
T Consensus 250 ~~g~~v~leCvvs~~p~p~v~Wlrng~~i~~ds~rivl~g~~slliS~a~~~dSg~YtC~Atn~~D~idasaev~V~a~P 329 (1381)
T KOG4221|consen 250 VEGDDVVLECVVSGVPKPSVKWLRNGEKISVDSYRIVLVGGSSLLISNATDDDSGKYTCRATNTNDSIDASAEVTVLAPP 329 (1381)
T ss_pred ccCCcEEEEEEecCCCCCceEEeeCCeeeeecceEEEEecccceEEeccccccCceEEEEecCCCcccccceEEEEEcCC
Confidence 99999999999999999999999999999988778888888899999999999999999999988888888889997553
Q ss_pred CCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCCCCcccccchhhhhhhhhhhhhhccc-ccchhhhhhhHH
Q psy10160 222 IHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAEAAAADKKRRSR-RSLSVVNKWSLR 300 (558)
Q Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~~~~~~~~~~gr-th~q~a~~~t~g 300 (558)
.+...|. .+. .+.+++.. ..|.+.|.|.|.+.|+||+-....+....+..++ ..+.-......|
T Consensus 330 ---~~~~~p~----~l~-----A~e~~die---~ec~~~g~p~p~v~w~kNgd~~ipsdy~ki~~~~~lrIlgi~~sdeg 394 (1381)
T KOG4221|consen 330 ---GFTKAPT----TLV-----AHESMDIE---FECPVSGKPIPTVRWYKNGDRIIPSDYFKIVGGGNLRILGIVKSDEG 394 (1381)
T ss_pred ---CCCCCCc----cee-----eeecccee---EeCCCCCCCcceEEEEecCcccCcccceEecCCCCcEEEEEecccch
Confidence 3332221 111 12223334 4455669999999999998766654433333333 333333444455
Q ss_pred Hh
Q psy10160 301 QA 302 (558)
Q Consensus 301 ~~ 302 (558)
.|
T Consensus 395 ~y 396 (1381)
T KOG4221|consen 395 FY 396 (1381)
T ss_pred hh
Confidence 44
No 50
>cd01594 Lyase_I_like Lyase class I_like superfamily: contains the lyase class I family, histidine ammonia-lyase and phenylalanine ammonia-lyase, which catalyze similar beta-elimination reactions. Lyase class I_like superfamily of enzymes that catalyze beta-elimination reactions and are active as homotetramers. The four active sites of the homotetrameric enzyme are each formed by residues from three different subunits. This superfamily contains the lyase class I family, histidine ammonia-lyase and phenylalanine ammonia-lyase. The lyase class I family comprises proteins similar to class II fumarase, aspartase, adenylosuccinate lyase, argininosuccinate lyase, and 3-carboxy-cis, cis-muconate lactonizing enzyme which, for the most part catalyze similar beta-elimination reactions in which a C-N or C-O bond is cleaved with the release of fumarate as one of the products. Histidine or phenylalanine ammonia-lyase catalyze a beta-elimination of ammonia from histidine and phenylalanine, respective
Probab=99.85 E-value=4.3e-21 Score=181.80 Aligned_cols=175 Identities=27% Similarity=0.263 Sum_probs=134.0
Q ss_pred eeecccceeEEEEeccCCCCCCCcccccchh-------hhhhhhh-hhhhhcccccchhhhhhhHHHhhcccccccccch
Q psy10160 243 YCQHHYYSQFCCESCTRAGQLPSYGPHIKRA-------VEAEAAA-ADKKRRSRRSLSVVNKWSLRQAFTTCYPVNLDPN 314 (558)
Q Consensus 243 ~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~-------l~~~~~~-~~~~~~grth~q~a~~~t~g~~~~~~~~~~l~~~ 314 (558)
++|.+.+..+...+... +.....+..+... +...... +++++.+|||.|+|+|+++||++.+ |.+.|.++
T Consensus 36 ~~h~g~s~~d~~~t~~~-~~~~~~l~~l~~~l~~~~~~l~~~a~~~~~~~~~~~th~q~A~p~t~g~~~~~-~~~~l~~~ 113 (231)
T cd01594 36 LVHKGRSSNDIGTTALR-LALRDALDDLLPLLKALIDALALKAEAHKGTVMPGRTHLQDAQPVTLGYELRA-WAQVLGRD 113 (231)
T ss_pred CCCCCCCCchHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCEeecccccccCccccHHHHHHH-HHHHHHHH
Confidence 34555555555554443 3333333333333 2333333 7899999999999999999999997 99999999
Q ss_pred HHHHHhHhhhhhhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHhhhhhhhc
Q psy10160 315 DRQALNIVSIFYFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIANDIRFLA 394 (558)
Q Consensus 315 ~~~l~~~~~~~~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a~d~~~~~ 394 (558)
++||..+ +++++++.|+.++.+++||++|+++|+
T Consensus 114 ~~rL~~~----------------------------------------------~~~~~~~~l~~~~~~l~r~a~d~~~~~ 147 (231)
T cd01594 114 LERLEEA----------------------------------------------AVAEALDALALAAAHLSKIAEDLRLLL 147 (231)
T ss_pred HHHHHHH----------------------------------------------HHHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 9999988 899999999999999999999999999
Q ss_pred cCCCccccceecCC--CCCCCCCCCCCCCchHHHHHHHHHHHHHcccHHHHhhccccccccccchhhHHHHHHHHHH
Q psy10160 395 SGPRCGLGELSLPE--NEPGSSIMPGKVNPTQCEALTMVAAQVMGNHVAVTIGGSNGHFELNVFKPLIVSNVLRSIR 469 (558)
Q Consensus 395 s~~~~e~~e~~~~~--~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (558)
+ .|++++.+|+ .++|||+||||+||+.+|.+++++..+.|....+.....+. ++.+...+...+..++...
T Consensus 148 ~---~~~~~~~~~~~~~~~gSS~mp~k~Np~~~e~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~ 220 (231)
T cd01594 148 S---GEFGELGEPFLPGQPGSSIMPQKVNPVAAELVRGLAGLVIGNLVAVLTALKGG-PERDNEDSPSMREILADSL 220 (231)
T ss_pred C---CCCCeeeCccCCCCCCCcCCCCCCCCHHHHHHHHHHHHHHhhHHHHHHHHhcc-cccccccCHHHHHHHHHHH
Confidence 7 6778888876 48999999999999999999999999999998887666554 3333333333344444443
No 51
>KOG4222|consensus
Probab=99.84 E-value=2e-20 Score=196.86 Aligned_cols=284 Identities=17% Similarity=0.196 Sum_probs=201.1
Q ss_pred eEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE--EEEEEEEeCCCCccCCCCc-cccC-ceeEEeccCCCCCCcEEEEe
Q psy10160 9 YELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV--SWTVTLQALPSEKVADPNA-IDYG-TILSSAFPSESASPVVTQTT 84 (558)
Q Consensus 9 ~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~--s~~l~V~~~p~~~~~~~~~-v~~~-~~~~~~~~~~~p~p~v~W~~ 84 (558)
..+.+|.|.|.+++.+|+|+|.|++.|..|... -++++|++.|.+...+... +..| +..+.|.+.+.|.|.|.|.+
T Consensus 182 ~lisgG~LlIsnvrksD~GtY~CVatNmvG~ReS~~A~lsv~e~P~f~~rp~~~~v~~g~~~~f~c~v~GdP~P~Vrwkk 261 (1281)
T KOG4222|consen 182 ALISGGNLLISNVRKSDEGTYACVATNMVGERESIPARLSVQEKPWFWKRPKDLAVLVGAAAEFDCRVGGDPQPTVRWKK 261 (1281)
T ss_pred EEecCCcEEEeccccCCCceeeeeecccccccccccceeeeccCCccccccccceeecccccccccccCCCCCCceeeec
Confidence 336899999999999999999999999999875 4577788777665444333 3333 56688999999999999999
Q ss_pred CCcccCCCCceeeccccc---------eeeceeEEeeccceeeEEeeeceeeeCcEEEecCCceEeeCCCcEEEEeEeec
Q psy10160 85 TTTTEATSPHVYAALTHC---------VPWSNVCLFGARSGYLKETQNGGYLVPVKVNITLETQVFGVGSDISIPCDVDG 155 (558)
Q Consensus 85 ~~~~~~~~~~~~~g~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~g 155 (558)
++..++.+...-...... .-..++|.+.+..+.+.......+..||.|...+.+..+..|..++|.|.+.|
T Consensus 262 ~~~~~P~~ry~i~~d~qtl~i~r~tp~deg~y~C~a~n~vG~l~asa~ltV~apP~f~kkp~dq~v~lg~~vt~pc~~~g 341 (1281)
T KOG4222|consen 262 DDPSLPRSRYSILDDTQTLRIDRVTPTDEGTYVCPAENLVGGLEASATLTVQAPPSFGKKPRDQKVALGGTVTFPCETLG 341 (1281)
T ss_pred cCCCCCccceeeeeccccccccccCCCcccceeeeccccccccccccceEEecCcccccccCccccccCceEEeeeecCC
Confidence 876666543221110011 11246888999989898888899999999999999999999999999999999
Q ss_pred cCCCeEEEEECCEE-ecc------CCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEeccC---CCCC
Q psy10160 156 YPIPQVFWYKDGQV-IEN------DGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVEGIF---IHPS 225 (558)
Q Consensus 156 ~P~p~i~W~~~g~~-l~~------~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~---~~p~ 225 (558)
+|.|.+.|.|.|.. +-. ...+..+...++|.|.++++.|.|.|.|...|..|.......+.+.+.. .||.
T Consensus 342 nP~PavfW~keg~q~llf~~~p~~~~~r~svs~~g~L~it~v~~~d~g~Yvcq~~~~~~ss~~~a~~~qt~~~~~~rPpp 421 (1281)
T KOG4222|consen 342 NPPPAVFWLKEGSQDLLFSASPPSSNGRGSVSPTGTLTITNVRQSDEGYYVCQTQTSAGSSLTKAYLEQTDVLTDSRPPP 421 (1281)
T ss_pred CCCcceEEeccCcceecccCCCCCcCccceecCCCCcccccccccccceEeecccccccccccceeEEEEeeeccCCCCc
Confidence 99999999997643 211 1236667777899999999999999999999999888655555443221 1222
Q ss_pred CCCCCccccceeEEeceeeecccceeEEEEeccCCCCCCCcccccchhhhhhhhhhh--hhhcccccchhhhhhhHHHhh
Q psy10160 226 CRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAEAAAAD--KKRRSRRSLSVVNKWSLRQAF 303 (558)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~~~~~~--~~~~grth~q~a~~~t~g~~~ 303 (558)
++. ....+.++-+ +......|.+.|.|-+.+.|++++........+ ....++.+....+-...|-|-
T Consensus 422 ~i~-~g~~nQtl~v----------~s~a~l~c~atg~P~p~i~wl~dg~~v~~~d~~~s~~~~~~l~i~dl~~~DtG~YT 490 (1281)
T KOG4222|consen 422 IIE-QGPANQTLPV----------GSTASLPCSATGAPTPNISWLKDGCNVMNPDSRISQQEIGSLRIRDLKGPDTGRYT 490 (1281)
T ss_pred eee-eccccccccc----------CcccccChhhhCCCCCCchhhhcccccccCCcccceeeeceeeeeeeecCCCccee
Confidence 221 1112222222 222335677889999999999999887655522 222245555554444444443
No 52
>KOG4194|consensus
Probab=99.83 E-value=1e-19 Score=179.88 Aligned_cols=205 Identities=19% Similarity=0.278 Sum_probs=162.4
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE--EEEEEEEeCCCCccCCCC-ccccCce-eEEeccCCCCCCcEEEEeCCccc
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV--SWTVTLQALPSEKVADPN-AIDYGTI-LSSAFPSESASPVVTQTTTTTTE 89 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~--s~~l~V~~~p~~~~~~~~-~v~~~~~-~~~~~~~~~p~p~v~W~~~~~~~ 89 (558)
+.|.+.+|...|+|.|+|+++|.+|..+ .+.++|.+.|.+...|.. .+..|.. -+.|.+.|.|.|.|.|.++++..
T Consensus 574 ~~L~L~nVt~td~grYQCVvtN~FGStysqk~KltV~~~PsFtktP~dltl~tg~mArl~CaAtG~P~PeIawqkdggtd 653 (873)
T KOG4194|consen 574 AILHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTVNQAPSFTKTPEDLTLRTGQMARLECAATGHPRPEIAWQKDGGTD 653 (873)
T ss_pred heeeeeeeecccCceEEEEEecccCcchhheeEEEeeccCccccCcccceeecccceeeeeeccCCCCcceeehhcCCCC
Confidence 5799999999999999999999999885 677788888877544432 3455654 48999999999999999998763
Q ss_pred CCC---Cceee----------ccccceeeceeEEeeccceeeEEeeeceeeeCcEEEecCCceEeeCCCcEEEEeEeecc
Q psy10160 90 ATS---PHVYA----------ALTHCVPWSNVCLFGARSGYLKETQNGGYLVPVKVNITLETQVFGVGSDISIPCDVDGY 156 (558)
Q Consensus 90 ~~~---~~~~~----------g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~g~ 156 (558)
-+. .+.+. .......--|.|.+.+..|.++....+.+...|.+.++..+..|..|+++.|.|.+.|.
T Consensus 654 FPAA~eRRl~Vmpedd~f~Itnvk~eD~GiYtC~A~n~AG~isanAtL~V~e~p~f~~PL~~~~V~~get~vlqC~a~~~ 733 (873)
T KOG4194|consen 654 FPAARERRLHVMPEDDVFFITNVKIEDQGIYTCTAQNVAGQISANATLTVLETPSFSIPLEDQLVVVGETLVLQCLAEGA 733 (873)
T ss_pred CchhhhheeeecCCCCEEEEecccccccceeEEeeeccccceeeceEEEEecCCcccccccceEEEecceEEEEEecCCC
Confidence 221 11111 01111122457888888899999999889899999999999999999999999999999
Q ss_pred CC-CeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEe
Q psy10160 157 PI-PQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVE 218 (558)
Q Consensus 157 P~-p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 218 (558)
|. |.+.|+|.++++....+.+....+.-|++.+...+|+|.|+|...|..|.....+.+.|.
T Consensus 734 ~a~pr~~W~k~d~pil~t~rh~f~d~dQllvv~~~~~~daG~yTcem~~~~~~~~~~i~l~~~ 796 (873)
T KOG4194|consen 734 PADPRLEWFKEDKPILITERHTFPDGDQLLVVKENLVEDAGIYTCEMSNTLGTERIHICLLVY 796 (873)
T ss_pred CCCccccccCCCCceEEeecccCCCCCeEEEEEehhhhhcceEEEEEEeeccceeeEEEEEEe
Confidence 98 999999999988766544444445578999999999999999999999998777766664
No 53
>PHA02785 IL-beta-binding protein; Provisional
Probab=99.81 E-value=2.4e-18 Score=170.10 Aligned_cols=193 Identities=17% Similarity=0.243 Sum_probs=121.0
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCCCC---ccCCCCccccC-ceeEEecc-----CCCCCCcEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALPSE---KVADPNAIDYG-TILSSAFP-----SESASPVVTQT 83 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p~~---~~~~~~~v~~~-~~~~~~~~-----~~~p~p~v~W~ 83 (558)
..|.|.++..+|+|.|+|.++|..|... +..|+|....+. ....++.+.+| ...+.|.. .+.|+|.++|+
T Consensus 82 ~~l~i~~~~~~DsG~Y~C~a~N~~g~~~~s~~L~V~~~~~~~~~~~~~~~~~~~g~~~~i~C~~~~~~~~~~~~~~i~W~ 161 (326)
T PHA02785 82 SNMLILNPTQSDSGIYICITKNETYCDMMSLNLTIVSVSESNIDLISYPQIVNERSTGEMVCPNINAFIASNVNADIIWS 161 (326)
T ss_pred ceEEEcccCcccCeEEEEEEECCCcceEEEEEEEEEecCCCccceeeccceecccCcEEEECCChhhcccCCCCceEEEc
Confidence 4599999999999999999999887654 666676554321 12223444444 44466753 35789999998
Q ss_pred eCCcccCCCCceeecccccee---------eceeEEeeccceeeEE----eeecee---eeCcEEEecCCceEeeCCCcE
Q psy10160 84 TTTTTEATSPHVYAALTHCVP---------WSNVCLFGARSGYLKE----TQNGGY---LVPVKVNITLETQVFGVGSDI 147 (558)
Q Consensus 84 ~~~~~~~~~~~~~~g~~~~~~---------~~~~~~~~~~~~~~~~----~~~~~~---~~p~~~~~~~~~~~v~~G~~v 147 (558)
++.. + ...+......+.+. -.|.|.+.+..+.... ...+.+ ..||.+ ..|....+..|+.+
T Consensus 162 k~~~-~-~~~r~~~~~~~~L~i~~v~~~d~G~Y~C~~~n~~g~~~~~~t~~v~l~V~~~~~pp~~-~~p~~~~~~~G~~v 238 (326)
T PHA02785 162 GHRR-L-RNKRLKQRTPGIITIEDVRKNDAGYYTCVLKYIYGDKTYNVTRIVKLEVRDRIIPPTM-QLPEGVVTSIGSNL 238 (326)
T ss_pred cCCc-c-CCcceEecCCCeEEEeecChhhCeEEEEEEEeccCCEEEeEEEEEEEEEeccCCCcee-cCCCcEEecCCCcE
Confidence 7542 2 11111100001111 1334555544332211 111122 134443 34566677889999
Q ss_pred EEEeEeeccCCC---eEEEEECCEEeccCC----ceEEEcc-----------CCeEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 148 SIPCDVDGYPIP---QVFWYKDGQVIENDG----VHYRITE-----------SNRLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 148 ~L~C~~~g~P~p---~i~W~~~g~~l~~~~----~~~~~~~-----------~~sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
+|.|.+.|.|.| .+.|+|||..+...+ .++.... .+.|.|.+|+.+|+|.|+|.|.|..|..
T Consensus 239 ~L~C~a~g~P~~~~~~v~W~kng~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~V~~~D~G~Y~C~A~n~~~~~ 318 (326)
T PHA02785 239 TIACRVSLRPPTTDADVFWISNGMYYEEDDEDGDGRISVANKIYTTDKRRVITSRLNINPVKEEDATTFTCMAFTIPSIS 318 (326)
T ss_pred EEEEEEECCCCCCCceEEEEECCEECCCcCCCCceeEEEecCccccccceeeeEEEEECCcchhcCeeeEEEEEeccCce
Confidence 999999999875 799999999885421 1322211 2479999999999999999999988544
No 54
>KOG4221|consensus
Probab=99.81 E-value=3.6e-19 Score=188.49 Aligned_cols=217 Identities=21% Similarity=0.297 Sum_probs=166.4
Q ss_pred ccccCCceE-ecCCeEEEcCCCCCCCEEEEEEEEeCCcceE--EEEEEEEeCCCC-----ccCC--CCcccc-CceeEEe
Q psy10160 2 IQVRSENYE-LNKNMLTIKRVEPERLGAYTCQAYNGLGRAV--SWTVTLQALPSE-----KVAD--PNAIDY-GTILSSA 70 (558)
Q Consensus 2 ~p~~~~r~~-~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~--s~~l~V~~~p~~-----~~~~--~~~v~~-~~~~~~~ 70 (558)
+|+.+ |+. +.+|.|.|.++++.|.|.|+|.++++..... .+.++|..-+.. +... +..+.+ .++++.|
T Consensus 181 l~~~~-r~i~lpsG~L~I~~~qp~d~g~yrc~vt~g~~~r~S~~a~ltv~s~~~~~~~~~fl~~p~~~~v~~g~~v~leC 259 (1381)
T KOG4221|consen 181 LPLDS-RVIVLPSGALEISGLQPSDTGEYRCVVTGGASQRTSNEAELTVLSDPGALNKLVFLDEPSNAVVVEGDDVVLEC 259 (1381)
T ss_pred ccCCC-cEEEcCCCcEEecccccCCCceEEEEEecCCcCCccceeEEEecCCcccccceeeecCCCccccccCCcEEEEE
Confidence 56666 544 6999999999999999999999999765443 445555421111 1112 233444 4778999
Q ss_pred ccCCCCCCcEEEEeCCcccCCCCce-eeccccce---------eeceeEEeeccceeeEEeeeceeeeCcEEEecCCceE
Q psy10160 71 FPSESASPVVTQTTTTTTEATSPHV-YAALTHCV---------PWSNVCLFGARSGYLKETQNGGYLVPVKVNITLETQV 140 (558)
Q Consensus 71 ~~~~~p~p~v~W~~~~~~~~~~~~~-~~g~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 140 (558)
++.+.|+|.|.|.+++..+...... ....-..+ .-.+.|.++|............+..||.+...+...+
T Consensus 260 vvs~~p~p~v~Wlrng~~i~~ds~rivl~g~~slliS~a~~~dSg~YtC~Atn~~D~idasaev~V~a~P~~~~~p~~l~ 339 (1381)
T KOG4221|consen 260 VVSGVPKPSVKWLRNGEKISVDSYRIVLVGGSSLLISNATDDDSGKYTCRATNTNDSIDASAEVTVLAPPGFTKAPTTLV 339 (1381)
T ss_pred EecCCCCCceEEeeCCeeeeecceEEEEecccceEEeccccccCceEEEEecCCCcccccceEEEEEcCCCCCCCCccee
Confidence 9999999999999998776654321 11111111 2245777777666777777778888999999999999
Q ss_pred eeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEecc
Q psy10160 141 FGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVEGI 220 (558)
Q Consensus 141 v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~ 220 (558)
..++.++.|.|.+.|+|.|.+.|+|||..+..++ .+++..++.|+|..+-..|.|.|.|.+.|..|.....+.+.|...
T Consensus 340 A~e~~die~ec~~~g~p~p~v~w~kNgd~~ipsd-y~ki~~~~~lrIlgi~~sdeg~yQcvaen~~G~a~a~a~l~vv~~ 418 (1381)
T KOG4221|consen 340 AHESMDIEFECPVSGKPIPTVRWYKNGDRIIPSD-YFKIVGGGNLRILGIVKSDEGFYQCVAENDAGSAQAAAQLEVVPQ 418 (1381)
T ss_pred eeeccceeEeCCCCCCCcceEEEEecCcccCccc-ceEecCCCCcEEEEEecccchhhhhhhccCcccccchhhheeccC
Confidence 9999999999999999999999999998887744 777888777999999999999999999999999998888866433
No 55
>KOG4222|consensus
Probab=99.78 E-value=1.3e-18 Score=183.34 Aligned_cols=278 Identities=21% Similarity=0.236 Sum_probs=197.8
Q ss_pred cCCceEecCCeEEEcCCC-----CCCCEEEEEEEEeCCcceEEE--EEEEEeCCCCccCCCCc---cccCceeEEec-cC
Q psy10160 5 RSENYELNKNMLTIKRVE-----PERLGAYTCQAYNGLGRAVSW--TVTLQALPSEKVADPNA---IDYGTILSSAF-PS 73 (558)
Q Consensus 5 ~~~r~~~~~~~L~I~~v~-----~~D~G~Y~C~a~n~~g~~~s~--~l~V~~~p~~~~~~~~~---v~~~~~~~~~~-~~ 73 (558)
.+.|+.+.+++|.+..+- ..|.|.|+|.++|..|..++. .+.+.+.+......|.. +.+.+.++.|- +.
T Consensus 78 ~shR~~lp~gsLf~l~~ahg~~a~~d~G~y~cvasn~~g~avSr~a~L~vavlrddfrv~prd~~~a~ge~avlEcgpP~ 157 (1281)
T KOG4222|consen 78 GSHRFLLPDGSLFLLRLAHGKKAGHDHGVYSCVASNRLGEAVSRGASLIVAVLRDDFRVSPRDVQAAVGEEAVLECGPPR 157 (1281)
T ss_pred CCcceecCCccEEEEecccCCcccCCCceeEeeecCccceeeecCceEEEEEechhcccCcccccccccceeEEeccCCC
Confidence 456888999998887652 239999999999999998754 55555555544444433 23446666665 56
Q ss_pred CCCCCcEEEEeCCcccC--CCCce----------------eeccccceeeceeEEeeccceeeEEeeeceeeeCcEEEec
Q psy10160 74 ESASPVVTQTTTTTTEA--TSPHV----------------YAALTHCVPWSNVCLFGARSGYLKETQNGGYLVPVKVNIT 135 (558)
Q Consensus 74 ~~p~p~v~W~~~~~~~~--~~~~~----------------~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 135 (558)
+.|.|.|.|++++..+. ..... ..|.|.|++.+.+.+.... .+.+.+..+|.|...
T Consensus 158 ghpeptvSw~Kdg~pl~~~~~~~~~lisgG~LlIsnvrksD~GtY~CVatNmvG~ReS~------~A~lsv~e~P~f~~r 231 (1281)
T KOG4222|consen 158 GHPEPTVSWVKDGKPLDHYDVPIIALISGGNLLISNVRKSDEGTYACVATNMVGERESI------PARLSVQEKPWFWKR 231 (1281)
T ss_pred CCCCCcceeecCCCccccccceeEEEecCCcEEEeccccCCCceeeeeecccccccccc------cceeeeccCCccccc
Confidence 67999999999987776 11111 2456666555554443332 234445578889999
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccC-CeEEEccCCCCCCeEEEEEEEeCCceeeEEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITES-NRLHINQANATDSGEYRCVASNSYTSDENAVT 214 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~-~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 214 (558)
+....|.+|..+.+.|.+.|.|.|.+.|.|++..++.. +|.+..+ .+|.|.+++..|.|.|.|.+.|..|..+....
T Consensus 232 p~~~~v~~g~~~~f~c~v~GdP~P~Vrwkk~~~~~P~~--ry~i~~d~qtl~i~r~tp~deg~y~C~a~n~vG~l~asa~ 309 (1281)
T KOG4222|consen 232 PKDLAVLVGAAAEFDCRVGGDPQPTVRWKKDDPSLPRS--RYSILDDTQTLRIDRVTPTDEGTYVCPAENLVGGLEASAT 309 (1281)
T ss_pred cccceeecccccccccccCCCCCCceeeeccCCCCCcc--ceeeeeccccccccccCCCcccceeeeccccccccccccc
Confidence 99999999999999999999999999999988877764 5666555 79999999999999999999999999999999
Q ss_pred EEEeccCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCCCCcccccchhhhhhhhh---------hhhhh
Q psy10160 215 IRVEGIFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAVEAEAAA---------ADKKR 285 (558)
Q Consensus 215 l~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l~~~~~~---------~~~~~ 285 (558)
+.|+++ |.+...+... . +..+.+.++- |.+.|.|+|++.|.+.+...+.-. ..+.-
T Consensus 310 ltV~ap---P~f~kkp~dq--~-------v~lg~~vt~p---c~~~gnP~PavfW~keg~q~llf~~~p~~~~~r~svs~ 374 (1281)
T KOG4222|consen 310 LTVQAP---PSFGKKPRDQ--K-------VALGGTVTFP---CETLGNPPPAVFWLKEGSQDLLFSASPPSSNGRGSVSP 374 (1281)
T ss_pred eEEecC---cccccccCcc--c-------cccCceEEee---eecCCCCCcceEEeccCcceecccCCCCCcCccceecC
Confidence 999655 4444333211 1 2222334444 556699999999999876654321 12333
Q ss_pred cccccchhhhhhhHHHhhcc
Q psy10160 286 RSRRSLSVVNKWSLRQAFTT 305 (558)
Q Consensus 286 ~grth~q~a~~~t~g~~~~~ 305 (558)
.|..|....++...|.|...
T Consensus 375 ~g~L~it~v~~~d~g~Yvcq 394 (1281)
T KOG4222|consen 375 TGTLTITNVRQSDEGYYVCQ 394 (1281)
T ss_pred CCCcccccccccccceEeec
Confidence 45667777777777777764
No 56
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=99.73 E-value=5.7e-17 Score=130.38 Aligned_cols=94 Identities=20% Similarity=0.267 Sum_probs=82.2
Q ss_pred cEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc---CCeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 130 VKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE---SNRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
|.|...+....+..|+.+.|.|.+.|.|.|.+.|+|+|..+..+. ++.+.. .+.|.|.++..+|+|.|+|.|.|..
T Consensus 1 p~~~~~p~~~~v~~G~~v~l~C~~~G~p~p~v~W~kdg~~l~~~~-~~~~~~~~~~s~L~I~~~~~~D~G~Ytc~a~N~~ 79 (98)
T cd05762 1 PQIIQFPEDMKVRAGESVELFCKVTGTQPITCTWMKFRKQIQEGE-GIKIENTENSSKLTITEGQQEHCGCYTLEVENKL 79 (98)
T ss_pred CceEECCcCEEEECCCEEEEEEEEcccCCCceEEEECCEEecCCC-cEEEEecCCeeEEEECCCChhhCEEEEEEEEcCC
Confidence 456667888999999999999999999999999999999997543 454432 4579999999999999999999999
Q ss_pred ceeeEEEEEEEeccCCCC
Q psy10160 207 TSDENAVTIRVEGIFIHP 224 (558)
Q Consensus 207 G~~~~~~~l~V~~~~~~p 224 (558)
|....++.|.|.+.|.+|
T Consensus 80 G~~~~~~~l~V~~~P~pP 97 (98)
T cd05762 80 GSRQAQVNLTVVDKPDPP 97 (98)
T ss_pred CceeEEEEEEEecCCCCC
Confidence 999999999999887666
No 57
>KOG4194|consensus
Probab=99.70 E-value=1.6e-16 Score=157.46 Aligned_cols=203 Identities=15% Similarity=0.123 Sum_probs=139.6
Q ss_pred cCceeEEeccCC--CCCCcEEEEeCCcccCCCCcee---------ec-------cccce---------eeceeEEeeccc
Q psy10160 63 YGTILSSAFPSE--SASPVVTQTTTTTTEATSPHVY---------AA-------LTHCV---------PWSNVCLFGARS 115 (558)
Q Consensus 63 ~~~~~~~~~~~~--~p~p~v~W~~~~~~~~~~~~~~---------~g-------~~~~~---------~~~~~~~~~~~~ 115 (558)
+....+.|.+.+ ..+-.+.|.+++...+...-.. .| .+.-+ ...|-|.++|..
T Consensus 518 g~nirftC~a~sssasplsi~WR~dnevq~rv~ved~a~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~F 597 (873)
T KOG4194|consen 518 GENIRFTCNAYSSSASPLSIEWRKDNEVQPRVDVEDFATFLSQNRNGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHF 597 (873)
T ss_pred ccceEEEEEeccCCCCCceeEeeeccccCcccchhcchhhhhhhccCccchhhhhhheeeeeeeecccCceEEEEEeccc
Confidence 345557777666 4566799999876443221100 00 00000 113456666666
Q ss_pred eee-EEeeeceeeeCcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEE-eccC-CceE-EEccCCeEEEccCC
Q psy10160 116 GYL-KETQNGGYLVPVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQV-IEND-GVHY-RITESNRLHINQAN 191 (558)
Q Consensus 116 ~~~-~~~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~-l~~~-~~~~-~~~~~~sL~I~~v~ 191 (558)
|.. ..+.+..+...|.|...|.+.+++.|+.+.|.|.++|.|.|+|.|.|+|.. .+.. .+|. .+.++..+.|.+|+
T Consensus 598 GStysqk~KltV~~~PsFtktP~dltl~tg~mArl~CaAtG~P~PeIawqkdggtdFPAA~eRRl~Vmpedd~f~Itnvk 677 (873)
T KOG4194|consen 598 GSTYSQKAKLTVNQAPSFTKTPEDLTLRTGQMARLECAATGHPRPEIAWQKDGGTDFPAARERRLHVMPEDDVFFITNVK 677 (873)
T ss_pred CcchhheeEEEeeccCccccCcccceeecccceeeeeeccCCCCcceeehhcCCCCCchhhhheeeecCCCCEEEEeccc
Confidence 533 345666777889999999999999999999999999999999999998765 5432 2343 44455689999999
Q ss_pred CCCCeEEEEEEEeCCceeeEEEEEEEeccCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCCC-Cccccc
Q psy10160 192 ATDSGEYRCVASNSYTSDENAVTIRVEGIFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLP-SYGPHI 270 (558)
Q Consensus 192 ~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~-~~~~w~ 270 (558)
.+|.|.|+|.|.|..|..+.+++|.|.+.| .+..+ .....+ ..|.+.. ..|.+.|.|. |...|+
T Consensus 678 ~eD~GiYtC~A~n~AG~isanAtL~V~e~p---~f~~P---L~~~~V------~~get~v---lqC~a~~~~a~pr~~W~ 742 (873)
T KOG4194|consen 678 IEDQGIYTCTAQNVAGQISANATLTVLETP---SFSIP---LEDQLV------VVGETLV---LQCLAEGAPADPRLEWF 742 (873)
T ss_pred ccccceeEEeeeccccceeeceEEEEecCC---ccccc---ccceEE------EecceEE---EEEecCCCCCCcccccc
Confidence 999999999999999999999999997553 22211 112222 2222333 4555667777 999999
Q ss_pred chhhhhhhhh
Q psy10160 271 KRAVEAEAAA 280 (558)
Q Consensus 271 ~~~l~~~~~~ 280 (558)
++...+...+
T Consensus 743 k~d~pil~t~ 752 (873)
T KOG4194|consen 743 KEDKPILITE 752 (873)
T ss_pred CCCCceEEee
Confidence 9988776555
No 58
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=99.70 E-value=5e-16 Score=144.04 Aligned_cols=65 Identities=25% Similarity=0.481 Sum_probs=54.1
Q ss_pred eeCCCcEEEEeEee-----ccCCCeEEEEECCEEeccCCceEEEcc-CCeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 141 FGVGSDISIPCDVD-----GYPIPQVFWYKDGQVIENDGVHYRITE-SNRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 141 v~~G~~v~L~C~~~-----g~P~p~i~W~~~g~~l~~~~~~~~~~~-~~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
+.+|+.+.|+|.+. |.|.|.+.|+|++.++..++ ++.+.. +++|.|.+++.+|+|.|+|.|+...
T Consensus 141 ~~~G~~v~L~C~~~~~~~~~~p~p~I~WyKng~~l~~~~-r~~~~~~~~~L~I~~V~~~DsG~YtC~a~~~~ 211 (227)
T PHA02826 141 FNSGKDSKLHCYGTDGISSTFKDYTLTWYKNGNIVLYTD-RIQLRNNNSTLVIKSATHDDSGIYTCNLRFNK 211 (227)
T ss_pred EecCCCEEEEeeCCCCccccCCCceEEEEECCEECCCCC-CEEEeCCCCEEEECcCCHHhCEEEEEEEEEeE
Confidence 45799999999986 34689999999999987554 555544 4589999999999999999999875
No 59
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.69 E-value=2.3e-16 Score=124.37 Aligned_cols=88 Identities=22% Similarity=0.417 Sum_probs=77.2
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
||.+...+.+..+.+|+.+.|.|.+.|+|.|.+.|+|++..+.... ++. ..++.|.|.+++.+|+|.|+|.|.|..|.
T Consensus 1 ~p~i~~~~~~~~~~~G~~v~l~C~~~G~P~P~v~W~k~~~~~~~~~-~~~-~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 78 (88)
T cd05851 1 PADINVKFKDTYALKGQNVTLECFALGNPVPVIRWRKILEPMPATA-EIS-MSGAVLKIFNIQPEDEGTYECEAENIKGK 78 (88)
T ss_pred CCceEEccccEEEeCCCcEEEEEEecccCCCEEEEEECCcCCCCCC-EEe-cCCCEEEECcCChhhCEEEEEEEEcCCCc
Confidence 5778888889999999999999999999999999999998776532 443 24568999999999999999999999999
Q ss_pred eeEEEEEEEe
Q psy10160 209 DENAVTIRVE 218 (558)
Q Consensus 209 ~~~~~~l~V~ 218 (558)
....+.|.|+
T Consensus 79 ~~~~~~l~V~ 88 (88)
T cd05851 79 DKHQARVYVQ 88 (88)
T ss_pred eEEEEEEEEC
Confidence 9999998873
No 60
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.67 E-value=3.9e-16 Score=118.95 Aligned_cols=74 Identities=28% Similarity=0.575 Sum_probs=66.8
Q ss_pred CCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 143 VGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+|+.+.|.|.+.|+|.|.+.|+|++..+..+. ++.+..+++|.|.+++.+|+|.|+|.|.|..|....++.|.|
T Consensus 1 eG~~v~l~C~~~g~P~p~i~W~k~g~~~~~~~-~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 74 (74)
T cd05745 1 EGQTVDFLCEAQGYPQPVIAWTKGGSQLSVDR-RHLVLSSGTLRISRVALHDQGQYECQAVNIVGSQRTVAQLTV 74 (74)
T ss_pred CCCeEEEEeECCEecCCEEEEEECCEECCCCC-CeEEccCCeEEEeeCCHHhCEEEEEEEEeCCCceeEEEEEeC
Confidence 68999999999999999999999999887643 555667789999999999999999999999999999988875
No 61
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.66 E-value=4.6e-16 Score=117.53 Aligned_cols=73 Identities=25% Similarity=0.477 Sum_probs=66.7
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
|+.+.|.|.+.|.|.|.|.|+|++..+..+ .++.+..+++|.|.+++.+|+|.|+|.|.|..|....++.|.|
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~k~~~~l~~~-~r~~~~~~g~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~~ 73 (73)
T cd05852 1 GGRVIIECKPKAAPKPKFSWSKGTELLVNN-SRISIWDDGSLEILNITKLDEGSYTCFAENNRGKANSTGVLSV 73 (73)
T ss_pred CCeEEEEEecceeCCCEEEEEeCCEecccC-CCEEEcCCCEEEECcCChhHCEEEEEEEECCCCceeEEEEEEC
Confidence 788999999999999999999999887654 4788888899999999999999999999999999999988875
No 62
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.66 E-value=8.9e-16 Score=120.91 Aligned_cols=81 Identities=26% Similarity=0.434 Sum_probs=70.4
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc----C---CeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE----S---NRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~----~---~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
|+.+.|.|.+.|.|+|.+.|+|++..+..+..+|.+.. . ++|.|.++..+|+|.|+|.|.|..|.....+.|.
T Consensus 1 g~~~~l~C~~~g~p~~~i~W~k~~~~i~~~~~r~~~~~~~~~~~~~s~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~L~ 80 (88)
T cd05735 1 GQKKEMSCTAHGEKPIIVRWEKEDRIINPEMSRYLVSTKEVGDEVISTLQILPTVREDSGFFSCHAINSYGEDRGIIQLT 80 (88)
T ss_pred CCeEEEEEEEECCCCCEEEEeeCCEECCCCCCcEEEEEecCCCcEEEEEEECCCCcccCEEEEEEEEcCCCcceEEEEEE
Confidence 78999999999999999999999998866544665432 1 4799999999999999999999999999999999
Q ss_pred EeccCCCC
Q psy10160 217 VEGIFIHP 224 (558)
Q Consensus 217 V~~~~~~p 224 (558)
|.++|.+|
T Consensus 81 V~~~P~~P 88 (88)
T cd05735 81 VQEPPDPP 88 (88)
T ss_pred EeCCCCCC
Confidence 98887665
No 63
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=99.64 E-value=1.1e-15 Score=115.88 Aligned_cols=71 Identities=20% Similarity=0.473 Sum_probs=62.0
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccC--C--eEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITES--N--RLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~--~--sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|.|.|.+.|+|++..+..++.++.+..+ + +|.|.+++.+|+|.|+|.|.|..|.....+.|.|
T Consensus 1 v~l~C~v~G~P~P~i~W~k~~~~i~~~~~r~~~~~~~~g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05892 1 VKLECQISAIPPPKIFWKRNNEMVQYNTDRISLYQDNSGRVTLLIKNVNKKDAGWYTVSAVNEAGVATCHARLDV 75 (75)
T ss_pred CEEEEEEEecCCCeEEEEECCEECcCCCCeEEEEEcCCCcEEEEECCCChhhCEEEEEEEEcCcCeEEEEEEEeC
Confidence 479999999999999999999998765557665432 3 7999999999999999999999999999988875
No 64
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=99.64 E-value=2.5e-15 Score=117.73 Aligned_cols=80 Identities=21% Similarity=0.408 Sum_probs=69.5
Q ss_pred ceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc---CCeEEEccCCCCCCeEEEEEEEeCCceeeEEEE
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE---SNRLHINQANATDSGEYRCVASNSYTSDENAVT 214 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 214 (558)
...+.+|+.+.|.|.+.|.|.|.+.|+|++.++...+.++.+.. .++|.|.++.++|+|.|+|.|.|..|....++.
T Consensus 4 ~~~v~~G~~v~l~c~~~G~P~P~v~W~k~~~~i~~~~~r~~~~~~~~~~~L~I~~~~~~D~G~Y~c~a~N~~G~~~~~~~ 83 (86)
T cd05894 4 TIVVVAGNKLRLDVPISGEPAPTVTWSRGDKAFTETEGRVRVESYKDLSSFVIEGAEREDEGVYTITVTNPVGEDHASLF 83 (86)
T ss_pred EEEEEcCCEEEEEeeEeecCCCeEEEEECCEECccCCCeEEEEEcCCeEEEEECCCccCcCEEEEEEEEeCCCcEEEEEE
Confidence 45678999999999999999999999999999976544565543 347999999999999999999999999998888
Q ss_pred EEE
Q psy10160 215 IRV 217 (558)
Q Consensus 215 l~V 217 (558)
|.|
T Consensus 84 l~V 86 (86)
T cd05894 84 VKV 86 (86)
T ss_pred EEC
Confidence 875
No 65
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=99.63 E-value=1.4e-15 Score=115.38 Aligned_cols=71 Identities=27% Similarity=0.491 Sum_probs=62.5
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCC----eEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESN----RLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~----sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|.|.|.+.|+|++..+..+..++.+..++ +|.|.+++.+|+|.|+|.|.|..|+.+.++.|.|
T Consensus 1 v~l~C~v~G~P~P~v~W~k~~~~l~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05893 1 VRLECRVSGVPHPQIFWKKENESLTHNTDRVSMHQDNCGYICLLIQGATKEDAGWYTVSAKNEAGIVSCTARLDV 75 (75)
T ss_pred CEEEEEEeEecCCEEEEEECCEECCCCCCeEEEEEcCCCEEEEEECCCCHHHCEEEEEEEEcCCCEEEEEEEEeC
Confidence 5799999999999999999999987655577665433 6999999999999999999999999999988875
No 66
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=99.62 E-value=4.4e-15 Score=119.51 Aligned_cols=82 Identities=22% Similarity=0.405 Sum_probs=69.7
Q ss_pred CceEeeCCCcEEEEeEeec-cCCCeEEEEECCEEeccCCceEEEcc-------CCeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 137 ETQVFGVGSDISIPCDVDG-YPIPQVFWYKDGQVIENDGVHYRITE-------SNRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~g-~P~p~i~W~~~g~~l~~~~~~~~~~~-------~~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
....+.+|+.+.|.|.+.| .|+|.+.|+|+|.++..+........ .++|.|.+++++|+|.|+|.|.|..|.
T Consensus 11 ~~~~v~~G~~v~L~c~v~g~~P~p~v~W~Kdg~~i~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Ytc~A~N~~G~ 90 (101)
T cd04975 11 TTIFVNLGENLNLVVEVEAYPPPPHINWTYDNRTLTNKLTEIVTSENESEYRYVSELKLVRLKESEAGTYTFLASNSDAS 90 (101)
T ss_pred ceEEEECCCCEEEEEEEEecCCCCccEEEeCCeeCCCCcceeEEEeccCcceEEEEEEEeecCHhhCeeEEEEEECCCcc
Confidence 4567889999999999999 89999999999999975443332222 257999999999999999999999999
Q ss_pred eeEEEEEEEe
Q psy10160 209 DENAVTIRVE 218 (558)
Q Consensus 209 ~~~~~~l~V~ 218 (558)
.+.++.|.|.
T Consensus 91 ~~~t~~L~V~ 100 (101)
T cd04975 91 KSLTFELYVN 100 (101)
T ss_pred EEEEEEEEEE
Confidence 9999999884
No 67
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=99.62 E-value=4.9e-15 Score=119.08 Aligned_cols=90 Identities=28% Similarity=0.608 Sum_probs=74.8
Q ss_pred CcEEEecC--CceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccC-CeEEEccCCCCCCeEEEEEEEeC
Q psy10160 129 PVKVNITL--ETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITES-NRLHINQANATDSGEYRCVASNS 205 (558)
Q Consensus 129 p~~~~~~~--~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~-~sL~I~~v~~~D~G~Y~C~a~N~ 205 (558)
||.+...+ ....+..|+.+.|.|.+.|.|.|.+.|+|+|..+.....++....+ +.|.|.+++.+|+|.|+|.|.|.
T Consensus 1 pp~i~~~~~~~~~~~~~G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~ 80 (95)
T cd05730 1 PPTIRARQSEVNATANLGQSVTLACDADGFPEPTMTWTKDGEPIESGEEKYSFNEDGSEMTILDVDKLDEAEYTCIAENK 80 (95)
T ss_pred CCccccCCcccceEEeCCCCEEEEEeccEeCCCEEEEEECCEECcCCCCEEEEeCCCCEEEECCCChhhCEEEEEEEEcC
Confidence 34444433 3456789999999999999999999999999988765446655544 46999999999999999999999
Q ss_pred CceeeEEEEEEEe
Q psy10160 206 YTSDENAVTIRVE 218 (558)
Q Consensus 206 ~G~~~~~~~l~V~ 218 (558)
.|....++.|.|.
T Consensus 81 ~G~~~~~~~L~V~ 93 (95)
T cd05730 81 AGEQEAEIHLKVF 93 (95)
T ss_pred CCeEEEEEEEEEE
Confidence 9999999999885
No 68
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.62 E-value=5.7e-15 Score=116.77 Aligned_cols=87 Identities=23% Similarity=0.373 Sum_probs=74.9
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
|+.+...+....+.+|+.+.|.|.+.|.|.|.+.|+|++..+.... .+. ..+++|.|.+++.+|+|.|+|.|.|..|.
T Consensus 1 p~~~~~~p~~~~~~~g~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~-~~~-~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~ 78 (88)
T cd04968 1 PSIIVVFPKDTYALKGQNVTLECFALGNPVPQIKWRKVDGSMPSSA-EIS-MSGAVLKIPNIQFEDEGTYECEAENIKGK 78 (88)
T ss_pred CCcEEECCCceEEeCCCcEEEEEEeeEeCCCEEEEEECCCcCCCcc-EEE-EeCCEEEECCCCcccCEEEEEEEEECCCc
Confidence 4566677788889999999999999999999999999887765543 232 35679999999999999999999999999
Q ss_pred eeEEEEEEE
Q psy10160 209 DENAVTIRV 217 (558)
Q Consensus 209 ~~~~~~l~V 217 (558)
...++.|.|
T Consensus 79 ~~~~~~l~V 87 (88)
T cd04968 79 DTHQGRIYV 87 (88)
T ss_pred EEEEEEEEE
Confidence 999988887
No 69
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=99.61 E-value=5.8e-15 Score=117.79 Aligned_cols=85 Identities=25% Similarity=0.499 Sum_probs=70.2
Q ss_pred EecCCceEeeCCCcEEEEeEeeccCC-CeEEEEE-CCEEeccCCceEEEccC----CeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 133 NITLETQVFGVGSDISIPCDVDGYPI-PQVFWYK-DGQVIENDGVHYRITES----NRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 133 ~~~~~~~~v~~G~~v~L~C~~~g~P~-p~i~W~~-~g~~l~~~~~~~~~~~~----~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
.+.|....+.+|+.+.|.|.+.|.|. |.+.|++ ++..+...+.++.+..+ ++|.|.+++.+|+|.|+|.|.|..
T Consensus 4 ~~~p~~~~v~~G~~v~l~C~v~G~P~~p~i~W~~~~g~~l~~~~~r~~v~~~~~~~~~L~I~~v~~~D~G~YtC~A~N~~ 83 (96)
T cd05865 4 DIVPSQGEISVGESKFFLCQVAGEAKDKDISWFSPNGEKLTPNQQRISVVRNDDYSSTLTIYNANIDDAGIYKCVVSNED 83 (96)
T ss_pred EEeCCccEECCCCeEEEEEEEeCCCCCCEEEEECCCCcCccccCCeEEEEeCCCCceEEEEeccChhhCEEEEEEEEcCC
Confidence 45566778899999999999999995 7999998 77766554445554322 589999999999999999999997
Q ss_pred -ceeeEEEEEEE
Q psy10160 207 -TSDENAVTIRV 217 (558)
Q Consensus 207 -G~~~~~~~l~V 217 (558)
|..+.++.|.|
T Consensus 84 ~g~~~~s~~l~v 95 (96)
T cd05865 84 EGESEATVNVKI 95 (96)
T ss_pred CCcEEEEEEEEE
Confidence 88889988887
No 70
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=99.61 E-value=7.7e-15 Score=117.00 Aligned_cols=87 Identities=29% Similarity=0.555 Sum_probs=75.8
Q ss_pred eCcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc---CCeEEEccCCCCCCeEEEEEEEe
Q psy10160 128 VPVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE---SNRLHINQANATDSGEYRCVASN 204 (558)
Q Consensus 128 ~p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N 204 (558)
.||.+...+....+.+|+.+.|.|.+.|+|.|.+.|+|+|..+..+. ++.+.. .++|.|.+++.+|+|.|+|.|.|
T Consensus 2 ~~~~~~~~p~~~~~~~G~~~~L~C~~~g~P~p~v~W~k~g~~l~~~~-~~~~~~~~~~~~L~i~~~~~~D~G~Y~C~a~N 80 (92)
T cd05747 2 LPATILTKPRSLTVSEGESARFSCDVDGEPAPTVTWMREGQIIVSSQ-RHQITSTEYKSTFEISKVQMSDEGNYTVVVEN 80 (92)
T ss_pred CCCcccccCccEEEeCCCcEEEEEEEeecCCCEEEEEECCEECCCCC-cEEEEEcCCeeEEEECCCCcccCEeEEEEEEc
Confidence 47888888889999999999999999999999999999998876543 555443 34899999999999999999999
Q ss_pred CCceeeEEEEE
Q psy10160 205 SYTSDENAVTI 215 (558)
Q Consensus 205 ~~G~~~~~~~l 215 (558)
..|....++.|
T Consensus 81 ~~G~~~~~~~l 91 (92)
T cd05747 81 SEGKQEAQFTL 91 (92)
T ss_pred CCCCEeEEEEe
Confidence 99999887765
No 71
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.61 E-value=5.8e-15 Score=111.33 Aligned_cols=71 Identities=25% Similarity=0.591 Sum_probs=63.2
Q ss_pred cEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 146 DISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 146 ~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
.+.|.|.+.|.|.|.+.|+|++..+.... ++.+..++.|.|.+++.+|+|.|+|.|.|..|+...++.|.|
T Consensus 1 ~v~l~C~~~G~P~p~v~W~k~g~~~~~~~-~~~~~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 71 (71)
T cd05723 1 DVIFECEVTGKPTPTVKWVKNGDMVIPSD-YFKIVKEHNLQVLGLVKSDEGFYQCIAENDVGNVQASAQLII 71 (71)
T ss_pred CEEEEEEEEEeCCCEEEEEECCeECCCCC-CEEEEecCCEEEEcCCcccCEEEEEEEEcCCCEEEEEEEEEC
Confidence 47899999999999999999999886544 566667778999999999999999999999999999988875
No 72
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=99.60 E-value=6.7e-15 Score=115.33 Aligned_cols=83 Identities=27% Similarity=0.505 Sum_probs=72.8
Q ss_pred EecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEE
Q psy10160 133 NITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENA 212 (558)
Q Consensus 133 ~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 212 (558)
...|.+..+..|+.+.|.|.+.|.|.|.+.|+|++..+.... ++.. .++.|.|.++..+|+|.|+|.|.|..|....+
T Consensus 3 ~~~p~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~g~~~~~~~-~~~~-~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~ 80 (85)
T cd05728 3 LKVISDTEADIGSSLRWECKASGNPRPAYRWLKNGQPLASEN-RIEV-EAGDLRITKLSLSDSGMYQCVAENKHGTIYAS 80 (85)
T ss_pred cccCCccEEcCCCcEEEEEEeeEeCCCEEEEEECCEECCCCC-eEEE-eCCEEEEeeCCHHHCEEEEEEEECCCCeEEEE
Confidence 345677889999999999999999999999999999887544 5544 56789999999999999999999999999998
Q ss_pred EEEEE
Q psy10160 213 VTIRV 217 (558)
Q Consensus 213 ~~l~V 217 (558)
+.|.|
T Consensus 81 ~~l~V 85 (85)
T cd05728 81 AELAV 85 (85)
T ss_pred EEEEC
Confidence 88865
No 73
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.60 E-value=6.8e-15 Score=111.76 Aligned_cols=73 Identities=26% Similarity=0.532 Sum_probs=66.3
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
|+.+.|.|.+.|.|.|.+.|+|++..+.... ++.+..+++|.|.+++.+|+|.|+|.|.|..|....++.|.|
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~~~~~~~~~-~~~~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 73 (73)
T cd04969 1 GGDVIIECKPKAAPKPTISWSKGTELLTNSS-RICIWPDGSLEILNVTKSDEGKYTCFAENFFGKANSTGSLSV 73 (73)
T ss_pred CCeEEEEEeeeEcCCCEEEEEECCEEcccCC-CEEECCCCeEEEccCChhHCEEEEEEEECCCCceEEEEEEEC
Confidence 7889999999999999999999999886544 667777889999999999999999999999999999988875
No 74
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=99.60 E-value=1.3e-14 Score=115.65 Aligned_cols=82 Identities=30% Similarity=0.549 Sum_probs=69.4
Q ss_pred cCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEc-c-C--CeEEEccCCCCCCeEEEEEEEeCCceee
Q psy10160 135 TLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRIT-E-S--NRLHINQANATDSGEYRCVASNSYTSDE 210 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~-~-~--~sL~I~~v~~~D~G~Y~C~a~N~~G~~~ 210 (558)
.|....+.+|+.+.|.|.+.|.|.|.+.|+|++..+..++ ++.+. . . .+|.|.+++.+|+|.|+|.|.|..|...
T Consensus 7 lp~~v~v~~G~~v~L~C~v~G~P~p~v~W~k~g~~l~~~~-~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 85 (92)
T cd05737 7 LPDVVTIMEGKTLNLTCTVFGDPDPEVSWLKNDQALALSD-HYNVKVEQGKYASLTIKGVSSEDSGKYGIVVKNKYGGET 85 (92)
T ss_pred CCceEEEeCCCcEEEEEEEEecCCCeEEEEECCEECccCC-CEEEEEcCCCEEEEEEccCChhhCEEEEEEEEECCCcce
Confidence 3456778999999999999999999999999999987654 44432 1 2 3799999999999999999999999999
Q ss_pred EEEEEEE
Q psy10160 211 NAVTIRV 217 (558)
Q Consensus 211 ~~~~l~V 217 (558)
..+.|.|
T Consensus 86 ~~~~v~v 92 (92)
T cd05737 86 VDVTVSV 92 (92)
T ss_pred EEEEEeC
Confidence 8888765
No 75
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.59 E-value=1.1e-14 Score=111.45 Aligned_cols=73 Identities=25% Similarity=0.497 Sum_probs=64.1
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCC--ceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDG--VHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~--~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
|+.+.|.|.+.|.|.|.+.|+|+|..+.... .++. ..+++|.|.+++.+|+|.|+|.|.|..|.....+.|.|
T Consensus 1 G~~v~l~C~~~G~P~p~i~W~k~g~~i~~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 75 (76)
T cd05867 1 GETARLDCQVEGIPTPNITWSINGAPIEGTDPDPRRH-VSSGALILTDVQPSDTAVYQCEARNRHGNLLANAHVHV 75 (76)
T ss_pred CCeEEEEEEeeEeCCCeEEEEECCEECCCCCCCceEE-eeCCEEEECCCChhhCEEEEEEEECCCCeEEEEEEEEE
Confidence 7889999999999999999999999886532 2343 35678999999999999999999999999999999887
No 76
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=99.58 E-value=2.2e-14 Score=115.61 Aligned_cols=81 Identities=21% Similarity=0.405 Sum_probs=68.7
Q ss_pred ceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc--------CCeEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE--------SNRLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~--------~~sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
...+..|+.+.|.|.+.|+|.|.+.|+|+|.++..+...+.... .++|.|.+++.+|+|.|+|.|.|..|..
T Consensus 12 ~~~~~~~~~~~l~~~v~g~P~P~v~W~kdg~~l~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~D~G~Ytc~A~N~~g~~ 91 (101)
T cd05859 12 LEFANLHEVKEFVVEVEAYPPPQIRWLKDNRTLIENLTEITTSEHNVQETRYVSKLKLIRAKEEDSGLYTALAQNEDAVK 91 (101)
T ss_pred eEEEecCCcEEEEEEEEEeCCCceEEEECCEECcCCcceEEeccccccceeeccEEEEeeCCHHHCEEEEEEEEcCCceE
Confidence 55678899999999999999999999999999876543222111 2579999999999999999999999999
Q ss_pred eEEEEEEEe
Q psy10160 210 ENAVTIRVE 218 (558)
Q Consensus 210 ~~~~~l~V~ 218 (558)
+.++.|.|.
T Consensus 92 ~~t~~l~V~ 100 (101)
T cd05859 92 SYTFALQIQ 100 (101)
T ss_pred EEEEEEEEE
Confidence 999998884
No 77
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=99.58 E-value=1.1e-14 Score=107.20 Aligned_cols=65 Identities=29% Similarity=0.630 Sum_probs=57.1
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|+|.|.+.|+|+|.++... ...+.|.|.++..+|+|.|+|.|+|..|..++++.+.|
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~------~~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~~l 65 (67)
T cd05863 1 VKLPVKVAAYPPPEFQWYKDGKLISGK------HSQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRISLEL 65 (67)
T ss_pred CEEEEEEEEeCCCEEEEEECCEECccc------CCcCEEEECCCCHHHCEEEEEEEEECCccEEEEEEEEE
Confidence 479999999999999999999988632 23468999999999999999999999998888877776
No 78
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=99.58 E-value=1.4e-14 Score=110.35 Aligned_cols=71 Identities=25% Similarity=0.457 Sum_probs=61.1
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccC--C--eEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITES--N--RLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~--~--sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|.|.|.+.|+|++..+..+..++.+..+ + +|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 1 v~L~C~v~G~P~P~v~W~k~~~~i~~~~~r~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 75 (75)
T cd05744 1 VRLECRVSAIPPPQIFWKKNNEMLTYNTDRISLYQDNCGRICLLIQNANKEDAGWYTVSAVNEAGVVSCNARLDV 75 (75)
T ss_pred CEEEEEEeecCCCeEEEEECCEECCCCCCcEEEEEcCCCeEEEEECCCCcccCEEEEEEEEcCCCcEEEEEEEeC
Confidence 479999999999999999999998765446655332 2 6999999999999999999999999999888865
No 79
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.57 E-value=2.1e-14 Score=109.75 Aligned_cols=74 Identities=26% Similarity=0.468 Sum_probs=63.3
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCCc-eEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDGV-HYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~-~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
|+.+.|.|.+.|.|.|.|.|+|+|.++..... ......++.|.|.+++.+|+|.|+|.|.|..|....++.|.|
T Consensus 1 g~~~~l~C~a~G~P~P~i~W~k~g~~i~~~~~~~~~~~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 75 (76)
T cd05868 1 GEDGTLICRANGNPKPSISWLTNGVPIEIAPTDPSRKVDGDTIIFSKVQERSSAVYQCNASNEYGYLLANAFVNV 75 (76)
T ss_pred CCCEEEEEEeeEeCCCeEEEEECCEEccccCCCceEEecCCEEEECCCCHhhCEEEEEEEEcCCCEEEEEEEEEe
Confidence 78899999999999999999999998864321 122234568999999999999999999999999999999987
No 80
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=99.57 E-value=2.9e-14 Score=114.88 Aligned_cols=89 Identities=25% Similarity=0.503 Sum_probs=71.4
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCC----ceEEEccC---CeEEEccCCCCCCeEEEEE
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDG----VHYRITES---NRLHINQANATDSGEYRCV 201 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~----~~~~~~~~---~sL~I~~v~~~D~G~Y~C~ 201 (558)
.|.+...+....+..|+.+.|.|.+.|.|.|.+.|++++..+.... .++.+..+ ++|.|.+++.+|+|.|+|.
T Consensus 2 ~p~i~~~~~~~~~~~g~~v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~~~~~v~~~~~~~~L~I~~v~~~D~G~Y~C~ 81 (97)
T cd05869 2 KPKITYVENQTAMELEEQITLTCEASGDPIPSITWRTSTRNISSEEKTLDGHIVVRSHARVSSLTLKYIQYTDAGEYLCT 81 (97)
T ss_pred CceEEEccCceEEEcCCCEEEEEEeeEeCCCEEEEEECCccccCCccccCccEEEEcCccEEEEEEecCccCcCEEEEEE
Confidence 3555556666666779999999999999999999999987764321 23333332 4799999999999999999
Q ss_pred EEeCCceeeEEEEEEE
Q psy10160 202 ASNSYTSDENAVTIRV 217 (558)
Q Consensus 202 a~N~~G~~~~~~~l~V 217 (558)
|.|..|..+.++.|.|
T Consensus 82 A~N~~G~~~~~~~l~v 97 (97)
T cd05869 82 ASNTIGQDSQSMYLEV 97 (97)
T ss_pred EecCCCCeeEEEEEEC
Confidence 9999999999988875
No 81
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.56 E-value=1.3e-14 Score=108.68 Aligned_cols=68 Identities=31% Similarity=0.697 Sum_probs=61.3
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTI 215 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 215 (558)
|.|.|.+.|.|.|.+.|+|++..+.... ++.+..+++|.|.+++.+|+|.|+|.|.|..|..+.++.|
T Consensus 1 v~L~C~~~g~P~p~i~W~k~g~~~~~~~-~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~L 68 (69)
T cd05746 1 VQIPCSAQGDPEPTITWNKDGVQVTESG-KFHISPEGYLAIRDVGVADQGRYECVARNTIGYASVSMVL 68 (69)
T ss_pred CEeEecceEeCCCEEEEEECCEECCCCC-CEEECCCCEEEECcCChhhCEEEEEEEECCCCcEEEEEEe
Confidence 4799999999999999999999887544 6777778899999999999999999999999999888776
No 82
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=99.56 E-value=3e-14 Score=113.07 Aligned_cols=83 Identities=19% Similarity=0.392 Sum_probs=68.4
Q ss_pred cCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCce-EE-EccCCeEEEccCCCCCCeEEEEEEEeCCceeeEE
Q psy10160 135 TLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVH-YR-ITESNRLHINQANATDSGEYRCVASNSYTSDENA 212 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~-~~-~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 212 (558)
++....+.+|+.+.|.|.+.|.|.|.+.|++++..+...... .. ....++|.|.+++.+|.|.|+|.|.|..|....+
T Consensus 6 ~p~~~~v~~G~~v~l~C~~~G~P~p~v~W~~~g~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~g~Y~C~A~N~~G~~~~~ 85 (90)
T cd04972 6 GPNATVVYEGGTATIRCTAEGSPLPKVEWIIAGLIVIQTRTDTLETTVDIYNLQLSNITSETQTTVTCTAENPVGQANVS 85 (90)
T ss_pred CCcCEEEcCCCcEEEEEEEEEcCCCeEEEEECCEEccCCccEEEEecCCEEEEEEecCCcccCEEEEEEEECCCCceeEE
Confidence 445666899999999999999999999999999887654321 11 1223479999999999999999999999999998
Q ss_pred EEEEE
Q psy10160 213 VTIRV 217 (558)
Q Consensus 213 ~~l~V 217 (558)
+.|.|
T Consensus 86 ~~L~v 90 (90)
T cd04972 86 VQVTV 90 (90)
T ss_pred EEEeC
Confidence 88865
No 83
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=99.56 E-value=2.4e-14 Score=110.52 Aligned_cols=77 Identities=25% Similarity=0.423 Sum_probs=65.6
Q ss_pred CcEEEEeEeeccC--CCeEEEEECCEEecc--CCceEEE----ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 145 SDISIPCDVDGYP--IPQVFWYKDGQVIEN--DGVHYRI----TESNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 145 ~~v~L~C~~~g~P--~p~i~W~~~g~~l~~--~~~~~~~----~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
+++.|.|.+.+.| .+.|.|+|+|..+.. ++.+|.. ...++|.|.+++.+|+|+|+|.|.|..+..+.++.|.
T Consensus 1 ~~~~l~C~v~~d~~l~~~~~W~~dg~~i~~~~~~~~~~~~~~~~~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a~a~L~ 80 (85)
T cd05853 1 ESIVLPCQVSHDHSLDIVFTWSFNGHLIDFQKDGDHFERVGGQDSAGDLMIRSIQLKHAGKYVCMVQTSVDKLSAAADLI 80 (85)
T ss_pred CcEEEEEEeccCCCCCcEEEEEECCEECcccCCCccEEEeccCCCCCcEEEecCCHHHCEEEEEEEEcccCceEEEEEEE
Confidence 4689999998744 778999999999973 3446665 2456899999999999999999999999999999999
Q ss_pred EeccC
Q psy10160 217 VEGIF 221 (558)
Q Consensus 217 V~~~~ 221 (558)
|.+||
T Consensus 81 V~~pP 85 (85)
T cd05853 81 VRGPP 85 (85)
T ss_pred EecCC
Confidence 98764
No 84
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.56 E-value=2.1e-14 Score=108.27 Aligned_cols=71 Identities=27% Similarity=0.558 Sum_probs=60.9
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEe
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVE 218 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 218 (558)
+.|.|.+.|.|.|.+.|+|++..+..+. ......+++|.|.+++.+|+|.|+|.|.|..|..+.++.|.|+
T Consensus 1 ~~L~C~~~G~P~P~v~W~k~~~~~~~~~-~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~Ve 71 (71)
T cd05876 1 LVLECIAEGLPTPEVHWDRIDGPLSPNR-TKKLNNNKTLQLDNVLESDDGEYVCTAENSEGSARHHYTVTVE 71 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCcCCCCCc-eeEEcCCCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEEEEEC
Confidence 4799999999999999999998776543 2233456799999999999999999999999999999998873
No 85
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.56 E-value=3.6e-14 Score=114.54 Aligned_cols=88 Identities=19% Similarity=0.485 Sum_probs=70.0
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEEC--CEEecc----CCceEEEcc---CCeEEEccCCCCCCeEEE
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKD--GQVIEN----DGVHYRITE---SNRLHINQANATDSGEYR 199 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~--g~~l~~----~~~~~~~~~---~~sL~I~~v~~~D~G~Y~ 199 (558)
+|.+. .+.+..+.+|+.++|.|.+.|.|.|.+.|+|+ +..+.. .+.++.+.. .++|.|.+++.+|+|.|+
T Consensus 2 ~p~i~-~~~~~~~~~G~~v~l~C~~~G~P~p~i~W~k~~~g~~~~~~~~~~~~r~~v~~~~~~~~L~I~~v~~~D~G~Y~ 80 (98)
T cd05870 2 QPHII-QLKNETTVENGAATLSCKAEGEPIPEITWKRASDGHTFSEGDKSPDGRIEVKGQHGESSLHIKDVKLSDSGRYD 80 (98)
T ss_pred CCEEE-eeccEEEcCCCcEEEEEecccCCCCeEEEEECCCCceeccCCcCcCceEEEeecCCeeEEEEeeCCcCCCEEEE
Confidence 44554 35678889999999999999999999999994 444432 123555542 347999999999999999
Q ss_pred EEEEeCCceeeEEEEEEE
Q psy10160 200 CVASNSYTSDENAVTIRV 217 (558)
Q Consensus 200 C~a~N~~G~~~~~~~l~V 217 (558)
|.|.|..|....++.|.|
T Consensus 81 C~A~N~~G~~~~~~~l~~ 98 (98)
T cd05870 81 CEAASRIGGHQKSMYLDI 98 (98)
T ss_pred EEEeccCCcceeEEEEeC
Confidence 999999999998888875
No 86
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=99.56 E-value=4.9e-14 Score=112.10 Aligned_cols=87 Identities=31% Similarity=0.601 Sum_probs=76.1
Q ss_pred cEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc---CCeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 130 VKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE---SNRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
|.|...+.+..+.+|+.+.|.|.+.|.|.|.+.|++++..+..+. ++.+.. ..+|.|.+++.+|+|.|+|.|.|..
T Consensus 1 P~~~~~~~~~~v~~G~~~~l~c~~~~~p~~~v~W~~~~~~l~~~~-~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~~~n~~ 79 (90)
T PF07679_consen 1 PVFTKKPKDVTVKEGESVTLECEVSGNPPPTVTWYKNGRPLTSSQ-RYQIESDGGSSSLTIKNVTREDAGTYTCVASNSS 79 (90)
T ss_dssp EEEEEESSEEEEETTSEEEEEEEEEESSSSEEEEEETTEEEESSS-SEEEEEETTEEEEEESSESGGGSEEEEEEEEETT
T ss_pred CEEEEecCCEEEeCCCEEEEEEEEEeCCCCcccccccccceeeee-eeeeecccceeEEccCCCChhhCEEEEEEEEECC
Confidence 567777889999999999999999999999999999999998754 444332 3479999999999999999999999
Q ss_pred ceeeEEEEEEE
Q psy10160 207 TSDENAVTIRV 217 (558)
Q Consensus 207 G~~~~~~~l~V 217 (558)
|..+..+.|.|
T Consensus 80 g~~~~~~~l~V 90 (90)
T PF07679_consen 80 GEATASVNLTV 90 (90)
T ss_dssp EEEEEEEEEEE
T ss_pred CEEEEEEEEEC
Confidence 99999998876
No 87
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=99.56 E-value=3.4e-14 Score=108.99 Aligned_cols=74 Identities=24% Similarity=0.422 Sum_probs=64.6
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCCce-EEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDGVH-YRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~-~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
|+.+.|.|.+.|.|.|.+.|+++|..+...... .....++.|.|.+++.+|+|.|+|.|.|..|.....+.|.|
T Consensus 1 G~~~~l~C~~~g~P~p~i~W~~~g~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 75 (76)
T cd04978 1 GETGRLDCEAEGIPQPTITWRLNGVPIEELPPDPRRRVDGGTLILSNVQPNDTAVYQCNASNVHGYLLANAFVHV 75 (76)
T ss_pred CCeEEEEEEceeeCCCEEEEEECCEECCCCCCcceEEccCCEEEECCCChhhCEEEEEEEEccCCeEEEeEEEEE
Confidence 788999999999999999999999988654322 23345678999999999999999999999999999999887
No 88
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=99.55 E-value=5e-14 Score=114.53 Aligned_cols=89 Identities=27% Similarity=0.517 Sum_probs=70.5
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccC----CceEEEccCCeEEEc-----cCCCCCCeEEE
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIEND----GVHYRITESNRLHIN-----QANATDSGEYR 199 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~----~~~~~~~~~~sL~I~-----~v~~~D~G~Y~ 199 (558)
||.+...+....+.+|+.+.|.|.+.|.|.|.+.|+|+|..+... ..+.....++.+.+. .++.+|+|.|+
T Consensus 1 ~P~i~~~p~~~~v~~G~~~~l~C~~~g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~D~G~Y~ 80 (100)
T cd07693 1 PPRIVEHPSDLIVSKGDPATLNCKAEGRPTPTIQWLKNGQPLETDKDDPRSHRIVLPSGSLFFLRVVHGRKGRSDEGVYV 80 (100)
T ss_pred CCeEEecCceeEEcCCCeEEEEeeCCcCCCCEEEEEECCEECccccCCCCcceEEecCCcEEEEEeeccCCCcCcCEEEE
Confidence 577788888999999999999999999999999999999988651 222333344443322 23689999999
Q ss_pred EEEEeCCce-eeEEEEEEE
Q psy10160 200 CVASNSYTS-DENAVTIRV 217 (558)
Q Consensus 200 C~a~N~~G~-~~~~~~l~V 217 (558)
|.|.|..|. .+..+.|.|
T Consensus 81 C~a~N~~G~~~s~~~~l~v 99 (100)
T cd07693 81 CVAHNSLGEAVSRNASLEV 99 (100)
T ss_pred EEEEccccceecceEEEEe
Confidence 999999999 567788776
No 89
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=99.55 E-value=4.6e-14 Score=111.16 Aligned_cols=83 Identities=33% Similarity=0.547 Sum_probs=70.7
Q ss_pred cCCceEeeCCCcEEEEeEe-eccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee-eEE
Q psy10160 135 TLETQVFGVGSDISIPCDV-DGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD-ENA 212 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~-~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~-~~~ 212 (558)
.|....+.+|+++.|.|.+ .|.|.|.+.|+|++..+.....++....+++|.|.+++.+|+|.|+|.|.|..|.. +..
T Consensus 2 ~p~~~~~~~G~~v~l~C~~~~g~p~p~i~W~k~g~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~ 81 (86)
T cd05724 2 EPSDTQVAVGEMAVLECSPPRGHPEPTVSWRKDGQPLNLDNERVRIVDDGNLLIAEARKSDEGTYKCVATNMVGERESAA 81 (86)
T ss_pred CCccEEEeCCCCEEEEEECCCCCCCCEEEEEECCEECCCCCCCEEEccCCEEEEeECCcccCEEEEEEEEeccCceeeee
Confidence 3567788899999999998 79999999999999998875556666667899999999999999999999999987 455
Q ss_pred EEEEE
Q psy10160 213 VTIRV 217 (558)
Q Consensus 213 ~~l~V 217 (558)
+.|.|
T Consensus 82 ~~l~V 86 (86)
T cd05724 82 ARLSV 86 (86)
T ss_pred EEEEC
Confidence 55543
No 90
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.55 E-value=3.5e-14 Score=112.66 Aligned_cols=78 Identities=23% Similarity=0.526 Sum_probs=67.8
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEec-------cCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIE-------NDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~-------~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
|+.+.|.|.+.|.|.|.+.|+|++..+. ....++.+..+++|.|.+++.+|+|.|+|.|.|..|.....+.|.
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~~~~~~~r~~v~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 80 (90)
T cd05726 1 GRTVTFQCEATGNPQPAIFWQKEGSQNLLFSYQPPQSSSRFSVSQTGDLTITNVQRSDVGYYICQTLNVAGSILTKAYLE 80 (90)
T ss_pred CCEEEEEEECCccCCCEEEEEeCCCcceeecccCCCCCCeEEECCCCeEEEeeCChhhCEEEEEEEEcCCCceEEEEEEE
Confidence 7889999999999999999999886431 123477777778999999999999999999999999999999999
Q ss_pred EeccC
Q psy10160 217 VEGIF 221 (558)
Q Consensus 217 V~~~~ 221 (558)
|.+..
T Consensus 81 V~~~~ 85 (90)
T cd05726 81 VTDVI 85 (90)
T ss_pred Eeecc
Confidence 98654
No 91
>PHA02785 IL-beta-binding protein; Provisional
Probab=99.55 E-value=1.4e-13 Score=136.26 Aligned_cols=190 Identities=12% Similarity=0.165 Sum_probs=114.6
Q ss_pred CceeEEecc-----CCCCCCcEEEEeCCcccCC------CC--------ceeeccccceeeceeEEeeccceeeEEeeec
Q psy10160 64 GTILSSAFP-----SESASPVVTQTTTTTTEAT------SP--------HVYAALTHCVPWSNVCLFGARSGYLKETQNG 124 (558)
Q Consensus 64 ~~~~~~~~~-----~~~p~p~v~W~~~~~~~~~------~~--------~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (558)
....+.|.. .+.|.|.++|++++..... .. ...+|.|.|.+. |..+.......+
T Consensus 42 e~~~l~C~~~~~~~~g~p~~~i~W~K~g~~~~~~~~~~~g~~l~i~~~~~~DsG~Y~C~a~-------N~~g~~~~s~~L 114 (326)
T PHA02785 42 EPVILPCPQINTLSSGYNILDILWEKRGADNDRIIPIDNGSNMLILNPTQSDSGIYICITK-------NETYCDMMSLNL 114 (326)
T ss_pred CCEEEECCCccccccCCCCceEEEEECCCccceEEEccCCceEEEcccCcccCeEEEEEEE-------CCCcceEEEEEE
Confidence 345567765 6788999999998643111 11 112455555544 443322222222
Q ss_pred eee--eCcEEEecCCceEeeCCCcEEEEeE-----eeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeE
Q psy10160 125 GYL--VPVKVNITLETQVFGVGSDISIPCD-----VDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGE 197 (558)
Q Consensus 125 ~~~--~p~~~~~~~~~~~v~~G~~v~L~C~-----~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~ 197 (558)
.+. .++.+...+.+..+.+|+.+.|.|. ..+.|.|.+.|+++.. + .+.++....++.|.|.+++.+|.|.
T Consensus 115 ~V~~~~~~~~~~~~~~~~~~~g~~~~i~C~~~~~~~~~~~~~~i~W~k~~~-~--~~~r~~~~~~~~L~i~~v~~~d~G~ 191 (326)
T PHA02785 115 TIVSVSESNIDLISYPQIVNERSTGEMVCPNINAFIASNVNADIIWSGHRR-L--RNKRLKQRTPGIITIEDVRKNDAGY 191 (326)
T ss_pred EEEecCCCccceeeccceecccCcEEEECCChhhcccCCCCceEEEccCCc-c--CCcceEecCCCeEEEeecChhhCeE
Confidence 221 1222222334455779999999997 3467999999988642 2 2336665567799999999999999
Q ss_pred EEEEEEeCCceee----EEEEEEEeccCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCCC---Cccccc
Q psy10160 198 YRCVASNSYTSDE----NAVTIRVEGIFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLP---SYGPHI 270 (558)
Q Consensus 198 Y~C~a~N~~G~~~----~~~~l~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~---~~~~w~ 270 (558)
|+|.|.|..|... ..+.|.|..+..+|.+. .| .. ... .. +......|.+.|.|+ +.+.|+
T Consensus 192 Y~C~~~n~~g~~~~~~t~~v~l~V~~~~~pp~~~-~p--~~-~~~------~~---G~~v~L~C~a~g~P~~~~~~v~W~ 258 (326)
T PHA02785 192 YTCVLKYIYGDKTYNVTRIVKLEVRDRIIPPTMQ-LP--EG-VVT------SI---GSNLTIACRVSLRPPTTDADVFWI 258 (326)
T ss_pred EEEEEEeccCCEEEeEEEEEEEEEeccCCCceec-CC--Cc-EEe------cC---CCcEEEEEEEECCCCCCCceEEEE
Confidence 9999999988764 34456665544444332 12 11 111 12 233345555657665 478999
Q ss_pred chhhhh
Q psy10160 271 KRAVEA 276 (558)
Q Consensus 271 ~~~l~~ 276 (558)
+|+...
T Consensus 259 kng~~i 264 (326)
T PHA02785 259 SNGMYY 264 (326)
T ss_pred ECCEEC
Confidence 997644
No 92
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.55 E-value=7.2e-14 Score=111.03 Aligned_cols=85 Identities=22% Similarity=0.414 Sum_probs=67.5
Q ss_pred cEEEecCCceEeeCC---CcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCC-CCCCeEEEEEEEeC
Q psy10160 130 VKVNITLETQVFGVG---SDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQAN-ATDSGEYRCVASNS 205 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G---~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~-~~D~G~Y~C~a~N~ 205 (558)
|.|...|....+.++ +.+.|.|.+.|+|.|.++|+|++..+.....++.+ .++.|.|.++. .+|+|.|+|.|.|.
T Consensus 2 P~f~~~P~~~~~~~~~~~~~v~l~C~a~G~P~P~i~W~k~~~~i~~~~~~~~~-~~g~L~I~~~~~~~D~G~Y~C~A~N~ 80 (93)
T cd05849 2 PVFEEQPIDTIYPEESTEGKVSVNCRARANPFPIYKWRKNNLDIDLTNDRYSM-VGGNLVINNPDKYKDAGRYVCIVSNI 80 (93)
T ss_pred CEEEECCCCEEecCCccCCeEEEeCcCccCCCCEEEEEECCEEccCCCCeEEE-ECCEEEECcCCcCCCCEEEEEEEEeC
Confidence 556666666666544 47999999999999999999999988654446654 46899999985 69999999999999
Q ss_pred Cceee-EEEEE
Q psy10160 206 YTSDE-NAVTI 215 (558)
Q Consensus 206 ~G~~~-~~~~l 215 (558)
.|... ..++|
T Consensus 81 ~G~~~s~~a~l 91 (93)
T cd05849 81 YGKVRSREATL 91 (93)
T ss_pred cceEEEccEEE
Confidence 99884 44444
No 93
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=99.54 E-value=9.1e-14 Score=110.94 Aligned_cols=84 Identities=24% Similarity=0.481 Sum_probs=65.6
Q ss_pred cEEEecCCceEee---CCCcEEEEeEeeccCCCeEEEEECCEEeccCC-ceEEEccCCeEEEccCC-CCCCeEEEEEEEe
Q psy10160 130 VKVNITLETQVFG---VGSDISIPCDVDGYPIPQVFWYKDGQVIENDG-VHYRITESNRLHINQAN-ATDSGEYRCVASN 204 (558)
Q Consensus 130 ~~~~~~~~~~~v~---~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~-~~~~~~~~~sL~I~~v~-~~D~G~Y~C~a~N 204 (558)
|.|...|.+..+. +|+.+.|.|.+.|.|.|.|.|+|+|..+.... .++. ..+++|.|.++. .+|+|.|+|.|.|
T Consensus 2 P~f~~~p~~~~~~~~~~g~~v~l~C~~~G~P~P~i~W~k~g~~l~~~~~~~~~-~~~g~L~i~~~~~~~D~G~Y~C~A~N 80 (94)
T cd05848 2 PVFVQEPDDAIFPTDSDEKKVILNCEARGNPVPTYRWLRNGTEIDTESDYRYS-LIDGNLIISNPSEVKDSGRYQCLATN 80 (94)
T ss_pred CeeEECCCcEEccCCCCCCEEEEEEEeeecCCCEEEEEECCeECccCCCceEE-eeCCeEEEccCCccCcCEEEEEEEEc
Confidence 4555566666553 47899999999999999999999999886433 2443 345789999985 6999999999999
Q ss_pred CCceee-EEEE
Q psy10160 205 SYTSDE-NAVT 214 (558)
Q Consensus 205 ~~G~~~-~~~~ 214 (558)
..|... ..+.
T Consensus 81 ~~G~~~S~~~~ 91 (94)
T cd05848 81 SIGSILSREAL 91 (94)
T ss_pred CCCeEEeccEE
Confidence 999884 3444
No 94
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=99.54 E-value=7.7e-14 Score=114.56 Aligned_cols=94 Identities=21% Similarity=0.303 Sum_probs=73.2
Q ss_pred eCcEEEecCCceEe----eCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEc--c-----CCeEEEccCC-CCCC
Q psy10160 128 VPVKVNITLETQVF----GVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRIT--E-----SNRLHINQAN-ATDS 195 (558)
Q Consensus 128 ~p~~~~~~~~~~~v----~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~--~-----~~sL~I~~v~-~~D~ 195 (558)
.+|.+...+....+ ..|+.+.|.|.+.|.|.|.+.|+|+|..+...+.++... . .++|.|.++. .+|.
T Consensus 3 ~~P~~~~~~~~~~~~~~~~~g~~v~L~C~a~G~P~p~i~W~k~g~~l~~~~~r~~~~~~~~~~~~~s~L~I~~v~~~~D~ 82 (109)
T cd05773 3 FAPDLQKGPQLRKVASRGDGSSDANLVCQAQGVPRVQFRWAKNGVPLDLGNPRYEETTEHTGTVHTSILTIINVSAALDY 82 (109)
T ss_pred cccccccCCceEEEEEecCCCCEEEEEEECcccCCCEEEEEECCEECCCCCCeEEEEeeccCccceeEEEECcCCccCCC
Confidence 35555555443232 246889999999999999999999999987544455422 1 2479999997 5999
Q ss_pred eEEEEEEEeCCceeeEEEEEEEeccC
Q psy10160 196 GEYRCVASNSYTSDENAVTIRVEGIF 221 (558)
Q Consensus 196 G~Y~C~a~N~~G~~~~~~~l~V~~~~ 221 (558)
|.|+|.|.|..|.....+.|.|.++|
T Consensus 83 G~Y~C~A~N~~G~~~~~i~L~~~~~p 108 (109)
T cd05773 83 ALFTCTAHNSLGEDSLDIQLVSTSRP 108 (109)
T ss_pred EEEEEEEEeCCccCcEEEEEEecCCC
Confidence 99999999999999999999996554
No 95
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.53 E-value=6.7e-14 Score=109.31 Aligned_cols=77 Identities=26% Similarity=0.420 Sum_probs=63.8
Q ss_pred CcEEEEeEeeccCCC--eEEEEECCEEeccC--CceEEE----ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 145 SDISIPCDVDGYPIP--QVFWYKDGQVIEND--GVHYRI----TESNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 145 ~~v~L~C~~~g~P~p--~i~W~~~g~~l~~~--~~~~~~----~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
+.++|.|.+.|.|.| .+.|+++|..+... ..++.. ...++|.|.+++.+|+|.|+|.|.|..|..++++.|.
T Consensus 1 ~~~~L~C~a~g~P~p~~~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~~~~L~ 80 (85)
T cd05854 1 ENLTLQCHASHDPTMDLTFTWSLDDFPIDLDKPNGHYRRMEVKETIGDLVIVNAQLSHAGTYTCTAQTVVDSASASATLV 80 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEccccCCCCcEEEEEecceEeEEEEccCChhhCeEEEEEEecCCCCEEEEEEEE
Confidence 468999999999998 47999999988643 223321 1346899999999999999999999999999999999
Q ss_pred EeccC
Q psy10160 217 VEGIF 221 (558)
Q Consensus 217 V~~~~ 221 (558)
|.++|
T Consensus 81 V~~~P 85 (85)
T cd05854 81 VRGPP 85 (85)
T ss_pred EECCC
Confidence 98653
No 96
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=99.53 E-value=9.4e-14 Score=110.43 Aligned_cols=81 Identities=31% Similarity=0.575 Sum_probs=68.7
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEE--ccC--CeEEEccCCCCCCeEEEEEEEeCCceeeE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRI--TES--NRLHINQANATDSGEYRCVASNSYTSDEN 211 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~--~~~--~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~ 211 (558)
|....+.+|+.+.|.|.+.|.|.|.+.|+|++..+..+. ++.+ ..+ .+|.|.+++.+|+|.|+|.|.|..|....
T Consensus 8 p~~v~v~eG~~v~L~C~v~g~P~p~i~W~k~~~~~~~~~-~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 86 (92)
T cd05891 8 PDVVTIMEGKTLNLTCTVFGNPDPEVIWFKNDQDIELSE-HYSVKLEQGKYASLTIKGVTSEDSGKYSINVKNKYGGETV 86 (92)
T ss_pred CCcEEEcCCCEEEEEEEEEEeCCCeEEEEECCEECCCCC-CEEEEEcCCCEEEEEECCCChhhCEEEEEEEEeCCCceee
Confidence 456778999999999999999999999999999886654 3332 222 37999999999999999999999999999
Q ss_pred EEEEEE
Q psy10160 212 AVTIRV 217 (558)
Q Consensus 212 ~~~l~V 217 (558)
++.|.|
T Consensus 87 ~~~v~~ 92 (92)
T cd05891 87 DVTVSV 92 (92)
T ss_pred EEEEEC
Confidence 888865
No 97
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.53 E-value=1.5e-13 Score=109.75 Aligned_cols=85 Identities=21% Similarity=0.401 Sum_probs=67.3
Q ss_pred cEEEecCCceEeeCC---CcEEEEeEeeccCCCeEEEEECCEEeccC-CceEEEccCCeEEEccCC-CCCCeEEEEEEEe
Q psy10160 130 VKVNITLETQVFGVG---SDISIPCDVDGYPIPQVFWYKDGQVIEND-GVHYRITESNRLHINQAN-ATDSGEYRCVASN 204 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G---~~v~L~C~~~g~P~p~i~W~~~g~~l~~~-~~~~~~~~~~sL~I~~v~-~~D~G~Y~C~a~N 204 (558)
|.|...|.+..+.+| +.+.|.|.+.|+|.|.++|+++|..+... +.++.+ .+++|.|.++. .+|+|.|+|.|+|
T Consensus 2 P~f~~~P~~~~~~~~~~g~~v~l~C~a~g~P~p~i~W~~~g~~l~~~~~~~~~~-~~g~L~I~~~~~~~D~G~Y~C~A~N 80 (94)
T cd05850 2 PVFEEQPSSLLFPEGSPEEKVTLGCRARASPPATYRWKMNGTEIKFAPESRYTL-VAGNLVINNPQKARDAGSYQCLAIN 80 (94)
T ss_pred CeeEECCCCEEecCCCCCCeEEEEeEceeCCCCEEEEEECCEECccCCCceEEE-ECCeEEEccCCccCcCEEEEEEEEc
Confidence 455667777777665 57999999999999999999999998643 335554 46789998865 5999999999999
Q ss_pred CCceee-EEEEE
Q psy10160 205 SYTSDE-NAVTI 215 (558)
Q Consensus 205 ~~G~~~-~~~~l 215 (558)
..|... ..+.|
T Consensus 81 ~~G~~~s~~a~l 92 (94)
T cd05850 81 RCGTVVSREANL 92 (94)
T ss_pred CcCcEEEEEEEE
Confidence 999884 45544
No 98
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=99.53 E-value=9e-14 Score=109.20 Aligned_cols=79 Identities=23% Similarity=0.542 Sum_probs=66.6
Q ss_pred eEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCc--eEEE-ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEE
Q psy10160 139 QVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGV--HYRI-TESNRLHINQANATDSGEYRCVASNSYTSDENAVTI 215 (558)
Q Consensus 139 ~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~--~~~~-~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 215 (558)
..+.+|+.+.|.|.+.|.|.|.+.|+|+|..+..+.. .+.. ....+|.|.++..+|+|.|+|.|.|..|....++.|
T Consensus 4 ~~v~~G~~~~L~C~~~g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~~~l~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 83 (85)
T cd05857 4 HAVPAANTVKFRCPAAGNPTPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHL 83 (85)
T ss_pred EEcCCCCEEEEEEEcCCCCCCEEEEEECCEECCCCCceeeeEEeCCceEEEEccCCcccCEEEEEEEEeCCCEEEEEEEE
Confidence 4577899999999999999999999999998875432 1222 234579999999999999999999999999999888
Q ss_pred EE
Q psy10160 216 RV 217 (558)
Q Consensus 216 ~V 217 (558)
.|
T Consensus 84 ~v 85 (85)
T cd05857 84 DV 85 (85)
T ss_pred EC
Confidence 75
No 99
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.53 E-value=1e-13 Score=109.45 Aligned_cols=84 Identities=30% Similarity=0.538 Sum_probs=69.1
Q ss_pred EEecCCceEeeCCCcEEEEeEeeccCCCeEEEEEC-CEEeccCCceEEEccCC---eEEEccCCCCCCeEEEEEEEeCCc
Q psy10160 132 VNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKD-GQVIENDGVHYRITESN---RLHINQANATDSGEYRCVASNSYT 207 (558)
Q Consensus 132 ~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~-g~~l~~~~~~~~~~~~~---sL~I~~v~~~D~G~Y~C~a~N~~G 207 (558)
+.+.+.+..+.+|+.+.|.|.+.|.|. .+.|+++ +..+..+ .++.+..++ +|.|.++..+|+|.|+|.|.|..|
T Consensus 3 ~~~~~~~~~v~~G~~v~l~C~~~G~P~-~v~W~k~~g~~~~~~-~r~~~~~~g~~~~L~I~~v~~~D~G~Y~C~A~N~~G 80 (92)
T cd05866 3 VSISLSKVELSVGESKFFTCTAIGEPE-SIDWYNPQGEKIVSS-QRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKG 80 (92)
T ss_pred EEEEecceEEcCCCeEEEEEEEEEeCC-eEEEEeCCCeEecCC-CCEEEEeCCCeeEEEEecCChHHCEEEEEEEEcCCC
Confidence 345667788999999999999999998 8999984 6666543 466665554 899999999999999999999999
Q ss_pred ee-eEEEEEEE
Q psy10160 208 SD-ENAVTIRV 217 (558)
Q Consensus 208 ~~-~~~~~l~V 217 (558)
.. .+++.|.|
T Consensus 81 ~~~~~~i~l~~ 91 (92)
T cd05866 81 QTQEATVVLEI 91 (92)
T ss_pred cEEEEEEEEEE
Confidence 87 57777765
No 100
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.52 E-value=7.4e-14 Score=109.52 Aligned_cols=77 Identities=25% Similarity=0.403 Sum_probs=63.9
Q ss_pred CcEEEEeEeeccCCC--eEEEEECCEEeccCC--ceE----EEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 145 SDISIPCDVDGYPIP--QVFWYKDGQVIENDG--VHY----RITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 145 ~~v~L~C~~~g~P~p--~i~W~~~g~~l~~~~--~~~----~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
+.+.|.|.+.|.|.| .+.|+|+|..+.... .++ ....+++|.|.+++.+|+|.|+|.|.|..|..+.++.|.
T Consensus 1 e~~~L~C~~~g~P~p~i~~~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~~~~l~ 80 (85)
T cd04970 1 ESITLQCHASHDPTLDLTFTWSFNGVPIDFDKDGGHYRRVGGKDSNGDLMIRNAQLKHAGKYTCTAQTVVDSLSASADLI 80 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEeeccCCCccEEEEecccccceEEEccCCHHhCeeeEEEEecCCCcEEEEEEEE
Confidence 468999999999988 568999999886432 122 223457899999999999999999999999999999999
Q ss_pred EeccC
Q psy10160 217 VEGIF 221 (558)
Q Consensus 217 V~~~~ 221 (558)
|.++|
T Consensus 81 V~~pP 85 (85)
T cd04970 81 VRGPP 85 (85)
T ss_pred EECCC
Confidence 98753
No 101
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=99.52 E-value=1e-13 Score=106.29 Aligned_cols=72 Identities=28% Similarity=0.638 Sum_probs=59.8
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc-CCeEEEccCCCCCCeEEEEEEEeCCceee--EEEEEEEe
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE-SNRLHINQANATDSGEYRCVASNSYTSDE--NAVTIRVE 218 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~-~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~--~~~~l~V~ 218 (558)
++|.|.+.|.|.|.+.|+|+|.++.....++.+.. .++|.|.+++.+|+|.|.|.|.|..|... ..++|.|.
T Consensus 1 v~L~C~~~g~P~p~v~W~k~g~~l~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~~l~v~ 75 (77)
T cd05760 1 VTLRCHIDGHPRPTYQWFRDGTPLSDGQGNYSVSSKERTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQNFTLSII 75 (77)
T ss_pred CEEEEEeeecCCCcEEEEECCEECCCCCccEEEeCCCCEEEEeeCCcccCEEEEEEEEeCCCeEeeCceEEEEEe
Confidence 57999999999999999999999876544544433 45899999999999999999999999874 56666663
No 102
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.52 E-value=8.6e-14 Score=106.06 Aligned_cols=73 Identities=26% Similarity=0.597 Sum_probs=62.9
Q ss_pred CCcEEEEeEeeccCCCeEEEEE-CCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYK-DGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~-~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
|+.+.|.|.+.|.|.|.+.|++ ++..+... .++....+++|.|.++..+|+|.|+|.|.|..|..+..+.|.|
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~~~~~~~~~~~-~~~~~~~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 74 (74)
T cd05764 1 GQRATLRCKARGDPEPAIHWISPDGKLISNS-SRTLVYDNGTLDILITTVKDTGSFTCIASNAAGEATATVELHI 74 (74)
T ss_pred CCeEEEEEEccCcCCCEEEEEeCCCEEecCC-CeEEEecCCEEEEEECChhhCEEEEEEEECCCCeEEEEEEEEC
Confidence 7889999999999999999997 56555443 4566667789999999999999999999999999988888765
No 103
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=99.52 E-value=1.3e-13 Score=111.10 Aligned_cols=88 Identities=25% Similarity=0.485 Sum_probs=70.6
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccC----CceEEEccC---CeEEEccCCCCCCeEEEEE
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIEND----GVHYRITES---NRLHINQANATDSGEYRCV 201 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~----~~~~~~~~~---~sL~I~~v~~~D~G~Y~C~ 201 (558)
+|++. .+.+..+.+|+.+.|.|.+.|.|.|.+.|++++..+... ..++.+... ++|.|.+++.+|+|.|+|.
T Consensus 2 ~P~i~-~~~~~~~~~g~~v~l~C~~~g~p~p~v~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 80 (96)
T cd05732 2 QPKIT-YLENQTAVELEQITLTCEAEGDPIPEITWRRATRNFSEGDKSLDGRIVVRGHARVSSLTLKDVQLTDAGRYDCE 80 (96)
T ss_pred Cccce-ecCceeEecCCcEEEEEEEeEcCCCcEEEEECCcccCCCCccccceEEEeCCccEEEEEECcCCcCcCEEeEEE
Confidence 34443 345677889999999999999999999999998666532 124444332 4799999999999999999
Q ss_pred EEeCCceeeEEEEEEE
Q psy10160 202 ASNSYTSDENAVTIRV 217 (558)
Q Consensus 202 a~N~~G~~~~~~~l~V 217 (558)
|.|..|..+.++.|.|
T Consensus 81 a~N~~G~~~~s~~l~v 96 (96)
T cd05732 81 ASNRIGGDQQSMYLEV 96 (96)
T ss_pred EEeCCCCcEEEEEEeC
Confidence 9999999998888865
No 104
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.51 E-value=6.1e-14 Score=105.24 Aligned_cols=69 Identities=29% Similarity=0.603 Sum_probs=60.4
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|.|.|.+.|+|++..++.. ++....+++|.|.+++.+|+|.|+|.|.|..|.....+.|.|
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~--~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 69 (69)
T cd05725 1 VEFQCEVGGDPVPTVLWRKEDGELPKG--RAEILDDKSLKIRNVTAGDEGSYTCEAENMVGKIEASASLTV 69 (69)
T ss_pred CEEEEECccCCCCEEEEEECCccCCCC--cEEEeeCCEEEECcCChhHCEEEEEEEEcCCCcEEEEEEEEC
Confidence 479999999999999999998776543 555557789999999999999999999999999998888765
No 105
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=99.51 E-value=1.4e-13 Score=104.89 Aligned_cols=71 Identities=28% Similarity=0.552 Sum_probs=60.8
Q ss_pred cEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc---CCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 146 DISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE---SNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 146 ~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
.+.|.|.+.|.|.|.+.|+|+|..+..+. ++.+.. .++|.|.++..+|+|.|+|.|.|..|..+.++.|.|
T Consensus 1 ~~~l~c~~~G~P~p~v~W~k~g~~l~~~~-~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 74 (74)
T cd05748 1 SVRLEVPISGRPTPTVTWSKDGKPLKLSG-RVQIETTASSTSLVIKNAERSDSGKYTLTLKNPAGEKSATINVKV 74 (74)
T ss_pred CEEEEeeEeeeCCCeEEEEECCEEcCCCC-eEEEEECCCeEEEEECCCCcCcCEEEEEEEECCCccEEEEEEEEC
Confidence 37899999999999999999999986543 444432 347999999999999999999999999999888875
No 106
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=99.51 E-value=1e-13 Score=104.37 Aligned_cols=69 Identities=28% Similarity=0.635 Sum_probs=60.2
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|.|.|.+.|+|+|..+..+. ++. ..+++|.|.+++.+|+|.|+|.|.|..|....++.+.|
T Consensus 1 ~~l~c~v~g~P~p~v~W~k~g~~l~~~~-~~~-~~~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~~~ 69 (71)
T cd04976 1 VRLPVKVKAYPPPEIQWYKNGKLISEKN-RTK-KSGHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTFTL 69 (71)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCC-EEE-cCCCEEEECcCCHHHCEEEEEEEEcCCccEEEEEEEEE
Confidence 4699999999999999999999987653 443 45678999999999999999999999999888877776
No 107
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.51 E-value=7.8e-14 Score=104.05 Aligned_cols=68 Identities=34% Similarity=0.634 Sum_probs=57.4
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|+|.|.+.|+|+|.++.... + ...+++|.|.++..+|+|.|+|.|.|..|..+...++.+
T Consensus 1 ~~~~c~v~G~P~P~v~W~k~g~~l~~~~-~--~~~~~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~~l 68 (70)
T cd05864 1 VKIPVKYYGYPPPEVKWYKNGQLIVLNH-T--FKRGVHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTFQL 68 (70)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCC-E--EccCCEEEECcCCHHHCEEEEEEEEECCCceeeEEEEEE
Confidence 3689999999999999999999987542 3 234568999999999999999999999998876666554
No 108
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=99.51 E-value=1.1e-13 Score=105.21 Aligned_cols=71 Identities=27% Similarity=0.561 Sum_probs=61.5
Q ss_pred EEEEeEeeccCCCeEEEEECCEEecc-CCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee-eEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIEN-DGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD-ENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~-~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~l~V 217 (558)
++|.|.+.|.|.|.|.|+|++..+.. .+.++....+++|.|.+++.+|+|.|+|.|.|..|.. +..+.|.|
T Consensus 1 a~l~C~~~G~P~p~v~W~k~~~~~~~~~~~~~~~~~~g~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~~a~l~v 73 (74)
T cd05738 1 ATMLCAASGNPDPEITWFKDFLPVDTTSNGRIKQLRSGALQIENSEESDQGKYECVATNSAGTRYSAPANLYV 73 (74)
T ss_pred CEEEEEEeEecCCEEEEEECCEECccCCCCCEEEcCCcEEEECCCChhhCEEEEEEEECCCCceEcccEEEEE
Confidence 47999999999999999999998863 2346777778899999999999999999999999986 67777776
No 109
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.49 E-value=2.5e-13 Score=109.00 Aligned_cols=86 Identities=26% Similarity=0.403 Sum_probs=70.3
Q ss_pred EEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCC-ceEEEccCCeEEEccC-----CCCCCeEEEEEEEeC
Q psy10160 132 VNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDG-VHYRITESNRLHINQA-----NATDSGEYRCVASNS 205 (558)
Q Consensus 132 ~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~-~~~~~~~~~sL~I~~v-----~~~D~G~Y~C~a~N~ 205 (558)
|...|.+..+.+|+++.|.|.+.|.|.|.+.|+|+|..+.... .++....+++|.|.++ +.+|.|.|+|.|.|.
T Consensus 2 f~~~P~~~~~~~g~~v~l~C~v~g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~l~i~~v~~~~~~~~D~G~Y~C~a~N~ 81 (95)
T cd05722 2 FLSEPSDIVAVRGGPVVLNCSAEGEPPPKIEWKKDGVLLNLVSDERRQQLPNGSLLITSVVHSKHNKPDEGFYQCVAQND 81 (95)
T ss_pred cEECCCCeEEcCCCCEEEeeecccCCCCEEEEEECCeECccccCcceEEccCCeEEEeeeeccCCCCCcCEEEEEEEECC
Confidence 3456677888899999999999999999999999999887543 2355556778888877 689999999999999
Q ss_pred -Ccee-eEEEEEEE
Q psy10160 206 -YTSD-ENAVTIRV 217 (558)
Q Consensus 206 -~G~~-~~~~~l~V 217 (558)
.|.. +..++|.|
T Consensus 82 ~~G~~~s~~~~l~v 95 (95)
T cd05722 82 SLGSIVSRTARLTV 95 (95)
T ss_pred ccCcEEEeeeEEeC
Confidence 9987 56676654
No 110
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=99.49 E-value=1.3e-13 Score=107.50 Aligned_cols=78 Identities=24% Similarity=0.447 Sum_probs=64.6
Q ss_pred EeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 140 VFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 140 ~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
....|+.+.|.|.+.|.|.|.+.|+|++..+.............+|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 5 ~~~~G~~v~L~C~~~g~p~p~i~W~k~~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~v~v 82 (82)
T cd05856 5 ARPVGSSVRLKCVASGNPRPDITWLKDNKPLTPTEIGESRKKKWTLSLKNLKPEDSGKYTCHVSNRAGEINATYKVDV 82 (82)
T ss_pred eccCCCeEEEEEEeeEeCCCcEEEEECCcCCcCCccceecCceEEEEEccCChhhCEEEEEEEEcCCccEEEEEEEeC
Confidence 356799999999999999999999999988765432222223358999999999999999999999999988888765
No 111
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=99.49 E-value=3e-13 Score=107.00 Aligned_cols=79 Identities=19% Similarity=0.506 Sum_probs=66.8
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEc-cCCeEEEccCCCCCCeEEEEEEEeCCcee-eEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRIT-ESNRLHINQANATDSGEYRCVASNSYTSD-ENAV 213 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~-~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~ 213 (558)
+..+.+.+|+.+.|.|.+.|. .|.+.|+|++..+... ++.+. .+++|.|.+++++|+|.|.|.|.|..|.. +..+
T Consensus 10 ~~~~~v~~g~~v~l~C~a~g~-~p~i~W~kng~~l~~~--~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~S~~~ 86 (91)
T cd05740 10 VGNQPPEDNQPVTLTCEAEGQ-ATYIWWVNNGSLLVPP--RLQLSNDNRTLTFNNVTRSDTGHYQCEASNEVSNMTSDPY 86 (91)
T ss_pred cCccccccCCcEEEEEEeCCC-CCEEEEEECCEECCCC--CEEEeCCCCEEEECcCChhhCEEEEEEEEcCCCCEEeeeE
Confidence 446678999999999999999 9999999999887643 34443 34689999999999999999999999986 5677
Q ss_pred EEEE
Q psy10160 214 TIRV 217 (558)
Q Consensus 214 ~l~V 217 (558)
.|.|
T Consensus 87 ~L~V 90 (91)
T cd05740 87 ILNV 90 (91)
T ss_pred EEEe
Confidence 7777
No 112
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=99.49 E-value=1.6e-13 Score=103.72 Aligned_cols=70 Identities=31% Similarity=0.596 Sum_probs=59.4
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|.|.|.+.|+|++..+.... ......+++|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~~-~~~~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05731 1 LLLECIAEGLPTPEISWIKIGGELPADR-TKFENFNKTLKIDNVSEEDDGEYRCTASNSLGSARHTISVTV 70 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCeECCCCc-eeEecCCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEEEEE
Confidence 4799999999999999999998775432 222234568999999999999999999999999999998887
No 113
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=99.49 E-value=2.4e-13 Score=104.81 Aligned_cols=79 Identities=28% Similarity=0.495 Sum_probs=66.8
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTI 215 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 215 (558)
|....+.+|+.+.|.|.+.|. .|.+.|+|+|.++..+. ++.+. +++|.|.+++.+|+|.|+|.|.|..|.....+.|
T Consensus 1 ~~~~~~~~G~~v~l~C~~~~~-~~~v~W~k~g~~l~~~~-~~~~~-~~~L~I~~~~~~DsG~Y~C~a~n~~g~~~~~~~v 77 (79)
T cd04973 1 VESYSAHPGDLLQLRCRLRDD-VQSINWTKDGVQLGENN-RTRIT-GEEVQIKDAVPRDSGLYACVTSSPSGSDTTYFSV 77 (79)
T ss_pred CCcEEecCCCCEEEEEEecCC-CceEEEeeCCcCCCCCc-eEEEe-CCEEEECCCChhhCEEEEEEEeCCCCcccEEEEE
Confidence 345678899999999999996 57899999999987644 56553 4689999999999999999999999998877776
Q ss_pred EE
Q psy10160 216 RV 217 (558)
Q Consensus 216 ~V 217 (558)
+|
T Consensus 78 ~V 79 (79)
T cd04973 78 NV 79 (79)
T ss_pred eC
Confidence 64
No 114
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=99.48 E-value=3.3e-13 Score=100.72 Aligned_cols=68 Identities=26% Similarity=0.541 Sum_probs=56.8
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTI 215 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 215 (558)
|+.+.|.|.+.|.|.|.|.|+|++..+.... ++. .....|.|.+++ |+|.|+|.|.|..|....++.|
T Consensus 1 G~~v~L~C~a~G~P~P~v~W~k~g~~l~~~~-~~~-~~~~~L~i~~~~--d~G~Y~C~A~N~~G~~~~~a~l 68 (69)
T cd05739 1 GGSVNLTCVAVGAPMPYVKWMKGGEELTKED-EMP-VGRNVLELTNIY--ESANYTCVAISSLGMIEATAQV 68 (69)
T ss_pred CCeEEEEEEeeecCCCEEEEEECCEECCCcc-cee-cCccEEEEeccc--cCeeEEEEEEeCCCEEEEEEEE
Confidence 6889999999999999999999999876543 333 234579999874 8999999999999998887765
No 115
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.47 E-value=2.7e-13 Score=103.58 Aligned_cols=71 Identities=28% Similarity=0.487 Sum_probs=58.5
Q ss_pred EEEEeEeeccCCCeEEEEECCEEec-c-CCceEEEc-cCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIE-N-DGVHYRIT-ESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~-~-~~~~~~~~-~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+.|.|.+.|.|.|.++|+|++.... . ...++.+. .++.|.|.+++.+|+|.|+|.|.|..|..+..+.|.|
T Consensus 1 a~l~C~~~G~P~P~v~W~k~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~l~V 74 (75)
T cd05763 1 ARLECAATGHPTPQIAWQKDGGTDFPAARERRMHVMPEDDVFFIVDVKIEDTGVYSCTAQNTAGSISANATLTV 74 (75)
T ss_pred CEeEeecccccCCEEEEEeCCCccCCcccccceEEecCCCEEEEeeCCcccCEEEEEEEEcCCCEEEeeEEEEE
Confidence 4799999999999999999986432 1 12244433 3568999999999999999999999999999999887
No 116
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=99.47 E-value=2.9e-13 Score=104.13 Aligned_cols=72 Identities=22% Similarity=0.369 Sum_probs=60.0
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEcc---CCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITE---SNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
|+.+.|.|.+.|.|.|.+.|++++..+.... ++.+.. .++|.|.+++.+|+|.|+|.|.|..|.......+.
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~~~~~~~~~~~-~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~~~ 75 (78)
T cd05743 1 GETVEFTCVATGVPTPIINWRLNWGHVPDSA-RVSITSEGGYGTLTIRDVKESDQGAYTCEAINTRGMVFGIPDGI 75 (78)
T ss_pred CCEEEEEEEEEEecCCEEEEEECCeECCCCC-CEEEEECCCEEEEEECCCChHHCEEEEEEEEecCCEEEecccEE
Confidence 7889999999999999999999998886543 444332 24799999999999999999999999987655443
No 117
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=99.47 E-value=5.6e-13 Score=107.58 Aligned_cols=86 Identities=21% Similarity=0.390 Sum_probs=69.8
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCC-eEEEEECCEEeccC-CceEEEccC-------CeEEEccCCCC-CCeEE
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIP-QVFWYKDGQVIEND-GVHYRITES-------NRLHINQANAT-DSGEY 198 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p-~i~W~~~g~~l~~~-~~~~~~~~~-------~sL~I~~v~~~-D~G~Y 198 (558)
||.+. .+....+.+|+.+.|.|.+.|.|.| .+.|++++..+... +.++.+... ++|.|.+++.+ |.|.|
T Consensus 2 pp~i~-~~~~~~~~~G~~v~L~C~~~g~P~P~~v~W~~~~~~i~~~~~~r~~i~~~~~~~~~~s~L~I~~v~~~d~~G~Y 80 (98)
T cd05758 2 PPIIT-SEATQYAILGDKGRVECFIFSTPPPDRIVWTWKENELESGSSGRYTVETDPSPGGVLSTLTISNTQESDFQTSY 80 (98)
T ss_pred CCeEc-CCCcEEEeCCCcEEEEEEEcccCCCCEeEEEECCEEccCCCCCCEEEEEecCCCceEEEEEECCccccccceeE
Confidence 55554 3456678999999999999999999 59999999988653 246665443 37999999984 48999
Q ss_pred EEEEEeCCceeeEEEEE
Q psy10160 199 RCVASNSYTSDENAVTI 215 (558)
Q Consensus 199 ~C~a~N~~G~~~~~~~l 215 (558)
+|.|.|..|.....+.|
T Consensus 81 ~C~A~N~~G~~~~~~~L 97 (98)
T cd05758 81 NCTAWNSFGSGTAIISL 97 (98)
T ss_pred EEEEEcCCCcccEEEEe
Confidence 99999999998887765
No 118
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=99.47 E-value=2.6e-13 Score=103.17 Aligned_cols=67 Identities=28% Similarity=0.576 Sum_probs=56.0
Q ss_pred EEeEeeccCCCeEEEEECCEEeccCCceEE--E------ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 149 IPCDVDGYPIPQVFWYKDGQVIENDGVHYR--I------TESNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 149 L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~--~------~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
+.|.+.|+|.|.++|+|+|.++..+. +.. + ...++|.|.++..+|+|.|+|.|+|..|+...++.+.
T Consensus 3 i~~~v~G~P~Pti~W~kng~~l~~~~-~~~~~~~~~~~~~~~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 77 (79)
T cd05855 3 IPFTVKGNPKPTLQWFHEGAILNESE-YICTKIHVINNTEYHGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVSAH 77 (79)
T ss_pred EEEEEeEeCCCceEEEECCEECCCCc-ceeeeeEeecccceEEEEEECCCCcccCEEEEEEEEcCCcccceEEEee
Confidence 78999999999999999999997654 221 1 1235799999999999999999999999998887764
No 119
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=99.45 E-value=4.2e-13 Score=106.31 Aligned_cols=74 Identities=31% Similarity=0.575 Sum_probs=58.4
Q ss_pred CCcEEEEeEeeccCCCeEEEEECC----EEeccCCceE-EE----------ccCCeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDG----QVIENDGVHY-RI----------TESNRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g----~~l~~~~~~~-~~----------~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
|+.+.|.|.+.|.|.|.|+|+|++ ..+...+..+ .. .....|.|.+++.+|+|.|+|.|.|..|.
T Consensus 1 G~~v~l~C~v~g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 80 (90)
T cd04974 1 GSDVEFHCKVYSDAQPHIQWLKHVEVNGSKYGPDGLPYVTVLKVAGINTTDNESEVLYLRNVSFDDAGEYTCLAGNSIGP 80 (90)
T ss_pred CCcEEEEEEEeCCCCCeEEEEEecccCCceeCCCCCceEEEEEecCCcccccccceEEEeccccccCcEEEEEeecccCc
Confidence 688999999999999999999953 3332222111 11 11247999999999999999999999999
Q ss_pred eeEEEEEEE
Q psy10160 209 DENAVTIRV 217 (558)
Q Consensus 209 ~~~~~~l~V 217 (558)
...++.|.|
T Consensus 81 ~~~sa~L~V 89 (90)
T cd04974 81 SHHSAWLTV 89 (90)
T ss_pred ccCCEEEEe
Confidence 999999987
No 120
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=99.44 E-value=7e-13 Score=101.95 Aligned_cols=76 Identities=16% Similarity=0.409 Sum_probs=61.1
Q ss_pred EecCCceEeeCCCcEEEEeEeeccCCC-eEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceee-
Q psy10160 133 NITLETQVFGVGSDISIPCDVDGYPIP-QVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDE- 210 (558)
Q Consensus 133 ~~~~~~~~v~~G~~v~L~C~~~g~P~p-~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~- 210 (558)
...|.+..+.+|+.+.|+|.+.|+|.| .|.|+|+|.++... +. ...+.|.|.++ .|+|.|.|.|+|..|...
T Consensus 2 ~~~P~~~~v~~G~~v~l~C~a~G~P~P~~I~W~k~g~~l~~~---~~-~~~s~L~i~~~--~d~g~Y~C~A~N~~G~~~s 75 (81)
T cd05749 2 TVEPEDLSVTANTPFNLTCQAVGPPEPVEILWWQGGSPLGDP---PA-PSPSVLNVPGL--NETSKFSCEAHNAKGVTTS 75 (81)
T ss_pred cCCCCceEEcCCCCEEEEEEeeeecCCeEEEEEECCEECCCC---CC-CCCCEEEEccc--cCCeEEEEEEEeccCcEEe
Confidence 345677889999999999999999999 79999999988641 11 23457999887 588999999999999764
Q ss_pred EEEE
Q psy10160 211 NAVT 214 (558)
Q Consensus 211 ~~~~ 214 (558)
..++
T Consensus 76 ~~a~ 79 (81)
T cd05749 76 RTGT 79 (81)
T ss_pred eeEE
Confidence 3444
No 121
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=99.44 E-value=7e-13 Score=102.21 Aligned_cols=68 Identities=29% Similarity=0.599 Sum_probs=56.3
Q ss_pred EEeEeeccCCCeEEEEECCEEeccCCceE-EE--------ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 149 IPCDVDGYPIPQVFWYKDGQVIENDGVHY-RI--------TESNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 149 L~C~~~g~P~p~i~W~~~g~~l~~~~~~~-~~--------~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
|.|.+.|+|.|.++|+|+|..+..+.... .. ...+.|.|.+++.+|+|.|+|.|.|..|..+.++.+.
T Consensus 3 i~~~v~G~P~P~v~W~k~g~~i~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 79 (81)
T cd04971 3 IPFTVRGNPKPTLTWYHNGAVLNESDYIRTEIHYEVTTPTEYHGCLQFDNPTHVNNGNYTLVASNEYGQDSKSISAH 79 (81)
T ss_pred EEEEeEeeCCCcEEEEECCEECcCCCceeEEEEeecccccccEEEEEECCCCcccCeEEEEEEEeCCCCeeeEEEee
Confidence 68999999999999999999997654211 11 1134799999999999999999999999999887765
No 122
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.43 E-value=7.5e-13 Score=98.87 Aligned_cols=68 Identities=24% Similarity=0.427 Sum_probs=56.1
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTI 215 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 215 (558)
+.|.|.+.|.|.|.+.|+|++.++..+..++.. .+++|.|.+++.+|+|.|+|.|.|..........+
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~~~~~~~-~~~~L~I~~v~~~D~G~YtC~a~~~~~~~~~~~~i 68 (72)
T cd07702 1 YRLTPKVKAFPAPEVIWLKDGLPAAEKCSRYHV-DGYSLVIKDVTEEDAGIYTILLGIKQYNLFKNLTI 68 (72)
T ss_pred CeEEeeEEEcCCCeEEEEECCEECCCCCcEEEe-CCCEEEECcCCHHHCEEEEEEEEccccceEeeEEE
Confidence 468999999999999999999998765445554 34589999999999999999999987666544433
No 123
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=99.42 E-value=8.4e-13 Score=104.67 Aligned_cols=74 Identities=27% Similarity=0.503 Sum_probs=58.7
Q ss_pred CCcEEEEeEeeccCCCeEEEEEC----CEEeccCCc-eEEEcc----------CCeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKD----GQVIENDGV-HYRITE----------SNRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~----g~~l~~~~~-~~~~~~----------~~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
|+.+.|.|.+.|.|.|.|.|+|+ +..+..++. ...+.. .++|.|.+++.+|+|.|+|.|.|..|.
T Consensus 1 G~~v~L~C~~~g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 80 (90)
T cd05858 1 GSTVEFVCKVYSDAQPHIQWLKHVEKNGSKYGPDGLPYVTVLKTAGVNTTDKEMEVLYLRNVTFEDAGEYTCLAGNSIGI 80 (90)
T ss_pred CCeEEEEEEEecCCCCEEEEEEecccCCcEeCCCCCeeEEEeccCCceecCCceeEEEEccCCHHHCEEEEEEEEeCCCc
Confidence 68899999999999999999984 444433221 111111 147999999999999999999999999
Q ss_pred eeEEEEEEE
Q psy10160 209 DENAVTIRV 217 (558)
Q Consensus 209 ~~~~~~l~V 217 (558)
...++.|.|
T Consensus 81 ~~~~a~L~V 89 (90)
T cd05858 81 SHHSAWLTV 89 (90)
T ss_pred ccceEEEEE
Confidence 999999887
No 124
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=99.42 E-value=2.1e-12 Score=102.62 Aligned_cols=85 Identities=26% Similarity=0.517 Sum_probs=64.6
Q ss_pred EEecCCceEeeCCCcEEEEeEeeccCCCeEEEEE-CCEEeccCCceEEEccC---CeEEEccCCCCCCeEEEEEEEeCCc
Q psy10160 132 VNITLETQVFGVGSDISIPCDVDGYPIPQVFWYK-DGQVIENDGVHYRITES---NRLHINQANATDSGEYRCVASNSYT 207 (558)
Q Consensus 132 ~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~-~g~~l~~~~~~~~~~~~---~sL~I~~v~~~D~G~Y~C~a~N~~G 207 (558)
+.+.|....+..|+.+.|.|.+.|.| |.+.|++ ++..+...+........ ++|+|.+++.+|+|.|+|.|.|..|
T Consensus 3 v~v~p~~~~v~~G~~~~l~C~~~G~p-~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~g 81 (92)
T cd04977 3 VDIVPSQGEISVGESKFFLCQVIGEP-KDISWFSPNGEKLVTQQQISVVQNDDVRSTLTIYNANIEDAGIYKCVATDAKG 81 (92)
T ss_pred EEEecCcEEECCCCeEEEEEEeEeeC-CeEEEECCCCCEeccCCCEEEEeCCCCEEEEEEecCCcccCEEEEEEEEcCCC
Confidence 34567778899999999999999997 5999998 56555543322222222 3799999999999999999999975
Q ss_pred e-eeEEEEEEE
Q psy10160 208 S-DENAVTIRV 217 (558)
Q Consensus 208 ~-~~~~~~l~V 217 (558)
. ...++.|.|
T Consensus 82 ~~~~~sv~l~~ 92 (92)
T cd04977 82 TESEATVNLKI 92 (92)
T ss_pred CcceeEEEEEC
Confidence 4 467776654
No 125
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.41 E-value=9e-13 Score=101.76 Aligned_cols=71 Identities=24% Similarity=0.482 Sum_probs=56.7
Q ss_pred EEEEeEeeccCCCeEEEEECCEEe-c------cCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee-eEEEEEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVI-E------NDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD-ENAVTIRV 217 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l-~------~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~l~V 217 (558)
++|.|.+.|+|.|.+.|+|++... . ....++....+++|.|.++..+|+|.|.|.|.|..|.. +..+.|.|
T Consensus 1 v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~~~~~r~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~s~~~~l~~ 79 (79)
T cd05734 1 VTLNCSAEGYPPPTIVWKHSKGRGHPQHTHTCCLAGRIQLLSNGSLLIKHVLEEDSGYYLCKVSNDVGADASKSMVLTV 79 (79)
T ss_pred CEeEeeCeEeCCCEEEEEECCCccccccccccccCCCEEEecCCeEEECcCCcccCEEEEEEEEeCCCCCCceEEEEeC
Confidence 579999999999999999964321 1 12335666677899999999999999999999999987 56666654
No 126
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.41 E-value=1.3e-12 Score=101.47 Aligned_cols=74 Identities=30% Similarity=0.468 Sum_probs=59.6
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCE---E--eccCC--ceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQ---V--IENDG--VHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~---~--l~~~~--~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
|+.+.|.|.+.|.|.|.+.|+|++. . +.... .++.....++|.|.+++.+|+|.|+|.|.|..|.....+.|.
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 80 (81)
T cd05765 1 GETASFHCDVTGRPPPEITWEKQVHGKENLIMRPNHVRGNVVVTNIGQLVIYNAQPQDAGLYTCTARNSGGLLRANFPLS 80 (81)
T ss_pred CCcEEEEeeccccCCCcEEEEecCCCCcceeecCCcccCCEEEccccEEEEccCCcccCEEEEEEEecCCceEEEEEEEe
Confidence 7899999999999999999999732 1 11111 123344557899999999999999999999999999998887
Q ss_pred E
Q psy10160 217 V 217 (558)
Q Consensus 217 V 217 (558)
|
T Consensus 81 v 81 (81)
T cd05765 81 V 81 (81)
T ss_pred C
Confidence 5
No 127
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=99.40 E-value=1.2e-12 Score=104.04 Aligned_cols=80 Identities=23% Similarity=0.313 Sum_probs=65.8
Q ss_pred CceEeeCCCcEEEEeEeec-----cCCCeEEEEECCEEecc---CCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 137 ETQVFGVGSDISIPCDVDG-----YPIPQVFWYKDGQVIEN---DGVHYRITESNRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~g-----~P~p~i~W~~~g~~l~~---~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
....+.+|+.+.|.|.+.| .|.|.+.|+|++..+.. ...++.. .+++|.|.++..+|+|.|+|.+.|..|.
T Consensus 7 ~~~~v~~G~~~~L~C~~~g~~~~~~p~~~v~Wyk~~~~~~~~~~~~~r~~~-~~~~L~I~~~~~~DsG~Y~C~~~N~~g~ 85 (94)
T cd05756 7 KKSYVLEGEPVVIKCPLFYSYIAQSPGLNLTWYKSDGKTPIPTEERSRMHQ-QKDLLWFLPAALEDSGLYTCVVRNSTYC 85 (94)
T ss_pred eEEEEecCCCeEEECCCCCcccccCCCceEEEEEcCCCCcccccccceeee-cCCeEEEccCCcccCeEEEEEEcCCCcc
Confidence 3556779999999999999 78999999999876532 1234332 3578999999999999999999999999
Q ss_pred eeEEEEEEE
Q psy10160 209 DENAVTIRV 217 (558)
Q Consensus 209 ~~~~~~l~V 217 (558)
....+.|.|
T Consensus 86 ~~~~~~L~v 94 (94)
T cd05756 86 MKVSISLTV 94 (94)
T ss_pred EEEEEEEEC
Confidence 998888765
No 128
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=99.39 E-value=2.5e-12 Score=98.46 Aligned_cols=72 Identities=31% Similarity=0.627 Sum_probs=61.5
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCC-ceEEEccCC-eEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEe
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDG-VHYRITESN-RLHINQANATDSGEYRCVASNSYTSDENAVTIRVE 218 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~-~~~~~~~~~-sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 218 (558)
+.|.|.+.|.|.|.+.|+|++..+..+. .++....++ .|.|.+++.+|+|.|+|.|.|..|.....+.|.|+
T Consensus 1 ~~L~C~v~g~P~p~v~W~k~~~~l~~~~~~~~~~~~~~~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 74 (76)
T cd05736 1 ASLRCHAEGIPLPRLTWLKNGMDITPKLSKQLTLIANGSELHISNVRYEDTGAYTCIAKNEAGVDEDISSLFVE 74 (76)
T ss_pred CEeEeEeeecCCCEEEEEECCEECCCCCCccEEEeCCCCEEEECcCCcccCEEEEEEEEcCCCCcceEEEEEEE
Confidence 3689999999999999999999876542 245444444 69999999999999999999999999999999885
No 129
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=99.36 E-value=6.6e-12 Score=99.79 Aligned_cols=81 Identities=25% Similarity=0.501 Sum_probs=62.5
Q ss_pred cEEEecCCceEeeC---CCcEEEEeEeeccCCCeEEEEECCEEeccC-CceEEEccCCeEEEccCC-CCCCeEEEEEEEe
Q psy10160 130 VKVNITLETQVFGV---GSDISIPCDVDGYPIPQVFWYKDGQVIEND-GVHYRITESNRLHINQAN-ATDSGEYRCVASN 204 (558)
Q Consensus 130 ~~~~~~~~~~~v~~---G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~-~~~~~~~~~~sL~I~~v~-~~D~G~Y~C~a~N 204 (558)
|.|...|.+..+.+ |+.+.|.|.+.|+|.|.+.|+|++..+... ..++.. .++.|.|.++. .+|+|.|+|.|.|
T Consensus 2 P~f~~~p~~~~~~~~~~~~~~~l~C~~~g~p~p~i~W~k~~~~l~~~~~~~~~~-~~~~L~i~~~~~~~d~G~Y~C~a~N 80 (91)
T cd04967 2 PVFEEQPDDTIFPEESDEGKVSLNCRARGSPPPTYRWLMNGTEIDDEPDSRYSL-VGGNLVISNPSKAKDAGRYQCLASN 80 (91)
T ss_pred CeeEeCCCCEEccCCCCCCEEEEEEeeeEcCCCEEEEEECCEECCCCCCCCEEE-ECCEEEEecCCccCCCEEEEEEEEc
Confidence 34555566665544 467999999999999999999999988432 334443 45789999887 4999999999999
Q ss_pred CCceeeE
Q psy10160 205 SYTSDEN 211 (558)
Q Consensus 205 ~~G~~~~ 211 (558)
..|....
T Consensus 81 ~~G~~~S 87 (91)
T cd04967 81 IVGTVLS 87 (91)
T ss_pred CCCEEEe
Confidence 9998743
No 130
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=99.36 E-value=5.5e-12 Score=96.45 Aligned_cols=64 Identities=27% Similarity=0.571 Sum_probs=51.2
Q ss_pred EEEEeEeeccCCCeEEEEECCEEecc-CCceEEE-ccCCeEEEccCC----CCCCeEEEEEEEeCCceee
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIEN-DGVHYRI-TESNRLHINQAN----ATDSGEYRCVASNSYTSDE 210 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~-~~~~~~~-~~~~sL~I~~v~----~~D~G~Y~C~a~N~~G~~~ 210 (558)
+.|.|.+.|+|.|.+.|+|++..+.. .+.++.+ ..+++|.|..+. .+|+|.|+|.|.|..|...
T Consensus 1 ~~l~C~~~G~P~P~v~W~k~g~~~~~~~~~~~~~~~~~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~ 70 (77)
T cd05875 1 IIIECEAKGNPVPTFQWTRNGKFFNVAKDPRVSMRRRSGTLVIDFSGGGRPEDYEGEYQCFARNNLGTAL 70 (77)
T ss_pred CEEEEeccccCCCEEEEEECCEEccCcCCCcEEEeCCCceEEEeccCCCCCCCCCEEEEEEEEeccceEE
Confidence 47999999999999999999987642 2334444 356799998864 2479999999999999874
No 131
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=99.35 E-value=9.1e-12 Score=96.56 Aligned_cols=70 Identities=23% Similarity=0.555 Sum_probs=60.3
Q ss_pred cCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 135 TLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
.|.+..+.+|+++.|.|.+.+ |.|.+.|+++|.++..+..++.+ .++.|.|.+++.+|+|.|+|.|.+..
T Consensus 2 ~P~~~~v~~G~~v~L~C~~~~-~~~~i~W~~ng~~i~~~~~r~~~-~~~~L~I~nv~~~DsG~Y~C~a~e~~ 71 (87)
T cd05873 2 DPRQRTFKLGNNAELKCSPKS-NLARVVWKFDGKVLTPESAKYLL-YRDGLLIFNASEADAGRYQCLSVEKS 71 (87)
T ss_pred CcceEEEECCCCEEEEEECCC-CCCeEEEEECCEECCCCCceEEE-ECCcEEEeCCCHHHCEEEEEEEEecc
Confidence 456788899999999999865 77899999999999876556665 45789999999999999999999874
No 132
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.34 E-value=7e-12 Score=95.84 Aligned_cols=69 Identities=28% Similarity=0.535 Sum_probs=53.5
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccC-CceEEEc-cCCeEEEccCCCC----CCeEEEEEEEeCCceeeE-EEEE
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIEND-GVHYRIT-ESNRLHINQANAT----DSGEYRCVASNSYTSDEN-AVTI 215 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~-~~~~~~~-~~~sL~I~~v~~~----D~G~Y~C~a~N~~G~~~~-~~~l 215 (558)
+.|.|.+.|.|.|.|.|+|++.++... ..++... .+++|.|..+..+ |.|.|+|.|.|..|.... .++|
T Consensus 1 ~~l~C~a~G~P~P~i~W~k~g~~l~~~~~~~~~~~~~~g~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~~~~~ 76 (77)
T cd05874 1 IVIQCEAKGKPPPSFSWTRNGTHFDIDKDPKVTMKPNTGTLVINIMNGEKAEAYEGVYQCTARNERGAAVSNNIVI 76 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCcCCCCEEEeCCCceEEEeccccCCCCCCCEEEEEEEEcCCCeEEeeEEEE
Confidence 479999999999999999999987432 2234433 4678999888743 789999999999998754 4443
No 133
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=99.34 E-value=4.4e-12 Score=96.92 Aligned_cols=75 Identities=28% Similarity=0.530 Sum_probs=60.1
Q ss_pred EEEecCCceEeeCCCcEEEEeEeeccCCC-eEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 131 KVNITLETQVFGVGSDISIPCDVDGYPIP-QVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 131 ~~~~~~~~~~v~~G~~v~L~C~~~g~P~p-~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
.+...|....+.+|++++|.|.+.+.|.+ .+.|+|+|..+.. .+++|.|.++ .+|+|.|+|.|.|. ..
T Consensus 2 vv~~~P~~~~v~~G~~V~L~C~~~~~p~~~~~~W~kng~~l~~--------~~~~l~i~~~-~~dsG~Y~C~a~~~--~~ 70 (78)
T cd05752 2 VVSLDPPWTTIFQGEKVTLTCNGFNSPEQNSTQWYHNGKLLET--------TTNSYRIRAA-NNDSGEYRCQTQGS--SL 70 (78)
T ss_pred eEEeCCCCeEeeCCCCEEEEEeCCCCCCCccEEEEECCEEeec--------cCCeEEEeec-ccCCEEeEEECCCC--cC
Confidence 45567788889999999999999999875 6999999987732 3457999999 99999999999986 33
Q ss_pred eEEEEEE
Q psy10160 210 ENAVTIR 216 (558)
Q Consensus 210 ~~~~~l~ 216 (558)
+..++|.
T Consensus 71 S~~v~l~ 77 (78)
T cd05752 71 SDPVHLE 77 (78)
T ss_pred CCCEEEe
Confidence 4444443
No 134
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=99.33 E-value=5.8e-12 Score=96.50 Aligned_cols=64 Identities=30% Similarity=0.598 Sum_probs=52.3
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccC-CceEEE-ccCCeEEEccCCC----CCCeEEEEEEEeCCceee
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIEND-GVHYRI-TESNRLHINQANA----TDSGEYRCVASNSYTSDE 210 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~-~~~~~~-~~~~sL~I~~v~~----~D~G~Y~C~a~N~~G~~~ 210 (558)
+.|.|.+.|+|.|.+.|+|++..+... ..++.. ..+++|.|.++.. +|+|.|+|.|.|..|...
T Consensus 1 i~l~C~~~G~P~P~v~W~k~g~~l~~~~~~~~~~~~~~g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~ 70 (77)
T cd05733 1 IVIKCEAKGNPPPTFSWTRNGTHFDPEKDPRVTMKPDSGTLVIDNMNGGRAEDYEGEYQCYASNELGTAI 70 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCCCCCCEEEeCCCCEEEEeccCCCCCcCCCEEEEEEEEcCCCcEE
Confidence 479999999999999999999988543 234443 3468999999854 799999999999999874
No 135
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=99.32 E-value=1.6e-11 Score=97.44 Aligned_cols=86 Identities=23% Similarity=0.422 Sum_probs=69.8
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeeccCCCe-EEEEECCEEeccC-CceEEEccC-------CeEEEccCCCCC-CeEE
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGYPIPQ-VFWYKDGQVIEND-GVHYRITES-------NRLHINQANATD-SGEY 198 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~-i~W~~~g~~l~~~-~~~~~~~~~-------~sL~I~~v~~~D-~G~Y 198 (558)
||.+ .......+.+|+.+.|.|.+.+.|+|. |.|.+++..+... ..+|.+... .+|.|.++..+| .|.|
T Consensus 2 pP~i-~~~~s~~~~~G~~~~L~C~~~s~P~P~~i~W~w~~~~i~~~~~~r~~I~~~~~~~g~~S~L~I~~~~~~d~~g~Y 80 (98)
T cd05898 2 PPII-SSEQVQYAVRGERGKVKCFIGSTPPPDRIAWAWKENVLESGTSERYTVERTSTGSGVLSTLTINNIMEADFQTHY 80 (98)
T ss_pred CCEE-ecCceEEEeCCCcEEEEEEEccCCCCcEEEEEEccccccCCCCCCEEEEEEccCCCcEEEEEECCCccccCCcEE
Confidence 5555 566677789999999999999999986 7999988877553 347766432 379999998877 7999
Q ss_pred EEEEEeCCceeeEEEEE
Q psy10160 199 RCVASNSYTSDENAVTI 215 (558)
Q Consensus 199 ~C~a~N~~G~~~~~~~l 215 (558)
.|.|.|.+|.....++|
T Consensus 81 ~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 81 NCTAWNSFGSGTAIIQL 97 (98)
T ss_pred EEEEEeCCccceEEEEe
Confidence 99999999999888776
No 136
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=99.31 E-value=1.4e-11 Score=96.50 Aligned_cols=77 Identities=25% Similarity=0.450 Sum_probs=64.3
Q ss_pred cCCceEeeCCCcEEEEeEeec-cCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEE
Q psy10160 135 TLETQVFGVGSDISIPCDVDG-YPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAV 213 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~ 213 (558)
.|....+.+|+.++|.|.+.+ .|.|.+.|++++..++.. ....++.|.|.+++.+|+|.|.|.|.|..|.....+
T Consensus 7 ~p~~~~v~~G~~v~L~C~~~~~~~~~~i~W~~~~~~~~~~----~~~~~~~L~I~~v~~~DsG~Y~C~a~n~~g~~~~~~ 82 (85)
T cd05754 7 EPRSQEVRPGADVSFICRAKSKSPAYTLVWTRVGGGLPSR----AMDFNGILTIRNVQLSDAGTYVCTGSNMLDTDEATA 82 (85)
T ss_pred CCCceEEcCCCCEEEEEEcCCCCCCcEEEEEECCCcCCCc----ccccCCEEEECCCCHHHCEEEEEEEeccCCeEeEEE
Confidence 455677899999999999975 788999999998765432 123467899999999999999999999999998877
Q ss_pred EE
Q psy10160 214 TI 215 (558)
Q Consensus 214 ~l 215 (558)
.|
T Consensus 83 ~l 84 (85)
T cd05754 83 TL 84 (85)
T ss_pred EE
Confidence 65
No 137
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=99.31 E-value=7.2e-12 Score=95.71 Aligned_cols=68 Identities=31% Similarity=0.664 Sum_probs=55.2
Q ss_pred EEEEeEeec-cCCCeEEEEECCEEeccCCce--EEEc---cCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEE
Q psy10160 147 ISIPCDVDG-YPIPQVFWYKDGQVIENDGVH--YRIT---ESNRLHINQANATDSGEYRCVASNSYTSDENAVT 214 (558)
Q Consensus 147 v~L~C~~~g-~P~p~i~W~~~g~~l~~~~~~--~~~~---~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 214 (558)
+.|.|.+.| .|.|.+.|+|++..+...... +.+. ..++|.|.+++.+|+|.|+|.|.|..|....++.
T Consensus 1 ~~l~C~~~g~~P~p~~~W~k~g~~l~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 74 (75)
T cd05750 1 LVLKCEATSEYPSLRFKWFKDGKELNRKNKPRNIKIRNKKKNSELQINKAKLADSGEYTCVVENILGNDTVTAN 74 (75)
T ss_pred CEEEEEccCCCCCceEEEEcCCeeccccCCcceEEEEecCceEEEEEccCCcccCeEEEEEEEEcCCceeEEEe
Confidence 469999999 999999999999988754321 1121 2357999999999999999999999999877654
No 138
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=99.28 E-value=9e-11 Score=101.36 Aligned_cols=114 Identities=20% Similarity=0.353 Sum_probs=74.0
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCCCCccCCCCccccCceeEEeccCCCCCCcEEEEeCCcccCCC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALPSEKVADPNAIDYGTILSSAFPSESASPVVTQTTTTTTEATS 92 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p~~~~~~~~~v~~~~~~~~~~~~~~p~p~v~W~~~~~~~~~~ 92 (558)
.+|.|.+++.+|+|.|+|.+.+..|... ...|.|..+
T Consensus 1 asL~i~~v~~~D~G~Y~C~~~~~~~~~~~~~~l~v~~~------------------------------------------ 38 (139)
T cd05771 1 ASLTLPGLTVHDEGTYICSVSTPPHQAQQIIQLSVSEP------------------------------------------ 38 (139)
T ss_pred CeEEECCCCHHHCEEEEEEEEccCcceeeEEEEEEecC------------------------------------------
Confidence 3799999999999999999998766643 445555433
Q ss_pred CceeeccccceeeceeEEeeccceeeEEeeeceeeeCcEEEecCCceEeeCCCcEEEEeEeecc-CC-CeEEEEECCEEe
Q psy10160 93 PHVYAALTHCVPWSNVCLFGARSGYLKETQNGGYLVPVKVNITLETQVFGVGSDISIPCDVDGY-PI-PQVFWYKDGQVI 170 (558)
Q Consensus 93 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~g~-P~-p~i~W~~~g~~l 170 (558)
|.+...+......+|+.+.|.|.+.|. |. +.|.|++++...
T Consensus 39 -------------------------------------P~v~~~~~~~~~~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~ 81 (139)
T cd05771 39 -------------------------------------PRVRLSLEKLVSMIEEPQTLICHIAGYYPLDVQVEWTREPPGD 81 (139)
T ss_pred -------------------------------------CceEEeCCCceeecCCcEEEEEEECCCCCCCeEEEEEECCCCC
Confidence 222233333334478899999999996 54 479999998542
Q ss_pred cc-----CCc---eEEEccCC------eEEEccCCCCCCeEEEEEEEeCC
Q psy10160 171 EN-----DGV---HYRITESN------RLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 171 ~~-----~~~---~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
.. .+. ......++ .|.+..-..++.+.|+|.+.+..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~dgt~~~~s~L~v~~~~~~~g~~ytC~V~H~~ 131 (139)
T cd05771 82 SPPPVSLSNVSFSSHRQHQDGTYSLSSHLTLEPGTEDAGATYTCRVSHVS 131 (139)
T ss_pred ccceeccCCeEecceEeCCCCCEEEEEEEEecCCccCCCCEEEEEEEcCC
Confidence 11 110 11122233 46665555556779999997753
No 139
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=99.27 E-value=3.7e-11 Score=95.03 Aligned_cols=81 Identities=16% Similarity=0.324 Sum_probs=64.8
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCC---ceEEEccCCeEEEccCCCCCCeEEEEEEEeCC-ceeeE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDG---VHYRITESNRLHINQANATDSGEYRCVASNSY-TSDEN 211 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~---~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~-G~~~~ 211 (558)
+....+.+|+.+.|.|.+.+ |.|.+.|+|++..+.... .++... .+.|.|.+++.+|+|.|.|.|.|.. +....
T Consensus 3 ~~~~~v~~g~~v~L~C~~~~-p~~~i~W~k~~~~~~~~~~~~~~~~~~-~~~L~I~~~~~~D~G~Y~C~a~~~~~~~~~~ 80 (89)
T cd04979 3 EKVVTVVEGNSVFLECSPKS-NLASVVWLFQGGPLQRKEEPEERLLVT-EDGLLIRSVSPADAGVYTCQSVEHGFKQTLA 80 (89)
T ss_pred ceEEEEECCCcEEEEEeCCC-CCceEEEEECCcccccccCcCceEEEc-CCCEEEccCCHHHCEEEEEEEecCccceeEe
Confidence 44567889999999999988 889999999998776542 344443 3569999999999999999999764 45567
Q ss_pred EEEEEEe
Q psy10160 212 AVTIRVE 218 (558)
Q Consensus 212 ~~~l~V~ 218 (558)
++.|.|.
T Consensus 81 ~~~l~V~ 87 (89)
T cd04979 81 TYSLNVL 87 (89)
T ss_pred EEEEEEe
Confidence 7888884
No 140
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=99.27 E-value=3.6e-11 Score=94.98 Aligned_cols=78 Identities=24% Similarity=0.455 Sum_probs=63.1
Q ss_pred ceEeeCCCcEEEEeEeec-----cCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEE
Q psy10160 138 TQVFGVGSDISIPCDVDG-----YPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENA 212 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g-----~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 212 (558)
.+.+.+|+.+.|.|...+ +|.|.+.|+|++.++.....++ ..++.|.|.++..+|+|.|+|.+.|..+.....
T Consensus 4 ~~~~~~g~~~~l~Cp~~~~~~~~~~~p~i~Wyk~~~~i~~~~~~~--~~~~~L~I~~v~~~DsG~YtC~~~n~~~~~~~~ 81 (92)
T cd05757 4 KQILFSTKGGKIVCPDLDDFKNENTLPPVQWYKDCKLLEGDRKRF--VKGSKLLIQNVTEEDAGNYTCKLTFTHNGKQYN 81 (92)
T ss_pred eEEEeeccCCEEECCChHHccCCCCCCcEEEeECCEECCCCccEE--ecCCEEEEeeCChhhCEEEEEEEEecCCCEEEE
Confidence 456778999999998754 3678999999999987654332 267799999999999999999999999888665
Q ss_pred EEEEE
Q psy10160 213 VTIRV 217 (558)
Q Consensus 213 ~~l~V 217 (558)
++..+
T Consensus 82 ~t~t~ 86 (92)
T cd05757 82 VTRTI 86 (92)
T ss_pred EEEEE
Confidence 55444
No 141
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=99.26 E-value=2.2e-11 Score=95.23 Aligned_cols=74 Identities=22% Similarity=0.354 Sum_probs=58.4
Q ss_pred CCcEEEEeEeecc--CCCeEEEEECCEEeccCCc---eEEE----ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEE
Q psy10160 144 GSDISIPCDVDGY--PIPQVFWYKDGQVIENDGV---HYRI----TESNRLHINQANATDSGEYRCVASNSYTSDENAVT 214 (558)
Q Consensus 144 G~~v~L~C~~~g~--P~p~i~W~~~g~~l~~~~~---~~~~----~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 214 (558)
|+.+.|.|.+.|. |.|.+.|.+++..+..... +... ...++|.|.+++.+|+|.|+|.|.|..|..+.+..
T Consensus 1 Ge~~~L~C~~~g~~~~~~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~DsG~Y~C~a~n~~~~~~~s~~ 80 (84)
T cd05742 1 GETLVLNCTVLTELNEGVDFQWTYPGKKRGRGKSMVTRQSLSEATELSSTLTIPNATLKDSGTYTCAASSGTMDQKESTK 80 (84)
T ss_pred CCeEEEEEEEEeCCCccEEEEEecCCcccCCceEeecccccccceEEEEEEEECCCChhhCEEEEEEEccCCCceEEEEE
Confidence 7899999999999 8889999988765432110 1110 11247999999999999999999999999998888
Q ss_pred EEE
Q psy10160 215 IRV 217 (558)
Q Consensus 215 l~V 217 (558)
|.|
T Consensus 81 v~v 83 (84)
T cd05742 81 VNI 83 (84)
T ss_pred EEE
Confidence 876
No 142
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=99.26 E-value=6.6e-11 Score=92.80 Aligned_cols=79 Identities=25% Similarity=0.524 Sum_probs=63.6
Q ss_pred eEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEE---ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEE
Q psy10160 139 QVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRI---TESNRLHINQANATDSGEYRCVASNSYTSDENAVTI 215 (558)
Q Consensus 139 ~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~---~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 215 (558)
..+..|+.+.|.|.+.+.|.|.+.|++++..+..+...... .....|.|.++..+|+|.|.|.+.|..|..+.++.|
T Consensus 4 ~~~~~G~~~~l~C~~~~~p~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~d~g~Y~C~~~n~~g~~~~~~~l 83 (85)
T cd05729 4 HAVPAGSTVRLKCPASGNPRPTITWLKDGKPFKKEHRIGGYKVRKKKWTLILESVVPSDSGKYTCIVENKYGSINHTYKV 83 (85)
T ss_pred eEecCCCcEEEEEEcCCCCCCeEEEEECCEECcccCceeEEEccCcEEEEEEeECCcccCEEEEEEEEECCceEEEEEEE
Confidence 34568999999999999999999999999887643311111 112369999999999999999999999998888887
Q ss_pred EE
Q psy10160 216 RV 217 (558)
Q Consensus 216 ~V 217 (558)
+|
T Consensus 84 ~v 85 (85)
T cd05729 84 DV 85 (85)
T ss_pred eC
Confidence 64
No 143
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=99.24 E-value=5.4e-11 Score=94.56 Aligned_cols=80 Identities=16% Similarity=0.331 Sum_probs=58.9
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEecc-------CCceEEEcc----CCeEEEccCCCCCCeEEEEEEEe
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIEN-------DGVHYRITE----SNRLHINQANATDSGEYRCVASN 204 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~-------~~~~~~~~~----~~sL~I~~v~~~D~G~Y~C~a~N 204 (558)
..+..+.+|+++.|.|.+.|.|.|.+.|++++..+.. .+.++.+.. ..+|.|.+++.+|+|.|+|.+..
T Consensus 4 ~~~~tv~~G~tv~L~C~v~g~~~~~v~W~k~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~nV~~~D~G~YtC~~~t 83 (95)
T cd05882 4 TQDETVAVGGTVTLKCGVKEHDNSSLQWSNTAQQTLYFGEKRALRDNRIQLVKSTPTELIISISNVQLSDEGEYTCSIFT 83 (95)
T ss_pred cccEEEecCCcEEEEEEEeCCCCCeEEEeccCccEEEeCCeEEEeCCeEEEEeCCCceEEEEECCCCcccCEEEEEEEEe
Confidence 3467789999999999999999999999997753310 122444321 24899999999999999999988
Q ss_pred CCceeeEEEEEE
Q psy10160 205 SYTSDENAVTIR 216 (558)
Q Consensus 205 ~~G~~~~~~~l~ 216 (558)
.-..+...+|.
T Consensus 84 -~~~~~~~~~~~ 94 (95)
T cd05882 84 -MPVRTAKATVT 94 (95)
T ss_pred -eccccEEEEEE
Confidence 22334444443
No 144
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=99.23 E-value=2.8e-11 Score=95.22 Aligned_cols=74 Identities=22% Similarity=0.380 Sum_probs=60.7
Q ss_pred CCceEeeCCCcEEEEeE-eeccCCCeEEEEECCEEe--ccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 136 LETQVFGVGSDISIPCD-VDGYPIPQVFWYKDGQVI--ENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~-~~g~P~p~i~W~~~g~~l--~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
.....+.+|+.+.|.|. -.|.|.|.+.|++++.++ ..+.+++....+|.|.|.+|+.+|+|.|+|.|+|.....
T Consensus 10 ~~~~~v~eG~~~~L~C~pP~g~P~p~~~W~k~~~~~~~~~d~r~~~~~~~G~L~fs~v~~~D~g~Y~C~A~n~~~~~ 86 (96)
T cd05727 10 RDEVKVKEGWGVVLFCDPPPHYPDLSYRWLLNEFPNFIPEDGRRFVSQTNGNLYIAKVEASDRGNYSCFVSSPSSTK 86 (96)
T ss_pred cCceeeeeCCcEEEeeCCCCCCCCCEEEEEECCcccccccCCCeEEeCCCCcEEEeecCHhhCceeEEEEEecccCC
Confidence 34566889999999996 688999999999998754 333445555558999999999999999999999987554
No 145
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=99.22 E-value=7.9e-11 Score=91.75 Aligned_cols=75 Identities=27% Similarity=0.450 Sum_probs=57.0
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEeccCC-c--eEEEcc---CCeEEEccCCCCCCeEEEEEEEeCCc--eeeEEEEE
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIENDG-V--HYRITE---SNRLHINQANATDSGEYRCVASNSYT--SDENAVTI 215 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~-~--~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N~~G--~~~~~~~l 215 (558)
|+.++|.|.+.|.|.|.+.|++.++...... . +..+.. ..+|.|.+++.+|+|.|+|.|.|..+ ..+.++.|
T Consensus 1 Ge~~~l~C~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~~sv~i 80 (84)
T cd05861 1 GETITVNCIVQGNEVVDFSWTYPGKDIGKGIPEVEEVKVPATTLRSTLTFPHATVEDSGTYECAAHESTQDQKAFKKVNI 80 (84)
T ss_pred CCcEEEEEEEECCCccEEEEEECCccCCCCceEEEEEecCCcEEEEEEEECCCCcCCCEEEEEEEEECccCcceeEEEEE
Confidence 7899999999999999999998775432111 0 111111 34799999999999999999999877 55777787
Q ss_pred EEe
Q psy10160 216 RVE 218 (558)
Q Consensus 216 ~V~ 218 (558)
.|.
T Consensus 81 ~V~ 83 (84)
T cd05861 81 TVH 83 (84)
T ss_pred EEe
Confidence 773
No 146
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=99.22 E-value=2.7e-11 Score=95.06 Aligned_cols=75 Identities=13% Similarity=0.298 Sum_probs=63.4
Q ss_pred cCCceEeeCCCcEEEEeE-eeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCe-EEEEEEEeCCcee
Q psy10160 135 TLETQVFGVGSDISIPCD-VDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSG-EYRCVASNSYTSD 209 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~-~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G-~Y~C~a~N~~G~~ 209 (558)
......|.+|+.+.|.|. ..|.|.|.|.|.+++...-..+.|+.+..+|+|.|.+|..+|+| .|.|.|.|.....
T Consensus 9 ~~~~v~V~eG~~~~L~C~pP~g~P~P~i~W~~~~~~~i~~~~Ri~~~~~GnL~fs~v~~~D~g~~Y~C~a~~~~~~~ 85 (95)
T cd05845 9 KIRPVEVEEGDSVVLPCNPPKSAVPLRIYWMNSDLLHITQDERVSMGQNGNLYFANVEEQDSHPDYICHAHFPGLRT 85 (95)
T ss_pred ccceeEEecCCCEEEEecCCCCCCCCEEEEECCCCccccccccEEECCCceEEEEEEehhhCCCCeEEEEEcccccc
Confidence 346677899999999997 79999999999987755434456888888899999999999999 8999999986443
No 147
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=99.20 E-value=8.3e-11 Score=89.96 Aligned_cols=68 Identities=28% Similarity=0.634 Sum_probs=53.7
Q ss_pred EEEEeEeec-cCCCeEEEEECCEEeccCC---ceEEEcc---CCeEEEccCCCCCCeEEEEEEEeCCceeeEEEE
Q psy10160 147 ISIPCDVDG-YPIPQVFWYKDGQVIENDG---VHYRITE---SNRLHINQANATDSGEYRCVASNSYTSDENAVT 214 (558)
Q Consensus 147 v~L~C~~~g-~P~p~i~W~~~g~~l~~~~---~~~~~~~---~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 214 (558)
+.|.|.+.+ .|.|.+.|+|+|..+.... .++.... .++|.|.+++.+|+|.|+|.|.|..|..+.++.
T Consensus 1 ~~L~C~a~~~~p~~~~~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~~~ 75 (76)
T cd05895 1 LVLRCETVSEYPSLRFKWFKNGKEIGAKNKPDNKIKIRKKKKSSELQISKASLADNGEYKCMVSSKLGNDSVTAN 75 (76)
T ss_pred CEEEEecccCCCCCceEEEECCcccccCCCCCceEEEEeCCcEEEEEECcCCcccCEEEEEEEEeCCCceeEEEe
Confidence 479999875 6889999999999886432 2233222 257999999999999999999999999887654
No 148
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=99.20 E-value=8.3e-11 Score=91.29 Aligned_cols=76 Identities=25% Similarity=0.422 Sum_probs=59.5
Q ss_pred cCCceEeeCCCcEEEEeEee-ccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee-eEE
Q psy10160 135 TLETQVFGVGSDISIPCDVD-GYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD-ENA 212 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~-~~~ 212 (558)
.+....+.+|+.++|.|.+. +.|.+.+.|+|+|..+... ..+.+|.|.+++.+|+|.|+|.+.|..|.. +..
T Consensus 5 ~~p~~~V~~G~~vtL~C~~~~~~~~~~~~w~k~g~~~~~~------~~~~~l~I~~~~~~dsG~Y~C~~~~~~~~~~s~~ 78 (83)
T cd05753 5 QVPSRVVFEGEPLVLRCHGWKNKPVYKVTYYRDGKAKKYS------HSNSNLSIPQATLSDSGSYHCSGIIGSYDYSSEP 78 (83)
T ss_pred ECCcceecCCCCEEEEeeCCCCCcceEEEEEECCeEcccc------CCCceEEECccCHHHCEEEEEEEEeCCceecCCC
Confidence 34455788999999999985 4667789999999876431 234689999999999999999999998865 344
Q ss_pred EEEE
Q psy10160 213 VTIR 216 (558)
Q Consensus 213 ~~l~ 216 (558)
+.|.
T Consensus 79 ~~i~ 82 (83)
T cd05753 79 VSIT 82 (83)
T ss_pred EEEE
Confidence 4444
No 149
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=99.18 E-value=5.8e-11 Score=110.30 Aligned_cols=151 Identities=14% Similarity=0.126 Sum_probs=97.1
Q ss_pred CceEeeCCCcEEEEeEeeccCCC-----------eEEEEECCEEe--ccCCce--------EE-EccCCeEEEccCCCCC
Q psy10160 137 ETQVFGVGSDISIPCDVDGYPIP-----------QVFWYKDGQVI--ENDGVH--------YR-ITESNRLHINQANATD 194 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~g~P~p-----------~i~W~~~g~~l--~~~~~~--------~~-~~~~~sL~I~~v~~~D 194 (558)
.+..+.+|+++.|.|.+.++|.| .+.|+|++... ...+.+ .. ...+++|.|.+++.+|
T Consensus 30 ~~~~v~eGe~v~L~C~~~~~~~~~~~~~~~~~~~~V~W~k~~s~~~v~~~~~~~~~~~i~~~~~~~r~~~L~I~~v~~~D 109 (227)
T PHA02826 30 TPVYAKFGDPMVLLCTGKHYKKSIFFDKTFITSYNVTWSKTDSLAFVRDSGARTKIKKITHNEIGDRSENLWIGNVINID 109 (227)
T ss_pred ceEEecCCCCEEEEccccccccccccccccCCCccEEEEeCCeEEEEEcCCCccccccccccceecCCCeEEECCCChHH
Confidence 45667899999999999886644 79999988652 111111 00 1124689999999999
Q ss_pred CeEEEEEEEeCCceeeEEEEEEEeccCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccC--CCCCCCcccccch
Q psy10160 195 SGEYRCVASNSYTSDENAVTIRVEGIFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTR--AGQLPSYGPHIKR 272 (558)
Q Consensus 195 ~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~--~g~~~~~~~w~~~ 272 (558)
+|.|+|.|.|..|....++.|.|..+. . +. . ...|....+.|..... .+.|.|.+.|+++
T Consensus 110 sG~Y~C~a~N~~~~~~~~i~L~V~~~~---~--------~~-~------~~~G~~v~L~C~~~~~~~~~~p~p~I~WyKn 171 (227)
T PHA02826 110 EGIYICTISSGNICEESTIRLTFDSGT---I--------NY-Q------FNSGKDSKLHCYGTDGISSTFKDYTLTWYKN 171 (227)
T ss_pred CEEEEEEEEECCcceEEEEEEEEecCC---c--------cc-e------EecCCCEEEEeeCCCCccccCCCceEEEEEC
Confidence 999999999999988888888884221 0 00 1 1223334444542211 1456899999999
Q ss_pred hhhhhhhhh-hh-hhcccccchhhhhhhHHHhhcc
Q psy10160 273 AVEAEAAAA-DK-KRRSRRSLSVVNKWSLRQAFTT 305 (558)
Q Consensus 273 ~l~~~~~~~-~~-~~~grth~q~a~~~t~g~~~~~ 305 (558)
+..+....+ .. ...+......++....|.|...
T Consensus 172 g~~l~~~~r~~~~~~~~~L~I~~V~~~DsG~YtC~ 206 (227)
T PHA02826 172 GNIVLYTDRIQLRNNNSTLVIKSATHDDSGIYTCN 206 (227)
T ss_pred CEECCCCCCEEEeCCCCEEEECcCCHHhCEEEEEE
Confidence 876543321 11 1123566677777777766653
No 150
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=99.16 E-value=2.3e-10 Score=91.32 Aligned_cols=80 Identities=15% Similarity=0.269 Sum_probs=59.2
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEE--------eccCCceEEEc----cCCeEEEccCCCCCCeEEEEEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQV--------IENDGVHYRIT----ESNRLHINQANATDSGEYRCVAS 203 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~--------l~~~~~~~~~~----~~~sL~I~~v~~~D~G~Y~C~a~ 203 (558)
+.+..+.+|+++.|+|.+.+.|.|.+.|++.+.. ... +.++... ...+|.|.+++.+|+|.|+|.+.
T Consensus 4 ~~~v~v~eG~~v~L~C~~~~~p~~~v~W~~~~~~~l~~~~~~~~~-~~r~~~~~~~~~~~sL~I~~v~~~DsG~Y~C~~~ 82 (95)
T cd07701 4 TQNVTVVEGGTANLTCRVDQNDNTSLQWSNPAQQTLYFDDKKALR-DNRIELVRASWHELSISISDVSLSDEGQYTCSLF 82 (95)
T ss_pred cceEEEecCCcEEEEEEEecCCceEEEEeCCCCeEEEEcCccccc-CCCEEEEECCCCcEEEEECcCCcccCEEEEEEeE
Confidence 4567789999999999999999999999863321 112 2355442 22489999999999999999999
Q ss_pred eCCceeeEEEEEEE
Q psy10160 204 NSYTSDENAVTIRV 217 (558)
Q Consensus 204 N~~G~~~~~~~l~V 217 (558)
+..+. +....|.|
T Consensus 83 t~~~~-~~~~~l~v 95 (95)
T cd07701 83 TMPVK-TSKAYLTV 95 (95)
T ss_pred eecCc-cEEEEEEC
Confidence 85333 55555554
No 151
>PF10415 FumaraseC_C: Fumarase C C-terminus; InterPro: IPR018951 Fumarase C catalyses the stereo-specific interconversion of fumarate to L-malate as part of the Krebs cycle. The full-length protein forms a tetramer with visible globular shape. FumaraseC_C is the C-terminal 65 residues referred to as domain 3. The core of the molecule consists of a bundle of 20 alpha-helices from the five-helix bundle of domain 2. The projections from the core of the tetramer are generated from domains 1 and 3 of each subunit []. This entry does not appear to be part of either the active site or the activation site but is helical in structure forming a little bundle. ; GO: 0016829 lyase activity, 0006099 tricarboxylic acid cycle; PDB: 3RRP_A 3OCE_D 3OCF_D 3E04_B 3GTD_A 3R6V_F 3R6Q_F 1J3U_B 1FUR_A 1YFE_A ....
Probab=99.14 E-value=2.7e-11 Score=83.98 Aligned_cols=55 Identities=53% Similarity=0.777 Sum_probs=48.9
Q ss_pred hhhhcccccChHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHhhhcCcccccCC
Q psy10160 503 LVTALNPHIGYDKAAKIAKTAHKEGTTLKVAALKLGYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 503 ~~~~la~~l~~~~a~~~~~~a~~~~~~~~~~~~~~~~l~~~~~~~~~~p~~~~~~ 557 (558)
++|.|++.+||+.|.+++++|.++|++++|++.+.+.|++++++++|||..++++
T Consensus 1 laTaL~p~iGYe~aa~iAk~A~~~g~svre~v~~~g~lt~ee~d~ll~p~~mt~P 55 (55)
T PF10415_consen 1 LATALNPYIGYEKAAEIAKEALAEGRSVREVVLEEGLLTEEELDELLDPERMTNP 55 (55)
T ss_dssp GGGGGHHHHHHHHHHHHHHHHHHHT--HHHHHHHTTSS-HHHHHHHTSHHHHTT-
T ss_pred CeeeccchhccHHHHHHHHHHHHcCCCHHHHHHHcCCCCHHHHHHHcCHHHcCCc
Confidence 4689999999999999999999999999999999999999999999999998875
No 152
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=99.11 E-value=4.6e-10 Score=82.00 Aligned_cols=63 Identities=33% Similarity=0.703 Sum_probs=53.1
Q ss_pred CCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCc
Q psy10160 143 VGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYT 207 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G 207 (558)
+|+.+.|.|.+.+.|.+.+.|++++..+.. . ......+..|.|.+++.+|+|.|+|.+.|..|
T Consensus 1 ~g~~~~l~C~~~~~~~~~v~W~~~~~~~~~-~-~~~~~~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 1 EGQSVTLTCPAEGDPVPNITWLKDGKPLPE-S-NRLSASGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred CCceEEEEeeCccCCCCeEEEEECCEECCC-C-CEEecCCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 588999999999999999999999988762 2 22334556899999999999999999999765
No 153
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=99.08 E-value=6.7e-10 Score=87.53 Aligned_cols=79 Identities=22% Similarity=0.431 Sum_probs=60.6
Q ss_pred eEeeCCCcEEEEeE-eec----cCCCeEEEEECCEEeccCCceEEE-ccCCeEEEccCCCCCCeEEEEEEEeCCceee--
Q psy10160 139 QVFGVGSDISIPCD-VDG----YPIPQVFWYKDGQVIENDGVHYRI-TESNRLHINQANATDSGEYRCVASNSYTSDE-- 210 (558)
Q Consensus 139 ~~v~~G~~v~L~C~-~~g----~P~p~i~W~~~g~~l~~~~~~~~~-~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~-- 210 (558)
+.+.+|....|.|+ ..+ .+.|.+.|+|++.++...+.++.. .....|.|.+|..+|+|.|+|.+.|..|...
T Consensus 5 ~~~~~~~~~~l~Cp~~~~f~~~~~~~~v~WYKd~~~l~~~~~~~~~~~~~~~L~I~~v~~~D~G~YtC~~~~~~~g~~y~ 84 (95)
T cd05897 5 QILFTSTSGKLVCPDLSDFTINRTDVELQWYKDSVLLDKDNEKFYSLKGSTYLHIIDVSLNDSGYYTCKLQFTHEGKKYN 84 (95)
T ss_pred eEeccccCcEEECCCHHHcccCCCCCcEEEccCCEECcCCCcceEecCCCCEEEEEEcChhhCEEEEEEEEEeeCCEEEE
Confidence 45678999999998 333 467799999999998765545544 2345799999999999999999999976553
Q ss_pred --EEEEEEE
Q psy10160 211 --NAVTIRV 217 (558)
Q Consensus 211 --~~~~l~V 217 (558)
+.+.|.|
T Consensus 85 vtr~~~l~v 93 (95)
T cd05897 85 ITRIIKLRI 93 (95)
T ss_pred EEEEEEEEE
Confidence 4445544
No 154
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=99.02 E-value=2.1e-09 Score=82.94 Aligned_cols=71 Identities=38% Similarity=0.709 Sum_probs=58.1
Q ss_pred eEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCc-eeeEEEEEEE
Q psy10160 139 QVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYT-SDENAVTIRV 217 (558)
Q Consensus 139 ~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G-~~~~~~~l~V 217 (558)
..+.+|+.+.|.|.+.+.|.+.+.|++++..+.... ..+.+.++..+|+|.|+|.+.|..+ ..+..+.|.|
T Consensus 9 ~~v~~g~~~~l~C~~~~~p~~~~~w~~~~~~~~~~~--------~~~~~~~~~~~~~g~y~C~~~~~~~~~~s~~~~v~V 80 (80)
T PF13895_consen 9 QSVEEGDSVTLTCSVSGNPPPQVQWYKNGSPINSSQ--------NGLFIPNVSPEDSGNYTCRASNGSGSNTSTSVNVTV 80 (80)
T ss_dssp SEEETTSEEEEEEEEESSSSSEEEEEETTEEEEEES--------SEEEESSEEGGGTEEEEEEEEETTEEEEEEEEEEEE
T ss_pred eEEeCCCcEEEEEEEEcccceeeeeeeeeeeeeeee--------eeeeeeeeccccCEEEEEEEEeCCCCeEeeeEEeeC
Confidence 557899999999999999999999999988776321 1277889999999999999999665 4456677665
No 155
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=99.01 E-value=2.9e-09 Score=84.08 Aligned_cols=78 Identities=17% Similarity=0.200 Sum_probs=59.1
Q ss_pred eEeeCCCcEEEEeEeeccCCCeEEEEECCE--Eec---cCCceEEEccCCeEEEccCCCCCCeEEEEEEE-eCCceeeEE
Q psy10160 139 QVFGVGSDISIPCDVDGYPIPQVFWYKDGQ--VIE---NDGVHYRITESNRLHINQANATDSGEYRCVAS-NSYTSDENA 212 (558)
Q Consensus 139 ~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~--~l~---~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~-N~~G~~~~~ 212 (558)
..+.+|+.+.|.|.. +.|.|.+.|+|.+. ... ..+.++.. .+++|.|.+++.+|+|.|+|.+. |..+.....
T Consensus 6 ~~~~eG~~v~L~C~~-~~p~p~v~Wykq~~g~~~~~~~~~~~r~~~-~~~~L~I~~~~~~DsG~Y~C~a~~~~~~~~~~~ 83 (91)
T cd05871 6 VYGVENNSTFLECLP-KSPQASVKWLFQRGGDQRKEEVKTEERLIH-TERGLLLRSLQRSDAGVYTCTAVEHSFSQTLAK 83 (91)
T ss_pred EEEecCCcEEEEEEC-CCCCceEEEEEECCCCCccccccccccEEE-ecCeEEEeeCChhHCEEEEEEEEccCCeEEEEE
Confidence 446789999999996 58999999998432 211 11235543 44679999999999999999998 577767778
Q ss_pred EEEEEe
Q psy10160 213 VTIRVE 218 (558)
Q Consensus 213 ~~l~V~ 218 (558)
++|.|.
T Consensus 84 ~~l~v~ 89 (91)
T cd05871 84 YTLHVI 89 (91)
T ss_pred EEEEEe
Confidence 888874
No 156
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=98.99 E-value=2.3e-09 Score=83.83 Aligned_cols=75 Identities=20% Similarity=0.329 Sum_probs=56.6
Q ss_pred CCcEEEEeEeeccCCC--eEEEEECCEEecc----CCceEEE----ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEE
Q psy10160 144 GSDISIPCDVDGYPIP--QVFWYKDGQVIEN----DGVHYRI----TESNRLHINQANATDSGEYRCVASNSYTSDENAV 213 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p--~i~W~~~g~~l~~----~~~~~~~----~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~ 213 (558)
|+++.|.|.+.+.|.| .+.|.+.+..... ...+... ...++|.|.+++.+|+|.|+|.|.|..|....+.
T Consensus 1 Ge~~~L~C~~~~~~~~~~~~~W~~p~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~t 80 (86)
T cd05862 1 GEKLVLNCTARTELNVGIDFQWDYPGKKEQRAKSVSENRRSLQEHTELSSTLTIENVTLSDLGRYTCTASSGQMIAKNST 80 (86)
T ss_pred CCcEEEEEEEEeCCCCcEEEEEEcCCcccccceecccccccccccceeeeEEEEecCCcccCEEEEEEEeecceEecccE
Confidence 7899999999987655 5799887754321 1101111 1234799999999999999999999999988888
Q ss_pred EEEEe
Q psy10160 214 TIRVE 218 (558)
Q Consensus 214 ~l~V~ 218 (558)
.|.|.
T Consensus 81 ~~~V~ 85 (86)
T cd05862 81 IVIVH 85 (86)
T ss_pred EEEEe
Confidence 88884
No 157
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=98.99 E-value=3.4e-09 Score=84.88 Aligned_cols=81 Identities=15% Similarity=0.261 Sum_probs=58.5
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEe-c------cCCceEEEc----cCCeEEEccCCCCCCeEEEEEEEe
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVI-E------NDGVHYRIT----ESNRLHINQANATDSGEYRCVASN 204 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l-~------~~~~~~~~~----~~~sL~I~~v~~~D~G~Y~C~a~N 204 (558)
+....+.+|+++.|.|.+.+.|.|.+.|++.+..+ . ..+.+|.+. ...+|.|.+++.+|+|.|+|.+.+
T Consensus 4 ~~~~~v~~G~~v~L~C~~~~~~~~~v~W~~p~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~~v~~~DsG~Y~C~~~~ 83 (95)
T cd05717 4 TQDVTVVEGGTATLKCRVKNNDNSSLQWSNPNQQTLYFNDKRALRDNRIQLVNFSANELSISISNVSLSDEGRYTCSLYT 83 (95)
T ss_pred CCcEEEcCCCCEEEEEEECCCCCceEEEeCCCCcEEEeccccccccCcEEEEcCCCCeeEEEEccCCcccCEEEEEEEec
Confidence 34667889999999999999999999998633211 0 112355542 234799999999999999999998
Q ss_pred CCceeeEEEEEEE
Q psy10160 205 SYTSDENAVTIRV 217 (558)
Q Consensus 205 ~~G~~~~~~~l~V 217 (558)
... .+..+.|.|
T Consensus 84 ~~~-~~~~~~~~v 95 (95)
T cd05717 84 MPV-QTAKATVTV 95 (95)
T ss_pred CCC-ceEEEEEEC
Confidence 753 355555543
No 158
>smart00409 IG Immunoglobulin.
Probab=98.94 E-value=1.5e-08 Score=78.82 Aligned_cols=80 Identities=33% Similarity=0.716 Sum_probs=65.3
Q ss_pred CceEeeCCCcEEEEeEeeccCCCeEEEEEC-CEEeccCCceEEEccC---CeEEEccCCCCCCeEEEEEEEeCCceeeEE
Q psy10160 137 ETQVFGVGSDISIPCDVDGYPIPQVFWYKD-GQVIENDGVHYRITES---NRLHINQANATDSGEYRCVASNSYTSDENA 212 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~-g~~l~~~~~~~~~~~~---~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 212 (558)
....+..|+.+.|.|.+.+.+.+.+.|+++ +..+...+ ++..... .+|.|.++..+|+|.|.|.+.|..+.....
T Consensus 2 ~~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~-~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~ 80 (86)
T smart00409 2 PSVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESG-RFSVSRSGSNSTLTISNVTPEDSGTYTCAATNSSGSASST 80 (86)
T ss_pred CcEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCC-cEEEEEcCCeeEEEEEeeccccCeEEEEEEEcCCCeEEEE
Confidence 345678899999999999998899999998 77776333 4444443 589999999999999999999998888777
Q ss_pred EEEEE
Q psy10160 213 VTIRV 217 (558)
Q Consensus 213 ~~l~V 217 (558)
+.|.|
T Consensus 81 ~~l~V 85 (86)
T smart00409 81 TTLTV 85 (86)
T ss_pred EEEEE
Confidence 77766
No 159
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=98.94 E-value=1.5e-08 Score=78.82 Aligned_cols=80 Identities=33% Similarity=0.716 Sum_probs=65.3
Q ss_pred CceEeeCCCcEEEEeEeeccCCCeEEEEEC-CEEeccCCceEEEccC---CeEEEccCCCCCCeEEEEEEEeCCceeeEE
Q psy10160 137 ETQVFGVGSDISIPCDVDGYPIPQVFWYKD-GQVIENDGVHYRITES---NRLHINQANATDSGEYRCVASNSYTSDENA 212 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~-g~~l~~~~~~~~~~~~---~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 212 (558)
....+..|+.+.|.|.+.+.+.+.+.|+++ +..+...+ ++..... .+|.|.++..+|+|.|.|.+.|..+.....
T Consensus 2 ~~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~-~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~ 80 (86)
T smart00410 2 PSVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESG-RFSVSRSGSNSTLTISNVTPEDSGTYTCAATNSSGSASST 80 (86)
T ss_pred CcEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCC-cEEEEEcCCeeEEEEEeeccccCeEEEEEEEcCCCeEEEE
Confidence 345678899999999999998899999998 77776333 4444443 589999999999999999999998888777
Q ss_pred EEEEE
Q psy10160 213 VTIRV 217 (558)
Q Consensus 213 ~~l~V 217 (558)
+.|.|
T Consensus 81 ~~l~V 85 (86)
T smart00410 81 TTLTV 85 (86)
T ss_pred EEEEE
Confidence 77766
No 160
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=98.93 E-value=1.1e-08 Score=80.58 Aligned_cols=81 Identities=22% Similarity=0.440 Sum_probs=65.8
Q ss_pred ceEeeCCCcEEEEeEeeccCCCe-EEEEECCEEeccCCce-EEEcc------CCeEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIPQ-VFWYKDGQVIENDGVH-YRITE------SNRLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p~-i~W~~~g~~l~~~~~~-~~~~~------~~sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
...|.+|+.+.|.|.+.++|+|. +.|.+++..+...... +.... .+.|.+.+++.+|.|.|+|.|.|..+..
T Consensus 12 ~~~v~~gE~~~L~V~ieAYP~p~~~~W~~~~~~l~~~~~~~~~~~~~~~~rY~S~L~L~Rlk~~E~G~YTf~a~N~~~~~ 91 (101)
T cd05860 12 TIFVNAGENLDLIVEYEAYPKPEHQQWIYMNRTLTNTSDHYVKSRNESNNRYVSELHLTRLKGTEGGTYTFLVSNSDASA 91 (101)
T ss_pred eEEEECCCCEEEEEEEEeCCCCeeeEEEcCCcccCccccceeEEeccCceEEEEEEEEeecChhhCcEEEEEEECCCCeE
Confidence 45688999999999999999998 9999988765433221 11111 1369999999999999999999999999
Q ss_pred eEEEEEEEe
Q psy10160 210 ENAVTIRVE 218 (558)
Q Consensus 210 ~~~~~l~V~ 218 (558)
+.++.|.|+
T Consensus 92 s~tF~l~v~ 100 (101)
T cd05860 92 SVTFNVYVN 100 (101)
T ss_pred EEEEEEEEe
Confidence 999998874
No 161
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=98.90 E-value=7.2e-09 Score=81.83 Aligned_cols=71 Identities=18% Similarity=0.266 Sum_probs=52.5
Q ss_pred EeeCCCcEEEEeEeeccCCCeEEEEECCEEe-ccC------------CceEEEc----cC--CeEEEccCCCCCCeEEEE
Q psy10160 140 VFGVGSDISIPCDVDGYPIPQVFWYKDGQVI-END------------GVHYRIT----ES--NRLHINQANATDSGEYRC 200 (558)
Q Consensus 140 ~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l-~~~------------~~~~~~~----~~--~sL~I~~v~~~D~G~Y~C 200 (558)
.+.+|+.|+|.|.+.+.|.+.+.|++++... ... ..++... .+ .+|+|.+++.+|+|+|.|
T Consensus 3 ~~~~G~~VtL~C~~s~~~~~~i~W~~~~~k~~~g~~~~l~~~~~~~~~~r~~~~~~~~~~g~~~L~I~~l~~sDsgtY~C 82 (94)
T cd07690 3 LGKKGDTAELPCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRNLWDQGSFPLIIKNLKIEDSDTYIC 82 (94)
T ss_pred EeeCCCCEEEEEEeCCCCCcEEEEEECCcEEccCcCCEEEEecccccCCCCceecccCCCCeEEEEECCCCHHHCEEEEE
Confidence 4678999999999999999999999766332 110 0111111 11 269999999999999999
Q ss_pred EEEeCCceee
Q psy10160 201 VASNSYTSDE 210 (558)
Q Consensus 201 ~a~N~~G~~~ 210 (558)
.+.|..+..+
T Consensus 83 ~v~~~~~~~~ 92 (94)
T cd07690 83 EVEDKKEEVE 92 (94)
T ss_pred EECCccceEE
Confidence 9999877653
No 162
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=98.86 E-value=4.7e-09 Score=77.19 Aligned_cols=59 Identities=37% Similarity=0.693 Sum_probs=45.0
Q ss_pred CCcEEEEeEe-eccCCCeEEEEECCEEeccCCceEEEccCCe----EEEccCCCCCCeEEEEEE
Q psy10160 144 GSDISIPCDV-DGYPIPQVFWYKDGQVIENDGVHYRITESNR----LHINQANATDSGEYRCVA 202 (558)
Q Consensus 144 G~~v~L~C~~-~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~s----L~I~~v~~~D~G~Y~C~a 202 (558)
|+.+.|.|.+ .+.|.+.+.|++++..............+.. |.|.+++.+|+|.|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 1 GSSVTLTCSVSSGPPPTTVTWSKNGQSLPEGSTTNRSTNSVSSTSRLTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp TSEEEEEEEEEESSSTSEEEEEETTTTTSEEEEEEEEETTTEEEEEEEESSCTGGGTEEEEEEE
T ss_pred CCeEEEEeecCCCCCCcEEEEEECCccccCcceeEeecccceeeeEEEEccCCHHHCEEEEEEC
Confidence 7899999999 7778889999999876554321222222222 999999999999999986
No 163
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=98.83 E-value=1.4e-08 Score=77.06 Aligned_cols=69 Identities=16% Similarity=0.319 Sum_probs=51.9
Q ss_pred cEEEEeEe-eccCCCeEEEEECCEEeccCC------ceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee---eEEEEE
Q psy10160 146 DISIPCDV-DGYPIPQVFWYKDGQVIENDG------VHYRITESNRLHINQANATDSGEYRCVASNSYTSD---ENAVTI 215 (558)
Q Consensus 146 ~v~L~C~~-~g~P~p~i~W~~~g~~l~~~~------~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~---~~~~~l 215 (558)
.+.|+|.. .|+|.|.|.|+|++.++.... +.|. ..++|.|.....+|.+.|+|+|.|..+.. .....|
T Consensus 1 ~~~L~C~s~~skP~a~i~W~k~~~~l~~~~~~~~~~~~~t--~~s~L~~~~~~~Ddg~~~~C~A~n~a~~~~~~~~~~~l 78 (80)
T cd05885 1 EVELTCLSPRSKPAATLRWYRDRKELKGVISQQENGKTVS--VSNTIRFPVDRKDDGAILSCEASHPALVSQKKQTQYSL 78 (80)
T ss_pred CEEEEEeCCCccCCCeEEEEECCEECCCCcccccCCceEE--EEEEEEEEeeeccCCcEEEEEEEChhhCCCCeeEEEEE
Confidence 36899996 568999999999999996421 1111 23479999999999999999999988754 344444
Q ss_pred E
Q psy10160 216 R 216 (558)
Q Consensus 216 ~ 216 (558)
.
T Consensus 79 ~ 79 (80)
T cd05885 79 D 79 (80)
T ss_pred e
Confidence 4
No 164
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=98.82 E-value=2.5e-08 Score=80.52 Aligned_cols=84 Identities=18% Similarity=0.218 Sum_probs=61.0
Q ss_pred ecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCE-----Ee----c---------cCCceEEEccCCeEEEccCCCCCC
Q psy10160 134 ITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQ-----VI----E---------NDGVHYRITESNRLHINQANATDS 195 (558)
Q Consensus 134 ~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~-----~l----~---------~~~~~~~~~~~~sL~I~~v~~~D~ 195 (558)
+.+.+..+.+|+++.|.|.....+...+.|+|... .+ + ....|..+..+++|.|.+++.+|+
T Consensus 3 ie~~p~~~~~G~~V~L~v~~~p~~~~~~~W~kg~~~~~~~~I~~y~~~~~~~~~gp~~~gR~~~~~ngSL~I~~v~~~D~ 82 (105)
T cd05774 3 IELVPPQVAEGENVLLLVHNLPENLLAYAWYKGKTVSPNFLIASYIISTNSSTPGPAYSGRETIYPNGSLLIQNVTQKDT 82 (105)
T ss_pred EeccCCcccCCCCEEEEecCCCCCceEEEEEcCCCCCCCEEEEEEECCCcccccCcccCCcEEEeCCCcEEEecCCcccC
Confidence 44556677899999999976433344799999621 11 1 012466677789999999999999
Q ss_pred eEEEEEEEeCCc-eeeEEEEEEE
Q psy10160 196 GEYRCVASNSYT-SDENAVTIRV 217 (558)
Q Consensus 196 G~Y~C~a~N~~G-~~~~~~~l~V 217 (558)
|.|+|.+.|... .....+.|.|
T Consensus 83 G~Y~~~v~~~~~~~~~~~v~l~V 105 (105)
T cd05774 83 GFYTLQTITTNFQVEQATVHLQV 105 (105)
T ss_pred EEEEEEEEeCCccEEEEEEEEEC
Confidence 999999999874 4456666654
No 165
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=98.79 E-value=3.4e-08 Score=76.65 Aligned_cols=72 Identities=22% Similarity=0.547 Sum_probs=50.8
Q ss_pred cEEEEeEeec-cCCCeEEEEECCEEeccCCceEEEccC-------CeEEEccCCCCCCeEEEEEEEeCCcee--eEEEEE
Q psy10160 146 DISIPCDVDG-YPIPQVFWYKDGQVIENDGVHYRITES-------NRLHINQANATDSGEYRCVASNSYTSD--ENAVTI 215 (558)
Q Consensus 146 ~v~L~C~~~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~-------~sL~I~~v~~~D~G~Y~C~a~N~~G~~--~~~~~l 215 (558)
.+.|.|.+.| +|.|.++|+|+|..+...........+ +.|.|.....+|.|.|+|.|.|..... ..+++|
T Consensus 1 ~~~L~C~v~g~~P~~~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~s~L~i~~~~~~~~~~y~C~a~n~~l~~~~~~s~~l 80 (82)
T cd05759 1 PYNLTCRARGAKPAAEIIWFRDGEVLDGATYSKELLKDGKRETTVSTLPITPSDHDTGRTFTCRARNEALPTGKETSVTL 80 (82)
T ss_pred CEEEEEEEeCccCCCEEEEEECCEEccCceeeeeEecCCCeEEEEEEEEEeCceecCCCEEEEEEcCccCCCCcEEEEEE
Confidence 3689999987 699999999999987543211111122 257788777888999999999976444 455555
Q ss_pred EE
Q psy10160 216 RV 217 (558)
Q Consensus 216 ~V 217 (558)
+|
T Consensus 81 ~v 82 (82)
T cd05759 81 DV 82 (82)
T ss_pred cC
Confidence 43
No 166
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=98.78 E-value=1.2e-08 Score=77.54 Aligned_cols=73 Identities=27% Similarity=0.563 Sum_probs=50.7
Q ss_pred cEEEecCCceEeeCCCcEEEEeEeeccC-CCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEe
Q psy10160 130 VKVNITLETQVFGVGSDISIPCDVDGYP-IPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASN 204 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G~~v~L~C~~~g~P-~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N 204 (558)
|.+...+.......+. +.|.|.+.+.| .+.+.|+ ................+++|.|.++..+|.|.|+|.|.|
T Consensus 2 P~I~~~~~~~~~~~~~-~~l~C~~~~~~~~~~~~W~-~~~~~~~~~~~~~~~~~~~L~i~~v~~~~~g~y~C~a~N 75 (75)
T PF13927_consen 2 PQISVPPPPVVTSGGS-VTLTCSAEGGPPPPSISWY-DSNPSFNSNSRGSSSSNSTLTISNVTRSDNGTYTCIASN 75 (75)
T ss_dssp SEEEEESTSEEETTEE-EEEEEEESSEESSEEEEEE-TEEEEEEEEEEEEEEEEEEEEESSCCGGGTEEEEEEEEE
T ss_pred CEEEEcCCCcEeecee-EEEEEEEccccCCeEEEEE-ecCCceeeeeeeccceeeEEEEccCCHHhCcEEEEEEEC
Confidence 5555555555554444 99999999988 7889999 211111111122233456899999999999999999998
No 167
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=98.77 E-value=5.1e-08 Score=75.06 Aligned_cols=77 Identities=21% Similarity=0.479 Sum_probs=59.4
Q ss_pred CceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee--eEEEE
Q psy10160 137 ETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD--ENAVT 214 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~--~~~~~ 214 (558)
....+.+|+.+.|.|...+. .+.+.|++++..+..+. ++.....| |.|.+++.+|+|.|.|.+. ..|.. ...+.
T Consensus 4 ~~~tv~~g~~v~L~C~~~s~-~A~v~W~~ng~~l~~~~-r~~~~~~G-LlI~~~~~~dsG~Y~C~s~-E~gf~~~~~~y~ 79 (85)
T cd05872 4 KNRTVAPGADVVLPCQLRSN-LASPVWLFNGTPLNAQF-SYRVGTDG-LLILVTSPEHSGTYRCYSE-EEGFQQLVASYS 79 (85)
T ss_pred eEEEEecCCCEEEECCCCCC-CccEEEEECCcccCCCc-ceEEeCCC-CEEEECCHhhCEEEEEEEe-cCCCeEEEEEEE
Confidence 35678899999999999885 66999999999987654 66555555 7789999999999999987 33444 35555
Q ss_pred EEE
Q psy10160 215 IRV 217 (558)
Q Consensus 215 l~V 217 (558)
|.|
T Consensus 80 l~v 82 (85)
T cd05872 80 LNV 82 (85)
T ss_pred EEE
Confidence 554
No 168
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=98.70 E-value=8.8e-08 Score=75.69 Aligned_cols=79 Identities=25% Similarity=0.398 Sum_probs=58.1
Q ss_pred ceEeeCCCcEEEEeEee------cc-----CCCeEEEEECCEEeccCC------ceEEEccCCeEEEccCCCCCCeEEEE
Q psy10160 138 TQVFGVGSDISIPCDVD------GY-----PIPQVFWYKDGQVIENDG------VHYRITESNRLHINQANATDSGEYRC 200 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~------g~-----P~p~i~W~~~g~~l~~~~------~~~~~~~~~sL~I~~v~~~D~G~Y~C 200 (558)
...+.+|+++.|.|... ++ +...+.|+|++..+.... .|.. ..+..|.|.++..+|+|.|+|
T Consensus 9 ~~~~~~GE~v~l~C~~~~~~~~~~~~~~~~~~~~v~WyK~~~~~~~~~~~~~~~~Ri~-~~~~~Lwf~Pa~~eDSG~Y~C 87 (104)
T cd05896 9 KYMVLAGEPVRIKCALFYGYIRTNYSMAQSAGLSLMWYKSSGDGEEPIEIIFDGVRMS-KEEDSIWFRPAELQDSGLYTC 87 (104)
T ss_pred eEEEcCCCeEEEECCCccccccccccccccCCceEEEEECCCCCCCCCcccccceeEE-EeCCEEEEEeCChhhCeEEEE
Confidence 35578999999999861 11 234799999975554422 1322 245689999999999999999
Q ss_pred EEEeCCceeeEEEEEEE
Q psy10160 201 VASNSYTSDENAVTIRV 217 (558)
Q Consensus 201 ~a~N~~G~~~~~~~l~V 217 (558)
++.|.......++.|+|
T Consensus 88 ~~rN~t~C~~~~i~l~V 104 (104)
T cd05896 88 VLRNSTYCMKVSMSLTV 104 (104)
T ss_pred EECCCCcceEEEEEEEC
Confidence 99999877777776654
No 169
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=98.66 E-value=2.9e-07 Score=72.66 Aligned_cols=68 Identities=16% Similarity=0.270 Sum_probs=52.5
Q ss_pred CceEeeCCCcEEEEeEeeccCCCeEEEEECCEEec-------cCCceEEEcc-CC---eEEEccCCCCCCeEEEEEEEe
Q psy10160 137 ETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIE-------NDGVHYRITE-SN---RLHINQANATDSGEYRCVASN 204 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~-------~~~~~~~~~~-~~---sL~I~~v~~~D~G~Y~C~a~N 204 (558)
++..+.+|+++.|+|.+.+.+...+.|++.+..+- ..+.||.... ++ +|.|.+++.+|+|.|.|.+..
T Consensus 5 ~nvtv~~G~ta~L~C~v~~~~~~~v~w~~~~~~~i~~~~~~~~~d~Rf~~~~~~~~~~tL~I~~vq~~D~G~Y~Cqv~t 83 (95)
T cd05881 5 EDVTVVEGEVAIISCRVKNNDDSVIQLLNPNRQTIYFRDVRPLKDSRFQLVNFSSNELRVSLSNVSLSDEGRYFCQLYT 83 (95)
T ss_pred CceEEcCCCcEEEEEEEccCCccEEEEEecCCcEEEecCccccCCcCEEEEeCCCCEEEEEECcCCcccCEEEEEEEEc
Confidence 46778999999999999998777788887664331 1234666544 22 699999999999999999875
No 170
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=98.64 E-value=8.9e-08 Score=75.80 Aligned_cols=73 Identities=15% Similarity=0.321 Sum_probs=53.7
Q ss_pred cEEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeC
Q psy10160 130 VKVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNS 205 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~ 205 (558)
|.+...+ ..+|.+|+.|+|.|... .|.+.+.|+|+|....... .......+.+.|.+|+.+|+|.|+|...|.
T Consensus 3 P~L~a~p-~~vV~~G~~VtL~C~~~-~~~~~f~l~k~g~~~~~~~-~~~~~~~~~f~i~~v~~~~~G~Y~C~~~~~ 75 (91)
T cd05751 3 PSLWAEP-SSVVPLGKPVTLRCQGP-YGAVEYRLYREGSTFAVKK-PPEPQNKAKFFIPSMKREHAGRYRCYYRSG 75 (91)
T ss_pred CEEEecC-CCccCCCCcEEEEEecC-CCCCEEEEEECCCCccccc-cCCCceeEEEEccCCChhHCEEEEEEEECC
Confidence 4444544 34678999999999886 6777899999987544211 001122347999999999999999999986
No 171
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.63 E-value=3.2e-07 Score=75.04 Aligned_cols=77 Identities=22% Similarity=0.396 Sum_probs=57.5
Q ss_pred CCCcEEEEeEeeccC------CCeEEEEECCE----E---e-cc---------CCceEEEcc----CCeEEEccCCCCCC
Q psy10160 143 VGSDISIPCDVDGYP------IPQVFWYKDGQ----V---I-EN---------DGVHYRITE----SNRLHINQANATDS 195 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P------~p~i~W~~~g~----~---l-~~---------~~~~~~~~~----~~sL~I~~v~~~D~ 195 (558)
.|+.++|.|.....| ...|.|+|... . + .. -..|+.+.. +.+|.|.+++.+|+
T Consensus 1 ~G~~vtL~C~~~~~~~~~~~~~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~Ds 80 (106)
T cd05877 1 RGGNVTLPCRYHYEPELSAPRKIRVKWTKLESDYLKEEDVLVAIGTRHKSYGSYQGRVFLRRAHDLDASLVITDLRLEDY 80 (106)
T ss_pred CCCcEEEEeEeECCCcCCCCccceEEEEEecCCCCeeEEEEEEcCcEEEeccCccCcEEecCCCCCcEEEEEccCChHHC
Confidence 489999999987764 34699998531 1 1 10 012444422 24799999999999
Q ss_pred eEEEEEEEeCCceeeEEEEEEEec
Q psy10160 196 GEYRCVASNSYTSDENAVTIRVEG 219 (558)
Q Consensus 196 G~Y~C~a~N~~G~~~~~~~l~V~~ 219 (558)
|.|.|.+.|..+.....+.|.|.+
T Consensus 81 G~Y~C~v~~~~~~~~~~~~l~v~~ 104 (106)
T cd05877 81 GRYRCEVIDGLEDESVVVALRLRG 104 (106)
T ss_pred EEEEEEEEecccceEEEEEEEEEE
Confidence 999999999999999999999965
No 172
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=98.61 E-value=1.6e-07 Score=74.59 Aligned_cols=74 Identities=19% Similarity=0.273 Sum_probs=55.3
Q ss_pred CCcEEEEeEeeccCCCeEEEEECCEEec-----------------cCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 144 GSDISIPCDVDGYPIPQVFWYKDGQVIE-----------------NDGVHYRITESNRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p~i~W~~~g~~l~-----------------~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
|++|+|.|.....+...+.|+++..... .-..|+.+..+++|.|.+++.+|+|.|.|.+.+..
T Consensus 1 G~~VtL~c~~~~~~~~~i~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~sL~I~~l~~~DsG~Y~c~v~~~~ 80 (92)
T cd05741 1 GESVTLPVSNLPENLQEITWYKGKDKSVEAEIASYIATNSTVFGPAYSGRETIYPNGSLLIQNLTKEDSGTYTLQIISTN 80 (92)
T ss_pred CCcEEEEcccCCCCCEEEEEECCCCCCcceEEEEEecCCceeECCCcCCeEEEcCCceEEEccCCchhcEEEEEEEEcCC
Confidence 7899999998876677899998653211 01235566667899999999999999999999887
Q ss_pred cee-eEEEEEEE
Q psy10160 207 TSD-ENAVTIRV 217 (558)
Q Consensus 207 G~~-~~~~~l~V 217 (558)
|.. ...+.|.|
T Consensus 81 ~~~~~~~~~l~v 92 (92)
T cd05741 81 GVTENAKFFLRV 92 (92)
T ss_pred CcEEEEEEEEEC
Confidence 544 45555543
No 173
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=98.57 E-value=5.9e-07 Score=73.50 Aligned_cols=77 Identities=26% Similarity=0.551 Sum_probs=56.3
Q ss_pred CCCcEEEEeEeeccC------CCeEEEEECC-----E-Ee-c-cCC---------ceEEE----ccCCeEEEccCCCCCC
Q psy10160 143 VGSDISIPCDVDGYP------IPQVFWYKDG-----Q-VI-E-NDG---------VHYRI----TESNRLHINQANATDS 195 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P------~p~i~W~~~g-----~-~l-~-~~~---------~~~~~----~~~~sL~I~~v~~~D~ 195 (558)
.|+.++|.|.....| .+.|.|+|.. . .+ . .++ .+... ..+.+|.|.+++.+|+
T Consensus 1 ~G~~V~L~C~~~~~~~~~~~~~~~i~W~k~~~~~~~~~~v~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~~v~~sD~ 80 (106)
T cd05714 1 LGGNVTLPCRFHLEPALSAPHGPRIKWTKLESDGAKEVDVLVAIGGRVKVYGSGRVRVPLYPADPGDASLVITDLRLEDS 80 (106)
T ss_pred CCCCEEEeEEeECCcccCCCCCcEEEEEEeCCCCCceEEEEEEcCCEEEEcCCCceEEEeeCCCCCcceEEECCCCHHHC
Confidence 489999999988764 4579999862 1 11 0 111 11111 1234899999999999
Q ss_pred eEEEEEEEeCCceeeEEEEEEEec
Q psy10160 196 GEYRCVASNSYTSDENAVTIRVEG 219 (558)
Q Consensus 196 G~Y~C~a~N~~G~~~~~~~l~V~~ 219 (558)
|.|.|.+.|..+.....+.|.|.+
T Consensus 81 G~Y~C~v~~~~~~~~~~v~L~V~~ 104 (106)
T cd05714 81 GRYRCEVIDGIEDEQDTVELEVRG 104 (106)
T ss_pred EEEEEEEEcCCCceEEEEEEEEEE
Confidence 999999999988888999999865
No 174
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.53 E-value=6.6e-07 Score=73.21 Aligned_cols=77 Identities=23% Similarity=0.457 Sum_probs=57.1
Q ss_pred CCCcEEEEeEeeccC------------CCeEEEEECC--E---Eec-c---------CCceEEEc------cCCeEEEcc
Q psy10160 143 VGSDISIPCDVDGYP------------IPQVFWYKDG--Q---VIE-N---------DGVHYRIT------ESNRLHINQ 189 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P------------~p~i~W~~~g--~---~l~-~---------~~~~~~~~------~~~sL~I~~ 189 (558)
.|++++|.|.....+ .+.|.|+|.. . .+. . -..|+.+. .+.+|+|.+
T Consensus 1 ~G~~VtLpC~~~~~~~~~~~~~~~~~~~~~I~W~k~~~g~~~~ii~~~~~~~~~~~~f~~R~sl~~~~~~~~~asL~I~n 80 (112)
T cd05900 1 LGSSLLIPCYFQDPIAKDPGAPTVAPLSPRIKWSFISKEKESVLLVATEGKVRVNTEYLDRVSLPNYPAIPSDATLEITE 80 (112)
T ss_pred CCCcEEEeeEEeCCcCccccccccCCCCCEEEEEEecCCCccEEEEEECCeEEECccccCeEEecccCCCCCCcEEEEee
Confidence 489999999987543 4589999842 1 110 0 01245443 245899999
Q ss_pred CCCCCCeEEEEEEEeCCceeeEEEEEEEec
Q psy10160 190 ANATDSGEYRCVASNSYTSDENAVTIRVEG 219 (558)
Q Consensus 190 v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 219 (558)
++.+|+|.|.|.+.+........+.|.|.+
T Consensus 81 l~~sDsG~Y~C~V~~g~~~~~~~v~l~v~g 110 (112)
T cd05900 81 LRSNDSGTYRCEVMHGIEDNYDTVEVQVKG 110 (112)
T ss_pred cccccCEEEEEEEecCCCCceeEEEEEEEe
Confidence 999999999999999888888999998875
No 175
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.52 E-value=3.9e-07 Score=74.99 Aligned_cols=73 Identities=25% Similarity=0.429 Sum_probs=54.5
Q ss_pred cCCceEeeCCCcEEEEeEeeccCCCeEEEEECCE---E---ec-------cCCceEEEcc-----CCeEEEccCCCCCCe
Q psy10160 135 TLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQ---V---IE-------NDGVHYRITE-----SNRLHINQANATDSG 196 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~---~---l~-------~~~~~~~~~~-----~~sL~I~~v~~~D~G 196 (558)
.+....+.+|+++.|.|.+.+.+.+.+.|+|... + +. ....++.+.. ..+|.|.+++.+|+|
T Consensus 4 ~~~~v~~~~G~~v~L~C~~~~~~~~~v~W~k~~~~~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~~~~~DsG 83 (109)
T cd04983 4 SPQSLSVQEGENVTLNCNYSTSTFYYLFWYRQYPGQGPQFLIYISSNGEEKEKGRFSATLDKSRKSSSLHISAAQLSDSA 83 (109)
T ss_pred cCCceEEcCCCCEEEEEEECCCCccEEEEEEECCCCCeEEEEEEecCCCcccCCcEEEEEcccCCEEEEEECCCCHHHCE
Confidence 4567788999999999999988888999998431 0 00 1123554432 237999999999999
Q ss_pred EEEEEEEeCCc
Q psy10160 197 EYRCVASNSYT 207 (558)
Q Consensus 197 ~Y~C~a~N~~G 207 (558)
.|.|.+.+..+
T Consensus 84 ~Y~C~~~~~~~ 94 (109)
T cd04983 84 VYFCALSESGG 94 (109)
T ss_pred EEEEEEecCCC
Confidence 99999997643
No 176
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=98.48 E-value=1.5e-06 Score=71.63 Aligned_cols=81 Identities=22% Similarity=0.298 Sum_probs=54.2
Q ss_pred CCceEeeCCCcEEEEeEeecc----CCCeEEEEE---------------CCEEeccC-C---ceEEEc-----cCCeEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGY----PIPQVFWYK---------------DGQVIEND-G---VHYRIT-----ESNRLHI 187 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~----P~p~i~W~~---------------~g~~l~~~-~---~~~~~~-----~~~sL~I 187 (558)
+.+..+..|+.+.|.|..... +...+.|.+ +|...... + .|.... .+.+|.|
T Consensus 5 ~~ev~a~~G~~v~L~C~f~~~~~~~~~~~v~W~~~~~~~~~~~~v~~y~~g~~~~~~~~~f~~Rv~f~g~~~~~daSI~I 84 (116)
T cd05879 5 DREVYGTVGSDVTLSCSFWSSEWISDDISFTWHYQPDGSRDAISIFHYGKGQPYIDDVGPFKERIEWVGNPSRKDGSIVI 84 (116)
T ss_pred cceEEEEcCCcEEEEEEEecCCCCCCcEEEEEEEcCCCCCccEEEEEeCCCceecccccCccCceEEeCCCCcCeeEEEE
Confidence 445677899999999998764 345799943 33332211 1 133322 2358999
Q ss_pred ccCCCCCCeEEEEEEEeCCceee--EEEEEE
Q psy10160 188 NQANATDSGEYRCVASNSYTSDE--NAVTIR 216 (558)
Q Consensus 188 ~~v~~~D~G~Y~C~a~N~~G~~~--~~~~l~ 216 (558)
.+++.+|+|.|+|.+.|.-+... ..+.|.
T Consensus 85 ~nv~~sD~G~Y~C~v~n~p~~~~~~~~~~l~ 115 (116)
T cd05879 85 HNLDYTDNGTFTCDVKNPPDIVGKSSQVTLY 115 (116)
T ss_pred ccCCcccCEEEEEEEEcCCCcCCceeEEEEE
Confidence 99999999999999999866443 344443
No 177
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=98.47 E-value=1.2e-06 Score=70.70 Aligned_cols=74 Identities=23% Similarity=0.422 Sum_probs=51.5
Q ss_pred CCcEEEEeEeeccCC---CeEEEEECCE--Ee---------cc--C---CceEEEcc------CCeEEEccCCCCCCeEE
Q psy10160 144 GSDISIPCDVDGYPI---PQVFWYKDGQ--VI---------EN--D---GVHYRITE------SNRLHINQANATDSGEY 198 (558)
Q Consensus 144 G~~v~L~C~~~g~P~---p~i~W~~~g~--~l---------~~--~---~~~~~~~~------~~sL~I~~v~~~D~G~Y 198 (558)
|+++.|.|....... ..+.|+|... .+ .. . ..|+.+.. +.+|.|.+++.+|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~v~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~sL~I~~v~~~D~G~Y 80 (100)
T cd05713 1 GEDAELPCHLSPKMSAEHMEVRWFRSQFSPAVHLYRDGQDQYGEQMPEYRGRTELLKDAIAEGSVALRIHNVRASDEGLY 80 (100)
T ss_pred CCcEEEEeEEcCCCCCCeeEEEEEECCCceeEEEEcCCcccccccCccccceEEeecccccCCcEEEEEEcCChhhCEEE
Confidence 788999999864322 2477877541 11 10 0 12443321 24799999999999999
Q ss_pred EEEEEeCCceeeEEEEEEE
Q psy10160 199 RCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 199 ~C~a~N~~G~~~~~~~l~V 217 (558)
.|.+.|..+..+..+.|.|
T Consensus 81 ~C~v~~~~~~~~~~i~l~v 99 (100)
T cd05713 81 TCFFQSDGFYEEATVELKV 99 (100)
T ss_pred EEEEecCCcEEEEEEEEEE
Confidence 9999998888888888877
No 178
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.39 E-value=1.2e-06 Score=72.07 Aligned_cols=72 Identities=18% Similarity=0.402 Sum_probs=53.0
Q ss_pred ecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCE--Ee---------------ccCCceEEEcc----CCeEEEccCCC
Q psy10160 134 ITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQ--VI---------------ENDGVHYRITE----SNRLHINQANA 192 (558)
Q Consensus 134 ~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~--~l---------------~~~~~~~~~~~----~~sL~I~~v~~ 192 (558)
..|....+.+|++++|.|.+.+ +.+.+.|+|... .. .....++.... ..+|.|.+++.
T Consensus 3 Q~p~~~~v~~G~~v~l~C~~~~-~~~~v~Wykq~~g~~~~~l~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~~~~~ 81 (110)
T cd05899 3 QSPRYLIKGRGQSVTLRCSQTS-GHDNMYWYRQDPGKGLQLLFYSNGGSLNEEEGDPKDRFSASRPSLTRSSLTIKSAEP 81 (110)
T ss_pred ECCCceEEcCCCcEEEEEEECC-CCCEEEEEEECCCCCcEEEEEEcCCCceEecCccCCceEEECcCCCccEEEECCCCh
Confidence 3456778899999999999988 778899998531 11 01123454322 23799999999
Q ss_pred CCCeEEEEEEEeCC
Q psy10160 193 TDSGEYRCVASNSY 206 (558)
Q Consensus 193 ~D~G~Y~C~a~N~~ 206 (558)
+|+|.|.|.+.+..
T Consensus 82 ~Dsg~Y~Ca~~~~~ 95 (110)
T cd05899 82 EDSAVYLCASSLGG 95 (110)
T ss_pred hhCEEEEEEeeCCC
Confidence 99999999998754
No 179
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=98.38 E-value=1.4e-06 Score=69.73 Aligned_cols=76 Identities=14% Similarity=0.312 Sum_probs=54.6
Q ss_pred eCCCcEEEEeEeec-cCCCeEEEEECCEEecc-------C---------CceEEEccC-CeEEEccCCCCCCeEEEEEEE
Q psy10160 142 GVGSDISIPCDVDG-YPIPQVFWYKDGQVIEN-------D---------GVHYRITES-NRLHINQANATDSGEYRCVAS 203 (558)
Q Consensus 142 ~~G~~v~L~C~~~g-~P~p~i~W~~~g~~l~~-------~---------~~~~~~~~~-~sL~I~~v~~~D~G~Y~C~a~ 203 (558)
..|++|+|.|.... .....+.|+|....+.. . ..|+.+..+ .+|.|.+++.+|+|.|.|.+.
T Consensus 2 ~~G~sVtL~c~~~~~~~~~~v~W~~~~~~~i~~~~~~~~~~~~~~~~~f~~R~~~~~~~~sL~I~~~~~~DsG~Y~c~v~ 81 (97)
T cd05775 2 ILGGSVTLPLNIPDGTEIESITWSFNTSLAIITPGEETAPEIIVTDPSYKERVNFSQNDYSLQISNLKMEDAGSYRAEIN 81 (97)
T ss_pred ccCCeEEEeCCCCCCcEEEEEEEecCCEeEEEecCCCCCCccEEeCCCceeeEEecCCceeEEECCCchHHCEEEEEEEE
Confidence 36999999998755 44456999986432210 0 024444443 689999999999999999999
Q ss_pred eCCcee-eEEEEEEE
Q psy10160 204 NSYTSD-ENAVTIRV 217 (558)
Q Consensus 204 N~~G~~-~~~~~l~V 217 (558)
+..|.. ...+.|.|
T Consensus 82 ~~~~~~~~~~f~L~v 96 (97)
T cd05775 82 TKNGVTITKEFTLHI 96 (97)
T ss_pred cCCCCeEEEEEEEEe
Confidence 988766 46677766
No 180
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=98.36 E-value=7.1e-07 Score=68.99 Aligned_cols=40 Identities=15% Similarity=0.375 Sum_probs=35.4
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCC
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALP 51 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p 51 (558)
.+++|.|.+++.+|+|.|+|.|.|..+... ++.|.|.++|
T Consensus 45 ~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a~a~L~V~~pP 85 (85)
T cd05853 45 SAGDLMIRSIQLKHAGKYVCMVQTSVDKLSAAADLIVRGPP 85 (85)
T ss_pred CCCcEEEecCCHHHCEEEEEEEEcccCceEEEEEEEEecCC
Confidence 457899999999999999999999998874 7888888765
No 181
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=98.36 E-value=2.9e-06 Score=68.23 Aligned_cols=73 Identities=21% Similarity=0.309 Sum_probs=51.8
Q ss_pred CcEEEEeEeeccC---CCeEEEEECCEE----e-----------cc-CCceEEEc----cCCeEEEccCCCCCCeEEEEE
Q psy10160 145 SDISIPCDVDGYP---IPQVFWYKDGQV----I-----------EN-DGVHYRIT----ESNRLHINQANATDSGEYRCV 201 (558)
Q Consensus 145 ~~v~L~C~~~g~P---~p~i~W~~~g~~----l-----------~~-~~~~~~~~----~~~sL~I~~v~~~D~G~Y~C~ 201 (558)
+.++|.|.....+ ...|.|+|.... + .. ...|.... .+.+|.|.+++.+|+|.|.|.
T Consensus 1 ~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~ 80 (98)
T cd05718 1 ESVTLECSFPVPGPVQITQVTWMKITGGSKQNIAVFHPQYGISIPPSYEGRVSFLNSSLEDATISISNLRLEDEGNYICE 80 (98)
T ss_pred CCEEEEeEeeCCCCceEEEEEEeeECCCCCEEEEEEecCCCcccCcCcCceEEEeCCCCCceEEEEccCCcccCEEEEEE
Confidence 4789999987765 346999985421 0 00 01132222 245899999999999999999
Q ss_pred EEe-CCceeeEEEEEEE
Q psy10160 202 ASN-SYTSDENAVTIRV 217 (558)
Q Consensus 202 a~N-~~G~~~~~~~l~V 217 (558)
+.+ ..|.....+.|.|
T Consensus 81 v~~~~~g~~~~~~~l~V 97 (98)
T cd05718 81 FATFPQGNRQKVTTLTV 97 (98)
T ss_pred EEeCCCCcEEEEEEEEe
Confidence 976 6788888888877
No 182
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=98.36 E-value=4.8e-06 Score=68.31 Aligned_cols=77 Identities=25% Similarity=0.522 Sum_probs=56.5
Q ss_pred CCCcEEEEeEeeccCC----------CeEEEEECC--EEec----cC---------CceEEEc------cCCeEEEccCC
Q psy10160 143 VGSDISIPCDVDGYPI----------PQVFWYKDG--QVIE----ND---------GVHYRIT------ESNRLHINQAN 191 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P~----------p~i~W~~~g--~~l~----~~---------~~~~~~~------~~~sL~I~~v~ 191 (558)
.|+.++|.|.....+. ..|.|+|.. +... .+ ..|+.+. .+.+|+|.+++
T Consensus 1 ~G~~V~LpC~~~~~~~~~~~~~~~~~~~i~W~k~~~~~~~~v~~~~~~~~~~~~~f~gR~~~~~~~~~~~~asL~I~~l~ 80 (110)
T cd05878 1 LSSSVLLPCYFTLPPALPPPSNAPESPRIKWTKLSGQKEVTVLVAQDGVVKVGQEYQGRVSLPNYPENRGDASLEISRLR 80 (110)
T ss_pred CCCCEEEeeEeeCCccccccccCCCCCEEEEEEecCCCcEEEEEEECCEEEecccccCeEEeccCCCCCCcEEEEECCCC
Confidence 3899999999877552 459999852 1110 00 1244442 23479999999
Q ss_pred CCCCeEEEEEEEeCCceeeEEEEEEEec
Q psy10160 192 ATDSGEYRCVASNSYTSDENAVTIRVEG 219 (558)
Q Consensus 192 ~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 219 (558)
.+|+|.|.|.+.......+..+.|.|.+
T Consensus 81 ~sD~G~Y~C~v~~~~~~~~~~v~l~V~g 108 (110)
T cd05878 81 SSDSGVYRCEVMHGIEDEQDTVPLEVTG 108 (110)
T ss_pred hhhCEEEEEEEEeCCCcceEEEEEEEEE
Confidence 9999999999999888888999999865
No 183
>PHA03376 BARF1; Provisional
Probab=98.35 E-value=3.5e-06 Score=72.76 Aligned_cols=122 Identities=18% Similarity=0.153 Sum_probs=69.4
Q ss_pred ceEeeCCCcEEEEeEeec---cCCCeEEEEECCE----E-ec-----------cCCceEEE---ccCCeEEEccCCCCCC
Q psy10160 138 TQVFGVGSDISIPCDVDG---YPIPQVFWYKDGQ----V-IE-----------NDGVHYRI---TESNRLHINQANATDS 195 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g---~P~p~i~W~~~g~----~-l~-----------~~~~~~~~---~~~~sL~I~~v~~~D~ 195 (558)
...+..|+.+.|+|.-.. .+.-.|.|+|.+. . +. ....++.+ ..+-+|.|.+++.+|.
T Consensus 20 pVta~VGEda~LsC~lnp~ssa~~MrIrWqKs~p~~~~VvL~~~ggdVv~~QmEyRGrtD~~~~~gnvsLvI~~l~lSDd 99 (221)
T PHA03376 20 AVTAFLGERVTLTSYWRRVSLGPEIEVSWFKLGPGEEQVLIGRMHHDVIFIEWPFRGFFDIHRSANTFFLVVTAANISHD 99 (221)
T ss_pred chhheeCCcEEEEecccCccCCCceEEEEEecCCCCCCEEEEEcCCeeeeeeeccccEEEEEecCCeEEEEEEeeeecCC
Confidence 445678999999998652 2444699999431 1 11 11123333 2334799999999999
Q ss_pred eEEEEEEEeCCceeeEEEEEEEeccCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCCCCcccccchhh
Q psy10160 196 GEYRCVASNSYTSDENAVTIRVEGIFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAV 274 (558)
Q Consensus 196 G~Y~C~a~N~~G~~~~~~~l~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l 274 (558)
|+|+|...-........-+|.+..|. ++.+...-..+.. ......+|...|.|+|.+.|+.+.-
T Consensus 100 GtY~C~fQkge~~~~k~ehLt~V~~~--------------~Lsv~a~~~dFp~-~~~~~i~C~sggfP~P~~~Wle~~~ 163 (221)
T PHA03376 100 GNYLCRMKLGETEVTKQEHLSVVKPL--------------TLSVHSERSQFPD-FSVLTVTCTVNAFPHPHVQWLMPEG 163 (221)
T ss_pred ceEEEEEEcCCCceeeeeeeeeeecc--------------eEEEEeccccCCC-CCeeEEEEecCCcCCchheeccccC
Confidence 99999998765444333333332110 0000000000000 0111145667799999999999853
No 184
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=98.34 E-value=2.4e-06 Score=69.83 Aligned_cols=73 Identities=18% Similarity=0.319 Sum_probs=52.0
Q ss_pred EecCCceEeeCCCcEEEEeEeeccC-CCeEEEEECC--E---Eec--------cCCceEEEccC---CeEEEccCCCCCC
Q psy10160 133 NITLETQVFGVGSDISIPCDVDGYP-IPQVFWYKDG--Q---VIE--------NDGVHYRITES---NRLHINQANATDS 195 (558)
Q Consensus 133 ~~~~~~~~v~~G~~v~L~C~~~g~P-~p~i~W~~~g--~---~l~--------~~~~~~~~~~~---~sL~I~~v~~~D~ 195 (558)
...|....+.+|++++|.|.+.+.+ ...+.|+|.. . .+. ....++....+ .+|.|.+++.+|+
T Consensus 4 ~Q~p~~~~v~~G~~v~L~C~~~~~~~~~~~~Wyrq~~g~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~L~I~~~~~~Ds 83 (106)
T cd04980 4 TQSPATLSVSPGESATISCKASQSVSSNYLAWYQQKPGQAPKLLIYGASTLASGTPSRFSGSGSGTDFTLTISRVEPEDA 83 (106)
T ss_pred EECCCcEEECCCCCEEEEEEECCCCCCCcEEEEEECCCCCcEEEEECccccCCCCCCCEEEeccCCEEEEEECCCChHHC
Confidence 3456677889999999999998766 5679999742 1 110 01124544332 2699999999999
Q ss_pred eEEEEEEEeC
Q psy10160 196 GEYRCVASNS 205 (558)
Q Consensus 196 G~Y~C~a~N~ 205 (558)
|.|.|.+.+.
T Consensus 84 g~Y~Ca~~~~ 93 (106)
T cd04980 84 AVYYCQQYGT 93 (106)
T ss_pred EEEEEEEeCC
Confidence 9999998764
No 185
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=98.27 E-value=2.6e-06 Score=69.53 Aligned_cols=68 Identities=24% Similarity=0.405 Sum_probs=49.9
Q ss_pred EeeCCCcEEEEeEeecc-CCCeEEEEECCE-----Eec-----------cCCceEEEcc-----CCeEEEccCCCCCCeE
Q psy10160 140 VFGVGSDISIPCDVDGY-PIPQVFWYKDGQ-----VIE-----------NDGVHYRITE-----SNRLHINQANATDSGE 197 (558)
Q Consensus 140 ~v~~G~~v~L~C~~~g~-P~p~i~W~~~g~-----~l~-----------~~~~~~~~~~-----~~sL~I~~v~~~D~G~ 197 (558)
.+.+|+.++|.|.+.+. +.+.+.|+|... .+. ....++.+.. ..+|.|.+++.+|+|.
T Consensus 2 ~v~~G~~v~L~C~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~r~~~~~~~~~~~~sL~I~~v~~~D~G~ 81 (105)
T cd00099 2 SVSEGESVTLSCTYSGSFSSYYIFWYRQKPGKGPELLIYISSNGSQYAGGVKGRFSGTRDSSKSSFTLTISSLQPEDSAV 81 (105)
T ss_pred eecCCCCEEEEEEEeCCcCcceEEEEEECCCCCCEEEEEEeCCCCccCccCCCcEEEEEeccCCEEEEEECCCCHHHCEE
Confidence 46789999999999987 677899998432 110 0122444332 2279999999999999
Q ss_pred EEEEEEeCCc
Q psy10160 198 YRCVASNSYT 207 (558)
Q Consensus 198 Y~C~a~N~~G 207 (558)
|.|.+.+..+
T Consensus 82 Y~C~v~~~~~ 91 (105)
T cd00099 82 YYCAVSLSGG 91 (105)
T ss_pred EEEEEecCCC
Confidence 9999998775
No 186
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=98.26 E-value=5.8e-06 Score=67.39 Aligned_cols=77 Identities=23% Similarity=0.442 Sum_probs=55.3
Q ss_pred CCCcEEEEeEeeccC-------CCeEEEEECC-----EEe----ccC---------CceEEEcc------CCeEEEccCC
Q psy10160 143 VGSDISIPCDVDGYP-------IPQVFWYKDG-----QVI----END---------GVHYRITE------SNRLHINQAN 191 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P-------~p~i~W~~~g-----~~l----~~~---------~~~~~~~~------~~sL~I~~v~ 191 (558)
.|+.+.|.|...-.| .|.|.|.|.. ... ..+ ..|..+.. +.+|.|.+++
T Consensus 1 ~~~~v~LpC~~~~~p~~~~~~~~~~I~W~k~~~~~~~~~~~v~v~~~~~~~~~~~y~gRvsl~~~~~~~~~asL~i~nv~ 80 (110)
T cd05902 1 LSSSVLLPCVFTLPPSASSPPEGPRIKWTKLRPASGQKQRPVLVARDNVVRVAKAFQGRVSLPGYPKNRYNASLVLSRLR 80 (110)
T ss_pred CCCcEEEeeEEEcCccccCCCCCCEEEEEEeCCCCCceEEEEEECCCCcEEEchhcccEEEeecCCCCCceEEEEECCCC
Confidence 378999999966433 3679999741 111 011 12444422 3489999999
Q ss_pred CCCCeEEEEEEEeCCceeeEEEEEEEec
Q psy10160 192 ATDSGEYRCVASNSYTSDENAVTIRVEG 219 (558)
Q Consensus 192 ~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 219 (558)
.+|+|.|.|.+.......+..+.|.|.+
T Consensus 81 ~~D~G~Y~C~v~~g~~~~~~~v~L~V~g 108 (110)
T cd05902 81 YSDSGTYRCEVVLGINDEQDTVPLEVTG 108 (110)
T ss_pred HHHCEEEEEEEEECCcccEEEEEEEEEE
Confidence 9999999999999887778999999865
No 187
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=98.26 E-value=8.9e-06 Score=61.95 Aligned_cols=72 Identities=13% Similarity=0.290 Sum_probs=49.0
Q ss_pred EEEEeEeec-cCCCeEEEEECCEEeccCCceEEEcc-----CCeEEEccCCCCCCeEEEEEEEeCCce-eeEEEEEEEe
Q psy10160 147 ISIPCDVDG-YPIPQVFWYKDGQVIENDGVHYRITE-----SNRLHINQANATDSGEYRCVASNSYTS-DENAVTIRVE 218 (558)
Q Consensus 147 v~L~C~~~g-~P~p~i~W~~~g~~l~~~~~~~~~~~-----~~sL~I~~v~~~D~G~Y~C~a~N~~G~-~~~~~~l~V~ 218 (558)
+.|.|.+.| .|.+.|.|++++.++........... .++|.|..-..+|...|+|+|.|+.-. ...+..|.|.
T Consensus 2 ~~L~C~s~gSkP~A~I~W~k~~~~l~~~~~~~~~~~~~~t~~S~L~~~p~~eDdG~~~~C~a~~~~l~~~~~~~~L~V~ 80 (82)
T cd05883 2 IELNCTAMASKPAATIRWFKGNKELTGKSTVEETWSRMFTVTSQLMLKVTKEDDGVPVICLVDHPAVKDLQTQRYLEVQ 80 (82)
T ss_pred EEEEEEecCCCCCCEEEEEECCEECcCcccceeccCCCcEEEEEEEEECchhhCCCEEEEEEcCcccCCceeeEEEEEE
Confidence 689999765 68889999999999865321100111 136888666666677999999997532 3566666664
No 188
>cd05755 Ig2_ICAM-1_like Second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ ICAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. ICAM-1 may be involved in organ targeted tumor metastasis. The interaction of ICAM-1 with leukocyte function-associated antigen-1 (LFA-1) plays a part in leukocyte-endothelial cell recognition. This group also contains ICAM-2, which also interacts with LFA-1. Transmigration of immature dendritic cells across resting endothelium is dependent on the interaction of ICAM-2 with, yet unidentified, ligand(s) on the dendritic cells. ICAM-1 has five Ig-like domains and ICAM-2 has two. ICAM-1 may also act as host receptor for viruses and parasites.
Probab=98.26 E-value=4.5e-06 Score=66.27 Aligned_cols=77 Identities=17% Similarity=0.374 Sum_probs=54.5
Q ss_pred cEEEecCCceEeeCCCcEEEEeEeec-cCCCe--EEEEECCEEeccCCceEEE------ccCCeEEEccCCCCCCe-EEE
Q psy10160 130 VKVNITLETQVFGVGSDISIPCDVDG-YPIPQ--VFWYKDGQVIENDGVHYRI------TESNRLHINQANATDSG-EYR 199 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G~~v~L~C~~~g-~P~p~--i~W~~~g~~l~~~~~~~~~------~~~~sL~I~~v~~~D~G-~Y~ 199 (558)
..+.+.+.+..+.+|+.++|.|.+.| .|.+. |.|+|++..+.... +.. ....+|.+. +.++|.| .|+
T Consensus 2 ~~V~l~~~p~~~~eG~~~tL~C~v~g~~P~a~L~i~W~rG~~~l~~~~--~~~~~~~~~~~~stlt~~-~~r~D~g~~~s 78 (100)
T cd05755 2 DSVELSPLPSWQPVGKNYTLQCDVPGVAPRQNLTVVLLRGNETLSRQP--FGDNTKSPVNAPATITIT-VDREDHGANFS 78 (100)
T ss_pred ceEEEecCCCcccCCCcEEEEEEEcCcCCCCcEEEEEeeCCEEcccce--eccccCCCceeEEEEEEe-cchhhCCcEEE
Confidence 34566677777899999999999876 67776 79999999886431 111 112356665 4455555 999
Q ss_pred EEEEeCCcee
Q psy10160 200 CVASNSYTSD 209 (558)
Q Consensus 200 C~a~N~~G~~ 209 (558)
|+|.+..+..
T Consensus 79 C~A~l~l~~~ 88 (100)
T cd05755 79 CETELDLRPE 88 (100)
T ss_pred EEEEeccCcc
Confidence 9999976554
No 189
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=98.26 E-value=1.2e-05 Score=65.72 Aligned_cols=76 Identities=22% Similarity=0.501 Sum_probs=55.6
Q ss_pred CCcEEEEeEeeccCC-----------CeEEEEEC-----CE-----Ee-c-cC---------CceEEEc------cCCeE
Q psy10160 144 GSDISIPCDVDGYPI-----------PQVFWYKD-----GQ-----VI-E-ND---------GVHYRIT------ESNRL 185 (558)
Q Consensus 144 G~~v~L~C~~~g~P~-----------p~i~W~~~-----g~-----~l-~-~~---------~~~~~~~------~~~sL 185 (558)
|++++|.|...-.|. +.|.|++- +. .+ . .+ ..|..+. .+.+|
T Consensus 2 ~g~v~LPC~f~~~p~~p~~~~~~~~~~rIkW~~~~~~~~g~~~~e~~Vlv~~~g~~~~~~~y~gRv~l~~~~~~~g~asL 81 (117)
T cd05901 2 SGSVVLPCRFSTLPTLPPSVITTSEFLRIKWTKIEVDKNGKDHKETTVLVAQNGIIKIGQEYMGRVSVPSHPEDQGDASL 81 (117)
T ss_pred CCCEEEeeEEEecCCCCCcccCCCCCcEEEEEEecccccccCCCccEEEEEECCEEEECCcccCcEEeeccCCcCCceEE
Confidence 688999999886552 36999874 11 11 0 01 1133332 23589
Q ss_pred EEccCCCCCCeEEEEEEEeCCceeeEEEEEEEec
Q psy10160 186 HINQANATDSGEYRCVASNSYTSDENAVTIRVEG 219 (558)
Q Consensus 186 ~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 219 (558)
.|.+++.+|+|.|.|.+.+........+.|.|.+
T Consensus 82 ~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V~G 115 (117)
T cd05901 82 TIVKLRASDAGVYRCEVMHGIEDTQDTVSLDVSG 115 (117)
T ss_pred EEcccccccCEEEEEEEEECCcccEEEEEEEEEE
Confidence 9999999999999999999999999999999975
No 190
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=98.24 E-value=8.1e-06 Score=67.89 Aligned_cols=73 Identities=19% Similarity=0.242 Sum_probs=49.1
Q ss_pred CCceEeeCCCcEEEEeEeeccC----CCeEEEEECCE------Ee-c-------c-CCce----EEEcc-----CCeEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYP----IPQVFWYKDGQ------VI-E-------N-DGVH----YRITE-----SNRLHI 187 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P----~p~i~W~~~g~------~l-~-------~-~~~~----~~~~~-----~~sL~I 187 (558)
|....+.+|+.++|.|...... ...+.|++... .+ . . ...+ +.+.. +.+|+|
T Consensus 5 p~~v~v~~G~~vtL~C~~s~~~~~~~~~~v~W~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~sL~I 84 (116)
T cd05715 5 PREVYAVNGSDVRLKCTFSSSEPISDDISVTWSFQPEGSGDTESIFHYHKGPYYPLKDGRFKDRVEWVGNPSRKDASIVI 84 (116)
T ss_pred CCeEEEEcCCCeEEEeEEeCCCCcCCceEEEEEEecCCCCCcEEEEEEcCCccccccCccccCcEEEecCCcCCeeEEEE
Confidence 4566788999999999886542 24599986321 11 0 0 1112 22222 247999
Q ss_pred ccCCCCCCeEEEEEEEeCCce
Q psy10160 188 NQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 188 ~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
.+++.+|+|.|.|.+.|.-+.
T Consensus 85 ~~v~~~D~G~Y~C~v~~~~~~ 105 (116)
T cd05715 85 HNLQFTDNGTYTCDVKNPPDI 105 (116)
T ss_pred eeCCcccCEEEEEEEEeCCCC
Confidence 999999999999999987553
No 191
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=98.24 E-value=6.4e-06 Score=68.21 Aligned_cols=73 Identities=18% Similarity=0.262 Sum_probs=49.3
Q ss_pred CCceEeeCCCcEEEEeEeeccC----CCeEEEEEC----CEE--ec---c-----CC----ceEEEc-----cCCeEEEc
Q psy10160 136 LETQVFGVGSDISIPCDVDGYP----IPQVFWYKD----GQV--IE---N-----DG----VHYRIT-----ESNRLHIN 188 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P----~p~i~W~~~----g~~--l~---~-----~~----~~~~~~-----~~~sL~I~ 188 (558)
+....+.+|+.+.|.|.....+ .+.|.|++. +.+ +. . .. .|+... .+.+|.|.
T Consensus 5 ~~~v~~~~G~~v~L~C~~s~~~~~~~~~~i~W~~~~~~~~~~~~v~~~~~~~~~~~~~~f~~R~~~~~~~~~~~~sL~I~ 84 (115)
T cd05880 5 SKEVEAVNGTDVRLKCTFSSSAPIGDTLVITWNFRPLDGGREESVFYYHKRPYPPPDGRFKGRVVWDGNIMRRDASILIW 84 (115)
T ss_pred CceEEEEcCCCEEEEEEEEeCCCCCCcEEEEEEEECCCCCceeEEEEECCCccccCcccccCeEEEecCCcCCceEEEEe
Confidence 4566788999999999976543 235999752 111 10 0 01 122221 23479999
Q ss_pred cCCCCCCeEEEEEEEeCCce
Q psy10160 189 QANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 189 ~v~~~D~G~Y~C~a~N~~G~ 208 (558)
+++.+|+|.|.|.+.|..+.
T Consensus 85 ~v~~~D~G~Y~C~v~~~~~~ 104 (115)
T cd05880 85 QLQPTDNGTYTCQVKNPPDV 104 (115)
T ss_pred eCChhhCEEEEEEEEeCCCC
Confidence 99999999999999997664
No 192
>PF10397 ADSL_C: Adenylosuccinate lyase C-terminus; InterPro: IPR019468 Adenylosuccinate lyase catalyses two steps in the synthesis of purine nucleotides: the conversion of succinylaminoimidazole-carboxamide ribotide into aminoimidazole-carboxamide ribotide (the fifth step of de novo IMP biosynthesis); the formation of adenosine monophosphate (AMP) from adenylosuccinate (the final step in the synthesis of AMP from IMP) []. This entry represents the C-terminal, seven alpha-helical, domain of adenylosuccinate lyase [].; PDB: 1YIS_A 1C3U_B 1C3C_A 3C8T_A 2PFM_B 1RE5_D 1Q5N_A 2VD6_D 2J91_B 2X75_A.
Probab=98.21 E-value=1.2e-06 Score=67.31 Aligned_cols=58 Identities=34% Similarity=0.536 Sum_probs=46.0
Q ss_pred hhhHhhhhhcccc-cChHHHHHHH----HHHHHcCCCHHHHHHHc----CCCCHHHHhhhcCcccccCC
Q psy10160 498 HESLMLVTALNPH-IGYDKAAKIA----KTAHKEGTTLKVAALKL----GYLTEEEFNKWVVPEDMLGP 557 (558)
Q Consensus 498 ~~~~~~~~~la~~-l~~~~a~~~~----~~a~~~~~~~~~~~~~~----~~l~~~~~~~~~~p~~~~~~ 557 (558)
++.+|+ +|++. +|+++||+++ ++|.++|.+|+|.+.++ ..|++++|+++|||..|+|.
T Consensus 6 SE~v~~--~L~~~G~gR~~Ah~lv~~~a~~a~~~~~~l~e~l~~d~~i~~~ls~~el~~l~dp~~ylg~ 72 (81)
T PF10397_consen 6 SERVML--ALAEKGLGRQEAHELVQEAAMEAWENGRDLREVLLADPEIAAYLSEEELEELFDPESYLGN 72 (81)
T ss_dssp HHHHHH--HHHHTTH-HHHHHHHHHHHHHHHHHTTS-HHHHHCTTHHHHTTSHHHHHHHHT-GGGGCTT
T ss_pred HHHHHH--HHHHHccCHHHHHHHHHHHHHHHHHHCCCHHHHHHCCHHHHhHCCHHHHHhhcCHHHHHhh
Confidence 456664 78887 9999999865 46778999999999864 67999999999999999985
No 193
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=98.21 E-value=2.9e-06 Score=63.84 Aligned_cols=41 Identities=24% Similarity=0.383 Sum_probs=34.2
Q ss_pred CCceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 6 SENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 6 ~~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
..|+.+ .+++|.|.+++.+|+|.|+|.|.|..|... ++.|+
T Consensus 30 ~~r~~~~~~g~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 72 (73)
T cd05852 30 NSRISIWDDGSLEILNITKLDEGSYTCFAENNRGKANSTGVLS 72 (73)
T ss_pred CCCEEEcCCCEEEECcCChhHCEEEEEEEECCCCceeEEEEEE
Confidence 456765 678999999999999999999999999875 44544
No 194
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=98.19 E-value=1.3e-05 Score=64.52 Aligned_cols=72 Identities=24% Similarity=0.449 Sum_probs=49.5
Q ss_pred cEEEEeEeeccC---CCeEEEEECCE-----Ee---cc-CC--------ceEEEc-----cCCeEEEccCCCCCCeEEEE
Q psy10160 146 DISIPCDVDGYP---IPQVFWYKDGQ-----VI---EN-DG--------VHYRIT-----ESNRLHINQANATDSGEYRC 200 (558)
Q Consensus 146 ~v~L~C~~~g~P---~p~i~W~~~g~-----~l---~~-~~--------~~~~~~-----~~~sL~I~~v~~~D~G~Y~C 200 (558)
+++|.|.....+ ...+.|+|... .+ .. .+ .|.... .+.+|.|.+++.+|+|.|.|
T Consensus 2 ~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~~Rv~f~~~~~~~~~sL~I~nv~~sD~GtY~C 81 (100)
T cd05888 2 DTRLPCRYNVSDGETVVQVLWIRENAGGVEEEIALLHFKYGQTEFHAYEGRVRFETPNPIADGALILRNAVQADEGKYKC 81 (100)
T ss_pred CEEEEeEEecCCCCcEEEEEEEEccCCCCcEEEEEEeccCCcccCCCccCcEEEeCCCCCCceEEEEecCccccceEEEE
Confidence 688999886544 33689998321 11 00 00 122222 14589999999999999999
Q ss_pred EEEe-CCceeeEEEEEEE
Q psy10160 201 VASN-SYTSDENAVTIRV 217 (558)
Q Consensus 201 ~a~N-~~G~~~~~~~l~V 217 (558)
.+.| +.|..+..+.|.|
T Consensus 82 ~v~~~p~g~~~~~~~L~V 99 (100)
T cd05888 82 RVITFPAGNFEAELVLTV 99 (100)
T ss_pred EEEeCCCCCeeeEEEEEe
Confidence 9998 6777778888877
No 195
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=98.18 E-value=1.1e-05 Score=62.39 Aligned_cols=62 Identities=13% Similarity=0.338 Sum_probs=42.6
Q ss_pred EEEEeEeec-cCCCeEEEEECCEEeccCCceEEEc-cCC------eEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 147 ISIPCDVDG-YPIPQVFWYKDGQVIENDGVHYRIT-ESN------RLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 147 v~L~C~~~g-~P~p~i~W~~~g~~l~~~~~~~~~~-~~~------sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
+.|.|.+.| +|.|.+.|++++.++.... ..... .++ .|.+.....+|.+.|+|.|.|.....
T Consensus 2 ~~L~C~~~~~~P~~~v~W~~~~~~l~~~~-~~~~~~~~~~~~~~s~l~~~~~~~d~g~~~~C~v~h~~l~~ 71 (82)
T cd05761 2 VELTCTSSGSKPAATIRWFKGDKELKGVK-LKEEDENGKTFTVTSSLRFQVDREDDGAPIICRVDHPALKS 71 (82)
T ss_pred EEEEEEecCcCcCCeEEEEECCEEccCce-eeEecCCCCEEEEEEEEEEEcchhhCCCEEEEEEeChhcCC
Confidence 689999976 4999999999999886432 11111 122 35554455566779999999976543
No 196
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=98.17 E-value=3e-06 Score=73.05 Aligned_cols=77 Identities=16% Similarity=0.138 Sum_probs=52.3
Q ss_pred eEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEeccCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCC
Q psy10160 184 RLHINQANATDSGEYRCVASNSYTSDENAVTIRVEGIFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQL 263 (558)
Q Consensus 184 sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~ 263 (558)
+|.|.+++.+|+|.|.|.+.|..|.....++|.|..+| .....+ ....... +......|.+.|..
T Consensus 2 sL~i~~v~~~D~G~Y~C~~~~~~~~~~~~~~l~v~~~P---~v~~~~---~~~~~~~---------~~~~~L~C~a~g~~ 66 (139)
T cd05771 2 SLTLPGLTVHDEGTYICSVSTPPHQAQQIIQLSVSEPP---RVRLSL---EKLVSMI---------EEPQTLICHIAGYY 66 (139)
T ss_pred eEEECCCCHHHCEEEEEEEEccCcceeeEEEEEEecCC---ceEEeC---CCceeec---------CCcEEEEEEECCCC
Confidence 69999999999999999999999999999999997543 221111 1111101 22223566676764
Q ss_pred CC--cccccchhhh
Q psy10160 264 PS--YGPHIKRAVE 275 (558)
Q Consensus 264 ~~--~~~w~~~~l~ 275 (558)
|+ .+.|++++..
T Consensus 67 P~~~~i~W~~~g~~ 80 (139)
T cd05771 67 PLDVQVEWTREPPG 80 (139)
T ss_pred CCCeEEEEEECCCC
Confidence 43 6899999754
No 197
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=98.16 E-value=5.2e-06 Score=69.09 Aligned_cols=70 Identities=19% Similarity=0.442 Sum_probs=50.8
Q ss_pred cCCceEeeCCCcEEEEeEeec--cCCCeEEEEECC--EEe------c----------cCCceEEEcc-----CCeEEEcc
Q psy10160 135 TLETQVFGVGSDISIPCDVDG--YPIPQVFWYKDG--QVI------E----------NDGVHYRITE-----SNRLHINQ 189 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g--~P~p~i~W~~~g--~~l------~----------~~~~~~~~~~-----~~sL~I~~ 189 (558)
.|....+.+|+.++|.|.+.+ .+.+.+.|+|.. ... . ....++.+.. ..+|.|.+
T Consensus 4 ~p~~~~~~~G~~v~l~C~~~~~~~~~~~v~Wyrq~~g~~~~~l~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~ 83 (116)
T cd04982 4 PQLSITREESKSVTISCKVSGIDFSTTYIHWYRQKPGQALERLLYVSSTSTQRKLSGGTKNKFEARKDVGKSTSTLTIQN 83 (116)
T ss_pred cCCeEEeCCCCCEEEEEEEeCCCccccEEEEEEECCCCCCEEEEEEecCCCcEEeCcccCCCEEEEEECCCCEEEEEEEE
Confidence 355667889999999999988 678889999842 110 0 0123554432 23699999
Q ss_pred CCCCCCeEEEEEEEe
Q psy10160 190 ANATDSGEYRCVASN 204 (558)
Q Consensus 190 v~~~D~G~Y~C~a~N 204 (558)
++.+|+|.|.|.+..
T Consensus 84 ~~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 84 LEKEDSATYYCAYWE 98 (116)
T ss_pred CCHHHCEEEEEEEec
Confidence 999999999998864
No 198
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=98.16 E-value=3.5e-06 Score=65.64 Aligned_cols=40 Identities=28% Similarity=0.364 Sum_probs=34.0
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCC
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALP 51 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p 51 (558)
..++|.|.+++.+|+|.|+|.|.|..|... ++.|.|..+|
T Consensus 45 ~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~~~~L~V~~~P 85 (85)
T cd05854 45 TIGDLVIVNAQLSHAGTYTCTAQTVVDSASASATLVVRGPP 85 (85)
T ss_pred eEeEEEEccCChhhCeEEEEEEecCCCCEEEEEEEEEECCC
Confidence 357999999999999999999999999875 6777776543
No 199
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=98.16 E-value=1.9e-05 Score=59.99 Aligned_cols=76 Identities=18% Similarity=0.354 Sum_probs=53.3
Q ss_pred ceEeeCCCcEEEEeEeeccCCC--eEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEE
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIP--QVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTI 215 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 215 (558)
+..+..|++++|+|.....+.| .|.|...+...... ......+|.+.++...|+|+.+|.++-..-.....+.+
T Consensus 8 ~~~lL~G~sLtLtl~~~s~s~p~~~i~w~~P~n~~~~~----~~~~~ktL~~~qv~~qdSG~WtC~V~~~~k~~~~~~~V 83 (88)
T cd07694 8 SDHVLSGTNLTLTLHGSSNSLPAFKVEWRGPGNKSKQI----LNQDKKTLNLVQLGPNDSGTWDCIVSVNSSEKTLKLDI 83 (88)
T ss_pred CCeeecCCcEEEEEecCCCCCCCccEEEeCCCCcccee----ccCCccEEEeceeCcccCCEEEEEEEECceEEEEEeeE
Confidence 3456789999999998664554 89998765432211 11244589999999999999999997554444455555
Q ss_pred EE
Q psy10160 216 RV 217 (558)
Q Consensus 216 ~V 217 (558)
.|
T Consensus 84 ~V 85 (88)
T cd07694 84 KV 85 (88)
T ss_pred EE
Confidence 55
No 200
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=98.15 E-value=1e-05 Score=66.85 Aligned_cols=84 Identities=23% Similarity=0.430 Sum_probs=56.1
Q ss_pred ecCCceEeeCCCcEEEEeEee-ccCCCeEEEEECCE-----Eec---cC----------CceEEEccC-----CeEEEcc
Q psy10160 134 ITLETQVFGVGSDISIPCDVD-GYPIPQVFWYKDGQ-----VIE---ND----------GVHYRITES-----NRLHINQ 189 (558)
Q Consensus 134 ~~~~~~~v~~G~~v~L~C~~~-g~P~p~i~W~~~g~-----~l~---~~----------~~~~~~~~~-----~sL~I~~ 189 (558)
..+....+.+|+.+.|.|... ......+.|++... .+. .. ..++.+..+ .+|.|.+
T Consensus 6 ~~~~~v~~~~G~~v~L~C~~~~~~~~~~v~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~sL~i~~ 85 (114)
T PF07686_consen 6 QPPSPVTVQEGESVTLPCSYSSSSNQSSVYWYRQSPGQGPQLIIRYSLSSTNETPTPSYSGRFTFSGNGSQNNFSLTIKN 85 (114)
T ss_dssp EEESEEEEETTSEEEEEEEEESSSSGSEEEEEEEETTSEEEEEEEEETTEEEEEEETTETTTEEEEEETTTTEEEEEESS
T ss_pred EeCCeEEEecCCCEEEEEEEeCCCCcceEEEEEECccccceeeeeeccceeeeccccceeeeeeeeecccCCeEEEEECC
Confidence 346677889999999999998 45566799998321 111 00 112222222 2699999
Q ss_pred CCCCCCeEEEEEEEeCC-ceeeEEEEEEE
Q psy10160 190 ANATDSGEYRCVASNSY-TSDENAVTIRV 217 (558)
Q Consensus 190 v~~~D~G~Y~C~a~N~~-G~~~~~~~l~V 217 (558)
++.+|+|.|.|.+.... ......+.|.|
T Consensus 86 l~~~DsG~Y~C~v~~~~~~~~~~~~~L~V 114 (114)
T PF07686_consen 86 LQPSDSGTYFCQVSTSNEQSFGNGTKLTV 114 (114)
T ss_dssp ESGGGEEEEEEEEEESSEEEEEEEEEEEE
T ss_pred CCcCcCEEEEEEEEECCCCEECCcEEEEC
Confidence 99999999999999872 23345555554
No 201
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=98.15 E-value=4e-06 Score=63.41 Aligned_cols=41 Identities=32% Similarity=0.381 Sum_probs=32.2
Q ss_pred CCceEe---cCC--eEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 6 SENYEL---NKN--MLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 6 ~~r~~~---~~~--~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
++|+.+ .++ +|.|.+++.+|+|.|+|.|.|..|... ++.|.
T Consensus 28 ~~r~~~~~~~~g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L~ 74 (75)
T cd05892 28 TDRISLYQDNSGRVTLLIKNVNKKDAGWYTVSAVNEAGVATCHARLD 74 (75)
T ss_pred CCeEEEEEcCCCcEEEEECCCChhhCEEEEEEEEcCcCeEEEEEEEe
Confidence 456664 222 799999999999999999999999875 44544
No 202
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=98.15 E-value=3e-05 Score=61.96 Aligned_cols=72 Identities=19% Similarity=0.337 Sum_probs=50.0
Q ss_pred cEEEEeEeecc-CCC---eEEEEECC--E--Eec--c-------C---CceEEEcc----CCeEEEccCCCCCCeEEEEE
Q psy10160 146 DISIPCDVDGY-PIP---QVFWYKDG--Q--VIE--N-------D---GVHYRITE----SNRLHINQANATDSGEYRCV 201 (558)
Q Consensus 146 ~v~L~C~~~g~-P~p---~i~W~~~g--~--~l~--~-------~---~~~~~~~~----~~sL~I~~v~~~D~G~Y~C~ 201 (558)
.+.|.|..... |.. .|.|.+.. . .+. . . ..|..... +.+|.|.+++.+|+|.|.|.
T Consensus 2 ~v~L~C~f~~~~~~~~~~~V~W~k~~~~~~~~va~y~~~~g~~~~~~f~~Rv~f~~~~~~daSi~i~nl~~~D~G~Y~C~ 81 (99)
T cd05886 2 DVVLHCSFINPLPPVKITQVTWQKLTNGSKQNVAIYNPSMGVSVLPPYRERVTFKNPSFEDGTISLSRLELEDEGVYICE 81 (99)
T ss_pred cEEEEeEeecCCCCCCeEEEEEEECCCCCceEEEEECCcCCcccCccccCcEEEcCCCCCcceEEEcCCccccCEEEEEE
Confidence 57899998742 222 48998742 1 110 0 0 12333221 36899999999999999999
Q ss_pred EEe-CCceeeEEEEEEE
Q psy10160 202 ASN-SYTSDENAVTIRV 217 (558)
Q Consensus 202 a~N-~~G~~~~~~~l~V 217 (558)
+.| +.|+.+..+.|.|
T Consensus 82 v~t~P~g~~~~~~~L~V 98 (99)
T cd05886 82 FATFPTGNRESQLNLTV 98 (99)
T ss_pred EEeCCCCCeEEEEEEEE
Confidence 999 7888888888887
No 203
>KOG3515|consensus
Probab=98.14 E-value=8.8e-06 Score=86.14 Aligned_cols=203 Identities=16% Similarity=0.187 Sum_probs=110.9
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeC--CcceE--EEEEEEEeCCCCccCC----CCccccCce-eEEec-cCCCCCCcEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNG--LGRAV--SWTVTLQALPSEKVAD----PNAIDYGTI-LSSAF-PSESASPVVT 81 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~--~g~~~--s~~l~V~~~p~~~~~~----~~~v~~~~~-~~~~~-~~~~p~p~v~ 81 (558)
....|.+...+.+|.|.|+|.|.|. .+... ...+.+.......... .+.+..+.. .+.|. ..++|.+.++
T Consensus 161 ~~s~l~~~v~Rka~~g~~tC~A~nr~s~~l~~~~~~~i~v~~~~~~~~~~~~~~~qsF~~g~~inlvc~~~gg~P~~~~~ 240 (741)
T KOG3515|consen 161 EPSLLKQTVSRKADNGNYTCPANNRNSPGLSFAKQLTIIVEAPCKGIGITGAQEQQSFTEGQTINLVCNAQGGNPSQQQT 240 (741)
T ss_pred cccceeeEEEEecCCceeEcccccccCccccccceeEeecccccccceecchhhcCcccccceEEEEehhhcCCcchhhh
Confidence 3557889999999999999999984 22222 3333333322222111 133445543 35554 4446999999
Q ss_pred EEeCCcccCCCCceeec-----cccce---------eeceeEEeeccceeeEEeeeceee-eCcEEEecCCceEeeCCCc
Q psy10160 82 QTTTTTTEATSPHVYAA-----LTHCV---------PWSNVCLFGARSGYLKETQNGGYL-VPVKVNITLETQVFGVGSD 146 (558)
Q Consensus 82 W~~~~~~~~~~~~~~~g-----~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~v~~G~~ 146 (558)
|+++......+...... .+... .....|.+.+. ...+....+. .+....+.+....+..|+.
T Consensus 241 w~~~s~~~~~~sl~~~~~sg~~v~~~~~~~~~r~~~~~~~kc~a~n~---~~~~~~tav~~~~~~~~Ist~~~~ls~g~s 317 (741)
T KOG3515|consen 241 WYKDSRPQSESSLLSQEPSGDTVSSTLVLRVGRQDLQAQLKCKASNL---LAASQITAVQVKPTAVPISTSDSGLSSGRS 317 (741)
T ss_pred hccccccchhhhcccCCCCCCcccccccccccccchhhhhhccccCc---cccceeeecccccccccccCcccccccccc
Confidence 99987555443111100 00000 11123554441 0001111111 2223334444555778999
Q ss_pred EEEEeE-eeccCCCeEEEEECCEEeccCCceEEEccC------CeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 147 ISIPCD-VDGYPIPQVFWYKDGQVIENDGVHYRITES------NRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 147 v~L~C~-~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~------~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
..+.|. ..++|.+.+.|+|+......+..-.+-..+ ..+......+.|.|.|+|.+.|.......+....+
T Consensus 318 ~r~~c~~sss~p~~~i~w~~~~~~~~~~~~~~~~t~~~~~v~~~~~~~q~~~~~~~g~v~c~a~~~~~~~~sss~~~l 395 (741)
T KOG3515|consen 318 ARSSCVSSSSKPPAHIAWYKDTKMPKGSQKASSKTSNMGGVAVISHYAQPSSQQDGGQVTCPADNLELAHSSSSSFLL 395 (741)
T ss_pred cccceeccCCCCccceeeeccCcccccccCcccCCCcccceeeEEeeecccchhcCceEEccccccccccccccceec
Confidence 999987 566788889999965544322111111111 14566677889999999999998865544433333
No 204
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=98.13 E-value=2.3e-05 Score=60.54 Aligned_cols=63 Identities=17% Similarity=0.350 Sum_probs=43.5
Q ss_pred EEEEeEeecc-CCCeEEEEECCEEeccCCceEEEccC-C------eEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 147 ISIPCDVDGY-PIPQVFWYKDGQVIENDGVHYRITES-N------RLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 147 v~L~C~~~g~-P~p~i~W~~~g~~l~~~~~~~~~~~~-~------sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
+.|.|.+.|. |.+.|+|+++|.++...........+ + +|.|.....+|...|+|.+.+.....
T Consensus 2 ~~LtC~a~g~~P~~~ItW~k~g~~l~~~~~~~~~~~~~~t~~~~s~l~~~~~~~d~g~~~tC~v~h~~l~~ 72 (83)
T cd07705 2 AKLRCTSSGSKPAANIKWRKGDQELEGAPTSVLEDGNGKTFTVSSSVEFQVTREDDGAEITCSVGHESLHD 72 (83)
T ss_pred EEEEEEecCccCCCEeEEEECCEECCCcceeEEECCCCCEEEEEEEEEEEecchhCCCEEEEEEECcccCC
Confidence 6899999874 99999999999987653211222222 2 35554555667789999999976443
No 205
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=98.12 E-value=6.8e-06 Score=64.48 Aligned_cols=39 Identities=28% Similarity=0.419 Sum_probs=33.4
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCCC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALPS 52 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p~ 52 (558)
.+|.|.++..+|+|.|+|.|.|..|... ++.|.|...|.
T Consensus 47 s~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~L~V~~~P~ 86 (88)
T cd05735 47 STLQILPTVREDSGFFSCHAINSYGEDRGIIQLTVQEPPD 86 (88)
T ss_pred EEEEECCCCcccCEEEEEEEEcCCCcceEEEEEEEeCCCC
Confidence 5799999999999999999999999874 67777776543
No 206
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=98.12 E-value=5.8e-06 Score=61.90 Aligned_cols=42 Identities=31% Similarity=0.291 Sum_probs=34.2
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEEE
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTLQ 48 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V~ 48 (558)
.++...+++|.|.+++.+|+|.|+|.|.|..|.. .+.++.|.
T Consensus 28 ~~~~~~~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~~~~ 70 (71)
T cd04976 28 NRTKKSGHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTFTLV 70 (71)
T ss_pred CEEEcCCCEEEECcCCHHHCEEEEEEEEcCCccEEEEEEEEEE
Confidence 4555677899999999999999999999999875 35555553
No 207
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=98.11 E-value=4.3e-06 Score=65.20 Aligned_cols=40 Identities=23% Similarity=0.367 Sum_probs=33.9
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCC
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALP 51 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p 51 (558)
.+++|.|.+++.+|+|.|+|.|.|..|... ++.|.|..+|
T Consensus 45 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~~~~l~V~~pP 85 (85)
T cd04970 45 SNGDLMIRNAQLKHAGKYTCTAQTVVDSLSASADLIVRGPP 85 (85)
T ss_pred ccceEEEccCCHHhCeeeEEEEecCCCcEEEEEEEEEECCC
Confidence 467899999999999999999999998764 6777776654
No 208
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=98.11 E-value=1e-05 Score=64.56 Aligned_cols=67 Identities=18% Similarity=0.434 Sum_probs=48.3
Q ss_pred eCCCcEEEEeEeecc-CC-CeEEEEECCEEeccCCc--eEEEccCC------eEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 142 GVGSDISIPCDVDGY-PI-PQVFWYKDGQVIENDGV--HYRITESN------RLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~-P~-p~i~W~~~g~~l~~~~~--~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
..|+.+.|.|.+.|. |. +.++|+++|..+..... ......++ .|.+.....+|.|.|+|.|.+....
T Consensus 11 ~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~~~~~~~~~~gt~~~~s~l~v~~~~~~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 11 LLGGSVTLTCLATGFYPPDITVTWLKNGKELTSGVTTTPPVPNSDGTYSVSSQLTVSPSDWNSGDTYTCVVTHESLP 87 (95)
T ss_pred HcCCCeEEEEEEeeEECCCcEEEEEECCEECCCceeccccccCCCCCEEEEEEEEECHHHhCCCCCEEEEEEeCCCC
Confidence 468999999999998 64 57999999998865431 11112223 3666666667999999999987654
No 209
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=98.10 E-value=4.9e-06 Score=62.99 Aligned_cols=41 Identities=22% Similarity=0.284 Sum_probs=32.0
Q ss_pred CCceEec-C--C--eEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 6 SENYELN-K--N--MLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 6 ~~r~~~~-~--~--~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
+.|+.+. + + +|.|.+++.+|+|.|+|.|.|..|... ++.|.
T Consensus 28 ~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~ 74 (75)
T cd05893 28 TDRVSMHQDNCGYICLLIQGATKEDAGWYTVSAKNEAGIVSCTARLD 74 (75)
T ss_pred CCeEEEEEcCCCEEEEEECCCCHHHCEEEEEEEEcCCCEEEEEEEEe
Confidence 4566652 2 2 699999999999999999999999875 44443
No 210
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=98.08 E-value=1.3e-05 Score=64.39 Aligned_cols=66 Identities=21% Similarity=0.324 Sum_probs=46.9
Q ss_pred EeeCCCcEEEEeEeecc--CCCeEEEEECCE--Ee---c--------cCCceEEEccC---CeEEEccCCCCCCeEEEEE
Q psy10160 140 VFGVGSDISIPCDVDGY--PIPQVFWYKDGQ--VI---E--------NDGVHYRITES---NRLHINQANATDSGEYRCV 201 (558)
Q Consensus 140 ~v~~G~~v~L~C~~~g~--P~p~i~W~~~g~--~l---~--------~~~~~~~~~~~---~sL~I~~v~~~D~G~Y~C~ 201 (558)
.+.+|++++|.|...+. ....+.|+|... .. - ....++....+ .+|.|.+++.+|+|.|.|.
T Consensus 2 ~v~~G~~v~l~C~~~~~~~~~~~i~Wy~q~~g~~~~~l~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~~Dsg~Y~C~ 81 (98)
T cd04984 2 SVSPGETVTITCTGSSGNISGNYVNWYQQKPGSAPRYLIYEDSDRPSGIPDRFSGSKSGNTASLTISGAQTEDEADYYCQ 81 (98)
T ss_pred ccCCCCCEEEEEEEcCCCcCCCCEEEEEECCCCCccEEEEeccccCCCCCCCEEEEccCCEEEEEECCCChhhCEEEEEE
Confidence 46789999999998775 556799998431 11 0 00124554333 2699999999999999999
Q ss_pred EEeC
Q psy10160 202 ASNS 205 (558)
Q Consensus 202 a~N~ 205 (558)
+.+.
T Consensus 82 ~~~~ 85 (98)
T cd04984 82 VWDS 85 (98)
T ss_pred EccC
Confidence 8753
No 211
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=98.07 E-value=8.8e-06 Score=60.56 Aligned_cols=37 Identities=27% Similarity=0.252 Sum_probs=30.8
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.++.|.|.++..+|+|.|+|.|.|..|... +.+++|.
T Consensus 32 ~~~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~~l~ 69 (70)
T cd05864 32 RGVHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTFQLV 69 (70)
T ss_pred cCCEEEECcCCHHHCEEEEEEEEECCCceeeEEEEEEE
Confidence 456899999999999999999999999764 5555554
No 212
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=98.07 E-value=7.7e-06 Score=60.14 Aligned_cols=37 Identities=24% Similarity=0.313 Sum_probs=30.5
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.++.|.|.++..+|+|.|+|.|.|..|... +..++|.
T Consensus 29 ~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~~l~ 66 (67)
T cd05863 29 SQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRISLELI 66 (67)
T ss_pred CcCEEEECCCCHHHCEEEEEEEEECCccEEEEEEEEEE
Confidence 456999999999999999999999999753 5555553
No 213
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=98.07 E-value=8e-06 Score=61.20 Aligned_cols=38 Identities=34% Similarity=0.444 Sum_probs=31.3
Q ss_pred EecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 10 ELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 10 ~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
...+++|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 32 ~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05876 32 LNNNKTLQLDNVLESDDGEYVCTAENSEGSARHHYTVTV 70 (71)
T ss_pred EcCCCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEEEEE
Confidence 34678999999999999999999999999864 444443
No 214
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=98.07 E-value=4.6e-05 Score=60.34 Aligned_cols=73 Identities=16% Similarity=0.312 Sum_probs=50.4
Q ss_pred CcEEEEeEeeccC-CCeEEEEECCE----Eec-c---C--------CceEEEc----cCCeEEEccCCCCCCeEEEEEEE
Q psy10160 145 SDISIPCDVDGYP-IPQVFWYKDGQ----VIE-N---D--------GVHYRIT----ESNRLHINQANATDSGEYRCVAS 203 (558)
Q Consensus 145 ~~v~L~C~~~g~P-~p~i~W~~~g~----~l~-~---~--------~~~~~~~----~~~sL~I~~v~~~D~G~Y~C~a~ 203 (558)
+.++|.|.....+ ...+.|.|... .+. . . ..|.... .+.+|.|.+++.+|+|.|.|.+.
T Consensus 1 ~~vtL~C~~~~~~~~~qV~W~k~~~~~~~~ia~y~~~~g~~~~~~y~~Rv~~~~~~~~d~sl~i~nv~~~D~G~Y~C~v~ 80 (96)
T cd05887 1 KNVTLKCRIQVNETITQSSWEKIHGKGSVTLAVHHPMYGISIQPDYQGRVSFKNYSLLDATIMLENVGFSDIGVYICKAV 80 (96)
T ss_pred CCEEEEEEecCCCcEEEEEEEEcCCCCcEEEEEEcccCCcccChhhCCcEEEcCCCCCccEEEEeCCCccccEEEEEEEE
Confidence 4689999976533 23589988421 111 0 0 1133331 24589999999999999999976
Q ss_pred e-CCceeeEEEEEEE
Q psy10160 204 N-SYTSDENAVTIRV 217 (558)
Q Consensus 204 N-~~G~~~~~~~l~V 217 (558)
+ +.|+...++.|.|
T Consensus 81 tfP~G~~~~~~~l~~ 95 (96)
T cd05887 81 TFPLGNTQSSTTVTV 95 (96)
T ss_pred eCCCCCeeEEEEEEE
Confidence 4 6888899998887
No 215
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=98.06 E-value=1.1e-05 Score=61.36 Aligned_cols=40 Identities=23% Similarity=0.428 Sum_probs=33.4
Q ss_pred ceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 8 NYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 8 r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
++...+++|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 35 ~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 75 (76)
T cd05867 35 RRHVSSGALILTDVQPSDTAVYQCEARNRHGNLLANAHVHV 75 (76)
T ss_pred eEEeeCCEEEECCCChhhCEEEEEEEECCCCeEEEEEEEEE
Confidence 5667788999999999999999999999999874 444443
No 216
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=98.04 E-value=1.4e-05 Score=63.02 Aligned_cols=43 Identities=26% Similarity=0.390 Sum_probs=34.8
Q ss_pred CceEe--cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 7 ENYEL--NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 7 ~r~~~--~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
.++.+ .+++|.|.+++.+|+|.|+|.|.|..|...+..+.|.+
T Consensus 46 ~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~S~~~~L~V 90 (91)
T cd05740 46 PRLQLSNDNRTLTFNNVTRSDTGHYQCEASNEVSNMTSDPYILNV 90 (91)
T ss_pred CCEEEeCCCCEEEECcCChhhCEEEEEEEEcCCCCEEeeeEEEEe
Confidence 44543 45699999999999999999999999988766666544
No 217
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=98.04 E-value=1.2e-05 Score=63.53 Aligned_cols=43 Identities=30% Similarity=0.420 Sum_probs=34.4
Q ss_pred CceEe-cCC---eEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 7 ENYEL-NKN---MLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 7 ~r~~~-~~~---~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
.|+.+ .++ +|.|.+++.+|+|.|+|.|.|..|......+.+.+
T Consensus 45 ~r~~~~~~g~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~i~l~~ 91 (92)
T cd05866 45 QRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKGQTQEATVVLEI 91 (92)
T ss_pred CCEEEEeCCCeeEEEEecCChHHCEEEEEEEEcCCCcEEEEEEEEEE
Confidence 45654 233 89999999999999999999999987666666553
No 218
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=98.01 E-value=1e-05 Score=61.14 Aligned_cols=36 Identities=36% Similarity=0.479 Sum_probs=30.3
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
..+++|.|.+++.+|+|.|+|.|.|..|... ++.|.
T Consensus 37 ~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~ 73 (74)
T cd05745 37 LSSGTLRISRVALHDQGQYECQAVNIVGSQRTVAQLT 73 (74)
T ss_pred ccCCeEEEeeCCHHhCEEEEEEEEeCCCceeEEEEEe
Confidence 4678999999999999999999999999864 44443
No 219
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=98.01 E-value=1.7e-05 Score=63.56 Aligned_cols=40 Identities=30% Similarity=0.384 Sum_probs=34.9
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCCC
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALPS 52 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p~ 52 (558)
.+.|.|.++..+|+|.|+|.|.|..|... ++.|.|...|.
T Consensus 55 ~s~L~I~~~~~~D~G~Ytc~a~N~~G~~~~~~~l~V~~~P~ 95 (98)
T cd05762 55 SSKLTITEGQQEHCGCYTLEVENKLGSRQAQVNLTVVDKPD 95 (98)
T ss_pred eeEEEECCCChhhCEEEEEEEEcCCCceeEEEEEEEecCCC
Confidence 56899999999999999999999999875 77777776654
No 220
>KOG3515|consensus
Probab=98.00 E-value=3.5e-05 Score=81.67 Aligned_cols=209 Identities=17% Similarity=0.095 Sum_probs=115.8
Q ss_pred ccccC-ceeEEeccCCCC-CCcEEEEeCCcccCCCCc-------eeeccccceeeceeEEeeccceeeE-EeeeceeeeC
Q psy10160 60 AIDYG-TILSSAFPSESA-SPVVTQTTTTTTEATSPH-------VYAALTHCVPWSNVCLFGARSGYLK-ETQNGGYLVP 129 (558)
Q Consensus 60 ~v~~~-~~~~~~~~~~~p-~p~v~W~~~~~~~~~~~~-------~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~p 129 (558)
.+..| ++.+.|.+.++| .+.+.|++.+..+..... +..+........+.|.+.+..+... ......+..|
T Consensus 18 ~~~~g~~v~l~C~v~~~pp~~~~eW~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~a~ns~~~~~~~~~~l~v~~~ 97 (741)
T KOG3515|consen 18 GLRLGEDVPLPCRVNSNPPEIDVEWYHSTSGEHGRYATIADPTLVTTGDVRDTVAELNCRAFNSVGMPSRCPMILDVDYP 97 (741)
T ss_pred hhccCCcceeeeecCCCCCCcceEEEecCcccccccccccCCceeeecchhhhhhhhhhhhcccccCceecceeeccccC
Confidence 45555 455888887765 567999998766651110 1111111111122344443322222 1122233345
Q ss_pred cEEEecCCceEeeCCCcEEEEeEe--eccCCCeEEEEECCEEeccCC-ceEEE---------ccCCeEEEccCCCCCCeE
Q psy10160 130 VKVNITLETQVFGVGSDISIPCDV--DGYPIPQVFWYKDGQVIENDG-VHYRI---------TESNRLHINQANATDSGE 197 (558)
Q Consensus 130 ~~~~~~~~~~~v~~G~~v~L~C~~--~g~P~p~i~W~~~g~~l~~~~-~~~~~---------~~~~sL~I~~v~~~D~G~ 197 (558)
+.-...........+..+.+.|.+ .+.|.+.+.|..++....... ..... .....+.+.....+|.|+
T Consensus 98 pa~~~~~~e~~~~~~~vvqi~c~~~~~~~P~~nlrW~~n~r~e~~~~~~~~~~~~~a~gss~t~~s~l~~~v~Rka~~g~ 177 (741)
T KOG3515|consen 98 PACLPELGEIFQVDKGVVQIICSAKVAGRPNPNLRWGFNNRAELNAVNQRGRVGAGALGSSYTEPSLLKQTVSRKADNGN 177 (741)
T ss_pred ccccccccchhhhcCCeEEEEEeecCCCCCCcceeeeeccEEeecccCCcccccccccCceeccccceeeEEEEecCCce
Confidence 554444445555678999999954 556777899999876543221 00000 123357888888999999
Q ss_pred EEEEEEeC---CceeeEEEEEEEeccCCCCCCCCCCccccceeEEeceeeecccceeEEEEeccCCCCCCCcccccchhh
Q psy10160 198 YRCVASNS---YTSDENAVTIRVEGIFIHPSCRDLPLFANCKLIVEGRYCQHHYYSQFCCESCTRAGQLPSYGPHIKRAV 274 (558)
Q Consensus 198 Y~C~a~N~---~G~~~~~~~l~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~c~~~~~~g~~~~~~~w~~~~l 274 (558)
|+|.|.|. .+.......+.|..+....... . ....+.+..+.+..++| ... .|.|.+...|+++..
T Consensus 178 ~tC~A~nr~s~~l~~~~~~~i~v~~~~~~~~~~--~-------~~~~qsF~~g~~inlvc-~~~-gg~P~~~~~w~~~s~ 246 (741)
T KOG3515|consen 178 YTCPANNRNSPGLSFAKQLTIIVEAPCKGIGIT--G-------AQEQQSFTEGQTINLVC-NAQ-GGNPSQQQTWYKDSR 246 (741)
T ss_pred eEcccccccCccccccceeEeecccccccceec--c-------hhhcCcccccceEEEEe-hhh-cCCcchhhhhccccc
Confidence 99999994 4444455556664332111111 0 01113344444556666 232 489999999999876
Q ss_pred hhhhh
Q psy10160 275 EAEAA 279 (558)
Q Consensus 275 ~~~~~ 279 (558)
.....
T Consensus 247 ~~~~~ 251 (741)
T KOG3515|consen 247 PQSES 251 (741)
T ss_pred cchhh
Confidence 65543
No 221
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=98.00 E-value=1.5e-05 Score=59.31 Aligned_cols=35 Identities=34% Similarity=0.547 Sum_probs=29.8
Q ss_pred CceE-ecCCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 7 ENYE-LNKNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 7 ~r~~-~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
.++. ..+++|.|.+++.+|+|.|+|.|.|..|...
T Consensus 27 ~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 62 (69)
T cd05725 27 GRAEILDDKSLKIRNVTAGDEGSYTCEAENMVGKIE 62 (69)
T ss_pred CcEEEeeCCEEEECcCChhHCEEEEEEEEcCCCcEE
Confidence 3444 3667999999999999999999999999864
No 222
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=98.00 E-value=1.3e-05 Score=59.80 Aligned_cols=42 Identities=29% Similarity=0.249 Sum_probs=32.8
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEEE
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTLQ 48 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V~ 48 (558)
.++...+++|.|.+++.+|+|.|+|.|+|..... ....+++.
T Consensus 29 ~~~~~~~~~L~I~~v~~~D~G~YtC~a~~~~~~~~~~~~i~~~ 71 (72)
T cd07702 29 SRYHVDGYSLVIKDVTEEDAGIYTILLGIKQYNLFKNLTITLI 71 (72)
T ss_pred cEEEeCCCEEEECcCCHHHCEEEEEEEEccccceEeeEEEEEE
Confidence 4666777899999999999999999999975443 35555543
No 223
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=97.98 E-value=1.5e-05 Score=62.58 Aligned_cols=40 Identities=28% Similarity=0.453 Sum_probs=33.0
Q ss_pred ceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 8 NYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 8 r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
++...++.|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 47 ~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 87 (88)
T cd05851 47 EISMSGAVLKIFNIQPEDEGTYECEAENIKGKDKHQARVYV 87 (88)
T ss_pred EEecCCCEEEECcCChhhCEEEEEEEEcCCCceEEEEEEEE
Confidence 4556778999999999999999999999999864 455544
No 224
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=97.98 E-value=2e-05 Score=59.50 Aligned_cols=43 Identities=26% Similarity=0.335 Sum_probs=34.1
Q ss_pred CCceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 6 SENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 6 ~~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
+.++.. .+++|.|.+++.+|+|.|+|.|.|..|...+....|.
T Consensus 29 ~~~~~~~~~g~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~~a~l~ 72 (74)
T cd05738 29 NGRIKQLRSGALQIENSEESDQGKYECVATNSAGTRYSAPANLY 72 (74)
T ss_pred CCCEEEcCCcEEEECCCChhhCEEEEEEEECCCCceEcccEEEE
Confidence 345554 5679999999999999999999999998765444443
No 225
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=97.97 E-value=2.2e-05 Score=62.37 Aligned_cols=65 Identities=18% Similarity=0.335 Sum_probs=45.5
Q ss_pred ceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccC--CceEEEccCCeEEEccCCCCCCeEEEEEEE
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIEND--GVHYRITESNRLHINQANATDSGEYRCVAS 203 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~--~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~ 203 (558)
..+|.+|++|+|.|.... +.-.+.|+|+|...... .....-.....+.|.+++.+|+|.|.|...
T Consensus 9 ~~vV~~G~~VTL~C~~~~-~~~~f~l~k~g~~~~~~~~~~~~~~~~~a~f~I~~~~~~~~G~Y~C~~~ 75 (94)
T cd05711 9 SPVVPSGENVTLQCHSDI-RFDRFILYKEGRSKPVLHLYEKHHGGFQASFPLGPVTPAHAGTYRCYGS 75 (94)
T ss_pred CCccCCCCeEEEEEecCC-CCCEEEEEECCCCCCceecccccCCeEEEEEEecCCCcccCEEEEEEEE
Confidence 456789999999998765 45579999988653221 000000012368999999999999999875
No 226
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=97.97 E-value=6.5e-05 Score=60.16 Aligned_cols=74 Identities=23% Similarity=0.353 Sum_probs=50.6
Q ss_pred CCcEEEEeEeeccCCC-eEEEEECCE----Eec---c-C--------CceEEEc----cCCeEEEccCCCCCCeEEEEEE
Q psy10160 144 GSDISIPCDVDGYPIP-QVFWYKDGQ----VIE---N-D--------GVHYRIT----ESNRLHINQANATDSGEYRCVA 202 (558)
Q Consensus 144 G~~v~L~C~~~g~P~p-~i~W~~~g~----~l~---~-~--------~~~~~~~----~~~sL~I~~v~~~D~G~Y~C~a 202 (558)
|++++|.|........ .+.|+|... .+. . . ..++... .+.+|.|.+++.+|+|.|.|.+
T Consensus 1 G~~vtL~C~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~nv~~~D~G~Y~C~~ 80 (97)
T cd05846 1 GGNVTLSCNLTLPEEVLQVTWQKIQGSSPENIATYSEKYGVKIQPSYFRRRSITSLGLNSTSITIWNVTLEDEGCYKCIF 80 (97)
T ss_pred CCcEEEEEEeCCCCeeEEEEEEEcCCCCceEEEEEcccCCcccCCCccCeEEEcCCCCCccEEEEeCCceeeeEEEEEEE
Confidence 7899999986654433 499998432 110 0 0 1122221 2347999999999999999998
Q ss_pred Ee-CCceeeEEEEEEE
Q psy10160 203 SN-SYTSDENAVTIRV 217 (558)
Q Consensus 203 ~N-~~G~~~~~~~l~V 217 (558)
.+ +.|.....+.|+|
T Consensus 81 ~~~p~g~~~~~~~L~v 96 (97)
T cd05846 81 NTFPDGSKSGTMCLTV 96 (97)
T ss_pred EeCCCCCeeeEEEEEE
Confidence 74 5777778888877
No 227
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=97.94 E-value=2e-05 Score=59.70 Aligned_cols=31 Identities=29% Similarity=0.316 Sum_probs=27.1
Q ss_pred eEEEcCCCCCCCEEEEEEEEeCCcceE-EEEE
Q psy10160 15 MLTIKRVEPERLGAYTCQAYNGLGRAV-SWTV 45 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l 45 (558)
+|.|.+++.+|+|.|+|.|.|..|... ++.|
T Consensus 42 ~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 73 (75)
T cd05744 42 CLLIQNANKEDAGWYTVSAVNEAGVVSCNARL 73 (75)
T ss_pred EEEECCCCcccCEEEEEEEEcCCCcEEEEEEE
Confidence 699999999999999999999999864 3443
No 228
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=97.93 E-value=2.5e-05 Score=59.94 Aligned_cols=42 Identities=31% Similarity=0.457 Sum_probs=34.0
Q ss_pred CCceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 6 SENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 6 ~~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
+.|+.. .+++|.|.+++.+|+|.|+|.|.|..|...+..+.|
T Consensus 35 ~~r~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~s~~~~l 77 (79)
T cd05734 35 AGRIQLLSNGSLLIKHVLEEDSGYYLCKVSNDVGADASKSMVL 77 (79)
T ss_pred CCCEEEecCCeEEECcCCcccCEEEEEEEEeCCCCCCceEEEE
Confidence 345553 678999999999999999999999999875555444
No 229
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=97.93 E-value=1.7e-05 Score=59.37 Aligned_cols=37 Identities=38% Similarity=0.508 Sum_probs=30.1
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
..+++|.|.+++.+|+|.|+|.|.|..|... ++.+.|
T Consensus 33 ~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05731 33 NFNKTLKIDNVSEEDDGEYRCTASNSLGSARHTISVTV 70 (71)
T ss_pred cCCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEEEEE
Confidence 3557999999999999999999999999763 444443
No 230
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.92 E-value=5.5e-05 Score=58.38 Aligned_cols=62 Identities=15% Similarity=0.357 Sum_probs=42.0
Q ss_pred EEEEeEeec-cCCCeEEEEECCEEeccCCceEEE-ccC------CeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 147 ISIPCDVDG-YPIPQVFWYKDGQVIENDGVHYRI-TES------NRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 147 v~L~C~~~g-~P~p~i~W~~~g~~l~~~~~~~~~-~~~------~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
+.|.|.+.| +|.+.++|+|+|..+......... ..+ .+|.+..-..+|...|+|++.|..-.
T Consensus 2 ~~LtC~a~gf~P~~~itW~kng~~l~~~~~~~~~~~~~~t~~~~s~L~~~~~~~d~g~~ytC~v~h~~l~ 71 (83)
T cd05884 2 MQLTCKTSGSKPAADIRWFKNDKEIKDVKYLKEEDANRKTFTVSSTLDFRVDRSDDGVAIICRVDHESLN 71 (83)
T ss_pred EEEEEEeCCccCCCEEEEEECCEECcCceeeEeeCCCCCEEEEEEEEEEEcccccCCCEEEEEEechhcC
Confidence 689999987 688889999999987543211111 111 24666555566677999999986533
No 231
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.92 E-value=4.3e-05 Score=63.54 Aligned_cols=72 Identities=22% Similarity=0.358 Sum_probs=51.0
Q ss_pred ecCCceEeeCCCcEEEEeEeecc-CCCeEEEEECC--EE---ec--------cCCceEEEcc-----CCeEEEccCCCCC
Q psy10160 134 ITLETQVFGVGSDISIPCDVDGY-PIPQVFWYKDG--QV---IE--------NDGVHYRITE-----SNRLHINQANATD 194 (558)
Q Consensus 134 ~~~~~~~v~~G~~v~L~C~~~g~-P~p~i~W~~~g--~~---l~--------~~~~~~~~~~-----~~sL~I~~v~~~D 194 (558)
..+....+.+|++++|.|..... ....+.|+|.. .. +. ....|+.+.. ..+|.|.+++.+|
T Consensus 4 q~~~~v~~~~G~~v~L~C~~~~~~~~~~v~Wyrq~~~~~~~~l~~~~~~~~~~~~~R~~~~~~~~~~~~sL~I~~~~~~D 83 (116)
T cd07706 4 QAQPDVSVQVGEEVTLNCRYETSWTNYYIFWYKQLPSGEMTFLIRQKSIYGNATKGRYSVNFQKAQKSISLTISALQLED 83 (116)
T ss_pred EeCCceEEcCCCCEEEEEEEeCCCCceEEEEEEECCCCceEEEEEecCccCCccCCeEEEEEeccCCEEEEEECCCCHHH
Confidence 34567778999999999998764 45569999832 11 10 1124665532 2379999999999
Q ss_pred CeEEEEEEEeC
Q psy10160 195 SGEYRCVASNS 205 (558)
Q Consensus 195 ~G~Y~C~a~N~ 205 (558)
+|.|.|.+.+.
T Consensus 84 sg~Y~C~~~~~ 94 (116)
T cd07706 84 SAKYFCALSTL 94 (116)
T ss_pred CEEEEEEEECC
Confidence 99999998853
No 232
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=97.91 E-value=0.00013 Score=63.81 Aligned_cols=84 Identities=14% Similarity=0.297 Sum_probs=60.6
Q ss_pred ceEeeCCCcEEEEeEee-ccCCCeEEEEECCEEec---cC--------CceEEE-c---cCCeEEEccCCCCCCeEEEEE
Q psy10160 138 TQVFGVGSDISIPCDVD-GYPIPQVFWYKDGQVIE---ND--------GVHYRI-T---ESNRLHINQANATDSGEYRCV 201 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~-g~P~p~i~W~~~g~~l~---~~--------~~~~~~-~---~~~sL~I~~v~~~D~G~Y~C~ 201 (558)
...|.+|+.++|.|... +...+.+.|.|....+. .. ..|+.. . .+.+|+|.+|+.+|+|.|.|.
T Consensus 24 ~v~V~ege~VtLsCs~t~s~~~~qVtWkK~~~~IatY~~~g~~i~~~Fk~Rve~mS~s~~~StItIknVt~sDeGcY~C~ 103 (189)
T PHA02987 24 KITVSEHVNVKISCNKTSSFNSILITWKKNNKTIAGYGPCGPVIVDKFKNKIEYLSKSFNESTILIKNVSLKDNGCYTCI 103 (189)
T ss_pred EEEEcCCCCEEEEEecCCCCccceEEEEEcCCCEEEEecCCcEEChhhcCeEEEeccCCCcceEEEEeCChhhCeEEEEE
Confidence 45678999999999974 66778899999643221 00 123332 1 235799999999999999998
Q ss_pred EEe-CCc-eeeEEEEEEEeccC
Q psy10160 202 ASN-SYT-SDENAVTIRVEGIF 221 (558)
Q Consensus 202 a~N-~~G-~~~~~~~l~V~~~~ 221 (558)
..- +.| ..+...-|.|....
T Consensus 104 F~tfp~G~~~~gt~CLtVt~~~ 125 (189)
T PHA02987 104 FNTLLSKNNEKGVVCLNVTTDS 125 (189)
T ss_pred EEecCCCCCceeEEEEEEEchh
Confidence 875 346 66788889997543
No 233
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=97.90 E-value=2.1e-05 Score=60.28 Aligned_cols=34 Identities=21% Similarity=0.385 Sum_probs=30.4
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.++.+.+++|.|.+++.+|+|.|+|.|.|..|..
T Consensus 38 ~~~~~~~~~L~I~~~~~~DsG~Y~C~a~n~~g~~ 71 (79)
T cd04973 38 NRTRITGEEVQIKDAVPRDSGLYACVTSSPSGSD 71 (79)
T ss_pred ceEEEeCCEEEECCCChhhCEEEEEEEeCCCCcc
Confidence 4677778899999999999999999999998875
No 234
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=97.90 E-value=2.7e-05 Score=59.32 Aligned_cols=39 Identities=31% Similarity=0.538 Sum_probs=32.3
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeC
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQAL 50 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~ 50 (558)
.+++|.|.+++.+|+|.|+|.|.|..|... +..++|.+.
T Consensus 36 ~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~~l~v~ 75 (77)
T cd05760 36 KERTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQNFTLSII 75 (77)
T ss_pred CCCEEEEeeCCcccCEEEEEEEEeCCCeEeeCceEEEEEe
Confidence 356899999999999999999999999874 456666553
No 235
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=97.90 E-value=3.7e-05 Score=60.66 Aligned_cols=44 Identities=25% Similarity=0.423 Sum_probs=35.4
Q ss_pred CCceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEe
Q psy10160 6 SENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQA 49 (558)
Q Consensus 6 ~~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~ 49 (558)
..|+.. .+++|.|.+++.+|+|.|+|.|.|..|... ++.|.|..
T Consensus 38 ~~r~~v~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 83 (90)
T cd05726 38 SSRFSVSQTGDLTITNVQRSDVGYYICQTLNVAGSILTKAYLEVTD 83 (90)
T ss_pred CCeEEECCCCeEEEeeCChhhCEEEEEEEEcCCCceEEEEEEEEee
Confidence 346665 467999999999999999999999999874 55666554
No 236
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.90 E-value=3.8e-05 Score=58.19 Aligned_cols=41 Identities=27% Similarity=0.439 Sum_probs=32.0
Q ss_pred CceEe--cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 7 ENYEL--NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 7 ~r~~~--~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
.|+.. .++.|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 31 ~~~~~~~~~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~l~V 74 (75)
T cd05763 31 RRMHVMPEDDVFFIVDVKIEDTGVYSCTAQNTAGSISANATLTV 74 (75)
T ss_pred cceEEecCCCEEEEeeCCcccCEEEEEEEEcCCCEEEeeEEEEE
Confidence 34443 457999999999999999999999999763 444443
No 237
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=97.89 E-value=4.7e-05 Score=61.12 Aligned_cols=68 Identities=22% Similarity=0.364 Sum_probs=47.7
Q ss_pred eEeeCCCcEEEEeEeec-cCCCeEEEEECCEE-----e-------ccCCceEEEcc-----CCeEEEccCCCCCCeEEEE
Q psy10160 139 QVFGVGSDISIPCDVDG-YPIPQVFWYKDGQV-----I-------ENDGVHYRITE-----SNRLHINQANATDSGEYRC 200 (558)
Q Consensus 139 ~~v~~G~~v~L~C~~~g-~P~p~i~W~~~g~~-----l-------~~~~~~~~~~~-----~~sL~I~~v~~~D~G~Y~C 200 (558)
..+.+|++++|.|.... .+...+.|+|.... + .....++.+.. ..+|.|.+++.+|+|.|.|
T Consensus 2 v~~~~G~~vtl~C~~~~~~~~~~~~W~r~~~~~~~~~l~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~v~~~DsG~Y~C 81 (98)
T cd05716 2 VTGELGGSVTIPCPYPPKNRSYEKYWCKWGSAGCCLIIVSEGSVQSQYEGRVSLTDDPDNGVFTVTLNQLRKEDAGWYWC 81 (98)
T ss_pred EEEEeCCeEEEEeeCCCCCCCcEeEeECCCCCCCCeEEECCCccccccCCCEEEEecCCCCEEEEEEcCCCHHHCEEEEE
Confidence 35678999999999765 35567899985421 1 11123454432 1279999999999999999
Q ss_pred EEEeCC
Q psy10160 201 VASNSY 206 (558)
Q Consensus 201 ~a~N~~ 206 (558)
.+.+..
T Consensus 82 ~~~~~~ 87 (98)
T cd05716 82 GVGDDG 87 (98)
T ss_pred EcccCC
Confidence 887754
No 238
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=97.89 E-value=2.6e-05 Score=58.74 Aligned_cols=40 Identities=28% Similarity=0.348 Sum_probs=32.0
Q ss_pred CceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 7 ENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 7 ~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
.++.+ .+++|.|.+++.+|+|.|+|.|.|..|... +..|.
T Consensus 31 ~~~~~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 72 (73)
T cd04969 31 SRICIWPDGSLEILNVTKSDEGKYTCFAENFFGKANSTGSLS 72 (73)
T ss_pred CCEEECCCCeEEEccCChhHCEEEEEEEECCCCceEEEEEEE
Confidence 35554 457899999999999999999999999874 44443
No 239
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=97.89 E-value=1.5e-05 Score=62.92 Aligned_cols=35 Identities=31% Similarity=0.474 Sum_probs=30.2
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
.+.|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 54 ~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~sa~L~V 89 (90)
T cd04974 54 SEVLYLRNVSFDDAGEYTCLAGNSIGPSHHSAWLTV 89 (90)
T ss_pred cceEEEeccccccCcEEEEEeecccCcccCCEEEEe
Confidence 46899999999999999999999999874 566655
No 240
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=97.88 E-value=2.9e-05 Score=57.73 Aligned_cols=35 Identities=29% Similarity=0.522 Sum_probs=30.3
Q ss_pred CceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 7 ENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 7 ~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
.++.+ .+++|.|.+++.+|+|.|+|.|.|..|...
T Consensus 28 ~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 63 (69)
T cd05746 28 GKFHISPEGYLAIRDVGVADQGRYECVARNTIGYAS 63 (69)
T ss_pred CCEEECCCCEEEECcCChhhCEEEEEEEECCCCcEE
Confidence 45554 478999999999999999999999999864
No 241
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=97.88 E-value=2.4e-05 Score=62.10 Aligned_cols=40 Identities=25% Similarity=0.252 Sum_probs=32.6
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
.|+...+++|.|.+++.+|+|.|+|.++|..|..+ ++.|+
T Consensus 53 ~r~~~~~~~L~I~~~~~~DsG~Y~C~~~N~~g~~~~~~~L~ 93 (94)
T cd05756 53 SRMHQQKDLLWFLPAALEDSGLYTCVVRNSTYCMKVSISLT 93 (94)
T ss_pred ceeeecCCeEEEccCCcccCeEEEEEEcCCCccEEEEEEEE
Confidence 45555678999999999999999999999998864 44443
No 242
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=97.86 E-value=4.8e-05 Score=60.29 Aligned_cols=42 Identities=26% Similarity=0.411 Sum_probs=34.8
Q ss_pred CCceEecCCeEEEcCCC-CCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 6 SENYELNKNMLTIKRVE-PERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 6 ~~r~~~~~~~L~I~~v~-~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
..++.+.++.|.|.++. .+|+|.|+|.|.|..|...+..+.|
T Consensus 49 ~~~~~~~~g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~s~~a~l 91 (93)
T cd05849 49 NDRYSMVGGNLVINNPDKYKDAGRYVCIVSNIYGKVRSREATL 91 (93)
T ss_pred CCeEEEECCEEEECcCCcCCCCEEEEEEEEeCcceEEEccEEE
Confidence 45777788999999985 6999999999999999886655544
No 243
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=97.85 E-value=3e-05 Score=61.83 Aligned_cols=36 Identities=25% Similarity=0.300 Sum_probs=28.3
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
++|.|.+++.+|+|.|+|.|.|..|...+..+.|.+
T Consensus 60 ~~L~I~~v~~~D~G~YtC~A~N~~~g~~~~s~~l~v 95 (96)
T cd05865 60 STLTIYNANIDDAGIYKCVVSNEDEGESEATVNVKI 95 (96)
T ss_pred eEEEEeccChhhCEEEEEEEEcCCCCcEEEEEEEEE
Confidence 589999999999999999999997444444444443
No 244
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=97.84 E-value=4.7e-05 Score=59.77 Aligned_cols=39 Identities=23% Similarity=0.392 Sum_probs=32.3
Q ss_pred eEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 9 YELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 9 ~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
+...+++|.|.+++.+|+|.|+|.|.|..|... +..|.|
T Consensus 48 ~~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 87 (88)
T cd04968 48 ISMSGAVLKIPNIQFEDEGTYECEAENIKGKDTHQGRIYV 87 (88)
T ss_pred EEEeCCEEEECCCCcccCEEEEEEEEECCCcEEEEEEEEE
Confidence 345778999999999999999999999999864 455544
No 245
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=97.84 E-value=3.8e-05 Score=57.50 Aligned_cols=40 Identities=20% Similarity=0.370 Sum_probs=31.9
Q ss_pred CceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 7 ENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 7 ~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
.++.. .++.|.|.+++.+|+|.|+|.|.|..|... ++.|.
T Consensus 29 ~~~~~~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~ 70 (71)
T cd05723 29 DYFKIVKEHNLQVLGLVKSDEGFYQCIAENDVGNVQASAQLI 70 (71)
T ss_pred CCEEEEecCCEEEEcCCcccCEEEEEEEEcCCCEEEEEEEEE
Confidence 34453 567899999999999999999999999874 44443
No 246
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=97.81 E-value=3.6e-05 Score=61.94 Aligned_cols=36 Identities=19% Similarity=0.290 Sum_probs=30.4
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.++|.|.+++.+|+|.|+|.|.|..|... ++.|.|.
T Consensus 64 ~~~L~i~~v~~~D~G~Ytc~A~N~~G~~~~t~~L~V~ 100 (101)
T cd04975 64 VSELKLVRLKESEAGTYTFLASNSDASKSLTFELYVN 100 (101)
T ss_pred EEEEEEeecCHhhCeeEEEEEECCCccEEEEEEEEEE
Confidence 36899999999999999999999999763 5566554
No 247
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=97.81 E-value=5.2e-05 Score=57.60 Aligned_cols=38 Identities=18% Similarity=0.393 Sum_probs=31.5
Q ss_pred EecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 10 ELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 10 ~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
...++.|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 37 ~~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 75 (76)
T cd05868 37 KVDGDTIIFSKVQERSSAVYQCNASNEYGYLLANAFVNV 75 (76)
T ss_pred EecCCEEEECCCCHhhCEEEEEEEEcCCCEEEEEEEEEe
Confidence 35667999999999999999999999999874 455443
No 248
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=97.81 E-value=6.8e-05 Score=61.28 Aligned_cols=65 Identities=25% Similarity=0.584 Sum_probs=44.7
Q ss_pred EeeCCCcEEEEeEeeccC-CCeEEEEECCEE---------e--cc----------CCceEEE--ccC---CeEEEccCCC
Q psy10160 140 VFGVGSDISIPCDVDGYP-IPQVFWYKDGQV---------I--EN----------DGVHYRI--TES---NRLHINQANA 192 (558)
Q Consensus 140 ~v~~G~~v~L~C~~~g~P-~p~i~W~~~g~~---------l--~~----------~~~~~~~--~~~---~sL~I~~v~~ 192 (558)
.+.+|++++|.|.+.+.. ...+.|+|.... + .. ...++.+ ... .+|+|.+++.
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~~~~Wyrq~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~~~~ 81 (107)
T cd07700 2 LVQTNNTVKLSCEAKGISENTRIYWLRWRQAPKDSHFEFLALWSPLGGATYGEEVSQEKFSIRVTSDSSRYRLHINRVKP 81 (107)
T ss_pred EEcCCCCEEEEEEEecCCCCCeEEEEEECCCCCCCccEEEEEEcCCCCeEEccccccCcEEEEEECCCCEEEEEECCCCH
Confidence 467899999999987643 457999984321 0 00 0124433 111 2599999999
Q ss_pred CCCeEEEEEEEe
Q psy10160 193 TDSGEYRCVASN 204 (558)
Q Consensus 193 ~D~G~Y~C~a~N 204 (558)
+|+|.|.|...+
T Consensus 82 ~Dsg~YyCa~~~ 93 (107)
T cd07700 82 EDSGTYFCMTVG 93 (107)
T ss_pred HHCEEEEEeEcC
Confidence 999999999764
No 249
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=97.80 E-value=4.6e-05 Score=57.86 Aligned_cols=39 Identities=23% Similarity=0.386 Sum_probs=32.1
Q ss_pred eEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 9 YELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 9 ~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
....++.|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 36 ~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 75 (76)
T cd04978 36 RRVDGGTLILSNVQPNDTAVYQCNASNVHGYLLANAFVHV 75 (76)
T ss_pred EEccCCEEEECCCChhhCEEEEEEEEccCCeEEEeEEEEE
Confidence 445678999999999999999999999999874 444443
No 250
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.79 E-value=8.6e-05 Score=54.60 Aligned_cols=60 Identities=33% Similarity=0.622 Sum_probs=45.0
Q ss_pred EEEEeEeeccCCCeEEEEECCEEeccCCc------eEEEccCCeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 147 ISIPCDVDGYPIPQVFWYKDGQVIENDGV------HYRITESNRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 147 v~L~C~~~g~P~p~i~W~~~g~~l~~~~~------~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
+.|.|.+.+.|.+.+.|++++........ .........|.|.+++.+|.|.|.|.+.+..
T Consensus 1 ~~l~C~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~d~g~y~C~~~~~~ 66 (74)
T cd00096 1 VTLTCLASGPPPPTITWLKNGKPLPSSVLTRVRSSRGTSSGSSTLTISNVTLEDSGTYTCVASNSA 66 (74)
T ss_pred CEEEEEecCCCCCcEEEEECCEECCCcccEEeccccCcceeEEEEEECccCcccCcEEEEEEecCc
Confidence 46899999978888999998876543221 1111223479999999999999999998876
No 251
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=97.77 E-value=6.4e-05 Score=58.61 Aligned_cols=39 Identities=26% Similarity=0.291 Sum_probs=30.9
Q ss_pred CceEec----CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEE
Q psy10160 7 ENYELN----KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTV 45 (558)
Q Consensus 7 ~r~~~~----~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l 45 (558)
+|+... .++|.|.++..+|+|.|+|.|.|..|... ++.|
T Consensus 41 ~r~~~~~~~~~~~L~I~~~~~~D~G~Y~c~a~N~~G~~~~~~~l 84 (86)
T cd05894 41 GRVRVESYKDLSSFVIEGAEREDEGVYTITVTNPVGEDHASLFV 84 (86)
T ss_pred CeEEEEEcCCeEEEEECCCccCcCEEEEEEEEeCCCcEEEEEEE
Confidence 355542 36899999999999999999999999863 3343
No 252
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=97.77 E-value=4.3e-05 Score=57.72 Aligned_cols=29 Identities=31% Similarity=0.342 Sum_probs=26.5
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
.++|.|.+++.+|+|.|+|.|.|..|...
T Consensus 39 ~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 67 (74)
T cd05748 39 STSLVIKNAERSDSGKYTLTLKNPAGEKS 67 (74)
T ss_pred eEEEEECCCCcCcCEEEEEEEECCCccEE
Confidence 45899999999999999999999999863
No 253
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=97.77 E-value=4.3e-05 Score=59.50 Aligned_cols=39 Identities=26% Similarity=0.351 Sum_probs=32.9
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEE
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTV 45 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l 45 (558)
.++...++.|.|.+++.+|+|.|+|.|.|..|... ++.|
T Consensus 44 ~~~~~~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 83 (85)
T cd05728 44 NRIEVEAGDLRITKLSLSDSGMYQCVAENKHGTIYASAEL 83 (85)
T ss_pred CeEEEeCCEEEEeeCCHHHCEEEEEEEECCCCeEEEEEEE
Confidence 46667788999999999999999999999999864 4443
No 254
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=97.75 E-value=3.8e-05 Score=60.80 Aligned_cols=35 Identities=34% Similarity=0.460 Sum_probs=28.7
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
++|+|.+++.+|+|.|+|.|.|..|......+.+.
T Consensus 57 ~~L~I~~v~~~D~G~Y~C~A~N~~g~~~~~sv~l~ 91 (92)
T cd04977 57 STLTIYNANIEDAGIYKCVATDAKGTESEATVNLK 91 (92)
T ss_pred EEEEEecCCcccCEEEEEEEEcCCCCcceeEEEEE
Confidence 48999999999999999999999776555555443
No 255
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=97.75 E-value=0.0001 Score=58.53 Aligned_cols=42 Identities=31% Similarity=0.474 Sum_probs=34.6
Q ss_pred CCceEecCCeEEEcCCC-CCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 6 SENYELNKNMLTIKRVE-PERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 6 ~~r~~~~~~~L~I~~v~-~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
..++.+.+++|.|.++. .+|+|.|+|.|+|..|...+..+.|
T Consensus 50 ~~~~~~~~g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~s~~a~l 92 (94)
T cd05850 50 ESRYTLVAGNLVINNPQKARDAGSYQCLAINRCGTVVSREANL 92 (94)
T ss_pred CceEEEECCeEEEccCCccCcCEEEEEEEEcCcCcEEEEEEEE
Confidence 34677778899998865 6999999999999999887766555
No 256
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.74 E-value=5.6e-05 Score=58.21 Aligned_cols=35 Identities=31% Similarity=0.511 Sum_probs=29.4
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
+.++|.|.+++.+|+|.|+|.|.|..|... ++.|+
T Consensus 45 ~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 80 (81)
T cd05765 45 NIGQLVIYNAQPQDAGLYTCTARNSGGLLRANFPLS 80 (81)
T ss_pred cccEEEEccCCcccCEEEEEEEecCCceEEEEEEEe
Confidence 457899999999999999999999999863 44443
No 257
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=97.73 E-value=8e-05 Score=58.07 Aligned_cols=41 Identities=27% Similarity=0.374 Sum_probs=32.9
Q ss_pred CceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 7 ENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 7 ~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
.++.. .+++|.|.+++.+|+|.|+|.|.|..|...+..+.|
T Consensus 43 ~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~l 84 (86)
T cd05724 43 ERVRIVDDGNLLIAEARKSDEGTYKCVATNMVGERESAAARL 84 (86)
T ss_pred CCEEEccCCEEEEeECCcccCEEEEEEEEeccCceeeeeEEE
Confidence 34443 468999999999999999999999999876554444
No 258
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.73 E-value=4.9e-05 Score=57.40 Aligned_cols=30 Identities=30% Similarity=0.467 Sum_probs=27.6
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
..+++|.|.+++.+|+|.|+|.|.|..|..
T Consensus 37 ~~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~ 66 (74)
T cd05764 37 YDNGTLDILITTVKDTGSFTCIASNAAGEA 66 (74)
T ss_pred ecCCEEEEEECChhhCEEEEEEEECCCCeE
Confidence 467899999999999999999999999976
No 259
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=97.73 E-value=5.4e-05 Score=60.76 Aligned_cols=39 Identities=28% Similarity=0.434 Sum_probs=31.1
Q ss_pred CceEec----CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEE
Q psy10160 7 ENYELN----KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTV 45 (558)
Q Consensus 7 ~r~~~~----~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l 45 (558)
.|+... .++|.|.+++.+|+|.|+|.|.|..|... ++.|
T Consensus 53 ~r~~v~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 96 (98)
T cd05870 53 GRIEVKGQHGESSLHIKDVKLSDSGRYDCEAASRIGGHQKSMYL 96 (98)
T ss_pred ceEEEeecCCeeEEEEeeCCcCCCEEEEEEEeccCCcceeEEEE
Confidence 456542 35899999999999999999999999764 4443
No 260
>PF08328 ASL_C: Adenylosuccinate lyase C-terminal; InterPro: IPR013539 This domain is found at the C terminus of adenylosuccinate lyase(ASL; PurB in Escherichia coli). It has been identified in bacteria, eukaryotes and archaea and is found together with the lyase domain IPR000362 from INTERPRO. ASL catalyses the cleavage of succinylaminoimidazole carboxamide ribotide to aminoimidazole carboxamide ribotide and fumarate and the cleavage of adenylosuccinate to adenylate and fumarate []. ; GO: 0004018 N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity, 0006188 IMP biosynthetic process; PDB: 2HVG_A 2QGA_C 2PTS_A 2PTR_A 2PTQ_B 3BHG_A 3GZH_A.
Probab=97.71 E-value=0.00011 Score=58.20 Aligned_cols=100 Identities=15% Similarity=0.193 Sum_probs=64.0
Q ss_pred ccccccchhhHHHHHHHHHHHHHHHHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccc-------cChHHHHHHHHH
Q psy10160 450 HFELNVFKPLIVSNVLRSIRLIADSATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPH-------IGYDKAAKIAKT 522 (558)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~-------l~~~~a~~~~~~ 522 (558)
.|+||...+...+++--.+....-+...+. +.|.+|.||+++|.+.|+++|. .||+. .|++.++|..|+
T Consensus 2 R~QRDLtDSTvlRNiGva~~~sliA~~s~l-kGl~Kl~vn~~~l~~dL~~nWe---VlaEpIQTvmRr~g~~~pYE~LK~ 77 (115)
T PF08328_consen 2 RWQRDLTDSTVLRNIGVAFGHSLIAYKSLL-KGLGKLEVNEERLAEDLDENWE---VLAEPIQTVMRRYGIPNPYEKLKE 77 (115)
T ss_dssp STTB-THHHHHHTTHHHHHHHHHHHHHHHH-HHHHTEEE-HHHHHHHHCT-GG---GGHHHHHHHHHHTT-SSHHHHHHH
T ss_pred cccccchHHHHHHhhhHHHHHHHHHHHHHH-HHHhcccCCHHHHHHHHHHCHH---HHHHHHHHHHHHcCCCCHHHHHHH
Confidence 478888777777777666666666665555 4899999999999999999997 47754 388888887776
Q ss_pred HHHcCCCH-----HHHHHHcCCCCHHHHhhh--cCccccc
Q psy10160 523 AHKEGTTL-----KVAALKLGYLTEEEFNKW--VVPEDML 555 (558)
Q Consensus 523 a~~~~~~~-----~~~~~~~~~l~~~~~~~~--~~p~~~~ 555 (558)
.. .|+.+ ++++.... ++++...++ +.|.+|+
T Consensus 78 lT-Rg~~it~~~l~~fI~~L~-ip~~~k~~L~~ltP~~Y~ 115 (115)
T PF08328_consen 78 LT-RGKKITKEDLREFIESLD-IPEEAKARLLALTPATYI 115 (115)
T ss_dssp HH-TTS---HHHHHHHHHTSS-S-HHHHHHHHH--CCC--
T ss_pred HH-cCCCCCHHHHHHHHHhCC-CCHHHHHHHHhcCccccC
Confidence 43 45443 33333344 788776665 5898885
No 261
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=97.70 E-value=4.9e-05 Score=61.20 Aligned_cols=36 Identities=25% Similarity=0.313 Sum_probs=30.6
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.++|.|.+++.+|+|.|+|.|.|..|... ++.+.|.
T Consensus 64 ~s~L~I~~v~~~D~G~Ytc~A~N~~g~~~~t~~l~V~ 100 (101)
T cd05859 64 VSKLKLIRAKEEDSGLYTALAQNEDAVKSYTFALQIQ 100 (101)
T ss_pred ccEEEEeeCCHHHCEEEEEEEEcCCceEEEEEEEEEE
Confidence 36899999999999999999999998864 6666654
No 262
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=97.69 E-value=7.1e-05 Score=57.53 Aligned_cols=29 Identities=24% Similarity=0.257 Sum_probs=26.4
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
.+.|.|.+++.+|+|.|+|.|.|..|...
T Consensus 45 ~~~L~I~~~~~~D~G~YtC~A~N~~G~~~ 73 (81)
T cd04971 45 HGCLQFDNPTHVNNGNYTLVASNEYGQDS 73 (81)
T ss_pred EEEEEECCCCcccCeEEEEEEEeCCCCee
Confidence 34799999999999999999999999863
No 263
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=97.69 E-value=0.0001 Score=58.54 Aligned_cols=41 Identities=29% Similarity=0.413 Sum_probs=33.4
Q ss_pred CceEecCCeEEEcCCC-CCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 7 ENYELNKNMLTIKRVE-PERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~-~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
.++...+++|.|.++. .+|+|.|+|.|.|..|...+..+.|
T Consensus 51 ~~~~~~~g~L~i~~~~~~~D~G~Y~C~A~N~~G~~~S~~~~l 92 (94)
T cd05848 51 YRYSLIDGNLIISNPSEVKDSGRYQCLATNSIGSILSREALL 92 (94)
T ss_pred ceEEeeCCeEEEccCCccCcCEEEEEEEEcCCCeEEeccEEE
Confidence 3566678899999985 6999999999999999886655544
No 264
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=97.68 E-value=0.00045 Score=54.76 Aligned_cols=71 Identities=23% Similarity=0.259 Sum_probs=46.3
Q ss_pred CcEEEEeEeecc-CCCeEEEEECCE----Eecc----C--------CceEEEc----cCCeEEEccCCCCCCeEEEEEEE
Q psy10160 145 SDISIPCDVDGY-PIPQVFWYKDGQ----VIEN----D--------GVHYRIT----ESNRLHINQANATDSGEYRCVAS 203 (558)
Q Consensus 145 ~~v~L~C~~~g~-P~p~i~W~~~g~----~l~~----~--------~~~~~~~----~~~sL~I~~v~~~D~G~Y~C~a~ 203 (558)
+.++|.|..... ..+.+.|.|... .+.. . ..|.... .+.+|.|.+++.+|+|.|+|.+.
T Consensus 1 ~~vtL~C~~~~~~~~~qV~W~k~~~~~~~~iavy~~~~g~~~~~~y~~Rv~f~~~~~~d~sI~i~nvt~~D~G~Y~C~~~ 80 (96)
T cd05889 1 EKMKLECVYPKTGVLIQVSWTKHNGSHKENIAVYHPIYGMHIEDKYRGRVYFLNSTREDMSLSFNNATEEDVGLYCCSLV 80 (96)
T ss_pred CCEEEEeEcCCCCcEEEEEEEEcCCCCCceEEEEECCCCCEECccccCeEEEecCCCCccEEEEcCCCcccCEEEEEEEE
Confidence 467899987532 345688988431 1110 0 1233322 24689999999999999999998
Q ss_pred eC-CceeeEEEEE
Q psy10160 204 NS-YTSDENAVTI 215 (558)
Q Consensus 204 N~-~G~~~~~~~l 215 (558)
+. .|...+.+.+
T Consensus 81 t~P~g~~~~~i~~ 93 (96)
T cd05889 81 TYPQGSWEKVIEV 93 (96)
T ss_pred eCCCCCeEEEEEE
Confidence 74 6777766654
No 265
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=97.68 E-value=4.4e-05 Score=60.21 Aligned_cols=34 Identities=35% Similarity=0.478 Sum_probs=29.3
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
++|.|.+++.+|+|.|+|.|.|..|... ++.|.|
T Consensus 55 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 89 (90)
T cd05858 55 EVLYLRNVTFEDAGEYTCLAGNSIGISHHSAWLTV 89 (90)
T ss_pred eEEEEccCCHHHCEEEEEEEEeCCCcccceEEEEE
Confidence 4799999999999999999999999864 555554
No 266
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=97.66 E-value=0.00012 Score=59.33 Aligned_cols=65 Identities=14% Similarity=0.276 Sum_probs=44.4
Q ss_pred EeeCCCcEEEEeEeeccCCCeEEEEECCEE-------e---cc-C----------CceEEEccC---CeEEEccCCCCCC
Q psy10160 140 VFGVGSDISIPCDVDGYPIPQVFWYKDGQV-------I---EN-D----------GVHYRITES---NRLHINQANATDS 195 (558)
Q Consensus 140 ~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~-------l---~~-~----------~~~~~~~~~---~sL~I~~v~~~D~ 195 (558)
.+.+|+.|+|.|.....-...+.|+|.... + .. . ..++..... .+|.|.+++.+|+
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~v~Wyrq~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~sDs 81 (104)
T cd05720 2 DAELGQKVELKCEVLNSSPTGCSWLFQPPGSAPQPTFLVYLSGSSKITWDEEELSSKRFSGSRSSNSFVLTLKNFQKENE 81 (104)
T ss_pred cccCCCeEEEEEEecCCCCCcEEEEEeCCCCCCCCEEEEEEeCCCCeeeccccCCCceEEEEecCCEEEEEECCCCHHHC
Confidence 367899999999986654556999984321 1 00 0 123433221 2699999999999
Q ss_pred eEEEEEEEe
Q psy10160 196 GEYRCVASN 204 (558)
Q Consensus 196 G~Y~C~a~N 204 (558)
|+|.|.+.+
T Consensus 82 gtY~Ca~~~ 90 (104)
T cd05720 82 GYYFCSVAS 90 (104)
T ss_pred EEEEEEEcc
Confidence 999998764
No 267
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=97.65 E-value=0.00012 Score=58.31 Aligned_cols=37 Identities=24% Similarity=0.292 Sum_probs=30.6
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.++.|.|.+++.+|+|.|+|.|.|..|... ++.|.|.
T Consensus 56 ~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~ 93 (95)
T cd05730 56 DGSEMTILDVDKLDEAEYTCIAENKAGEQEAEIHLKVF 93 (95)
T ss_pred CCCEEEECCCChhhCEEEEEEEEcCCCeEEEEEEEEEE
Confidence 345799999999999999999999999864 5555554
No 268
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=97.65 E-value=0.00016 Score=56.96 Aligned_cols=29 Identities=28% Similarity=0.369 Sum_probs=26.7
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.++.|.|.+++.+|+|.|+|.+.|..+..
T Consensus 50 ~~~~L~I~~v~~~DsG~YtC~~~n~~~~~ 78 (92)
T cd05757 50 KGSKLLIQNVTEEDAGNYTCKLTFTHNGK 78 (92)
T ss_pred cCCEEEEeeCChhhCEEEEEEEEecCCCE
Confidence 77899999999999999999999987765
No 269
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=97.65 E-value=0.00019 Score=54.47 Aligned_cols=36 Identities=33% Similarity=0.385 Sum_probs=30.3
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
+..|.|.+++.+|+|.|+|.+.|..|... ++.|.|+
T Consensus 38 ~~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 74 (76)
T cd05736 38 GSELHISNVRYEDTGAYTCIAKNEAGVDEDISSLFVE 74 (76)
T ss_pred CCEEEECcCCcccCEEEEEEEEcCCCCcceEEEEEEE
Confidence 35799999999999999999999999874 5566553
No 270
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=97.64 E-value=8.1e-05 Score=56.63 Aligned_cols=28 Identities=25% Similarity=0.267 Sum_probs=26.0
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.++|.|.++..+|+|.|+|.|+|..|..
T Consensus 43 ~~~L~i~~~~~~D~G~YtC~A~N~~G~~ 70 (79)
T cd05855 43 HGCLQLDNPTHLNNGIYTLVAKNEYGED 70 (79)
T ss_pred EEEEEECCCCcccCEEEEEEEEcCCccc
Confidence 3589999999999999999999999976
No 271
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=97.63 E-value=0.00033 Score=55.53 Aligned_cols=75 Identities=20% Similarity=0.414 Sum_probs=44.8
Q ss_pred CcEEEecCCceEeeCCCcEEEEeEeecc-CCC-eEEEEECCEEeccCC--ceEEEccCCeEE---EccCCCCCCeEEEEE
Q psy10160 129 PVKVNITLETQVFGVGSDISIPCDVDGY-PIP-QVFWYKDGQVIENDG--VHYRITESNRLH---INQANATDSGEYRCV 201 (558)
Q Consensus 129 p~~~~~~~~~~~v~~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~~~--~~~~~~~~~sL~---I~~v~~~D~G~Y~C~ 201 (558)
||.+.+.+.... |+.++|.|.+.|. |.+ .+.|.++|..+.... ..+....+++.. .-.+...|.+.|+|.
T Consensus 2 pP~v~v~~~~~~---~~~~~L~C~a~gF~P~~i~v~W~~~g~~~~~~~~~~~~~~~~d~ty~~~s~l~v~~~~~~~ytC~ 78 (93)
T cd07698 2 PPEVRVTRKRAP---DGSLTLSCHATGFYPRDIEVTWLRDGEDSVDDVESGEILPNGDGTYQLWVTLEVPPEDKARYSCR 78 (93)
T ss_pred CCEEEEEecCCC---CCcEEEEEEEEEEeCCCcEEEEEECCEECcccccccceEECCCCeEEEEEEEEECCCCCCEEEEE
Confidence 444444433322 7889999999996 544 689999996432211 122223333221 223445588999999
Q ss_pred EEeCC
Q psy10160 202 ASNSY 206 (558)
Q Consensus 202 a~N~~ 206 (558)
+.+..
T Consensus 79 V~H~~ 83 (93)
T cd07698 79 VEHSG 83 (93)
T ss_pred EEeCC
Confidence 98754
No 272
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=97.63 E-value=0.00018 Score=58.13 Aligned_cols=45 Identities=27% Similarity=0.191 Sum_probs=35.0
Q ss_pred ccCCceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 4 VRSENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 4 ~~~~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
..++|..+ .+++|.|.+++.+|+|.|+|.+.+.........+.+.
T Consensus 59 ~~~gR~~~~~ngSL~I~~v~~~D~G~Y~~~v~~~~~~~~~~~v~l~ 104 (105)
T cd05774 59 AYSGRETIYPNGSLLIQNVTQKDTGFYTLQTITTNFQVEQATVHLQ 104 (105)
T ss_pred ccCCcEEEeCCCcEEEecCCcccCEEEEEEEEeCCccEEEEEEEEE
Confidence 34567775 6799999999999999999999997755545555443
No 273
>PF14698 ASL_C2: Argininosuccinate lyase C-terminal; PDB: 1XWO_A 2E9F_A 1TJW_C 1TJU_A 1DCN_B 1K7W_B 1HY1_C 1TJV_B 1AUW_A 1U15_B ....
Probab=97.62 E-value=1.5e-05 Score=58.85 Aligned_cols=55 Identities=24% Similarity=0.298 Sum_probs=38.4
Q ss_pred Hhhhhhcccc-----cChHHHHHH----HHHHHHcCCCHHHHHHH-----cCCCCHHHHhhhcCcccccC
Q psy10160 501 LMLVTALNPH-----IGYDKAAKI----AKTAHKEGTTLKVAALK-----LGYLTEEEFNKWVVPEDMLG 556 (558)
Q Consensus 501 ~~~~~~la~~-----l~~~~a~~~----~~~a~~~~~~~~~~~~~-----~~~l~~~~~~~~~~p~~~~~ 556 (558)
+++||+||++ ++||+||++ |+.|.++|+++.++..+ ...++ +++.++|||++++.
T Consensus 1 f~~ATdlAD~LVr~GipFR~AH~iVg~~V~~a~~~~~~l~~l~~~~~~~~~~~~~-~~~~~~l~~~~~V~ 69 (70)
T PF14698_consen 1 FSTATDLADYLVRKGIPFREAHHIVGRLVRLAEEEGKPLSELTLEELQEISPEFE-EDVREALDPEASVE 69 (70)
T ss_dssp TGGHHHHHHHHHHTTS-HHHHHHHHHHHHHHHHHTTS-GGGS-HHHHHHH-TT---GGGGGGSSHHHHHT
T ss_pred CccHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHcCCChhhCCHHHHHHHhHHhH-HHHHHHCCHHHHhc
Confidence 4678899876 599999985 56778899887775443 24454 89999999998764
No 274
>PF08205 C2-set_2: CD80-like C2-set immunoglobulin domain ; InterPro: IPR013162 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the C2-set type domains found in the T-cell antigen CD80, as well as in related proteins. CD80 (B7-1) is a glycoprotein expressed on antigen-presenting cells []. The shared ligands on CD80 and CD86 (B7-2) deliver the co-stimulatory signal through CD28 and CTLA-4 on T-cells, where CD28 augments the T-cell response and CTLA-4 attenuates it [].; PDB: 3S58_A 3O3U_N 3CJJ_A 3S59_A 2PF6_B 2PET_A 3ALP_A 3SKU_D 3U83_A 3U82_B ....
Probab=97.61 E-value=0.00042 Score=54.44 Aligned_cols=66 Identities=24% Similarity=0.565 Sum_probs=43.2
Q ss_pred CCcEEEEeEe-eccCCCeEEEEECCEEeccCCceEE-EccC------CeEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 144 GSDISIPCDV-DGYPIPQVFWYKDGQVIENDGVHYR-ITES------NRLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 144 G~~v~L~C~~-~g~P~p~i~W~~~g~~l~~~~~~~~-~~~~------~sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
|+.+.+.|.+ .|+|.|.|+|+.++..+........ ...+ .+|.+..-..++...++|.|.|..-..
T Consensus 14 ~~~~~~~C~s~~~~P~~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~~S~l~~~~~~~~~~~~~~C~~~~~~~~~ 87 (89)
T PF08205_consen 14 GEEVTLTCSSSGGYPPPQITWYLDGGPVVASNTTQSSSPDNGLFTVSSTLTLTPTREDHGKTLTCRASHPALSQ 87 (89)
T ss_dssp TEEEEEEEEEEEEBS-EEEEEEETTCEECEEEEEEEEETTTTTEEEEEEEEEETTGGGTTEEEEEEEEETTCCE
T ss_pred ceEEEEEEEeCCeECCeEEEEEECCCceeeeeeeeeeccCCCcceEEEEEEEEcChHHCCeEEEEEEECCccCC
Confidence 7899999964 6789999999999987721110111 1111 246665544556779999999976543
No 275
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=97.61 E-value=9.3e-05 Score=57.46 Aligned_cols=35 Identities=31% Similarity=0.405 Sum_probs=29.1
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
.++|.|.+++.+|+|.|+|.|.|..|... +..|.|
T Consensus 48 ~s~L~I~~v~~~DsG~Y~C~a~n~~~~~~~s~~v~v 83 (84)
T cd05742 48 SSTLTIPNATLKDSGTYTCAASSGTMDQKESTKVNI 83 (84)
T ss_pred EEEEEECCCChhhCEEEEEEEccCCCceEEEEEEEE
Confidence 35899999999999999999999998764 555443
No 276
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=97.59 E-value=0.00017 Score=59.04 Aligned_cols=39 Identities=28% Similarity=0.432 Sum_probs=31.0
Q ss_pred CCeEEEcCCC-CCCCEEEEEEEEeCCcceE-EEEEEEEeCC
Q psy10160 13 KNMLTIKRVE-PERLGAYTCQAYNGLGRAV-SWTVTLQALP 51 (558)
Q Consensus 13 ~~~L~I~~v~-~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p 51 (558)
+++|.|.+++ .+|.|.|+|.|.|..|... ++.|.+...|
T Consensus 68 ~s~L~I~~v~~~~D~G~Y~C~A~N~~G~~~~~i~L~~~~~p 108 (109)
T cd05773 68 TSILTIINVSAALDYALFTCTAHNSLGEDSLDIQLVSTSRP 108 (109)
T ss_pred eeEEEECcCCccCCCEEEEEEEEeCCccCcEEEEEEecCCC
Confidence 3689999998 5999999999999999873 5555555443
No 277
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=97.58 E-value=0.00013 Score=56.73 Aligned_cols=35 Identities=26% Similarity=0.454 Sum_probs=29.1
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
...+|.|.+++.+|+|.|+|.|.|..|... ++.|.
T Consensus 49 ~~~~l~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 84 (85)
T cd05857 49 QHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLD 84 (85)
T ss_pred CceEEEEccCCcccCEEEEEEEEeCCCEEEEEEEEE
Confidence 355899999999999999999999999864 44443
No 278
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=97.57 E-value=0.00019 Score=54.58 Aligned_cols=41 Identities=29% Similarity=0.490 Sum_probs=32.2
Q ss_pred CceEe--cCCeEEEcCCCC----CCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 7 ENYEL--NKNMLTIKRVEP----ERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 7 ~r~~~--~~~~L~I~~v~~----~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
.++.. .+++|.|.+++. +|+|.|+|.|.|..|...+..+.|
T Consensus 30 ~~~~~~~~~g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~~~~l 76 (77)
T cd05733 30 PRVTMKPDSGTLVIDNMNGGRAEDYEGEYQCYASNELGTAISNEIHL 76 (77)
T ss_pred CCEEEeCCCCEEEEeccCCCCCcCCCEEEEEEEEcCCCcEEccccEE
Confidence 44443 468999999865 799999999999999887655544
No 279
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=97.57 E-value=0.00014 Score=57.79 Aligned_cols=42 Identities=26% Similarity=0.400 Sum_probs=31.3
Q ss_pred CCceEec-----CCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 6 SENYELN-----KNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 6 ~~r~~~~-----~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
+.|+.+. +.+|.|.+|+.+|+|.|+|.+........+.+|+|
T Consensus 49 ~~r~~~~~~~~~~~~L~I~nV~~~D~G~YtC~~~t~~~~~~~~~~~v 95 (95)
T cd05882 49 DNRIQLVKSTPTELIISISNVQLSDEGEYTCSIFTMPVRTAKATVTV 95 (95)
T ss_pred CCeEEEEeCCCceEEEEECCCCcccCEEEEEEEEeeccccEEEEEEC
Confidence 4566532 46999999999999999999998554445555543
No 280
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=97.56 E-value=0.00027 Score=53.75 Aligned_cols=36 Identities=36% Similarity=0.503 Sum_probs=29.8
Q ss_pred cCCeEEEcCCCCC----CCEEEEEEEEeCCcceEEEEEEE
Q psy10160 12 NKNMLTIKRVEPE----RLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 12 ~~~~L~I~~v~~~----D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
.+++|.|..+..+ |+|.|+|.|.|..|...+..+.|
T Consensus 37 ~~g~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~~~~~ 76 (77)
T cd05874 37 NTGTLVINIMNGEKAEAYEGVYQCTARNERGAAVSNNIVI 76 (77)
T ss_pred CCceEEEeccccCCCCCCCEEEEEEEEcCCCeEEeeEEEE
Confidence 5789999888754 78999999999999887665554
No 281
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=97.55 E-value=0.00012 Score=58.67 Aligned_cols=33 Identities=30% Similarity=0.493 Sum_probs=28.2
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
+.|.|.+++.+|+|.|+|.|.|..|... +..|.
T Consensus 63 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 96 (97)
T cd05869 63 SSLTLKYIQYTDAGEYLCTASNTIGQDSQSMYLE 96 (97)
T ss_pred EEEEEecCccCcCEEEEEEEecCCCCeeEEEEEE
Confidence 5899999999999999999999999874 44443
No 282
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=97.55 E-value=0.00018 Score=57.43 Aligned_cols=28 Identities=36% Similarity=0.593 Sum_probs=26.1
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
++|.|.+++.+|+|.|+|.|.|..|...
T Consensus 62 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 89 (96)
T cd05732 62 SSLTLKDVQLTDAGRYDCEASNRIGGDQ 89 (96)
T ss_pred EEEEECcCCcCcCEEeEEEEEeCCCCcE
Confidence 4899999999999999999999999863
No 283
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=97.52 E-value=0.00011 Score=58.09 Aligned_cols=28 Identities=36% Similarity=0.392 Sum_probs=25.8
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
.+|.|.+++.+|+|.|+|.|.|..|...
T Consensus 58 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 85 (92)
T cd05737 58 ASLTIKGVSSEDSGKYGIVVKNKYGGET 85 (92)
T ss_pred EEEEEccCChhhCEEEEEEEEECCCcce
Confidence 3799999999999999999999999863
No 284
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=97.51 E-value=0.00022 Score=55.25 Aligned_cols=37 Identities=22% Similarity=0.321 Sum_probs=28.2
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEEEe
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTLQA 49 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V~~ 49 (558)
..+|.|.+++.+|+|.|+|.|.|..+.. .+..+.|.|
T Consensus 45 ~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~~sv~i~V 82 (84)
T cd05861 45 RSTLTFPHATVEDSGTYECAAHESTQDQKAFKKVNITV 82 (84)
T ss_pred EEEEEECCCCcCCCEEEEEEEEECccCcceeEEEEEEE
Confidence 4589999999999999999999976522 344444444
No 285
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=97.50 E-value=0.00037 Score=53.03 Aligned_cols=42 Identities=29% Similarity=0.395 Sum_probs=32.3
Q ss_pred CCceEe--cCCeEEEcCCCC----CCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 6 SENYEL--NKNMLTIKRVEP----ERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 6 ~~r~~~--~~~~L~I~~v~~----~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
+.++.. .+++|.|.+++. +|+|.|+|.|.|..|...+..+.|
T Consensus 29 ~~~~~~~~~~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~~~~~ 76 (77)
T cd05875 29 DPRVSMRRRSGTLVIDFSGGGRPEDYEGEYQCFARNNLGTALSNKILL 76 (77)
T ss_pred CCcEEEeCCCceEEEeccCCCCCCCCCEEEEEEEEeccceEEEEEEEE
Confidence 445554 578999998752 469999999999999887666554
No 286
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=97.50 E-value=0.00023 Score=55.93 Aligned_cols=43 Identities=28% Similarity=0.372 Sum_probs=33.7
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
.++....+.|.|.+++.+|+|.|+|.+.|..+.....+++|.+
T Consensus 44 ~~~~~~~~~L~I~~~~~~D~G~Y~C~a~~~~~~~~~~~~~l~V 86 (89)
T cd04979 44 ERLLVTEDGLLIRSVSPADAGVYTCQSVEHGFKQTLATYSLNV 86 (89)
T ss_pred ceEEEcCCCEEEccCCHHHCEEEEEEEecCccceeEeEEEEEE
Confidence 4566666789999999999999999999877665555555554
No 287
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=97.50 E-value=0.00015 Score=55.80 Aligned_cols=34 Identities=35% Similarity=0.573 Sum_probs=28.3
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
..+|.|.+++.+|+|.|+|.+.|..|.. +..+.|
T Consensus 47 ~~~L~i~~v~~~D~G~Y~C~a~N~~G~~-~~~~~v 80 (82)
T cd05856 47 KWTLSLKNLKPEDSGKYTCHVSNRAGEI-NATYKV 80 (82)
T ss_pred eEEEEEccCChhhCEEEEEEEEcCCccE-EEEEEE
Confidence 3689999999999999999999999975 334444
No 288
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=97.50 E-value=0.00047 Score=57.22 Aligned_cols=70 Identities=19% Similarity=0.416 Sum_probs=47.8
Q ss_pred cCCceEeeCCCcEEEEeEeeccC--CCeEEEEECC--E-E--e---cc----------CCceEEEccC---C--eEEEcc
Q psy10160 135 TLETQVFGVGSDISIPCDVDGYP--IPQVFWYKDG--Q-V--I---EN----------DGVHYRITES---N--RLHINQ 189 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~P--~p~i~W~~~g--~-~--l---~~----------~~~~~~~~~~---~--sL~I~~ 189 (558)
.|....+.+|++++|.|...+.- ...+.|+|.. + + + .. -..+|....+ . +|.|.+
T Consensus 3 ~~~~~~v~~G~~vtL~C~~~~~~~~~~~~~WYkQ~~g~~p~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~ 82 (117)
T cd04981 3 ESGPGLVKPGQSLKLSCKASGFTFTSYGVNWVRQAPGKGLEWIGFINPGGGETYYADSVKGRFTITRDTSKSTVYLQLNS 82 (117)
T ss_pred cCCCeEEcCCCCEEEEEEEeCCCcccceEEEEEECCCCCcEEEEEEecCCCceEeCcccCCcEEEEEEccCCEEEEEECC
Confidence 35567789999999999876543 4568999832 1 1 1 00 0124544321 2 699999
Q ss_pred CCCCCCeEEEEEEEe
Q psy10160 190 ANATDSGEYRCVASN 204 (558)
Q Consensus 190 v~~~D~G~Y~C~a~N 204 (558)
++.+|+|.|.|.+..
T Consensus 83 ~~~~Dsa~YyCa~~~ 97 (117)
T cd04981 83 LTPEDTAVYYCARGL 97 (117)
T ss_pred CCHHHCEEEEEEEEc
Confidence 999999999998765
No 289
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=97.48 E-value=0.00031 Score=55.33 Aligned_cols=42 Identities=19% Similarity=0.435 Sum_probs=32.1
Q ss_pred CCceEecCCeEEEcCCCCCCCEEEEEEEEe-CCcceE-EEEEEE
Q psy10160 6 SENYELNKNMLTIKRVEPERLGAYTCQAYN-GLGRAV-SWTVTL 47 (558)
Q Consensus 6 ~~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~~-s~~l~V 47 (558)
..|+...+++|.|.+++.+|+|.|+|.+.| ..+... ++.|.|
T Consensus 45 ~~r~~~~~~~L~I~~~~~~DsG~Y~C~a~~~~~~~~~~~~~l~v 88 (91)
T cd05871 45 EERLIHTERGLLLRSLQRSDAGVYTCTAVEHSFSQTLAKYTLHV 88 (91)
T ss_pred cccEEEecCeEEEeeCChhHCEEEEEEEEccCCeEEEEEEEEEE
Confidence 357777788999999999999999999984 655443 444444
No 290
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=97.47 E-value=0.00064 Score=56.66 Aligned_cols=70 Identities=23% Similarity=0.325 Sum_probs=47.1
Q ss_pred CCceEeeCCCcEEEEeEeeccC------CCeEEEEECCEE------ec--c--------CCceEEEcc-----CCeEEEc
Q psy10160 136 LETQVFGVGSDISIPCDVDGYP------IPQVFWYKDGQV------IE--N--------DGVHYRITE-----SNRLHIN 188 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P------~p~i~W~~~g~~------l~--~--------~~~~~~~~~-----~~sL~I~ 188 (558)
|....+.+|+.|+|.|.....+ ...+.|+|.... +. . -..|+.+.. +.+|.|.
T Consensus 6 P~~v~~~~G~~VtL~C~f~~~~~~~~~~~~~~~Wykq~~g~~~~~~~~~~~~~~~~~~~f~gR~~~~~~~~~~~~sL~I~ 85 (119)
T cd05712 6 PKSVSVQEGLCVLIPCSFSYPADWPVSNGVHGIWYKGHPYPKNRPPVATNNRSRLVHESTRGRFRLLGDLGKKNCSLLIS 85 (119)
T ss_pred CCEEEEeccccEEEEEEeeCcccccCCCceEEEEEeCCCCCCCCCcEEEcCCCccccccccccEEEecCCCCCEEEEEEc
Confidence 4566788999999999865322 234899985311 10 0 012554421 1379999
Q ss_pred cCCCCCCeEEEEEEEeC
Q psy10160 189 QANATDSGEYRCVASNS 205 (558)
Q Consensus 189 ~v~~~D~G~Y~C~a~N~ 205 (558)
+++.+|+|.|.|.+...
T Consensus 86 ~l~~~Dsg~Y~C~~~~~ 102 (119)
T cd05712 86 DAQPEDSGKYFFRVELG 102 (119)
T ss_pred cCChhhCeEEEEEEEcC
Confidence 99999999999988664
No 291
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=97.47 E-value=0.00036 Score=55.14 Aligned_cols=44 Identities=23% Similarity=0.212 Sum_probs=34.8
Q ss_pred cCCceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 5 RSENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 5 ~~~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
..+|+.+ .+++|.|.+++.+|+|.|+|.+.+..|......+.+.
T Consensus 47 ~~~R~~~~~~~sL~I~~l~~~DsG~Y~c~v~~~~~~~~~~~~~l~ 91 (92)
T cd05741 47 YSGRETIYPNGSLLIQNLTKEDSGTYTLQIISTNGVTENAKFFLR 91 (92)
T ss_pred cCCeEEEcCCceEEEccCCchhcEEEEEEEEcCCCcEEEEEEEEE
Confidence 3456665 6689999999999999999999988777665555543
No 292
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=97.46 E-value=0.00038 Score=54.96 Aligned_cols=29 Identities=24% Similarity=0.259 Sum_probs=25.2
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
++..|.|.+|+.+|+|.|+|.+.+..|..
T Consensus 53 ~~~~L~I~~v~~~D~G~YtC~~~~~~~g~ 81 (95)
T cd05897 53 GSTYLHIIDVSLNDSGYYTCKLQFTHEGK 81 (95)
T ss_pred CCCEEEEEEcChhhCEEEEEEEEEeeCCE
Confidence 34689999999999999999999986544
No 293
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=97.45 E-value=0.00032 Score=56.05 Aligned_cols=43 Identities=23% Similarity=0.336 Sum_probs=35.0
Q ss_pred CceEe--cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 7 ENYEL--NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 7 ~r~~~--~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
+|+.+ ++.+|.|.+++.+|+|.|.|.+.+..|...+..+.|.+
T Consensus 52 ~R~~~~~~~~sL~I~~~~~~DsG~Y~c~v~~~~~~~~~~~f~L~v 96 (97)
T cd05775 52 ERVNFSQNDYSLQISNLKMEDAGSYRAEINTKNGVTITKEFTLHI 96 (97)
T ss_pred eeEEecCCceeEEECCCchHHCEEEEEEEEcCCCCeEEEEEEEEe
Confidence 45555 34799999999999999999999988887766666655
No 294
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=97.45 E-value=0.00026 Score=55.86 Aligned_cols=38 Identities=29% Similarity=0.422 Sum_probs=31.7
Q ss_pred CCceEecCCeEEEcCCCC-CCCEEEEEEEEeCCcceEEE
Q psy10160 6 SENYELNKNMLTIKRVEP-ERLGAYTCQAYNGLGRAVSW 43 (558)
Q Consensus 6 ~~r~~~~~~~L~I~~v~~-~D~G~Y~C~a~n~~g~~~s~ 43 (558)
..++...++.|.|.++.. +|+|.|+|.|.|..|...+.
T Consensus 50 ~~~~~~~~~~L~i~~~~~~~d~G~Y~C~a~N~~G~~~S~ 88 (91)
T cd04967 50 DSRYSLVGGNLVISNPSKAKDAGRYQCLASNIVGTVLSR 88 (91)
T ss_pred CCCEEEECCEEEEecCCccCCCEEEEEEEEcCCCEEEec
Confidence 346667788999998874 99999999999999987654
No 295
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=97.45 E-value=0.00015 Score=55.42 Aligned_cols=28 Identities=43% Similarity=0.654 Sum_probs=26.2
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
+.|.|.+++.+|+|.|+|.|.|..|...
T Consensus 42 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 69 (78)
T cd05743 42 GTLTIRDVKESDQGAYTCEAINTRGMVF 69 (78)
T ss_pred EEEEECCCChHHCEEEEEEEEecCCEEE
Confidence 5899999999999999999999999874
No 296
>smart00407 IGc1 Immunoglobulin C-Type.
Probab=97.44 E-value=0.00076 Score=50.98 Aligned_cols=61 Identities=18% Similarity=0.384 Sum_probs=39.8
Q ss_pred cEEEEeEeecc-CC-CeEEEEECCEEeccCCce--EEEccCC------eEEEccCCCCCCeEEEEEEEeCC
Q psy10160 146 DISIPCDVDGY-PI-PQVFWYKDGQVIENDGVH--YRITESN------RLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 146 ~v~L~C~~~g~-P~-p~i~W~~~g~~l~~~~~~--~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
.++|.|.+.|. |. ..+.|+|+|.++..+... .....++ .|.+.....++...|+|.+....
T Consensus 1 ~~~L~C~a~gf~P~~i~v~W~k~g~~~~~~~~~~~~~~~~~gt~~~~s~L~v~~~~~~~~~~~tC~V~H~~ 71 (75)
T smart00407 1 KATLVCLVSGFYPPDITVTWLRNGQEVTSGVSTTDPLKNSDGTYFLSSYLTVSASTWESGDTYTCQVTHEG 71 (75)
T ss_pred CeEEEEEEEeEeCCCCEEEEEECCEECCCCEEECceEECCCCCEEEEEEEEEccccCCCCCEEEEEEEEcC
Confidence 36899999996 54 479999999874332111 1112233 46665556677789999997653
No 297
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=97.43 E-value=0.0002 Score=54.08 Aligned_cols=29 Identities=31% Similarity=0.484 Sum_probs=26.5
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
.++|.|.+++.+|+|.|+|.|.|..|...
T Consensus 42 ~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 70 (75)
T cd05750 42 NSELQINKAKLADSGEYTCVVENILGNDT 70 (75)
T ss_pred eEEEEEccCCcccCeEEEEEEEEcCCcee
Confidence 46899999999999999999999999863
No 298
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=97.42 E-value=0.00032 Score=55.88 Aligned_cols=42 Identities=29% Similarity=0.392 Sum_probs=31.4
Q ss_pred CCceEe-----cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 6 SENYEL-----NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 6 ~~r~~~-----~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
+.||.. ...+|.|.+++.+|+|.|+|.+.+......+..|+|
T Consensus 49 ~~r~~~~~~~~~~~~L~I~~v~~~DsG~Y~C~~~~~~~~~~~~~~~v 95 (95)
T cd05717 49 DNRIQLVNFSANELSISISNVSLSDEGRYTCSLYTMPVQTAKATVTV 95 (95)
T ss_pred cCcEEEEcCCCCeeEEEEccCCcccCEEEEEEEecCCCceEEEEEEC
Confidence 456664 235899999999999999999998665544555543
No 299
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=97.42 E-value=0.00032 Score=55.82 Aligned_cols=42 Identities=21% Similarity=0.317 Sum_probs=32.1
Q ss_pred CCceEe-----cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 6 SENYEL-----NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 6 ~~r~~~-----~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
++|+.. ...+|.|.+++.+|+|.|+|.+.+..+...++.|+|
T Consensus 49 ~~r~~~~~~~~~~~sL~I~~v~~~DsG~Y~C~~~t~~~~~~~~~l~v 95 (95)
T cd07701 49 DNRIELVRASWHELSISISDVSLSDEGQYTCSLFTMPVKTSKAYLTV 95 (95)
T ss_pred CCCEEEEECCCCcEEEEECcCCcccCEEEEEEeEeecCccEEEEEEC
Confidence 456653 235899999999999999999998666655666553
No 300
>PHA03376 BARF1; Provisional
Probab=97.42 E-value=0.00046 Score=59.97 Aligned_cols=80 Identities=14% Similarity=0.165 Sum_probs=47.3
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCCCCccCC-CCcc-ccCceeEEeccCCCCCCcEEEEeCCcc
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALPSEKVAD-PNAI-DYGTILSSAFPSESASPVVTQTTTTTT 88 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p~~~~~~-~~~v-~~~~~~~~~~~~~~p~p~v~W~~~~~~ 88 (558)
++-+|.|.+++.+|.|.|+|.......... ..++++..+-...+.. .... ..+..-..|...+.|.|.+.|..+.+.
T Consensus 85 gnvsLvI~~l~lSDdGtY~C~fQkge~~~~k~ehLt~V~~~~Lsv~a~~~dFp~~~~~~i~C~sggfP~P~~~Wle~~~~ 164 (221)
T PHA03376 85 NTFFLVVTAANISHDGNYLCRMKLGETEVTKQEHLSVVKPLTLSVHSERSQFPDFSVLTVTCTVNAFPHPHVQWLMPEGV 164 (221)
T ss_pred CeEEEEEEeeeecCCceEEEEEEcCCCceeeeeeeeeeecceEEEEeccccCCCCCeeEEEEecCCcCCchheeccccCC
Confidence 344899999999999999999987554332 2222221100000000 0000 022233567788899999999988655
Q ss_pred cCC
Q psy10160 89 EAT 91 (558)
Q Consensus 89 ~~~ 91 (558)
.+.
T Consensus 165 ~~~ 167 (221)
T PHA03376 165 EPA 167 (221)
T ss_pred CCC
Confidence 443
No 301
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=97.41 E-value=0.00024 Score=55.33 Aligned_cols=36 Identities=39% Similarity=0.466 Sum_probs=29.3
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.++|.|.+++.+|+|.|+|.|.|..|... +..|.|.
T Consensus 49 ~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~t~~~V~ 85 (86)
T cd05862 49 SSTLTIENVTLSDLGRYTCTASSGQMIAKNSTIVIVH 85 (86)
T ss_pred eeEEEEecCCcccCEEEEEEEeecceEecccEEEEEe
Confidence 46899999999999999999999887653 5555553
No 302
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=97.40 E-value=0.00022 Score=54.09 Aligned_cols=28 Identities=25% Similarity=0.455 Sum_probs=25.9
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.++|.|.+++.+|+|.|+|.+.|..|..
T Consensus 43 ~~~L~I~~~~~~DsG~Y~C~a~N~~g~~ 70 (76)
T cd05895 43 SSELQISKASLADNGEYKCMVSSKLGND 70 (76)
T ss_pred EEEEEECcCCcccCEEEEEEEEeCCCce
Confidence 3689999999999999999999999875
No 303
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=97.39 E-value=0.00066 Score=54.26 Aligned_cols=42 Identities=21% Similarity=0.394 Sum_probs=31.3
Q ss_pred CCceEe-----cCCeEEEcCCCCCCCEEEEEEEEe-CCcceEEEEEEEE
Q psy10160 6 SENYEL-----NKNMLTIKRVEPERLGAYTCQAYN-GLGRAVSWTVTLQ 48 (558)
Q Consensus 6 ~~r~~~-----~~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~~s~~l~V~ 48 (558)
.+|..+ ++++|.|.+++.+|+|.|+|.+.| ..|. .+..+.+.
T Consensus 50 ~~Rv~f~~~~~~daSi~i~nl~~~D~G~Y~C~v~t~P~g~-~~~~~~L~ 97 (99)
T cd05886 50 RERVTFKNPSFEDGTISLSRLELEDEGVYICEFATFPTGN-RESQLNLT 97 (99)
T ss_pred cCcEEEcCCCCCcceEEEcCCccccCEEEEEEEEeCCCCC-eEEEEEEE
Confidence 455554 458999999999999999999999 5664 34444443
No 304
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=97.39 E-value=0.00037 Score=54.12 Aligned_cols=31 Identities=23% Similarity=0.358 Sum_probs=28.0
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
.|+.+.++.|.|.+++.+|+|.|+|.+.+..
T Consensus 41 ~r~~~~~~~L~I~nv~~~DsG~Y~C~a~e~~ 71 (87)
T cd05873 41 AKYLLYRDGLLIFNASEADAGRYQCLSVEKS 71 (87)
T ss_pred ceEEEECCcEEEeCCCHHHCEEEEEEEEecc
Confidence 5788888999999999999999999999864
No 305
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=97.38 E-value=0.00023 Score=56.30 Aligned_cols=27 Identities=37% Similarity=0.465 Sum_probs=25.4
Q ss_pred eEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 15 MLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
+|.|.+++.+|+|.|+|.|.|..|...
T Consensus 59 ~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 85 (92)
T cd05891 59 SLTIKGVTSEDSGKYSINVKNKYGGET 85 (92)
T ss_pred EEEECCCChhhCEEEEEEEEeCCCcee
Confidence 899999999999999999999999873
No 306
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=97.37 E-value=0.00028 Score=55.97 Aligned_cols=34 Identities=18% Similarity=0.205 Sum_probs=30.2
Q ss_pred CceEecCCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 7 ENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 7 ~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.|+...+..|.|.++..+|+|.|+|+++|.....
T Consensus 63 ~Ri~~~~~~Lwf~Pa~~eDSG~Y~C~~rN~t~C~ 96 (104)
T cd05896 63 VRMSKEEDSIWFRPAELQDSGLYTCVLRNSTYCM 96 (104)
T ss_pred eeEEEeCCEEEEEeCChhhCeEEEEEECCCCcce
Confidence 3777889999999999999999999999977544
No 307
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=97.36 E-value=0.00019 Score=56.70 Aligned_cols=35 Identities=20% Similarity=0.333 Sum_probs=28.6
Q ss_pred CCceEe-cCCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 6 SENYEL-NKNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 6 ~~r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.+++.. .+|.|.|.+|+.+|+|.|+|.|.|..+..
T Consensus 51 ~r~~~~~~~G~L~fs~v~~~D~g~Y~C~A~n~~~~~ 86 (96)
T cd05727 51 GRRFVSQTNGNLYIAKVEASDRGNYSCFVSSPSSTK 86 (96)
T ss_pred CCeEEeCCCCcEEEeecCHhhCceeEEEEEecccCC
Confidence 344544 47999999999999999999999976543
No 308
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=97.32 E-value=0.00029 Score=55.51 Aligned_cols=34 Identities=32% Similarity=0.360 Sum_probs=28.5
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
.++|.|.+++.+|.|.|+|.|.|..|... ++.|+
T Consensus 55 ~~~L~I~~v~~~D~g~Y~C~A~N~~G~~~~~~~L~ 89 (90)
T cd04972 55 IYNLQLSNITSETQTTVTCTAENPVGQANVSVQVT 89 (90)
T ss_pred EEEEEEecCCcccCEEEEEEEECCCCceeEEEEEe
Confidence 35899999999999999999999999864 44443
No 309
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=97.32 E-value=0.00034 Score=55.37 Aligned_cols=28 Identities=29% Similarity=0.418 Sum_probs=26.0
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.++|.|.+++.+|+|.|+|.|.|..|..
T Consensus 58 ~~~L~i~~~~~~D~G~Y~C~a~N~~G~~ 85 (92)
T cd05747 58 KSTFEISKVQMSDEGNYTVVVENSEGKQ 85 (92)
T ss_pred eeEEEECCCCcccCEeEEEEEEcCCCCE
Confidence 3589999999999999999999999976
No 310
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=97.30 E-value=0.00024 Score=54.94 Aligned_cols=37 Identities=22% Similarity=0.298 Sum_probs=30.8
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
.++.|.|.+++.+|+|.|+|.+.|..|...|..+.+.
T Consensus 46 ~~~~l~I~~~~~~dsG~Y~C~~~~~~~~~~s~~~~i~ 82 (83)
T cd05753 46 SNSNLSIPQATLSDSGSYHCSGIIGSYDYSSEPVSIT 82 (83)
T ss_pred CCceEEECccCHHHCEEEEEEEEeCCceecCCCEEEE
Confidence 3568999999999999999999999987666555554
No 311
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=97.30 E-value=0.00028 Score=55.47 Aligned_cols=35 Identities=46% Similarity=0.595 Sum_probs=28.9
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVT 46 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~ 46 (558)
...+|.|.+++.+|+|.|+|.+.|..|... ++.|.
T Consensus 54 ~~~~L~I~~v~~~D~G~Y~C~~~n~~g~~~~~~~l~ 89 (90)
T PF07679_consen 54 GSSSLTIKNVTREDAGTYTCVASNSSGEATASVNLT 89 (90)
T ss_dssp TEEEEEESSESGGGSEEEEEEEEETTEEEEEEEEEE
T ss_pred ceeEEccCCCChhhCEEEEEEEEECCCEEEEEEEEE
Confidence 346899999999999999999999988763 44443
No 312
>cd05772 IgC_SIRP Signal-regulatory protein (SIRP) immunoglobulin-like domain. IgC_SIRP: Immunoglobulin-like domain of signal-regulatory proteins (SIRP); the signal-regulatory proteins (SIRP) are Ig-like cell surface receptors detected in hematopoietic and non-hematopoietic cells. While their extracellular domains are similar, SIRP are classified as alpha or beta based on the length of the intracytoplasmic domain. Those having a 110- to 113-amino acid tail are classified as SIRP-alpha, and those having a 5-amino acid tail as SIRP-beta. SIRP-alpha and SIRP-beta molecules are thought to have complementary roles in signal regulation: SIRP-alpha inhibit signalling via their immunoreceptor tyrosine (IT)-based inhibition motifs while SIRP-beta are activating. SIRP-beta lack the cytoplasmic domainof SIRP-alpha, and associate with at least one other transmembrane protein (DAP-12 or KARAP). The IT-based activation motifs within DAP-12's cytoplasmic domain may link SIRP-beta to the activating
Probab=97.28 E-value=0.0031 Score=51.50 Aligned_cols=68 Identities=15% Similarity=0.366 Sum_probs=43.7
Q ss_pred ceEeeCCCcEEEEeEeecc-CC-CeEEEEECCEEeccCCceEEEccC-C------eEEEccCCCCCCe-EEEEEEEeCC
Q psy10160 138 TQVFGVGSDISIPCDVDGY-PI-PQVFWYKDGQVIENDGVHYRITES-N------RLHINQANATDSG-EYRCVASNSY 206 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~-P~-p~i~W~~~g~~l~~~~~~~~~~~~-~------sL~I~~v~~~D~G-~Y~C~a~N~~ 206 (558)
......|+.++|.|.+.|. |. ..++|+|||..+...........+ + .|.+. ....|.| .|+|.+....
T Consensus 15 ~~~~~~g~~~tL~C~a~gF~P~~i~v~W~kng~~~~~~~~~~~p~~d~~ty~~~S~L~~~-~~~~d~~~~ytC~V~H~~ 92 (111)
T cd05772 15 SGRANPGQSVNFTCSAHGFSPRDITVKWLKNGNELSAEQPNITPEGDSVSYNVTSTVQVK-LTEDDVHSQVTCEVQHRT 92 (111)
T ss_pred hhccCCCCCEEEEEEEeeEeCCCCEEEEEECCEECcccccceeeCCCCCcEEEEEEEEEE-CccccccCceEEEEEeCC
Confidence 3445578889999999985 54 479999999998643222221222 1 34444 3445544 5999998864
No 313
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=97.26 E-value=0.00072 Score=53.82 Aligned_cols=38 Identities=39% Similarity=0.495 Sum_probs=31.1
Q ss_pred ecCCeEEEcCC-----CCCCCEEEEEEEEeC-CcceEEEEEEEE
Q psy10160 11 LNKNMLTIKRV-----EPERLGAYTCQAYNG-LGRAVSWTVTLQ 48 (558)
Q Consensus 11 ~~~~~L~I~~v-----~~~D~G~Y~C~a~n~-~g~~~s~~l~V~ 48 (558)
..+++|.|.++ +.+|+|.|+|.|.|. .|...+..+.|.
T Consensus 51 ~~~~~l~i~~v~~~~~~~~D~G~Y~C~a~N~~~G~~~s~~~~l~ 94 (95)
T cd05722 51 LPNGSLLITSVVHSKHNKPDEGFYQCVAQNDSLGSIVSRTARLT 94 (95)
T ss_pred ccCCeEEEeeeeccCCCCCcCEEEEEEEECCccCcEEEeeeEEe
Confidence 46778888887 689999999999999 998876666554
No 314
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=97.25 E-value=0.0015 Score=51.70 Aligned_cols=72 Identities=15% Similarity=0.242 Sum_probs=43.6
Q ss_pred CCcEEEEeEe-eccCCCeEEEEECCEEeccCCceEEEccCC------eEEEccCCCCCCeEEEEEEEeCCcee--eEEEE
Q psy10160 144 GSDISIPCDV-DGYPIPQVFWYKDGQVIENDGVHYRITESN------RLHINQANATDSGEYRCVASNSYTSD--ENAVT 214 (558)
Q Consensus 144 G~~v~L~C~~-~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~G~~--~~~~~ 214 (558)
.....+.|.+ .|+|.+.|+|+++..... ........++ .|.+.....+|.-.|+|++.|..-.. ..++.
T Consensus 15 ~~~~va~C~s~~gkP~a~ItW~~~~~~~~--~~~~~~~~~g~~tv~S~l~~~p~~~d~G~~~tC~v~h~~l~~~~~~~~~ 92 (95)
T cd05719 15 EPVTVATCVSANGKPPATISWETTLGGEA--ETQSKENPNGTVTVTSEYRLVPSREANGKELTCVVSHPTLQEPQRFSVT 92 (95)
T ss_pred CccEEEEEECCCCcCCCEEEEEeCCCCcc--eeEeecCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCCCeEEEEE
Confidence 3467899997 689999999999721110 0011112222 46665555555669999999986433 44455
Q ss_pred EEE
Q psy10160 215 IRV 217 (558)
Q Consensus 215 l~V 217 (558)
|+|
T Consensus 93 L~V 95 (95)
T cd05719 93 LNV 95 (95)
T ss_pred eeC
Confidence 443
No 315
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=97.24 E-value=0.00071 Score=50.15 Aligned_cols=32 Identities=25% Similarity=0.480 Sum_probs=25.7
Q ss_pred ceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 8 NYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 8 r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
++...+..|.|.++ +|+|.|+|.|.|..|...
T Consensus 32 ~~~~~~~~L~i~~~--~d~G~Y~C~A~N~~G~~~ 63 (69)
T cd05739 32 EMPVGRNVLELTNI--YESANYTCVAISSLGMIE 63 (69)
T ss_pred ceecCccEEEEecc--ccCeeEEEEEEeCCCEEE
Confidence 34445568999997 489999999999999763
No 316
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=97.23 E-value=0.00078 Score=54.20 Aligned_cols=35 Identities=29% Similarity=0.224 Sum_probs=28.1
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
.+|.|.+++.+|+|.|+|.+.|..+. ....+.+++
T Consensus 65 ~sL~I~~v~~~D~G~Y~C~v~~~~~~-~~~~i~l~v 99 (100)
T cd05713 65 VALRIHNVRASDEGLYTCFFQSDGFY-EEATVELKV 99 (100)
T ss_pred EEEEEEcCChhhCEEEEEEEecCCcE-EEEEEEEEE
Confidence 58999999999999999999987665 444555543
No 317
>cd07692 Ig_CD3_epsilon Immunoglobulin (Ig)-like domain of CD3 epsilon chain. Ig_CD3_epsilon; immunoglobulin (Ig)-like domain of CD3 epsilon chain. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=97.23 E-value=0.00078 Score=48.12 Aligned_cols=52 Identities=25% Similarity=0.527 Sum_probs=36.7
Q ss_pred eCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeC
Q psy10160 142 GVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNS 205 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~ 205 (558)
..|.+|+|+|+..+. .+.|.+++..+..++ ..+.+.+-. +++|.|.|.+.+.
T Consensus 5 isGTtVtlTCP~~~~---~i~W~~n~~~~~g~~--------~~~~~~~~~-e~~G~Y~C~~~~~ 56 (65)
T cd07692 5 ISGTTVTVTCPLSGD---DIKWKKNDQVSQGSD--------EKYLSLNHF-SSSGYYHCTADNA 56 (65)
T ss_pred EeccEEEEECCCCCC---CceEEeCCccCCCCC--------ceEEeeccC-CCCceEEEEeCCC
Confidence 468999999986533 299999986554432 234444445 8899999998654
No 318
>cd07699 IgC_L Immunoglobulin Constant domain. IgC_L: Immunoglobulin (Ig) light chain constant (C) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.22 E-value=0.00082 Score=53.97 Aligned_cols=66 Identities=17% Similarity=0.383 Sum_probs=41.9
Q ss_pred eeCCCcEEEEeEeec-cC-CCeEEEEECCEEeccCC--ceEEEccCC------eEEEccCCCCCCeEEEEEEEeCC
Q psy10160 141 FGVGSDISIPCDVDG-YP-IPQVFWYKDGQVIENDG--VHYRITESN------RLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 141 v~~G~~v~L~C~~~g-~P-~p~i~W~~~g~~l~~~~--~~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
...++.++|.|.+.| +| ...+.|++||..+..+. .......++ .|.+..-...+...|+|.+....
T Consensus 14 ~~~~~~~~L~C~~~gfyP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~~sC~V~H~~ 89 (100)
T cd07699 14 LEKSGKATLVCLINDFYPGFATVQWKVDGATVSSGVQTSTTEQQSDNTYSLSSYLTLTKSDWNKHKVYTCEVTHEG 89 (100)
T ss_pred HccCCCcEEEEEEEeEECCCCEEEEEECCEECcccEeccccEECCCCCEEEEEEEEEcHHHhCCCCeEEEEEEecC
Confidence 446788999999999 45 34589999999875321 011112233 34454444445679999987754
No 319
>PHA02633 hypothetical protein; Provisional
Probab=97.21 E-value=0.00095 Score=46.66 Aligned_cols=38 Identities=18% Similarity=0.231 Sum_probs=29.5
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEEEe
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTLQA 49 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V~~ 49 (558)
++..|+|.++..+|+|.|.|..+|..-.. .++.++|..
T Consensus 16 ~~~nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~~ 54 (63)
T PHA02633 16 NCNNMLILNPTQSDSGIYMCITKNETYSDMMKFDLCICL 54 (63)
T ss_pred ccccEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEee
Confidence 56789999999999999999999855443 255665543
No 320
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=97.14 E-value=0.00065 Score=52.80 Aligned_cols=31 Identities=29% Similarity=0.417 Sum_probs=27.9
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
..++.|.|.+++.+|+|.|+|.|.|..|...
T Consensus 49 ~~~~~L~I~~v~~~DsG~Y~C~a~n~~g~~~ 79 (85)
T cd05754 49 DFNGILTIRNVQLSDAGTYVCTGSNMLDTDE 79 (85)
T ss_pred ccCCEEEECCCCHHHCEEEEEEEeccCCeEe
Confidence 3568999999999999999999999998764
No 321
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=97.14 E-value=0.0029 Score=49.84 Aligned_cols=63 Identities=19% Similarity=0.339 Sum_probs=40.1
Q ss_pred eCCCcEEEEeEeecc-CCC-eEEEEECCEEeccCCc--eEEEccCCeEEEc---cCCCCCCeEEEEEEEeC
Q psy10160 142 GVGSDISIPCDVDGY-PIP-QVFWYKDGQVIENDGV--HYRITESNRLHIN---QANATDSGEYRCVASNS 205 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~~~~--~~~~~~~~sL~I~---~v~~~D~G~Y~C~a~N~ 205 (558)
..|+..+|.|.+.|. |.. .+.|.|||..+. +.. ......+++..+. .+..++...|+|.+.-.
T Consensus 13 ~~g~~~~L~C~a~gFyP~~i~v~W~~dg~~~~-~~~~~~~~p~~d~tyq~~s~l~~~~~~~~~ysC~V~H~ 82 (93)
T cd05770 13 ENGKPNVLNCYVTGFHPPDIEIRLLKNGVKIP-KVEQSDLSFSKDWTFYLLKSTEFTPTKGDEYACRVRHN 82 (93)
T ss_pred cCCCceEEEEEEEEEeCCCCEEEEEECCEECC-CcEECcEEECCCCCEEEEEEEEECCCCCCeEEEEEEEC
Confidence 457778999999995 433 489999999876 321 1222333332221 23456777899998764
No 322
>smart00406 IGv Immunoglobulin V-Type.
Probab=97.14 E-value=0.00097 Score=51.01 Aligned_cols=56 Identities=20% Similarity=0.500 Sum_probs=37.5
Q ss_pred cEEEEeEeeccCCC--eEEEEECCE-----Eec------------cCCceEEEccC-----CeEEEccCCCCCCeEEEEE
Q psy10160 146 DISIPCDVDGYPIP--QVFWYKDGQ-----VIE------------NDGVHYRITES-----NRLHINQANATDSGEYRCV 201 (558)
Q Consensus 146 ~v~L~C~~~g~P~p--~i~W~~~g~-----~l~------------~~~~~~~~~~~-----~sL~I~~v~~~D~G~Y~C~ 201 (558)
++.|.|.+.....+ .+.|++... .+. ....|+.+... .+|.|.+++.+|+|.|.|.
T Consensus 1 ~v~l~C~~~~~~~~~~~v~W~~~~~~~~~~~l~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~L~i~~~~~~D~G~Y~C~ 80 (81)
T smart00406 1 SVTLSCKASGFTFSSYYVSWVRQPPGKGLEWLGYIGSSGSTYYQQSYKGRVTISKDTSKNDVSLTISNLRVEDTGTYYCA 80 (81)
T ss_pred CEEEEEEEeccccceeEEEEEEeCCCCCeEEEEEEcCCCcEEECcccCCcEEEEecCcCCEEEEEEcCCCHHHCEEEEEc
Confidence 47899998776554 688988431 010 01234444332 3699999999999999996
No 323
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=97.14 E-value=0.0017 Score=51.45 Aligned_cols=42 Identities=26% Similarity=0.409 Sum_probs=31.1
Q ss_pred CCceEe-----cCCeEEEcCCCCCCCEEEEEEEEe-CCcceE-EEEEEE
Q psy10160 6 SENYEL-----NKNMLTIKRVEPERLGAYTCQAYN-GLGRAV-SWTVTL 47 (558)
Q Consensus 6 ~~r~~~-----~~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~~-s~~l~V 47 (558)
.+|..+ .+.+|.|.+++.+|+|.|+|.+.+ +.|... +..|+|
T Consensus 47 ~~Rv~~~~~~~~d~sl~i~nv~~~D~G~Y~C~v~tfP~G~~~~~~~l~~ 95 (96)
T cd05887 47 QGRVSFKNYSLLDATIMLENVGFSDIGVYICKAVTFPLGNTQSSTTVTV 95 (96)
T ss_pred CCcEEEcCCCCCccEEEEeCCCccccEEEEEEEEeCCCCCeeEEEEEEE
Confidence 345554 378999999999999999999866 666653 444443
No 324
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=97.10 E-value=0.0016 Score=52.33 Aligned_cols=35 Identities=17% Similarity=0.339 Sum_probs=27.6
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEe-CCcceEEEEEEEE
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYN-GLGRAVSWTVTLQ 48 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~~s~~l~V~ 48 (558)
+.+|.|.+++.+|+|.|.|.+.+ ..|.. +..+.|.
T Consensus 63 ~~sL~I~nv~~sD~GtY~C~v~~~p~g~~-~~~~~L~ 98 (100)
T cd05888 63 DGALILRNAVQADEGKYKCRVITFPAGNF-EAELVLT 98 (100)
T ss_pred ceEEEEecCccccceEEEEEEEeCCCCCe-eeEEEEE
Confidence 56999999999999999999998 55653 4444443
No 325
>cd05767 IgC_MHC_II_alpha Class II major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_II_alpha: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II alpha chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosom
Probab=97.10 E-value=0.0035 Score=49.47 Aligned_cols=61 Identities=21% Similarity=0.463 Sum_probs=38.9
Q ss_pred eCCCcEEEEeEeecc-CCC-eEEEEECCEEeccCCc--eEEEccCC------eEEEccCCCCCCeEEEEEEEeC
Q psy10160 142 GVGSDISIPCDVDGY-PIP-QVFWYKDGQVIENDGV--HYRITESN------RLHINQANATDSGEYRCVASNS 205 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~~~~--~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~ 205 (558)
..|+..+|.|.+.|. |.. .+.|.+||..+..+.. ......++ .|.+. .++...|+|.+.-.
T Consensus 13 ~~~~~~tL~C~a~gFyP~~I~v~W~~~g~~~~~~~~~~~~~~~~Dgty~~~s~L~v~---~~~~~~ytC~V~H~ 83 (94)
T cd05767 13 ELGEPNTLICFVDNFFPPVLNVTWLKNGVPVTDGVSETRYYPRQDLSFQKFSYLNFT---PEEGDIYSCIVEHW 83 (94)
T ss_pred cCCCCeEEEEEEEEEECCcCEEEEEECCeEccCceEEeeeEeCCCCcEEEEEEEEEE---CCCCCeEEEEEEeC
Confidence 346678999999994 543 5899999988754211 11122233 34443 35566999998764
No 326
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=97.07 E-value=0.0015 Score=53.14 Aligned_cols=43 Identities=23% Similarity=0.387 Sum_probs=32.2
Q ss_pred CCceEec-----CCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 6 SENYELN-----KNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 6 ~~r~~~~-----~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.+|+.+. +.+|.|.+++.+|+|.|+|.+.+..+... .+.|.|.
T Consensus 55 ~~R~~~~~~~~~~~sL~I~~v~~~DsG~Y~C~v~~~~~~~~~~~~l~v~ 103 (106)
T cd05877 55 QGRVFLRRAHDLDASLVITDLRLEDYGRYRCEVIDGLEDESVVVALRLR 103 (106)
T ss_pred cCcEEecCCCCCcEEEEEccCChHHCEEEEEEEEecccceEEEEEEEEE
Confidence 4566652 35899999999999999999999777653 4444443
No 327
>PHA02914 Immunoglobulin-like domain protein; Provisional
Probab=97.07 E-value=0.11 Score=50.61 Aligned_cols=82 Identities=21% Similarity=0.348 Sum_probs=54.1
Q ss_pred CCceEeeCCCcEEEEeEeec--c-CCCeEEEEECCEEecc----------------CCceEEEcc---------CCeEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDG--Y-PIPQVFWYKDGQVIEN----------------DGVHYRITE---------SNRLHI 187 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g--~-P~p~i~W~~~g~~l~~----------------~~~~~~~~~---------~~sL~I 187 (558)
..+..+..|+++.|.|..+- + ....+.|.-.|-++.+ .+..|.++. +++|+|
T Consensus 271 ~~~~~~~~g~~v~~~c~~s~~~~e~i~~~~w~~t~~~~~~~~g~~~~~~~v~~~~~~~~~~~i~~~~~~s~dlk~STLTI 350 (500)
T PHA02914 271 FDEVMLEVGKRVDIECFFSMCGNENISNAKWIDTGFEIGPLIGTVKSKDIVEGDFAEDDDFMISAHANYSDDLKNSTLTI 350 (500)
T ss_pred cceeEeccCcEEEEEEEEeecCCcccccceEEecCCcccceeEEEEecceeecccccCCceEEEEecccccchhhceEEe
Confidence 44555677999999998654 3 3345889876644431 012333322 358999
Q ss_pred ccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 188 NQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 188 ~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+++..+..|=|+|+|....-.....--|.|
T Consensus 351 kka~I~N~GCY~~~a~~g~~~~ec~~Cl~V 380 (500)
T PHA02914 351 KKAHINNAGCYEAQAFMGKFKEECRHCFKV 380 (500)
T ss_pred eeEEEEcCCceEEEEecCcchhhhhhheEe
Confidence 999999999999999887554444444444
No 328
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=97.03 E-value=0.0016 Score=53.26 Aligned_cols=36 Identities=19% Similarity=0.464 Sum_probs=27.5
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
.+.+|+|.+++.+|+|.|+|.+.+...... ...|.|
T Consensus 72 ~~asL~I~nl~~sDsG~Y~C~V~~g~~~~~~~v~l~v 108 (112)
T cd05900 72 SDATLEITELRSNDSGTYRCEVMHGIEDNYDTVEVQV 108 (112)
T ss_pred CCcEEEEeecccccCEEEEEEEecCCCCceeEEEEEE
Confidence 467999999999999999999997654432 344444
No 329
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=96.99 E-value=0.0026 Score=50.82 Aligned_cols=36 Identities=22% Similarity=0.359 Sum_probs=27.0
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEe-CCcceEEEEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYN-GLGRAVSWTVTLQ 48 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~~s~~l~V~ 48 (558)
.+.+|.|.+++.+|+|.|.|.+.+ ..|.. ...+.|.
T Consensus 60 ~~~sL~I~~v~~~D~G~Y~C~v~~~~~g~~-~~~~~l~ 96 (98)
T cd05718 60 EDATISISNLRLEDEGNYICEFATFPQGNR-QKVTTLT 96 (98)
T ss_pred CceEEEEccCCcccCEEEEEEEEeCCCCcE-EEEEEEE
Confidence 356999999999999999999976 45544 3344443
No 330
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=96.98 E-value=0.002 Score=52.76 Aligned_cols=43 Identities=19% Similarity=0.387 Sum_probs=30.7
Q ss_pred cCCceEe-------cCCeEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEE
Q psy10160 5 RSENYEL-------NKNMLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTL 47 (558)
Q Consensus 5 ~~~r~~~-------~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V 47 (558)
+.+|+.+ ++.+|+|.+++.+|+|.|.|.+....... ....|.|
T Consensus 56 f~gR~~~~~~~~~~~~asL~I~~l~~sD~G~Y~C~v~~~~~~~~~~v~l~V 106 (110)
T cd05878 56 YQGRVSLPNYPENRGDASLEISRLRSSDSGVYRCEVMHGIEDEQDTVPLEV 106 (110)
T ss_pred ccCeEEeccCCCCCCcEEEEECCCChhhCEEEEEEEEeCCCcceEEEEEEE
Confidence 3456654 34689999999999999999999854333 2444444
No 331
>cd07691 Ig_CD3_gamma_delta Immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. Ig_CD3_gamma_delta; immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=96.97 E-value=0.0032 Score=45.31 Aligned_cols=50 Identities=20% Similarity=0.426 Sum_probs=38.1
Q ss_pred CCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEe
Q psy10160 143 VGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASN 204 (558)
Q Consensus 143 ~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N 204 (558)
..+.|.|+|.+. -+|.|++ |..+... .+.+|.+..+..+-.|.|.|.++|
T Consensus 5 ~~~~V~L~C~~~----tsi~W~k-G~~~~~~-------~~~tlnLGs~~~DPRG~Y~C~~s~ 54 (69)
T cd07691 5 SEGKVFLKCNGA----TNITWKK-GKEILEV-------SNTLLDLGSRINDPRGTYSCKESE 54 (69)
T ss_pred cCceEEEEecCC----CcEEEec-Ccccccc-------cccEEeccCcccCCCcceEecCcc
Confidence 356799999762 3599999 6554321 256788889999999999999887
No 332
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=96.97 E-value=0.0016 Score=52.21 Aligned_cols=29 Identities=38% Similarity=0.551 Sum_probs=23.3
Q ss_pred CCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 21 VEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 21 v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
++.+|+|.|+|.|.|..|...+..+.|.+
T Consensus 71 ~~~~D~G~Y~C~a~N~~G~~~s~~~~l~v 99 (100)
T cd07693 71 KGRSDEGVYVCVAHNSLGEAVSRNASLEV 99 (100)
T ss_pred CCcCcCEEEEEEEEccccceecceEEEEe
Confidence 47999999999999999986655555543
No 333
>cd05766 IgC_MHC_II_beta Class II major histocompatibility complex (MHC) beta chain immunoglobulin domain. IgC_MHC_II_beta: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II beta chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosome be
Probab=96.97 E-value=0.0093 Score=47.17 Aligned_cols=66 Identities=21% Similarity=0.373 Sum_probs=41.1
Q ss_pred eCCCcEEEEeEeecc-CCC-eEEEEECCEEeccCC--ceEEEccCCeEEE---ccCCCCCCeEEEEEEEeCCc
Q psy10160 142 GVGSDISIPCDVDGY-PIP-QVFWYKDGQVIENDG--VHYRITESNRLHI---NQANATDSGEYRCVASNSYT 207 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~~~--~~~~~~~~~sL~I---~~v~~~D~G~Y~C~a~N~~G 207 (558)
..|+.++|.|.+.|. |.. .+.|+++|..+...- ....-..+++..+ -.+..++...|+|.+.....
T Consensus 12 ~~~~~~~L~C~~~gFyP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgTy~~~s~L~~~~~~~~~ysC~V~H~~l 84 (94)
T cd05766 12 SLSHPHLLVCHVWGFYPPEITVKWFKNGQEETEGVVSTELIPNGDWTYQILVMLETTPSRGDTYTCVVEHSSL 84 (94)
T ss_pred cCCCCeEEEEEEeeecCCCCEEEEEECCeecCCCceecceEECCCCcEEEEEEEEEcCCCCCEEEEEEEeCCC
Confidence 368899999999995 544 589999998875421 1111122332211 12334566799999887543
No 334
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=96.97 E-value=0.0014 Score=53.30 Aligned_cols=37 Identities=19% Similarity=0.425 Sum_probs=28.9
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.+.+|.|.+++.+|+|.|.|.+.+..+... ...|.|.
T Consensus 66 ~~~sL~I~~v~~sD~G~Y~C~v~~~~~~~~~~v~L~V~ 103 (106)
T cd05714 66 GDASLVITDLRLEDSGRYRCEVIDGIEDEQDTVELEVR 103 (106)
T ss_pred CcceEEECCCCHHHCEEEEEEEEcCCCceEEEEEEEEE
Confidence 457999999999999999999998766532 4444443
No 335
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=96.94 E-value=0.0019 Score=53.28 Aligned_cols=34 Identities=21% Similarity=0.337 Sum_probs=28.0
Q ss_pred cCCceEe------cCCeEEEcCCCCCCCEEEEEEEEeCCc
Q psy10160 5 RSENYEL------NKNMLTIKRVEPERLGAYTCQAYNGLG 38 (558)
Q Consensus 5 ~~~r~~~------~~~~L~I~~v~~~D~G~Y~C~a~n~~g 38 (558)
+.+|+.+ ++.+|.|.+++.+|+|.|+|.+.|..+
T Consensus 65 f~~Rv~f~g~~~~~daSI~I~nv~~sD~G~Y~C~v~n~p~ 104 (116)
T cd05879 65 FKERIEWVGNPSRKDGSIVIHNLDYTDNGTFTCDVKNPPD 104 (116)
T ss_pred ccCceEEeCCCCcCeeEEEEccCCcccCEEEEEEEEcCCC
Confidence 3456653 557999999999999999999999665
No 336
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=96.90 E-value=0.0023 Score=50.53 Aligned_cols=42 Identities=21% Similarity=0.389 Sum_probs=30.2
Q ss_pred cccCCceEec---CC--eEEEcCCCCCCCEEEEEEEEeCCcceEEEE
Q psy10160 3 QVRSENYELN---KN--MLTIKRVEPERLGAYTCQAYNGLGRAVSWT 44 (558)
Q Consensus 3 p~~~~r~~~~---~~--~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~ 44 (558)
+..++||... +. +|.|.+++.+|+|.|.|.+....-.....+
T Consensus 46 ~~~d~Rf~~~~~~~~~~tL~I~~vq~~D~G~Y~Cqv~t~p~~~~~~~ 92 (95)
T cd05881 46 PLKDSRFQLVNFSSNELRVSLSNVSLSDEGRYFCQLYTDPPQEAYTT 92 (95)
T ss_pred ccCCcCEEEEeCCCCEEEEEECcCCcccCEEEEEEEEcccCeEEEEE
Confidence 3456788742 22 699999999999999999987544333333
No 337
>cd05768 IgC_CH4 CH4 domain (fourth constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH4: The fourth immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.90 E-value=0.0028 Score=51.06 Aligned_cols=65 Identities=15% Similarity=0.395 Sum_probs=39.3
Q ss_pred eeCCCcEEEEeEeeccCCC--eEEEEECCEEeccCCc---eEEEcc--CC------eEEEccCCCCCCeEEEEEEEeC
Q psy10160 141 FGVGSDISIPCDVDGYPIP--QVFWYKDGQVIENDGV---HYRITE--SN------RLHINQANATDSGEYRCVASNS 205 (558)
Q Consensus 141 v~~G~~v~L~C~~~g~P~p--~i~W~~~g~~l~~~~~---~~~~~~--~~------sL~I~~v~~~D~G~Y~C~a~N~ 205 (558)
+..|+.++|.|.+.|.-++ .+.|.++|.++...+. ...... ++ .|.+..-...+...|+|.+.-.
T Consensus 13 ~~~~~~~tL~C~a~gFyP~~i~v~W~k~g~~~~~~~~~~~~~~~~~~~dgTy~~~s~L~v~~~~w~~~~~ytC~V~H~ 90 (102)
T cd05768 13 LSLQETATLTCLVKGFSPSDIFVKWLQNGQPLSKQKYVTTAPMQEPGGNESYFLYSKLTVSAEDWNAGDVFTCVVGHE 90 (102)
T ss_pred hCcCCceEEEEEEeeEeCCCCEEEEEECCEECCcccccccCcccccCCCCeEEEEEEEEEcHHHhcCCCcEEEEeEeC
Confidence 3457889999999995443 4799999988753210 001111 23 3444332234556899998764
No 338
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=96.87 E-value=0.0049 Score=48.70 Aligned_cols=64 Identities=9% Similarity=0.157 Sum_probs=39.8
Q ss_pred CcEEEEeEe-eccCCCeEEEEECCEEeccCCceEEEccC------CeEEEccCCCCCCeEEEEEEEeCCceee
Q psy10160 145 SDISIPCDV-DGYPIPQVFWYKDGQVIENDGVHYRITES------NRLHINQANATDSGEYRCVASNSYTSDE 210 (558)
Q Consensus 145 ~~v~L~C~~-~g~P~p~i~W~~~g~~l~~~~~~~~~~~~------~sL~I~~v~~~D~G~Y~C~a~N~~G~~~ 210 (558)
....+.|.+ .|+|.+.|+|+++..... ........+ +.|.+..-..+|...|+|++.|..-...
T Consensus 16 ~~~va~C~s~~gkPaa~IsW~~~~~g~~--~~~~~~~~~gt~tv~S~l~~~P~~~d~Gk~ltC~v~h~al~~~ 86 (95)
T cd07703 16 PVPVAKCVSANGRPPARISWSSTLGGNA--NTTSKENGDGTVTVTSEYSLVPTPEANGKEVTCKVEHETLQEP 86 (95)
T ss_pred ccEEEEEEcCCCCCCcEEEEEcCCCCCe--eEEEEeCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCCC
Confidence 457899976 588999999998722111 001111112 2466655555566699999999864443
No 339
>cd05847 IgC_CH2_IgE CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin E (IgE). IgC_CH2_IgE: The second constant domain of the heavy chain of immunoglobulin E (IgE). The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma, and mu, all consisting of a variable domain (VH) and three (in alpha, delta, and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). The different classes of antibodies vary in their heavy chains; the IgE class has the epsilon type. This domain (Cepsilon2) of IgE is in place of the flexible hinge region found in IgG.
Probab=96.87 E-value=0.0044 Score=49.01 Aligned_cols=66 Identities=26% Similarity=0.441 Sum_probs=40.9
Q ss_pred CCCcEEEEeEeecc-CC-CeEEEEECCEEeccCCc--eEEEccCC------eEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 143 VGSDISIPCDVDGY-PI-PQVFWYKDGQVIENDGV--HYRITESN------RLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 143 ~G~~v~L~C~~~g~-P~-p~i~W~~~g~~l~~~~~--~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
.++.+.|.|.+.|. |. ..+.|.++|..+..... ......++ .|.+..-...+...|+|.+......
T Consensus 13 ~~~~~~L~C~a~gFyP~~I~vtW~~dg~~~~~~~~~s~~~~~~~~Ty~~~S~L~v~~~~w~~~~~ytC~V~H~~~~ 88 (94)
T cd05847 13 TSETIQLLCLISGYTPGTIEVEWLVDGQVATLVAASTAPQKEEGSTFSTTSELNVTQEDWKSGKTYTCKVTHQGTT 88 (94)
T ss_pred CCCCEEEEEEEEeEECCCCEEEEEECCEECcCceeecccEECCCCcEEEEEEEEEchHHhcCCCeEEEEEEECCee
Confidence 45669999999994 54 35899999988633210 11112222 3545433334567999999876543
No 340
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=96.84 E-value=0.0022 Score=51.37 Aligned_cols=28 Identities=29% Similarity=0.597 Sum_probs=24.7
Q ss_pred CeEEEcCCCCCC-CEEEEEEEEeCCcceE
Q psy10160 14 NMLTIKRVEPER-LGAYTCQAYNGLGRAV 41 (558)
Q Consensus 14 ~~L~I~~v~~~D-~G~Y~C~a~n~~g~~~ 41 (558)
++|.|.+++.+| .|.|+|.|.|..|...
T Consensus 64 s~L~I~~v~~~d~~G~Y~C~A~N~~G~~~ 92 (98)
T cd05758 64 STLTISNTQESDFQTSYNCTAWNSFGSGT 92 (98)
T ss_pred EEEEECCccccccceeEEEEEEcCCCccc
Confidence 389999999955 9999999999999863
No 341
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=96.83 E-value=0.0039 Score=51.04 Aligned_cols=37 Identities=19% Similarity=0.470 Sum_probs=29.0
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQ 48 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~ 48 (558)
.+.+|.|.+++.+|+|.|+|.+.+.....+ ...|.|.
T Consensus 77 g~asL~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V~ 114 (117)
T cd05901 77 GDASLTIVKLRASDAGVYRCEVMHGIEDTQDTVSLDVS 114 (117)
T ss_pred CceEEEEcccccccCEEEEEEEEECCcccEEEEEEEEE
Confidence 467999999999999999999998765543 4455443
No 342
>PHA02633 hypothetical protein; Provisional
Probab=96.83 E-value=0.0035 Score=43.86 Aligned_cols=38 Identities=26% Similarity=0.399 Sum_probs=33.1
Q ss_pred cCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEe
Q psy10160 181 ESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVE 218 (558)
Q Consensus 181 ~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 218 (558)
....|.|-++..+|+|.|.|...|..-....++.|.|.
T Consensus 16 ~~~nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~ 53 (63)
T PHA02633 16 NCNNMLILNPTQSDSGIYMCITKNETYSDMMKFDLCIC 53 (63)
T ss_pred ccccEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEe
Confidence 34579999999999999999999988888888888884
No 343
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=96.75 E-value=0.0027 Score=48.69 Aligned_cols=35 Identities=23% Similarity=0.380 Sum_probs=27.6
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
...+.|.|.++ .|+|.|+|.|+|..|...+..++|
T Consensus 46 ~~~s~L~i~~~--~d~g~Y~C~A~N~~G~~~s~~a~~ 80 (81)
T cd05749 46 PSPSVLNVPGL--NETSKFSCEAHNAKGVTTSRTGTV 80 (81)
T ss_pred CCCCEEEEccc--cCCeEEEEEEEeccCcEEeeeEEe
Confidence 34678999887 589999999999999876544443
No 344
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=96.74 E-value=0.0054 Score=48.57 Aligned_cols=40 Identities=15% Similarity=0.263 Sum_probs=29.8
Q ss_pred CceEe-----cCCeEEEcCCCCCCCEEEEEEEEe-CCcceEEEEEEE
Q psy10160 7 ENYEL-----NKNMLTIKRVEPERLGAYTCQAYN-GLGRAVSWTVTL 47 (558)
Q Consensus 7 ~r~~~-----~~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~~s~~l~V 47 (558)
+|..+ .+.+|.|.+|+.+|+|.|+|...+ +.|.. +..+.|
T Consensus 48 ~Rv~f~~~~~~d~sI~i~nvt~~D~G~Y~C~~~t~P~g~~-~~~i~~ 93 (96)
T cd05889 48 GRVYFLNSTREDMSLSFNNATEEDVGLYCCSLVTYPQGSW-EKVIEV 93 (96)
T ss_pred CeEEEecCCCCccEEEEcCCCcccCEEEEEEEEeCCCCCe-EEEEEE
Confidence 45554 358999999999999999999987 45543 444444
No 345
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=96.70 E-value=0.0032 Score=51.36 Aligned_cols=36 Identities=17% Similarity=0.378 Sum_probs=27.1
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
.+.+|.|.+++.+|+|.|.|.......... ...|.|
T Consensus 70 ~~asL~i~nv~~~D~G~Y~C~v~~g~~~~~~~v~L~V 106 (110)
T cd05902 70 YNASLVLSRLRYSDSGTYRCEVVLGINDEQDTVPLEV 106 (110)
T ss_pred ceEEEEECCCCHHHCEEEEEEEEECCcccEEEEEEEE
Confidence 356999999999999999999998553322 444444
No 346
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=96.65 E-value=0.0027 Score=45.32 Aligned_cols=28 Identities=46% Similarity=0.609 Sum_probs=24.7
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCc
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLG 38 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g 38 (558)
..+..|.|.+++.+|+|.|+|.+.|..|
T Consensus 36 ~~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 36 ASGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred cCCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 4567999999999999999999998764
No 347
>cd07696 IgC_CH3 CH3 domain (third constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH3: The third immunoglobulin constant domain (IgC) of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.63 E-value=0.0085 Score=47.57 Aligned_cols=69 Identities=10% Similarity=0.214 Sum_probs=39.7
Q ss_pred ceEeeCCCcEEEEeEeecc--CCC-eEEEEECCEEec-cCCceEEEccCCe------EEEccCCCCCCeEEEEEEEeCC
Q psy10160 138 TQVFGVGSDISIPCDVDGY--PIP-QVFWYKDGQVIE-NDGVHYRITESNR------LHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~--P~p-~i~W~~~g~~l~-~~~~~~~~~~~~s------L~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
...+..|+.++|.|.+.|. |.. .++|.|+++... ..........+++ |.+..-..++.-.|+|.+....
T Consensus 8 ~~~l~~~~~~tLtC~v~gf~yP~~i~v~W~r~~~~~~~~~~~~~~~~~dgty~~~s~l~v~~~~w~~g~~ysC~V~H~~ 86 (96)
T cd07696 8 PKQLLLTKSVKLTCLVTNLTSPEGVNVTWTRGSGEPVKASIQPPESHNNATLSVTSTLNVSTDDWISGDTFQCKVTHPD 86 (96)
T ss_pred HHHhccCCCeEEEEEEeCCCCCCCcEEEEEECCeEeeeEEecccccCCCCCEEEEEEEEeCHHHccCCCcEEEEEECCC
Confidence 3335568999999999998 432 489999874332 1110111122333 4343322233458999987653
No 348
>cd05721 IgV_CTLA-4 Immunoglobulin (Ig) domain of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). IgV_CTLA-4: domain similar to the variable(v)-type immunoglobulin (Ig) domain found in cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is involved in the regulation of T cell response, acting as an inhibitor of intracellular signalling. CTLA-4 is similar to CD28, a T cell co-receptor protein that recognizes the B7 proteins (CD80 and CD86). CD28 binding of the B7 proteins occurs after the presentation of antigen to the T cell receptor (TCR) via the peptide-MHC complex on the surface of an antigen presenting cell (APC). CTLA-4 also binds the B7 molecules with a higher affinity than does CD28. The B7/CTLA-4 interaction generates inhibitory signals down-regulating the response, and may prevent T cell activation by weak TCR signals. CD28 and CTLA-4 then elicit opposing signals in the regulation of T cell responsiveness and homeostasis. T cell activation leads to increased
Probab=96.59 E-value=0.012 Score=47.66 Aligned_cols=68 Identities=10% Similarity=0.163 Sum_probs=45.0
Q ss_pred cCCceEeeCCCcEEEEeEeeccCCC---eEEEEECCE-Eec-------------cCCceEEEccC-----CeEEEccCCC
Q psy10160 135 TLETQVFGVGSDISIPCDVDGYPIP---QVFWYKDGQ-VIE-------------NDGVHYRITES-----NRLHINQANA 192 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~P~p---~i~W~~~g~-~l~-------------~~~~~~~~~~~-----~sL~I~~v~~ 192 (558)
++....+..|+.++|.|.++|.-.. .+.|.|... .+. ....++.+..+ -+|.|.+++.
T Consensus 4 ~~~~~lv~p~~sv~LsC~~sg~~~s~e~~~~wvRq~pg~lE~c~~~~~~g~~~~~~~~r~tcs~~~s~ntv~L~l~~L~a 83 (115)
T cd05721 4 QQSPVLASSNGAASLVCEYTYNGFSKEFRASLLKGADSAVEVCAVTGNMSNQLQTSLDGFNCDGTLGNEQVNFTLQNLRA 83 (115)
T ss_pred ecCCeEEcCCCCEEEEEEecCCccccEEEEEEEEeCCCCcEEEEEEeCCCccccccCCCeEEeEeCCCCEEEEEEcCCCH
Confidence 3456677889999999999886544 477887321 110 01123322221 1699999999
Q ss_pred CCCeEEEEEE
Q psy10160 193 TDSGEYRCVA 202 (558)
Q Consensus 193 ~D~G~Y~C~a 202 (558)
+|.+.|.|..
T Consensus 84 ~DTa~Y~Ca~ 93 (115)
T cd05721 84 NQTDIYFCKI 93 (115)
T ss_pred HHCeEEEEEe
Confidence 9999999974
No 349
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=96.58 E-value=0.0033 Score=48.57 Aligned_cols=27 Identities=33% Similarity=0.516 Sum_probs=24.8
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
..|.|.+++.+|+|.|+|.+.|..|..
T Consensus 51 ~~l~i~~~~~~d~g~Y~C~~~n~~g~~ 77 (85)
T cd05729 51 WTLILESVVPSDSGKYTCIVENKYGSI 77 (85)
T ss_pred EEEEEeECCcccCEEEEEEEEECCceE
Confidence 479999999999999999999999875
No 350
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=96.58 E-value=0.0016 Score=49.57 Aligned_cols=24 Identities=25% Similarity=0.483 Sum_probs=21.9
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeC
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNG 36 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~ 36 (558)
.+++|.|.++ .+|+|.|+|.|.|.
T Consensus 45 ~~~~l~i~~~-~~dsG~Y~C~a~~~ 68 (78)
T cd05752 45 TTNSYRIRAA-NNDSGEYRCQTQGS 68 (78)
T ss_pred cCCeEEEeec-ccCCEEeEEECCCC
Confidence 6679999999 99999999999875
No 351
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=96.54 E-value=0.0018 Score=51.09 Aligned_cols=26 Identities=23% Similarity=0.310 Sum_probs=23.3
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcc
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGR 39 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~ 39 (558)
.+|+|.+++.+|+|+|.|.+.|..+.
T Consensus 65 ~~L~I~~l~~sDsgtY~C~v~~~~~~ 90 (94)
T cd07690 65 FPLIIKNLKIEDSDTYICEVEDKKEE 90 (94)
T ss_pred EEEEECCCCHHHCEEEEEEECCccce
Confidence 46999999999999999999987654
No 352
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=96.52 E-value=0.007 Score=48.28 Aligned_cols=29 Identities=31% Similarity=0.374 Sum_probs=24.2
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEe-CCcce
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYN-GLGRA 40 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~ 40 (558)
.+.+|.|.+++.+|+|.|.|...+ +.|..
T Consensus 59 ~~~sL~I~nv~~~D~G~Y~C~~~~~p~g~~ 88 (97)
T cd05846 59 NSTSITIWNVTLEDEGCYKCIFNTFPDGSK 88 (97)
T ss_pred CccEEEEeCCceeeeEEEEEEEEeCCCCCe
Confidence 467899999999999999999876 44543
No 353
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=96.46 E-value=0.007 Score=48.11 Aligned_cols=28 Identities=29% Similarity=0.573 Sum_probs=25.1
Q ss_pred CeEEEcCCCCCC-CEEEEEEEEeCCcceE
Q psy10160 14 NMLTIKRVEPER-LGAYTCQAYNGLGRAV 41 (558)
Q Consensus 14 ~~L~I~~v~~~D-~G~Y~C~a~n~~g~~~ 41 (558)
..|.|.++..+| .|.|.|.|.|..|...
T Consensus 64 S~L~I~~~~~~d~~g~Y~C~a~N~~G~d~ 92 (98)
T cd05898 64 STLTINNIMEADFQTHYNCTAWNSFGSGT 92 (98)
T ss_pred EEEEECCCccccCCcEEEEEEEeCCccce
Confidence 589999998877 8999999999999874
No 354
>PF07654 C1-set: Immunoglobulin C1-set domain; InterPro: IPR003597 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [, ], and in various T-cell receptors.; PDB: 3BVN_D 3BXN_A 3PWV_E 3L9R_F 2XFX_B 1BMG_A 1K8I_A 3M1B_G 3M17_C 1EXU_A ....
Probab=96.35 E-value=0.018 Score=44.35 Aligned_cols=62 Identities=21% Similarity=0.489 Sum_probs=41.1
Q ss_pred CCCcEEEEeEeecc-CCC-eEEEEECCEEeccCCce--EEEccCC------eEEEccCCCCCCeEEEEEEEeCCc
Q psy10160 143 VGSDISIPCDVDGY-PIP-QVFWYKDGQVIENDGVH--YRITESN------RLHINQANATDSGEYRCVASNSYT 207 (558)
Q Consensus 143 ~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~~~~~--~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~G 207 (558)
.++.+.|.|.+.|. |.. .|.|+++|..+...... .....++ .|.+. .++...|+|.+.....
T Consensus 7 ~~~~~~L~C~v~~f~P~~i~v~W~~~~~~~~~~~~~~~~~~~~dgty~~~s~l~v~---~~~~~~ysC~V~H~~l 78 (83)
T PF07654_consen 7 LGGSVTLTCLVSGFYPKDITVTWLKNGKEVTEGVETTPPPPNSDGTYSVTSSLTVT---WNSGDEYSCRVTHESL 78 (83)
T ss_dssp STSEEEEEEEEEEEBSSTEEEEEEETTEEETTTEEEEEEEEETTSEEEEEEEEEEE---TTTTGGEEEEEEETTS
T ss_pred CCCCEEEEEEEEEEECCCcEEEEEeccceeeeeeeecccccccccceeeeEEEEec---CCCCCEEEEEEEECCC
Confidence 48899999999995 544 48999999887643211 1112333 35554 5566689999987543
No 355
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=96.33 E-value=0.0049 Score=50.95 Aligned_cols=27 Identities=30% Similarity=0.467 Sum_probs=24.1
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcc
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGR 39 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~ 39 (558)
+.+|.|.+++.+|+|.|+|.+.|..+.
T Consensus 78 ~~sL~I~~v~~~D~G~Y~C~v~~~~~~ 104 (115)
T cd05880 78 DASILIWQLQPTDNGTYTCQVKNPPDV 104 (115)
T ss_pred ceEEEEeeCChhhCEEEEEEEEeCCCC
Confidence 568999999999999999999986653
No 356
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=96.32 E-value=0.0096 Score=45.89 Aligned_cols=30 Identities=27% Similarity=0.476 Sum_probs=25.3
Q ss_pred CCceEecCCeEEEcCCCCCCCEEEEEEEEe
Q psy10160 6 SENYELNKNMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 6 ~~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
+.|+......|.|.+++.+|+|.|+|.+.-
T Consensus 39 ~~r~~~~~~GLlI~~~~~~dsG~Y~C~s~E 68 (85)
T cd05872 39 QFSYRVGTDGLLILVTSPEHSGTYRCYSEE 68 (85)
T ss_pred CcceEEeCCCCEEEECCHhhCEEEEEEEec
Confidence 356777777788999999999999999873
No 357
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=96.29 E-value=0.0076 Score=49.90 Aligned_cols=27 Identities=22% Similarity=0.351 Sum_probs=23.8
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcc
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGR 39 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~ 39 (558)
+.+|+|.+++.+|+|.|.|.+.|..+.
T Consensus 79 ~~sL~I~~v~~~D~G~Y~C~v~~~~~~ 105 (116)
T cd05715 79 DASIVIHNLQFTDNGTYTCDVKNPPDI 105 (116)
T ss_pred eeEEEEeeCCcccCEEEEEEEEeCCCC
Confidence 368999999999999999999986654
No 358
>cd07697 IgC_TCR_gamma T cell receptor (TCR) gamma chain constant immunoglobulin domain. IgC_TCR_gamma; immunoglobulin (Ig) constant (C) domain of the gamma chain of gamma-delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha-beta TCRs but a small subset contain gamma-delta TCRs. Alpha-beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma-delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma-delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds.
Probab=96.29 E-value=0.018 Score=45.53 Aligned_cols=32 Identities=16% Similarity=0.210 Sum_probs=24.2
Q ss_pred eeCCCcEEEEeEeecc-CCC-eEEEEECCEEecc
Q psy10160 141 FGVGSDISIPCDVDGY-PIP-QVFWYKDGQVIEN 172 (558)
Q Consensus 141 v~~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~ 172 (558)
+..+..++|.|.+.|. |.. .++|.++|..+..
T Consensus 13 ~~~~~~~tL~C~a~gFyP~~I~v~W~kng~~~~~ 46 (96)
T cd07697 13 IEKQGQGIYLCLLENFFPDVIQVHWREGNSPSIL 46 (96)
T ss_pred HccCCCEEEEEEEEEEeCCCeEEEEEECCEECcC
Confidence 3446779999999994 543 4799999988643
No 359
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=96.27 E-value=0.0032 Score=49.64 Aligned_cols=35 Identities=23% Similarity=0.240 Sum_probs=29.3
Q ss_pred CCceEe-cCCeEEEcCCCCCCCE-EEEEEEEeCCcce
Q psy10160 6 SENYEL-NKNMLTIKRVEPERLG-AYTCQAYNGLGRA 40 (558)
Q Consensus 6 ~~r~~~-~~~~L~I~~v~~~D~G-~Y~C~a~n~~g~~ 40 (558)
++|+.. .+|.|.|.+|+.+|+| .|.|.|.|.....
T Consensus 49 ~~Ri~~~~~GnL~fs~v~~~D~g~~Y~C~a~~~~~~~ 85 (95)
T cd05845 49 DERVSMGQNGNLYFANVEEQDSHPDYICHAHFPGLRT 85 (95)
T ss_pred cccEEECCCceEEEEEEehhhCCCCeEEEEEcccccc
Confidence 456665 5799999999999999 8999999976543
No 360
>cd05769 IgC_TCR_beta T cell receptor (TCR) beta chain constant immunoglobulin domain. IgC_TCR_beta: Constant domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the beta chain. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The antigen binding site is formed by the variable domains of the alpha and beta chains, located at the N-terminus of each chain. Alpha/beta TCRs recognize antigens differently from gamma/delta TCRs.
Probab=96.23 E-value=0.025 Score=46.47 Aligned_cols=75 Identities=13% Similarity=0.304 Sum_probs=45.4
Q ss_pred CCceEeeCCCcEEEEeEeecc-CCC-eEEEEECCEEeccCCc--eEEEccC-C------eEEEccCCCCC-CeEEEEEEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGY-PIP-QVFWYKDGQVIENDGV--HYRITES-N------RLHINQANATD-SGEYRCVAS 203 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~~~~--~~~~~~~-~------sL~I~~v~~~D-~G~Y~C~a~ 203 (558)
+....+..++.++|.|.+.|. |.. .+.|.|||..+..... ......+ + .|.+..-...| ...|+|.+.
T Consensus 10 ps~~e~~~~~~~tL~Cla~gFyP~~I~V~W~kng~~l~~g~~~~~~~~~~~~gTYs~~S~L~v~~~~w~~~~~~ytC~V~ 89 (115)
T cd05769 10 PSEAEIRNKRKATLVCLATGFYPDHVSLSWKVNGKEVTDGVATDPQALRENTSTYSISSRLRVSATEWFNPRNTFTCIVQ 89 (115)
T ss_pred cChHHhccCCCcEEEEEEEeEeCCCcEEEEEECCEECCCCcccccceecCCCCeEEEEEEEEEChHHhccCCCeEEEEEE
Confidence 333334467789999999995 543 6899999988764211 0111221 2 35555443333 568999998
Q ss_pred eCCceee
Q psy10160 204 NSYTSDE 210 (558)
Q Consensus 204 N~~G~~~ 210 (558)
-......
T Consensus 90 H~g~~~~ 96 (115)
T cd05769 90 FYGGTDT 96 (115)
T ss_pred EeCCccc
Confidence 7644443
No 361
>cd07704 Ig2_Nectin-3-4_like Second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3), nectin-4 (poliovirus receptor related protein 4) and similar proteins. Ig2_Nectin-3-4_like: domain similar to the second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and nectin-4 (poliovirus receptor related protein 4). Nectin-3 and nectin-4 belong to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development. Nect
Probab=96.21 E-value=0.016 Score=45.78 Aligned_cols=67 Identities=15% Similarity=0.271 Sum_probs=43.1
Q ss_pred eEeeCCCcEEE-EeE-eeccCCCeEEEEECCEEeccCCceEEEccCC------eEEEccCCCCCCeEEEEEEEeCCc
Q psy10160 139 QVFGVGSDISI-PCD-VDGYPIPQVFWYKDGQVIENDGVHYRITESN------RLHINQANATDSGEYRCVASNSYT 207 (558)
Q Consensus 139 ~~v~~G~~v~L-~C~-~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~G 207 (558)
..+.+|+.+.+ .|. +.|.|.+.|+|+.+...... ..-....++ ++.+..-..+|.-.++|.+....-
T Consensus 11 ~~~~~g~~~~vA~C~sa~gkPaa~IsW~~~~~G~~~--~~~~~~~ngT~TV~S~~~l~p~r~d~G~~vtC~V~H~al 85 (97)
T cd07704 11 LLIDGGNGTTLAACCAAEGRPAADVTWETNVYGTSE--SHSQEHPNGTTTVTSEYIWVPSRHANGHPLTCVVSHPAL 85 (97)
T ss_pred eEeecCcceeEEEEEccCCccCCEeEEeCCCCCccc--eeeecCCCCCEEEEEEEEEEeCHHHCCcEEEEEEeCccc
Confidence 44678888888 887 57889999999986332211 011111222 466655555666799999988743
No 362
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=96.14 E-value=0.0074 Score=55.64 Aligned_cols=50 Identities=22% Similarity=0.294 Sum_probs=40.5
Q ss_pred CCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCC
Q psy10160 157 PIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 157 P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
.-|.+.|...+...-.+.++..+.+.|.|.+.+...+++|.|+|..+-..
T Consensus 11 iDP~y~W~GP~g~~l~gn~~~nIT~TG~L~~~~F~esmSG~YTCtLsYk~ 60 (271)
T PF07354_consen 11 IDPTYLWTGPNGKPLSGNSYVNITETGKLMFKNFQESMSGSYTCTLSYKP 60 (271)
T ss_pred CCCceEEECCCCcccCCCCeEEEccCceEEeeccccccCCceEEEEEEEe
Confidence 46889999765444344558889999999999999999999999987654
No 363
>PHA03273 envelope glycoprotein C; Provisional
Probab=96.03 E-value=0.42 Score=47.93 Aligned_cols=76 Identities=17% Similarity=0.069 Sum_probs=50.0
Q ss_pred eEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEEEe-CCCCccCCCCccccC-ceeEEeccCCC-CC--CcEEEEeCCcc
Q psy10160 15 MLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTLQA-LPSEKVADPNAIDYG-TILSSAFPSES-AS--PVVTQTTTTTT 88 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V~~-~p~~~~~~~~~v~~~-~~~~~~~~~~~-p~--p~v~W~~~~~~ 88 (558)
.|.|..+...++|.|+=...+..+.. ....++|.. .++.....+..+.+| ..--.|.+... |+ ..+.|+.|+..
T Consensus 199 ~LtI~sltaaTeGvYtWr~~~~n~t~~~~~~VtV~~yr~Psvsv~~~PvL~Ge~y~A~C~aa~YYPp~Sv~~rWf~dg~~ 278 (486)
T PHA03273 199 PLTIKSVDWRTAGVYVWSLYAKNGTLVNSTSVTVSTYNAPLVDLSVHPSLKGENYRAVCVVASYFPHSSVKLRWYKNAKE 278 (486)
T ss_pred ceEEEecchhhceEEEEEEecCCCceeeeeEEEEEEecCCcccccCCccccCCCceEEEEeeeecCCCceEEEEEeCCee
Confidence 49999999999999997766655443 355666643 334444555555555 44456666554 33 24889999987
Q ss_pred cC
Q psy10160 89 EA 90 (558)
Q Consensus 89 ~~ 90 (558)
+.
T Consensus 279 V~ 280 (486)
T PHA03273 279 VD 280 (486)
T ss_pred cc
Confidence 77
No 364
>cd04985 IgC_CH1 CH1 domain (first constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH1: The first immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fab antigen-binding fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.00 E-value=0.055 Score=42.81 Aligned_cols=63 Identities=11% Similarity=0.328 Sum_probs=36.9
Q ss_pred CCCcEEEEeEeecc-CCC-eEEEEECCEEeccCCc--eEEEccCC------eEEEccCCCCCCeEEEEEEEeCC
Q psy10160 143 VGSDISIPCDVDGY-PIP-QVFWYKDGQVIENDGV--HYRITESN------RLHINQANATDSGEYRCVASNSY 206 (558)
Q Consensus 143 ~G~~v~L~C~~~g~-P~p-~i~W~~~g~~l~~~~~--~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~ 206 (558)
.++.++|.|.+.|. |.. .++|.|+|.. ..... ......++ .|.+..-.-...-.|+|.+....
T Consensus 15 ~~~~~~L~C~a~gFyP~~i~vtW~k~g~~-~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~ytC~V~H~~ 87 (95)
T cd04985 15 SSDSVTLGCLATGFLPEPVTFTWNSGSNS-TSGVKTYPAVLQSGGLYTASSQLTVPASEWKGKESFYCKVEHPS 87 (95)
T ss_pred CCCcEEEEEEEeeEECCCcEEEEeECCEE-CCCcEECCCEeCCCCCEEEEEEEEEeHHHcCCCCcEEEEEEeCC
Confidence 46679999999995 443 4899999987 32110 01111123 24443322222557999988754
No 365
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=95.92 E-value=0.012 Score=44.69 Aligned_cols=34 Identities=44% Similarity=0.636 Sum_probs=27.9
Q ss_pred eEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 15 MLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
.|.|.+++.+|+|.|+|.+.+..+...+..+.|.
T Consensus 46 ~~~~~~~~~~~~g~y~C~~~~~~~~~~s~~~~v~ 79 (80)
T PF13895_consen 46 GLFIPNVSPEDSGNYTCRASNGSGSNTSTSVNVT 79 (80)
T ss_dssp EEEESSEEGGGTEEEEEEEEETTEEEEEEEEEEE
T ss_pred eeeeeeeccccCEEEEEEEEeCCCCeEeeeEEee
Confidence 4889999999999999999997776556666554
No 366
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=95.91 E-value=0.0063 Score=44.10 Aligned_cols=18 Identities=56% Similarity=0.936 Sum_probs=17.5
Q ss_pred EEEcCCCCCCCEEEEEEE
Q psy10160 16 LTIKRVEPERLGAYTCQA 33 (558)
Q Consensus 16 L~I~~v~~~D~G~Y~C~a 33 (558)
|.|.+++.+|+|.|+|.|
T Consensus 47 L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 47 LTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp EEESSCTGGGTEEEEEEE
T ss_pred EEEccCCHHHCEEEEEEC
Confidence 999999999999999986
No 367
>KOG1480|consensus
Probab=95.91 E-value=0.0035 Score=65.72 Aligned_cols=87 Identities=29% Similarity=0.484 Sum_probs=67.5
Q ss_pred EEecCCceEeeCCCcEEEEeE-eeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceee
Q psy10160 132 VNITLETQVFGVGSDISIPCD-VDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDE 210 (558)
Q Consensus 132 ~~~~~~~~~v~~G~~v~L~C~-~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~ 210 (558)
+...+.-..|.++..+.+.|. ..+.|...+.|+|++..+.++ ..........|++..+...|.|+|+|.|.|.++...
T Consensus 132 f~~~p~~q~V~~~s~~~l~cr~pe~~paae~~w~k~e~~~~pd-~n~~~~~d~~li~~~arlsd~~nytc~a~ni~~~r~ 210 (909)
T KOG1480|consen 132 FEQSPVGQEVQEETTLQLPCRPPEGDPKAEVEWLKNEVVIDPD-ANVIRASDHNLIISQARLSDSGNYTCEATNIVAKRK 210 (909)
T ss_pred hccChhhheecccccccccccCcccchhhhhhccccCCCCCcc-ccchhhhcCCccccchhhhhcccceeeeehhhcccc
Confidence 334555667788888999987 578888899999999888773 344555667899999999999999999999988763
Q ss_pred ---EEEEEEEec
Q psy10160 211 ---NAVTIRVEG 219 (558)
Q Consensus 211 ---~~~~l~V~~ 219 (558)
..+.+.|.+
T Consensus 211 ~~~~~v~vyv~g 222 (909)
T KOG1480|consen 211 SDPATVQVYVNG 222 (909)
T ss_pred ccceEEEEEEcC
Confidence 445555543
No 368
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=95.90 E-value=0.017 Score=43.94 Aligned_cols=34 Identities=50% Similarity=0.664 Sum_probs=27.5
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
.+|.|.+++.+|+|.|+|.+.+..+..... +.|.
T Consensus 51 ~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~-~~l~ 84 (86)
T smart00410 51 STLTISNVTPEDSGTYTCAATNSSGSASST-TTLT 84 (86)
T ss_pred eEEEEEeeccccCeEEEEEEEcCCCeEEEE-EEEE
Confidence 689999999999999999999877765432 4443
No 369
>smart00409 IG Immunoglobulin.
Probab=95.90 E-value=0.017 Score=43.94 Aligned_cols=34 Identities=50% Similarity=0.664 Sum_probs=27.5
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQ 48 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~ 48 (558)
.+|.|.+++.+|+|.|+|.+.+..+..... +.|.
T Consensus 51 ~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~-~~l~ 84 (86)
T smart00409 51 STLTISNVTPEDSGTYTCAATNSSGSASST-TTLT 84 (86)
T ss_pred eEEEEEeeccccCeEEEEEEEcCCCeEEEE-EEEE
Confidence 689999999999999999999877765432 4443
No 370
>PF08204 V-set_CD47: CD47 immunoglobulin-like domain; InterPro: IPR013270 This family represents the CD47 leukocyte antigen V-set like Ig domain [, ].; PDB: 2VSC_B 2JJS_D 2JJT_C.
Probab=95.89 E-value=0.02 Score=47.49 Aligned_cols=75 Identities=21% Similarity=0.414 Sum_probs=46.0
Q ss_pred CCCcEEEEeEeecc-----CCCeEEEEECCEEecc-CCc--eEE--------E----ccCCeEEEccCCCCCCeEEEEEE
Q psy10160 143 VGSDISIPCDVDGY-----PIPQVFWYKDGQVIEN-DGV--HYR--------I----TESNRLHINQANATDSGEYRCVA 202 (558)
Q Consensus 143 ~G~~v~L~C~~~g~-----P~p~i~W~~~g~~l~~-~~~--~~~--------~----~~~~sL~I~~v~~~D~G~Y~C~a 202 (558)
=+++|.|+|.+... +.-.|.|.+++..+-. ++. +.. + .++.+|.+...+.- .|+|+|.+
T Consensus 26 CN~tV~IPC~v~n~~~~ni~~m~VkWk~~~~~If~~dg~~~~~~~~~f~sa~i~~l~kG~aSL~~~~~~a~-~GnYTCeV 104 (130)
T PF08204_consen 26 CNDTVVIPCFVNNLEANNISEMYVKWKFKNKDIFIFDGTNNKSTSDNFPSAKISELLKGNASLKMDKSDAV-EGNYTCEV 104 (130)
T ss_dssp T-SEEEE--BBSS---SSGGGEEEEEEETTEEEEEEETTTTEEEEGGGTT-BEGGGGGTB--EEEEHHHHH--EEEEEEE
T ss_pred cCCCEEEEeEeccccccccceEEEEEEECCeEEEEEcCccceecccCccccchhHhhCCCEEEEEcchhcc-ccceEEEE
Confidence 47889999998752 2234899999876632 111 110 1 11235877764433 79999999
Q ss_pred EeCCceeeEEEEEEEe
Q psy10160 203 SNSYTSDENAVTIRVE 218 (558)
Q Consensus 203 ~N~~G~~~~~~~l~V~ 218 (558)
.+.....+..+.|.+.
T Consensus 105 t~~~~ege~~i~Lk~~ 120 (130)
T PF08204_consen 105 TELSREGETTIELKYR 120 (130)
T ss_dssp EETTEEEEEEEEEEE-
T ss_pred EecCCCceEEEEEEEE
Confidence 9999988888888874
No 371
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=95.74 E-value=0.018 Score=45.62 Aligned_cols=34 Identities=24% Similarity=0.311 Sum_probs=28.5
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
+.|.|.+++.+|+|.|+|.|.|...... ++.|.|
T Consensus 65 S~L~L~Rlk~~E~G~YTf~a~N~~~~~s~tF~l~v 99 (101)
T cd05860 65 SELHLTRLKGTEGGTYTFLVSNSDASASVTFNVYV 99 (101)
T ss_pred EEEEEeecChhhCcEEEEEEECCCCeEEEEEEEEE
Confidence 6899999999999999999999887663 555554
No 372
>cd04986 IgC_CH2 CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH2: The second immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=95.65 E-value=0.03 Score=44.45 Aligned_cols=66 Identities=17% Similarity=0.275 Sum_probs=37.8
Q ss_pred eeCCCcEEEEeEeecc--CCC-eEEEEECCEEeccCCceEEEccCC------eEEEccCCCCCCeEEEEEEEeCCc
Q psy10160 141 FGVGSDISIPCDVDGY--PIP-QVFWYKDGQVIENDGVHYRITESN------RLHINQANATDSGEYRCVASNSYT 207 (558)
Q Consensus 141 v~~G~~v~L~C~~~g~--P~p-~i~W~~~g~~l~~~~~~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~G 207 (558)
...++.++|.|.+.|. |.+ .+.|.++|.. ...........++ .|.+..-.-.-...|+|.+.....
T Consensus 16 l~~~~~atLtClV~~f~~P~~i~V~W~~~g~~-~~~~t~~~~~~dgTys~~S~L~v~~~~W~~g~~ytC~V~H~~l 90 (99)
T cd04986 16 LLLGSSASLTCTLSGLRDPEGAVFTWTPSGGK-EAVQTSAESDQCGCYSVSSVLPGCAEEWNKGEPFACTVTHPEG 90 (99)
T ss_pred hCcCCccEEEEEEeccCCCCCeEEEEEECCcc-CcEEcCcccCCCCCEEEEEEEEeCHHHhcCCCeEEEEEECCCc
Confidence 4468899999999994 433 4899999865 1100000112233 344432222333479999987543
No 373
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=95.53 E-value=0.01 Score=44.31 Aligned_cols=24 Identities=42% Similarity=0.606 Sum_probs=22.2
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEe
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
.+++|.|.++..+|.|.|+|.|.|
T Consensus 52 ~~~~L~i~~v~~~~~g~y~C~a~N 75 (75)
T PF13927_consen 52 SNSTLTISNVTRSDNGTYTCIASN 75 (75)
T ss_dssp EEEEEEESSCCGGGTEEEEEEEEE
T ss_pred eeeEEEEccCCHHhCcEEEEEEEC
Confidence 557899999999999999999987
No 374
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=95.38 E-value=0.014 Score=45.97 Aligned_cols=24 Identities=29% Similarity=0.505 Sum_probs=21.9
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeC
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNG 36 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~ 36 (558)
.+.+.|.+|+.+|+|.|+|...|.
T Consensus 52 ~~~f~i~~v~~~~~G~Y~C~~~~~ 75 (91)
T cd05751 52 KAKFFIPSMKREHAGRYRCYYRSG 75 (91)
T ss_pred eEEEEccCCChhHCEEEEEEEECC
Confidence 457999999999999999999986
No 375
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=95.31 E-value=0.021 Score=46.66 Aligned_cols=24 Identities=38% Similarity=0.577 Sum_probs=22.0
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
.+|.|.+++.+|+|.|.|.+....
T Consensus 79 ~sL~i~~l~~~DsG~Y~C~v~~~~ 102 (114)
T PF07686_consen 79 FSLTIKNLQPSDSGTYFCQVSTSN 102 (114)
T ss_dssp EEEEESSESGGGEEEEEEEEEESS
T ss_pred EEEEECCCCcCcCEEEEEEEEECC
Confidence 479999999999999999999873
No 376
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=95.18 E-value=0.018 Score=46.53 Aligned_cols=25 Identities=32% Similarity=0.462 Sum_probs=23.0
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCc
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLG 38 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g 38 (558)
.+|.|.+++.+|+|.|.|.+.+..+
T Consensus 67 ~sL~I~~v~~~D~G~Y~C~v~~~~~ 91 (105)
T cd00099 67 FTLTISSLQPEDSAVYYCAVSLSGG 91 (105)
T ss_pred EEEEECCCCHHHCEEEEEEEecCCC
Confidence 4899999999999999999998775
No 377
>PHA03270 envelope glycoprotein C; Provisional
Probab=95.15 E-value=1.5 Score=43.78 Aligned_cols=78 Identities=9% Similarity=-0.007 Sum_probs=51.7
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEEEeC-CCCccCCCCccccC-ceeEEeccCCCCCC---cEEEEeCCc
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTLQAL-PSEKVADPNAIDYG-TILSSAFPSESASP---VVTQTTTTT 87 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V~~~-p~~~~~~~~~v~~~-~~~~~~~~~~~p~p---~v~W~~~~~ 87 (558)
..|.|..+....+|.|+=...+..+.. +...++|..+ ++.....+..+.+| ..--.|.+...-+| .+.|+.|+.
T Consensus 182 ~~L~I~slt~aTeGvY~Wr~~~~~~~~~~~~~VtV~~yr~Psvsv~~~PvL~Ge~Y~AtC~va~YYPp~Sv~lrWf~ng~ 261 (466)
T PHA03270 182 QRLVIQELTLATQGMYYWARGPADRPHRYGTWTRVRMFRRPSLSIRPHAVLEGEPFGATCVAANYYPGDRAAFRWFEGGD 261 (466)
T ss_pred ceEEEEEcccccceEEEEEEecCCCceeeeeEEEEEEecCCcccccCCccccCCCceEEEEeeeecCCCceEEEEEeCCc
Confidence 469999999999999999987766543 3445666533 33344445555444 44456666554333 478999998
Q ss_pred ccCC
Q psy10160 88 TEAT 91 (558)
Q Consensus 88 ~~~~ 91 (558)
.+..
T Consensus 262 ~V~~ 265 (466)
T PHA03270 262 EVFA 265 (466)
T ss_pred cccC
Confidence 7754
No 378
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=95.06 E-value=0.025 Score=46.14 Aligned_cols=33 Identities=12% Similarity=0.207 Sum_probs=26.4
Q ss_pred cCCceEe------cCCeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 5 RSENYEL------NKNMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 5 ~~~r~~~------~~~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
..+|+.+ ...+|.|.+++.+|+|.|.|.+.+..
T Consensus 55 ~~~r~~~~~~~~~~~~~L~I~~~~~~DsG~Y~C~~~~~~ 93 (109)
T cd04983 55 EKGRFSATLDKSRKSSSLHISAAQLSDSAVYFCALSESG 93 (109)
T ss_pred cCCcEEEEEcccCCEEEEEECCCCHHHCEEEEEEEecCC
Confidence 3466654 23489999999999999999999754
No 379
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=95.01 E-value=0.049 Score=47.92 Aligned_cols=43 Identities=21% Similarity=0.254 Sum_probs=32.0
Q ss_pred CCceEe-----cCCeEEEcCCCCCCCEEEEEEEEe-CCcceE--EEEEEEE
Q psy10160 6 SENYEL-----NKNMLTIKRVEPERLGAYTCQAYN-GLGRAV--SWTVTLQ 48 (558)
Q Consensus 6 ~~r~~~-----~~~~L~I~~v~~~D~G~Y~C~a~n-~~g~~~--s~~l~V~ 48 (558)
.+|+.+ .+.+|.|.+|+.+|+|.|+|.... +.|... ...|+|.
T Consensus 72 k~Rve~mS~s~~~StItIknVt~sDeGcY~C~F~tfp~G~~~~gt~CLtVt 122 (189)
T PHA02987 72 KNKIEYLSKSFNESTILIKNVSLKDNGCYTCIFNTLLSKNNEKGVVCLNVT 122 (189)
T ss_pred cCeEEEeccCCCcceEEEEeCChhhCeEEEEEEEecCCCCCceeEEEEEEE
Confidence 357775 778999999999999999999875 455233 4455554
No 380
>KOG4597|consensus
Probab=94.94 E-value=0.029 Score=55.80 Aligned_cols=83 Identities=18% Similarity=0.115 Sum_probs=62.9
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEE---CCEEeccCC----ceEEEccCCeEEEccCCCCCCeEEEEEEEeCCce
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYK---DGQVIENDG----VHYRITESNRLHINQANATDSGEYRCVASNSYTS 208 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~---~g~~l~~~~----~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~ 208 (558)
+....+..+++.+++|-+.|.|.|.|+|.+ |...+.... .+..+.+...|+|-+....|+|-|+|.+.|..|.
T Consensus 203 pa~w~vg~wetcS~tCg~~G~q~r~V~c~qv~anr~~vv~~~nq~~e~p~vtstcql~ic~ewq~~a~w~tCs~rcg~g~ 282 (560)
T KOG4597|consen 203 PAEWFVGDWETCSSTCGVQGRQYRVVTCEQVFANRENVVMRPNQTVENPVVTSTCQLVICNEWQADAGWYTCSARCGAGF 282 (560)
T ss_pred cchhhcccchhhcccccccCCcCceeeeehhhccccceeecCccccCCcceeeeeeEEEcchhhcCCCceeeccccccce
Confidence 344556789999999999999999999976 332221111 1122233347999999999999999999999999
Q ss_pred eeEEEEEEEe
Q psy10160 209 DENAVTIRVE 218 (558)
Q Consensus 209 ~~~~~~l~V~ 218 (558)
..+.+.+.+.
T Consensus 283 ~~rdv~c~s~ 292 (560)
T KOG4597|consen 283 LRRDVPCSSV 292 (560)
T ss_pred eeccceeeee
Confidence 9999888774
No 381
>cd07689 Ig2_VCAM-1 Second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106) and intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ VCAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. The interaction of VCAM-1 binding to the beta1 integrin very late antigen (VLA-4) expressed by lymphocytes and monocytes mediates the adhesion of leucocytes to blood vessel walls, and regulates migration across the endothelium. During metastasis, some circulating cancer cells extravasate to a secondary site by a similar process. VCAM-1 may be involved in organ targeted tumor metastasis and may also act as host receptors for viruses and parasites. VCAM-1 contains seven Ig domains.
Probab=94.74 E-value=0.12 Score=40.67 Aligned_cols=61 Identities=20% Similarity=0.398 Sum_probs=40.1
Q ss_pred eeCCCcEEEEeEeec-cCC--CeEEEEECCEEeccCCceEEE--------ccCCeEEEccCCCCCCe-EEEEEEEe
Q psy10160 141 FGVGSDISIPCDVDG-YPI--PQVFWYKDGQVIENDGVHYRI--------TESNRLHINQANATDSG-EYRCVASN 204 (558)
Q Consensus 141 v~~G~~v~L~C~~~g-~P~--p~i~W~~~g~~l~~~~~~~~~--------~~~~sL~I~~v~~~D~G-~Y~C~a~N 204 (558)
+.+|+.+++.|.+.+ +|. ..+.|++....+.... +.- .....+.|.. +++|.| .|+|.|.=
T Consensus 12 l~~G~~vtv~C~v~~v~P~~~l~v~LlkG~~~l~~~~--f~~~~~~ks~~~~~~~vtftp-treD~g~~fsC~A~L 84 (99)
T cd07689 12 LEEGKPVTVKCEVPDVYPFDRLEIELLKGETLLPSKS--FLEDMDKKSLETKSLEVTFTP-TIEDIGKVLVCRAKL 84 (99)
T ss_pred ccCCceEEEEEEecCcccCCceEEEEecCcceecccc--cccccccCCCCCcceeEEEec-chhhCCcEEEEEEEE
Confidence 368999999999865 555 4689998776655321 110 1123466655 477777 99999853
No 382
>PHA03269 envelope glycoprotein C; Provisional
Probab=94.18 E-value=4.5 Score=41.10 Aligned_cols=77 Identities=10% Similarity=0.087 Sum_probs=48.8
Q ss_pred eEEEcCCCCCCCEEEEEEEEeCC-cce-EEEEEEEEeC-CCCccCCCCccccC-ceeEEeccCCC-CC--CcEEEEeCCc
Q psy10160 15 MLTIKRVEPERLGAYTCQAYNGL-GRA-VSWTVTLQAL-PSEKVADPNAIDYG-TILSSAFPSES-AS--PVVTQTTTTT 87 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n~~-g~~-~s~~l~V~~~-p~~~~~~~~~v~~~-~~~~~~~~~~~-p~--p~v~W~~~~~ 87 (558)
.|.|.++...++|.|+=...+.. +.. .+..++|... ++.....+..+.+| ..--.|.+... |+ ..+.|+.|+.
T Consensus 290 pL~I~sltaATeGvY~Wrv~~~~n~t~~~~~~VtV~~yr~PsVsV~p~PVL~Ge~YkAtC~vA~YYPp~SvrlrWf~ng~ 369 (566)
T PHA03269 290 SLHILSLDASTEGTYIWRVIHTANKNVINEHHITVMSYKRPNITVIGDPVLLGNPYAAYCKVNKYYPPHSVIVKWTSNFG 369 (566)
T ss_pred ceEEeecccccCceEEEEEecCCCCceeeeeEEEEEEecCCCccccCCccccCCCceEEEEeeeecCCCceEEEEEeCCc
Confidence 69999999999999987765433 222 3556666543 23444445555555 44456666554 33 2478999987
Q ss_pred ccCC
Q psy10160 88 TEAT 91 (558)
Q Consensus 88 ~~~~ 91 (558)
.+..
T Consensus 370 ~V~~ 373 (566)
T PHA03269 370 NIGK 373 (566)
T ss_pred ccCc
Confidence 7764
No 383
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=93.93 E-value=0.063 Score=42.77 Aligned_cols=24 Identities=21% Similarity=0.296 Sum_probs=21.5
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
.+|.|.+++.+|+|.|.|.+.+..
T Consensus 64 ~~L~I~~v~~~DsG~Y~C~~~~~~ 87 (98)
T cd05716 64 FTVTLNQLRKEDAGWYWCGVGDDG 87 (98)
T ss_pred EEEEEcCCCHHHCEEEEEEcccCC
Confidence 379999999999999999998754
No 384
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=93.92 E-value=0.1 Score=43.28 Aligned_cols=32 Identities=25% Similarity=0.314 Sum_probs=25.2
Q ss_pred CCceEec------CCeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 6 SENYELN------KNMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 6 ~~r~~~~------~~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
.+|+.+. +.+|.|.+++.+|+|.|.|......
T Consensus 66 ~gR~~~~~~~~~~~~sL~I~~l~~~Dsg~Y~C~~~~~~ 103 (119)
T cd05712 66 RGRFRLLGDLGKKNCSLLISDAQPEDSGKYFFRVELGD 103 (119)
T ss_pred cccEEEecCCCCCEEEEEEccCChhhCeEEEEEEEcCC
Confidence 4566651 2489999999999999999987643
No 385
>PF11465 Receptor_2B4: Natural killer cell receptor 2B4; InterPro: IPR024303 2B4 is a transmembrane receptor which is expressed primarily on natural killer (NK) cells. It plays a role in activating NK-mediated cytotoxicity through its interaction with CD48 on target cells in a subset of CD8 T cells []. The structure of 2B4 consists of an immunoglobulin variable domain fold and contains two beta-sheets. One of the beta-sheets, the six-stranded sheet, contains structural features that may have a role in ligand recognition and receptor function []. This entry represents the 2B4 immunoglobulin domain.; GO: 0005488 binding; PDB: 2PTU_D 2PTT_B 1Z2K_A.
Probab=93.83 E-value=0.21 Score=39.56 Aligned_cols=39 Identities=21% Similarity=0.309 Sum_probs=31.6
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
..+-+|.|+.+++.|+|.|.-.+++..|...+....|.+
T Consensus 68 ~enlaLlIkaAq~qDSG~Y~LEvT~~sG~V~~~~FqVsV 106 (108)
T PF11465_consen 68 SENLALLIKAAQPQDSGLYCLEVTNESGKVCTKNFQVSV 106 (108)
T ss_dssp TTTTEEEESS-SGGG-EEEEEEEEETTSCEEEEEEEEEE
T ss_pred ccCceEEEeecCcccCceEEEEEEcCCCcEEEEEEEEEe
Confidence 467799999999999999999999999998766666654
No 386
>PHA03042 CD47-like protein; Provisional
Probab=93.64 E-value=0.31 Score=45.39 Aligned_cols=70 Identities=23% Similarity=0.400 Sum_probs=47.9
Q ss_pred CCcEEEEeEeecc-----CCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEe
Q psy10160 144 GSDISIPCDVDGY-----PIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVE 218 (558)
Q Consensus 144 G~~v~L~C~~~g~-----P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 218 (558)
++++.++|.+..- -.-.+.|.++++.+-..+. .+..+|++.. +..=.|+|+|+|.+..-+..+.+.|+-.
T Consensus 31 N~TV~IpC~v~n~~~~ni~~~~V~Wkf~~~~If~~n~----tn~aSL~~~f-~~~l~GNYTCEv~~l~n~gk~~IeLk~~ 105 (286)
T PHA03042 31 NKTIVIVCNLNLLIYYNISNIHINWKFNNKVIFKKNN----TNTSSLKFNF-SKNLSGNYTCEAINKFNKIKNTIELQYV 105 (286)
T ss_pred CceEEEEeecCChhhcCccceEEEEEeCCeeEEEecC----CcceEEEEec-cccCCCceeEEEeecccCccEEEEEEEE
Confidence 6789999998763 2345899999987654321 1223576643 3344899999999987767777776654
No 387
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=93.05 E-value=0.094 Score=42.83 Aligned_cols=24 Identities=42% Similarity=0.588 Sum_probs=21.7
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
.+|.|.+++.+|+|.|.|.+.+..
T Consensus 72 ~~L~I~~~~~~Dsg~Y~Ca~~~~~ 95 (110)
T cd05899 72 SSLTIKSAEPEDSAVYLCASSLGG 95 (110)
T ss_pred cEEEECCCChhhCEEEEEEeeCCC
Confidence 589999999999999999998754
No 388
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=92.86 E-value=0.16 Score=38.61 Aligned_cols=28 Identities=11% Similarity=0.088 Sum_probs=24.8
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
.++|.|...+.+|.+.|+|.|.|..+..
T Consensus 42 ~s~L~~~~~~~Ddg~~~~C~A~n~a~~~ 69 (80)
T cd05885 42 SNTIRFPVDRKDDGAILSCEASHPALVS 69 (80)
T ss_pred EEEEEEEeeeccCCcEEEEEEEChhhCC
Confidence 4579999999999999999999988754
No 389
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=92.79 E-value=0.096 Score=41.70 Aligned_cols=23 Identities=30% Similarity=0.543 Sum_probs=20.6
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNG 36 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~ 36 (558)
.+|.|.+++.+|+|.|.|.+.+.
T Consensus 63 ~~L~I~~~~~~Dsg~Y~C~~~~~ 85 (98)
T cd04984 63 ASLTISGAQTEDEADYYCQVWDS 85 (98)
T ss_pred EEEEECCCChhhCEEEEEEEccC
Confidence 47999999999999999998753
No 390
>smart00406 IGv Immunoglobulin V-Type.
Probab=92.63 E-value=0.059 Score=40.86 Aligned_cols=20 Identities=35% Similarity=0.571 Sum_probs=18.2
Q ss_pred CeEEEcCCCCCCCEEEEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQA 33 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a 33 (558)
.+|.|.+++.+|+|.|.|.+
T Consensus 62 ~~L~i~~~~~~D~G~Y~C~v 81 (81)
T smart00406 62 VSLTISNLRVEDTGTYYCAV 81 (81)
T ss_pred EEEEEcCCCHHHCEEEEEcC
Confidence 47999999999999999963
No 391
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=92.21 E-value=0.095 Score=42.45 Aligned_cols=23 Identities=52% Similarity=0.810 Sum_probs=20.6
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNG 36 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~ 36 (558)
..|.|.+++.+|+|.|.|.+.+.
T Consensus 71 ~~L~I~~~~~~Dsg~Y~Ca~~~~ 93 (106)
T cd04980 71 FTLTISRVEPEDAAVYYCQQYGT 93 (106)
T ss_pred EEEEECCCChHHCEEEEEEEeCC
Confidence 37999999999999999999754
No 392
>PF11465 Receptor_2B4: Natural killer cell receptor 2B4; InterPro: IPR024303 2B4 is a transmembrane receptor which is expressed primarily on natural killer (NK) cells. It plays a role in activating NK-mediated cytotoxicity through its interaction with CD48 on target cells in a subset of CD8 T cells []. The structure of 2B4 consists of an immunoglobulin variable domain fold and contains two beta-sheets. One of the beta-sheets, the six-stranded sheet, contains structural features that may have a role in ligand recognition and receptor function []. This entry represents the 2B4 immunoglobulin domain.; GO: 0005488 binding; PDB: 2PTU_D 2PTT_B 1Z2K_A.
Probab=92.02 E-value=0.46 Score=37.66 Aligned_cols=39 Identities=26% Similarity=0.242 Sum_probs=31.1
Q ss_pred ccCCeEEEccCCCCCCeEEEEEEEeCCcee-eEEEEEEEe
Q psy10160 180 TESNRLHINQANATDSGEYRCVASNSYTSD-ENAVTIRVE 218 (558)
Q Consensus 180 ~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~l~V~ 218 (558)
.++.+|.|+.++..|+|.|.-+++|..|.. .+.+++.|.
T Consensus 68 ~enlaLlIkaAq~qDSG~Y~LEvT~~sG~V~~~~FqVsVF 107 (108)
T PF11465_consen 68 SENLALLIKAAQPQDSGLYCLEVTNESGKVCTKNFQVSVF 107 (108)
T ss_dssp TTTTEEEESS-SGGG-EEEEEEEEETTSCEEEEEEEEEEE
T ss_pred ccCceEEEeecCcccCceEEEEEEcCCCcEEEEEEEEEee
Confidence 456799999999999999999999999988 366677663
No 393
>PHA03271 envelope glycoprotein C; Provisional
Probab=91.51 E-value=15 Score=36.63 Aligned_cols=80 Identities=11% Similarity=0.053 Sum_probs=49.4
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcce---EEEEEEEEeCCCCccCCCCccccC-ceeEEeccCCCCCC---cEEEEeCC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRA---VSWTVTLQALPSEKVADPNAIDYG-TILSSAFPSESASP---VVTQTTTT 86 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~---~s~~l~V~~~p~~~~~~~~~v~~~-~~~~~~~~~~~p~p---~v~W~~~~ 86 (558)
=.|.|.+|...|+|.|+-...+...+. +...+.+-..|+.....+..+..| ..--.|.+...-+| .++|+.++
T Consensus 207 m~v~I~svD~~t~Gy~~v~~~d~~N~~i~e~~~~~~v~~RPPsVsV~a~PVL~Ge~YkAtC~vAnYYPP~SvrlrWf~nG 286 (490)
T PHA03271 207 MGVEIRNVDYADNGYIQVIMRDPFNRPLLDKHIYIRVCQRPASVDVLAPPVLSGENYKASCIVRHFYPPGSVYVSWRQNG 286 (490)
T ss_pred eeEEEEEeecccceEEEEEecCCCCCccccceEEEEEEecCCCccccCCccccCCCceEEEEeeeecCCCceEEEEEeCC
Confidence 379999999999997755555544333 233444445566555555555555 44456666554333 47899998
Q ss_pred cccCCCC
Q psy10160 87 TTEATSP 93 (558)
Q Consensus 87 ~~~~~~~ 93 (558)
.......
T Consensus 287 ~~V~~~~ 293 (490)
T PHA03271 287 NIATPRK 293 (490)
T ss_pred ccccCcc
Confidence 7665443
No 394
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=91.46 E-value=0.16 Score=41.95 Aligned_cols=31 Identities=26% Similarity=0.385 Sum_probs=25.0
Q ss_pred cCCceEec------CCeEEEcCCCCCCCEEEEEEEEe
Q psy10160 5 RSENYELN------KNMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 5 ~~~r~~~~------~~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
.++|+.+. +.+|.|.+++.+|+|.|.|.+..
T Consensus 57 ~~~R~~~~~~~~~~~~sL~I~~~~~~Dsg~Y~C~~~~ 93 (116)
T cd07706 57 TKGRYSVNFQKAQKSISLTISALQLEDSAKYFCALST 93 (116)
T ss_pred cCCeEEEEEeccCCEEEEEECCCCHHHCEEEEEEEEC
Confidence 34677652 23799999999999999999985
No 395
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=91.27 E-value=0.63 Score=35.72 Aligned_cols=37 Identities=14% Similarity=0.386 Sum_probs=27.3
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
++.+|.+.+++..|+|.++|.+.-. ++...+.+.|.+
T Consensus 49 ~~ktL~~~qv~~qdSG~WtC~V~~~-~k~~~~~~~V~V 85 (88)
T cd07694 49 DKKTLNLVQLGPNDSGTWDCIVSVN-SSEKTLKLDIKV 85 (88)
T ss_pred CccEEEeceeCcccCCEEEEEEEEC-ceEEEEEeeEEE
Confidence 5569999999999999999999754 333344444444
No 396
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=91.09 E-value=1.8 Score=32.84 Aligned_cols=52 Identities=23% Similarity=0.382 Sum_probs=33.8
Q ss_pred CCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEE-EeCCceeeEEEEEEE
Q psy10160 158 IPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVA-SNSYTSDENAVTIRV 217 (558)
Q Consensus 158 ~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a-~N~~G~~~~~~~l~V 217 (558)
.|.+.|.-.+... ......+.......+|+|...|.| .|..-.....+.|.|
T Consensus 26 ~~~~~l~~~~~k~--------~~~~~~~~~~~~~~~d~G~w~C~a~~~~~k~~~s~~~i~v 78 (80)
T PF05790_consen 26 KPSLFLENPGKKS--------LETKKLVSTFTPTTEDSGTWVCTASDNEPKERESKIEILV 78 (80)
T ss_dssp CEEEEEECSSCEE--------EEESSEEEEESBTCGGSEEEEEEEEECTTEEEEEEEEEEE
T ss_pred ChhheeeccCccc--------cccceEEEEecCCCCCCEEEEEEEcCCceEEEEEEEEEEc
Confidence 4567776554332 123345667788899999999999 665555556566555
No 397
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=91.04 E-value=0.2 Score=41.34 Aligned_cols=30 Identities=27% Similarity=0.556 Sum_probs=24.1
Q ss_pred CCceEe------cCCeEEEcCCCCCCCEEEEEEEEe
Q psy10160 6 SENYEL------NKNMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 6 ~~r~~~------~~~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
..|+.. ...+|.|.+++.+|+|.|.|.+..
T Consensus 63 ~~r~~~~~~~~~~~~~L~I~~~~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 63 KNKFEARKDVGKSTSTLTIQNLEKEDSATYYCAYWE 98 (116)
T ss_pred CCCEEEEEECCCCEEEEEEEECCHHHCEEEEEEEec
Confidence 456664 124799999999999999999875
No 398
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=90.99 E-value=0.32 Score=37.09 Aligned_cols=26 Identities=23% Similarity=0.304 Sum_probs=21.2
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcc
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGR 39 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~ 39 (558)
+.|.|.....+|.|.|+|.|.|....
T Consensus 46 s~L~i~~~~~~~~~~y~C~a~n~~l~ 71 (82)
T cd05759 46 STLPITPSDHDTGRTFTCRARNEALP 71 (82)
T ss_pred EEEEEeCceecCCCEEEEEEcCccCC
Confidence 46888888888999999999986543
No 399
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=90.21 E-value=0.18 Score=40.64 Aligned_cols=22 Identities=32% Similarity=0.517 Sum_probs=19.9
Q ss_pred CeEEEcCCCCCCCEEEEEEEEe
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
.+|.|.+++.+|+|.|.|...+
T Consensus 69 ~~L~I~~~~~sDsgtY~Ca~~~ 90 (104)
T cd05720 69 FVLTLKNFQKENEGYYFCSVAS 90 (104)
T ss_pred EEEEECCCCHHHCEEEEEEEcc
Confidence 3799999999999999998864
No 400
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=89.93 E-value=0.3 Score=39.61 Aligned_cols=21 Identities=43% Similarity=0.763 Sum_probs=19.4
Q ss_pred eEEEcCCCCCCCEEEEEEEEe
Q psy10160 15 MLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n 35 (558)
.|.|.+++.+|+|.|.|...+
T Consensus 73 ~L~I~~~~~~Dsg~YyCa~~~ 93 (107)
T cd07700 73 RLHINRVKPEDSGTYFCMTVG 93 (107)
T ss_pred EEEECCCCHHHCEEEEEeEcC
Confidence 699999999999999999864
No 401
>PHA02982 hypothetical protein; Provisional
Probab=89.85 E-value=0.62 Score=41.51 Aligned_cols=75 Identities=19% Similarity=0.284 Sum_probs=46.6
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCCcceE--EEEEEEEeCCCCccCCCCccccCceeEEeccCCCCCCcEEEEeCCcc
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGLGRAV--SWTVTLQALPSEKVADPNAIDYGTILSSAFPSESASPVVTQTTTTTT 88 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~--s~~l~V~~~p~~~~~~~~~v~~~~~~~~~~~~~~p~p~v~W~~~~~~ 88 (558)
.+.++|+|.+++.+..|.|+|++....+... ...+.|+.-.-...- .. ...+....|.+...-.+...|..+|..
T Consensus 97 g~~STLTIkk~~i~N~GCYtc~~ks~~~k~E~c~kCl~V~~~~V~~~W--~e-~nNeT~V~CyVgS~~~dvp~W~V~GVv 173 (251)
T PHA02982 97 GNSSTFTMKKPDPQNLGCFTCEAKDAEGKEETCEKCLEIQKEDILYVV--EE-HNNETIITCFVGSKHGDVPRFIVAGIV 173 (251)
T ss_pred ccceeEEeccCCcccCCceEEEEecCCCchheeheeeeEecceEEEEE--Ee-cCCeEEEEEEEEeccCCCccEEEeeEE
Confidence 3678999999999999999999998776553 334444211000000 00 112445677777765555588877653
No 402
>PF06328 Lep_receptor_Ig: Ig-like C2-type domain; InterPro: IPR010457 This entry represents a ligand-binding domain that displays similarity to C2-set immunoglobulin domains (antibody constant domain 2) []. The two cysteine residues form a disulphide bridge.; PDB: 3L5H_A 1P9M_A 1I1R_A 2D9Q_B.
Probab=89.13 E-value=1.6 Score=33.86 Aligned_cols=65 Identities=20% Similarity=0.486 Sum_probs=40.8
Q ss_pred cCCceEeeCCCcEEEEeEeecc-----CCCeEEEEECCEEeccCCceEEEccCC--eEEEccCCCCCCeEEEEE
Q psy10160 135 TLETQVFGVGSDISIPCDVDGY-----PIPQVFWYKDGQVIENDGVHYRITESN--RLHINQANATDSGEYRCV 201 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~-----P~p~i~W~~~g~~l~~~~~~~~~~~~~--sL~I~~v~~~D~G~Y~C~ 201 (558)
.++..++..|+.++..|...-. +...|.|..++..++.+ +|....++ ++++.+......-.|-|.
T Consensus 9 ~p~~pvv~lGS~vtasC~l~~~c~~~~~a~~I~Wkln~~~iP~~--qy~~in~~~SsVT~~~~~~~~~~L~cC~ 80 (89)
T PF06328_consen 9 SPPSPVVSLGSNVTASCVLKQNCSHSVNASQIVWKLNGEKIPGS--QYRVINDTVSSVTLPNLNPTGATLFCCK 80 (89)
T ss_dssp ECSSSEEETTS-EEEEEEE-CCCHCT-STTCEEEECSSCESTCG--CEEEESTTEEEEEESS--SSEEEEEEEE
T ss_pred ecCCCEEeCCCCEEEEEEEECCCCCCcccceEEEEECCEECChh--HcceeCCeEEEEEEccCCCCCceEEEEE
Confidence 4556678899999999997532 44569999998876653 55544544 466666555444455554
No 403
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=88.68 E-value=0.49 Score=33.69 Aligned_cols=27 Identities=41% Similarity=0.529 Sum_probs=23.5
Q ss_pred ecCCeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 11 LNKNMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 11 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
.....|.|.+++.+|+|.|.|.+.+..
T Consensus 40 ~~~~~l~i~~~~~~d~g~y~C~~~~~~ 66 (74)
T cd00096 40 SGSSTLTISNVTLEDSGTYTCVASNSA 66 (74)
T ss_pred eeEEEEEECccCcccCcEEEEEEecCc
Confidence 345689999999999999999998865
No 404
>PF02480 Herpes_gE: Alphaherpesvirus glycoprotein E; InterPro: IPR003404 Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation [].; GO: 0016020 membrane; PDB: 2GJ7_F 2GIY_B.
Probab=88.07 E-value=0.7 Score=47.58 Aligned_cols=43 Identities=26% Similarity=0.233 Sum_probs=0.0
Q ss_pred ceEecCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEeC
Q psy10160 8 NYELNKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQAL 50 (558)
Q Consensus 8 r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~~ 50 (558)
++..+.+.|.|.+++.+|+|.|+-..++..+......+.|.+.
T Consensus 83 ~~~~~~~~l~i~~a~~~~~GvY~l~~~~~~~~~~~~~~~v~v~ 125 (439)
T PF02480_consen 83 RLTFNKGGLSILNATEQDSGVYTLYVRNDSGWAHQSVVFVTVK 125 (439)
T ss_dssp -------------------------------------------
T ss_pred ceeecCCceEEeccccccCeeEEEEecCCCCceEEEEEEEEEc
Confidence 3334668899999999999999999998777664333444443
No 405
>PHA03283 envelope glycoprotein E; Provisional
Probab=87.37 E-value=5.2 Score=41.10 Aligned_cols=38 Identities=24% Similarity=0.337 Sum_probs=28.9
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEe
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQA 49 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~ 49 (558)
+.+.|.|.+++.+|+|.|+-..++..+..+ .+.|+|+.
T Consensus 132 ~~~~l~I~~at~~~aGVYtly~r~d~~~~~~vflvtVk~ 170 (542)
T PHA03283 132 ERSVLQIQRATPNIAGVYTLHVSSDGMMKHSVFFVTVKK 170 (542)
T ss_pred CCCeeEEEecccccCeEEEEEecCCCceEEEEEEEEecC
Confidence 457899999999999999999998777433 33444443
No 406
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=86.14 E-value=0.83 Score=35.99 Aligned_cols=22 Identities=23% Similarity=0.505 Sum_probs=19.6
Q ss_pred CeEEEcCCCCCCCEEEEEEEEe
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
..+.|.+++.+|+|.|.|....
T Consensus 55 a~f~I~~~~~~~~G~Y~C~~~~ 76 (94)
T cd05711 55 ASFPLGPVTPAHAGTYRCYGSY 76 (94)
T ss_pred EEEEecCCCcccCEEEEEEEEC
Confidence 4789999999999999999853
No 407
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=83.91 E-value=0.74 Score=38.00 Aligned_cols=21 Identities=24% Similarity=0.456 Sum_probs=19.5
Q ss_pred eEEEcCCCCCCCEEEEEEEEe
Q psy10160 15 MLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n 35 (558)
.|.|.+++.+|+|.|.|.+..
T Consensus 77 ~L~I~~~~~~Dsa~YyCa~~~ 97 (117)
T cd04981 77 YLQLNSLTPEDTAVYYCARGL 97 (117)
T ss_pred EEEECCCCHHHCEEEEEEEEc
Confidence 699999999999999998865
No 408
>PHA02982 hypothetical protein; Provisional
Probab=83.32 E-value=2.6 Score=37.78 Aligned_cols=73 Identities=15% Similarity=0.369 Sum_probs=47.2
Q ss_pred ceEeeCCCcEEEEeEee-ccCCCeEEEEECCE-Eec----------c-------CCceEEEc--c-CCeEEEccCCCCCC
Q psy10160 138 TQVFGVGSDISIPCDVD-GYPIPQVFWYKDGQ-VIE----------N-------DGVHYRIT--E-SNRLHINQANATDS 195 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~-g~P~p~i~W~~~g~-~l~----------~-------~~~~~~~~--~-~~sL~I~~v~~~D~ 195 (558)
+.....+++|.|.|... +...-+..|.+++. .+. . ....+.++ . .++|+|+++..+..
T Consensus 33 dv~a~vd~~V~L~C~~~~~~~i~~~~W~~~~~~~la~~~~~~~~iN~~~y~~~~~kd~y~~sv~g~~STLTIkk~~i~N~ 112 (251)
T PHA02982 33 DVNATVDQEVKLQCLFKDADEISRAMWKGDAGFMLAQEANGGTGINAFNYVPGPYKDKYALSVSGNSSTFTMKKPDPQNL 112 (251)
T ss_pred hhhccCCCcEEEEecCCCcchhhhheeeCCCCeEEEeeecCcceeccccccCCccceeEEEEEeccceeEEeccCCcccC
Confidence 34456799999999842 22233478987542 221 0 01122222 2 34899999999999
Q ss_pred eEEEEEEEeCCceee
Q psy10160 196 GEYRCVASNSYTSDE 210 (558)
Q Consensus 196 G~Y~C~a~N~~G~~~ 210 (558)
|=|+|++....+..+
T Consensus 113 GCYtc~~ks~~~k~E 127 (251)
T PHA02982 113 GCFTCEAKDAEGKEE 127 (251)
T ss_pred CceEEEEecCCCchh
Confidence 999999998776654
No 409
>PHA02865 MHC-like TNF binding protein; Provisional
Probab=82.91 E-value=4.7 Score=39.54 Aligned_cols=21 Identities=19% Similarity=0.496 Sum_probs=16.9
Q ss_pred cEEEEeEeeccCCC--eEEEEEC
Q psy10160 146 DISIPCDVDGYPIP--QVFWYKD 166 (558)
Q Consensus 146 ~v~L~C~~~g~P~p--~i~W~~~ 166 (558)
.++|+|.|.|.=+. .+.|.|+
T Consensus 216 ~~tL~C~A~GFYP~~I~v~W~kd 238 (338)
T PHA02865 216 NTTLFCTFDSHYPSSVAAKWYNS 238 (338)
T ss_pred CceEEEEEEeEeCCccEEEEEec
Confidence 58999999996333 4789999
No 410
>PF06832 BiPBP_C: Penicillin-Binding Protein C-terminus Family; InterPro: IPR009647 This conserved region of approximately 90 residues is found in a sub-group of bacterial Penicillin-Binding Proteins (PBPs). A variable length loop region separates this region from the transpeptidase unit (IPR001460 from INTERPRO). It is predicted to be a beta fold.
Probab=82.66 E-value=20 Score=27.67 Aligned_cols=73 Identities=15% Similarity=0.347 Sum_probs=45.5
Q ss_pred CcEEEecCCceEeeC--C--CcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEe
Q psy10160 129 PVKVNITLETQVFGV--G--SDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASN 204 (558)
Q Consensus 129 p~~~~~~~~~~~v~~--G--~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N 204 (558)
++.+..+....++.. + +...|.+.+.+. .+.+.|+.||..+.... ....+.+. ....|.|+-.+..
T Consensus 10 ~l~I~~P~~g~~~~~~~~~~~~~~l~l~a~~~-~~~~~W~vdg~~~g~~~------~~~~~~~~---~~~~G~h~l~vvD 79 (89)
T PF06832_consen 10 PLRITSPPDGAVLALDPGIPERQPLVLKAAGG-RGPVYWFVDGEPLGTTQ------PGHQLFWQ---PDRPGEHTLTVVD 79 (89)
T ss_pred CCEEEecCCCCEEEeCCCCCccceEEEEEeCC-CCcEEEEECCEEcccCC------CCCeEEeC---CCCCeeEEEEEEc
Confidence 445554444444322 2 356677777776 55899999999884322 22234443 2457999999988
Q ss_pred CCceeeE
Q psy10160 205 SYTSDEN 211 (558)
Q Consensus 205 ~~G~~~~ 211 (558)
..|....
T Consensus 80 ~~G~~~~ 86 (89)
T PF06832_consen 80 AQGRSAS 86 (89)
T ss_pred CCCCEEE
Confidence 8887654
No 411
>KOG0613|consensus
Probab=81.50 E-value=2.9 Score=47.68 Aligned_cols=80 Identities=15% Similarity=0.103 Sum_probs=58.8
Q ss_pred ceEeeCCCcEEEEeEeeccCCCe-EEEEECCEEeccCCceE-EE---ccCCeEEEccCCCCCCeEEEEEEEeCCceeeEE
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIPQ-VFWYKDGQVIENDGVHY-RI---TESNRLHINQANATDSGEYRCVASNSYTSDENA 212 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p~-i~W~~~g~~l~~~~~~~-~~---~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 212 (558)
...++.+..+.+.|...+.+.|. +.|++++.....+.+.. .. .....+.|..+...+.+.|.|.|.|..|.....
T Consensus 343 ~v~a~d~~~v~m~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ts~~~~~~~~~~~e~~~~~~~a~n~~g~~~~~ 422 (1205)
T KOG0613|consen 343 SVTARDNTLVEMPTALSGTQKPDEAQGYHGEEVSSESLGALPCPVGTVTSHTYTIKDAGPGEGYFTRVPAVNKGGTEQTI 422 (1205)
T ss_pred eeccccCcceeecccccCCcCCchheeecccccccccccccccccccccCcchhhhhcCcccccccccceeccCCccccc
Confidence 44557788899999999999998 99999876554432111 11 112368899999999999999999999988655
Q ss_pred EEEEE
Q psy10160 213 VTIRV 217 (558)
Q Consensus 213 ~~l~V 217 (558)
....|
T Consensus 423 ~~~~v 427 (1205)
T KOG0613|consen 423 AESTV 427 (1205)
T ss_pred chhhc
Confidence 44444
No 412
>PHA03052 Hypothetical protein; Provisional
Probab=80.48 E-value=4.6 Score=29.05 Aligned_cols=35 Identities=37% Similarity=0.703 Sum_probs=27.1
Q ss_pred CceEeeCCCcEEEEeEee-ccC--CCeEEEEECCEEec
Q psy10160 137 ETQVFGVGSDISIPCDVD-GYP--IPQVFWYKDGQVIE 171 (558)
Q Consensus 137 ~~~~v~~G~~v~L~C~~~-g~P--~p~i~W~~~g~~l~ 171 (558)
....+..|+.+++.|++. |.| .+.+.|.-|+..+.
T Consensus 5 ~~i~~slGs~ltI~Ckv~lg~g~~~a~V~W~~N~~~~e 42 (69)
T PHA03052 5 EGIVTSLGSNLTITCKVSLRPPTTDADVFWISNGMYYE 42 (69)
T ss_pred ccEEEEccCCceEeEEEEecCCCcceEEEEEeCCcEEe
Confidence 556678899999999984 333 34689999998883
No 413
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=78.83 E-value=2.1 Score=39.95 Aligned_cols=30 Identities=20% Similarity=0.317 Sum_probs=24.7
Q ss_pred ceEe-cCCeEEEcCCCCCCCEEEEEEEEeCC
Q psy10160 8 NYEL-NKNMLTIKRVEPERLGAYTCQAYNGL 37 (558)
Q Consensus 8 r~~~-~~~~L~I~~v~~~D~G~Y~C~a~n~~ 37 (558)
++.+ ..|.|++.+...+++|.|+|+.+...
T Consensus 30 ~~nIT~TG~L~~~~F~esmSG~YTCtLsYk~ 60 (271)
T PF07354_consen 30 YVNITETGKLMFKNFQESMSGSYTCTLSYKP 60 (271)
T ss_pred eEEEccCceEEeeccccccCCceEEEEEEEe
Confidence 3444 56899999999999999999997643
No 414
>PHA03189 UL14 tegument protein; Provisional
Probab=76.73 E-value=16 Score=34.90 Aligned_cols=74 Identities=18% Similarity=0.368 Sum_probs=41.3
Q ss_pred cCCceEeeCCCcEEEEeEeeccCCC--eEE-----EEE----------CCEEeccCC------ceEEEccCC-----eEE
Q psy10160 135 TLETQVFGVGSDISIPCDVDGYPIP--QVF-----WYK----------DGQVIENDG------VHYRITESN-----RLH 186 (558)
Q Consensus 135 ~~~~~~v~~G~~v~L~C~~~g~P~p--~i~-----W~~----------~g~~l~~~~------~~~~~~~~~-----sL~ 186 (558)
.+.+..+..|+.+++.|.+-..-.| +|. |.- +|..+..+. .+++....+ +|+
T Consensus 58 spAP~l~pyGdrvtVpC~fp~H~WPevsIrarfCys~e~s~eLv~da~~G~~l~ndl~~~L~~~~W~Fedlg~aq~ltLt 137 (348)
T PHA03189 58 SPAPLLVPYGDRVTVPCTFPTHDWPEVSIRARFCYSPERSRELVVDADSGGELHNDLTYRLPEASWKFEDLGAAQRLTLT 137 (348)
T ss_pred CCCccccCCCceeeeeeeecCCCCceeeEEEEEeeccccceEEEEEcccCCEeccccceecccceeeeecccceeEEEEE
Confidence 3456667789999999997544333 332 321 122222111 112221111 455
Q ss_pred EccCCCCCCeEEEEEEEeCCcee
Q psy10160 187 INQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 187 I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
+ ++..+.+|.|.|+..|..-..
T Consensus 138 F-~v~t~taG~Y~CvLrN~tHgl 159 (348)
T PHA03189 138 F-RVSTSTAGMYECVLRNETHGL 159 (348)
T ss_pred E-EEEecccceEEEEecccccee
Confidence 5 566788999999999975433
No 415
>PHA03282 envelope glycoprotein E; Provisional
Probab=75.66 E-value=5.2 Score=40.40 Aligned_cols=46 Identities=13% Similarity=0.146 Sum_probs=33.2
Q ss_pred CCceEecCCeEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEEEeCC
Q psy10160 6 SENYELNKNMLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTLQALP 51 (558)
Q Consensus 6 ~~r~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V~~~p 51 (558)
+.|+...|++|.|.+++.+|+|.|+-.+....... +...+.+.+.|
T Consensus 116 ~~rvs~~n~tl~l~~a~~~DsG~Y~L~~~~~~~~~~~~~~v~l~V~p 162 (540)
T PHA03282 116 PPRVAVVNGTLVLREARETDSGMYVLSVSRAPNSTAARAVVFLVVGP 162 (540)
T ss_pred CcceeEecceEEEeeccccCCceEEEEecCCCCchhheEEEEEEecC
Confidence 56788889999999999999999999976533333 33334444443
No 416
>KOG1026|consensus
Probab=74.77 E-value=2.8 Score=45.63 Aligned_cols=75 Identities=19% Similarity=0.390 Sum_probs=51.6
Q ss_pred ceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
...+..|..+++.|.+.+.|.|.+.|+.++...........+..+-...+.+ ++|.+.|..|....++.+.+
T Consensus 201 ~~~v~~~~~~~~~c~~~~~~vp~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~--------~~c~~E~~~~~~~~~v~~~~ 272 (774)
T KOG1026|consen 201 NLTVEEGSSITLKCSQAGIPVPCHYWFPNCLASSNTNQTSSLCRSECEVLEN--------DLCIAENAVARSNPSILLVV 272 (774)
T ss_pred hhhhcccchheeeeecccCCCcceeeecccccccCCCcccccccccceeeec--------hhhHHHHhhhhcCceeeeEE
Confidence 4556789999999999999999999998876554422111111111122221 89999999999988777777
Q ss_pred ecc
Q psy10160 218 EGI 220 (558)
Q Consensus 218 ~~~ 220 (558)
..+
T Consensus 273 ~~p 275 (774)
T KOG1026|consen 273 DLP 275 (774)
T ss_pred ecc
Confidence 543
No 417
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=72.62 E-value=15 Score=27.92 Aligned_cols=24 Identities=21% Similarity=0.437 Sum_probs=19.9
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEe
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
....+.......+|+|.++|.|.+
T Consensus 41 ~~~~~~~~~~~~~d~G~w~C~a~~ 64 (80)
T PF05790_consen 41 TKKLVSTFTPTTEDSGTWVCTASD 64 (80)
T ss_dssp ESSEEEEESBTCGGSEEEEEEEEE
T ss_pred cceEEEEecCCCCCCEEEEEEEcC
Confidence 445678888999999999999953
No 418
>KOG1480|consensus
Probab=71.52 E-value=2 Score=45.98 Aligned_cols=38 Identities=26% Similarity=0.338 Sum_probs=30.9
Q ss_pred EecCCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEE
Q psy10160 10 ELNKNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTL 47 (558)
Q Consensus 10 ~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V 47 (558)
...++.|+|..++..|.|+|+|+|.|..+...+.+++|
T Consensus 179 ~~~d~~li~~~arlsd~~nytc~a~ni~~~r~~~~~~v 216 (909)
T KOG1480|consen 179 RASDHNLIISQARLSDSGNYTCEATNIVAKRKSDPATV 216 (909)
T ss_pred hhhcCCccccchhhhhcccceeeeehhhccccccceEE
Confidence 34678999999999999999999999888765444433
No 419
>cd07691 Ig_CD3_gamma_delta Immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. Ig_CD3_gamma_delta; immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=70.77 E-value=5.7 Score=28.91 Aligned_cols=24 Identities=17% Similarity=0.459 Sum_probs=20.6
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEe
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
++.+|.+-++..+=.|.|+|.+++
T Consensus 31 ~~~tlnLGs~~~DPRG~Y~C~~s~ 54 (69)
T cd07691 31 SNTLLDLGSRINDPRGTYSCKESE 54 (69)
T ss_pred cccEEeccCcccCCCcceEecCcc
Confidence 356788888888889999999987
No 420
>cd05890 Ig2_Nectin-1_like Second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig2_Nectin-1_like: domain similar to the second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectins also heterophilically trans-interact with other CAMs such as nectin-like molecules (necls); nectin-1 for example, has been shown to trans-interact with necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is associ
Probab=67.12 E-value=23 Score=27.68 Aligned_cols=68 Identities=18% Similarity=0.328 Sum_probs=40.5
Q ss_pred cEEEEeE-eeccCCCeEEEEEC--CEEeccCCceEEEccCC------eEEEccCCCCCCeEEEEEEEeCCceeeEEEEEE
Q psy10160 146 DISIPCD-VDGYPIPQVFWYKD--GQVIENDGVHYRITESN------RLHINQANATDSGEYRCVASNSYTSDENAVTIR 216 (558)
Q Consensus 146 ~v~L~C~-~~g~P~p~i~W~~~--g~~l~~~~~~~~~~~~~------sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~ 216 (558)
.+.-.|. +.|.|++.|+|.-+ |.. .. .-....+| .+.+-.....|.-.-+|++.-..-....++.|+
T Consensus 22 v~VA~CiSa~GrPpa~ItW~t~l~G~~-et---q~~~~~~GT~TV~S~y~lVPs~~~~gk~lTCvV~h~~~~~~~~~~L~ 97 (98)
T cd05890 22 MLVATCVSANGKPPSVVRWDTRLKGEA-EF---QEIRNQNGTVTVISRYRLVPSREAHKQKLTCIVNYRNDRFTDSVTLN 97 (98)
T ss_pred EEEEEEEcCCCcCCcEeEEEccCCCce-ee---eeeCCCCCCEEEEEEEEEeECHHHcCCEeEEEEEeccccccccEEec
Confidence 3567898 78999999999743 321 10 00011222 244445566777799999887654445555554
Q ss_pred E
Q psy10160 217 V 217 (558)
Q Consensus 217 V 217 (558)
|
T Consensus 98 v 98 (98)
T cd05890 98 V 98 (98)
T ss_pred C
Confidence 3
No 421
>PHA02914 Immunoglobulin-like domain protein; Provisional
Probab=66.74 E-value=42 Score=33.50 Aligned_cols=34 Identities=12% Similarity=0.367 Sum_probs=25.8
Q ss_pred eEEEccCCCCCCeEEEEEEEeC-CceeeEEEEEEE
Q psy10160 184 RLHINQANATDSGEYRCVASNS-YTSDENAVTIRV 217 (558)
Q Consensus 184 sL~I~~v~~~D~G~Y~C~a~N~-~G~~~~~~~l~V 217 (558)
++.+.+++.+|.|.|+|...-. .-.-.+.+.|.|
T Consensus 82 sf~~~Nvs~sdEGrYrCIFYLn~~EtyrH~I~vrV 116 (500)
T PHA02914 82 SFIEENIGEHEDGDFKCIFYLGDNESHKHEILVRK 116 (500)
T ss_pred EEEecCcccccCCcEEEEEEeCCceeEEEEEEEEE
Confidence 6888899999999999988743 333356666666
No 422
>KOG1026|consensus
Probab=65.99 E-value=12 Score=41.02 Aligned_cols=151 Identities=10% Similarity=0.049 Sum_probs=85.6
Q ss_pred ceeEEeccCCCCCCcEEEEeCCcccCCCCcee-ecccc-ceeeceeEEeeccceeeEEeeeceeeeCcEEEecCCceEee
Q psy10160 65 TILSSAFPSESASPVVTQTTTTTTEATSPHVY-AALTH-CVPWSNVCLFGARSGYLKETQNGGYLVPVKVNITLETQVFG 142 (558)
Q Consensus 65 ~~~~~~~~~~~p~p~v~W~~~~~~~~~~~~~~-~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~ 142 (558)
.....|...+.|.|.+.|..++.......... ..... ++..+.+|.+.+..+.........+..|...........
T Consensus 209 ~~~~~c~~~~~~vp~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~c~~E~~~~~~~~~v~~~~~~p~~~~~~~~~~~-- 286 (774)
T KOG1026|consen 209 SITLKCSQAGIPVPCHYWFPNCLASSNTNQTSSLCRSECEVLENDLCIAENAVARSNPSILLVVDLPKAEVLLCSPLS-- 286 (774)
T ss_pred hheeeeecccCCCcceeeecccccccCCCcccccccccceeeechhhHHHHhhhhcCceeeeEEecccccccCCCCcc--
Confidence 45578899999999999998875554432221 11122 233456777777665555444444444433222211110
Q ss_pred CCCcEEEEeE---eeccCCCeEEEEECCEEeccCCceE-EEccC-CeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 143 VGSDISIPCD---VDGYPIPQVFWYKDGQVIENDGVHY-RITES-NRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 143 ~G~~v~L~C~---~~g~P~p~i~W~~~g~~l~~~~~~~-~~~~~-~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
+ .-.|. +.++|.|...|..++..+...+... ..... +-+....-+-.+.|.|+|.+.|..|.........+
T Consensus 287 --~--~~~C~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~t~s~~~~C~~~~~~~h~~~~~~~~~~e~~~g~~~~r~~g~~ 362 (774)
T KOG1026|consen 287 --D--HHNCIPIGITANPGPALHWCYNGSGLNYRGTVCVTKSGKEQCLPWNDPPHSHNGNYTLFPELPGGKNYCRNPGGF 362 (774)
T ss_pred --c--cCceeeeeccCCCCCceeeeecCccceEecccccccccCcCCcccCcCcccccCcceeeecccCccccccCcCcc
Confidence 0 22344 3367778899998876654322110 01111 22333333567789999999999999877766666
Q ss_pred eccC
Q psy10160 218 EGIF 221 (558)
Q Consensus 218 ~~~~ 221 (558)
...|
T Consensus 363 ~~~P 366 (774)
T KOG1026|consen 363 MSRP 366 (774)
T ss_pred ccCC
Confidence 5444
No 423
>PHA03240 envelope glycoprotein M; Provisional
Probab=64.30 E-value=11 Score=33.81 Aligned_cols=38 Identities=21% Similarity=0.266 Sum_probs=25.5
Q ss_pred cCCeEEEccCCCCCCeEEEEEEEeCCceee----EEEEEEEe
Q psy10160 181 ESNRLHINQANATDSGEYRCVASNSYTSDE----NAVTIRVE 218 (558)
Q Consensus 181 ~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~----~~~~l~V~ 218 (558)
.|++|.|-+|..+|.|+|.-.-....|..+ .-++|.|+
T Consensus 103 ~NstL~i~~vn~sd~~nYcr~k~~~~g~~e~pt~sC~~l~~r 144 (258)
T PHA03240 103 HNSTLIIAHLNLSDAGEYCRKKCPPKGDCEFPTMSCFRLILR 144 (258)
T ss_pred ccceEEEEEEeecCcchhhhccCCCCCCcCCCcceeeeEeee
Confidence 467899999999999998544444445541 23456653
No 424
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=64.17 E-value=7.8 Score=29.40 Aligned_cols=25 Identities=4% Similarity=-0.059 Sum_probs=18.9
Q ss_pred eeEEeccCC-CCCCcEEEEeCCcccC
Q psy10160 66 ILSSAFPSE-SASPVVTQTTTTTTEA 90 (558)
Q Consensus 66 ~~~~~~~~~-~p~p~v~W~~~~~~~~ 90 (558)
..+.|.+.+ .|.+.|+|++++..+.
T Consensus 2 ~~L~C~~~~~~P~~~v~W~~~~~~l~ 27 (82)
T cd05761 2 VELTCTSSGSKPAATIRWFKGDKELK 27 (82)
T ss_pred EEEEEEecCcCcCCeEEEEECCEEcc
Confidence 345676655 5889999999987765
No 425
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=63.47 E-value=28 Score=27.05 Aligned_cols=25 Identities=16% Similarity=0.049 Sum_probs=19.4
Q ss_pred cCceeEEeccCCC-CCC-cEEEEeCCc
Q psy10160 63 YGTILSSAFPSES-ASP-VVTQTTTTT 87 (558)
Q Consensus 63 ~~~~~~~~~~~~~-p~p-~v~W~~~~~ 87 (558)
.+...+.|.+.+. |++ .++|.+++.
T Consensus 14 ~~~~~L~C~a~gF~P~~i~v~W~~~g~ 40 (93)
T cd07698 14 DGSLTLSCHATGFYPRDIEVTWLRDGE 40 (93)
T ss_pred CCcEEEEEEEEEEeCCCcEEEEEECCE
Confidence 4567889999996 444 789999885
No 426
>PHA03281 envelope glycoprotein E; Provisional
Probab=63.17 E-value=52 Score=34.24 Aligned_cols=29 Identities=17% Similarity=0.331 Sum_probs=24.8
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcce
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRA 40 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~ 40 (558)
..+.|.|.+++..++|.|+-..+...|..
T Consensus 296 ~~~vL~I~nAT~~naGVYtly~rg~~G~s 324 (642)
T PHA03281 296 EPGVLKFEHMEAHHAGVYIWNLQGSDGEN 324 (642)
T ss_pred cCCeeEEEecccccceeEEEEecCCCCcc
Confidence 46789999999999999999998766644
No 427
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=62.30 E-value=13 Score=28.29 Aligned_cols=35 Identities=11% Similarity=0.104 Sum_probs=23.9
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE--EEEEEEE
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV--SWTVTLQ 48 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~--s~~l~V~ 48 (558)
++|.|..-..+|...|+|.|.|..-... +..+.|.
T Consensus 44 S~L~~~p~~eDdG~~~~C~a~~~~l~~~~~~~~L~V~ 80 (82)
T cd05883 44 SQLMLKVTKEDDGVPVICLVDHPAVKDLQTQRYLEVQ 80 (82)
T ss_pred EEEEEECchhhCCCEEEEEEcCcccCCceeeEEEEEE
Confidence 4788877777778899999998553222 4444443
No 428
>PHA03270 envelope glycoprotein C; Provisional
Probab=61.61 E-value=99 Score=31.40 Aligned_cols=80 Identities=10% Similarity=0.118 Sum_probs=46.1
Q ss_pred eCcEEEecCCceEeeCCCcEEEEeEeeccCCC---eEEEEECCEEeccCC---ceEEEccCCeEEEccCCCCCCe-----
Q psy10160 128 VPVKVNITLETQVFGVGSDISIPCDVDGYPIP---QVFWYKDGQVIENDG---VHYRITESNRLHINQANATDSG----- 196 (558)
Q Consensus 128 ~p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p---~i~W~~~g~~l~~~~---~~~~~~~~~sL~I~~v~~~D~G----- 196 (558)
.+|.+.+.+. -+.+|+...-.|.+..+-+| .+.|++|+.++.... .......++-..++-++.++.+
T Consensus 220 r~Psvsv~~~--PvL~Ge~Y~AtC~va~YYPp~Sv~lrWf~ng~~V~~~~~i~~~~~~~~dGfs~vStvtsea~~~~~~P 297 (466)
T PHA03270 220 RRPSLSIRPH--AVLEGEPFGATCVAANYYPGDRAAFRWFEGGDEVFAPERVRTRVDAQRDGFSATSTLTSEARAGLAPP 297 (466)
T ss_pred cCCcccccCC--ccccCCCceEEEEeeeecCCCceEEEEEeCCccccCcceeeeeeEecCCCeeEEEEEeccccccCCCC
Confidence 3554444433 34689999999998886555 389999999885311 1222222332223333333322
Q ss_pred -EEEEEEEeCCcee
Q psy10160 197 -EYRCVASNSYTSD 209 (558)
Q Consensus 197 -~Y~C~a~N~~G~~ 209 (558)
+.+|.+.=..+..
T Consensus 298 PsLrC~v~W~rd~v 311 (466)
T PHA03270 298 RNLTCEFTWHRDSV 311 (466)
T ss_pred CCceEEEEEccCCc
Confidence 7889877544443
No 429
>cd07692 Ig_CD3_epsilon Immunoglobulin (Ig)-like domain of CD3 epsilon chain. Ig_CD3_epsilon; immunoglobulin (Ig)-like domain of CD3 epsilon chain. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=60.49 E-value=9 Score=27.62 Aligned_cols=22 Identities=23% Similarity=0.212 Sum_probs=17.4
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNG 36 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~ 36 (558)
..+.+.+-. +++|.|+|.+.+.
T Consensus 35 ~~~~~~~~~-e~~G~Y~C~~~~~ 56 (65)
T cd07692 35 EKYLSLNHF-SSSGYYHCTADNA 56 (65)
T ss_pred ceEEeeccC-CCCceEEEEeCCC
Confidence 466676777 9999999999753
No 430
>KOG0613|consensus
Probab=60.33 E-value=25 Score=40.54 Aligned_cols=144 Identities=10% Similarity=-0.109 Sum_probs=81.8
Q ss_pred ceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 138 TQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 138 ~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
..+...++...+.|...+.+.|.+.|+.+....... ..+..+..|.+-..++.+.|+|...+..+.....+.-.+
T Consensus 238 ~s~t~e~s~~~i~~~l~~~~G~~~~~~~~~l~e~~~-----~~~~~t~~i~~~~~~~~~s~t~~~~~~~~q~~~~v~~~~ 312 (1205)
T KOG0613|consen 238 MSVTLEASDRKIQLTLRAPRGPYSAHILGYLIEQRK-----HKGGNTKTIQNDGPEPELSWTVADKRQGCQDRFKVTEEA 312 (1205)
T ss_pred cccccchhheeeeEEeecCCCchHHHHhcchhhhcc-----cCCCccccccccCCccccceeeecccCCcccceeeeEEe
Confidence 334457888999999999999999998775432211 233346778888888999999999999888865554443
Q ss_pred ecc---CCCCCCCCCCccccceeEEec---eeeecccceeEEEEeccCCCCCCCc-ccccchhhhhhhhh-hhhhhccc
Q psy10160 218 EGI---FIHPSCRDLPLFANCKLIVEG---RYCQHHYYSQFCCESCTRAGQLPSY-GPHIKRAVEAEAAA-ADKKRRSR 288 (558)
Q Consensus 218 ~~~---~~~p~~~~~~~~~~~~~~~~~---~~~~~g~~~~~~c~~~~~~g~~~~~-~~w~~~~l~~~~~~-~~~~~~gr 288 (558)
... ..++.....-.... ..++.. ..+..+. ...+-..|...+.++|. ..|++......... ....+.++
T Consensus 313 ~i~~~~~~p~~~~~aaa~~~-~~~v~~~~~~~v~a~d-~~~v~m~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (1205)
T KOG0613|consen 313 PIGKGKPGPESLQAAAARPP-EVPVGLVRNLSVTARD-NTLVEMPTALSGTQKPDEAQGYHGEEVSSESLGALPCPVGT 389 (1205)
T ss_pred eccccccCchhhhhhccCCc-cccccccccceecccc-CcceeecccccCCcCCchheeeccccccccccccccccccc
Confidence 211 11111111111111 111111 1111222 23333455555777777 89999876655544 43333333
No 431
>PF03921 ICAM_N: Intercellular adhesion molecule (ICAM), N-terminal domain; InterPro: IPR013768 Intercellular adhesion molecules (ICAMs) and vascular cell adhesion molecule-1 (VCAM-1) are part of the immunoglobulin superfamily. They are important in inflammation, immune responses and in intracellular signalling events []. The ICAM family consists of five members, designated ICAM-1 to ICAM-5. They are known to bind to leucocyte integrins CD11/CD18 during inflammation and in immune responses. In addition, ICAMs may exist in soluble forms in human plasma, due to activation and proteolysis mechanisms at cell surfaces. ICAM-1 (CD54) contains five Ig-like domains. It is expressed on leucocytes, endothelial and epithelial cells, and is upregulated in response to bacterial invasion. The protein is a ligand for lymphocyte-function associated (LFA) antigens and also a receptor for CD11a,b/CD18, fibrinogen, human rhinovirus and Plasmodium falciparum-infected erythrocytes. ICAM-1 binding sites for CD11a/CD18 and its other binding partners are located in the first domain and are overlapping. ICAM-1 domain 2 seems to play an important role in maintaining the conformation of domain 1 and particularly the structural integrity of the LFA-1 ligand-binding site []. The 3-dimensional atomic structure of the tandem N-terminal Ig-like domains (D1 and D2) of ICAM-1 has been determined to 2.2A resolution and fitted into a cryoelectron microscopy reconstruction of a rhinovirus-ICAM-1 complex []. Extensive charge interactions between ICAM-1 and human rhinovirusesare largely conserved in major and minor receptor groups of rhinoviruses. The interaction of ICAMs with LFA-1 is mediated by a divalent cation bound to the insertion (I)-domain on the alpha chain of LFA-1 and the carboxyl group of a conserved glutamic acid residue on ICAMs. ICAM-2 (CD102) has two Ig-like domains. It is expressed on endothelial cells, leucocytes and platelets, and binds to CD11a'b/CD18. The protein is refractory to proinflammatory cytokines, and plays an important role in the adhesion of leucocytes to the uninduced endothelium []. ICAM-3 (CD50) contains five Ig-like domains and binds to leucocyte integrins CD11a'd/CD18. The protein plays an important role in the immune response and perhaps in signal transduction []. ICAM-4 (LW blood group Ag) is red blood cell (RBC) specific and binds to CD11a'b/CD18. It is associated with the RBC Rh antigens and could be important in retaining immature red cells in the bone marrow, or in the uptake of senescent cells into the spleen []. ICAM-5 (telencephalin) has nine Ig-like domains and is confined to the telencephalon of the brain. The role of this CD11a/CD18 binding molecule is not yet known []. VCAM-1 was first described as a cytokine-inducible endothelial adhesion molecule. It can bind to leucocyte integrin VL-4 (very late antigen-4) to recruit leucocytes to sites of inflammation []. The predominant form of VCAM-1 in vivo has an N-terminal extracellular region comprising seven Ig-like domains []. A conserved integrin-binding motif has been identified in domains 1 and 4, variants of which are present in the N-terminal domain of all members of the integrin-binding subgroup of the immunoglobulin superfamily. The structure of a VLA-4-binding fragment comprising the first two domains of VCAM-1 has been determined to 1.8A resolution. The integrin-binding motif is exposed and forms the N-terminal region of the loop between beta-strands C and D of domain 1 []. VCAM-1 domains 1 and 2 are structurally similar to ICAM-1 and ICAM-2 []. This entry represents the N-terminal domain of ICAM proteins such as ICAM-2, ICAM-3 and ICAM-4.; PDB: 3BN3_B 1T0P_B 1ZXQ_A 3TCX_A 1MQ8_A 1Z7Z_I 1IC1_A 1IAM_A.
Probab=59.05 E-value=84 Score=24.49 Aligned_cols=82 Identities=16% Similarity=0.218 Sum_probs=48.4
Q ss_pred EEecCCceEeeCCCcEEEEeEeeccCCCe-EEEEECC-EEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee
Q psy10160 132 VNITLETQVFGVGSDISIPCDVDGYPIPQ-VFWYKDG-QVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD 209 (558)
Q Consensus 132 ~~~~~~~~~v~~G~~v~L~C~~~g~P~p~-i~W~~~g-~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~ 209 (558)
+.+.|....|..|+++.+.|..+= |.|. +.|.-.- +.....+ ..-..+.+.+|+. | ..-.|.+.=.....
T Consensus 6 v~v~P~~~vV~~G~Sv~VNCStsC-~~p~~~GLET~L~k~~~~~g-----~~W~~f~LsnV~~-d-s~~~C~~~C~g~Q~ 77 (91)
T PF03921_consen 6 VRVSPEEPVVPPGGSVWVNCSTSC-PQPEKIGLETSLSKTELDSG-----PQWKAFQLSNVTE-D-SSPLCFFNCSGEQS 77 (91)
T ss_dssp EEEESSEEEEETTEEEEEEEEESS-SS-SEEEEESSSEEEEEEEE-----TTEEEEEEEEE-S-C-EEEEEEEEETTEEE
T ss_pred EEEECCccEECCCCCEEEEEcCCC-CCCCcceEEEecCCcccCCC-----CcEEEEEEEcccc-C-CeEEEEEEcCCeEE
Confidence 456778888999999999999743 4443 4553221 1110001 1112577888886 5 46689887544444
Q ss_pred eEEEEEEEeccC
Q psy10160 210 ENAVTIRVEGIF 221 (558)
Q Consensus 210 ~~~~~l~V~~~~ 221 (558)
..++.|.|..+|
T Consensus 78 ~~~~~ItVY~~P 89 (91)
T PF03921_consen 78 SASANITVYKPP 89 (91)
T ss_dssp EEEEEEEEEB--
T ss_pred EeEEeeEEeCCC
Confidence 678888886544
No 432
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=56.55 E-value=5.7e+02 Score=33.27 Aligned_cols=78 Identities=10% Similarity=0.069 Sum_probs=43.6
Q ss_pred EecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEE--EEEeCCceee
Q psy10160 133 NITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRC--VASNSYTSDE 210 (558)
Q Consensus 133 ~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C--~a~N~~G~~~ 210 (558)
.+......+..+..+.+.=.........+.|.+.+........ +....+ -...|.|+- .+.|..|...
T Consensus 1515 tinas~~~vpl~~sV~Fta~~s~Gs~v~ysWdFGDg~ts~~~n-----pt~~yT-----Y~spGtYtVtLTvtN~~Gs~~ 1584 (2740)
T TIGR00864 1515 TINASLTNVPLNGSVHFEAHLDAGDDVRFSWILCDHCTPIFGG-----NTIFYT-----FRSVGTFNIIVTAENDVGAAQ 1584 (2740)
T ss_pred EEcCCCccccccceEEEEEEccCCCceeEEEEeCCCCccccCC-----CceEEe-----ecCCceEEEEEEEecCCCccc
Confidence 3344444455666777774333323446899886543221110 000111 134577766 5679999998
Q ss_pred EEEEEEEecc
Q psy10160 211 NAVTIRVEGI 220 (558)
Q Consensus 211 ~~~~l~V~~~ 220 (558)
+++.+.|..+
T Consensus 1585 ~T~~i~V~~~ 1594 (2740)
T TIGR00864 1585 ASIFLFVLQE 1594 (2740)
T ss_pred eeEEEEEeec
Confidence 8888888654
No 433
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=56.45 E-value=14 Score=28.15 Aligned_cols=25 Identities=4% Similarity=-0.122 Sum_probs=19.1
Q ss_pred eEEeccCC-CCCCcEEEEeCCcccCC
Q psy10160 67 LSSAFPSE-SASPVVTQTTTTTTEAT 91 (558)
Q Consensus 67 ~~~~~~~~-~p~p~v~W~~~~~~~~~ 91 (558)
.+.|.+.+ .|.+.|+|++++..+..
T Consensus 3 ~LtC~a~g~~P~~~ItW~k~g~~l~~ 28 (83)
T cd07705 3 KLRCTSSGSKPAANIKWRKGDQELEG 28 (83)
T ss_pred EEEEEecCccCCCEeEEEECCEECCC
Confidence 45676666 48899999999977654
No 434
>KOG2700|consensus
Probab=53.40 E-value=9.5 Score=38.45 Aligned_cols=33 Identities=12% Similarity=-0.069 Sum_probs=26.7
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHHHHHHHcccH
Q psy10160 408 ENEPGSSIMPGKVNPTQCEALTMVAAQVMGNHV 440 (558)
Q Consensus 408 ~~~~gSS~MP~K~NP~~~e~~~~~~~~~~~~~~ 440 (558)
++..|+|+||||.||+.+++..+.-........
T Consensus 325 Ertl~dSa~~rivlP~~Fl~ad~~L~~~~ni~~ 357 (481)
T KOG2700|consen 325 ERTLDDSANRRIVLPDAFLTADGNLGTLLNILE 357 (481)
T ss_pred hcccccccccceechHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999887665554443
No 435
>cd05721 IgV_CTLA-4 Immunoglobulin (Ig) domain of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). IgV_CTLA-4: domain similar to the variable(v)-type immunoglobulin (Ig) domain found in cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is involved in the regulation of T cell response, acting as an inhibitor of intracellular signalling. CTLA-4 is similar to CD28, a T cell co-receptor protein that recognizes the B7 proteins (CD80 and CD86). CD28 binding of the B7 proteins occurs after the presentation of antigen to the T cell receptor (TCR) via the peptide-MHC complex on the surface of an antigen presenting cell (APC). CTLA-4 also binds the B7 molecules with a higher affinity than does CD28. The B7/CTLA-4 interaction generates inhibitory signals down-regulating the response, and may prevent T cell activation by weak TCR signals. CD28 and CTLA-4 then elicit opposing signals in the regulation of T cell responsiveness and homeostasis. T cell activation leads to increased
Probab=53.03 E-value=12 Score=30.50 Aligned_cols=20 Identities=15% Similarity=0.416 Sum_probs=18.7
Q ss_pred eEEEcCCCCCCCEEEEEEEE
Q psy10160 15 MLTIKRVEPERLGAYTCQAY 34 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~ 34 (558)
+|.|.+++.+|++.|.|..+
T Consensus 75 ~L~l~~L~a~DTa~Y~Ca~e 94 (115)
T cd05721 75 NFTLQNLRANQTDIYFCKIE 94 (115)
T ss_pred EEEEcCCCHHHCeEEEEEee
Confidence 89999999999999999874
No 436
>PF08204 V-set_CD47: CD47 immunoglobulin-like domain; InterPro: IPR013270 This family represents the CD47 leukocyte antigen V-set like Ig domain [, ].; PDB: 2VSC_B 2JJS_D 2JJT_C.
Probab=52.78 E-value=9.5 Score=31.89 Aligned_cols=35 Identities=20% Similarity=0.325 Sum_probs=20.2
Q ss_pred CCeEEEcCCCCCCCEEEEEEEEeCCcceEEEEEEEEe
Q psy10160 13 KNMLTIKRVEPERLGAYTCQAYNGLGRAVSWTVTLQA 49 (558)
Q Consensus 13 ~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~s~~l~V~~ 49 (558)
+.+|.+.....- .|.|+|.+....... +..+.++.
T Consensus 85 ~aSL~~~~~~a~-~GnYTCeVt~~~~eg-e~~i~Lk~ 119 (130)
T PF08204_consen 85 NASLKMDKSDAV-EGNYTCEVTELSREG-ETTIELKY 119 (130)
T ss_dssp B--EEEEHHHHH--EEEEEEEEETTEEE-EEEEEEEE
T ss_pred CEEEEEcchhcc-ccceEEEEEecCCCc-eEEEEEEE
Confidence 346787764444 899999998766433 33344443
No 437
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=52.24 E-value=8.6 Score=29.88 Aligned_cols=24 Identities=21% Similarity=0.195 Sum_probs=18.4
Q ss_pred eEEEcCCCCCCCEEEEEEEEeCCc
Q psy10160 15 MLTIKRVEPERLGAYTCQAYNGLG 38 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n~~g 38 (558)
.|.|....-.|.|.|+|.+.+...
T Consensus 63 ~l~v~~~~~~~~~~y~C~v~h~~~ 86 (95)
T cd00098 63 QLTVSPSDWNSGDTYTCVVTHESL 86 (95)
T ss_pred EEEECHHHhCCCCCEEEEEEeCCC
Confidence 466666556699999999998664
No 438
>PHA03271 envelope glycoprotein C; Provisional
Probab=48.63 E-value=1.8e+02 Score=29.41 Aligned_cols=80 Identities=13% Similarity=0.248 Sum_probs=45.8
Q ss_pred eCcEEEecCCceEeeCCCcEEEEeEeeccCCC---eEEEEECCEEeccCCc-eEE---E-ccCC-----eEEEccCCCCC
Q psy10160 128 VPVKVNITLETQVFGVGSDISIPCDVDGYPIP---QVFWYKDGQVIENDGV-HYR---I-TESN-----RLHINQANATD 194 (558)
Q Consensus 128 ~p~~~~~~~~~~~v~~G~~v~L~C~~~g~P~p---~i~W~~~g~~l~~~~~-~~~---~-~~~~-----sL~I~~v~~~D 194 (558)
.||.+.+.+.. +..|+...-.|.+..+-+| .+.|++||.++..... ... . ..++ +|.+.+...+.
T Consensus 246 RPPsVsV~a~P--VL~Ge~YkAtC~vAnYYPP~SvrlrWf~nG~~V~~~~~rdt~~~w~d~~~g~S~VSTltl~a~~~~~ 323 (490)
T PHA03271 246 RPASVDVLAPP--VLSGENYKASCIVRHFYPPGSVYVSWRQNGNIATPRKDRDGSFWWFESGRGATLVSTITLGNSGIDP 323 (490)
T ss_pred cCCCccccCCc--cccCCCceEEEEeeeecCCCceEEEEEeCCccccCccccceeEEEecCCCceeEEEEEEcccccCCC
Confidence 45544444333 4689999999999887555 3899999988754221 111 1 1111 34343332222
Q ss_pred CeEEEEEEEeCCcee
Q psy10160 195 SGEYRCVASNSYTSD 209 (558)
Q Consensus 195 ~G~Y~C~a~N~~G~~ 209 (558)
--..+|.+.=..+..
T Consensus 324 PPsLRCeV~W~rd~v 338 (490)
T PHA03271 324 PPKISCLVAWKQGDM 338 (490)
T ss_pred CCCceEEEEEccCCc
Confidence 238899887555433
No 439
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=47.62 E-value=23 Score=27.03 Aligned_cols=25 Identities=4% Similarity=-0.118 Sum_probs=18.5
Q ss_pred eEEeccCC-CCCCcEEEEeCCcccCC
Q psy10160 67 LSSAFPSE-SASPVVTQTTTTTTEAT 91 (558)
Q Consensus 67 ~~~~~~~~-~p~p~v~W~~~~~~~~~ 91 (558)
.+.|.+.+ .|...|+|++++..+..
T Consensus 3 ~LtC~a~gf~P~~~itW~kng~~l~~ 28 (83)
T cd05884 3 QLTCKTSGSKPAADIRWFKNDKEIKD 28 (83)
T ss_pred EEEEEeCCccCCCEEEEEECCEECcC
Confidence 35666666 67888999999987643
No 440
>PHA03283 envelope glycoprotein E; Provisional
Probab=45.25 E-value=1e+02 Score=32.18 Aligned_cols=38 Identities=18% Similarity=0.190 Sum_probs=32.8
Q ss_pred CeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEecc
Q psy10160 183 NRLHINQANATDSGEYRCVASNSYTSDENAVTIRVEGI 220 (558)
Q Consensus 183 ~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~ 220 (558)
+.|.|.+++.+++|.|+=...|..+.....+.|.|+++
T Consensus 134 ~~l~I~~at~~~aGVYtly~r~d~~~~~~vflvtVk~~ 171 (542)
T PHA03283 134 SVLQIQRATPNIAGVYTLHVSSDGMMKHSVFFVTVKKP 171 (542)
T ss_pred CeeEEEecccccCeEEEEEecCCCceEEEEEEEEecCC
Confidence 46999999999999999999998886667788888873
No 441
>cd05755 Ig2_ICAM-1_like Second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ ICAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. ICAM-1 may be involved in organ targeted tumor metastasis. The interaction of ICAM-1 with leukocyte function-associated antigen-1 (LFA-1) plays a part in leukocyte-endothelial cell recognition. This group also contains ICAM-2, which also interacts with LFA-1. Transmigration of immature dendritic cells across resting endothelium is dependent on the interaction of ICAM-2 with, yet unidentified, ligand(s) on the dendritic cells. ICAM-1 has five Ig-like domains and ICAM-2 has two. ICAM-1 may also act as host receptor for viruses and parasites.
Probab=43.38 E-value=85 Score=24.97 Aligned_cols=31 Identities=10% Similarity=-0.080 Sum_probs=21.4
Q ss_pred cccC-ceeEEeccCC-CCCCc--EEEEeCCcccCC
Q psy10160 61 IDYG-TILSSAFPSE-SASPV--VTQTTTTTTEAT 91 (558)
Q Consensus 61 v~~~-~~~~~~~~~~-~p~p~--v~W~~~~~~~~~ 91 (558)
+.+| ...+.|.+.+ .|.+. |+|++++..+..
T Consensus 13 ~~eG~~~tL~C~v~g~~P~a~L~i~W~rG~~~l~~ 47 (100)
T cd05755 13 QPVGKNYTLQCDVPGVAPRQNLTVVLLRGNETLSR 47 (100)
T ss_pred ccCCCcEEEEEEEcCcCCCCcEEEEEeeCCEEccc
Confidence 3444 5667777666 57776 699999877653
No 442
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=43.28 E-value=63 Score=25.25 Aligned_cols=25 Identities=0% Similarity=-0.106 Sum_probs=18.3
Q ss_pred eeEEeccCCCCC--CcEEEEeCCcccC
Q psy10160 66 ILSSAFPSESAS--PVVTQTTTTTTEA 90 (558)
Q Consensus 66 ~~~~~~~~~~p~--p~v~W~~~~~~~~ 90 (558)
..+.|.+.+.-+ -.++|.+++..+.
T Consensus 18 ~~L~C~a~gFyP~~i~v~W~~dg~~~~ 44 (93)
T cd05770 18 NVLNCYVTGFHPPDIEIRLLKNGVKIP 44 (93)
T ss_pred eEEEEEEEEEeCCCCEEEEEECCEECC
Confidence 468888888533 3579999998765
No 443
>PF05924 SAMP: SAMP Motif; InterPro: IPR009224 This short region is found repeated in the mid region of the adenomatous polyposis proteins (APCs). This motif binds axin [].; GO: 0008013 beta-catenin binding, 0016055 Wnt receptor signaling pathway; PDB: 1EMU_B 2RQU_B.
Probab=39.84 E-value=8.2 Score=20.44 Aligned_cols=9 Identities=33% Similarity=0.505 Sum_probs=3.1
Q ss_pred CCCCCCCCC
Q psy10160 413 SSIMPGKVN 421 (558)
Q Consensus 413 SS~MP~K~N 421 (558)
+|+||.|+-
T Consensus 11 ~sAmPk~~~ 19 (20)
T PF05924_consen 11 GSAMPKRRR 19 (20)
T ss_dssp HCTS-----
T ss_pred HHhcccccC
Confidence 578887763
No 444
>COG5475 Uncharacterized small protein [Function unknown]
Probab=39.03 E-value=1.1e+02 Score=21.17 Aligned_cols=26 Identities=19% Similarity=0.463 Sum_probs=18.3
Q ss_pred eEEEccCCCCCCeEEEEEEEeCCceeeE
Q psy10160 184 RLHINQANATDSGEYRCVASNSYTSDEN 211 (558)
Q Consensus 184 sL~I~~v~~~D~G~Y~C~a~N~~G~~~~ 211 (558)
..++...+.+ |.|.|...|.+|....
T Consensus 19 ~Mtvs~~ss~--Gmy~C~Wf~g~g~~~~ 44 (60)
T COG5475 19 RMTVSGYSSD--GMYECRWFDGYGVKRE 44 (60)
T ss_pred eEEEeccccC--CeEEEEEecCCCcccc
Confidence 3555555433 9999999999985543
No 445
>PHA03286 envelope glycoprotein E; Provisional
Probab=38.76 E-value=78 Score=32.27 Aligned_cols=30 Identities=30% Similarity=0.338 Sum_probs=26.4
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV 41 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 41 (558)
.++.|.|.+++.+++|.|+-..+|+.|...
T Consensus 125 ~~~~L~I~nAt~qnaGiYtly~rnd~~~~~ 154 (492)
T PHA03286 125 RGKELTILNASSQNAGIYIRYSRNGTRTAV 154 (492)
T ss_pred CCCceEEeeccccccceEEEEEcCCCCcEE
Confidence 446899999999999999999999887764
No 446
>PHA03269 envelope glycoprotein C; Provisional
Probab=38.46 E-value=3.3e+02 Score=28.31 Aligned_cols=33 Identities=24% Similarity=0.341 Sum_probs=26.8
Q ss_pred EeeCCCcEEEEeEeeccCCC---eEEEEECCEEecc
Q psy10160 140 VFGVGSDISIPCDVDGYPIP---QVFWYKDGQVIEN 172 (558)
Q Consensus 140 ~v~~G~~v~L~C~~~g~P~p---~i~W~~~g~~l~~ 172 (558)
-+.+|+...-.|.+..+-+| .+.|++|+.++..
T Consensus 338 PVL~Ge~YkAtC~vA~YYPp~SvrlrWf~ng~~V~~ 373 (566)
T PHA03269 338 PVLLGNPYAAYCKVNKYYPPHSVIVKWTSNFGNIGK 373 (566)
T ss_pred ccccCCCceEEEEeeeecCCCceEEEEEeCCcccCc
Confidence 35789999999999886544 3899999988874
No 447
>PHA03112 IL-18 binding protein; Provisional
Probab=38.03 E-value=1.2e+02 Score=25.64 Aligned_cols=26 Identities=19% Similarity=0.474 Sum_probs=20.2
Q ss_pred eCCCcEEEEeEeecc-CCCe-EEEEECC
Q psy10160 142 GVGSDISIPCDVDGY-PIPQ-VFWYKDG 167 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~-P~p~-i~W~~~g 167 (558)
.+|+.+.|+|.+-++ |.-+ +.|.+++
T Consensus 36 k~~~~vvL~C~gcs~fp~fS~lYWl~gn 63 (141)
T PHA03112 36 KETEKVVLECRGCSYFPKFSYVYWLIGN 63 (141)
T ss_pred CCCCEEEEEEECccCCCCceEEEEEcCC
Confidence 468999999999876 5434 7899765
No 448
>cd05772 IgC_SIRP Signal-regulatory protein (SIRP) immunoglobulin-like domain. IgC_SIRP: Immunoglobulin-like domain of signal-regulatory proteins (SIRP); the signal-regulatory proteins (SIRP) are Ig-like cell surface receptors detected in hematopoietic and non-hematopoietic cells. While their extracellular domains are similar, SIRP are classified as alpha or beta based on the length of the intracytoplasmic domain. Those having a 110- to 113-amino acid tail are classified as SIRP-alpha, and those having a 5-amino acid tail as SIRP-beta. SIRP-alpha and SIRP-beta molecules are thought to have complementary roles in signal regulation: SIRP-alpha inhibit signalling via their immunoreceptor tyrosine (IT)-based inhibition motifs while SIRP-beta are activating. SIRP-beta lack the cytoplasmic domainof SIRP-alpha, and associate with at least one other transmembrane protein (DAP-12 or KARAP). The IT-based activation motifs within DAP-12's cytoplasmic domain may link SIRP-beta to the activating
Probab=38.00 E-value=38 Score=27.54 Aligned_cols=28 Identities=4% Similarity=-0.179 Sum_probs=20.9
Q ss_pred cCceeEEeccCCC-CC-CcEEEEeCCcccC
Q psy10160 63 YGTILSSAFPSES-AS-PVVTQTTTTTTEA 90 (558)
Q Consensus 63 ~~~~~~~~~~~~~-p~-p~v~W~~~~~~~~ 90 (558)
++...+.|.+.+. |. ..++|++|+..+.
T Consensus 21 g~~~tL~C~a~gF~P~~i~v~W~kng~~~~ 50 (111)
T cd05772 21 GQSVNFTCSAHGFSPRDITVKWLKNGNELS 50 (111)
T ss_pred CCCEEEEEEEeeEeCCCCEEEEEECCEECc
Confidence 3456788888885 53 5789999998765
No 449
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=37.69 E-value=1.1e+03 Score=31.01 Aligned_cols=99 Identities=8% Similarity=0.030 Sum_probs=56.9
Q ss_pred eeccceeeEEeeeceeeeCc-EEEecCCceEeeCCCcEEEEeEeeccCCCeEEEEECCEE-ecc-CCceEEEccCCeEEE
Q psy10160 111 FGARSGYLKETQNGGYLVPV-KVNITLETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQV-IEN-DGVHYRITESNRLHI 187 (558)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~-l~~-~~~~~~~~~~~sL~I 187 (558)
+.|..+.........+..++ .+........+..|+.+.|.+.....+.-.+.|...+.. ... .+..+.
T Consensus 1848 AsN~vs~~~~s~~~~VQe~I~~L~L~as~~~~~~n~~v~fsa~l~~GS~Vtf~w~fGdgs~~~~t~~~t~~--------- 1918 (2740)
T TIGR00864 1848 ASNAVSGKSASREFFAEEPIFGLELKASKKIAAIGEKVEFQILLAAGSAVNFRLQIGGAAPEVLQPGPRFS--------- 1918 (2740)
T ss_pred EEcccCcceeeeeEEEEEecceEEEecccccccCCCEEEEEEEecCCCceEEEEEeCCCCceeecCCCeEE---------
Confidence 44444444444444444444 333444555667899999999988888888999876432 111 111111
Q ss_pred ccCCCCCCeEE--EEEEEeCCceeeEEEEEEEecc
Q psy10160 188 NQANATDSGEY--RCVASNSYTSDENAVTIRVEGI 220 (558)
Q Consensus 188 ~~v~~~D~G~Y--~C~a~N~~G~~~~~~~l~V~~~ 220 (558)
+.-. --|.| +-.|.|..+.....+.+.|.++
T Consensus 1919 HsY~--~~G~Y~VtV~A~N~Vs~~~a~~~V~Vle~ 1951 (2740)
T TIGR00864 1919 HSFP--RVDDHMVNLRAKNEVSCAQANLHIEVLEA 1951 (2740)
T ss_pred eecC--CCCcEEEEEEEEeccceeeeeEEEEEEEe
Confidence 1111 12334 4467788888877777777554
No 450
>PF02440 Adeno_E3_CR1: Adenovirus E3 region protein CR1; InterPro: IPR003471 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []. This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D virus) 49 Kd protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.
Probab=35.67 E-value=92 Score=22.37 Aligned_cols=21 Identities=43% Similarity=0.808 Sum_probs=13.9
Q ss_pred eeCCCcEEEEeEeeccCCCeEEEEE
Q psy10160 141 FGVGSDISIPCDVDGYPIPQVFWYK 165 (558)
Q Consensus 141 v~~G~~v~L~C~~~g~P~p~i~W~~ 165 (558)
|..|+.++|. |.|...+.|++
T Consensus 2 v~~G~N~TL~----Gp~~~~V~Wy~ 22 (63)
T PF02440_consen 2 VTVGSNVTLV----GPPDGPVTWYK 22 (63)
T ss_pred EeEcCcEEEe----CCCCCceEEEE
Confidence 4567777775 43545699984
No 451
>KOG0200|consensus
Probab=34.62 E-value=1.7e+02 Score=32.07 Aligned_cols=26 Identities=38% Similarity=0.586 Sum_probs=23.3
Q ss_pred EecCCeEEEcCCCCCCCEEEEEEEEe
Q psy10160 10 ELNKNMLTIKRVEPERLGAYTCQAYN 35 (558)
Q Consensus 10 ~~~~~~L~I~~v~~~D~G~Y~C~a~n 35 (558)
......+.+..+...|.|.|+|.+.|
T Consensus 9 ~~~~~~~~~~~~~~~~~~~y~~~~~~ 34 (609)
T KOG0200|consen 9 RINHWFLIIDSVVPGDKGFYTCLVSN 34 (609)
T ss_pred eeccceEEEEEEEecCCccEEEEEec
Confidence 34677899999999999999999999
No 452
>KOG4597|consensus
Probab=33.22 E-value=36 Score=34.75 Aligned_cols=36 Identities=25% Similarity=0.211 Sum_probs=29.6
Q ss_pred cCCeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEE
Q psy10160 12 NKNMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTL 47 (558)
Q Consensus 12 ~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V 47 (558)
+-..|.|-+....|+|.|+|.+.|..|... .+++.+
T Consensus 255 stcql~ic~ewq~~a~w~tCs~rcg~g~~~rdv~c~s 291 (560)
T KOG4597|consen 255 STCQLVICNEWQADAGWYTCSARCGAGFLRRDVPCSS 291 (560)
T ss_pred eeeeEEEcchhhcCCCceeeccccccceeeccceeee
Confidence 346899999999999999999999998764 455544
No 453
>PF04255 DUF433: Protein of unknown function (DUF433); InterPro: IPR007367 This is a family of uncharacterised proteins.; PDB: 2GA1_B.
Probab=32.40 E-value=67 Score=22.29 Aligned_cols=28 Identities=18% Similarity=0.078 Sum_probs=20.2
Q ss_pred HHHHcCCCHHHHHHHcCCCCHHHHhhhc
Q psy10160 522 TAHKEGTTLKVAALKLGYLTEEEFNKWV 549 (558)
Q Consensus 522 ~a~~~~~~~~~~~~~~~~l~~~~~~~~~ 549 (558)
...+.|.++.|++.+...|+.+++++++
T Consensus 26 ~~~~~G~s~eeI~~~yp~Lt~~~i~aAl 53 (56)
T PF04255_consen 26 DLLAAGESPEEIAEDYPSLTLEDIRAAL 53 (56)
T ss_dssp HHHHTT--HHHHHHHSTT--HHHHHHHH
T ss_pred HHHHcCCCHHHHHHHCCCCCHHHHHHHH
Confidence 3458899999999998889999999876
No 454
>PHA03273 envelope glycoprotein C; Provisional
Probab=29.40 E-value=1.5e+02 Score=30.39 Aligned_cols=34 Identities=18% Similarity=0.182 Sum_probs=25.3
Q ss_pred eEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEE
Q psy10160 184 RLHINQANATDSGEYRCVASNSYTSDENAVTIRV 217 (558)
Q Consensus 184 sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 217 (558)
.|.|..++..++|.|+=...+..|......++.|
T Consensus 199 ~LtI~sltaaTeGvYtWr~~~~n~t~~~~~~VtV 232 (486)
T PHA03273 199 PLTIKSVDWRTAGVYVWSLYAKNGTLVNSTSVTV 232 (486)
T ss_pred ceEEEecchhhceEEEEEEecCCCceeeeeEEEE
Confidence 4999999999999999776676565544444555
No 455
>PF03174 CHB_HEX_C: Chitobiase/beta-hexosaminidase C-terminal domain; InterPro: IPR004867 O-Glycosyl hydrolases 3.2.1. from EC are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycosyl hydrolases, based on sequence similarity, has led to the definition of 85 different families [, ]. This classification is available on the CAZy (CArbohydrate-Active EnZymes) web site. This short domain is found in members of the glycoside hydrolase family 20 (GH20 from CAZY) and represents the C-terminal domain in chitobiases and beta-hexosaminidases 3.2.1.52 from EC. It is composed of a beta sandwich structure []. The function of this domain is unknown. ; GO: 0004563 beta-N-acetylhexosaminidase activity, 0005975 carbohydrate metabolic process; PDB: 1C7T_A 1QBA_A 1QBB_A 1C7S_A.
Probab=29.21 E-value=1.2e+02 Score=22.45 Aligned_cols=65 Identities=14% Similarity=0.257 Sum_probs=28.5
Q ss_pred CCceEeeCCCcEEEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEE
Q psy10160 136 LETQVFGVGSDISIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENA 212 (558)
Q Consensus 136 ~~~~~v~~G~~v~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 212 (558)
+....+..+..+.|.|. .|...|.+..||..-......| -..+...+.+.+.+.+....|..+..
T Consensus 7 p~~G~~~~~~~v~l~~~---~~~~~I~YT~DGs~Pt~~s~~Y---------~~Pi~i~~~~~vka~a~~~~g~~s~v 71 (75)
T PF03174_consen 7 PPSGTYDEGQTVTLSSD---TPGATIYYTLDGSEPTKSSPLY---------TGPITIPESGTVKARAFDNGGNVSEV 71 (75)
T ss_dssp ---EEEEETTEEEEE-S---STTSEEEEESSSSSS----EE-----------CCC--B--S--EEEEE-TTS-B---
T ss_pred CCCCcEecCeEEEEEeC---CCCCEEEEEcCCCcccccCccc---------CcCEEeCCCcEEEEEEEcCCCCcCcc
Confidence 34445566888999993 3445788887765422211122 22344455666888888777666543
No 456
>PF02124 Marek_A: Marek's disease glycoprotein A; InterPro: IPR001038 Equid herpesvirus 1 (Equine herpesvirus 1, EHV-1) glycoprotein 13 (EHV-1 gp13) has the characteristic features of a membrane-spanning protein: an N-terminal signal sequence; a hydrophobic membrane anchor region; a charged C-terminal cytoplasmic tail; and an exterior domain with nine potential N-glycosylation sites []. EHV-1 gp13 is the structural homologue of the gC-like glycoproteins of the Human herpesvirus 1 (HHV-1) and Human herpesvirus 2 (HHV-2) (gC-1 and gC-2 respectively), Pseudorabies virus (strain Indiana-Funkhauser/Becker) (PRV) (gIII) and Human herpesvirus 3 (HHV-3) (gp66). Secretory glycoprotein GP57-65 precursor (glycoprotein A - GA) is similar to Herpesvirus glycoprotein C, and belongs to the immunoglobulin gene superfamily [, ]. GA is thought to play an immunoevasive role in the pathogenesis of Marek's disease. It is a candidate for causing the early-stage immunosuppression that occurs after MDHV infection.
Probab=29.04 E-value=4.6e+02 Score=24.11 Aligned_cols=18 Identities=22% Similarity=0.473 Sum_probs=14.8
Q ss_pred eCCCcEEEEeEeeccCCC
Q psy10160 142 GVGSDISIPCDVDGYPIP 159 (558)
Q Consensus 142 ~~G~~v~L~C~~~g~P~p 159 (558)
...+.++-+|...|+|.+
T Consensus 146 ~~~~~~~YtC~l~GYP~~ 163 (211)
T PF02124_consen 146 DEDGPVEYTCRLIGYPDI 163 (211)
T ss_pred ccCCceeEEEEEeeCCCC
Confidence 356788999999999974
No 457
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=28.69 E-value=62 Score=25.39 Aligned_cols=20 Identities=10% Similarity=0.215 Sum_probs=15.1
Q ss_pred eeEEecc-CCCCCCcEEEEeC
Q psy10160 66 ILSSAFP-SESASPVVTQTTT 85 (558)
Q Consensus 66 ~~~~~~~-~~~p~p~v~W~~~ 85 (558)
.+..|.. .+.|.+.|+|+++
T Consensus 18 ~va~C~s~~gkP~a~ItW~~~ 38 (95)
T cd05719 18 TVATCVSANGKPPATISWETT 38 (95)
T ss_pred EEEEEECCCCcCCCEEEEEeC
Confidence 3445554 6789999999986
No 458
>PHA03282 envelope glycoprotein E; Provisional
Probab=26.64 E-value=86 Score=32.15 Aligned_cols=38 Identities=29% Similarity=0.298 Sum_probs=27.4
Q ss_pred cCCeEEEccCCCCCCeEEEEEEEeCCce--eeEEEEEEEe
Q psy10160 181 ESNRLHINQANATDSGEYRCVASNSYTS--DENAVTIRVE 218 (558)
Q Consensus 181 ~~~sL~I~~v~~~D~G~Y~C~a~N~~G~--~~~~~~l~V~ 218 (558)
.|++|.|.+++.+|+|.|+-.+...-.. ....+.|.|.
T Consensus 122 ~n~tl~l~~a~~~DsG~Y~L~~~~~~~~~~~~~~v~l~V~ 161 (540)
T PHA03282 122 VNGTLVLREARETDSGMYVLSVSRAPNSTAARAVVFLVVG 161 (540)
T ss_pred ecceEEEeeccccCCceEEEEecCCCCchhheEEEEEEec
Confidence 3778999999999999999986432222 2455666664
No 459
>COG1102 Cmk Cytidylate kinase [Nucleotide transport and metabolism]
Probab=26.20 E-value=64 Score=28.24 Aligned_cols=50 Identities=18% Similarity=0.151 Sum_probs=30.2
Q ss_pred hhhcCCCCChhHHHHHHHHHHhHhCCCcccCCChhHHhhcCcHHHHHHHHHHHHHHHHHHHh
Q psy10160 326 YFTYLVKLSELLETKCAAKIAELTGLPFKSAPNKFEALAAHDALVEVSGALNTVAVSLMKIA 387 (558)
Q Consensus 326 ~~~g~~g~~~~~~~~~~~~~a~~lg~~~~~~~~~~~~~~~~d~~~~~~~~l~~~~~~l~k~a 387 (558)
-.+|+.|++.+. +...+|+.|||+. +++-+.|-+.+.-..+--...+|+|
T Consensus 4 tIsG~pGsG~TT---va~~lAe~~gl~~---------vsaG~iFR~~A~e~gmsl~ef~~~A 53 (179)
T COG1102 4 TISGLPGSGKTT---VARELAEHLGLKL---------VSAGTIFREMARERGMSLEEFSRYA 53 (179)
T ss_pred EeccCCCCChhH---HHHHHHHHhCCce---------eeccHHHHHHHHHcCCCHHHHHHHH
Confidence 346777776655 5688999999983 3444555555554444444444444
No 460
>PF12643 MazG-like: MazG-like family
Probab=26.17 E-value=2.1e+02 Score=22.64 Aligned_cols=54 Identities=20% Similarity=0.240 Sum_probs=37.5
Q ss_pred HHHHHHHhhhcCcccCHHHHHHHHhhhHhhhhhcccccChH--HHHHHHHHHHHcC
Q psy10160 474 SATAFTDKCVSGIVANEENIHRLLHESLMLVTALNPHIGYD--KAAKIAKTAHKEG 527 (558)
Q Consensus 474 ~~~~~~~~~l~~l~v~~~~~~~~~~~~~~~~~~la~~l~~~--~a~~~~~~a~~~~ 527 (558)
.+..+.....++-.++.++|.+.+..-++..-.||+.||+. +.-++++.-.+.+
T Consensus 18 el~elfq~~~~~~~~~~e~i~deLAdvii~~ylLa~rLGid~~~lD~~i~~KL~~~ 73 (98)
T PF12643_consen 18 ELLELFQWLTSGSEVAQEAIKDELADVIIYCYLLADRLGIDFRELDEIIKEKLKKN 73 (98)
T ss_pred HHHHHHhhcccCcchHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHhc
Confidence 44455555667767888999999998888878899998866 3445554444433
No 461
>PHA03290 envelope glycoprotein I; Provisional
Probab=24.06 E-value=1.8e+02 Score=28.48 Aligned_cols=40 Identities=18% Similarity=0.237 Sum_probs=29.0
Q ss_pred CeEEEcCCCCCCCEEEEEEEEeCCcceE-EEEEEEEeCCCC
Q psy10160 14 NMLTIKRVEPERLGAYTCQAYNGLGRAV-SWTVTLQALPSE 53 (558)
Q Consensus 14 ~~L~I~~v~~~D~G~Y~C~a~n~~g~~~-s~~l~V~~~p~~ 53 (558)
--|.|.+.+.+|+|.|.-.+.-...... -+.+.+.++|..
T Consensus 129 vLL~I~~P~~~DSGiY~LRV~Ldga~~sDvF~lsv~Vyp~g 169 (357)
T PHA03290 129 IIFKINKPGIEDAGIYLLLVQLDHSRLFDGFFLGLNVYPAG 169 (357)
T ss_pred eEEEeCCCCcccCeeEEEEEEeCCCcccceEEEEEEEecCC
Confidence 3799999999999999999986443332 345666666543
No 462
>PF10940 DUF2618: Protein of unknown function (DUF2618); InterPro: IPR021237 This bacterial family of proteins has no known function. The sequences within the family are highly conserved.
Probab=24.00 E-value=14 Score=22.81 Aligned_cols=9 Identities=33% Similarity=0.390 Sum_probs=6.5
Q ss_pred CCCCCCCCC
Q psy10160 412 GSSIMPGKV 420 (558)
Q Consensus 412 gSS~MP~K~ 420 (558)
|+|+|||-|
T Consensus 2 ~~~lMaHIR 10 (40)
T PF10940_consen 2 GRSLMAHIR 10 (40)
T ss_pred cchHHHHHH
Confidence 678888754
No 463
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=21.46 E-value=1.1e+02 Score=24.12 Aligned_cols=33 Identities=15% Similarity=0.075 Sum_probs=21.4
Q ss_pred eEEEcCCCCCCCEEEEEEEEeCCcce-EEEEEEE
Q psy10160 15 MLTIKRVEPERLGAYTCQAYNGLGRA-VSWTVTL 47 (558)
Q Consensus 15 ~L~I~~v~~~D~G~Y~C~a~n~~g~~-~s~~l~V 47 (558)
.|.+..-..+|.-.|+|.+.+..-.. ....+++
T Consensus 60 ~l~~~P~~~d~Gk~ltC~v~h~al~~~~~~~~~l 93 (95)
T cd07703 60 EYSLVPTPEANGKEVTCKVEHETLQEPQLLPVTL 93 (95)
T ss_pred EEEEecCHHHCCCEEEEEEeCcccCCCeEEEEEE
Confidence 56676556667779999999855332 3444443
No 464
>cd07704 Ig2_Nectin-3-4_like Second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3), nectin-4 (poliovirus receptor related protein 4) and similar proteins. Ig2_Nectin-3-4_like: domain similar to the second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and nectin-4 (poliovirus receptor related protein 4). Nectin-3 and nectin-4 belong to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development. Nect
Probab=21.34 E-value=1e+02 Score=24.42 Aligned_cols=20 Identities=15% Similarity=0.034 Sum_probs=16.0
Q ss_pred EEeccCCCCCCcEEEEeCCc
Q psy10160 68 SSAFPSESASPVVTQTTTTT 87 (558)
Q Consensus 68 ~~~~~~~~p~p~v~W~~~~~ 87 (558)
.||...+.|++.|+|+.+..
T Consensus 23 ~C~sa~gkPaa~IsW~~~~~ 42 (97)
T cd07704 23 ACCAAEGRPAADVTWETNVY 42 (97)
T ss_pred EEEccCCccCCEeEEeCCCC
Confidence 56778888999999997643
No 465
>PF11049 KSHV_K1: Glycoprotein K1 of Kaposi's sarcoma-associated herpes virus; InterPro: IPR021022 This is a highly glycosylated cytoplasmic and membrane protein similar to the immunoglobulin receptor family that is expressed as an inducible early-lytic-cycle gene product in primary effusion lymphoma cell-lines. This domain would appear to be the cytoplasmic region of the protein [].
Probab=21.19 E-value=1.4e+02 Score=21.57 Aligned_cols=55 Identities=15% Similarity=0.421 Sum_probs=31.1
Q ss_pred EEEeEeeccCCCeEEEEECCEEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCceeeEEEEEEEe
Q psy10160 148 SIPCDVDGYPIPQVFWYKDGQVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSDENAVTIRVE 218 (558)
Q Consensus 148 ~L~C~~~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 218 (558)
+|.|..... -.++|+-||..+-. + ...++.+..+ .++++|+-.. ...+++.+.-.
T Consensus 2 tltC~s~~s--LPiswYcN~TRLlR------l-t~~Tlt~~~l----tcNFtCV~qS---Gh~hSiWItW~ 56 (71)
T PF11049_consen 2 TLTCPSNAS--LPISWYCNGTRLLR------L-TQQTLTVVTL----TCNFTCVGQS---GHRHSIWITWY 56 (71)
T ss_pred ceecCCCCC--CcccEEECCceeee------e-cCCeEeeeee----eEEeeecCCC---CCCceEEEEEc
Confidence 477876543 23899999876532 1 2235555443 4788886432 22455665553
No 466
>PRK13696 hypothetical protein; Provisional
Probab=21.17 E-value=2.2e+02 Score=20.36 Aligned_cols=34 Identities=18% Similarity=0.145 Sum_probs=19.5
Q ss_pred HHHHHHHHHHHcCCCHHHHHH---------------HcCCCCHHHHhhhc
Q psy10160 515 KAAKIAKTAHKEGTTLKVAAL---------------KLGYLTEEEFNKWV 549 (558)
Q Consensus 515 ~a~~~~~~a~~~~~~~~~~~~---------------~~~~l~~~~~~~~~ 549 (558)
+|++... +.+.|.||.|++. ..+.+++++.+++.
T Consensus 11 d~Y~~L~-~kk~~~SFSevi~~L~~~~~~~~~~l~~~~Gil~dee~~e~~ 59 (62)
T PRK13696 11 DVYEKLL-EIKGDKSFSEVIRELIEKKKGNLDKLMKAFGILSEEEAEELK 59 (62)
T ss_pred HHHHHHH-HHhCCCCHHHHHHHHHHHhhccHHHHHHHHCCCCHHHHHHHH
Confidence 4444333 4456666666443 23668888877654
No 467
>PF02480 Herpes_gE: Alphaherpesvirus glycoprotein E; InterPro: IPR003404 Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation [].; GO: 0016020 membrane; PDB: 2GJ7_F 2GIY_B.
Probab=20.97 E-value=52 Score=34.14 Aligned_cols=38 Identities=29% Similarity=0.342 Sum_probs=0.0
Q ss_pred CCeEEEccCCCCCCeEEEEEEEeCCceee-EEEEEEEec
Q psy10160 182 SNRLHINQANATDSGEYRCVASNSYTSDE-NAVTIRVEG 219 (558)
Q Consensus 182 ~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~-~~~~l~V~~ 219 (558)
.+.|.|.+++.+|+|.|+=...|.-|... ..+.|.|.+
T Consensus 88 ~~~l~i~~a~~~~~GvY~l~~~~~~~~~~~~~~~v~v~~ 126 (439)
T PF02480_consen 88 KGGLSILNATEQDSGVYTLYVRNDSGWAHQSVVFVTVKG 126 (439)
T ss_dssp ---------------------------------------
T ss_pred CCceEEeccccccCeeEEEEecCCCCceEEEEEEEEEcC
Confidence 46799999999999999999988776663 556777765
No 468
>PHA03281 envelope glycoprotein E; Provisional
Probab=20.73 E-value=7.2e+02 Score=26.36 Aligned_cols=39 Identities=15% Similarity=0.224 Sum_probs=30.9
Q ss_pred CCeEEEccCCCCCCeEEEEEEEeCCceee-EEEEEEEecc
Q psy10160 182 SNRLHINQANATDSGEYRCVASNSYTSDE-NAVTIRVEGI 220 (558)
Q Consensus 182 ~~sL~I~~v~~~D~G~Y~C~a~N~~G~~~-~~~~l~V~~~ 220 (558)
.+.|.|.+.+..++|.|+=......|... ..+.|.|++.
T Consensus 297 ~~vL~I~nAT~~naGVYtly~rg~~G~s~~svfLVtVkg~ 336 (642)
T PHA03281 297 PGVLKFEHMEAHHAGVYIWNLQGSDGENMYATFLVKLKGD 336 (642)
T ss_pred CCeeEEEecccccceeEEEEecCCCCcceeEEEEEEecCC
Confidence 45799999999999999998887766554 4677788753
No 469
>COG2442 Uncharacterized conserved protein [Function unknown]
Probab=20.49 E-value=1.5e+02 Score=22.40 Aligned_cols=31 Identities=13% Similarity=0.047 Sum_probs=24.2
Q ss_pred HHHHHHcCCCHHHHHHHcCCCCHHHHhhhcC
Q psy10160 520 AKTAHKEGTTLKVAALKLGYLTEEEFNKWVV 550 (558)
Q Consensus 520 ~~~a~~~~~~~~~~~~~~~~l~~~~~~~~~~ 550 (558)
+-..+..|.+..|++..-..|+.+++.++++
T Consensus 36 Il~~l~~G~s~eeil~dyp~Lt~~dI~aal~ 66 (79)
T COG2442 36 ILEMLAAGESIEEILADYPDLTLEDIRAALR 66 (79)
T ss_pred HHHHHHCCCCHHHHHHhCCCCCHHHHHHHHH
Confidence 3445668899888888888889998888774
No 470
>KOG3611|consensus
Probab=20.11 E-value=1.5e+02 Score=32.98 Aligned_cols=71 Identities=21% Similarity=0.372 Sum_probs=43.8
Q ss_pred cEEEEeEeeccCCCeEEEEEC--C----EEeccCCceEEEccCCeEEEccCCCCCCeEEEEEEEeCCcee-eEEEEEEEe
Q psy10160 146 DISIPCDVDGYPIPQVFWYKD--G----QVIENDGVHYRITESNRLHINQANATDSGEYRCVASNSYTSD-ENAVTIRVE 218 (558)
Q Consensus 146 ~v~L~C~~~g~P~p~i~W~~~--g----~~l~~~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~l~V~ 218 (558)
...|.|...+.-.+ +.|+.. + .++...+ .......|.+.+..++..|+|.|.|.+.+..-.. ...+.+.+.
T Consensus 571 ~~~l~c~~~~~~a~-~~w~~~~~~~~~~~~~~~~~-~~~~~~~G~lll~~~q~~~~G~y~c~~~e~~~~~~~~~~~~~~~ 648 (737)
T KOG3611|consen 571 SEVLRCVPSSNQAP-VVWYHQSTKDGRKEEVRQRD-VVSRTDEGGLVLLSVQKLDGGTYPCYADESSFVSTVISVNLHVA 648 (737)
T ss_pred cceeeccccccccc-eeeEeeccCccccceeccCc-ceeecccCceeEEEEeeccCcccccccccCccccceEEEeeeec
Confidence 57888987775444 788732 2 1222222 3333345668888999999999999988653322 344455553
Done!